<SEC-DOCUMENT>0000055529-24-000021.txt : 20240628
<SEC-HEADER>0000055529-24-000021.hdr.sgml : 20240628
<ACCEPTANCE-DATETIME>20240628114717
ACCESSION NUMBER:		0000055529-24-000021
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		102
CONFORMED PERIOD OF REPORT:	20240430
FILED AS OF DATE:		20240628
DATE AS OF CHANGE:		20240628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KEWAUNEE SCIENTIFIC CORP /DE/
		CENTRAL INDEX KEY:			0000055529
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY APPARATUS & FURNITURE [3821]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				380715562
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-05286
		FILM NUMBER:		241083096

	BUSINESS ADDRESS:	
		STREET 1:		2700 W FRONT ST
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28677
		BUSINESS PHONE:		7048737202

	MAIL ADDRESS:	
		STREET 1:		P O BOX 1842
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28687-1842

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/
		DATE OF NAME CHANGE:	19861216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE MANUFACTURING CO
		DATE OF NAME CHANGE:	19680108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>kequ-20240430.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7,d:7c2284e7bf3e47828f4617b389f29ad2-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:kequ="http://www.kewaunee.com/20240430" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>kequ-20240430</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-32">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-35">0000055529</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-796">http://fasb.org/us-gaap/2023#PensionExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-801">http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-804">http://fasb.org/us-gaap/2023#PensionExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-805">http://fasb.org/us-gaap/2023#PensionExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-806">http://fasb.org/us-gaap/2023#PensionExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="kequ-20240430.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="compensation_plan"><xbrli:measure>kequ:compensation_plan</xbrli:measure></xbrli:unit><xbrli:unit id="renewaloption"><xbrli:measure>kequ:renewalOption</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>kequ:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayAsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KoncepoScientechInternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KequipGlobalLabSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">kequ:FiscalYearTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">kequ:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-08-26</xbrli:startDate><xbrli:endDate>2015-08-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">April&#160;30</ix:nonNumeric>, 2024</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.641%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">0-5286</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">KEWAUNEE SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:48.540%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">38-0715562</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">2700 West Front Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Statesville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">North Carolina</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">28677-2927</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">704</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">873-7202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:31.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.484%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name&#160;of&#160;Exchange&#160;on&#160;which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common&#160;Stock&#160;$2.50&#160;par&#160;value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">KEQU</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.158%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:54.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.532%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-24">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant has filed a report on and attestation to its management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">'</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of shares of voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-29">26,982,424</ix:nonFraction> based on the last reported sale price of the registrant's Common Stock on October&#160;31, 2023, the last business day of the registrant's most recently completed second fiscal quarter. Only shares beneficially owned by directors and executive officers of the registrant (excluding shares subject to options) and each person owning more than 5% of the outstanding Common Stock of the registrant were excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes. As of June&#160;24, 2024, the registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">2,840,143</ix:nonFraction> shares of Common Stock.</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;28, 2024, indicated in this report are incorporated by reference into Part&#160;III hereof.</span></div></ix:nonNumeric><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:76.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.671%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table&#160;of&#160;Contents</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page&#160;or<br/>Reference</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_16">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_19">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_19">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1712">Item 1C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1712">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1712">ybersecur</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1712">ity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1712">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_22">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_22">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_25">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_25">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_28">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_28">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_31">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_34">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_34">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_34">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_37">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_37">Reserved.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_37">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_43">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_43">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_64">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_64">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_64">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_139">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_139">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_139">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_142">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_142">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_142">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_145">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_145">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_148">Item&#160;9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_148">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_148">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_151">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_154">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_154">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_154">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_157">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_157">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_157">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_160">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_160">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_160">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_163">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_163">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_163">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_166">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_166">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_166">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_169">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_172">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_172">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_172">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_175">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_175">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_175">48</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_178">EXHIBIT&#160;INDEX</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_178">49</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_181">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_181">52</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_13"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this Annual Report, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers&#8217; required delivery schedules; risks related to fluctuations in the Company&#8217;s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; risks associated with our ability to identify and complete strategic acquisitions or to successfully integrate any businesses that we may acquire; acts of terrorism, war, governmental action, natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_16"> Item&#160;1A</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report, which you should review carefully. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;1. Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through purchase orders and contracts submitted by customers through our dealers, our subsidiaries in Singapore and India, and a national distributor. Products are sold principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, and manufacturing facilities. We consider the markets in which we compete to be highly competitive, with a significant amount of the business involving competitive public bidding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customer orders to require delivery at extended future dates, as products are frequently installed in buildings yet to be constructed. Changes or delays in building construction may cause delays in delivery of the orders and our recognition of the sale. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between quotation of an order and delivery of the product. The impact of such possible increases is considered when determining the sales price. The primary raw materials and products manufactured by others and used by us in our products are cold-rolled carbon and stainless steel, hardwood lumber and plywood, paint, chemicals, resins, hardware, plumbing and electrical fittings. Such materials and products are purchased from multiple suppliers and are typically readily available.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our need for working capital and our credit practices are comparable to those of other companies manufacturing, selling and installing similar products in similar markets. Since our products are used in building construction projects, in many cases payments for our products are received over longer periods of time than payments for many other types of manufactured products, thus requiring increased working capital. In addition, payment terms associated with certain projects provide for a retention amount until final completion of the project, thus also increasing required working capital. On average, payments for our products are received during the quarter following shipment, with the exception of the retention amounts which are collected at the final completion of the project.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold various patents and patent rights, but do not consider that our success or growth is dependent upon our patents or patent rights. Our business is not dependent upon licenses, franchises, concessions, trademarks, royalty agreements, or labor contracts.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is not generally cyclical, although domestic sales are sometimes lower during our third quarter because of slower construction activity in certain areas of the country during the winter months. Sales for two of the Company's domestic dealers and our national stocking distributor represented, in the aggregate, approximately 42% and 35% of the Company's sales in fiscal years 2024 and 2023, respectively. Loss of all or part of our sales to a large customer would have a material effect on our financial operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our order backlog at April&#160;30, 2024 was $155.6 million, as compared to $147.9 million at April&#160;30, 2023. Based on scheduled shipment dates and past experience, we estimate that not less than 88% of our order backlog at April&#160;30, 2024 will be shipped during fiscal year 2025. However, it may be expected that delays in shipments will occur because of customer rescheduling or delay in completion of projects which involve the installation of our products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENT INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_124">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item&#160;8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form&#160;10-K for information concerning our Domestic and International business segments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the industries in which we participate to be highly competitive and believe that the principal deciding factors are price, product performance, and customer service. A significant portion of our business is based upon competitive public bidding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND EXPERIMENTATION EXPENDITURES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount spent and expensed by us during the fiscal year ended April&#160;30, 2024 on research and experimentation expenditures activities related to new or redesigned products was $920,000. The amount spent for similar purposes in the fiscal year ended April&#160;30, 2023 was $1,012,000.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL COMPLIANCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last two fiscal years, compliance with federal, state, or local provisions enacted or adopted regulating the discharge of materials into the environment has had no material effect on us and such regulation is not expected to have a material effect on our earnings or competitive position in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CULTURE AND WORKFORCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company of passionate, talented, and motivated people. We embrace collaboration and creativity, and encourage the iteration of ideas to address complex challenges in technology and society.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, the Company had 556 Domestic employees and 450 International employees. Our people are critical for our continued success, so we work hard to create an environment where employees can have fulfilling careers, and be happy, healthy, and productive. We offer competitive benefits and programs to take care of the diverse needs of our employees and their families, including opportunities for career growth and development, resources to support their financial health, and access to excellent healthcare choices and resources, including access to an onsite medical clinic and separate gym facility and regular access to onsite specialists. Our competitive compensation programs help us to attract and retain top candidates, and we will continue to invest in recruiting talented people to technical and non-technical roles, and rewarding them well.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that open and honest communication among team members, managers, and leaders helps create a collaborative work environment where everyone can contribute, grow, and succeed. Team members are encouraged to come to their managers with questions, feedback, or concerns, and the Company conducts surveys that gauge employee engagement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When necessary, we contract with businesses around the world to provide specialized services where we do not have appropriate in-house expertise or resources. We also contract with temporary staffing agencies when we need to cover short-term leaves, when we have spikes in business needs, or when we need to quickly incubate special projects. We choose our partners and staffing agencies carefully and continually make improvements to promote a respectful and positive working environment for everyone - employees, vendors, and temporary staff alike.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We make available, free of charge through this website, our annual report to stockholders. Our Form&#160;10-K and 10-Q financial reports may be obtained by stockholders by writing the Secretary of the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company, Kewaunee Scientific Corporation, P.O. Box&#160;1842, Statesville, NC 28687-1842. The public may also obtain information on our reports, proxy, and information statements at the Securities and Exchange Commission ("SEC") Internet site </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS OF THE REGISTRANT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in Part III, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_154">Item&#160;10(b)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Executive Officers and Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report on Form 10-K.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the following risks before you decide to buy shares of our common stock. If any of the following risks actually occur, our business, results of operations, or financial condition would likely suffer. In such case, the trading price of our common stock would decline, and you may lose all or part of the money you paid to buy our stock.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This and other public reports may contain forward-looking statements based on current expectations, assumptions, estimates and projections about us and our industry. These forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those forward-looking statements as a result of many factors, including those more fully described below and elsewhere in our public reports. We do not undertake to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Specific to our Company</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose a large customer, our sales and profits would decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have substantial sales to three of our domestic channel partners. The combined sales to two dealers and our national stocking distributor accounted for approximately 42% of our sales in fiscal year 2024. Loss of all or a part of our sales to a large channel partner would have a material effect on our revenues and profits until an alternative channel partner could be developed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the talents and efforts of key management and our Associates. If we are unable to retain or motivate key personnel, hire qualified personnel, or maintain and continue to adapt our corporate culture, we may not be able to grow or operate effectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance largely depends on the talents and efforts of our Associates. Our ability to compete effectively and our future success depends on our continuing to identify, hire, develop, motivate, and retain key management and highly skilled personnel for all areas of our organization. In addition, our total compensation program may not always be successful in attracting new employees and retaining and motivating our existing employees. Restrictive immigration policy and regulatory changes may also affect our ability to hire, mobilize, or retain some of our global talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we believe that our corporate culture fosters innovation, creativity, and teamwork. As our organization grows and evolves, we may need to implement more complex organizational management structures or adapt our corporate culture and work environments to ever-changing circumstances, such as during times of a natural disaster or pandemic, and these changes could affect our ability to compete effectively or have an adverse effect on our corporate culture. With the constant evolution of workforce dynamics, if we do not manage these changes effectively, it could materially adversely affect our culture, reputation, and operational flexibility.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to other risks that might also cause our actual results to vary materially from our forecasts, targets, or projections, including:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to anticipate the need for and appropriately invest in information technology and logistical resources necessary to support our business, including managing the costs associated with such resources;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to generate sufficient future positive operating cash flows and, if necessary, secure and maintain adequate external financing to fund our operations and any future growth; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interruptions in service by common carriers that ship goods within our distribution channels.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and reputation are impacted by information technology system failures and network disruptions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and our global supply chain, are exposed to information technology system failures or network disruptions caused by natural disasters, accidents, power disruptions, telecommunications failures, acts of terrorism or war, computer viruses, physical or electronic break-ins, ransomware or other cybersecurity incidents, or other events or disruptions. System redundancy and other continuity measures may be ineffective or inadequate, and our, or our vendors', business continuity and disaster recovery planning may not be sufficient for all eventualities. Such failures or disruptions can adversely impact our business by, among other things, </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preventing access to our cloud-based systems, interfering with customer transactions or impeding the manufacturing and shipping of our products. These events could materially adversely affect our business, reputation, results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future cybersecurity incidents could expose us to liability and damage our reputation and our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, process, store, and transmit large amounts of data, and it is critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our information technology systems are essential to our efforts to manufacture our products, process customer sales transactions, manage inventory levels, conduct business with our suppliers and other business partners, and record, summarize and analyze the results of our operations. These systems contain, among other things, material operational, financial and administrative information related to our business. As with most companies, there will always be some risk of physical or electronic break-ins, computer viruses, or similar disruptions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we, like all entities, are the target of cybercriminals who attempt to compromise our systems. From time to time, we experience threats and intrusions that may require remediation to protect sensitive information, including our intellectual property and personal information, and our overall business. Any physical or electronic break-in, computer virus, cybersecurity attack or other security breach or compromise of the information handled by us or our service providers may jeopardize the security or integrity of information in our computer systems and networks or those of our customers and cause significant interruptions in our and our customers' operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any systems and processes that we have developed that are designed to protect customer, associate and vendor information, and intellectual property, and to prevent data loss and other security attacks, cannot provide absolute security. In addition, we may not successfully implement remediation plans to address all potential exposures. It is possible that we may have to expend additional financial and other resources to address these problems. Failure to prevent or mitigate data loss or other security incidents could expose us or our customers, associates and vendors to a risk of loss or misuse of such information, cause customers to lose confidence in our data protection measures, damage our reputation, adversely affect our operating results or result in litigation or potential liability for us.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we expect to continue to make investments in our information technology infrastructure. The implementation of these investments may be more costly or take longer than we anticipate, or could otherwise adversely affect our business operations, which could negatively impact our financial position, results of operations or cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal controls over financial reporting may not be effective at preventing or detecting material misstatements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal controls over financial reporting may not prevent or detect material misstatements in the Company's consolidated financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot guarantee that our share repurchase program will enhance long-term stockholder value, or that it will successfully mitigate the dilutive effect of employee equity awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our Board of Directors authorized a share repurchase program that does not have an expiration date, the program does not obligate us to acquire any particular amount of Common Stock and it may be terminated at any time. We cannot guarantee that the program will be fully consummated, that it will enhance long-term stockholder value, or that it will successfully mitigate the dilutive effect of employee equity awards. Any repurchases will reduce the amount of cash we have available to fund working capital, capital expenditures, strategic acquisitions or business opportunities, and other general corporate requirements. In addition, the program could affect the trading price of our Common Stock and increase volatility, and any announcement of a termination of this program may result in a decrease in the trading price of our Common Stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales to customers outside the United States or with international operations expose us to risks inherent in international sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2024, 33% of our revenues were derived from sales outside of the United States. A key element of our growth strategy is to expand our worldwide customer base and our international operations. Operating in international markets requires significant resources and management attention and subjects us to regulatory, economic and political risks that are different from those in the United States. We cannot assure you that our expansion efforts into other international markets will be successful. Our experience in the United States and other international markets in which we already have a presence may not be relevant to our ability to expand in other emerging markets. Our international expansion efforts may not be successful in creating further demand for our products outside of the United States or in effectively selling our products in the international markets we enter. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to compete effectively, our revenue and profit margins could decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face a variety of competition in all of the markets in which we participate. Competitive pricing, including price competition or the introduction of new products, could have material adverse effects on our revenues and profit margins.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends to a significant extent on the specification or approval of our products by architects, engineers, and customers. If a significant segment of those communities were to decide that the design, materials, manufacturing, testing, or quality control of our products is inferior to that of any of our competitors, our sales and profits would be materially and adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An increase in the price of raw materials could negatively affect our sales and profits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to require delivery at extended future dates, as products are frequently installed in buildings yet to be constructed. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between the quotation of an order and the delivery of the products. Our principal raw materials are steel, including stainless steel, wood and epoxy resin. Numerous factors beyond our control, such as general economic conditions, competition, worldwide demand, labor costs, energy costs, and import duties and other trade restrictions, influence prices for our raw materials. We have not always been able, and in the future we might not be able, to increase our product prices in amounts that correspond to increases in costs of raw materials. Where we are not able to increase our prices, increases in our raw material costs will adversely affect our profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Events outside our control may affect our operating results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have little control over the timing of shipping customer orders, as customers' required delivery dates are subject to change by the customer. Construction delays and customer changes to product designs are among the factors that may delay the start of manufacturing. Weather conditions, such as unseasonably warm, cold, or wet weather, can also affect and sometimes delay projects. Political and economic events can also affect our revenues. When sales do not meet our expectations, our operating results will be reduced for the relevant quarters.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal markets are in the laboratory and healthcare building construction industry. This industry is subject to significant volatility due to various factors, none of which is within our control. Declines in construction activity or demand for our products could materially and adversely affect our business and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face numerous manufacturing and supply chain risks. In addition, our reliance upon sole or limited sources of supply for certain materials, components, and services could cause production interruptions, delays and inefficiencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase materials, components, and equipment from third parties for use in our manufacturing operations. Our results of operations could be adversely impacted if we are unable to adjust our purchases to reflect changes in customer demand and market fluctuations. Suppliers may extend lead times, limit supplies, or increase prices. If we cannot purchase sufficient products at competitive prices and of sufficient quality on a timely enough basis to meet increasing demand, we may not be able to satisfy market demand, product shipments may be delayed, our costs may increase, or we may breach out contractual commitments and incur liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some of our businesses purchase certain required products from sole or limited source suppliers for reasons of quality assurance, regulatory requirements, cost effectiveness, availability or uniqueness of design. If these or other suppliers encounter financial, operating, or other difficulties, or if our relationship with them changes, we might not be able to quickly establish or qualify replacement sources of supply. The supply chains for our businesses have been impacted in the past by factors outside our control and could be disrupted in the future for such reasons as supplier capacity constraints, supplier bankruptcy or exiting of the business for other reasons, decreased availability of key raw materials or commodities and external events such as natural disasters, pandemics or other public health problems, war, terrorist actions, governmental actions and legislative or regulatory changes. Any of these factors could result in production interruptions, delays, extended lead times and inefficiencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and other operating results depend in large part on our ability to manufacture our products in sufficient quantities and in a timely manner. Any interruptions we experience in the manufacture of our products or changes to the way we manufacture products could delay our ability to recognize revenues in a particular period. In addition, we must maintain sufficient production capacity in order to meet anticipated customer demand, which carries fixed costs that we may not be able to offset because we cannot always immediately adapt our production capacity and related cost structures to changing market conditions, which would adversely affect our operating margins. If we are unable to manufacture our products consistently, in sufficient quantities, and on a timely basis, our revenues, gross margins, and our other operating results will be materially and adversely affected.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions in the financial markets have historically created, and may continue to create, uncertainty in economic conditions that may adversely affect our customers and our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial markets in the United States, Europe and Asia have in the past been, and may in the future be, volatile. The tightening of credit in financial markets, worsening of economic conditions, a prolonged global, national or regional economic recession or other similar events could have a material adverse effect on the demand for our products and on our sales, pricing and profitability. We are unable to predict the likely occurrence or duration of these adverse economic conditions and the impact these events may have on our operations and the end users who purchase our products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth may depend on our ability to penetrate new international markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International laws and regulations, construction customs, standards, techniques and methods differ from those in the United States. Significant challenges of conducting business in foreign countries include, among other factors, geopolitical tensions, local acceptance of our products, political instability, currency controls, changes in import and export regulations, changes in tariff and freight rates and fluctuations in foreign exchange rates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of geopolitical instability, including as a result of Russia's invasion of Ukraine, may adversely affect us and heighten significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing geopolitical instability could negatively impact the global and U.S. economies in the future, including by causing supply chain disruptions, rising energy costs, volatility in capital markets and foreign currency exchange rates, rising interest rates, and heightened cybersecurity risks. The extent to which such geopolitical instability adversely affects our business, financial condition, and results of operations, as well as our liquidity and capital profile, is highly uncertain and unpredictable. If geopolitical instability adversely affects us, it may also have the effect of heightening other risks related to our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the military conflict between Russia and Ukraine that began in February 2022, the United States and other North Atlantic Treaty Organization member states, as well as non-member states, announced targeted economic sanctions on Russia. The long-term impact on our business resulting from the disruption of trade in the region caused by the conflict and associated sanctions and boycotts is uncertain at this time due to the fluid nature of the ongoing military conflict and response. The potential impacts include supply chain and logistics disruptions, financial impacts including volatility in foreign exchange and interest rates, increased inflationary pressure on raw materials and energy, and other risks, including an elevated risk of cybersecurity threats and the potential for further sanctions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Compliance Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business and results of operations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the extent to which the U.S. or other countries will impose quotas, duties, tariffs, taxes or other similar restrictions upon the import or export of our products or raw materials in the future, nor can we predict future trade policy or the terms of any renegotiated trade agreements and their impact on our business.&#160;Changes in U.S. trade policy could result in one or more foreign governments adopting responsive trade policies making it more difficult or costly for us to import our products or raw materials from those countries. This, together with tariffs already imposed, or that may be imposed in the future, by the U.S., could require us to increase prices to our customers which may reduce demand, or, if we are unable to increase prices, result in lowering our margin on products sold. The adoption and expansion of trade restrictions, the occurrence of a trade war, or other governmental action related to tariffs or trade agreements or policies has the potential to adversely impact demand for our products, our costs, our customers, our suppliers, and the U.S. economy, which in turn could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expectations related to environmental, social, and governance ("ESG") considerations could expose us to potential liabilities, increased costs, and reputational harm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations, and other measures that govern a wide range of topics, including those related to matters beyond our core products and services. For instance, new laws, regulations, policies, and international accords relating to ESG matters, including sustainability, climate change, human capital, and diversity, are being developed and formalized in Europe, the U.S., and elsewhere, which may entail specific, target-driven frameworks and/or disclosure requirements. The implementation of these may require considerable investments. Any failure, or perceived failure, by us to adhere to any public statements or initiatives, comply with federal, state or international environmental social and governance laws and regulations, or meet evolving and varied stakeholder expectations and standards could result in legal and regulatory proceedings against us and could materially adversely affect the Company's business reputation, results of operations, financial condition, and stock price.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is likely to be volatile and could drop.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Common Stock could be subject to wide fluctuations in response to quarter-to-quarter variation in operating results, announcement of technological innovations or new products by us or our competitors, general conditions in the construction and construction materials industries, relatively low trading volume in our common stock and other events or factors. In addition, in recent years, the stock market has experienced extreme price fluctuations. This volatility has had a substantial effect on the market prices of securities issued by many companies for reasons unrelated to the operating performance of those companies. Securities market fluctuations may adversely affect the market price of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stockholders may experience future dilution as a result of future issuances of our shares of common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to raise additional capital, we may in the future, without stockholder approval, issue additional shares of our common stock or securities convertible into or exchangeable for our common stock for various considerations, including in connection with acquisitions, financing or refinancing transactions or otherwise. The consideration that we receive for any such additional shares of our common stock may represent per share amounts that are greater or lesser than the price per share paid by you. Any such issuances of additional shares of our common stock or securities convertible into shares of common stock will dilute our stockholders&#8217; overall existing ownership in us and could make our stock less attractive to investors, which may result in a material adverse effect on the trading price of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently, and may in the future, have assets held at financial institutions that may exceed the insurance coverage offered by the Federal Deposit Insurance Corporation ("FDIC"), the loss of which would have a severe negative effect on our operations and liquidity.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may maintain our cash assets at financial institutions in the U.S. in amounts that may be in excess of the FDIC insurance limit of $250,000. Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry of the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. In the event of a failure or liquidity issues of or at any of the financial institutions where we maintain our deposits or other assets, we may incur a loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect upon our liquidity, financial condition, and our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, if our customers or partners experience liquidity issues as a result of financial institution defaults or non-performance where they hold cash assets, their ability to pay us may become impaired and could have a material adverse effect on our results of operations, including the collection of accounts receivable and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of investor concerns on U.S. or international financial systems could impact our ability to obtain favorable financing terms in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on terms favorable to us, or at all, and could have material adverse impacts on our liquidity, our business, financial condition or results of operations, and our prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of future pandemics could adversely affect our business, results of operations, financial condition, and liquidity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe we successfully navigated the risks associated with the COVID-19 pandemic and were able to successfully maintain our business operations, the extent of the impact of future COVID-19 variations or other pandemics on our business and financial results is, by nature of this type of event, highly uncertain. The sweeping nature of pandemics makes it extremely difficult to predict how and to what extent our business and operations could be affected in the long run. Our workforce, and the workforce of our vendors, service providers, and counterparties, could be affected by a pandemic, which could result in an adverse impact on our ability to conduct business. No assurance can be given that the actions we take to protect our Associates and our operations will be sufficient, nor can we predict the level of disruption that could occur to our employees' ability to provide customer support and service. New processes, procedures, and controls may be required to respond to any changes in our business environment. Further, should any key employees become ill during the course of a future health event and be unable to work, our ability to operate our internal controls may be adversely impacted.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional factors related to major public health issues that could have material and adverse effects on our ability to successfully operate include, but are not limited to, the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effectiveness of any governmental and non-governmental organizations in combating the spread and severity, including any legal and regulatory responses;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A general decline in business activity, especially as it relates to our customers' expansion or consolidation activities;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The destabilization of the financial markets, which could negatively impact our customer growth and access to capital, along with our customers' ability to make payments for their purchase orders; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Severe disruptions to and instability in the global financial markets, and deterioration in credit and financing conditions, which could affect our access to capital necessary to fund business operations or current investment and growth strategies.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may pursue strategic acquisitions from time to time, in which case we would be subject to the general risks associated with acquisitions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we consider, and in the future may pursue, strategic acquisitions of businesses in support of our growth strategy. If we are unable to complete acquisitions or successfully integrate and develop acquired businesses, we could experience material adverse impacts to our financial results as a result of any of the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the diversion of management&#8217;s attention to integration matters;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in achieving anticipated cost savings, synergies, business opportunities, and growth prospects;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in the integration of operations and systems, inclusive of internal controls;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in managing the expanded operations of a larger and more complex company;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in keeping existing customers and obtaining new customers;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in attracting and retaining key personnel;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated expenses resulting from integration activities and disputes with third parties; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated liabilities of acquired third parties.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_1712"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span id="i997eefa5c4c44c448a19016db3174c9e_106"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1C. <span id="i997eefa5c4c44c448a19016db3174c9e_107"></span>Cybersecurity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's cybersecurity risk management program is integrated into the overall risk management framework, including risk identification, assessment, and mitigation across all business areas. We have collaborated with external consultants and built a cybersecurity program designed to protect and safeguard the integrity of our information systems, which aligns with industry best practices and regulatory requirements. Our cybersecurity program includes systems and processes for assessing, identifying, and managing material risks from cybersecurity threats and include maintenance and monitoring of information security policies aligned with information technology controls, information systems configuration management and infrastructure security systems. We also have implemented processes to oversee and identify such risks from cybersecurity threats associated with the use of third-party service providers. We conduct periodic testing of these controls and systems, including vulnerability scanning and penetration testing. We strive to foster a shared responsibility for the Company&#8217;s cybersecurity with all of our employees, conducting periodic phishing simulation campaigns and providing regular, mandatory cybersecurity training. Additionally, we maintain cyber insurance coverage, including protection against social engineering fraud, to further mitigate potential financial losses from cybersecurity incidents. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not believe that any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations or financial conditions. While we do not believe that any such risks have yet to materially affect the Company, the Company cannot guarantee that its ongoing and robust approach towards cybersecurity will be able to prevent all cybersecurity incidents that could have a material effect on the Company in the future. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_16">Item 1A</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more information on our cybersecurity-related risks.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Governance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On behalf of the Board of Directors, the Audit Committee provides oversight of the Company's management of cybersecurity risk. They periodically review and discuss with management, including the Company&#8217;s Vice President of Information Technology and Engineering, the Company's significant financial risk exposures for matters related to cybersecurity risk, including the steps management has taken to monitor and manage such exposures. The Board of Directors also receives prompt and timely information regarding any cybersecurity incident that meets established reporting thresholds, as well as ongoing updates regarding any such incident until it has been addressed. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Vice President of Information Technology and Engineering leads the overall cybersecurity strategy and risk management program. This includes overseeing risk assessments, developing security policies and procedures, and managing the IT security team. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_154">Item 10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Executive Officers and Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for more detail on his education and experience. Senior executives, including the Company's CEO and CFO, integrate cybersecurity risks into the overall business strategy and financial planning.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;2. Properties</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease and operate three adjacent manufacturing facilities in Statesville, North Carolina. These facilities also house our corporate offices, as well as sales and marketing, administration, engineering and drafting personnel. These facilities together comprise 414,000 square feet and are located on 20 acres of land. On March 24, 2022, we entered into a Sale-Leaseback Arrangement (defined below), pursuant to which we sold, and now lease, our manufacturing and office facilities in Statesville, North Carolina. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K for information concerning the Sale-Leaseback Arrangement. In addition, we lease our primary distribution facility and other warehouse facilities totaling 366,000 square feet in Statesville, North Carolina. We also lease an office facility in Charlotte, North Carolina. In Bangalore, India, we lease and operate a manufacturing facility comprising 119,000 square feet. Our international sales and administrative offices are located in Singapore, India, and Saudi Arabia. We believe our facilities are suitable for their respective uses and are adequate for our current needs.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_25"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;3. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in disputes and litigation relating to claims arising out of our operations in the ordinary course of business. Further, we are periodically subject to government audits and inspections. We believe that any such matters presently pending will not, individually or in the aggregate, have a material adverse effect on our results of operations or financial condition.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_28"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_31"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the NASDAQ Global Market, under the symbol KEQU. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;24, 2024, there were 90 stockholders of record. The declaration and payment of&#160;any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_160">Item&#160;12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in this Form&#160;10-K for a discussion of securities authorized for issuance under our equity compensation plans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHARE REPURCHASE PLAN</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1721">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_1721">8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in Part II, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this Form 10-K for a discussion of activity related to the share repurchase plan that was adopted on August 31, 2023.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;6. Reserved</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_43"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation is a recognized leader in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. Kewaunee Scientific Corporation's website is located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through purchase orders and contracts submitted by customers through our dealers, our subsidiaries in Singapore and India, and a national distributor. Products are sold principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, manufacturing facilities and users of networking furniture. We consider the markets in which we compete to be highly competitive, with a significant amount of the market requiring competitive public bidding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customer orders to require delivery at extended future dates, as products are frequently to be installed in buildings yet to be constructed. Changes or delays in building construction may cause delays in delivery of the orders and our recognition of the sale. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between quotation of an order and delivery of the product. The impact of such possible increases is considered when determining the sales price. The principal raw materials and products manufactured by others used in our products are cold-rolled carbon and stainless steel, hardwood lumbers and plywood, paint, chemicals, resins, hardware, plumbing and electrical fittings. Such materials and products are purchased from multiple suppliers and are typically readily available.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have made estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of our consolidated financial statements in conformity with generally accepted accounting principles in the United States of America. Actual results could differ significantly from those estimates. We believe that the following discussion addresses our most critical accounting estimates, which are those that are most important to the portrayal of our financial condition and results of operations, and require management's most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluation of the allowance for credit losses involves management judgments and estimates. We evaluate the collectability of our trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to us, or a project dispute makes it unlikely that the outstanding amount owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount we believe will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for credit losses is estimated and recorded based on our recent past loss history and an overall assessment of past due trade accounts receivable amounts outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Reserves</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's domestic operations are self-insured for employee health care costs. The Company has purchased specific stop-loss insurance policies to limit claims above a certain amount. Estimated medical costs were accrued for claims incurred but not reported using assumptions based upon historical loss experiences. The Company's exposure reflected in the self-insurance reserves varies depending upon market conditions in the insurance industry, availability of cost-effective insurance coverage, and actual claims versus estimated future claims.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the U.S. (federal and state) and foreign jurisdictions. Tax laws, regulations, administrative practices, and interpretations in various jurisdictions may be subject to significant change, with or without notice, due to economic, political, and other conditions, and significant judgment is required in evaluating and estimating our provision and accruals for these taxes. In addition, our actual and forecasted earnings are subject to change due to economic, political, and other conditions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rates could be affected by numerous factors, such as changes in our business operations, acquisitions, investments, entry into new businesses and geographies, intercompany transactions, the relative amount of our foreign earnings, including earnings being lower than anticipated in jurisdictions where we have lower statutory rates and higher than anticipated in </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdictions where we have higher statutory rates, losses incurred in jurisdictions for which we are not able to realize related tax benefits, the applicability of special tax regimes, changes in foreign currency exchange rates, changes to our forecasts of income and loss and the mix of jurisdictions to which they relate, changes in our deferred tax assets and liabilities, their valuation, and the assumptions around their realization in connection with any associated valuation, and interpretations related to tax laws and accounting rules in various jurisdictions.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales for fiscal year 2024 were $203.8 million, a decrease compared to fiscal year 2023 sales of $219.5 million. Domestic Segment sales for fiscal year 2024 were $137.2 million, a decrease of 6.5% compared to fiscal year 2023 sales of $146.7 million. The decrease in Domestic sales was predominantly related to the reduction in non-product revenue related to the Company's decision to stop selling directly to end users. This revenue typically includes freight, installation services and buyouts. International Segment sales for fiscal year 2024 were $66.5 million, a decrease of 8.6% from fiscal year 2023 sales of $72.8 million. International sales decreased when compared to the prior year period due to the delivery of several large projects in the comparable prior year period that were booked in earlier fiscal years.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our order backlog was $155.6 million at April&#160;30, 2024, as compared to $147.9 million at April&#160;30, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit represented 25.5% and 16.2% of sales in fiscal years 2024 and 2023, respectively. The increase in gross profit margin percentage is primarily being generated from Domestic operations. Specifically, the increase is primarily driven by improved manufacturing productivity, cost containment actions, and the pricing of new orders in response to higher raw material input costs when compared to the prior year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses were $33.8 million and $30.2 million in fiscal years 2024 and 2023, respectively, and 16.6% and 13.8% of sales, respectively. The increase in operating expenses in fiscal year 2024 as compared to fiscal year 2023 was primarily due to increases in SG&amp;A wages, benefits, incentive and stock-based compensation of $2,572,000, corporate governance expenses of $170,000, depreciation expense of $164,000, bad debt expense of $156,000, and increases in international operating expenses of $616,000, partially offset by decreases in consulting and professional services of $557,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension expense was $4,177,000 and $71,000 in fiscal years 2024 and 2023, respectively. The increase in pension expense was due to the Company successfully annuitizing its pension obligation, which had been in a frozen state since 2005. Terminating the pension resulted in a one-time expense of $4,019,000 for accounting losses that were being amortized from the Balance Sheet based on an annual evaluation of the pension plan. By annuitizing the pension obligation, the Company has eliminated all future responsibility for the plan and future administrative costs associated with maintaining and managing the pension plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $814,000 and $939,000 in fiscal years 2024 and 2023, respectively. The decrease in other income in fiscal year 2024 was primarily due to the elimination of interest income earned from the Note Receivable related to the Sale-Leaseback financing transaction that was settled in the prior year, partially offset by interest earned on the increased Domestic cash balances and increased interest on International cash balances when compared to the prior fiscal year. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on this transaction.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $1,799,000 and $1,734,000 in fiscal years 2024 and 2023, respectively. The interest expense for fiscal year 2024 was relatively unchanged from the prior fiscal year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit was $5.9 million for fiscal year 2024, or 45.3% of pretax earnings, as compared to income tax expense of $3.1 million for fiscal year 2023, or 69.8% of pretax earnings. The income tax benefit for fiscal year 2024 is primarily due to the favorable impact of the reduction of the Domestic valuation allowance of $6.6 million that was required to be established in fiscal year 2020 per ASC 740 and $3.9 million related to prior years' unrecognized tax benefits related to the settlement of the Company's domestic pension plans. Income tax expense for fiscal year 2024 excluding these one-time benefits is $4.5 million or 34.4% of pretax earnings. At April 30, 2024, the Company has a Domestic valuation allowance of $808,000 for specific federal and state tax credits as compared to $8.5 million for the Company's Domestic net deferred tax assets at April 30, 2023. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_109">Note 6</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for fiscal year 2023 was unfavorably impacted by the increase in the valuation allowance attributable to changes to Internal Revenue Code Section 174 Research and Experimental Expenditures, which became effective during the fiscal year. The primary impact of this change was the amortization of current year expenditures over a five year period, as compared to prior fiscal years where research expenditures were deductible in the year incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings attributable to the non-controlling interest related to our subsidiaries that are not 100% owned by the Company were $304,000 and $621,000 for fiscal years 2024 and 2023, respectively. The changes in the net earnings attributable to the non-controlling interest for each year were due to changes in the levels of net income of the subsidiaries.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings were $18,753,000, or $6.38 per diluted share, as compared to $738,000, or $0.25 per diluted share, for fiscal years ended April 30, 2024 and April 30, 2023, respectively. The increase in net earnings was attributable to the factors discussed above.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity have historically been funds generated from operating activities, supplemented as needed by borrowings under our revolving credit facility. Additionally, certain machinery and equipment are financed by non-cancelable operating and financing leases. We believe that these sources of funds will be sufficient to support ongoing business requirements, including capital expenditures, through fiscal year 2025.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, we had $3,000,000 outstanding under our $15.0 million revolving credit facility. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_103">Note 4</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt and Other Credit Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report for additional information concerning our credit facility. In fiscal year 2022, we executed a Sale-Leaseback financing transaction with respect to our manufacturing and corporate facilities in Statesville, North Carolina to provide additional liquidity. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information. We did not have any off balance sheet arrangements at April&#160;30, 2024 or 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the cash payment obligations for our lease and financing arrangements as of April&#160;30, 2024: </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAYMENTS DUE BY PERIOD</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">($ in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:42.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Contractual Cash Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1 Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2-3&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4-5&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;5&#160;years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Lease Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale-Leaseback Financing Transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Contractual Cash Obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,538&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's operating activities provided cash of $19,564,000 in fiscal year 2024, primarily from operations and decreases in receivables of $741,000, decreases in inventories of $1,210,000, increases in accounts payable and accrued expenses of $691,000, and increases in deferred revenue of $277,000. Operating activities used cash of $3,790,000 in fiscal year 2023, primarily for increases in receivables of $4,947,000 and decreases in accounts payable and accrued expenses of $5,558,000, partially offset by cash from operations, decreases in inventories of $1,907,000, and increases in deferred revenue of $568,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financing activities used cash of $3,014,000 during fiscal year 2024 as a result of the net decrease in short-term borrowings of $488,000, repayments on our financing liability of $642,000, and the repurchase of outstanding shares as part of our announced share repurchase program for $1,998,000, partially offset by net proceeds from long-term debt of $114,000. The Company's financing activities provided cash of $14,931,000 during fiscal year 2023 from proceeds of $13,629,000 from the Sale-Leaseback transaction and proceeds from the net increase in short-term borrowings of $1,998,000, partially offset by repayment of long-term debt of $121,000. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the April&#160;30, 2024 accounts receivable balances are expected to be collected during the first quarter of fiscal year 2025, with the exception of retention amounts on fixed-price contracts which are collected when the entire construction project is completed and all retention funds are paid by the owner.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures were $4,373,000 and $4,148,000 in fiscal years 2024 and 2023, respectively. Capital expenditures in fiscal year 2024 were funded primarily from financing activities. Fiscal year 2025 capital expenditures are anticipated to be approximately $4.0 million. The fiscal year 2025 expenditures are expected to be funded primarily by operating activities, supplemented as needed by borrowings under our revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital was $56.0 million at April&#160;30, 2024, up from $47.9 million at April&#160;30, 2023, and the ratio of current assets to current liabilities was 2.4-to-1.0 at April&#160;30, 2024, up from a ratio of 2.2-to-1.0 at April 30, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No dividends were declared or paid on the Company's common stock during the last two fiscal years. The declaration and payment of&#160;any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial condition, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_58"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING STANDARDS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_94">Note 1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our Consolidated Financial Statements in this Form 10-K for a discussion of new accounting pronouncements, which is incorporated herein by reference.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUTLOOK</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Outlook</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's ability to predict future demand for its products continues to be limited given its role as subcontractor or supplier to dealers for subcontractors. Demand for the Company's products is also dependent upon the number of laboratory and healthcare construction projects planned and/or current progress in projects already under construction. The Company's earnings are also impacted by fluctuations in prevailing pricing for projects in the laboratory construction marketplace and costs of raw materials, including steel, wood, and epoxy resin.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is operating more efficiently than in the past due to its ability to focus solely on supporting its dealers and distribution channel partners domestically while continuing to provide turnkey solutions in the international markets it serves. The improved focus of the organization, combined with a strong global management team, a healthy backlog, improved manufacturing capabilities, and end-use markets that continue to prioritize investment in projects that require the products Kewaunee designs and manufactures, positions the Company well.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk in the area of interest rates. This exposure is associated with balances outstanding under our revolving credit facility and certain lease obligations for production machinery, all of which are priced on a floating rate basis. We had $3 million outstanding under our revolving credit facility at April&#160;30, 2024, bearing interest at floating rates. We believe that our current exposure to interest rate market risk is not material.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. We derive net sales in U.S. dollars and other currencies including Indian rupees, Singapore dollars, and other currencies. For&#160;fiscal year 2024,&#160;29%&#160;of net sales were derived in currencies other than U.S. dollars. We incur expenses in currencies other than U.S. dollars relating to specific contracts with customers and for our operations outside the U.S.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the long term, net sales to international markets may increase as a percentage of total net sales and, consequently, a greater portion of our business could be denominated in foreign currencies. As a result, operating results may become more subject to fluctuations based upon changes in the exchange rates of certain currencies in relation to the U.S. dollar. To the extent we engage in international sales denominated in U.S. dollars, an increase in the value of the U.S. dollar relative to foreign currencies could make our products less competitive in international markets. This effect is also impacted by costs of raw materials from international sources and costs of our sales, service, and manufacturing locations outside the U.S.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have foreign currency cash accounts to operate our global business. These accounts are impacted by changes in foreign currency rates. Cash balances at&#160;April 30, 2024 of $11.2 million&#160;were held by our foreign subsidiaries and denominated in currencies other than U.S. dollars.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;8. Financial Statements and Supplementary Data</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:93.009%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">Report of Independent Registered Public Accounting Firm (</a><ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-36">Forvis Mazars, LLP</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">, </a><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-37">Atlanta, GA</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">, PCAOB Firm No. </a><ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-38">686</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76">Consolidated Statements of Operations&#8212;Years ended April 30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76">4</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76"> and 202</a>3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79">Consolidated Statements of Comprehensive Income&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79">4</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79"> and 202</a>3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">Consolidated Statements of Stockholders' Equity&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">4</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82"> and 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85">Consolidated Balance Sheets&#8212;April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85">4</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85"> and 202</a>3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88">Consolidated Statements of Cash Flows&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88">4</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88"> and 202</a>3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88">24</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_91">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_136">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_136">43</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report Of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Kewaunee Scientific Corporation</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Kewaunee Scientific Corporation (the "Company") as of April 30, 2024 and 2023, the related consolidated statements of operations, comprehensive income, stockholders' equity and cash flows for each of the years in the two-year period ended April 30, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of April 30, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the two-year period ended April 30, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ Forvis Mazars, LLP</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2020.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Atlanta, Georgia</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">June 28, 2024</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_76"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ and shares in thousands, except per share amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-39">203,755</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-40">219,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-41">151,704</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-42">183,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-43">52,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-44">35,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-45">33,770</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-46">30,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-47">18,281</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-48">5,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PensionExpense" format="ixt:num-dot-decimal" scale="3" id="f-49">4,177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PensionExpense" scale="3" id="f-50">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="f-51">814</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="f-52">939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-53">1,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-54">1,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-55">13,119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-56">4,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-57">5,938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-58">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-59">19,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-60">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net earnings attributable to the non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-61">304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-62">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Kewaunee Scientific Corporation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-63">18,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-64">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per share attributable to Kewaunee Scientific Corporation stockholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-65">6.51</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-66">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-67">6.38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-68">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-69">2,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-70">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-71">2,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-72">2,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-73">19,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-74">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-75">598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-76">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Postretirement benefit plans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss included in net income</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-77">4,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:fixed-zero" scale="3" id="f-78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on postretirement benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-79">3,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:fixed-zero" scale="3" id="f-80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-81">509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-82">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total postretirement benefit plans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-83">658</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="f-84">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income, net of tax</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-85">19,117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-86">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to the non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-87">304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-88">621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Kewaunee Scientific Corporation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-89">18,813</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-90">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_82"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:34.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.610%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.486%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee Scientific Corporation</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ in thousands, except shares and per share amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-91">6,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">4,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-93">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-94">28,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-95">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-96">35,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-97">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-98">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-99">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-100">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-101">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-102">576</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-103">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-104">7,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-105">5,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-106">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-107">28,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-108">3,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-109">37,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-110">18,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-111">18,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-112">60</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-113">60</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-114">189</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-115">347</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-116">536</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of Treasury Stock, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-117">66,191</ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-118">1,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-119">1,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">7,273</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-121">5,406</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-122">2,051</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-123">47,514</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-124">3,382</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">54,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:72.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ and shares in thousands, except per share amounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-126">23,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-127">8,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-128">2,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-129">5,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables, less allowance: $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-130">588</ix:nonFraction> (2024); $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-131">476</ix:nonFraction> (2023)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-132">45,064</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-133">46,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-134">20,679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-135">21,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-136">5,136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-137">6,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-138">96,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-139">87,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-140">17,649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-141">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-142">7,454</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-143">9,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-144">7,401</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="f-145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-146">5,445</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-147">5,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-148">134,766</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-149">118,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-150">3,099</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-151">3,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of financing liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityCurrent" scale="3" id="f-152">713</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:FinancingLiabilityCurrent" scale="3" id="f-153">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-154">111</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-155">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-156">2,123</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-157">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-158">23,262</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-159">23,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee compensation and amounts withheld</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-160">6,041</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-161">4,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-162">4,374</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-163">4,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-164">1,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-165">1,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-166">40,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-167">40,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of financing liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-168">27,420</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-169">28,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-170">235</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-171">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-172">5,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-173">7,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued pension and deferred compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:AccruedEmployeeBenefitPlanCosts" format="ixt:num-dot-decimal" scale="3" id="f-174">3,008</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:AccruedEmployeeBenefitPlanCosts" format="ixt:num-dot-decimal" scale="3" id="f-175">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-176">1,218</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-177">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-178">462</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-179">455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-180">78,557</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-181">80,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and Contingencies (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_118">Note 10</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-31" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-182"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-20" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-183"/></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-184"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-185">2.50</ix:nonFraction></ix:nonFraction> par value, Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-186"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-187">5,000</ix:nonFraction></ix:nonFraction> shares;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issued&#8212; <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-188">2,909</ix:nonFraction> shares (2024); <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-189">2,833</ix:nonFraction> shares (2023)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding&#8212; <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-190">2,839</ix:nonFraction> shares (2024); <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-191">2,830</ix:nonFraction> shares (2023)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-192">7,273</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-193">7,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-194">5,406</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-195">5,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-196">47,514</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-197">28,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-198">3,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-199">3,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock in treasury, at cost: <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:TreasuryStockCommonShares" scale="3" id="f-200">70</ix:nonFraction> shares (2024); <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:TreasuryStockCommonShares" scale="3" id="f-201">3</ix:nonFraction> shares (2023)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="f-202">2,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="f-203">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Kewaunee Scientific Corporation Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">54,760</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">37,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-206">1,449</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-207">1,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-208">56,209</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-209">38,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-210">134,766</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-211">118,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_88"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.739%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">19,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-213">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash used by operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-214">3,125</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-215">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-216">276</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-217">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-218">1,028</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-219">886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" format="ixt:num-dot-decimal" scale="3" id="f-220">7,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" scale="3" id="f-221">516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="f-222">741</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-223">4,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-224">1,210</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-225">1,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="f-226">691</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-227">5,558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-228">277</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-229">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="f-230">286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="f-231">1,508</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-232">19,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-233">3,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-234">4,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-235">4,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-236">4,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-237">4,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-238">148,061</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-239">60,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-240">148,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-241">58,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale-leaseback transaction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:ProceedsFromFinancingLiability" format="ixt:fixed-zero" scale="3" id="f-242">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:ProceedsFromFinancingLiability" format="ixt:num-dot-decimal" scale="3" id="f-243">13,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on financing liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:PaymentsOnFinancingLiability" scale="3" id="f-244">642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:PaymentsOnFinancingLiability" scale="3" id="f-245">575</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="f-246">202</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="f-248">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="f-249">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of Treasury Stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-250">1,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-251">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-252">3,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-253">14,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-254">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-255">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase in Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-256">12,123</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-257">6,921</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-258">13,815</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-259">6,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, Cash Equivalents and Restricted Cash at End of Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-260">25,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-261">13,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Flow Information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-262">1,799</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-263">1,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-264">6,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-265">3,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets obtained under new operating leases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-266">200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-267">3,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets obtained under new finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-268">204</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-269">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_91"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-270" continuedAt="f-270-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-270-1" continuedAt="f-270-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-271" continuedAt="f-271-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-271-1"> The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2024 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is <ix:nonFraction unitRef="number" contextRef="c-32" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-272">100</ix:nonFraction>% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is <ix:nonFraction unitRef="number" contextRef="c-33" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-273">100</ix:nonFraction>% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is <ix:nonFraction unitRef="number" contextRef="c-34" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-274">94</ix:nonFraction>% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is <ix:nonFraction unitRef="number" contextRef="c-35" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-275">80</ix:nonFraction>% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is <ix:nonFraction unitRef="number" contextRef="c-36" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-276">70</ix:nonFraction>% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.</ix:continuation> Included in the consolidated financial statements are net assets of $<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="f-277">18,547,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="f-278">16,786,000</ix:nonFraction> at April&#160;30, 2024 and 2023, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-279">66,517,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-280">72,778,000</ix:nonFraction> were included in the consolidated statements of operations for fiscal years 2024 and 2023, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-281" continuedAt="f-281-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2024 and 2023, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-281-1">The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" id="f-282" continuedAt="f-282-1" escape="true">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:</ix:nonNumeric></span></div><ix:continuation id="f-282-1"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"/><td style="width:59.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.918%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.919%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-283">23,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-284">8,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-285">2,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-286">5,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-287">25,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-288">13,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-289" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="f-290" continuedAt="f-290-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-290-1"> Receivables are stated at the amount owed by the customer, net of allowances for estimated credit losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for credit losses is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential credit losses, a reserve for credit losses is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" id="f-291" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for credit losses for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-292">476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-293">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-294">276</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-295">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="f-296">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="f-297">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-298">588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-299">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-270-2" continuedAt="f-270-3"><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" id="f-300" continuedAt="f-300-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unbilled Receivables</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-300-1"> Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.</ix:continuation> The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2024 and 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-301">11,840,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-302">13,459,000</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-303" continuedAt="f-303-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-303-1"> The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-304" continuedAt="f-304-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-304-1"> Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-305" continuedAt="f-305-1" escape="true">Property, plant and equipment consisted of the following at April&#160;30:</ix:nonNumeric></span></div><ix:continuation id="f-305-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-306">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-307">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-308">17,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-309">17,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-45" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-310">5</ix:nonNumeric>-<ix:nonNumeric contextRef="c-46" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-311">40</ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-312">46,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-313">44,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-49" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-314">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-50" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-315">10</ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-316">64,234</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-317">61,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-318">46,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-319">44,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-320">17,649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-321">16,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentImpairment" id="f-322" escape="true">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.</ix:nonNumeric> There were <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-323"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-324">no</ix:nonFraction></ix:nonFraction> impairments in fiscal years 2024 or 2023.</span></div><ix:nonNumeric contextRef="c-1" name="kequ:OtherAssetsPolicyTextBlock" id="f-325" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2024 and 2023 included $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-326">312,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-327">1,191,000</ix:nonFraction>, respectively, of unbilled retainage, $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="0" id="f-328">2,611,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="0" id="f-329">2,352,000</ix:nonFraction>, respectively, of assets held in a trust account for non-qualified benefit plan, and $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="0" id="f-330">31,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="0" id="f-331">111,000</ix:nonFraction>, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-332" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for credit losses, self-insurance reserves, and income taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-333" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#8217;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-334">30,275,000</ix:nonFraction> in sales proceeds.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of the Buyer, entering into a lease agreement. The lease arrangement is for a <ix:nonNumeric contextRef="c-31" name="kequ:FinancingLiabilityTermOfContract" format="ixt-sec:durwordsen" id="f-335">20-year</ix:nonNumeric> term. At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). The Company concluded that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For additional information on the accounting for the Sale-Leaseback Arrangement, refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-336" continuedAt="f-336-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-270-3" continuedAt="f-270-4"><ix:continuation id="f-336-1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-337" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2024 and 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:50.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-338">1,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-339">1,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-340">1,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-341">1,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-342">Total</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-343">1,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-344">1,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-345">2,642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-346">3,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-347">3,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-348">Total</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-349">3,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-350">3,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:50.698%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-351">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-352">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-353">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-354">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-355">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-356">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-357">2,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-358">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-359">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-360">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-361">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains <ix:nonFraction unitRef="compensation_plan" contextRef="c-31" decimals="INF" name="kequ:NumberOfNonqualifiedCompensationPlans" format="ixt-sec:numwordsen" scale="0" id="f-362"><ix:nonFraction unitRef="compensation_plan" contextRef="c-20" decimals="INF" name="kequ:NumberOfNonqualifiedCompensationPlans" format="ixt-sec:numwordsen" scale="0" id="f-363">two</ix:nonFraction></ix:nonFraction> non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-364" continuedAt="f-364-1" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ConstructionContractorReceivableRetainage" format="ixt:num-dot-decimal" scale="0" id="f-365">294,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ConstructionContractorReceivableRetainage" format="ixt:num-dot-decimal" scale="0" id="f-366">235,000</ix:nonFraction> at April&#160;30, 2024 and 2023, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-270-4" continuedAt="f-270-5"><ix:continuation id="f-364-1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-367" continuedAt="f-367-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Concentration </span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-367-1">The Company performs credit evaluations of its customers.</ix:continuation> Revenues from three of the Company's domestic dealers represented in the aggregate approximately <ix:nonFraction unitRef="number" contextRef="c-72" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-368">45</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-73" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-369">36</ix:nonFraction>% of the Company's sales in fiscal years 2024 and 2023, respectively. Accounts receivable for two domestic customers represented approximately <ix:nonFraction unitRef="number" contextRef="c-74" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-370">21</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-75" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-371">23</ix:nonFraction>% of the Company's total accounts receivable as of April&#160;30, 2024 and 2023, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="f-372" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-373" continuedAt="f-373-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-373-1"> In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under AC 740, the Company evaluates the realization of all deferred income tax assets and determines if a valuation allowance is required on an annual basis. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2024 or 2023.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-374" continuedAt="f-374-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Experimentation Expenditures</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-374-1"> Research and experimentation expenditures are charged to cost of products sold in the periods incurred.</ix:continuation> Expenditures for research and experimentation expenditures were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="0" id="f-375">920,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="0" id="f-376">1,012,000</ix:nonFraction> for the fiscal years ended April&#160;30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-377" continuedAt="f-377-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-377-1"> Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.</ix:continuation> Advertising costs for the years ended April&#160;30, 2024 and 2023 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="0" id="f-378">336,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="0" id="f-379">226,000</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-380" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-381" continuedAt="f-381-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-381-1"> Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.</ix:continuation> There were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-382">no</ix:nonFraction> antidilutive RSUs and stock options outstanding at April&#160;30, 2024. There were <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-383">33,900</ix:nonFraction> antidilutive RSUs and stock options outstanding at April&#160;30, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-384" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:65.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-385">2,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-386">2,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="f-387">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="f-388">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-389">2,938</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-390">2,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-391" continuedAt="f-391-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Stock Options and Other Equity Awards</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-391-1"> Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.</ix:continuation> The Company granted <ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-392">117,747</ix:nonFraction> RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2024 and <ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-393">87,969</ix:nonFraction> RSUs in fiscal year 2023. There were <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-394"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-395">no</ix:nonFraction></ix:nonFraction> stock options granted during fiscal years 2024 and 2023. (See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_112">Note&#160;7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-396" escape="true"><ix:continuation id="f-270-5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company adopted this standard effective May 1, 2023. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures," which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2025. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements for Income Tax Disclosures," which requires public business entities to, on an annual basis, (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. This ASU also provides for additional disclosure requirements to provide clarity for investors related to income tax disclosures. This guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2026. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div></ix:continuation></ix:nonNumeric><div id="i7c2284e7bf3e47828f4617b389f29ad2_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 - <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-397" continuedAt="f-397-1" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="f-397-1" continuedAt="f-397-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary performance obligations identified by the Company:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laboratory Furniture</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the marketplace such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-397-2" continuedAt="f-397-3"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installation Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Terms and Transaction Prices</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allocation of Transaction Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients Used</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the following practical expedients:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment terms with the Company's customers which are one year or less are not considered a significant financing component.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-397-3"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-398" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"/><td style="width:52.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.600%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.080%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-399">131,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-400">66,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-401">198,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-402">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-404">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-405">137,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-406">66,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-407">203,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"/><td style="width:52.180%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.260%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.600%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.600%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-408">141,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-409">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-410">214,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-411">4,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-413">4,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-414">146,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-415">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-416">219,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing balances of contract assets included $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-417">11,840,000</ix:nonFraction> in accounts receivable and $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-418">312,000</ix:nonFraction> in other current assets at April&#160;30, 2024. The opening balance of contract assets arising from contracts with customers included $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-419">13,459,000</ix:nonFraction> in accounts receivable and $<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-420">1,191,000</ix:nonFraction> in other assets at April&#160;30, 2023. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-421">4,374,000</ix:nonFraction> at April&#160;30, 2024 and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-422">4,097,000</ix:nonFraction> at April&#160;30, 2023. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended April&#160;30, 2024, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately <ix:nonFraction unitRef="number" contextRef="c-94" decimals="INF" name="kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage" scale="-2" id="f-423">100</ix:nonFraction>% of the contract liability balance at April&#160;30, 2024 is expected to be recognized as revenue during fiscal year 2025.</span></div></ix:continuation><div id="i7c2284e7bf3e47828f4617b389f29ad2_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-424" continuedAt="f-424-1" escape="true">Inventories</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-425" escape="true"><ix:continuation id="f-424-1" continuedAt="f-424-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"/><td style="width:74.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-426">3,042</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-427">3,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-428">1,931</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-429">2,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-430">15,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-431">16,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-432">20,679</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-433">21,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-424-2">At April&#160;30, 2024 and 2023, the Company's international subsidiaries' inventories were $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:FIFOInventoryAmount" format="ixt:num-dot-decimal" scale="0" id="f-434">3,239,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:FIFOInventoryAmount" format="ixt:num-dot-decimal" scale="0" id="f-435">2,740,000</ix:nonFraction>, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-436" continuedAt="f-436-1" escape="true">Long-term Debt and Other Credit Arrangements </ix:nonNumeric></span></div><ix:continuation id="f-436-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-437">15.0</ix:nonFraction>&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="0" id="f-438">1,000,000</ix:nonFraction>, up to a maximum borrowing availability of $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" format="ixt:num-dot-decimal" scale="6" id="f-439">30.0</ix:nonFraction>&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus <ix:nonFraction unitRef="number" contextRef="c-98" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-440">4.10</ix:nonFraction>%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, there was $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="0" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="0" id="f-441">3,000,000</ix:nonFraction> outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="0" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-442">11,587,000</ix:nonFraction>. At April&#160;30, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="0" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="0" id="f-443">3,548,000</ix:nonFraction> outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="0" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-444">10,286,000</ix:nonFraction>. The borrowing rate under the Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="c-99" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-445">9.54</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-100" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-446">9.02</ix:nonFraction>% as of April&#160;30, 2024 and 2023, respectively. The Company was in compliance with all financial covenants under its revolving credit facility at April&#160;30, 2024 and 2023. In addition, the Company's International subsidiaries had a balance outstanding of $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="f-447">99,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="f-448">39,000</ix:nonFraction> in short-term borrowings related to overdraft protection and short-term loan arrangements at April&#160;30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, there were foreign bank guarantees outstanding to customers in the amounts of $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="6" id="f-449">7.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="0" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-450">435,000</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="0" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-451">226,000</ix:nonFraction> with expiration dates in fiscal years 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April&#160;30, 2023, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $<ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="6" id="f-452">5.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-453">142,000</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-454">3,000</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-455">233,000</ix:nonFraction> with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India.</span></div></ix:continuation><div id="i7c2284e7bf3e47828f4617b389f29ad2_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SaleLeasebackTransactionDisclosureTextBlock" id="f-456" continuedAt="f-456-1" escape="true">Sale-Leaseback Financing Transaction</ix:nonNumeric></span></div><ix:continuation id="f-456-1" continuedAt="f-456-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#8217;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a <ix:nonNumeric contextRef="c-31" name="kequ:FinancingLiabilityTermOfContract" format="ixt-sec:durwordsen" id="f-457">20-year</ix:nonNumeric> term, with <ix:nonFraction unitRef="renewaloption" contextRef="c-1" decimals="0" name="kequ:FinancingLiabilityNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-458">four</ix:nonFraction> renewal options of <ix:nonNumeric contextRef="c-31" name="kequ:FinancingLiabilityRenewalTerm" format="ixt-sec:durwordsen" id="f-459">five years</ix:nonNumeric> each. Under the terms of the Lease Agreement, the Company&#8217;s initial basic rent is approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:FinancingLiabilityBasicMonthlyPayment" format="ixt:num-dot-decimal" scale="0" id="f-460">158,000</ix:nonFraction> per month, with annual increases of approximately <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="kequ:FinancingLiabilityAnnualIncreasePercent" scale="-2" id="f-461">2</ix:nonFraction>% each year of the initial term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of <ix:nonFraction unitRef="number" contextRef="c-31" decimals="INF" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" id="f-462">4.75</ix:nonFraction>% to reflect the Company&#8217;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#8220;lease payments&#8221; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:fixed-zero" scale="0" id="f-463">No</ix:nonFraction> gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;30, 2024, the carrying value of the financing liability was $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-464">28,133,000</ix:nonFraction>, net of $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="0" id="f-465">648,000</ix:nonFraction> in debt issuance costs, of which $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-466">713,000</ix:nonFraction> was classified as current on the Consolidated Balance Sheet with $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-467">27,420,000</ix:nonFraction> classified as long-term. As of April&#160;30, 2023, the carrying value of the financing liability was $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-468">28,774,000</ix:nonFraction>, net of $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="0" id="f-469">708,000</ix:nonFraction> in debt issuance costs, of which $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:FinancingLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-470">642,000</ix:nonFraction> was classified as current on the Consolidated Balance Sheet with $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-471">28,132,000</ix:nonFraction> classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-456-2" continuedAt="f-456-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expense associated with the financing arrangement was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:InterestExpenseFinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-472">1,287,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:InterestExpenseFinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-473">1,316,000</ix:nonFraction> for the years ended April 30, 2024 and 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will depreciate the building down to zero over the <ix:nonNumeric contextRef="c-110" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-474">20-year</ix:nonNumeric> assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-475">41,000</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="c-1" name="kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" id="f-476" continuedAt="f-476-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:</span></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><ix:continuation id="f-476-1"><ix:continuation id="f-456-3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"/><td style="width:67.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearOne" format="ixt:num-dot-decimal" scale="3" id="f-477">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-478">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearThree" format="ixt:num-dot-decimal" scale="3" id="f-479">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearFour" format="ixt:num-dot-decimal" scale="3" id="f-480">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearFive" format="ixt:num-dot-decimal" scale="3" id="f-481">2,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaidAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-482">31,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityToBePaid" format="ixt:num-dot-decimal" scale="3" id="f-483">41,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-484">13,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="3" id="f-485">28,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-486" continuedAt="f-486-1" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="f-486-1" continuedAt="f-486-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="kequ:TaxWithholdingExpense" format="ixt:num-dot-decimal" scale="0" id="f-487">371,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="kequ:TaxWithholdingExpense" format="ixt:num-dot-decimal" scale="0" id="f-488">406,000</ix:nonFraction> for the years ended April 30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-489" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax (benefit) expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"/><td style="width:64.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-490">2,332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-491">691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-492">65</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-493">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-494">2,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-495">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-496">5,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-497">2,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-498">10,378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-499">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-500">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-501">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-502">275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-503">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-504">10,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-505">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-506">5,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-507">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-486-2" continuedAt="f-486-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-508" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax (benefit) expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"/><td style="width:66.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.707%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-509">2,755</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="f-510">945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-511">575</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-512">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="f-513">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="f-514">433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-515">243</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-516">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of pension settlement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" format="ixt:num-dot-decimal" scale="3" id="f-517">3,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" format="ixt:fixed-zero" scale="3" id="f-518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" scale="3" id="f-519">743</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" scale="3" id="f-520">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="3" id="f-521">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="3" id="f-522">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in valuation allowance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-523">6,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-524">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on unremitted earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" scale="3" id="f-525">371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" scale="3" id="f-526">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-527">83</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-528">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-529">5,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-530">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-531" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:74.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="3" id="f-532">152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="3" id="f-533">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-534">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-535">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="3" id="f-536">950</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-537">1,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-538">170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-539">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="f-540">638</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="f-541">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxAssetsSection174REAddback" format="ixt:num-dot-decimal" scale="3" id="f-542">2,303</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxAssetsSection174REAddback" format="ixt:num-dot-decimal" scale="3" id="f-543">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:fixed-zero" scale="3" id="f-544">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-545">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="f-546">296</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="f-547">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-548">152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-549">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxAssetsProceedsOnSaleLeaseback" format="ixt:num-dot-decimal" scale="3" id="f-550">6,316</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxAssetsProceedsOnSaleLeaseback" format="ixt:num-dot-decimal" scale="3" id="f-551">6,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxAssetLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-552">1,211</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxAssetLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-553">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-554">332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-555">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-556">12,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-557">14,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-558">1,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-559">1,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxLiabilitiesSaleLeasebackProperty" format="ixt:num-dot-decimal" scale="3" id="f-560">1,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxLiabilitiesSaleLeasebackProperty" format="ixt:num-dot-decimal" scale="3" id="f-561">1,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxLiabilitiesPrepaidPensionCost" format="ixt:fixed-zero" scale="3" id="f-562">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxLiabilitiesPrepaidPensionCost" scale="3" id="f-563">919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="kequ:DeferredTaxLiabilitiesAPB23Assertion" format="ixt:num-dot-decimal" scale="3" id="f-564">1,572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="kequ:DeferredTaxLiabilitiesAPB23Assertion" format="ixt:num-dot-decimal" scale="3" id="f-565">1,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-566">1,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-567">1,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-568">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-569">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-570">5,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-571">6,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-572">926</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-573">8,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-574">6,183</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-575">943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, non-current</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-576">7,401</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="f-577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, non-current</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-578">1,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-579">943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-580">6,183</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-581">943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-486-3"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both positive and negative, to determine the amount of any required valuation allowance. As of April&#160;30, 2024, our deferred tax assets primarily related to proceeds on a prior sale leaseback and Section 174 research and expenditures addbacks. A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-582">926,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-583">8,568,000</ix:nonFraction> was recorded against our net deferred tax asset balance as of April 30, 2024 and 2023, respectively. For the year ended April 30, 2024, we recorded a net decrease in valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-584">6,579,000</ix:nonFraction>, as compared to a net increase of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-585">1,667,000</ix:nonFraction> for the year ended April 30, 2023, based on management's reassessment of the amount of its deferred tax assets that are more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state and local tax returns with statutes of limitation generally ranging from <ix:nonNumeric contextRef="c-113" name="kequ:FederalStateAndLocalTaxReturnsPeriod" format="ixt-sec:duryear" id="f-586">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-114" name="kequ:FederalStateAndLocalTaxReturnsPeriod" format="ixt-sec:duryear" id="f-587">4</ix:nonNumeric> years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2020 or state and local tax examinations for years prior to fiscal year 2019. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of <ix:nonNumeric contextRef="c-113" name="kequ:ForeignSubsidiariesTaxReturnsPeriod" format="ixt-sec:duryear" id="f-588">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c-114" name="kequ:ForeignSubsidiariesTaxReturnsPeriod" format="ixt-sec:duryear" id="f-589">7</ix:nonNumeric> years and are generally no longer subject to examination for years prior to fiscal year 2018. The Company has no unrecognized tax benefits.</span></div></ix:continuation><div id="i7c2284e7bf3e47828f4617b389f29ad2_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 - <ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-590" continuedAt="f-590-1" escape="true">Stock Options and Share-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="f-590-1" continuedAt="f-590-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stockholders approved the 2023 Omnibus Incentive Plan ("2023 Plan") in August, 2023, which enables the Company to grant a broad range of equity based awards, with potential recipients including directors, consultants and employees. The 2023 Plan replaced the 2017 Omnibus Incentive Plan (the "2017 Plan"). All outstanding equity granted under the 2017 Plan remain subject to, and will be settled under, the 2017 Plan. At the date of approval of the 2023 Plan, there were&#8239;<ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-591">64,633</ix:nonFraction>&#8239;shares available for new awards under the 2017 Plan, and <ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-592">168,791</ix:nonFraction> shares available for issuance under equity awards outstanding under the 2017 Plan.&#8239;These shares that were available for new awards and any shares subject to outstanding awards under the 2017 Plan that subsequently cease to be subject to such awards are available under the 2023 Plan. The 2023 Plan also increased the total number of shares reserved for issuance under the Company's equity compensation plans by <ix:nonFraction unitRef="shares" contextRef="c-117" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-593">310,000</ix:nonFraction>, for a total of <ix:nonFraction unitRef="shares" contextRef="c-118" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-594">374,633</ix:nonFraction> shares initially reserved for issuance under the 2023 Plan. At April&#160;30, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-119" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-595">383,572</ix:nonFraction> shares available for future issuance under the 2023 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2023 Plan and the 2017 Plan, in the aggregate, the Company recorded stock-based compensation expense for employees of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-596">1,018,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-597">845,000</ix:nonFraction> and deferred income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-598">223,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-599">199,000</ix:nonFraction> in fiscal years 2024 and 2023, respectively. The RSUs granted under the 2023 Plan and the 2017 Plan include grants with both a service and performance component vesting over a <ix:nonNumeric contextRef="c-120" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-600">3</ix:nonNumeric> year period and grants with only service components vesting over a <ix:nonNumeric contextRef="c-122" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-601">3</ix:nonNumeric> year period. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="0" id="f-602">1,656,000</ix:nonFraction> will be recorded over the remaining vesting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2024. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-603" continuedAt="f-603-1" escape="true">The following table summarizes the RSU activity and weighted averages.</ix:nonNumeric></span></div><ix:continuation id="f-603-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"/><td style="width:48.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.621%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-604">159,640</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-605">11.94</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-125" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-606">144,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-607">12.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-608">117,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-609">15.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-610">87,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-611">13.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-612">103,519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-613">11.03</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-614">50,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-615">13.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-616">5,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-617">10.54</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-618">22,841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-619">15.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-620">168,791</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-621">15.35</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-622">159,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-623">11.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders approved the 2008 Key Employee Stock Option Plan in fiscal year 2009 which allowed the Company to grant options on an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-624">300,000</ix:nonFraction> shares of the Company's common stock and an amendment to the plan in August&#160;2015, authorizing an additional <ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-625">300,000</ix:nonFraction> shares. Under the plan, options were granted at not less than the fair market value at the date of grant with options exercisable in such installments, for such terms (up to <ix:nonNumeric contextRef="c-129" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-626">10</ix:nonNumeric> years). This plan was replaced by the 2017 Omnibus Plan with all outstanding options granted under the prior plan to remain subject to the prior plan. The last grant of options, issued on August 31, 2016, under the prior plan will expire August 31, 2026. The Company did not record any compensation expense related to outstanding stock options in fiscal years 2024 or 2023.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-590-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued new shares of common stock to satisfy options exercised during fiscal years 2024 and 2023. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-627" continuedAt="f-627-1" escape="true">Stock option activity and weighted average exercise price are summarized as follows:</ix:nonNumeric></span></div><ix:continuation id="f-627-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:40.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-628">33,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-629">19.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-630">47,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-631">19.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-632">3,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-633">16.09</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-634">7,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-635">20.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-636">5,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-637">22.21</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-638">5,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-639">14.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-640">24,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-641">20.05</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-642">33,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-643">19.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-644">24,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-645">20.05</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-646">33,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-20" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-647">19.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-648" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2024:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.717%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-649">15.85</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-650">23.62</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-651">24,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-652">20.05</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-653">1.68</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-654">386,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-655">24,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-656">20.05</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-657">386,584</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_1721"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 - <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-658" continuedAt="f-658-1" escape="true">Stockholder's Equity</ix:nonNumeric></span></div><ix:continuation id="f-658-1" continuedAt="f-658-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-659">5,000,000</ix:nonFraction> shares of Common Stock, par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-660">2.50</ix:nonFraction> per share. Holders of the Company's Common Stock are entitled to 1 vote per share. At April&#160;30, 2024, and April&#160;30, 2023, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-661">2,839,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-662">2,830,000</ix:nonFraction> shares, respectively, of Common Stock issued and outstanding. The Company has not declared or paid any dividends with respect to its Common Stock during the fiscal year ended April 30, 2024. The declaration and payment of any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2023, the Board of Directors of the Company adopted a share repurchase program with authorization to repurchase up to <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="0" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-663">100,000</ix:nonFraction> shares. There is no expiration date and currently, management has no plans to terminate this program. During the fiscal year ended April 30, 2024, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-664">66,191</ix:nonFraction> shares of the Company's common stock for approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="kequ:TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-665">1,992,000</ix:nonFraction>, excluding other costs such as broker commissions and fees.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockByClassTextBlock" id="f-666" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share repurchase activity for the three months ended April 30, 2024:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.553%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.554%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares that May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 - 29</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-131" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-667">6,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-131" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="f-668">29.18</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-132" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-669">6,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-133" decimals="2" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-670">63,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 - 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-134" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-671">12,758</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-134" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="f-672">31.63</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-673">12,758</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="2" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-674">50,854</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - 30</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-675">17,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-137" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" id="f-676">35.11</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-677">17,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="2" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-678">33,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-679">36,735</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-140" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" id="f-680">36,735</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">        On August 31, 2023, the Board of Directors of Kewaunee Scientific Corporation (the "Company") adopted a share repurchase program with authorization to repurchase up to <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="0" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="f-681">100,000</ix:nonFraction> shares of our Company's common stock, which commenced on September 1, 2023 and has no expiration date. The share repurchase program is designed to help offset the impact of future share dilution from employee stock issuances. The timing and amount of any repurchases under this program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions or any combination thereof. The program does not obligate the Company to acquire any particular amount of its common stock, and the share repurchase program may be suspended or discontinued at any time at the Company's discretion.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Excludes other costs such as broker commissions and fees.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><ix:continuation id="f-658-2" continuedAt="f-658-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions that occurred under the share repurchase program prior to the fourth quarter of fiscal year 2024 are presented in Item 2, Unregistered Sales of Equity Securities and Use of Proceeds, in the corresponding interim report on Form 10-Q for the periods ended </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm">October</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm"> 31, 2023</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552924000009/kequ-20240131.htm">January 31, 2024</a></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-658-3">, respectively.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 - <ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-682" continuedAt="f-682-1" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:continuation id="f-682-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="f-683" continuedAt="f-683-1" escape="true">The before tax income (loss), related income tax effect, and accumulated balances are as follows:</ix:nonNumeric></span></div><ix:continuation id="f-683-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-684">2,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-685">1,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-686">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-687">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-688">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-689">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-690">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-691">2,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-692">609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-693">3,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-694">549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-695">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-696">598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-697">509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-698">509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss included in net income</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-699">4,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-700">4,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on postretirement benefit plans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-701">3,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:num-dot-decimal" scale="3" id="f-702">3,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-703">3,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="3" id="f-704">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-705">3,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10 - <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-706" continuedAt="f-706-1" escape="true">Leases, Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-706-1" continuedAt="f-706-2"><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-707">7,454,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-708">9,170,000</ix:nonFraction> at April&#160;30, 2024 and 2023, respectively. Operating cash paid to settle lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-1" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-709">2,594,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-710">2,278,640</ix:nonFraction> for the fiscal year ended April 30, 2024 and 2023, respectively. The Company's leases have remaining lease terms of up to <ix:nonNumeric contextRef="c-1" name="kequ:LesseeRemainingLeaseTerm" format="ixt-sec:duryear" id="f-711">8</ix:nonNumeric> years. In addition, some of the leases may include options to extend the leases for up to <ix:nonNumeric contextRef="c-1" name="kequ:LesseeOptiontoExtendTerm" format="ixt-sec:duryear" id="f-712">5</ix:nonNumeric> years or options to terminate the leases within <ix:nonNumeric contextRef="c-1" name="kequ:LesseeOptiontoTerminateTerm" format="ixt-sec:duryear" id="f-713">1</ix:nonNumeric> year. Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-714">3,458,000</ix:nonFraction> for the twelve months ended April 30, 2024, inclusive of period cost for short-term leases, not included in lease liabilities, of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:OperatingLeaseShortTermExpense" format="ixt:num-dot-decimal" scale="0" id="f-715">864,000</ix:nonFraction>. Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-716">3,344,000</ix:nonFraction> for the fiscal year ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:OperatingLeaseShortTermExpense" format="ixt:num-dot-decimal" scale="0" id="f-717">1,065,000</ix:nonFraction>.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, the weighted average remaining lease term for the capitalized operating leases was <ix:nonNumeric contextRef="c-31" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-718">4.2</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-719">5.1</ix:nonFraction>%. At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was <ix:nonNumeric contextRef="c-20" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-720">5.1</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-721">5.0</ix:nonFraction>%. For the financing leases, the weighted average remaining lease term was <ix:nonNumeric contextRef="c-31" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-722">4.5</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-723">8.3</ix:nonFraction>% at April&#160;30, 2024 as compared to <ix:nonNumeric contextRef="c-20" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-724">3.1</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-20" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-725">6.8</ix:nonFraction>% at April&#160;30, 2023. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-706-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-727" continuedAt="f-727-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-726" continuedAt="f-726-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</span></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:center"><ix:continuation id="f-727-1"><ix:continuation id="f-726-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"/><td style="width:60.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.221%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.158%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.198%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-728">2,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-729">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-730">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-731">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-732">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-733">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-734">1,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-735">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-736">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-737">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-738">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="f-739">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-740">9,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="f-741">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-742">2,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-743">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-744">7,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="f-745">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into a new lease that has not yet commenced as of April&#160;30, 2024 with future minimum lease payments in aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" format="ixt:num-dot-decimal" scale="0" id="f-746">681,000</ix:nonFraction> that are not yet reflected on the Condensed Consolidated Balance Sheet. This lease is expected to commence in the second quarter of fiscal year 2025 with a lease term of <ix:nonNumeric contextRef="c-31" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="f-747">3</ix:nonNumeric> years.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.</span></div></ix:continuation><div id="i7c2284e7bf3e47828f4617b389f29ad2_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 - <ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-748" continuedAt="f-748-1" escape="true">Retirement Benefits</ix:nonNumeric></span></div><ix:continuation id="f-748-1" continuedAt="f-748-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended April 30 ,2024, the Company settled its non-contributory defined benefit plans by transferring approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="kequ:DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" scale="6" id="f-749">17.8</ix:nonFraction> million of pension obligations through the purchase of group annuity contracts for all remaining liabilities under the pension plan. In connection with the transfer, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="0" id="f-750">287,000</ix:nonFraction> in cash to the pension plan, which was intended to fully fund the Company&#8217;s remaining defined benefit pension liabilities.&#8239;These non-contributory defined benefit pension plans, which covered some domestic employees, were amended as of April 30, 2005. Following this amendment, no further benefits have been earned under the plans, and no additional participants have been added. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-748-2" continuedAt="f-748-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="f-751" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:74.439%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.413%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:fixed-zero" scale="3" id="f-752">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-753">18,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-754">18,368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-755">20,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-756">890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-757">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="3" id="f-758">53</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-759">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-760">1,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-761">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-762">17,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" format="ixt:fixed-zero" scale="3" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:fixed-zero" scale="3" id="f-764">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-765">18,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-766">17,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-767">18,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-768">1,292</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-769">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="3" id="f-770">287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="3" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-772">1,558</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-773">1,386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" format="ixt:num-dot-decimal" scale="3" id="f-774">17,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan" format="ixt:fixed-zero" scale="3" id="f-775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-776">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-777">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="3" id="f-778">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="f-779">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="f-780">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="3" id="f-781">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" format="ixt:fixed-zero" scale="3" id="f-782">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-783">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:fixed-zero" scale="3" id="f-784">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-785">1,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:fixed-zero" scale="3" id="f-786">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-787">3,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-788">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2021</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:73.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-789">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-790">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="f-791" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:73.247%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.508%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-792">890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-793">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-794">1,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-795">1,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-796">Recognition of net loss</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="f-797">580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="f-798">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" scale="3" id="f-799">158</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" scale="3" id="f-800">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-801">Effect of settlement</span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:num-dot-decimal" scale="3" id="f-802">4,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="3" id="f-803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-804"><span style="-sec-ix-hidden:f-805"><span style="-sec-ix-hidden:f-806">Total net periodic pension expense plus special events</span></span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="3" id="f-807">4,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-808">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:continuation id="f-748-3"><ix:nonNumeric contextRef="c-1" name="kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" id="f-809" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.431%"><tr><td style="width:1.0%"/><td style="width:66.519%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.138%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-810">12,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-151" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-811">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-812">4,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-152" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-813">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-814">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-153" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-815">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-816">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-20" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-817">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" id="f-818" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:62.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-819">7,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-822">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-825">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-828">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-831">4,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-833">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-834">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-837">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-840">17,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age <ix:nonNumeric contextRef="c-1" name="kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" format="ixt-sec:duryear" id="f-843">21</ix:nonNumeric>, completed <ix:nonNumeric contextRef="c-1" name="kequ:DefinedContributionPlanEligibilityMinimumServicePeriod" format="ixt-sec:durwordsen" id="f-844">three months</ix:nonNumeric> of service, and who elect to participate. The plan provides that the Company make matching contributions equal to <ix:nonFraction unitRef="number" contextRef="c-114" decimals="INF" name="kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" scale="-2" id="f-845">100</ix:nonFraction>% of the employee's qualifying contribution up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-846">3</ix:nonFraction>% of the employee's compensation, and make matching contributions equal to <ix:nonFraction unitRef="number" contextRef="c-113" decimals="INF" name="kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" scale="-2" id="f-847">50</ix:nonFraction>% of the employee's contributions between <ix:nonFraction unitRef="number" contextRef="c-114" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-848">3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-113" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-849">5</ix:nonFraction>% of the employee's compensation, resulting in a maximum employer contribution equal to <ix:nonFraction unitRef="number" contextRef="c-114" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-850">4</ix:nonFraction>% of the employee's compensation. The Company's matching contributions were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:DefinedContributionPlanEmployerMatchingContributionsAmount" format="ixt:num-dot-decimal" scale="0" id="f-851">957,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:DefinedContributionPlanEmployerMatchingContributionsAmount" format="ixt:num-dot-decimal" scale="0" id="f-852">932,000</ix:nonFraction> for years ending April&#160;30, 2024 and 2023. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2024 and 2023.</span></div></ix:continuation><div id="i7c2284e7bf3e47828f4617b389f29ad2_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-853" continuedAt="f-853-1" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="f-853-1" continuedAt="f-853-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are classified into <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-854">two</ix:nonFraction> business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_94">Note&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-855" escape="true"><ix:continuation id="f-853-2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:49.979%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-856">137,238</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-857">66,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-858">203,755</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" scale="3" id="f-859">636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-860">4,062</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" sign="-" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-861">4,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:fixed-zero" scale="3" id="f-862">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-863">2,524</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-864">408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-865">193</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-866">3,125</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-867">15,048</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-868">6,295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-869">8,224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-870">13,119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-871">3,240</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-872">2,935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-873">12,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-874">5,938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-875">304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-876">304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-877">11,808</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-878">3,055</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-879">3,890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-880">18,753</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-881">91,656</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-882">43,110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-883">134,766</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-884">3,759</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="f-885">614</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-886">4,373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-887">1,175</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-888">66,517</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-889">67,692</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-890">146,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-891">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-892">219,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-893">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-894">9,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" sign="-" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-895">11,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:fixed-zero" scale="3" id="f-896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-897">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-898">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-899">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-900">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-901">3,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-902">7,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-903">6,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-904">4,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-906">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-907">889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-908">3,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-909">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-910">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-911">3,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-912">4,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-913">7,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-914">738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-915">80,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-916">38,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-917">118,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-918">2,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-919">1,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-920">4,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-921">2,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-922">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-923">75,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_136"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent Of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in the Registration Statements on Forms S&#8209;8 (Nos. 333-274371, 333&#8209;160276, 333&#8209;176447, 333&#8209;213413, and 333&#8209;220389) of Kewaunee Scientific Corporation of our reports dated June 28, 2024, with respect to the consolidated financial statements of Kewaunee Scientific Corporation, included in this Annual Report on Form 10&#8209;K for the year ended April 30, 2024.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ Forvis Mazars, LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Atlanta, Georgia</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 28, 2024</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are intended to ensure that the information required to be disclosed in our filings under the Securities Exchange Act of 1934 (the "Exchange Act") is properly and timely recorded, processed, summarized, and reported. Our management, including the Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of disclosure controls and procedures as of April&#160;30, 2024 pursuant to Exchange Act Rule&#160;13a-14. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures are effective. In designing disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives, and that management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States. Management conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded the Company maintained effective internal control over financial reporting as of April&#160;30, 2024.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management's report in this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our internal controls over financial reporting that occurred during our fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9B. Other Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 26, 2024 (the "Effective Date"), Kewaunee Scientific Corporation (the "Company") and Donald T. Gardner III, the Company's Vice President, Finance and Chief Financial Officer, entered into a Retention Bonus Agreement (the "Agreement"). Pursuant to the terms of the Agreement, Mr. Gardner will be paid a cash retention bonus in the amount of $150,000 (the "Bonus"). If Mr. Gardner voluntarily resigns from employment with the Company other than for Good Reason, or if the Company terminates Mr. Gardner's employment for Cause, in each case before the date that is 36 months from the Effective Date, Mr. Gardner will reimburse the Company 100% of the gross amount of the Bonus. For purposes of the Agreement, Cause and Good Reason have the definitions ascribed to those terms in the Change of Control Employment Agreement, dated as of June 18, 2019, by and between the Company and Mr. Gardner, a copy of which was filed as </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex102.htm">Exhibit 10.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's Current Report on Form 8-K filed on June 21, 2019. This summary of the material terms of the Agreement is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.22 to this Annual Report on Form 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Trading Plans of Directors and Executive Officers</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in the Company's securities by its directors or executive officers are required to be made in accordance with its <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-924">Insider Trading Policy</ix:nonNumeric>, which, among other things, requires that the transaction be in accordance with applicable U.S. federal securities laws that prohibit trading while in the possession of material nonpublic information. Rule 10b5-1 under the Securities Exchange Act of 1934 provides an affirmative defense that enables prearranged transactions in securities in a manner that avoids concerns about initiating transactions at a future date while possibly in possession of material nonpublic information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended April 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed the Company of the <ix:nonNumeric contextRef="c-139" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-925"><ix:nonNumeric contextRef="c-139" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-926">adoption</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-139" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-927"><ix:nonNumeric contextRef="c-139" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-928">termination</ix:nonNumeric></ix:nonNumeric> of a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as defined in Item 408 of Regulation S-K).</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_148"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART III</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:10pt;padding-left:49.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">The information appearing in the sections entitled "Election of Directors" and "Meetings and Committees of the Board" included in our Proxy Statement for use in connection with our annual meeting of stockholders to be held on August&#160;28, 2024 (the "Proxy Statement") is incorporated herein by reference. The Proxy Statement will be filed with the SEC within 120 days of our most recently completed fiscal year.</span></div><div style="margin-top:10pt;padding-left:49.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The names and ages of our executive officers as of June&#160;28, 2024 and their business experience during the past five years are set forth below: </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Officers</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:23.792%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.374%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.096%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald T. Gardner III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Finance, Chief Financial Officer, Treasurer and Secretary</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ryan S. Noble</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Sales and Marketing&#8212;Americas</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth D. Phillips</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Human Resources</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandar Ranade</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President of Information Technology and Engineering</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas J. Batdorff</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President of Manufacturing Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boopathy Sathyamurthy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Kewaunee Scientific Corporation Singapore Pte. Ltd., Managing Director, International Operations</span></td></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas D. Hull III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in November 2015 as Vice President, Finance, Chief Financial Officer, Treasurer and Secretary. Mr. Hull was elected President and Chief Executive Officer and appointed as a member of the Board of Directors in March 2019. Mr. Hull earned a Bachelor of Science degree in Accounting from LaRoche College and an MBA from the University of Pittsburgh, Joseph M. Katz School of Business. He is a certified public accountant (inactive status) and a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants. Prior to joining the Company, Mr. Hull held several management positions with Ernst &amp; Young, LLP in Pittsburgh, Pennsylvania from 1998 through 2011. From 2011 until joining the Company in 2015, he served as the Vice President of Finance, Accounting, and Information Technology with ATI Specialty Materials in Charlotte, North Carolina.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Donald T. Gardner III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in April 2019 as Vice President of Finance and Chief Financial Officer and was also elected by the Board of Directors to the positions of Secretary and Treasurer. Mr. Gardner has a Bachelor of Science degree in Accounting from the Indiana University of Pennsylvania and a Master of Business Administration from the University of Pittsburgh, Joseph M. Katz School of Business. Prior to joining the Company, from 2017 to 2019, he served as Vice President, Financial Planning &amp; Analysis of Victra, a privately held retailer of wireless products and services. During 2017, he served as the Chief Financial Officer of Component Sourcing International, a privately held provider of global sourcing supply chain solutions. From February 2016 to June 2017, Mr. Gardner served in various leadership roles for Dollar Express Stores, LLC, most recently as Vice President and Treasurer. Dollar Express was an operator of discount retail stores that was sold to a strategic buyer in 2017. Mr. Gardner was a key member of the leadership team that completed the transaction and full wind down of the Company. From 2012 to February 2016, he worked at ATI Specialty Materials, a manufacturer of technically advanced specialty materials and complex components, serving in various financial leadership roles.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ryan S. Noble</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in July 2018 as Vice President of Sales and Marketing - Americas. He has a Bachelor of Science degree from the University of Tennessee. Prior to joining the Company, he was a Regional Sales Director at Wausau Window and Wall Systems, a manufacturer of metal and glass solutions for commercial buildings from 2014 to 2018. From 2008 to 2014, he held several sales management positions at AGC Glass Company, a glass and high performance coatings manufacturer for architectural, residential, interior, and industrial applications.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elizabeth D. Phillips</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in August 2006 as Human Resources and Training Manager. She was promoted to Director of Human Resources in June 2007 and was elected Vice President of Human Resources in June 2009. Ms. Phillips has a Bachelor of Science degree in Psychology and a Minor in Management from Western Carolina University and holds HR certifications to include SPHR and SHRM-SCP. Prior to joining the Company, she held Human Resources leadership positions at Thomasville Furniture and Hickory Chair and lastly, prior to joining Kewaunee, was Director of Human Resources for Vanguard Furniture Co., Inc., a manufacturer of household furniture, from April 2004 until August 2006.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mandar Ranade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in December 2019 as Vice President of Information Technology. In February 2020, Mr. Ranade's responsibilities were expanded to include Engineering and Standards oversight and he now holds the position of Vice President of Information Technology and Engineering. He has a Master of Business Administration, Finance, from the University of Leeds, Leeds, United Kingdom, and a Bachelor of Engineering, Polymers, from University of Pune, Pune, India. He also has certifications as a Project Management Professional, Certified Scrum Master, ITIL (Foundation) Certification and a Master of Oracle Applications. Prior to joining the Company, Mr. Ranade most recently held the position of Division IT Leader for EnPro Industries-Fairbanks Morse, Wisconsin from 2018 to November 2019. From 2015 to 2018, he held several Director positions, the most recent being Director of Technical Services, with Aurora Health Care, ACL Laboratories, Milwaukee, Wisconsin. Prior to these positions he was Senior Manager of IT with IMS Health, Milwaukee, Wisconsin, from 2010 to 2015, and ThermoFisher Scientific in Two Rivers, Wisconsin, from 2005 to 2010. From 1995 to 2005, he held various IT positions with GE Healthcare, Milwaukee, Wisconsin and Mumbai, India, idm Limited, in Doncaster, UK, and GREAVES Limited, Mumbai, India</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Douglas J. Batdorff</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in June 2020 as Vice President of Manufacturing Operations. He has significant experience in directing and guiding manufacturing operations, focusing on improvement of business performance, maximizing growth and profitability. Mr. Batdorff has a Bachelor of Science Degree in Mechanical Engineering from Michigan State University and a Masters in Manufacturing Operations from Kettering University. Prior to joining the Company, Mr. Batdorff was the Chief Operations Officer for Legacy Cabinets, Inc. in Eastaboga, Alabama from 2018 to 2019. From 2005 to 2018 he held various management positions with Steelcase, the most recent as Director of Manufacturing - US Operations from 2014 to 2018. He was with General Motors, Lansing, Michigan from 1998 to 2004 in many management roles, the most recent being Manufacturing Coordinator - General Assembly - Final Process.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bhoopathy Sathyamurthy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in 2000 as General Manager of India Operations and Kewaunee Labway India Pvt. Ltd. He was subsequently promoted to Managing Director of Kewaunee Labway India Pvt. Ltd. He has served as Managing Director of International Operations, which includes responsibilities for all sales and operations in Asia, as well as sales efforts in the Middle East, since September 2013. Mr. Sathyamurthy was elected Vice President of Kewaunee Scientific Corporation Singapore Pte. Ltd., the holding company for Kewaunee's subsidiaries in India and Singapore, in September 2014. He holds a Bachelor Degree in Mechanical Engineering from University of Madras and a Masters of Business Administration from University of Madras.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our code of ethics that applies to our Chief Executive Officer and Chief Financial Officer, entitled "Ethics Obligations for Chief Executive Officer and Employees with Financial Reporting Responsibilities," is available free of charge through our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site. We intend to satisfy any disclosure requirements under Item 5.05 of Form 8-K regarding an amendment to, or waiver from, a provision of the Code of Ethics by posting such information on our website.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Election of Directors &#8211; Meetings and Committees of the Board" in our Proxy Statement is incorporated herein by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delinquent Section 16(a) Reports</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Delinquent Section 16(a) Reports" in our Proxy Statement, if applicable, is incorporated herein by reference.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_157"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;11. Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Compensation Discussion and Analysis," "Compensation Tables," "Agreements with Certain Executives," and "Election of Directors &#8211; Compensation Committee Interlocks and Insider Participation" in the Proxy Statement is incorporated herein by reference.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Security Ownership of Directors and Executive Officers" and "Security Ownership of Certain Beneficial Owners" in the Proxy Statement is incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information as of April&#160;30, 2024 with respect to compensation plans under which our equity securities are authorized for issuance:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"/><td style="width:49.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.082%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>securities&#160;to&#160;be<br/>issued upon<br/>exercise&#160;of<br/>outstanding<br/>options,&#160;warrants<br/>and rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise&#160;price&#160;of<br/>outstanding&#160;options,<br/>warrants and&#160;rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities<br/>remaining&#160;available&#160;for<br/>future issuance under<br/>equity&#160;compensation<br/>plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans approved by Security Holders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008 Key Employee Stock Option Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Omnibus Incentive Plan</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Omnibus Incentive Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans not approved by Security Holders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total Equity Compensation Plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383,572&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_112"> Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Company's consolidated financial statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_163"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Election of Directors" and "Agreements with Certain Executives" in the Proxy Statement is incorporated herein by reference.</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_166"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;14. Principal Accountant Fees and Services</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Ratification of Appointment of Independent Registered Public Accounting Firm&#8212;Audit Fees and Non-Audit Fees" in the Proxy Statement is incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_169"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART IV</span></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed or incorporated by reference as part of this Annual Report:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.516%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_70">19</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76">Consolidated Statements of Operations&#8212;Years ended April&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_76">20</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79">Consolidated Statements of Comprehensive Income&#8212;Years ended April&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_79">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">Consolidated Statements of Stockholders' Equity&#8212;Years ended April&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85">Consolidated Balance Sheets&#8212;April&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88">Consolidated Statements of Cash Flows&#8212;Years ended April&#160;30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_88">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_91">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_91">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_136">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_136">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Financial Statement Schedules</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement schedules have been omitted because the information required has been separately disclosed in the consolidated financial statements or related notes.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits required by Item&#160;601 of Regulation&#160;S-K are listed in the Exhibit Index, which is attached hereto at pages&#160;49 through 51 and which is incorporated herein by reference.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_175"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;16. Form 10-K Summary</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KEWAUNEE SCIENTIFIC CORPORATION</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:2.353%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Articles of incorporation and bylaws</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312518222169/d614312dex31.htm">Conformed copy of Restated Certificate of Incorporation (reflecting all amendments to date)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312520120021/d923297d8k.htm">By-Laws (as amended as of April 21, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Registrant's Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000040/exhibit41.htm">Description of Capital Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Material Contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552924000009/kequ-20240131.htm">Re-Established Retirement Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective January 1, 2024)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312505242780/dex1030.htm">Kewaunee Scientific Corporation Executive Severance Pay Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515403383/d83123dex101.htm">401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective June&#160;29, 2015)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3A*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552920000006/first401kadmendment.htm">First Amendment to the 401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective January 1, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3B*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000013/kequ-20230430.htm">Second Amendment to the 401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation effective May 15, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515260753/d14316ddef14a.htm">Amended and Restated 2008 Key Employee Stock Option Plan effective August&#160;26, 2015</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552923000006/iibcreditagreement.htm">Credit and Security Agreement, dated as of December 19, 2022, by and among Kewaunee Scientific Corporation, Mid Cap Funding IV Trust, as agent, and the lenders from time to time party thereto</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneefullyexecute.htm">Agreement for Purchase and Sale of Real Property dated as of December 22, 2021 between CAI Investments Sub Series 100, LLC and Kewaunee Scientific Corporation </a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6A</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex1stamendmen.htm">First Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 21, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6B</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex2ndamendmen.htm">Second Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 24, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6C</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex3rdamendmen.htm">Third Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 26, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6D</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000055529/000119312522089748/d340464dex105.htm">Fourth Amendment to the Agreement for Purchase and Sale of Real Property dated as of March 23, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1068a.htm">401Plus Executive Deferred Compensation Plan (as amended and restated January&#160;1, 2009)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7A*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1068a.htm">Amendment No. One to the Kewaunee Scientific Corporation 401Plus Executive Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7B*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312518077010/d544804dex1068b.htm">Amendment No. Two to the Kewaunee Scientific Corporation 401Plus Executive Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1069.htm">Pension Equalization Plan (as amended and restated January&#160;1, 2009)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8A*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1069a.htm">Amendment No. One to the Kewaunee Scientific Corporation Pension Equalization Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312517232927/d405586ddef14a.htm">Kewaunee Scientific Corporation 2017 Omnibus Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000019/kequ-20230731.htm">Kewaunee Scientific Corporation 2023 Omnibus Incentive Plan, as amended</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312519128960/d645439dex101.htm">Offer Letter to Donald T. Gardner III dated April 2, 2019.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex101.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Thomas D. Hull III.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex102.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Donald T. Gardner III.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000055529/000119312519178888/d765375dex105.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Elizabeth D. Phillips.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex106.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Ryan S. Noble</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000040/empagree.htm">Employment agreement dated October 1, 2017 between Kewaunee Labway India Pvt. Ltd and Bhoopathy Sathyamurthy.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:2.353%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:74.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000050/offerlettermandarranade1.htm">Employment Agreement dated as of October 28, 2019 between Kewaunee Scientific Corporation and Mandar Ranade</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000055529/000005552920000006/changeofcontroldocforman.htm">Change of Control Employment Agreement dated as of December 2, 2019 between Kewaunee Scientific Corporation and Mandar Ranade</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552920000010/dougbatdorffofferletter.htm">Offer Letter dated as of May 7, 2020 between Kewaunee Scientific Corporation and Douglas J. Batdorff</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552920000010/changeofcontrolbatdorff.htm">Change of Control Employment Agreement dated as of June 1, 2020 between Kewaunee Scientific Corporation and Douglas J. Batdorff</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312524075248/d808180dex101.htm">Retention Bonus Agreement, dated March 18, 2024, by and between Kewaunee Scientific Corporation and Thomas D. Hull III.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022.htm">R</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022.htm">etention Bonus Agreement, dated June </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022.htm">26</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex1022.htm">, 2024, by and between Kewaunee Scientific Corporation and Donald T. Gardner III</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2112024.htm">Subsidiaries of the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">Consent dated June </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">28</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm"> of F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">orvis Mazars</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">, LLP, Independent Registered Public Accounting Firm (incorporated by reference to page&#160;4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="forvisconsentupdated.htm"> of this Report on Form 10-K)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="certification311.htm">Certification of Principal Executive Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="certification312.htm">Certification of Principal Financial Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322.htm">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm">K</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm">ewaunee S</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm">cientific Corporation </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm">Incentive-Based Compensation R</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm">ecovery</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex971clawbackpolicy.htm"> Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;The referenced exhibit is a management contract or compensatory plan or arrangement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(All other exhibits are either inapplicable or not required.)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Footnotes</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed with this Form 10-K with the Securities and Exchange Commission.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October&#160;31, 2005, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2023, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January 31, 2024, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2015, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as Appendix A to the Kewaunee Scientific Corporation Proxy Statement for its Annual Meeting of Stockholders on August&#160;26, 2015 (Commission File No.&#160;0-5286) filed on July&#160;23, 2015, and incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October&#160;31, 2015, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended July 31, 2023, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No. 0-5286) filed on December 19, 2022, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as Appendix A to the Kewaunee Scientific Corporation Proxy Statement for its Annual Meeting of Stockholders on August&#160;30, 2017 (Commission File No.&#160;0-5286) filed on July&#160;21, 2017, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January&#160;31, 2018, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No. 0-5286) filed on March 30, 2022, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on April 30, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on June 21, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October 31, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January&#160;31, 2020, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on April 27, 2020, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2020, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File 0-5286) for the quarterly period ended January 31, 2022, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No. 0-5286) filed on March 22, 2024, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i7c2284e7bf3e47828f4617b389f29ad2_181"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7c2284e7bf3e47828f4617b389f29ad2_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KEWAUNEE SCIENTIFIC CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: June&#160;28, 2024 </span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities indicated on June&#160;28, 2024.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.999%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial and Accounting Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald T. Gardner III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald T. Gardner III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasurer and Secretary</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A majority of the Board of Directors:</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Keith M. Gehl</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;John D. Russell</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith M. Gehl</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John&#160;D.&#160;Russell</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Margaret B. Pyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald F. Shaw</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Margaret B. Pyle</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald F. Shaw</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull, III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull, III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David S. Rhind</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David&#160;S.&#160;Rhind</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>2
<FILENAME>ex1022.htm
<DESCRIPTION>EX-10.22
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1022</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex1022001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1022001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>exhibit2112024.htm
<DESCRIPTION>EX-21.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit2112024</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit2112024001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit2112024001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">`          Exhibit 21.1           Name of Subsidiary  Jurisdiction of Organization  Percentage Ownership   Kewaunee Labway Asia Pte. Ltd.  Singapore  100%   Kewaunee Labway India Pvt. Ltd.  India  94%   Kewaunee Scientific Corporation Singapore Pte. Ltd.  Singapore  100%   Koncepo Scientech International Pvt. Ltd. India 80%  Kequip Global Lab Solutions Pvt. Ltd. India 70%      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>forvisconsentupdated.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>forvisconsentupdated</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- forvisconsentupdated001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="forvisconsentupdated001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Consent of Independent Registered Public Accounting Firm  We consent to the incorporation by reference in the Registration Statements on Forms  S-8 (Nos. 333-274371,  333-160276, 333-176447, 333-213413, and 333-220389) of Kewaunee Scientific Corporation of our reports dated  June 28, 2024, with respect to the consolidated financial statements of Kewaunee Scientific Corporation, included  in this Annual Report on Form 10-K for the year ended April 30, 2024.      Atlanta, Georgia  June 28, 2024&nbsp;   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>certification311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>certification311</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1023;"><!-- certification311001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="certification311001.jpg" title="slide1" width="1023" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 31.1   CERTIFICATION    I, Thomas D. Hull III, certify that:    1. I have reviewed this report on Form 10-K of Kewaunee Scientific Corporation;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a  material fact necessary to make the statements made, in light of the circumstances under which such statements were made,  not misleading with respect to the period covered by this report;   3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly  present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the  periods presented in this report;    4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as  defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:      a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed  under our supervision, to ensure that material information relating to the registrant, including its consolidated  subsidiaries, is made known to us by others within those entities, particularly during the period in which this  report is being prepared;   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be  designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting  and the preparation of financial statements for external purposes in accordance with generally accepted  accounting principles;    c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our  conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered  by this report based on such evaluation; and   d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred  during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual  report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control  over financial reporting; and   5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons  performing the equivalent functions):   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial  reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize  and report financial information; and   b) Any fraud, whether or not material, that involves management or other employees who have a significant  role in the registrant&#8217;s internal control over financial reporting.   /s/ Thomas D. Hull III  Thomas D. Hull III President and Chief Executive Officer   Date: June 28, 2024   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>certification312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>certification312</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1023;"><!-- certification312001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="certification312001.jpg" title="slide1" width="1023" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 31.2   CERTIFICATION    I, Donald T. Gardner III, certify that:   1. I have reviewed this report on Form 10-K of Kewaunee Scientific Corporation;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a  material fact necessary to make the statements made, in light of the circumstances under which such statements were made,  not misleading with respect to the period covered by this report;   3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly  present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the  periods presented in this report;    4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as  defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:      a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed  under our supervision, to ensure that material information relating to the registrant, including its consolidated  subsidiaries, is made known to us by others within those entities, particularly during the period in which this  report is being prepared;   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be  designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting  and the preparation of financial statements for external purposes in accordance with generally accepted  accounting principles;    c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our  conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered  by this report based on such evaluation; and   d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred  during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual  report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control  over financial reporting; and   5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons  performing the equivalent functions):   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial  reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize  and report financial information; and   b) Any fraud, whether or not material, that involves management or other employees who have a significant  role in the registrant&#8217;s internal control over financial reporting.   /s/ Donald T. Gardner III  Donald T. Gardner III Vice President, Finance and Chief Financial Officer   Date: June 28, 2024  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit321</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1023;"><!-- exhibit321001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit321001.jpg" title="slide1" width="1023" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 32.1   CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the accompanying Annual Report of Kewaunee Scientific Corporation (the &#8220;Company&#8221;) on Form 10-K for  the fiscal year ended April 30, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Thomas D.  Hull III, President and Chief Executive Officer of the Company, hereby certify pursuant to 18   U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:    (1) such Form 10-K of the Company for the period ended April 30, 2024, fully complies with the requirements of section  13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and   (2) the information contained in such Form 10-K of the Company for the period ended April 30, 2024, fairly presents, in all  material respects, the financial condition and results of operations of the Company.      Date: June 28, 2024  /s/ Thomas D. Hull III  Thomas D. Hull III President and Chief Executive Officer   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit322</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1023;"><!-- exhibit322001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit322001.jpg" title="slide1" width="1023" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 32.2   CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the accompanying Annual Report of Kewaunee Scientific Corporation (the &#8220;Company&#8221;) on Form 10-K for  the fiscal year ended April 30, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Donald T.  Gardner III, Vice President, Finance and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:   (1) such Form 10-K of the Company for the period ended April 30, 2024, fully complies with the requirements of section  13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and   (2) the information contained in such Form 10-K of the Company for the period ended April 30, 2024, fairly presents, in all  material respects, the financial condition and results of operations of the Company.      Date: June 28, 2024   /s/ Donald T. Gardner III  Donald T. Gardner III Vice President, Finance and Chief  Financial Officer   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>9
<FILENAME>ex971clawbackpolicy.htm
<DESCRIPTION>EX-97.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex971clawbackpolicy</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- ex971clawbackpolicy001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex971clawbackpolicy001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">317077084.1       KEWAUNEE SCIENTIFIC CORPORATION  INCENTIVE-BASED COMPENSATION RECOVERY POLICY  EFFECTIVE DECEMBER 1, 2023    1. Policy Purpose. The purpose of this Kewaunee Scientific Corporation (the &#8220;Company&#8221;) Incentive-Based  Compensation Recovery Policy (this &#8220;Policy&#8221;) is to enable the Company to recover Erroneously  Awarded Compensation in the event that the Company is required to prepare an Accounting  Restatement. This Policy is intended to comply with the requirements set forth in applicable rules of The  NASDAQ Stock Market (the &#8220;Rules&#8221;) and shall be construed and interpreted in accordance with such  intent. Unless otherwise defined in this Policy, capitalized terms shall have the meaning ascribed to such  terms in Section 7.    2. Policy Administration. This Policy shall be administered by the Compensation Committee of the Board  (the &#8220;Committee&#8221;) unless the Board determines to administer this Policy itself. The Committee has full  and final authority to make all determinations under this Policy, in each case to the extent permitted  under the Rules and in compliance with (or pursuant to an exemption from the application of) Section  409A of the Code. All determinations and decisions made by the Committee pursuant to the provisions  of this Policy shall be final, conclusive and binding on all persons, including the Company, its affiliates,  its stockholders and Executive Officers. Any action or inaction by the Committee with respect to an  Executive Officer under this Policy in no way limits the Committee&#8217;s actions or decisions not to act with  respect to any other Executive Officer under this Policy or under any similar policy, agreement or  arrangement, nor shall any such action or inaction serve as a waiver of any rights the Company may  have against any Executive Officer other than as set forth in this Policy.     3. Policy Application. This Policy applies to all Incentive-Based Compensation received by a person: (a)  after beginning service as an Executive Officer; (b) who served as an Executive Officer at any time  during the performance period for such Incentive-Based Compensation; (c) while the Company had a  class of securities listed on a national securities exchange or a national securities association; and (d)  during the three completed fiscal years immediately preceding the Accounting Restatement Date. In  addition to such last three completed fiscal years, the immediately preceding clause (d) includes any  transition period that results from a change in the Company&#8217;s fiscal year within or immediately  following such three completed fiscal years; provided, however, that a transition period between the last  day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a  period of nine to twelve months shall be deemed a completed fiscal year. For purposes of this Section 3,  Incentive-Based Compensation is deemed received in the Company&#8217;s fiscal period during which the  Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if  the payment or grant of the Incentive-Based Compensation occurs after the end of that period. For the  avoidance of doubt, Incentive-Based Compensation that is subject to both a Financial Reporting  Measure vesting condition and a service-based vesting condition shall be considered received when the  relevant Financial Reporting Measure is achieved, even if the Incentive-Based Compensation continues  to be subject to the service-based vesting condition.    4. Policy Recovery Requirement. In the event of an Accounting Restatement, the Company must recover,  reasonably promptly, Erroneously Awarded Compensation, in amounts determined pursuant to this  Policy. The Company&#8217;s obligation to recover Erroneously Awarded Compensation is not dependent on  if or when the Company files restated financial statements. Recovery under this Policy with respect to an  Executive Officer shall not require the finding of any misconduct by such Executive Officer or such  Executive Officer being found responsible for the accounting error leading to an Accounting  Restatement. In the event of an Accounting Restatement, the Company shall satisfy the Company&#8217;s  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex971clawbackpolicy002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex971clawbackpolicy002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2  317077084.1       obligations under this Policy to recover any amount owed from any applicable Executive Officer by  exercising its sole and absolute discretion in how to accomplish such recovery, to the extent permitted  under the Rules and in compliance with (or pursuant to an exemption from the application of) Section  409A of the Code. The Company&#8217;s recovery obligation pursuant to this Section 4 shall not apply to the  extent that the Committee, or in the absence of the Committee, a majority of the independent directors  serving on the Board, determines that such recovery would be impracticable and:    a. The direct expense paid to a third party to assist in enforcing this Policy would exceed the  amount to be recovered. Before concluding that it would be impracticable to recover any  amount of Erroneously Awarded Compensation based on expense of enforcement, the  Company must make a reasonable attempt to recover such Erroneously Awarded  Compensation, document such reasonable attempt(s) to recover, and provide that  documentation to the Stock Exchange;     b. Recovery would violate home country law where that law was adopted prior to November  28, 2022. Before concluding that it would be impracticable to recover any amount of  Erroneously Awarded Compensation based on violation of home country law, the Company  must obtain an opinion of home country counsel, acceptable to the Stock Exchange, that  recovery would result in such a violation, and must provide such opinion to the Stock  Exchange; or    c. Recovery would likely cause an otherwise tax-qualified retirement plan, under which  benefits are broadly available to employees of the registrant, to fail to meet the requirements  of Section 401(a)(13) or Section 411(a) of the Code.    5. Policy Prohibition on Indemnification and Insurance Reimbursement. The Company is prohibited from  indemnifying any Executive Officer or former Executive Officer against the loss of Erroneously  Awarded Compensation. Further, the Company is prohibited from paying or reimbursing an Executive  Officer for purchasing insurance to cover any such loss.     6. Required Policy-Related Filings. The Company shall file all disclosures with respect to this Policy in  accordance with the requirements of the federal securities laws, including disclosures required by U.S.  Securities and Exchange Commission filings.    7. Definitions.    a. &#8220;Accounting Restatement&#8221; means an accounting restatement due to the material  noncompliance of the Company with any financial reporting requirement under the  securities laws, including any required accounting restatement to correct an error in  previously issued financial statements that is material to the previously issued financial  statements, or that would result in a material misstatement if the error were corrected in the  current period or left uncorrected in the current period.    b. &#8220;Accounting Restatement Date&#8221; means the earlier to occur of: (i) the date the Board, a  committee of the Board, or the officer or officers of the Company authorized to take such  action if the Board action is not required, concludes, or reasonably should have concluded,  that the Company is required to prepare an Accounting Restatement; and (ii) the date a  court, regulator, or other legally authorized body directs the Company to prepare an  Accounting Restatement.    c. &#8220;Board&#8221; means the board of directors of the Company.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex971clawbackpolicy003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex971clawbackpolicy003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3  317077084.1       d. &#8220;Code&#8221; means the U.S. Internal Revenue Code of 1986, as amended. Any reference to a  section of the Code or regulation thereunder includes such section or regulation, any valid  regulation or other official guidance promulgated under such section, and any comparable  provision of any future legislation or regulation amending, supplementing, or superseding  such section or regulation.    e. &#8220;Erroneously Awarded Compensation&#8221; means, in the event of an Accounting Restatement,  the amount of Incentive-Based Compensation previously received that exceeds the amount  of Incentive-Based Compensation that otherwise would have been received had it been  determined based on the restated amounts in such Accounting Restatement, and must be  computed without regard to any taxes paid by the relevant Executive Officer; provided,  however, that for Incentive-Based Compensation based on stock price or total stockholder  return, where the amount of Erroneously Awarded Compensation is not subject to  mathematical recalculation directly from the information in an Accounting Restatement: (i)  the amount of Erroneously Awarded Compensation must be based on a reasonable estimate  of the effect of the Accounting Restatement on the stock price or total stockholder return  upon which the Incentive-Based Compensation was received; and (ii) the Company must  maintain documentation of the determination of that reasonable estimate and provide such  documentation to the Stock Exchange.    f. &#8220;Executive Officer&#8221; means the Company&#8217;s president, principal financial officer, principal  accounting officer (or if there is no such accounting officer, the controller), any vice- president of the Company in charge of a principal business unit, division, or function (such  as sales, administration, or finance), any other officer who performs a policy-making  function, or any other person who performs similar policy-making functions for the  Company. An executive officer of the Company&#8217;s parent or subsidiary is deemed an  &#8220;Executive Officer&#8221; if the executive officer performs such policy making functions for the  Company.     g. &#8220;Financial Reporting Measure&#8221; means any measure that is determined and presented in  accordance with the accounting principles used in preparing the Company&#8217;s financial  statements, and any measure that is derived wholly or in part from such measure; provided,  however, that a Financial Reporting Measure is not required to be presented within the  Company&#8217;s financial statements or included in a filing with the U.S. Securities and  Exchange Commission to qualify as a &#8220;Financial Reporting Measure.&#8221; For purposes of this  Policy, &#8220;Financial Reporting Measure&#8221; includes, but is not limited to, stock price and total  stockholder return.     h. &#8220;Incentive-Based Compensation&#8221; means any compensation that is granted, earned, or vested  based wholly or in part upon the attainment of a Financial Reporting Measure.    i. &#8220;Stock Exchange&#8221; means the national stock exchange on which the Company&#8217;s common  stock is listed.    8. Acknowledgement. Each Executive Officer shall sign and return to the Company, within 30 calendar  days following the later of (i) the effective date of this Policy first set forth above or (ii) the date the  individual becomes an Executive Officer, the Acknowledgement Form attached hereto as Exhibit A,  pursuant to which the Executive Officer agrees to be bound by, and to comply with, the terms and  conditions of this Policy.    9. Severability. The provisions in this Policy are intended to be applied to the fullest extent of the law. To  the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex971clawbackpolicy004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex971clawbackpolicy004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4  317077084.1       law, such provision shall be applied to the maximum extent permitted, and shall automatically be  deemed amended in a manner consistent with its objectives to the extent necessary to conform to any  limitations required under applicable law.    10. Amendment; Termination. The Board may amend this Policy from time to time in its sole and absolute  discretion and shall amend this Policy as it deems necessary to reflect the Rules, to comply with (or  maintain an exemption from the application of) Section 409A of the Code. The Board may terminate  this Policy at any time.    11. Other Recovery Obligations; General Rights. To the extent that the application of this Policy would  provide for recovery of Incentive-Based Compensation that the Company recovers pursuant to Section  304 of the Sarbanes-Oxley Act or other recovery obligations, the amount the relevant Executive Officer  has already reimbursed the Company will be credited to the required recovery under this Policy. This  Policy shall not limit the rights of the Company to take any other actions or pursue other remedies that  the Company may deem appropriate under the circumstances and under applicable law, in each case to  the extent permitted under the Rules and in compliance with (or pursuant to an exemption from the  application of) Section 409A of the Code. Nothing contained in this Policy shall limit the Company&#8217;s  ability to seek recoupment, in appropriate circumstances (including circumstances beyond the scope of  this Policy) and as permitted by applicable law, of any amounts from any individual, in each case to the  extent permitted under the Rules and in compliance with (or pursuant to an exemption from the  application of) Section 409A of the Code.    12. Successors. This Policy is binding and enforceable against all Executive Officers and their beneficiaries,  heirs, executors, administrators or other legal representatives.    13. Governing Law; Venue. This Policy and all rights and obligations hereunder are governed by and  construed in accordance with the internal laws of the State of Delaware, excluding any choice of law  rules or principles that may direct the application of the laws of another jurisdiction. All actions arising  out of or relating to this Policy shall be heard and determined exclusively in the Court of Chancery of  the State of Delaware or, if such court declines to exercise jurisdiction or if subject matter jurisdiction  over the matter that is the subject of any such legal action or proceeding is vested exclusively in the U.S.  federal courts, the U.S. District Court for the District of Delaware.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>kequ-20240430.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:kequ="http://www.kewaunee.com/20240430" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.kewaunee.com/20240430">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20240430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20240430_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20240430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20240430_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.kewaunee.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.kewaunee.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofStockholdersEquity" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity">
        <link:definition>0000005 - Statement - Consolidated Statement of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofStockholdersEquityParenthetical" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical">
        <link:definition>0000006 - Statement - Consolidated Statement of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000007 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000008 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000009 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.kewaunee.com/role/RevenueRecognition">
        <link:definition>0000011 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.kewaunee.com/role/Inventories">
        <link:definition>0000012 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtandOtherCreditArrangements" roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements">
        <link:definition>0000013 - Disclosure - Long-term Debt and Other Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransaction" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction">
        <link:definition>0000014 - Disclosure - Sale-Leaseback Financing Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.kewaunee.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensation" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation">
        <link:definition>0000016 - Disclosure - Stock Options and Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.kewaunee.com/role/StockholdersEquity">
        <link:definition>0000017 - Disclosure - Stockholder's Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingencies" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies">
        <link:definition>0000019 - Disclosure - Leases, Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefits" roleURI="http://www.kewaunee.com/role/RetirementBenefits">
        <link:definition>0000020 - Disclosure - Retirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.kewaunee.com/role/SegmentInformation">
        <link:definition>0000021 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.kewaunee.com/role/RevenueRecognitionTables">
        <link:definition>9954473 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.kewaunee.com/role/InventoriesTables">
        <link:definition>9954474 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionTables" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables">
        <link:definition>9954475 - Disclosure - Sale-Leaseback Financing Transaction (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.kewaunee.com/role/IncomeTaxesTables">
        <link:definition>9954476 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationTables" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables">
        <link:definition>9954477 - Disclosure - Stock Options and Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.kewaunee.com/role/StockholdersEquityTables">
        <link:definition>9954478 - Disclosure - Stockholder's Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>9954479 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesTables" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables">
        <link:definition>9954480 - Disclosure - Leases, Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsTables" roleURI="http://www.kewaunee.com/role/RetirementBenefitsTables">
        <link:definition>9954481 - Disclosure - Retirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.kewaunee.com/role/SegmentInformationTables">
        <link:definition>9954482 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>9954483 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails">
        <link:definition>9954484 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail">
        <link:definition>9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail">
        <link:definition>9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail">
        <link:definition>9954487 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail">
        <link:definition>9954488 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail">
        <link:definition>9954489 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail">
        <link:definition>9954490 - Disclosure - Revenue Recognition - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesSummaryofInventoriesDetail" roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail">
        <link:definition>9954491 - Disclosure - Inventories - Summary of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail">
        <link:definition>9954492 - Disclosure - Inventories - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail">
        <link:definition>9954493 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionNarrativeDetails" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails">
        <link:definition>9954494 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails">
        <link:definition>9954495 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1">
        <link:definition>9954495 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>9954496 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxExpenseDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail">
        <link:definition>9954497 - Disclosure - Income Taxes - Income Tax Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeTaxReconciliationDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail">
        <link:definition>9954498 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail">
        <link:definition>9954499 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1">
        <link:definition>9954499 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail">
        <link:definition>9954500 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails">
        <link:definition>9954501 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail">
        <link:definition>9954502 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail">
        <link:definition>9954503 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>9954504 - Disclosure - Stockholder's Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareRepurchaseActivityDetails" roleURI="http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails">
        <link:definition>9954505 - Disclosure - Stockholder's Equity - Share Repurchase Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail">
        <link:definition>9954506 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>9954507 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails">
        <link:definition>9954508 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1">
        <link:definition>9954508 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail">
        <link:definition>9954509 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail">
        <link:definition>9954510 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail">
        <link:definition>9954511 - Disclosure - Retirement Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail">
        <link:definition>9954512 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail">
        <link:definition>9954513 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail">
        <link:definition>9954514 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetail" roleURI="http://www.kewaunee.com/role/SegmentInformationDetail">
        <link:definition>9954515 - Disclosure - Segment Information - (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="kequ_ProceedsFromFinancingLiability" abstract="false" name="ProceedsFromFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_AccruedEmployeeBenefitPlanCosts" abstract="false" name="AccruedEmployeeBenefitPlanCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_NonQualifiedCompensationPlanMember" abstract="true" name="NonQualifiedCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_LesseeOptiontoExtendTerm" abstract="false" name="LesseeOptiontoExtendTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityAnnualIncreasePercent" abstract="false" name="FinancingLiabilityAnnualIncreasePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanLiquidAlternativesMember" abstract="true" name="DefinedBenefitPlanLiquidAlternativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_PubliclyAnnouncedProgramsMember" abstract="true" name="PubliclyAnnouncedProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_KewauneeLabwayAsiaMember" abstract="true" name="KewauneeLabwayAsiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaid" abstract="false" name="FinancingLiabilityToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_PaymentsOnFinancingLiability" abstract="false" name="PaymentsOnFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_TaxWithholdingExpense" abstract="false" name="TaxWithholdingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_UnbilledRetainageCurrent" abstract="false" name="UnbilledRetainageCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" abstract="false" name="ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" abstract="false" name="DefinedContributionPlanEmployerMatchingContributionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_TwoThousandAndEightPlanMember" abstract="true" name="TwoThousandAndEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanEmergingMarketsMember" abstract="true" name="DefinedBenefitPlanEmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LesseeOptiontoTerminateTerm" abstract="false" name="LesseeOptiontoTerminateTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_TradingSecuritiesMember" abstract="true" name="TradingSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_DeferredTaxAssetsSection174REAddback" abstract="false" name="DeferredTaxAssetsSection174REAddback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_KewauneeScientificCorporationSingaporeMember" abstract="true" name="KewauneeScientificCorporationSingaporeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" abstract="true" name="TwoThousandSeventeenOmnibusIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_InternationalOperationsMember" abstract="true" name="InternationalOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_KoncepoScientechInternationalMember" abstract="true" name="KoncepoScientechInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" abstract="false" name="DeferredTaxAssetsProceedsOnSaleLeaseback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" abstract="false" name="DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearFive" abstract="false" name="FinancingLiabilityToBePaidYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearFour" abstract="false" name="FinancingLiabilityToBePaidYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_OtherAssetsPolicyTextBlock" abstract="false" name="OtherAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_ForeignSubsidiariesTaxReturnsPeriod" abstract="false" name="ForeignSubsidiariesTaxReturnsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityNumberOfRenewalOptions" abstract="false" name="FinancingLiabilityNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kequ_FinancingLiabilityNoncurrent" abstract="false" name="FinancingLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_CreditAgreementMidCapFundingIVTrustMember" abstract="true" name="CreditAgreementMidCapFundingIVTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityCurrent" abstract="false" name="FinancingLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesPrepaidPensionCost" abstract="false" name="DeferredTaxLiabilitiesPrepaidPensionCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesAPB23Assertion" abstract="false" name="DeferredTaxLiabilitiesAPB23Assertion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" abstract="false" name="DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityRenewalTerm" abstract="false" name="FinancingLiabilityRenewalTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_ForeignSubsidiariesMember" abstract="true" name="ForeignSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityTermOfContract" abstract="false" name="FinancingLiabilityTermOfContract" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidAfterYearFive" abstract="false" name="FinancingLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_KequipGlobalLabSolutionsMember" abstract="true" name="KequipGlobalLabSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" abstract="false" name="ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_KewauneeLabwayIndiaMember" abstract="true" name="KewauneeLabwayIndiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_OperatingLeaseShortTermExpense" abstract="false" name="OperatingLeaseShortTermExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_NumberOfNonqualifiedCompensationPlans" abstract="false" name="NumberOfNonqualifiedCompensationPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kequ_RevenuesIncludingIntersegmentMarkup" abstract="false" name="RevenuesIncludingIntersegmentMarkup" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DeferredTaxAssetLeaseLiability" abstract="false" name="DeferredTaxAssetLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" abstract="false" name="DefinedContributionPlanEligibilityMinimumServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" abstract="true" name="TwoThousandTwentyThreeOmnibusIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" abstract="false" name="DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" abstract="false" name="LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" abstract="false" name="ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityUndiscountedExcessAmount" abstract="false" name="FinancingLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearThree" abstract="false" name="FinancingLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiability" abstract="false" name="FinancingLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" abstract="false" name="ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearTwo" abstract="false" name="FinancingLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityTable" abstract="true" name="FinancingLiabilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityAbstract" abstract="true" name="FinancingLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" abstract="false" name="DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" abstract="false" name="DeferredTaxLiabilitiesSaleLeasebackProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_RestrictedStockUnitsRSUsServiceComponentMember" abstract="true" name="RestrictedStockUnitsRSUsServiceComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_RevenueRecognitionTable" abstract="true" name="RevenueRecognitionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_RevenueRecognitionLineItems" abstract="true" name="RevenueRecognitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_InternationalSubsidiariesMember" abstract="true" name="InternationalSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" abstract="false" name="ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" abstract="false" name="TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" abstract="true" name="DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_KewauneeScientificCorporationMember" abstract="true" name="KewauneeScientificCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_DomesticOperationsMember" abstract="true" name="DomesticOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_LesseeRemainingLeaseTerm" abstract="false" name="LesseeRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" abstract="false" name="DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="kequ_FinancingLiabilityBasicMonthlyPayment" abstract="false" name="FinancingLiabilityBasicMonthlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FiscalYearTwoThousandTwentyFourMember" abstract="true" name="FiscalYearTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_FederalStateAndLocalTaxReturnsPeriod" abstract="false" name="FederalStateAndLocalTaxReturnsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityLineItems" abstract="true" name="FinancingLiabilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_InterestExpenseFinancingLiability" abstract="false" name="InterestExpenseFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearOne" abstract="false" name="FinancingLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>kequ-20240430_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6dff93d-26ea-4521-b940-3d259894e401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_901e31e8-693f-412a-b5d1-c61c5729aa26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f6dff93d-26ea-4521-b940-3d259894e401" xlink:to="loc_us-gaap_ProfitLoss_901e31e8-693f-412a-b5d1-c61c5729aa26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ef856cfd-b30c-4229-9aa4-5dffec7af676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f6dff93d-26ea-4521-b940-3d259894e401" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ef856cfd-b30c-4229-9aa4-5dffec7af676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ef44ce3-dc8f-4e0b-a99e-cb2fbfb5fdca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8939c470-b8f6-4450-b35a-c172a7301502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1ef44ce3-dc8f-4e0b-a99e-cb2fbfb5fdca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8939c470-b8f6-4450-b35a-c172a7301502" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b443e633-8d69-45f1-aab4-5fde08913e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1ef44ce3-dc8f-4e0b-a99e-cb2fbfb5fdca" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b443e633-8d69-45f1-aab4-5fde08913e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c35c158a-19ff-46f9-be6f-0ff36e9346fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_016e11c0-96ee-4e54-9f99-6e2bf117a625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c35c158a-19ff-46f9-be6f-0ff36e9346fd" xlink:to="loc_us-gaap_GrossProfit_016e11c0-96ee-4e54-9f99-6e2bf117a625" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1b8d4060-0bdc-4908-afd5-7918adc5c1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c35c158a-19ff-46f9-be6f-0ff36e9346fd" xlink:to="loc_us-gaap_OperatingExpenses_1b8d4060-0bdc-4908-afd5-7918adc5c1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ee7f55f9-7ae6-4b12-8eef-a1a0919ff822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b143110-a1da-4f53-84f4-1037c6544602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ee7f55f9-7ae6-4b12-8eef-a1a0919ff822" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7b143110-a1da-4f53-84f4-1037c6544602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ed014900-4d1b-401d-8355-86258d5e5662" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ee7f55f9-7ae6-4b12-8eef-a1a0919ff822" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ed014900-4d1b-401d-8355-86258d5e5662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f55700c8-0537-48e0-bb53-344e72bd2dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_160e1df9-2624-4583-9af8-c1610510f623" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f55700c8-0537-48e0-bb53-344e72bd2dcd" xlink:to="loc_us-gaap_OperatingIncomeLoss_160e1df9-2624-4583-9af8-c1610510f623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_4c0095b0-268c-4ba2-8c24-93541e65e056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f55700c8-0537-48e0-bb53-344e72bd2dcd" xlink:to="loc_us-gaap_OtherIncome_4c0095b0-268c-4ba2-8c24-93541e65e056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_46f94918-e2f7-4151-9818-1f534260ad30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f55700c8-0537-48e0-bb53-344e72bd2dcd" xlink:to="loc_us-gaap_InterestExpense_46f94918-e2f7-4151-9818-1f534260ad30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_470612f5-4d53-4a81-8ef2-4e9f9f67bbee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f55700c8-0537-48e0-bb53-344e72bd2dcd" xlink:to="loc_us-gaap_PensionExpense_470612f5-4d53-4a81-8ef2-4e9f9f67bbee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_158a9505-510e-4efd-bc42-730f9d9c0d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_60bf4a65-e2d3-4eb6-8545-9d616c742071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_158a9505-510e-4efd-bc42-730f9d9c0d94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_60bf4a65-e2d3-4eb6-8545-9d616c742071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_c1ef4226-15ad-4e77-954c-55635182da54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_158a9505-510e-4efd-bc42-730f9d9c0d94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_c1ef4226-15ad-4e77-954c-55635182da54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_1895cd02-76e8-4bd2-851b-26f12f9ff5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_158a9505-510e-4efd-bc42-730f9d9c0d94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_1895cd02-76e8-4bd2-851b-26f12f9ff5dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5007d0ce-3e2f-4eb9-9021-21e760fcf59a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb7e027e-f66a-473d-9e0a-384ccf0f6834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5007d0ce-3e2f-4eb9-9021-21e760fcf59a" xlink:to="loc_us-gaap_ProfitLoss_bb7e027e-f66a-473d-9e0a-384ccf0f6834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6633112d-9e70-43c4-9aee-aab15e8a036d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5007d0ce-3e2f-4eb9-9021-21e760fcf59a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6633112d-9e70-43c4-9aee-aab15e8a036d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_854d5599-d8b8-4df3-8863-ecc48ff76b55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5007d0ce-3e2f-4eb9-9021-21e760fcf59a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_854d5599-d8b8-4df3-8863-ecc48ff76b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8a0a6515-b9dc-4ed5-93a2-9f5f5f5e402f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c93fac8f-29b7-4b6f-8c27-8ccb2c0e08bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8a0a6515-b9dc-4ed5-93a2-9f5f5f5e402f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c93fac8f-29b7-4b6f-8c27-8ccb2c0e08bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e75d926d-2f8b-44e7-ad2b-84187c79922a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8a0a6515-b9dc-4ed5-93a2-9f5f5f5e402f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e75d926d-2f8b-44e7-ad2b-84187c79922a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4fefc77b-2e3d-4ed9-a24b-fcc66577c2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:to="loc_us-gaap_CommonStockValue_4fefc77b-2e3d-4ed9-a24b-fcc66577c2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2cb56be6-6ec8-4335-ae09-1653b6579070" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2cb56be6-6ec8-4335-ae09-1653b6579070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5514c0c6-c83f-4912-a335-7c749f29e25f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5514c0c6-c83f-4912-a335-7c749f29e25f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f9133e91-5d2c-4380-9186-04a58f5c7691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f9133e91-5d2c-4380-9186-04a58f5c7691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_912ba310-f68d-4c20-95bc-3f4583754d20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_b2b049c8-cba8-4242-953a-0aaeb71d0481" xlink:to="loc_us-gaap_TreasuryStockValue_912ba310-f68d-4c20-95bc-3f4583754d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ddf8101-1622-48f4-864f-f86f3eeb2dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d2180fbd-b85a-4465-b729-1cc081003c37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ddf8101-1622-48f4-864f-f86f3eeb2dcd" xlink:to="loc_us-gaap_Liabilities_d2180fbd-b85a-4465-b729-1cc081003c37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eef4a190-5bc8-4dff-b34b-4d622da1c04e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ddf8101-1622-48f4-864f-f86f3eeb2dcd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eef4a190-5bc8-4dff-b34b-4d622da1c04e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_00f4cdae-97e9-46c4-8a4d-972bfd483e43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ddf8101-1622-48f4-864f-f86f3eeb2dcd" xlink:to="loc_us-gaap_CommitmentsAndContingencies_00f4cdae-97e9-46c4-8a4d-972bfd483e43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_354e4352-47d9-463e-bf3e-f65c57044096" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_354e4352-47d9-463e-bf3e-f65c57044096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5a876cdc-1a8b-40ec-88ca-842622af6285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5a876cdc-1a8b-40ec-88ca-842622af6285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f673855c-5ba5-470f-9874-dd67d864f0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f673855c-5ba5-470f-9874-dd67d864f0a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts_4c0f70af-79e7-4eac-a2ef-5866034e3510" xlink:href="kequ-20240430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_kequ_AccruedEmployeeBenefitPlanCosts_4c0f70af-79e7-4eac-a2ef-5866034e3510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_dd3e7869-a6be-4038-ad4f-9c536dc65a20" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_dd3e7869-a6be-4038-ad4f-9c536dc65a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd6a0f35-2d2e-42bf-b064-8cd77f033e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cd6a0f35-2d2e-42bf-b064-8cd77f033e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9806681b-fdee-4f84-85e9-813772230f21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_36d8159f-22f6-455a-94dd-ce95cae121ab" xlink:to="loc_us-gaap_LiabilitiesCurrent_9806681b-fdee-4f84-85e9-813772230f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec38f324-d8c4-42ff-b2ae-faf7493bd9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5bd07ba1-e0e6-4163-a29b-15d29559b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec38f324-d8c4-42ff-b2ae-faf7493bd9dd" xlink:to="loc_us-gaap_StockholdersEquity_5bd07ba1-e0e6-4163-a29b-15d29559b1a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_281c5749-a465-4764-9f8c-b11172647a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ec38f324-d8c4-42ff-b2ae-faf7493bd9dd" xlink:to="loc_us-gaap_MinorityInterest_281c5749-a465-4764-9f8c-b11172647a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e904f869-e92d-43bb-9cd3-099fb652babd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e904f869-e92d-43bb-9cd3-099fb652babd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_08bb4101-f814-45c8-8b8e-e4880a62ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:to="loc_us-gaap_AssetsCurrent_08bb4101-f814-45c8-8b8e-e4880a62ffdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ab93e871-bf26-4bfe-88ba-a214ac11c523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ab93e871-bf26-4bfe-88ba-a214ac11c523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9e7fc0c-5fd5-4625-a7ad-87a0e18f766f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9e7fc0c-5fd5-4625-a7ad-87a0e18f766f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9299174c-01e5-477e-b49c-db0ddde71ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e1e484cd-1173-44b7-b4a6-32a9e6f65a9f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9299174c-01e5-477e-b49c-db0ddde71ca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a7c4f384-14c6-4628-804e-f92697836568" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_a7c4f384-14c6-4628-804e-f92697836568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d653f54-2cdb-4d7f-9201-3cd831d15f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d653f54-2cdb-4d7f-9201-3cd831d15f70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9318ac22-6bdf-4965-91fe-0f7db87a1d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:to="loc_us-gaap_InventoryNet_9318ac22-6bdf-4965-91fe-0f7db87a1d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_adf6d33d-c805-484d-a900-0c74ce5f3ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_adf6d33d-c805-484d-a900-0c74ce5f3ac1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fa6ea36a-8641-4ae7-9dcd-fad941ab0ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_319db8c0-aa97-42e4-a68e-bf54f50b05ab" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fa6ea36a-8641-4ae7-9dcd-fad941ab0ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_cc0f8bce-7b14-4a15-865a-739265dab2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_ShortTermBorrowings_cc0f8bce-7b14-4a15-865a-739265dab2bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_02a53003-137a-4319-bccf-180e1382ce99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_02a53003-137a-4319-bccf-180e1382ce99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_797f2066-447c-4a79-935b-18cc62798788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_797f2066-447c-4a79-935b-18cc62798788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8c22e57f-a855-4d35-b049-8e99b9bd2172" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8c22e57f-a855-4d35-b049-8e99b9bd2172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d83bc1ba-5cbc-48f3-9d0f-046f6450fb39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d83bc1ba-5cbc-48f3-9d0f-046f6450fb39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58bee5e8-8a98-4670-9fc3-efe1080b8ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_58bee5e8-8a98-4670-9fc3-efe1080b8ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_e64c2afa-7f7f-4749-8e8e-0497e2377591" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_kequ_FinancingLiabilityCurrent_e64c2afa-7f7f-4749-8e8e-0497e2377591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_50c50879-e392-44ef-8324-b4c574d77cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_4cd966b7-b15f-4837-870e-15bf3e58133f" xlink:to="loc_us-gaap_AccountsPayableCurrent_50c50879-e392-44ef-8324-b4c574d77cc0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31d0e233-777a-4632-bb38-7eea0ffa629d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_b348d44e-96af-4e0e-99b5-55eb3e34666b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_31d0e233-777a-4632-bb38-7eea0ffa629d" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_b348d44e-96af-4e0e-99b5-55eb3e34666b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0be4e85b-4f25-4847-a092-75f2e1685f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b56c0478-48c8-4f77-a79c-a65a3b1b9575" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0be4e85b-4f25-4847-a092-75f2e1685f0e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b56c0478-48c8-4f77-a79c-a65a3b1b9575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d3c2616-9f02-4797-b7a4-de8352681785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0be4e85b-4f25-4847-a092-75f2e1685f0e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7d3c2616-9f02-4797-b7a4-de8352681785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c43a4d1b-a822-4b6d-9c04-13fa691bb592" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0be4e85b-4f25-4847-a092-75f2e1685f0e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c43a4d1b-a822-4b6d-9c04-13fa691bb592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_377a923e-50a9-4b37-831f-f76ea7432a35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0be4e85b-4f25-4847-a092-75f2e1685f0e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_377a923e-50a9-4b37-831f-f76ea7432a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb63fa1c-e0f2-48e2-927c-f3d53db41fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_ProfitLoss_bb63fa1c-e0f2-48e2-927c-f3d53db41fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e89f2366-9588-40fe-9584-0510f24718f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_Depreciation_e89f2366-9588-40fe-9584-0510f24718f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0c8e48f7-a152-4a60-996c-6ec05e34b478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0c8e48f7-a152-4a60-996c-6ec05e34b478" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5431310e-1d11-40d0-9041-91097aa71468" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_ShareBasedCompensation_5431310e-1d11-40d0-9041-91097aa71468" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_b3639123-c659-4824-97a1-8d2d6594e8ab" xlink:href="kequ-20240430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_b3639123-c659-4824-97a1-8d2d6594e8ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc3b9533-3f6b-4754-8ce7-cbb0e93c12ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc3b9533-3f6b-4754-8ce7-cbb0e93c12ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5af069c9-a122-4c87-b363-bce6010f00c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5af069c9-a122-4c87-b363-bce6010f00c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_06d45dce-0c6e-4033-8076-24591e190a85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_06d45dce-0c6e-4033-8076-24591e190a85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5026741f-d75b-40d6-9dec-6cb0db658911" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5026741f-d75b-40d6-9dec-6cb0db658911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_78df0f1a-1a77-432e-9b02-27af5da51fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_715fd77a-d6e7-46f4-b678-4871cbe9ecd4" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_78df0f1a-1a77-432e-9b02-27af5da51fad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_75cdeb2e-19a2-49d8-8d6b-a96f596f079c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_75cdeb2e-19a2-49d8-8d6b-a96f596f079c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_52c7e298-3218-4053-8a4f-809c012a33fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_52c7e298-3218-4053-8a4f-809c012a33fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability_a07276b5-3afc-4eb7-86bc-487b1db3a5a9" xlink:href="kequ-20240430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_kequ_ProceedsFromFinancingLiability_a07276b5-3afc-4eb7-86bc-487b1db3a5a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_e0b5872b-26a8-42a8-ba63-b821dc0a6d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_e0b5872b-26a8-42a8-ba63-b821dc0a6d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability_6364d912-c8bb-4268-befe-61875a05b824" xlink:href="kequ-20240430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_kequ_PaymentsOnFinancingLiability_6364d912-c8bb-4268-befe-61875a05b824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ec494c6e-e435-4ada-a7e1-3c17e7e4357e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ec494c6e-e435-4ada-a7e1-3c17e7e4357e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_3a7c799e-24f1-4d2d-9972-de783c57ba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a1fc2b4-d9bd-4c63-be97-fd8173899895" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_3a7c799e-24f1-4d2d-9972-de783c57ba9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2a45e87-3299-4def-b2aa-b85242317e39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f0ad79a-b4a9-46e1-af04-de7701df5b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2a45e87-3299-4def-b2aa-b85242317e39" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f0ad79a-b4a9-46e1-af04-de7701df5b8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_21704ff2-d406-4d7d-aa04-e5565d68a7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2a45e87-3299-4def-b2aa-b85242317e39" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_21704ff2-d406-4d7d-aa04-e5565d68a7ba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1bec652c-5b5d-4996-ad69-306fe71f99f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c08e962a-9146-405f-b83a-aa401c808150" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1bec652c-5b5d-4996-ad69-306fe71f99f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c08e962a-9146-405f-b83a-aa401c808150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_85d89ed7-8ec1-4ac1-accb-970877182221" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1bec652c-5b5d-4996-ad69-306fe71f99f7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_85d89ed7-8ec1-4ac1-accb-970877182221" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_723e9a3d-c3d1-4cbd-8617-bd9a5dbf0851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c45a6941-6bbe-4d3a-a575-288da88df9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_723e9a3d-c3d1-4cbd-8617-bd9a5dbf0851" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c45a6941-6bbe-4d3a-a575-288da88df9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7d4bbc08-c6b0-4c76-b0c0-7ebec2320b0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_723e9a3d-c3d1-4cbd-8617-bd9a5dbf0851" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7d4bbc08-c6b0-4c76-b0c0-7ebec2320b0f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#InventoriesSummaryofInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b4339b85-e6ef-487e-82f9-b64d23de796d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_108d97c1-66a5-4ba3-a126-9765e2a640cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b4339b85-e6ef-487e-82f9-b64d23de796d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_108d97c1-66a5-4ba3-a126-9765e2a640cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_897740c6-0b6f-4d8f-acbd-a830924f2ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b4339b85-e6ef-487e-82f9-b64d23de796d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_897740c6-0b6f-4d8f-acbd-a830924f2ac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b12186db-f6c2-45ac-9c9e-b17052c276b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b4339b85-e6ef-487e-82f9-b64d23de796d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_b12186db-f6c2-45ac-9c9e-b17052c276b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_c591d499-a167-4840-80c1-5c2abac48846" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_349aa6e5-efe1-401b-a19e-85f4bf5dee7b" xlink:href="kequ-20240430.xsd#kequ_FinancingLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_c591d499-a167-4840-80c1-5c2abac48846" xlink:to="loc_kequ_FinancingLiability_349aa6e5-efe1-401b-a19e-85f4bf5dee7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_069e57ce-9f53-4062-ab35-9db44220d2b0" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_c591d499-a167-4840-80c1-5c2abac48846" xlink:to="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_069e57ce-9f53-4062-ab35-9db44220d2b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo_db2c32ca-ec81-4f91-a59c-2ab2dd03a67f" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearTwo_db2c32ca-ec81-4f91-a59c-2ab2dd03a67f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne_7fe791f2-2b71-4a47-9a8b-046088179782" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearOne_7fe791f2-2b71-4a47-9a8b-046088179782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_7628d844-643a-401b-9cfc-4b8101a90bb6" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_7628d844-643a-401b-9cfc-4b8101a90bb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive_c61e41c4-7668-446f-9a91-386b239add30" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFive_c61e41c4-7668-446f-9a91-386b239add30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour_8c41e4e0-1ba9-4474-b216-b2ecd1afdc48" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFour_8c41e4e0-1ba9-4474-b216-b2ecd1afdc48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree_1de26944-8a77-4594-8665-0c3a8da51384" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_61b14929-8d6d-48f9-bf81-7d1f76881907" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearThree_1de26944-8a77-4594-8665-0c3a8da51384" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesIncomeTaxExpenseDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eb76d64e-58f4-4a68-afc8-fada4228f534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_27f46034-646f-4d8f-a5fd-30902bd649e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eb76d64e-58f4-4a68-afc8-fada4228f534" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_27f46034-646f-4d8f-a5fd-30902bd649e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_07f01678-6c6e-4f1c-9ba2-68f09c1d533c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eb76d64e-58f4-4a68-afc8-fada4228f534" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_07f01678-6c6e-4f1c-9ba2-68f09c1d533c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dd190401-e635-4c9b-966d-d97bd26efae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_eb76d64e-58f4-4a68-afc8-fada4228f534" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_dd190401-e635-4c9b-966d-d97bd26efae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_773d2e87-068e-4d5e-a9d1-646218314a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0aed496e-fa7a-40c8-9ce0-f7ccc193fe59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_773d2e87-068e-4d5e-a9d1-646218314a9d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_0aed496e-fa7a-40c8-9ce0-f7ccc193fe59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7522f308-eb73-4718-8fc2-958c77c82bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_773d2e87-068e-4d5e-a9d1-646218314a9d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7522f308-eb73-4718-8fc2-958c77c82bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9b344aff-e151-4ade-803d-ce41d4a523b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d5dc74bc-06a0-49eb-baa9-918522e452ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9b344aff-e151-4ade-803d-ce41d4a523b8" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d5dc74bc-06a0-49eb-baa9-918522e452ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a5baa09c-e741-41e8-a6a6-14cad5896c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9b344aff-e151-4ade-803d-ce41d4a523b8" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a5baa09c-e741-41e8-a6a6-14cad5896c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4c7645da-9b02-412b-b4af-eeceaa3013a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9b344aff-e151-4ade-803d-ce41d4a523b8" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_4c7645da-9b02-412b-b4af-eeceaa3013a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesScheduleofIncomeTaxReconciliationDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_7b96b57e-2cd3-4644-81f7-3eac52c73149" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_7b96b57e-2cd3-4644-81f7-3eac52c73149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_bc2a3b12-764d-4030-b563-1ed9d43449f7" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_bc2a3b12-764d-4030-b563-1ed9d43449f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_959f866a-fbb9-4b4f-8042-2e0aa0acaf75" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_959f866a-fbb9-4b4f-8042-2e0aa0acaf75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7a281843-db7f-4fe7-97f6-d4f7dd599bde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7a281843-db7f-4fe7-97f6-d4f7dd599bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fc7ec119-6155-4d3c-8749-9218c384c305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_fc7ec119-6155-4d3c-8749-9218c384c305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1ef565f4-cf8b-4435-91c9-cf2abeaf56b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_1ef565f4-cf8b-4435-91c9-cf2abeaf56b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2324e520-21e6-4922-a84f-1685527fb551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2324e520-21e6-4922-a84f-1685527fb551" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_77159872-f86a-412b-90b5-5ba232f899d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_77159872-f86a-412b-90b5-5ba232f899d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_ded4e4af-ed3c-4028-b8db-7a1df47545be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_ded4e4af-ed3c-4028-b8db-7a1df47545be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d70c0c38-49e9-43d6-9183-7be5f974bcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c218e4d0-b437-48fc-b2e7-2112a660582a" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d70c0c38-49e9-43d6-9183-7be5f974bcf0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_51d69103-9750-4b63-b581-c95239b6b649" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b8700519-8769-4b65-8b37-f9f2981be8da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_51d69103-9750-4b63-b581-c95239b6b649" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b8700519-8769-4b65-8b37-f9f2981be8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc5c4b75-8368-40a0-99da-2336b2650e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_51d69103-9750-4b63-b581-c95239b6b649" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc5c4b75-8368-40a0-99da-2336b2650e4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_b07fadac-fcaa-457b-8eea-2b442304aa47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_b07fadac-fcaa-457b-8eea-2b442304aa47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b5179062-7d83-40b7-a448-85e79c8b9281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b5179062-7d83-40b7-a448-85e79c8b9281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_07b8db16-df19-4a68-8751-89bd01715c96" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_07b8db16-df19-4a68-8751-89bd01715c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_7d509eed-b71c-42d9-8eaf-3915b7f5f578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_7d509eed-b71c-42d9-8eaf-3915b7f5f578" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_f7999eed-8718-4245-879c-1a2819f6f5fb" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_f7999eed-8718-4245-879c-1a2819f6f5fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_eb19339a-67e5-442a-a53e-55b6b4e111fc" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_df08cc42-3314-4b59-b495-b9f9b9178c71" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_eb19339a-67e5-442a-a53e-55b6b4e111fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fbd9bec6-e422-464e-aa0d-079258eecf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_a759a0a7-c3df-403d-9c3e-c4c26d637130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fbd9bec6-e422-464e-aa0d-079258eecf7d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_a759a0a7-c3df-403d-9c3e-c4c26d637130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e23fab53-61c5-4b9d-9650-86dc0afbfbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_fbd9bec6-e422-464e-aa0d-079258eecf7d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e23fab53-61c5-4b9d-9650-86dc0afbfbc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_cb3fdd79-a814-461e-8459-813142e3980d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_cb3fdd79-a814-461e-8459-813142e3980d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_94159658-693a-4a6e-a601-9d126e2fdae7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_94159658-693a-4a6e-a601-9d126e2fdae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_4f66b26c-eb52-4b40-a16e-067ddca76dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_4f66b26c-eb52-4b40-a16e-067ddca76dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_ee3c021e-e36b-4423-9356-1cd6dc093111" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_ee3c021e-e36b-4423-9356-1cd6dc093111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_54722e40-93ca-4f58-be04-b5625843b656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_54722e40-93ca-4f58-be04-b5625843b656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3d0d6811-03f2-4495-af61-9ded120cb6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3d0d6811-03f2-4495-af61-9ded120cb6f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_15e8a8f5-ff2e-45da-8a7f-dcd1ea513fc7" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_15e8a8f5-ff2e-45da-8a7f-dcd1ea513fc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_7e60aafe-b855-4e33-b324-1d1d3f49d17b" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_7e60aafe-b855-4e33-b324-1d1d3f49d17b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_a155223b-0488-431b-9fba-9eb0fe3fb2d3" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_a155223b-0488-431b-9fba-9eb0fe3fb2d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_38cb5867-7606-4723-b967-bf0959625fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_38cb5867-7606-4723-b967-bf0959625fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_363ddbf5-00c4-43ee-9f1c-2f073be78428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_363ddbf5-00c4-43ee-9f1c-2f073be78428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7ad8d949-863b-45e8-aed3-9d8986d7f59d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_faa4bade-d294-44f3-807a-e9d7a8f47e95" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7ad8d949-863b-45e8-aed3-9d8986d7f59d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_256a33c0-1d40-4939-a2c6-24d6b6db4401" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9613c8cf-fa9f-47a8-9327-f5bdafab4cea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_256a33c0-1d40-4939-a2c6-24d6b6db4401" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_9613c8cf-fa9f-47a8-9327-f5bdafab4cea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_321c98f3-3539-45b3-9084-ddc0c67d8eef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_256a33c0-1d40-4939-a2c6-24d6b6db4401" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_321c98f3-3539-45b3-9084-ddc0c67d8eef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88c238b1-282f-45b5-b4b0-4c062003fc90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_256a33c0-1d40-4939-a2c6-24d6b6db4401" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_88c238b1-282f-45b5-b4b0-4c062003fc90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4308c6ae-dddb-4f3a-ab84-dfe4a173326b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_712cf2da-90e9-49ca-afce-213f7195b7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4308c6ae-dddb-4f3a-ab84-dfe4a173326b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_712cf2da-90e9-49ca-afce-213f7195b7d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8bd4cc66-6b25-441e-ac1c-d601f3a94ace" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4308c6ae-dddb-4f3a-ab84-dfe4a173326b" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8bd4cc66-6b25-441e-ac1c-d601f3a94ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_bb5ab65e-d2bb-4cc9-9019-f3d7da11beef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4308c6ae-dddb-4f3a-ab84-dfe4a173326b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_bb5ab65e-d2bb-4cc9-9019-f3d7da11beef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f18e2ae0-23ac-4628-85df-e977712d0f73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f18e2ae0-23ac-4628-85df-e977712d0f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5e1a7916-5731-480d-b9ba-ecc698e1aea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5e1a7916-5731-480d-b9ba-ecc698e1aea7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6bd95911-2766-4f00-8711-82ec884614af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6bd95911-2766-4f00-8711-82ec884614af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b787438f-489a-49d8-ac3b-4c7a945d3be5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b787438f-489a-49d8-ac3b-4c7a945d3be5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e7e591ef-1c01-4580-af9f-ec22c8ce388b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e7e591ef-1c01-4580-af9f-ec22c8ce388b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c705138b-f579-42b9-9b68-75ebe7675d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5cd235f0-ee31-4d5a-8ece-b2d8f271d71c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c705138b-f579-42b9-9b68-75ebe7675d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_37a65b31-896b-4264-b4c4-9d6129a5bc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f8b0a748-87a9-4a17-8afd-7c2005fb8de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_37a65b31-896b-4264-b4c4-9d6129a5bc6c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f8b0a748-87a9-4a17-8afd-7c2005fb8de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e4c25cef-3956-4f78-8fff-f43784bf6be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_37a65b31-896b-4264-b4c4-9d6129a5bc6c" xlink:to="loc_us-gaap_FinanceLeaseLiability_e4c25cef-3956-4f78-8fff-f43784bf6be6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f93233cb-4db4-4545-bb78-101723fbe8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_101db8ca-29dc-4569-bf4e-cbb92de7aeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f93233cb-4db4-4545-bb78-101723fbe8f9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_101db8ca-29dc-4569-bf4e-cbb92de7aeb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6ea0f160-ddac-4b17-a728-166865acf496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f93233cb-4db4-4545-bb78-101723fbe8f9" xlink:to="loc_us-gaap_OperatingLeaseLiability_6ea0f160-ddac-4b17-a728-166865acf496" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_493c1485-1334-4df6-9eac-e92e12c5fc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_493c1485-1334-4df6-9eac-e92e12c5fc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6fa33744-687a-4482-bfea-29333c2253ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6fa33744-687a-4482-bfea-29333c2253ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_43b29b35-0d2a-4fe7-978c-e9c4ad6a7320" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_43b29b35-0d2a-4fe7-978c-e9c4ad6a7320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6afda39d-c39c-4476-98ed-26c14e930702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6afda39d-c39c-4476-98ed-26c14e930702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5ad61c89-d799-4cc6-8ae8-c1c62577d885" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5ad61c89-d799-4cc6-8ae8-c1c62577d885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_cceb11c5-2863-4bbc-a44d-23bc6b80a19a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_999485ef-1d31-4eed-a2c9-4a5b1f9e2376" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_cceb11c5-2863-4bbc-a44d-23bc6b80a19a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4a2d703e-44b1-4871-9918-26c101e19ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4fd6822e-c2f1-4885-9434-96ec0c0fdaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4a2d703e-44b1-4871-9918-26c101e19ac0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_4fd6822e-c2f1-4885-9434-96ec0c0fdaaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_349259d0-b2ac-4701-9df8-7d66a9dbe054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4a2d703e-44b1-4871-9918-26c101e19ac0" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_349259d0-b2ac-4701-9df8-7d66a9dbe054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6dba662e-c34f-4c28-9a37-3bfb330d3367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_fef84390-1035-482e-9b5c-7641329c7f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6dba662e-c34f-4c28-9a37-3bfb330d3367" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_fef84390-1035-482e-9b5c-7641329c7f9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_12e4baf3-fe13-40f6-bda6-daef79bb32d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_6dba662e-c34f-4c28-9a37-3bfb330d3367" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_12e4baf3-fe13-40f6-bda6-daef79bb32d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_90faab82-d615-4688-b937-5fae05afbecc" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5cb948cd-560a-47c3-8b8a-458b69c0b141" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_90faab82-d615-4688-b937-5fae05afbecc" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5cb948cd-560a-47c3-8b8a-458b69c0b141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7549e744-7eb1-4141-80d7-3809c2eaa34f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_90faab82-d615-4688-b937-5fae05afbecc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7549e744-7eb1-4141-80d7-3809c2eaa34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3cd2b4d2-2cfd-4399-b382-e5f903f72d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_90faab82-d615-4688-b937-5fae05afbecc" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3cd2b4d2-2cfd-4399-b382-e5f903f72d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c34f16c7-ae5d-4e9c-8f82-20981b54cdbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_a938ec93-c675-4c9b-a3b5-cc7b39e42f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c34f16c7-ae5d-4e9c-8f82-20981b54cdbc" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_a938ec93-c675-4c9b-a3b5-cc7b39e42f8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_a5be5e50-bc97-4a2d-aaba-2fde736cd4bc" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c34f16c7-ae5d-4e9c-8f82-20981b54cdbc" xlink:to="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_a5be5e50-bc97-4a2d-aaba-2fde736cd4bc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>kequ-20240430_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:to="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9efd2eb0-3fd5-468f-89ec-72eda97f95cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:to="loc_us-gaap_EquityComponentDomain_9efd2eb0-3fd5-468f-89ec-72eda97f95cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:to="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9e3d6438-f62e-4fe4-aa5e-d93e4980e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_CommonStockMember_9e3d6438-f62e-4fe4-aa5e-d93e4980e1de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7c825a4f-591a-459e-b977-c1744592feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7c825a4f-591a-459e-b977-c1744592feb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_41d1319f-cbaa-42ed-b314-9cbefa7adc62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_TreasuryStockCommonMember_41d1319f-cbaa-42ed-b314-9cbefa7adc62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_898c9bde-e32b-4ab5-828c-9974cb638756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_RetainedEarningsMember_898c9bde-e32b-4ab5-828c-9974cb638756" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac994816-28aa-42e0-92e3-262999d0d551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac994816-28aa-42e0-92e3-262999d0d551" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d19bfb8-388e-4f7e-bc95-4155be599b15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_StockholdersEquity_7d19bfb8-388e-4f7e-bc95-4155be599b15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_475d7aad-b470-4409-86ae-4f991d2edb86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_NetIncomeLoss_475d7aad-b470-4409-86ae-4f991d2edb86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4e561719-583a-48fc-922e-ebbca0c1dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4e561719-583a-48fc-922e-ebbca0c1dd26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7e20924c-797d-4024-8144-57715ddf4214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7e20924c-797d-4024-8144-57715ddf4214" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f88252cb-861e-41be-87d2-234f23133ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f88252cb-861e-41be-87d2-234f23133ad4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dccdb68c-3840-4120-8fa1-aa830abc85be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_71c954cb-56ab-42c1-9ca3-c4a85bc82383_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:to="loc_srt_OwnershipDomain_71c954cb-56ab-42c1-9ca3-c4a85bc82383_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:to="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember_28222057-3755-4f39-b137-ab2d20b8ec9f" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:to="loc_kequ_KewauneeScientificCorporationMember_28222057-3755-4f39-b137-ab2d20b8ec9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_1878fd6e-273a-4b08-9f4e-65ef507fb667" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_1878fd6e-273a-4b08-9f4e-65ef507fb667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b0c70119-6fc7-48e4-8c67-2568018e3f41_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:to="loc_dei_EntityDomain_b0c70119-6fc7-48e4-8c67-2568018e3f41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:to="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember_f61149d4-8c0b-4678-a426-455b6f39803f" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeLabwayAsiaMember_f61149d4-8c0b-4678-a426-455b6f39803f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_dfc440de-4bfa-41d6-94c1-0aa1dbfeb2b7" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_dfc440de-4bfa-41d6-94c1-0aa1dbfeb2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember_4234b873-b92b-40b8-bd2a-147eb9ac1d07" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeLabwayIndiaMember_4234b873-b92b-40b8-bd2a-147eb9ac1d07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember_7291affc-3fb0-4e69-9045-22fc0c9d6599" xlink:href="kequ-20240430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KoncepoScientechInternationalMember_7291affc-3fb0-4e69-9045-22fc0c9d6599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember_dfcada32-a67c-40d0-ae26-e588f02e22aa" xlink:href="kequ-20240430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KequipGlobalLabSolutionsMember_dfcada32-a67c-40d0-ae26-e588f02e22aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_913133e8-c625-4439-8625-5c2252707918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_913133e8-c625-4439-8625-5c2252707918" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_06e4dcfa-ced7-4480-9f94-4a79a0d2eecf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_06e4dcfa-ced7-4480-9f94-4a79a0d2eecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_e747bd24-7868-4059-b498-84324a87cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_e747bd24-7868-4059-b498-84324a87cf8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2008a60d-9510-4c72-934e-a93cb12fba64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2008a60d-9510-4c72-934e-a93cb12fba64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7ff889db-a4c7-44a3-8595-9386ffb35064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7ff889db-a4c7-44a3-8595-9386ffb35064" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9da3ee0b-65d3-400b-b943-e99202ac5596_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9da3ee0b-65d3-400b-b943-e99202ac5596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember_581da3a5-a44c-4885-b851-a316d369c23e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:to="loc_us-gaap_SalesRevenueSegmentMember_581da3a5-a44c-4885-b851-a316d369c23e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_5f84d113-bcce-4803-a81e-d3413fc8a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:to="loc_us-gaap_AccountsReceivableMember_5f84d113-bcce-4803-a81e-d3413fc8a5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6277e40d-c80d-4cd4-838e-496184183ea6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6277e40d-c80d-4cd4-838e-496184183ea6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_9026446f-58e1-4889-a85a-aacde983bf8c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:to="loc_srt_SubsidiariesMember_9026446f-58e1-4889-a85a-aacde983bf8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:to="loc_us-gaap_GeographicDistributionDomain_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:to="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_e1f5f65f-55a7-46e9-aae6-cfcaf8b3978c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_e1f5f65f-55a7-46e9-aae6-cfcaf8b3978c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_03779bcd-52f1-4737-a574-05a281a86ce3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:to="loc_srt_ConsolidationItemsDomain_03779bcd-52f1-4737-a574-05a281a86ce3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:to="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d433fd06-d3b0-418f-aea6-15ae314e4ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:to="loc_us-gaap_OperatingSegmentsMember_d433fd06-d3b0-418f-aea6-15ae314e4ce5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_51043d92-4d6d-4934-87f7-90203db171ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:to="loc_us-gaap_SegmentDomain_51043d92-4d6d-4934-87f7-90203db171ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:to="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_0efddb68-497b-4be0-a2f1-cfedf298786d" xlink:href="kequ-20240430.xsd#kequ_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:to="loc_kequ_InternationalOperationsMember_0efddb68-497b-4be0-a2f1-cfedf298786d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d227b8d5-5334-4960-b7b9-c6fa41a2f34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d227b8d5-5334-4960-b7b9-c6fa41a2f34b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_2d2ff5be-39ad-408c-879d-df1de31a0b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetsNet_2d2ff5be-39ad-408c-879d-df1de31a0b39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_102b1e1e-0ce3-47bb-ad2a-6104baa3fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_102b1e1e-0ce3-47bb-ad2a-6104baa3fba4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_66ce7cef-4205-442d-99ea-b9e5bfd7c796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_66ce7cef-4205-442d-99ea-b9e5bfd7c796" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5fb168e2-919a-4e07-ba9b-2888562dcd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetImpairmentCharges_5fb168e2-919a-4e07-ba9b-2888562dcd5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_230166fd-735a-4e28-b673-72e76df4bc88" xlink:href="kequ-20240430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_kequ_UnbilledRetainageCurrent_230166fd-735a-4e28-b673-72e76df4bc88" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_7c902187-f2e3-4539-a6e5-eb356d9fb8de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetsHeldInTrust_7c902187-f2e3-4539-a6e5-eb356d9fb8de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_9dbd902f-e8d4-4dc4-871b-07b2be9ab3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_9dbd902f-e8d4-4dc4-871b-07b2be9ab3e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9a6af223-e888-409c-b9cb-617238db7816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9a6af223-e888-409c-b9cb-617238db7816" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_a9058b39-16e0-4c40-88e0-6efc0facbbb1" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_a9058b39-16e0-4c40-88e0-6efc0facbbb1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage_f60e8337-aaba-4d89-9a35-481f66788503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ConstructionContractorReceivableRetainage_f60e8337-aaba-4d89-9a35-481f66788503" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7425a41b-a7e2-472f-81a2-e233aba34b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7425a41b-a7e2-472f-81a2-e233aba34b1c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_669ec194-51f2-41ad-83c4-1c6625676ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_669ec194-51f2-41ad-83c4-1c6625676ebb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5cd6f9c8-4ff4-4a02-b165-7595d167b5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AdvertisingExpense_5cd6f9c8-4ff4-4a02-b165-7595d167b5d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5193e60d-246b-41ee-b874-570c7a049c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5193e60d-246b-41ee-b874-570c7a049c70" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_afdcb52e-a075-4402-8634-7c3caf5503c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_afdcb52e-a075-4402-8634-7c3caf5503c8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_52754e6e-bb37-4e1e-a7a2-c8699d98f226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_52754e6e-bb37-4e1e-a7a2-c8699d98f226" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f7705fd1-f696-439f-8129-2fbe42db5e98_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f7705fd1-f696-439f-8129-2fbe42db5e98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_112d33e3-76bf-4ec6-b531-b3915d238ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_LandMember_112d33e3-76bf-4ec6-b531-b3915d238ec3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_58543127-449d-4e5d-b799-3f115170ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_BuildingImprovementsMember_58543127-449d-4e5d-b799-3f115170ad10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0ab77fe0-5e72-4ec3-bd16-02492eb45256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0ab77fe0-5e72-4ec3-bd16-02492eb45256" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:to="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c2939695-aff5-4c4f-a57b-f1aa6f313b1a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:to="loc_srt_RangeMember_c2939695-aff5-4c4f-a57b-f1aa6f313b1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:to="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0d52b22b-719b-4494-b6a8-be2ac45e4159" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:to="loc_srt_MinimumMember_0d52b22b-719b-4494-b6a8-be2ac45e4159" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bac8e6bc-e75a-479a-9da5-3ba00c3c7f15" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:to="loc_srt_MaximumMember_bac8e6bc-e75a-479a-9da5-3ba00c3c7f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1f442f85-57ff-409d-a46a-a70874b66290" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1f442f85-57ff-409d-a46a-a70874b66290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_802f294d-c02e-4404-b32c-9dde3812346c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_802f294d-c02e-4404-b32c-9dde3812346c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52db8638-7e83-45d4-8691-eb11d10ade1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_52db8638-7e83-45d4-8691-eb11d10ade1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_efd0e5b6-6859-4f49-aa81-f55d2108fabe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_efd0e5b6-6859-4f49-aa81-f55d2108fabe" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196040b3-bf6e-49d4-a5f0-3cbe719ad44d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_196040b3-bf6e-49d4-a5f0-3cbe719ad44d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b13d3140-b100-4d01-9ed6-3c1826f03d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b13d3140-b100-4d01-9ed6-3c1826f03d61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_55a7b1fd-e9e1-4a20-a7d0-e3b2fe2715c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_55a7b1fd-e9e1-4a20-a7d0-e3b2fe2715c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b2a429bd-f211-4353-98cf-5cb0d8d9a693_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:to="loc_us-gaap_EquityComponentDomain_b2a429bd-f211-4353-98cf-5cb0d8d9a693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:to="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember_a31f42b4-a253-493a-9b86-5bd3cbc86fa5" xlink:href="kequ-20240430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:to="loc_kequ_NonQualifiedCompensationPlanMember_a31f42b4-a253-493a-9b86-5bd3cbc86fa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember_6b10099e-e2b0-41cf-8459-c569e5f201f5" xlink:href="kequ-20240430.xsd#kequ_TradingSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:to="loc_kequ_TradingSecuritiesMember_6b10099e-e2b0-41cf-8459-c569e5f201f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember_617f893e-5622-4ca7-8a95-d5d04ee4f312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:to="loc_us-gaap_CashSurrenderValueMember_617f893e-5622-4ca7-8a95-d5d04ee4f312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_069de521-c9e5-4c66-acd9-668ceca055c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_us-gaap_DerivativeAssets_069de521-c9e5-4c66-acd9-668ceca055c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d61c9c8d-7f54-4f30-9de2-ab02cc760a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_us-gaap_DerivativeLiabilities_d61c9c8d-7f54-4f30-9de2-ab02cc760a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1c4fa6ab-0981-4efe-a482-26631bb2d310" xlink:href="kequ-20240430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1c4fa6ab-0981-4efe-a482-26631bb2d310" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans_3dda1efa-7166-4d72-9ba1-a0627eff0047" xlink:href="kequ-20240430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_NumberOfNonqualifiedCompensationPlans_3dda1efa-7166-4d72-9ba1-a0627eff0047" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1d38e70e-e760-41e4-961f-579d56c373fc" xlink:href="kequ-20240430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1d38e70e-e760-41e4-961f-579d56c373fc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:to="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_0b99b6e9-6b3c-4f82-8240-7e718fbf635f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:to="loc_us-gaap_GeographicDistributionDomain_0b99b6e9-6b3c-4f82-8240-7e718fbf635f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:to="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_bb7efdbb-f1f7-4cb2-bed7-d6ce22c0cce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_bb7efdbb-f1f7-4cb2-bed7-d6ce22c0cce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_eb8fc768-9d56-491d-bed1-62312cfbc13a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_eb8fc768-9d56-491d-bed1-62312cfbc13a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_f255554e-a1c0-45de-983f-9ce6fbc41af6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_f255554e-a1c0-45de-983f-9ce6fbc41af6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3447f478-7276-4bc3-889c-17dc900feaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:to="loc_us-gaap_TransferredOverTimeMember_3447f478-7276-4bc3-889c-17dc900feaa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_751f85d0-9b62-4358-989f-0539ab5143b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_751f85d0-9b62-4358-989f-0539ab5143b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cabe3302-bddb-4a1d-b80d-f5cb243fbecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cabe3302-bddb-4a1d-b80d-f5cb243fbecc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognitionAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_9dff763e-a9b2-4a13-b20e-ea79938a21a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_9dff763e-a9b2-4a13-b20e-ea79938a21a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember_ad70f4ce-d646-46cd-b07c-9058eec4013f" xlink:href="kequ-20240430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:to="loc_kequ_FiscalYearTwoThousandTwentyFourMember_ad70f4ce-d646-46cd-b07c-9058eec4013f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c51e7164-3651-4786-b754-5f33cb957b84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c51e7164-3651-4786-b754-5f33cb957b84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f7cc2cb-e78b-482c-a870-f2cd5659a579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f7cc2cb-e78b-482c-a870-f2cd5659a579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_44c5c3ff-dda7-4d01-b93e-770eac86da51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_44c5c3ff-dda7-4d01-b93e-770eac86da51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_2b418c98-1ac1-4de7-b1bd-87748d745943" xlink:href="kequ-20240430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_kequ_UnbilledRetainageCurrent_2b418c98-1ac1-4de7-b1bd-87748d745943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_557a3117-7a13-4812-a1a8-e8065c7da314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_557a3117-7a13-4812-a1a8-e8065c7da314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_6255092b-84e4-42de-9252-3c9ae6ec1b94" xlink:href="kequ-20240430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_6255092b-84e4-42de-9252-3c9ae6ec1b94" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#InventoriesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:to="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:to="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_beaca0d5-df58-4504-bffe-0601e73798d0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_beaca0d5-df58-4504-bffe-0601e73798d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember_61c5caaf-9ae9-4e65-8c98-25118134877b" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:to="loc_kequ_ForeignSubsidiariesMember_61c5caaf-9ae9-4e65-8c98-25118134877b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount_e03e46a9-812f-4b90-b1fc-35d64d83e292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:to="loc_us-gaap_FIFOInventoryAmount_e03e46a9-812f-4b90-b1fc-35d64d83e292" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_94e8918c-36b3-45ca-99f4-04e722ea8a13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:to="loc_us-gaap_CreditFacilityDomain_94e8918c-36b3-45ca-99f4-04e722ea8a13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:to="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d44a2669-427b-4de4-bbd9-044a18070c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_us-gaap_LineOfCreditMember_d44a2669-427b-4de4-bbd9-044a18070c30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember_0992f24a-3a9b-46a1-894c-796818fe3a84" xlink:href="kequ-20240430.xsd#kequ_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_kequ_TermLoanBMember_0992f24a-3a9b-46a1-894c-796818fe3a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1cf3c982-fd9d-4388-8d99-2d96c90d9775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1cf3c982-fd9d-4388-8d99-2d96c90d9775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72be452f-0090-44a4-9b68-902a491ca38f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_72be452f-0090-44a4-9b68-902a491ca38f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6920add2-646d-49a8-af10-c66bf4808a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6920add2-646d-49a8-af10-c66bf4808a0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d75bcf50-c2e6-43c4-a6ef-8e3e0629e53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d75bcf50-c2e6-43c4-a6ef-8e3e0629e53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57982d9e-fbc8-4bad-a0c9-049d96a69abc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57982d9e-fbc8-4bad-a0c9-049d96a69abc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_5d831af9-3ee2-4939-ad16-1c46736f883d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_5d831af9-3ee2-4939-ad16-1c46736f883d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_cb80d520-5781-4e17-8602-19b33f937578_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:to="loc_us-gaap_VariableRateDomain_cb80d520-5781-4e17-8602-19b33f937578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:to="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember_17b66c68-ad73-442d-af3b-a240d82e2485" xlink:href="kequ-20240430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:to="loc_kequ_SecuredOvernightFinancingRateSOFRMember_17b66c68-ad73-442d-af3b-a240d82e2485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bdcbcc23-4292-4dab-9644-b46bb5fd16bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bdcbcc23-4292-4dab-9644-b46bb5fd16bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_a43caab6-e3b5-474a-847f-cb1ae7e0dfd5" xlink:href="kequ-20240430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:to="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_a43caab6-e3b5-474a-847f-cb1ae7e0dfd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6a39da2e-9b92-4654-9c9c-a16108967045_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6a39da2e-9b92-4654-9c9c-a16108967045_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3b9fce29-f2ad-4521-a864-5488b6836321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:to="loc_us-gaap_LineOfCreditMember_3b9fce29-f2ad-4521-a864-5488b6836321" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fc1c528c-fa26-45e8-8a86-569d34542844_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fc1c528c-fa26-45e8-8a86-569d34542844_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember_ae62a294-93f4-4f3c-a62e-7e2ca370d0ae" xlink:href="kequ-20240430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:to="loc_kequ_InternationalSubsidiariesMember_ae62a294-93f4-4f3c-a62e-7e2ca370d0ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28b3c630-03ed-4344-92ce-7da42a30c251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28b3c630-03ed-4344-92ce-7da42a30c251" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_68dc126c-cbce-418d-a920-ed56246a3f44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCredit_68dc126c-cbce-418d-a920-ed56246a3f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_437596de-c465-4156-91df-529577ed2170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_437596de-c465-4156-91df-529577ed2170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2bedbc3f-d846-4675-b2b8-54c454b26d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2bedbc3f-d846-4675-b2b8-54c454b26d6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0d95c818-82c7-48df-87ef-f0cd42099c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0d95c818-82c7-48df-87ef-f0cd42099c96" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_3b09f282-bbb0-4ed0-a718-1588cc57e415" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_3b09f282-bbb0-4ed0-a718-1588cc57e415" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_5f8ff774-81fb-4961-95c6-5448f7727b6d" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_5f8ff774-81fb-4961-95c6-5448f7727b6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_42e85194-78f8-4915-8d32-6d3775d6a19f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_ShortTermBorrowings_42e85194-78f8-4915-8d32-6d3775d6a19f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_a356448a-0466-42a4-a982-ecc0826279df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_a356448a-0466-42a4-a982-ecc0826279df" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:to="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f114879-59af-4091-9cd0-42f89d84ab29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1f114879-59af-4091-9cd0-42f89d84ab29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_0b80f84b-ad96-4626-ab2a-7b5fb41af64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:to="loc_us-gaap_BuildingMember_0b80f84b-ad96-4626-ab2a-7b5fb41af64e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_432a2cd4-94b5-4acb-a395-7812cb24bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:to="loc_us-gaap_LandMember_432a2cd4-94b5-4acb-a395-7812cb24bb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1b56f032-1085-4716-a5d3-4d4adc59cbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1b56f032-1085-4716-a5d3-4d4adc59cbe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_be55ef59-38ee-4065-a99e-ae3b8a14c692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_be55ef59-38ee-4065-a99e-ae3b8a14c692" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_2294c8af-1d73-4777-b85b-459849bd8a4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_2294c8af-1d73-4777-b85b-459849bd8a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_cc102fb3-b318-4871-9008-2b64841d9b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_cc102fb3-b318-4871-9008-2b64841d9b69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:to="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19e174cb-192e-4f71-81ba-98627595946a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:to="loc_srt_RangeMember_19e174cb-192e-4f71-81ba-98627595946a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:to="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0a109947-4b81-4b3e-ab4b-ec0bea3d8be3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:to="loc_srt_MinimumMember_0a109947-4b81-4b3e-ab4b-ec0bea3d8be3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4d66b0f-e44b-43e3-bc80-4930c26aa018" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:to="loc_srt_MaximumMember_a4d66b0f-e44b-43e3-bc80-4930c26aa018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense_88fa7d97-5069-428a-b730-b72733306065" xlink:href="kequ-20240430.xsd#kequ_TaxWithholdingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_TaxWithholdingExpense_88fa7d97-5069-428a-b730-b72733306065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_0640defa-3ad8-483a-a294-d8c648d0e7b7" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_0640defa-3ad8-483a-a294-d8c648d0e7b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_befcc124-f3a4-4fe6-8ed3-e90be08ba919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_befcc124-f3a4-4fe6-8ed3-e90be08ba919" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_bd427a6e-654e-4fca-9da7-ac111aecf15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_bd427a6e-654e-4fca-9da7-ac111aecf15d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_5c2d7b7c-fb8e-4af0-b655-3e7a50ee91e8" xlink:href="kequ-20240430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_5c2d7b7c-fb8e-4af0-b655-3e7a50ee91e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_5005faa4-e6ef-434d-bf99-79f6338e5daf" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_5005faa4-e6ef-434d-bf99-79f6338e5daf" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_88620276-6d0f-4358-9c5e-d55f8758c67e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_88620276-6d0f-4358-9c5e-d55f8758c67e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e2962429-7bba-4355-a3a5-f80b84b3d90d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e2962429-7bba-4355-a3a5-f80b84b3d90d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_5d0b1161-d8c0-46c5-8b46-745f110a0967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_5d0b1161-d8c0-46c5-8b46-745f110a0967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7b2c51f8-2d4f-4dc8-a5cd-d570fad835ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7b2c51f8-2d4f-4dc8-a5cd-d570fad835ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_2d071eb9-ce0d-41a2-9e32-81c3343b364d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_2d071eb9-ce0d-41a2-9e32-81c3343b364d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0bc31d3c-73f9-43cf-a6ee-f442c9382175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0bc31d3c-73f9-43cf-a6ee-f442c9382175" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_32c72875-5f64-47f0-a7a4-86c0cae9e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_32c72875-5f64-47f0-a7a4-86c0cae9e9c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_55f4f988-01a3-4810-886d-60aff756cdd8" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_55f4f988-01a3-4810-886d-60aff756cdd8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_2efc72e5-7bad-450f-af2a-d3c349d080f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_2efc72e5-7bad-450f-af2a-d3c349d080f5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_2d2a7f55-9fc2-4dd1-a4eb-12d9a078ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_2d2a7f55-9fc2-4dd1-a4eb-12d9a078ac30" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_71e536b9-29c5-4d41-880d-c5c88e5edce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_71e536b9-29c5-4d41-880d-c5c88e5edce5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_84733479-15e3-431f-9e54-d94039d783d7" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_84733479-15e3-431f-9e54-d94039d783d7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_11075ef5-1265-4540-8831-be7d19e884f8" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_11075ef5-1265-4540-8831-be7d19e884f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_26c2b0f4-c657-422e-9e79-574039c1ff41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_26c2b0f4-c657-422e-9e79-574039c1ff41" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a440fb2a-5408-488b-91b2-69e32413a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a440fb2a-5408-488b-91b2-69e32413a3df" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_edb18df7-8767-44db-a12b-a416eae49d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_edb18df7-8767-44db-a12b-a416eae49d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_af42fdd9-9e72-4a14-8525-78934b190edf" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_af42fdd9-9e72-4a14-8525-78934b190edf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_404ed020-c963-4a41-9bfb-3011bc9be563" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_404ed020-c963-4a41-9bfb-3011bc9be563" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_0344d72c-8b3a-4e5b-b654-2f36264fa77b" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_0344d72c-8b3a-4e5b-b654-2f36264fa77b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4711866a-7b1d-4fb3-81d0-89ace0f9aa06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4711866a-7b1d-4fb3-81d0-89ace0f9aa06" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_d4116f2d-c7b6-402a-a032-7fa0a02dbd93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_d4116f2d-c7b6-402a-a032-7fa0a02dbd93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b064a877-c228-43b8-9f27-77549752ae26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b064a877-c228-43b8-9f27-77549752ae26" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8d03e470-9c95-4923-a3d2-6ed3638a07d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8d03e470-9c95-4923-a3d2-6ed3638a07d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_54408c87-b37b-4112-8033-a73264c2810d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_54408c87-b37b-4112-8033-a73264c2810d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f8c7c36a-5184-487c-aa1e-8538e62621b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f8c7c36a-5184-487c-aa1e-8538e62621b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e309bb64-ecf8-4e85-9cb6-2ea557ac78b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e309bb64-ecf8-4e85-9cb6-2ea557ac78b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_402f1872-2adb-4cd0-be1d-8b2ec05776ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_402f1872-2adb-4cd0-be1d-8b2ec05776ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a8e64896-b57e-4ba5-91f8-4b17b171b719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aa871f25-5eea-4e4c-870d-bbace028e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5b247020-2f48-4879-9b77-3865340787a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:to="loc_us-gaap_PlanNameDomain_5b247020-2f48-4879-9b77-3865340787a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:to="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_431ffe35-4b6b-410a-bbca-d0e3308d2f06" xlink:href="kequ-20240430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_431ffe35-4b6b-410a-bbca-d0e3308d2f06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember_b5ab0abb-e6b8-4079-a478-fbb69c48ca82" xlink:href="kequ-20240430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandAndEightPlanMember_b5ab0abb-e6b8-4079-a478-fbb69c48ca82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_ad20cf52-5845-4a90-ac06-8a63995f7d11" xlink:href="kequ-20240430.xsd#kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_ad20cf52-5845-4a90-ac06-8a63995f7d11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d98c83f-ee5c-4af7-bfb6-8962690508c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3d98c83f-ee5c-4af7-bfb6-8962690508c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_5cd73de1-f20a-47f6-8c2d-31e404feb6df" xlink:href="kequ-20240430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_5cd73de1-f20a-47f6-8c2d-31e404feb6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_45851c01-dcf8-4551-bc90-24f5d1024b57_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:to="loc_srt_RangeMember_45851c01-dcf8-4551-bc90-24f5d1024b57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:to="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c595169-c470-4d91-b732-03aef2b6b02a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:to="loc_srt_MinimumMember_0c595169-c470-4d91-b732-03aef2b6b02a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7b5b971f-1530-4a50-8e70-9bbbbe8236f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:to="loc_srt_MaximumMember_7b5b971f-1530-4a50-8e70-9bbbbe8236f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:to="loc_us-gaap_VestingDomain_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:to="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_a28d79ae-4f7e-45ac-97f4-c1761fb43dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_a28d79ae-4f7e-45ac-97f4-c1761fb43dc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d44b9f98-71ef-40b1-9ce5-1e14047e0785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d44b9f98-71ef-40b1-9ce5-1e14047e0785" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_36822af5-468a-46a8-b2cf-341232740719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_36822af5-468a-46a8-b2cf-341232740719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_273c5982-7ace-4de7-a88f-50d65412f745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_273c5982-7ace-4de7-a88f-50d65412f745" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_95a8dc16-e5ef-478c-b57a-0840fef7fbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_95a8dc16-e5ef-478c-b57a-0840fef7fbd0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58aa3bdb-cf92-4f89-b777-af5d45494858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58aa3bdb-cf92-4f89-b777-af5d45494858" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_50fed401-cf90-4feb-adc9-22ab4a7f8e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_50fed401-cf90-4feb-adc9-22ab4a7f8e7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4c5feeaa-7630-4083-be9f-a848c86fdb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4c5feeaa-7630-4083-be9f-a848c86fdb48" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_43186093-a100-48fb-b2db-4c39219b3c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_43186093-a100-48fb-b2db-4c39219b3c7a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c2759269-2576-4aa0-8f1b-44f63f0b845c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c2759269-2576-4aa0-8f1b-44f63f0b845c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1e5f2f8e-90ad-4b3e-9362-e0c58b4f7ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1e5f2f8e-90ad-4b3e-9362-e0c58b4f7ce5" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:to="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4825add9-f336-41de-ad56-70465471bfdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4825add9-f336-41de-ad56-70465471bfdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_70d47dfa-8ded-4653-97b8-9dcdead211e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_70d47dfa-8ded-4653-97b8-9dcdead211e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_697ab5f2-b672-470b-b6df-da0daadfcbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_697ab5f2-b672-470b-b6df-da0daadfcbf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c00d9882-a54b-4b34-aa4d-03f2735e105b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c00d9882-a54b-4b34-aa4d-03f2735e105b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36694768-dc62-4f00-9223-13d36cd000f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36694768-dc62-4f00-9223-13d36cd000f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6f28256d-52a1-443a-a728-cfa960c77a15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6f28256d-52a1-443a-a728-cfa960c77a15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7801923f-bd60-4459-9a7c-1f34f0d5bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d19e5d6c-dd46-4c89-8bfc-2d204b3e4ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d19e5d6c-dd46-4c89-8bfc-2d204b3e4ecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fa12126e-76c4-4930-b3f3-54813a8f64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fa12126e-76c4-4930-b3f3-54813a8f64cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87b40dd2-3628-4fc2-8dfc-09f2392850c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87b40dd2-3628-4fc2-8dfc-09f2392850c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_335f846e-59ad-4c94-9906-30ee28a5d20a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_335f846e-59ad-4c94-9906-30ee28a5d20a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1deb7f23-45e7-45df-ad80-46ca808e34fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockholdersEquityShareRepurchaseActivityDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4e4d4a62-ca17-4595-ab7f-2268b67a82af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4e4d4a62-ca17-4595-ab7f-2268b67a82af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PubliclyAnnouncedProgramsMember_935975ea-0f39-44ba-bb51-5007b22bbb82" xlink:href="kequ-20240430.xsd#kequ_PubliclyAnnouncedProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:to="loc_kequ_PubliclyAnnouncedProgramsMember_935975ea-0f39-44ba-bb51-5007b22bbb82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dc76baa4-e093-40d6-8e63-3960ca5cf72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dc76baa4-e093-40d6-8e63-3960ca5cf72d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_cef8ba52-5d87-4d85-b260-e5025116c7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_cef8ba52-5d87-4d85-b260-e5025116c7d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_5e3e8d43-0123-4fb2-b15a-91c5418674d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_5e3e8d43-0123-4fb2-b15a-91c5418674d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86c5e5dd-df77-4570-b9e9-7321628765ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:to="loc_us-gaap_EquityComponentDomain_86c5e5dd-df77-4570-b9e9-7321628765ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:to="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f4bac3e4-201d-4917-9197-87cf409ce4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f4bac3e4-201d-4917-9197-87cf409ce4fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_89b117fb-98a8-4998-a690-ffe9acbf13cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_89b117fb-98a8-4998-a690-ffe9acbf13cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c28fb05-bb92-4a9e-9376-72f792a0b707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c28fb05-bb92-4a9e-9376-72f792a0b707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fcdb799f-965b-4fc7-9642-e3bc23826683" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fcdb799f-965b-4fc7-9642-e3bc23826683" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5b894c1a-20a8-4fe6-a0be-2d553a0e695a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5b894c1a-20a8-4fe6-a0be-2d553a0e695a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_881f2268-9340-469c-b8e9-b87122501b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_881f2268-9340-469c-b8e9-b87122501b84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_61bce5c3-481d-4b22-b4a3-0e88319e9690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_61bce5c3-481d-4b22-b4a3-0e88319e9690" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bfb938c5-6fd8-4ea1-ae85-dc8449739862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c233f238-ce42-42fd-8dd5-cb4b7281f1e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c233f238-ce42-42fd-8dd5-cb4b7281f1e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_32308719-0731-4994-87f9-be25c9ea4fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_32308719-0731-4994-87f9-be25c9ea4fbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:to="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_832c2992-e6cf-4c96-92cf-d4c9b9029f25_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:to="loc_srt_RangeMember_832c2992-e6cf-4c96-92cf-d4c9b9029f25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:to="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e084f171-c9a4-4aeb-a283-be4047ade89c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:to="loc_srt_MaximumMember_e084f171-c9a4-4aeb-a283-be4047ade89c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ffc217e-1893-4b3a-a87b-c5a6c4d882e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:to="loc_srt_MinimumMember_0ffc217e-1893-4b3a-a87b-c5a6c4d882e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_a6771353-81e3-41c1-98e7-9b76384056ce" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_a6771353-81e3-41c1-98e7-9b76384056ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_cd635c27-1ecb-47db-912b-e5887954cd30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_cd635c27-1ecb-47db-912b-e5887954cd30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_4b60c679-1b71-4d6c-bcfe-bfd9f5b232f4" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_4b60c679-1b71-4d6c-bcfe-bfd9f5b232f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_21f1d5aa-2bb1-4bb4-a1dd-53c7d0127642" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_21f1d5aa-2bb1-4bb4-a1dd-53c7d0127642" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_6a517b2a-40db-4df2-9966-873f3d8b70a5" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_6a517b2a-40db-4df2-9966-873f3d8b70a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_68ec121e-d3f0-400e-b1ea-2d7edb9ab34f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_68ec121e-d3f0-400e-b1ea-2d7edb9ab34f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_0bfeeb5e-951d-4ac5-b7d8-a9f2a39f42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_0bfeeb5e-951d-4ac5-b7d8-a9f2a39f42ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_c5d1213d-63c5-4ab1-a181-2280543a322c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_c5d1213d-63c5-4ab1-a181-2280543a322c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_75a37f2c-af94-4284-9381-06293974ade6" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_75a37f2c-af94-4284-9381-06293974ade6" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_41603651-fad4-4ba1-a48f-c45b03c99eb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_41603651-fad4-4ba1-a48f-c45b03c99eb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_7d8425e1-40a7-4e38-8eaa-4abffc966bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_7d8425e1-40a7-4e38-8eaa-4abffc966bea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_65da08b3-429a-410b-85db-aedf909e034b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_65da08b3-429a-410b-85db-aedf909e034b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_707fde5c-865b-4b03-843b-f80c6d4dc20a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_707fde5c-865b-4b03-843b-f80c6d4dc20a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f1e3232f-640f-4c35-8585-c1ef58c8bd23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f1e3232f-640f-4c35-8585-c1ef58c8bd23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_f4d49dd3-1cc3-49d7-9951-9d03070da5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_f4d49dd3-1cc3-49d7-9951-9d03070da5cf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54239fb7-183c-4b54-92d1-3f7c246f6da5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54239fb7-183c-4b54-92d1-3f7c246f6da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1dc0c54f-1482-4c42-bd65-466011942485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1dc0c54f-1482-4c42-bd65-466011942485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_04dbe361-fafc-4c5e-9f11-4271ab2b0f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_04dbe361-fafc-4c5e-9f11-4271ab2b0f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ac050b5f-2ed6-420d-ac01-6efe024c766c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ac050b5f-2ed6-420d-ac01-6efe024c766c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d7009a9b-b55e-46f7-9c27-cb376d250a27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d7009a9b-b55e-46f7-9c27-cb376d250a27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_bdaae05b-297c-4d3e-af30-4fac3a436c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_bdaae05b-297c-4d3e-af30-4fac3a436c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_b0424374-375e-40a3-b850-a1604076df6f" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_b0424374-375e-40a3-b850-a1604076df6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_1fa3ec08-66db-4ef1-9a11-15ee17638840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_1fa3ec08-66db-4ef1-9a11-15ee17638840" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_b1cf40c6-8042-4f32-a392-871a2139d159" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_b1cf40c6-8042-4f32-a392-871a2139d159" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_964b449f-11d6-4298-8ef0-036360931a41" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_964b449f-11d6-4298-8ef0-036360931a41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e2105353-3160-451f-91e6-911a77e91539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e2105353-3160-451f-91e6-911a77e91539" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_ecc393e0-e312-440f-ab5d-91ebd22166ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_ecc393e0-e312-440f-ab5d-91ebd22166ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_338d8954-e25b-4bb2-92d5-00981e372fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_338d8954-e25b-4bb2-92d5-00981e372fb6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8b2020a9-0572-4e1c-a52b-8f5d7df74949_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:to="loc_us-gaap_SegmentDomain_8b2020a9-0572-4e1c-a52b-8f5d7df74949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:to="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember_31bdfc19-5302-4d8f-bd15-cf6b6385514d" xlink:href="kequ-20240430.xsd#kequ_DomesticOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:to="loc_kequ_DomesticOperationsMember_31bdfc19-5302-4d8f-bd15-cf6b6385514d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_5ef102a1-6136-4ad9-93b9-d8b6ea408cb3" xlink:href="kequ-20240430.xsd#kequ_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:to="loc_kequ_InternationalOperationsMember_5ef102a1-6136-4ad9-93b9-d8b6ea408cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ec431752-f91b-4f59-8d6d-ac1d641594b5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:to="loc_srt_ConsolidationItemsDomain_ec431752-f91b-4f59-8d6d-ac1d641594b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:to="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d16d6ea1-98bd-4d64-bc45-b1d3e1e8b98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_OperatingSegmentsMember_d16d6ea1-98bd-4d64-bc45-b1d3e1e8b98e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5abae19e-6c76-452c-b827-481b266bfe42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5abae19e-6c76-452c-b827-481b266bfe42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_43f803eb-fab8-4991-90bd-74cd77d030da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_43f803eb-fab8-4991-90bd-74cd77d030da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78828eb1-d3c6-4310-a7f0-d93e84b5b572_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:to="loc_srt_SegmentGeographicalDomain_78828eb1-d3c6-4310-a7f0-d93e84b5b572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:to="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4056886b-532d-4f75-a768-ef024f825bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:to="loc_us-gaap_NonUsMember_4056886b-532d-4f75-a768-ef024f825bb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52ed7d8f-f966-4baf-ab0a-d11ccb66ee9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52ed7d8f-f966-4baf-ab0a-d11ccb66ee9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup_9727eccc-d8ca-4ff3-925d-195c20ad03b1" xlink:href="kequ-20240430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_kequ_RevenuesIncludingIntersegmentMarkup_9727eccc-d8ca-4ff3-925d-195c20ad03b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_91133c07-fae6-48fa-baa9-30134e5430b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_Depreciation_91133c07-fae6-48fa-baa9-30134e5430b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db540270-9273-4298-8a1f-ab71112df88a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db540270-9273-4298-8a1f-ab71112df88a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6b9d23ff-c23c-4b84-beb4-c8570a349dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6b9d23ff-c23c-4b84-beb4-c8570a349dbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4a3e3516-1f0d-40ad-8c3c-926a0150e409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4a3e3516-1f0d-40ad-8c3c-926a0150e409" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a4fb24a-6e80-40a1-8a85-e2c0f3a8bd34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_NetIncomeLoss_3a4fb24a-6e80-40a1-8a85-e2c0f3a8bd34" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_541103c7-958a-455e-94ab-56c269fcef39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_Assets_541103c7-958a-455e-94ab-56c269fcef39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_85768d67-d9a2-4efa-9c8f-20cd295badab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_85768d67-d9a2-4efa-9c8f-20cd295badab" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_PensionExpense" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_068b090e-be4c-42d6-bc7d-b67bea25d8bf" xlink:href="kequ-20240430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_068b090e-be4c-42d6-bc7d-b67bea25d8bf" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>kequ-20240430_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_af438b7a-72ff-403e-a20b-626b2e42fcee_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_eb6a52ef-7eae-45c3-b872-452786b57c6d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_09ad5db9-0d5b-486b-9c24-298a849845a5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_5b079f02-de97-4bed-927b-63d4c68762b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a0e8522-11ce-47a2-822c-cb649c320b4a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less: net earnings attributable to the non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6e3f67a2-46a5-4c87-bcef-24a004ea20fc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_50d3c134-e3d7-4e8b-af95-8710eab2404f_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e8d502ab-d008-4814-acc8-01540c87f485_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3c611289-2d45-4726-a6df-18668a918f81_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loan agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_962eaf2f-f5ab-455c-847b-d1426189dcc0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9bbde675-9d00-4c04-b8c8-316642c5b3c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ee13d08a-2f22-42b8-892e-82f5df8c24d3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Terms of award (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_ee37493a-64db-4c00-b82f-4ae2b2a1e548_terseLabel_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal, state and local tax returns period (in years)</link:label>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_label_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Federal, state and local tax returns period</link:label>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_documentation_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Federal, state and local tax returns period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:href="kequ-20240430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:to="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_cdcc4a3d-9bea-4e32-a36a-be9a6f2ce48c_terseLabel_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense on financing liability</link:label>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_label_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Financing Liability</link:label>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_documentation_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InterestExpenseFinancingLiability" xlink:href="kequ-20240430.xsd#kequ_InterestExpenseFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InterestExpenseFinancingLiability" xlink:to="lab_kequ_InterestExpenseFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_117989d2-415c-475f-8ecd-577d3e87fa67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_69247e0f-d578-42ce-8d68-c5ca234bc699_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_58b8afda-5e41-466e-9d2a-c13b31aae0c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e748574d-1696-41f0-a325-a9ae0d9f9676_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_3280af82-a399-4d88-95bd-0632fb491849_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_43390c7c-c34e-4a18-a0b9-c52114bab517_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_43a9dffe-c06d-4a7a-8af4-560ac4afb0ed_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate at period end</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_583e80cb-b46c-4617-b178-e089ccf41da3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt and Other Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_612b96bf-3772-4590-9677-308b8c1a86fc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenueRecognitionTable_72845738-8d52-4a96-bd74-fe89ad81c730_terseLabel_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionTable_label_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionTable_documentation_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenueRecognitionTable" xlink:to="lab_kequ_RevenueRecognitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b0776adf-9380-42ba-869d-a0febf8d041b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_715f191f-d9bb-4201-b4d2-8660fef61b23_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Experimentation Expenditures</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_b73b4a8f-199c-49d8-90c2-3973d66cea4d_terseLabel_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to terminate, term (in years)</link:label>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_label_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Option to Terminate, Term</link:label>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_documentation_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Option to Terminate, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoTerminateTerm" xlink:href="kequ-20240430.xsd#kequ_LesseeOptiontoTerminateTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeOptiontoTerminateTerm" xlink:to="lab_kequ_LesseeOptiontoTerminateTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0a215043-4bce-43d4-bf8d-eed39682389a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentImpairment_5ca4fb68-9b74-463a-bd83-66d9d54c8c2f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Impairment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentImpairment_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Impairment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_815d9236-c520-40ef-9cdf-b30119623e4b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, net</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_41184083-7286-4a81-aa3c-715036dffc28_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income taxes on postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_17252999-d5ab-48c7-8d4b-2b59582ee10b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes on postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_b947de4b-7e3f-448a-a400-eae09dddd2f2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After-tax actuarial loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cadd0e7c-2b96-4345-b1b6-a9b897fbde0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_6f8c99a0-071f-4556-b242-61bac7b5554e_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_d9e727e1-8ba9-43af-969f-4bdf1338189d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4d2a2e18-8a3c-43ea-adca-39df2fd8e871_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_9df5bfeb-5056-48a4-9079-19ce6a9f6952_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c1579780-19b2-4126-9ac9-3e53c8cbd2b3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_d968ef82-50dc-407a-b2f0-711e811c06c4_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, After Year Five</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:to="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_1a713af9-d92f-4dfe-9e95-f12b8ef24e9f_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearFour" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_ef7e3891-c78c-4135-b9bb-752b9c421976_terseLabel_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled retainage included in other assets</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_60757138-0d61-4ff7-aba7-4d00368077b9_verboseLabel_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contract assets in other assets</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_label_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Retainage, Current</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_documentation_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unbilled Retainage, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent" xlink:href="kequ-20240430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_UnbilledRetainageCurrent" xlink:to="lab_kequ_UnbilledRetainageCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_58907162-b83b-49c8-986d-34ce54b2a1fa_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_44897de3-8a66-4ce9-ba1a-98008a56df59_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_aa17c682-edba-4ae1-8fd4-9059d746aadb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_e098f3b2-28b6-4485-a166-9bf8030abc16_verboseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset, Section 174 addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_14be9aa8-db60-4cd2-b55c-7a878bd02717_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Section 174 R&amp;E Addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Section 174 R&amp;E Addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Section 174 R&amp;E Addback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetsSection174REAddback" xlink:to="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DomesticOperationsMember_84ead396-2b5c-4287-aa40-564f40df95c5_terseLabel_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_kequ_DomesticOperationsMember_label_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Operations [Member]</link:label>
    <link:label id="lab_kequ_DomesticOperationsMember_documentation_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Domestic operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember" xlink:href="kequ-20240430.xsd#kequ_DomesticOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DomesticOperationsMember" xlink:to="lab_kequ_DomesticOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_789ad9c6-b4ac-4305-b5c9-a94ffcef63d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d0e0931-171a-47b7-9ed2-26f541f6a43c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_91656ce9-dd0b-4263-bb09-bda6d61202eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholder's Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_1ca21557-77aa-4d22-b99e-682a5149b80e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_549f258b-c8bc-406b-8bc5-e1c67ca6c4b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_fd65962b-8cf8-42da-95fa-f4af1f9314f8_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_b69c82fe-b20d-47b2-b554-891f896530e9_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ae95a12f-d83a-44ed-ba18-62ee62e5d686_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2ac2731b-546c-4170-8f1e-a42914f55d35_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c1dbaef1-6f61-44fa-81ce-398801f8094d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_9bb358cb-c7ab-4ba9-be97-49056d510da9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_54ded40d-71f6-4afa-a2e3-0b1adb41c3cb_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d2687dd4-f1c6-4479-8242-9a7215717c99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_81cb6eb9-ef5b-44d5-a792-5f1e102fdad8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d0318c13-084e-45c4-9781-6661d02c145a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7de456a0-544b-4431-ab09-9c86041e752d_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common stock in treasury, at cost: 70000 shares (2024); 3 shares (2023)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3c26e137-1606-498a-8a29-b196b807a1d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables, less allowance: $588 (2024); $476 (2023)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_62b2393c-7bb9-4db2-aa24-aa71a742c1a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_9b201751-78f9-4e2a-bfca-b561e945b01b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_12abb8d6-cf5a-4686-b288-876b2c7c9062_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7cd22366-93a3-4b4e-be60-dc854b21fe0f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8ce38d0c-a607-4050-bb1c-e5610a861c4a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b37c4d45-bf5b-4ffd-a4b6-0bca65f25be9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionContractorReceivableRetainage_d4e3eff5-53c3-4f06-85ff-00a8b90d91fa_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retainage included in accounts receivable</link:label>
    <link:label id="lab_us-gaap_ConstructionContractorReceivableRetainage_label_en-US" xlink:label="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction Contractor, Receivable, Retainage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionContractorReceivableRetainage" xlink:to="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_e9f56b88-22b7-456a-92e9-79d1774df6e9_totalLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Excluding Settlement Cost Component</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Excluding Settlement Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:to="lab_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0d523ae9-bcb4-4889-b2a4-6e378a5072e2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_01b68a99-3d90-4f64-a497-f2c70f912bce_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on sale leaseback agreement</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_5444eb2d-b0ce-48a7-bf2f-10515fd79033_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Liability [Line Items]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_label_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability [Line Items]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityLineItems" xlink:to="lab_kequ_FinancingLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e77e39ac-7807-4be9-b2ae-2157647545d5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6b5ecaed-102d-45d4-a9b7-a92d2ca6d98e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net earnings (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_73984e6a-faaf-4d12-ba71-07ad31df43e2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_54782200-958d-4b1d-b527-a4dfe7c87c3e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4d812392-788b-4082-81b8-b3c265fd1cc8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1d614119-84a7-4e55-aaef-9d8d64091f37_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_57bea611-bb48-43f0-a926-30da9a92f001_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_9527fba0-37e7-475c-afc6-f0a260caf787_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_4bb5ba2c-828b-4584-9e67-80650dd5f03f_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Actual benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_ca101ac1-a9dd-4121-9e58-99bd672f1b26_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual rental increase, as a percent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Annual Increase, Percent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Annual Increase, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAnnualIncreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:to="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_56151e23-4d79-47c8-a2f6-89360d98e6ff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_444bb605-9815-443d-a08d-b9953e8b6259_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_0097aba0-cae7-4d74-8a49-e873ff4748ca_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b841f136-5542-4011-b508-7e0039ff36e3_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_08268d9e-c4cf-4d40-9279-7e1c868fbb3b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_e3745ac4-79d2-4540-a206-d564ab58e825_terseLabel_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowing availability</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_label_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_documentation_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:to="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_23f17d4a-cbb4-4ee1-9df4-894a3cb9d78f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Basic to Diluted Weighted Average Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_26279d30-981c-4c8c-bfcd-12083779378f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2725cfb5-77da-4591-8359-610771ed9cbf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_471ae7eb-ce7d-46d2-8cc0-da0fd84efb70_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of RSU Activity and Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1cbdd23c-bb14-4b76-9156-8becde777f43_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of RSUs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_ba49d8cc-20bd-419b-8d1e-1b7ebcb4d860_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c3904fa9-7255-45e7-815b-13db624ef732_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_0eee144b-1ea1-480f-bb44-390ad3b21040_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_de046629-191a-41d8-ac31-2b76d1ee3b66_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_69d385c9-70dc-459e-a5b9-5ba1f7db2bad_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aa11a974-a8c3-42bd-b3f3-562893986aae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b158427a-0e1c-46ac-8670-0768c98916a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionExpense_a979698d-a5c1-4f53-b5e2-5003d1bdf1a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Pension expense</link:label>
    <link:label id="lab_us-gaap_PensionExpense_label_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionExpense" xlink:to="lab_us-gaap_PensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_78d80ae6-e22d-43bf-8aae-85b30f6c34b6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_5f7b6dcf-c84a-4374-90c5-da86a18f98b4_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4cb72d45-d1a5-47bc-b6ae-83e7998bdee2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8b464066-25ec-42af-9482-a3ba9394039c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2610b233-f0a1-4b4b-9747-7ebf5eeb4656_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_5f95056b-7bf8-41c6-96c7-ea1d6871a4b8_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_5d146650-2967-4d6b-a0ce-37611a9aba8e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_bb475c20-3fed-4b35-8f65-d17a7a145024_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Point in Time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b412a3d7-0712-49cf-a1ca-56b98923d08f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_PubliclyAnnouncedProgramsMember_f0a9cdd0-bc1f-4d02-b3f9-9b36ed03fbaf_terseLabel_en-US" xlink:label="lab_kequ_PubliclyAnnouncedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Publicly Announced Programs</link:label>
    <link:label id="lab_kequ_PubliclyAnnouncedProgramsMember_label_en-US" xlink:label="lab_kequ_PubliclyAnnouncedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Publicly Announced Programs [Member]</link:label>
    <link:label id="lab_kequ_PubliclyAnnouncedProgramsMember_documentation_en-US" xlink:label="lab_kequ_PubliclyAnnouncedProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Publicly Announced Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PubliclyAnnouncedProgramsMember" xlink:href="kequ-20240430.xsd#kequ_PubliclyAnnouncedProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_PubliclyAnnouncedProgramsMember" xlink:to="lab_kequ_PubliclyAnnouncedProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_40f9a16b-7fe8-40c4-b620-1176b812ddf1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityTable_23ae6f5d-7a9a-43ae-b4ee-0f98a999de60_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Liability [Table]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTable_label_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability [Table]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTable_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityTable" xlink:to="lab_kequ_FinancingLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f4ae6bef-8f40-4f21-b399-32654e22f48d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_66e7cae0-678b-4461-be5e-0f64e973c297_terseLabel_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kequip Global Lab Solutions Pvt. Ltd.</link:label>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_label_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kequip Global Lab Solutions [Member]</link:label>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_documentation_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kequip Global Lab Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember" xlink:href="kequ-20240430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KequipGlobalLabSolutionsMember" xlink:to="lab_kequ_KequipGlobalLabSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_b30d3c9c-e830-4939-8b01-6502770f6b04_negatedTerseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:to="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_30da6ad7-f1e3-4d10-88b7-3f19c59a6529_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_bedde5c2-3676-4c68-9817-93dc2a091f7d_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_309d394d-f03c-4655-bd70-3990fe03b86c_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_7c808e20-1c7d-4a72-a3eb-495249e1515b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Debt Issuance Cost on Sale Leaseback</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_IncomeTaxesLineItems_b5f30b64-3a30-4f76-87c4-9e89afd42a2c_terseLabel_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_kequ_IncomeTaxesLineItems_label_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_kequ_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_IncomeTaxesLineItems" xlink:to="lab_kequ_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2ac59f6a-48bd-4f39-a19a-3bc6ba3af237_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f2a1e8a1-5380-4e98-b541-d12db1fbee9d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of stock options and RSUs (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_d801ad94-f030-4438-9583-ff1df799f932_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Projected Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_68725572-8dc2-4059-9e4e-48bfb6a42bc7_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan remaining pension plan liabilities</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Remaining Pension Plan Liabilities</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Remaining Pension Plan Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:to="lab_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_ccf4baae-840e-4073-b455-3c08227bfc05_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_7b5a6757-26ad-408e-9955-89049f3144c7_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_f7bf1707-0850-4c81-a4c2-9f25d389d2c9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1ee6bad7-c4b8-46de-b490-6b0cd507cb5c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8095c139-9bed-4cdc-8f39-fc5d2a521a48_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Anti-dilutive options exclude from computation of earning per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9c1ee0a3-0395-4606-88f1-38242c6deee7_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9dd0953e-564c-45bf-ac9d-b25cabdbd38c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_c0213602-fc12-4955-b975-1e29dca2b5a1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_576a04ce-7a57-4191-bd18-796cb4db8853_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0dc56377-4b65-487c-bdfc-703794b98574_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining estimated compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cfe55b55-229c-4d56-9098-77bb3665d83d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_4893985b-7036-47b5-8ebf-90d4468e6cc6_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_7406c6ee-219e-498a-a2d1-00f3bb1507e3_verboseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fixed Income Securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_7e4edc30-85b6-47aa-aae0-3f5095a96ee4_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed Income</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c4f07ab9-4fb2-4033-8400-6879c3439ca6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized under stock option plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_057a77be-f097-4c2e-8661-40226a081fdc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property plant and equipment gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_c3beb732-3fde-494e-ba7a-4d0efd75d4c0_terseLabel_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_label_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues Including Intersegment Markup</link:label>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_documentation_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenues including intersegment markup.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup" xlink:href="kequ-20240430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenuesIncludingIntersegmentMarkup" xlink:to="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_031c6c22-5271-4d14-ad3a-fad10046d7d3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_21900e43-f0a2-4c2f-b4d7-0863c0240ce4_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets obtained under new operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_55562e95-3a49-4ec0-afce-814ce106e4b5_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bc3d8875-66aa-4396-8132-a6d0b933d482_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_81943b8b-2859-4d58-90c5-5674051e8292_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_80ee576e-6a89-4a32-9762-699785be1371_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dfb1b81a-8687-4b2d-881e-7afd17cb845b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_8166ae9c-2703-411d-a2ed-abb30307b278_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_9f01a809-9636-4efe-afe4-d01ef1a1408a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a874a09c-4943-4376-99c9-5ca6addf6e7c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2616b0b5-3182-45fc-8386-6f16aba38881_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_83434027-66b0-44ea-a199-1fa7880b174a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cc966403-8be5-4054-a30b-261c2cf87252_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_0ec55b31-42cf-4982-a0b8-23b213995ae1_terseLabel_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease term (in years)</link:label>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_label_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Remaining Lease Term</link:label>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_documentation_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeRemainingLeaseTerm" xlink:href="kequ-20240430.xsd#kequ_LesseeRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeRemainingLeaseTerm" xlink:to="lab_kequ_LesseeRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_13935a87-54ba-47d7-9cd7-192cbc933828_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_7162bb20-7ba2-4b21-88aa-c4d54e49cd5e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b6e6662-a9a1-473a-be01-91f2d10944ab_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_bbed954e-2ce1-4b4b-9816-bb3801983362_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4d72d62a-e43f-41b8-ab74-624fed54f046_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_c4f89c80-809d-475b-9f94-a819affc2b15_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average Price Paid Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f03f8282-db0d-4040-a77c-796f9f8911d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_7e907f98-54f7-47bc-b692-dc70c772531c_negatedTerseLabel_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of pension settlement</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_label_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_documentation_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:to="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_ca3f750e-7eb7-417b-9bc0-3a48b553cf09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Share Repurchase Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2fac26a8-ae9f-46a0-804e-6cc41e413c39_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22356b43-d499-4ee9-8c17-acc6d12db234_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at End of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02160b96-4b40-4b85-a137-7be03814a0a1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_a958b10a-52eb-4050-9433-d712b403530f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0503c10a-3356-4f17-bf19-b3523812701c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4db401ad-b9c2-42da-bb46-c26f86f963a9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, Plan asset percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_58777709-617d-447d-a2fb-218145f365aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7c74d2c4-96a1-4b37-a914-b7bea868851f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_4e799335-f4e6-4b16-9e0a-77ed971ec40b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average Assumptions Used to Determine Benefit Obligations at April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dffbc933-5146-4947-bcc3-3a14f1209247_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_6ef561e5-b620-4425-b4ff-0b0901d44ff0_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a43454d9-414c-4020-ab7e-4f59942166c7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_970a3265-aafb-408e-8c27-8e2608349429_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b5ef9c6a-e1d6-42f5-bb36-a038593f1da2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting for Stock Options and Other Equity Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a72b9356-941e-4865-802d-756763c640bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2160c85b-45c9-4003-8d59-e707aa10da8a_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3df94849-95c3-4e2d-81cf-f1e36b251706_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_620ab4ed-5ca5-44cf-acf0-6de0281cca7e_negatedTerseLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Book basis in excess of tax basis of Sale Leaseback property</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Sale Leaseback Property</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Sale Leaseback Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:to="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_caa3b214-4979-407f-8c5e-8ca1c8f5ee50_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_95b5d50f-d65e-4d9a-9461-b3a4d1a461be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_f775e4ae-3e24-4eb6-af14-faab907b256d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9219a5ff-b53c-41d9-99a4-ab7ce1f02232_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_0cbb62fd-e271-436a-8c02-8bbc0b2daad5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5a655862-31fb-4d81-82a3-61297bc62e19_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_acc0be9a-6483-43ca-a807-ef7ec232aa04_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dbc15396-2973-435f-b5b1-e09e3e6e15a8_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Funded status&#8212;under</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_44c0456a-3f37-4058-9685-8105001ef828_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transfer to insurer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_50f548bd-794e-4973-805d-afe94e46cbc6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_d0f12b11-5cd0-4996-9124-c293a71f6ff4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in number of shares reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_64556ce6-a283-478c-bd9b-1ba7b0da1531_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Age limit of employees to be eligible for contribution (in years)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Age Limit Of Employees To Be Eligible For Catch Up Contributions</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined contribution plan age limit of employees to be eligible for catch up contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:to="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_cd470c21-afcc-48f3-accc-356e073c547c_negatedTerseLabel_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayments on financing liability</link:label>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_label_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments On Financing Liability</link:label>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_documentation_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments On Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability" xlink:href="kequ-20240430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_PaymentsOnFinancingLiability" xlink:to="lab_kequ_PaymentsOnFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3ebcb302-68df-4ebf-8809-3f8b4788a693_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6e5a3fa4-257e-4430-9ac6-03333e6c8225_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_53e409fa-26b9-45d8-8487-583bf4f6e773_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f4c59762-b6fd-440c-aa5b-a8b04b1b1c84_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_708407b8-9c22-4ba5-addb-7799dc770c2e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Large Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Large Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_82da71f0-2489-4116-ae10-01d7094fd68a_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets (liabilities) classified in the balance sheet:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_64428c30-c916-4988-91b3-57f0813c7087_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_72a9678f-316f-4afc-950f-af80c36e3aed_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of controlling interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Ownership Percentage, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_60f14c53-4f3c-4927-9222-c5b62ca485c0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ff86ed07-40bc-4c6f-bfe9-b65617d165e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_bbd01975-d781-4ea7-82f0-f69a1de2a804_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash surrender value of life insurance policies included in other assets</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1677cdb9-6c1b-4a46-8530-6c96d693ead5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_b040e4c3-2d8f-4c82-8e51-7b7fd0ee42e8_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net actual loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_014aa425-6bb8-4903-9486-79ed4e9ab233_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7a9c0562-90aa-4eb4-9a2b-7a2c64f445ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_49ab7405-01bc-4638-b59d-b7b006b7c218_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_f1f8773c-04a4-4650-af50-628667534307_negatedTerseLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">APB 23 Assertion</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, APB 23 Assertion</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, APB 23 Assertion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:to="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_1745256a-01d2-410e-abec-3d0ec73ad92f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_1005a6e0-5d5b-4e3f-95be-47d1cffbfc1e_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7f040c70-2942-4118-b2b0-565df9c224dc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_e3cc4efd-4cb9-4d4c-a992-a6eba632ad7c_terseLabel_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes on unremitted earnings</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_label_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Taxes On Unremitted Earnings</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_documentation_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Taxes On Unremitted Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:to="lab_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_05a32949-5329-49d1-92e4-bd0fca802b52_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_540f55bb-0244-4b76-b63d-0f5fba2477ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_63156c13-8e1a-481d-b553-ec2eed593ef2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f5b2fd5c-2ca5-4349-bef1-33f640358ae0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_7146d6d4-a28d-4ca2-bc43-45aae6db8f35_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_a7d49737-7862-4002-ba0e-fe6b86e27b78_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Materials and components</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_39613377-0f50-45ca-b262-cf2a1dcc699a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_12835c4e-0cf7-475a-a518-54f5bca391c2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_96ec0a94-705b-4d66-9931-069c8910e377_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_f8f3d238-d1a6-4bec-8024-aaa3e8cf90af_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_7f843b40-e2e5-4c50-b11b-14b1ed401883_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_3b9829b2-8205-4c72-93d1-075ebac6e636_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_07ac3d52-5a03-4c7e-a3e7-8c533f504629_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3db118e7-18b8-4544-8eed-c00d2b1e8ad0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e59dfafb-0f65-4a3e-985e-a0f9245ea3e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0473aeeb-b73a-4b98-bef1-f0b561e281f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49e74afa-e211-4527-af4c-7717ad5b2882_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f852a9c4-0dd8-47d7-a230-26dc78efafd7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_a17ce95f-214d-466d-86c0-7270ee4691fc_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Allowance For Doubtful Accounts</link:label>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Allowance For Doubtful Accounts [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:to="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_916d022e-ff0d-4a0d-a0dc-9fe3131050ab_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_adf159dc-b421-447d-828a-d50cd5708b7e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_4cc7faaa-39c2-4c74-af18-423c1fc845f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory reserves and capitalized costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_0534e741-e5de-43ab-80a9-249f5c4f9769_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_fa8f47c5-fa2b-47c0-863f-3f56d7594991_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_79877719-69b6-4fa6-ab9a-4eae84d1dbf4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_443defe8-ee94-4b5e-a5d2-014cee0a9d07_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_41b5e25d-b78d-453c-8049-faf380ea9cfb_terseLabel_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to extend, term (in years)</link:label>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_label_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Option to Extend, Term</link:label>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_documentation_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Option to Extend, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoExtendTerm" xlink:href="kequ-20240430.xsd#kequ_LesseeOptiontoExtendTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeOptiontoExtendTerm" xlink:to="lab_kequ_LesseeOptiontoExtendTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_de67cbb7-09d8-4377-9bac-6f9863666aa7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_be79092f-46d2-4db2-b346-fe0e2d26b75d_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_fd3bcf93-dd54-43fc-92f9-fecf83f07cde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_492ada76-89d0-49d4-848b-122d6bb7dfd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Treasury Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_5c60c07e-c70c-4fa1-9302-436fcd91fb1d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_bb2e75cc-e5e1-4292-ace9-e701cd90686d_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9022d80f-fb49-4a4d-a9df-c19da2499c56_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_79377b09-aa22-4beb-a0b5-7d71dcfd7650_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer matching contributions</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contributions, Amount</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contributions, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:to="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_3c6b672d-0af4-4fe8-a2c0-95bc2641284e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TermLoanBMember_5abcf92f-1276-404d-9eac-4ea478e58282_verboseLabel_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_kequ_TermLoanBMember_label_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_kequ_TermLoanBMember_documentation_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember" xlink:href="kequ-20240430.xsd#kequ_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TermLoanBMember" xlink:to="lab_kequ_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_226484c3-d12b-4475-b64a-bfd35d25c498_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9e1cffd-8468-4e11-93dd-918794a94af7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_0adca055-ec3a-46c1-905e-7618e9c3aae5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_778516bc-0e79-4afc-818d-01f8ec66362e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6d4d46d6-85b9-42c0-9537-b2bfc3784f90_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d7b3a41-1e8d-4a8a-a57c-0635ee0e59be_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_45ceb2e2-f421-4b5f-959a-cfc24dc790be_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_8e26e0bf-3865-4e25-b542-7a74ed671032_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b779b031-834f-4091-8707-b3cf127e4453_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_168205c4-b126-4d43-a1ee-65c45d78dc70_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_bbe20c18-cbf6-4454-aade-573cdf1d4629_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_c1b8df92-3a1f-44a1-9a3a-8cb34de7a33c_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_ec8b4b23-02ac-4db2-8468-b17cd2f9c9e1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale-Leaseback Financing Transaction</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Leaseback Transactions [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleLeasebackTransactionDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:to="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_44bd25e0-a17c-4d22-b15f-26006083ae3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c0161673-0def-4fbb-bf0f-d42f63c62247_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_1f67e772-a52f-46a4-8810-df1bfd9fe804_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty Three Omnibus Incentive Plan</link:label>
    <link:label id="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Twenty Three Omnibus Incentive Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Tweny Three Omnibus Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:href="kequ-20240430.xsd#kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:to="lab_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_3bb0c53a-fe75-463a-b8a3-b817637b11e0_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0f2c1fee-11d0-4fd8-8c4a-5977fd19a091_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_38b058c0-6f15-41f6-aea0-a1ce478a1f7f_terseLabel_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued pension and deferred compensation costs</link:label>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_label_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefit Plan Costs</link:label>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_documentation_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts" xlink:href="kequ-20240430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AccruedEmployeeBenefitPlanCosts" xlink:to="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a1ffce6b-aea3-4f5b-bf35-afa824936c47_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f4d6d625-6730-4b8f-98c6-77b8a86943db_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_5dd86c5e-8aa4-41cd-a4de-722c96a2d595_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiability_a8482c7b-500d-4f20-a51e-c52705b66e6f_verboseLabel_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiability_b25673a0-817d-4e8b-9272-99fb34413bfa_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_kequ_FinancingLiability_label_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability</link:label>
    <link:label id="lab_kequ_FinancingLiability_documentation_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability" xlink:href="kequ-20240430.xsd#kequ_FinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiability" xlink:to="lab_kequ_FinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_1279a6f1-68e2-4c63-92ba-d3afe1d53b1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_c66fdc3f-7e27-434b-8d18-38084c8788a7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Concentration</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_b3661877-5a7f-43f4-878e-1382bc2a31aa_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_778a6061-b58a-49ca-a594-bb7577b6dc01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d9831267-431f-488c-9fb1-f866de334efa_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_bcaf5e05-0ce7-4816-adaa-4eb4a7416455_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_37abc759-182b-4f3a-b75d-77931ee8d133_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_6650a494-5ce0-4edd-95ad-8ee5f70af973_totalLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Minimum Liability Payments</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaid" xlink:to="lab_kequ_FinancingLiabilityToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_e2ad0d0a-0b05-425d-b290-443d4ec236c7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_91aa23c0-66d2-4927-9cd1-d68bf9cba890_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1d1852aa-fc93-4fec-a1f3-ec786b5431d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_dfd50678-cc70-46b7-a839-2afd454cf981_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_7bc70f9d-d4ba-4ea9-a5ad-c2b5b1fea185_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local taxes, net of federal income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_14ef0d8f-2912-4297-9978-e2228c426269_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a10ffb04-ed25-4c98-9861-8f84179eb9db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_4733390d-63c0-4111-a1ba-6dafa85973a5_terseLabel_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal Year 2024</link:label>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal Year Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal Year Two Thousand Twenty Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:href="kequ-20240430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:to="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_9ba68c30-dcc7-4b8b-860b-8c615ad3614a_terseLabel_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International Subsidiaries</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_label_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_documentation_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ForeignSubsidiariesMember" xlink:to="lab_kequ_ForeignSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_df2e65f9-b23e-4a95-910f-2769ad697469_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_075616d0-1677-4012-b599-7e3ca6f823d5_terseLabel_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International Subsidiaries</link:label>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_label_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">International Subsidiaries [Member]</link:label>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_documentation_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">International Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember" xlink:href="kequ-20240430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InternationalSubsidiariesMember" xlink:to="lab_kequ_InternationalSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_52829bb3-8d74-48ba-8764-1372c9dfef6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_604d26ec-b423-4363-896c-5f4249b6a753_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3a2c67e5-42e1-4933-ad23-efcb71184969_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of&#160;Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_9ce1a733-6063-4feb-a749-301728b3b27a_terseLabel_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non Qualified Compensation Plans</link:label>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_label_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Qualified Compensation Plan [Member]</link:label>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_documentation_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Qualified Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember" xlink:href="kequ-20240430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_NonQualifiedCompensationPlanMember" xlink:to="lab_kequ_NonQualifiedCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2f97a064-379d-44e5-a527-97e73e710090_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_3659c1a9-8cf9-4481-bad4-7664e9a8a582_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized actuarial loss, defined benefit plans</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_a9ef8b01-ce91-43f2-ac85-c295be194229_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_e2f6f27d-89d9-45fa-b835-ea15ee76effd_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liquid Alternatives</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Liquid Alternatives [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Liquid Alternatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:to="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_5207113f-276d-468e-b633-d3d3864ca500_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transfer to insurer</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_54185371-5b83-4fd8-9f6a-0775a0acbfa4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_60599ff8-0c44-4608-b375-1627f5ae1d1f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9683e72e-9df4-4a53-8084-3e364219e3b5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9ba4cf58-e770-41e6-bde1-d9b849591969_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_6553e502-4545-424f-8218-01100aa6d6f8_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_9783a98e-038e-4ebb-9610-b5b581ceeb0b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options and Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_1df4cd48-29f2-41b4-a5ed-3b6d92979b28_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_43c259c3-56d5-44b3-ac91-6ddefe2633c2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20502690-efd9-412e-ad07-142b1e9ab8bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_03a9103d-fcc2-42e7-9a88-f1961535d419_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum Pension Liability Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e28b9453-53fd-40c6-a59c-66926bfa06ff_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_4bf046a2-0650-40a8-9d08-33ffca4b8fcc_terseLabel_en-US" xlink:label="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease not yet commenced amount</link:label>
    <link:label id="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</link:label>
    <link:label id="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="kequ-20240430.xsd#kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_ccf5c3ab-6c90-4722-a944-1df6617696f7_terseLabel_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_label_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Policy Text Block]</link:label>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounting policy for other noncurrent assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OtherAssetsPolicyTextBlock" xlink:href="kequ-20240430.xsd#kequ_OtherAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_OtherAssetsPolicyTextBlock" xlink:to="lab_kequ_OtherAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7d7467c1-9804-4082-b81d-8a0d6d5550a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_250e155a-122b-40a2-90bb-ac354c46a0f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_3cf2d597-b75c-4f22-be44-9b3f3678c18d_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled Receivables</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_a59d78c4-7523-4756-b270-155d90f05aef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2655d13e-5f97-4b0f-84d1-70c806ee35d9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net earnings per share attributable to Kewaunee Scientific Corporation stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_2ac9cd0d-fe49-4b7a-ae1b-3a05e8508351_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_f0cdab9a-5d46-4e88-a24c-473159758e3b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_d27233f1-0a53-4893-958a-ea5fe155e367_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_10a7c0fb-60dd-45cf-92cd-eee5eacbf56f_terseLabel_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="kequ-20240430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_c4deb2a8-3061-470f-9aa8-b41a911cff78_negatedLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid pension</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Prepaid Pension Cost</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities Prepaid Pension Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:to="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_f56edbfe-a94f-4e5f-b76e-5d9c322dccb2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5c0c490a-d317-4c60-aff0-ff430568ce49_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_406b98cf-215b-4219-9f63-3629b2f04f2c_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial basic monthly rent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_label_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Basic Monthly Payment</link:label>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Basic Monthly Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityBasicMonthlyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:to="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_09b931ea-5478-4019-8068-6adb7faaf051_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax (benefit) expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_47473bc1-1763-4a4f-b340-cf811c9658b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9f2a2bcd-391a-4d0b-9454-99f4021c3bd6_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net periodic pension expense plus special events</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_fbc19107-d53f-4781-9159-177548aecc31_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_83ea511a-2298-4dd6-91e0-f97ac64a6362_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property plant and equipment impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_916c4502-0105-4e77-b589-63e2368f53e5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_27a2c43b-a2c2-46ff-b2e9-4055da57b3f8_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_8c639146-2369-4f66-8e1e-279e3e644326_terseLabel_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_label_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation [Member]</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_documentation_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeScientificCorporationMember" xlink:to="lab_kequ_KewauneeScientificCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_cc78a710-adca-4a19-af34-709aaf885cef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b757b87b-ab3b-4559-8692-daf563257274_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_fd9d8a8e-132a-4716-be64-6998fc68af67_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds on Sale Leaseback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Proceeds on Sale Leaseback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Proceeds on Sale Leaseback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:to="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_04010bf9-d51e-4a39-9cc1-e08687739ce1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_281d1f4a-5513-4a02-8e66-a3a1afc8a8fa_terseLabel_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of non-qualified compensation plans maintained</link:label>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_label_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Nonqualified Compensation Plans</link:label>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_documentation_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of nonqualified compensation plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans" xlink:href="kequ-20240430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_NumberOfNonqualifiedCompensationPlans" xlink:to="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_97d710d0-5cc5-47ae-a7c1-5fc4a7e806b6_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4b7618ce-8dfc-4a36-85de-304e018b7a46_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_d648d0a7-c758-4adc-8f65-6b6fa0118213_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_label_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Renewal Term</link:label>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityRenewalTerm" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityRenewalTerm" xlink:to="lab_kequ_FinancingLiabilityRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_35cf9717-da2e-4349-8576-222db9a82da3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_ea71f544-ba8a-457b-afa5-6dc8799e7da2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_0aba9eba-42eb-4c68-b681-109c9d4b09a2_terseLabel_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, short term, expense</link:label>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_label_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Short Term, Expense</link:label>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_documentation_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Short Term, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OperatingLeaseShortTermExpense" xlink:href="kequ-20240430.xsd#kequ_OperatingLeaseShortTermExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_OperatingLeaseShortTermExpense" xlink:to="lab_kequ_OperatingLeaseShortTermExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_ac6c565b-f7f5-4933-873d-3b0f3d598e6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d0fef058-1916-4871-85e8-5cfa26d33376_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current tax (benefit) expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ae87d553-9c59-49d6-b9c1-0fac9fc22b71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_24725036-a64e-4363-9f82-3322aab635da_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a236d954-83e3-4f77-a3be-c35db3d71537_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits (state, net of federal benefits)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b6636ae4-858e-47c5-8534-c8c43b1156dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAbstract_1c1d4d94-c5bf-4c33-8a50-4418ccfcdbf6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4b68fb7a-f740-4a51-9955-7d3149582610_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ef86b15c-a3c9-443a-8b2a-8dd1f0382f94_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_e9f04175-059a-4e6d-bb7b-f9cd2195a36e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_48eae134-0888-4581-8b4d-84af5a90558a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in unrecognized actuarial loss on pension obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_95142005-72db-4d9e-829e-4b7da5d2b477_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_9e4708f4-23f1-4c45-8ebe-9e83fdd102ff_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_059cd132-5bd7-4e46-8ea2-78cdec0d4e9d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_d779f875-bad9-4d19-bb5b-20e6b51c7dd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_cf716d4a-0932-40a2-8ba7-f47f8c5193a5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_5b63fef1-5747-49ec-85fc-f0bf99a1d4d3_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3350cdf8-208d-488b-aa28-a280b5a09d5e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_481df412-98e0-4735-b3a1-d42d3975730a_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f8aba7f6-9df8-4b3e-938b-2ac6c1b97d51_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_efa10924-9303-4881-b72f-5c11092bc2d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4576f9ab-18e1-4739-ae56-7afa47aa38e0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Kewaunee Scientific Corporation Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_53f87883-0d44-4df9-8657-994c17ded873_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_319bc422-5294-418d-bb26-16958f300d7a_terseLabel_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kewaunee Labway Asia Pte. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_label_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kewaunee Labway Asia [Member]</link:label>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_documentation_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kewaunee Labway Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeLabwayAsiaMember" xlink:to="lab_kequ_KewauneeLabwayAsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_58f44919-96fb-4c07-ad63-49c681edb414_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c530603a-ae00-4500-95af-23f4ff4cdd80_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_05093733-63fe-480c-8ff5-b60f4bcfe725_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4da1bca7-1e28-45bb-8ba5-5b13750d28a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_592eeee6-4a9f-471c-9c05-4ca94ac51071_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueMember_e9f5e9f9-647e-461b-b722-25904fb9c256_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Surrender Value of Life Insurance Policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueMember_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Surrender Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueMember" xlink:to="lab_us-gaap_CashSurrenderValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InternationalOperationsMember_5e5d4f5f-3c2d-47fb-872d-d2f05e0d35a4_terseLabel_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_kequ_InternationalOperationsMember_label_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">International Operations [Member]</link:label>
    <link:label id="lab_kequ_InternationalOperationsMember_documentation_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">International operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember" xlink:href="kequ-20240430.xsd#kequ_InternationalOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InternationalOperationsMember" xlink:to="lab_kequ_InternationalOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d3b30fdd-ad46-4ef6-8691-38720801413b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_88f79699-f06b-43ee-89de-9f243e11f00c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_2ac52a18-341a-4195-96ca-b780d997ecff_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion of financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Noncurrent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityNoncurrent" xlink:to="lab_kequ_FinancingLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_18a8b078-6e72-4a4d-bf3d-67486a753eed_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a50ad387-6121-404c-83bd-d79074160aec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_cb112011-f5ed-4d73-83d6-86465dcb4295_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets held in trust account for non-qualified benefit plans included in other assets</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset, Held-in-Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrust" xlink:to="lab_us-gaap_AssetsHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_da080b89-6637-41d8-83ae-27934f4e6b80_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_f1f46f69-b5d0-4217-91e8-85ec8a086a46_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Fair Value Assets in Defined Benefit Pension Plans</link:label>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Allocation Of Plan Assets Fair Value Hierarchy Table [Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:to="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3c63263e-01d5-41b9-b164-43f5081a67a5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_238050fc-05e5-4f10-b3a4-74d7ee1b5100_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_45bbe176-666e-495a-b0ac-6f38322a3c1f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_9e015f96-f96c-4f45-ab9e-0edb7d8d0188_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs on financing liability</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_53eb2400-840f-41ef-812e-d2db9ed652fe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_5d13f0dd-c10a-4b85-8f0a-242fc8ca0297_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenditures for segment assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_908b3468-1245-45ab-87ef-78b951a6007b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_148fa87a-f049-40d0-893b-1ddf5d5dbb1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, non-current</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_0d21d4e0-5c23-480e-9c19-91f3db4f6f51_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5878f2d4-9153-47e7-9410-72fc974658b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_88bcbb9e-2362-4344-b8bc-3caeed8c3ad0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of foreign subsidiary income to parent</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_253026a8-9a0d-4c17-b663-26ef163a28e0_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Lease Liability</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetLeaseLiability" xlink:to="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d7438e3a-f22d-45b3-8518-4eded18b2397_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8dd32a1e-97af-47de-96ea-b41bd3f173b3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_88526818-151d-4175-8a90-aad151a8aef9_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Small/Mid Cap</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:to="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b6926d1e-70b8-41ee-bbc7-178fe7468fdc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unused and available credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d02c614a-e6b7-47ed-be23-d247c2aa7bc8_terseLabel_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional tranche available, minimum amount</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ae849292-5ff6-4430-b6b8-19633a11d866_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_4a3ee97d-f359-4dc4-b15a-c2d55c705f0d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_b4e2abf3-89f9-484a-aa89-b28ee65fe760_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_6d703336-0ec6-434f-baf7-15f7e9dacbf4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8a72b9d3-1581-4101-8a58-2717a2db0dab_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c9b41b0c-8dd5-42f5-9096-7845cfd8e0d6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6dad8848-e265-4b33-ba8f-f4c2481c8ade_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_378d483e-4b88-480f-b10a-6cba11d543f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_c31f3da5-a312-4a8b-8c6e-838f69f05ab6_terseLabel_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale-leaseback transaction</link:label>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_label_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Financing Liability</link:label>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_documentation_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability" xlink:href="kequ-20240430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ProceedsFromFinancingLiability" xlink:to="lab_kequ_ProceedsFromFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_95549eda-60a7-49f8-ad7a-68ac0ac27749_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9bf87e42-688e-4fc4-a285-d115d49a4cc0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total postretirement benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_b6f0ff25-267c-4299-99c7-c99297a1ed71_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2008 Plan</link:label>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Eight Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand And Eight Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember" xlink:href="kequ-20240430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandAndEightPlanMember" xlink:to="lab_kequ_TwoThousandAndEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6bb4b16a-954d-44fd-b7bb-029080bc6c47_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5f7460a8-06db-4d9a-a47b-bcf2581a99f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_2d9ccb32-1a95-442e-b0e4-402a2f3bf8af_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_03d8d3e7-1a00-4a69-b98d-0e3453cf1230_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ee63bdf-6104-4966-8efa-18919e8bd994_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_02515762-1ff5-4eda-803c-78c9fe663b68_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_ef94f462-fa43-4ae1-a153-3618fbc61ef8_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearTwo" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_cb2950a1-9e4a-41bd-bb6d-acbd94d9b307_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ef0e20bd-c54b-41bf-a3ea-9bb484ed550e_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a6822f4a-7e62-46a9-b3bd-45734967852c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_785847bd-5ad1-47ef-a549-6d80240ecfab_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_3e061e6d-4977-45d7-8e99-c721bcb2097a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_8db44332-1653-4c70-be41-026e550150aa_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum service period of employees to be eligible for contribution (in months)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Eligibility Minimum Service Period</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined contribution plan eligibility minimum service period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:to="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_b0a4fb60-74c7-40a4-93c7-9d72e2fef2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price range lower limit (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_c3e00e57-d4b3-4564-9080-be3ba86c7865_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9fe2dc22-f541-4e05-90d2-66925d20ac59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock Option Activity and Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_a11f120d-a8e2-42de-b45d-189ad6e00570_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearFive" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6ef96967-4a0f-489e-b27a-049edbc8e2cc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2c647b22-8a1c-490c-a785-474961e8495e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_06ce451d-e4a3-4337-9fdd-414763592e9f_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Matching contributions by company (as a percent)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Employer Matching Percent Of Employee Contribution</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined contribution plan employer matching percent of employee contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:to="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_c6f38355-2167-4498-a75d-de06d1c81815_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Projected benefit obligations, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_d219b7e4-19af-4579-bde5-06eeec1a5624_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Projected benefit obligations, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_01c4149f-5847-44ee-9f3d-5799db20fd0d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2d180c14-a24f-478c-b269-6abc9b9b3f14_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_f01d59cb-379c-4a92-9add-36617a100df5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_615c2dfa-dd20-45c7-8482-275ce5bd9f1f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_f2632c7a-04d0-417a-9ea3-31f63d656129_terseLabel_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for deferred income taxes</link:label>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_label_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense Benefit Net Of Rate Adjustment</link:label>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_documentation_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred income tax expense benefit net of rate adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:href="kequ-20240430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:to="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_47515824-791a-494e-a19a-1f7275be8d86_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e1440c38-513b-4a7e-a3a3-f424e5d0dac0_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_823f38ab-a87d-44ef-b950-ee322a51de00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f52fc76a-8186-4e66-9a04-468c8cace08d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_50ee3b74-c624-43a6-b0df-51c96cd2f985_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_1db87123-bbbd-4526-89af-118a0060110c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, non-current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4dab25e2-b182-45f3-a10b-e2a64e9844ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases, Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_12f6467f-dad5-493a-a5d1-8a11148e2f4b_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b8de3ad4-5d1f-499f-9623-ade3a8367fa3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_24720923-85e0-4cb1-9292-753fe3b4a398_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7fc511e4-e692-47bf-98f3-0415441c6468_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_1e23d7c6-be12-426b-9132-98c3c7f04d8e_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_659c2940-f8d9-46c0-a809-3a4651935248_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b61f778d-6331-4182-8815-5abe56c212f8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0c0eb383-83c4-4172-b37b-eb17cf44dcdd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_dfae631d-a854-4a16-bb77-84ccf1ba9aef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_84e577a0-83db-4789-a7a1-f6809427d528_terseLabel_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liability recognized as revenue percentage</link:label>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_label_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized Percentage</link:label>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_documentation_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract with customer, liability, revenue recognized percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:href="kequ-20240430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_184071a3-09be-49d1-9a55-1b3f1a8bdb5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_2d911736-ed9b-41d7-9323-f5d7e552602e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityAbstract_label_en-US" xlink:label="lab_kequ_FinancingLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability [Abstract]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAbstract_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityAbstract" xlink:to="lab_kequ_FinancingLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_178fc6e6-b4a3-47ad-9bb9-199070e4042a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_76fe0fc9-7b8d-43eb-9ef9-e30930d21f2a_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d54df23b-0f80-443e-9777-5742f0038218_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_db145346-4651-452f-b211-8d09336c08e8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plan, Plan asset</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f365e4f4-1107-414b-a47a-df619dfc9375_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_eb620049-bb90-4c8a-8216-0db89b4c789b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_a6a475a7-9757-415a-b5b9-651060f3e475_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_723eaca2-246c-4db4-8d01-f93d6f1fb458_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year One</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearOne" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AuditInformationAbstract_label_en-US" xlink:label="lab_kequ_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_kequ_AuditInformationAbstract_documentation_en-US" xlink:label="lab_kequ_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AuditInformationAbstract" xlink:href="kequ-20240430.xsd#kequ_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AuditInformationAbstract" xlink:to="lab_kequ_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d21783bc-7441-4009-a5fd-d6c05359fa9b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9249c8a9-4eb2-4f99-807c-29f84b919f78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_a44fc6c9-db00-4fe6-9db3-34c476d4571f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_ba56af87-13ee-4210-9288-640ed079f147_terseLabel_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SignificantAccountingPoliciesTable" xlink:to="lab_kequ_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6212278a-4f79-4609-b4df-f98ca1eb4720_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Actual benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_73284d66-da42-4e16-a75c-556525a21e8e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d022bde8-2d58-43cf-af98-c0bc8fc55f32_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_fa974d49-c37f-47cc-ba2f-00f5c6f32464_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_819296d2-c023-4d49-8770-9adc31862090_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_c46f23b3-a5e7-410a-84ad-37e998811da5_terseLabel_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service Components</link:label>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_label_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs), Service Component [Member]</link:label>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_documentation_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs), Service Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:href="kequ-20240430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:to="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_538cf960-9119-49f4-873b-65a5e29e42fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_44898c31-1d7a-4a18-ad8b-dffad52a2c6c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_01d5525d-aa34-42d0-b067-79cc3d9061aa_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_acdfc01b-67ad-4806-abc8-1f7023fea7e9_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Current</link:label>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityCurrent" xlink:to="lab_kequ_FinancingLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_f93c5b0d-48d1-4faa-b8fb-15742fb386a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_da83c89f-999a-4034-b83a-2b61bfeefa5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_82455683-4616-4163-9e2d-399a55cf2c9c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_7fac957d-481f-421c-b2aa-b1c0fcd004cb_terseLabel_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust</link:label>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_label_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust [Member]</link:label>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_documentation_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:href="kequ-20240430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:to="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_d07223e9-e5f5-4e97-bf38-a8b12d2a1b00_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_c607b5c2-5571-46f7-b200-07aa9ccf71b9_terseLabel_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Koncepo Scientech International</link:label>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_label_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Koncepo Scientech International [Member]</link:label>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_documentation_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Koncepo Scientech International.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember" xlink:href="kequ-20240430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KoncepoScientechInternationalMember" xlink:to="lab_kequ_KoncepoScientechInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b21e422d-60a5-465a-a1f0-7dfa651cb6a9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net earnings to net cash used by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_f7573299-3738-4dbd-ad51-80badf8c54bd_terseLabel_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="kequ-20240430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5a3f4243-fe93-4719-beec-f159f44e1e58_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c8b06c8d-9a12-4c99-aa80-dc379840aead_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_0c338eb1-5522-4c44-a43a-245f84e37b76_terseLabel_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_label_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_documentation_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenueRecognitionLineItems" xlink:to="lab_kequ_RevenueRecognitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_ff26c14a-3338-45e7-9a56-a7be73419f6f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued employee benefit expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bc6cb020-3589-4f74-90a4-ceb97645fbcf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less comprehensive income attributable to the non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_eadecec0-07b7-4ad4-942e-141ca161a437_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_f928b1a7-2d41-4b91-a7c7-3cf600e73d3d_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Plan Assets by Asset Categories</link:label>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Plan Assets By Asset Category Table [Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:to="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_306dd57a-3460-46e6-acb5-7cc701fa1640_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TradingSecuritiesMember_68069a07-3b2c-4fdd-856d-b7a54558b101_terseLabel_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Securities Held in Non-Qualified Compensation Plans</link:label>
    <link:label id="lab_kequ_TradingSecuritiesMember_label_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Securities [Member]</link:label>
    <link:label id="lab_kequ_TradingSecuritiesMember_documentation_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trading Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember" xlink:href="kequ-20240430.xsd#kequ_TradingSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TradingSecuritiesMember" xlink:to="lab_kequ_TradingSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_06bbb36b-a18f-419f-a140-360ead5295c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_b51f6af1-436e-42ee-ad38-ab6771269a20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_8437d5d0-606e-4ac5-85ba-660a00420c82_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_186b64ec-9e77-4425-9cc1-92e90d7158b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2047f223-a1cb-408c-b5aa-b5b9fc52fa5d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_0356c5ec-4deb-415a-b5fb-dc83f79a3018_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_8336b624-c42c-4d24-b538-6e754f0b843d_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_56ddf194-b050-4b57-89ed-19ca75e271ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canceled (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9e0c2a1d-be52-42db-a9ea-f494103f3171_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_73793892-679f-45e3-b183-0f3dd5e2bf1d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_3b34a59f-0ea0-446d-82ce-f123ac945c0d_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_85dfd5c1-b127-4756-b313-82192c012c32_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amounts Recognized in the Consolidated Balance Sheets consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b51e4cbf-cdf8-4073-9d8b-2831061674d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_3e866569-5923-40f9-be17-860640724301_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_label_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Number of Renewal Options</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Number of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:to="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TaxWithholdingExpense_5703187c-78e4-4175-818d-7c451656eacd_terseLabel_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax withholding expense</link:label>
    <link:label id="lab_kequ_TaxWithholdingExpense_label_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Withholding Expense</link:label>
    <link:label id="lab_kequ_TaxWithholdingExpense_documentation_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Withholding Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense" xlink:href="kequ-20240430.xsd#kequ_TaxWithholdingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TaxWithholdingExpense" xlink:to="lab_kequ_TaxWithholdingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_5a700b6a-9147-4b48-a0a3-b05a193d05d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b77b4699-5c45-4abf-bb48-9f503ae7a41d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions by employer per employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a1e158dc-9bf9-49ba-b635-69f4d4960e24_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Benefit Obligation, April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_0be521c0-33cc-43e0-9551-247ede2c1881_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_49c2d038-5694-40cf-98ab-b35cd78bc82e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy for Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_550c5db3-e67b-4d16-abdc-12bb4d08a1c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_4ec70de3-344a-41b6-b241-ca04b1721a83_verboseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares that May Yet Be Purchased Under the Plans or Programs</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_051f6e33-e312-4f49-89bd-69735f955a47_terseLabel_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign subsidiaries tax returns period (in years)</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_label_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign subsidiaries tax returns period</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_documentation_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign subsidiaries tax returns period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:to="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_96f47cce-e21b-405d-b707-dec91ef9b51e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2f6d812b-7d0c-44d3-a3e2-88fb1ceb390f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4c81bc50-5403-490b-941e-d740af604bfb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_972fc1a7-1032-4d49-9cb6-72cf905441a6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_f0001c61-2857-40a0-8271-51661f5be2c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price range upper limit (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2b5f5ae9-68e1-42d2-9bd5-63f16e068776_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale agreement for property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_08851485-ddba-4834-9c8a-5aa681b06c68_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_1a6c8b82-9373-4e03-a1b0-9bea8b43bfc9_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_fdcdb52d-470c-4e54-a70d-e98d73e7df11_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_f31cb1f9-caff-4380-b4dd-25f2b41b352a_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_660b7779-87ee-4699-a297-a1cb26d3a761_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c60cffe9-24e9-4b07-ba57-a33d2ba70948_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_497ce93e-79df-4f78-8949-c2886e4085eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_e3a3f10a-96c1-4296-b4da-2515a9a34052_terseLabel_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:href="kequ-20240430.xsd#kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:to="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_fc4e5dc6-f96a-4e53-a05f-1765164e8afa_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_560a182d-c7b0-4de6-9767-c385fe9ab56c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease, weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a00f39c6-701a-46a7-931d-777d298942a4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_ca528fd7-b79e-4585-8f36-57954fc1a8c9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_61ec088a-20db-476d-ad06-d75a6352c9c8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_320b9c16-a403-4459-b97a-7ab05f9407c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlement loss included in net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_bc078e61-6c4a-42f6-bb9d-3d8a10ebea42_terseLabel_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:href="kequ-20240430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_54cad7c3-ac41-4caa-85dd-5ec97311e732_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e0a2018a-6e1a-49b5-8f51-9b3aa80777b3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3be29122-df55-4f2c-a901-3ea7beb3994f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6e1a5417-e61a-4191-b6d1-b71823392882_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_a7dc3c0c-a465-4331-bffd-86c8dde89ac2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_071bddf3-92b2-4370-a57a-264b41059c7c_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_927022ba-a845-43ad-8377-9767639e8c0d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_6bf5a9d2-7f9c-438f-8d1c-05884150ab1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_a1743359-c57a-4576-9153-346167f2e076_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Write-offs, net</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3ae8a64e-a7a4-4b87-8d82-354789b28751_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation and amounts withheld</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_ae870a18-5275-448b-a824-e0e1ff8918f4_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_c40a8b88-27bd-4596-a6c3-86907738eb88_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of business segment</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_3ef3bc73-c491-4a73-b829-12b19ca12a6f_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017 Plan</link:label>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen Omnibus Incentive Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand seventeen omnibus incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:href="kequ-20240430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:to="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_18c111f0-c23c-4b4c-bf6c-93b67fbb3277_terseLabel_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kewaunee Labway India Pvt. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_label_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kewaunee Labway India [Member]</link:label>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_documentation_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kewaunee Labway India [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeLabwayIndiaMember" xlink:to="lab_kequ_KewauneeLabwayIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_985e4760-46e0-4c91-91d3-f965f0a23555_terseLabel_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Return to provision adjustment</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_label_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_documentation_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:to="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_945252a4-33c2-429c-b04e-bc6fc1c361d2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_39a63f0a-b92f-4650-ad87-590b126f1d18_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_fd541bf3-e2b2-4cc7-b120-36e6ddc89667_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b030d063-8f17-4e38-b502-b72e524c5e21_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_5b0b759f-4e50-4f5b-8c33-325304795bba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of differing US and foreign tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ecec040-53d8-4086-8a03-d900222bd33d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffedf7c7-ef94-497f-93de-0c33304ecd0b_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales transferred to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ac1687dd-5a53-4501-b80b-ee337d348d15_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_980fe885-f770-47d9-a3b9-949856c067b4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_84aabda1-cb3b-499d-9637-249fe400f6b7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_716e782b-3b7e-4dcf-87b5-3b98b3b618ab_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8ec65420-f425-452d-950a-8400e0bf638e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Recognition of net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9e6ad438-4de3-48b1-a7ba-a79941aeae65_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FIFOInventoryAmount_e1f6537d-91de-49a8-875f-e6ac12f099b6_terseLabel_en-US" xlink:label="lab_us-gaap_FIFOInventoryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories measured using FIFO method</link:label>
    <link:label id="lab_us-gaap_FIFOInventoryAmount_label_en-US" xlink:label="lab_us-gaap_FIFOInventoryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FIFO Inventory Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FIFOInventoryAmount" xlink:to="lab_us-gaap_FIFOInventoryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9359c49c-34bf-4783-95db-e651d37e341e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2cad391b-c10f-49e6-85aa-214f7fed837d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0c75918a-982e-4625-847a-4cdd52b4be09_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_8cbe916b-3aa2-4716-b8f3-ee3bcf5de2b4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected long-term return on plan assets (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_676db345-c4a0-4ead-ab3a-fab6ecdb36b6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date, Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_644bfd57-5a8e-4e50-af7e-8a243e426a14_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_9038e9ac-2fd6-4376-925c-ab5482ba9903_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_f4db41cb-fc48-4579-bff7-986f2a4384ef_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_532967b8-beda-47a0-bc9d-5ca6b6b36c7f_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Emerging Markets [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:to="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d93101e0-0c76-4e69-a337-3ce0d085d7a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, variable interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_1d8b10cf-4232-4a71-97fd-c766dae2d61f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e409e142-91b1-444a-a441-5e80191266e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_67640614-8bd4-4707-9569-f16db7d56ff2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_8adfe4b3-2559-4890-9dbb-760570fda1a8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_6b09ecd8-7cc2-477e-a73c-deab66c10336_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_773f691a-c1e5-49c0-9d36-dea138cd73de_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a13f55e-8b1c-4172-b465-1a43c5af9a18_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding-diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_20997310-54c6-472e-b7ca-3d68860bd43a_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability</link:label>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:to="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_319936da-7514-402b-8948-ef6e91a41b66_terseLabel_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems" xlink:to="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_f5d76e62-6b4f-4955-a4f6-29f230e93d24_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_39d49ae4-0aa4-4d83-88ca-24bffa1036f9_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets obtained under new finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7ee97709-de2e-4b22-9761-b49697ec1b32_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in number of shares available under stock option plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9a86b11f-f9f5-4c15-93d1-e978e33b2f86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_4292c896-d00c-4791-acfb-2e69f7fce198_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_a150ecac-29a9-48bb-ad20-9bb4760a0f68_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0e3b4e81-3a51-4144-9053-28d9f2889701_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2eb98afe-5690-4958-8c8c-8a1f7b5cd23e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_926cd2a7-d4f3-4988-b1bf-500ef002d468_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_a44a723d-d5ce-4bb0-8885-d3b2f1f950a5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_faefc5c5-15e5-45ef-8540-ae1703a9060f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_12d6bc46-1a71-4827-bb19-919678d1bac6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_6aae5c0e-11ba-4a09-bf92-e79dcbea33bc_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_c3cbd2c5-8480-4473-bd5b-f983cd5d2586_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_cf48a1fd-3bf4-4c79-aa3e-0b1653df9c5e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_IncomeTaxesTable_bc29a254-434f-4798-a95e-4accba74d484_terseLabel_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_kequ_IncomeTaxesTable_label_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_kequ_IncomeTaxesTable_documentation_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_IncomeTaxesTable" xlink:to="lab_kequ_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_897b0502-ac6c-48da-b4a9-479066736caf_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_02900fe5-8412-4e21-a5f5-945d9978b5c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_01c89e0d-f61d-40a2-bd91-403977283dc6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c8f5826c-99bc-4afa-a7de-e5e34080fe56_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_f0ab908c-a867-4a85-85b0-2abdb03fbc1e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e9d5e8f6-4171-4fdb-807f-0f921e84b5d5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_b8bc3df7-c2d2-4e7c-ad83-5820d3173483_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55223cbe-e12e-471e-9394-41ac71ce2a94_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase in Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_af2cdf87-a79f-4d5d-8b93-d550c9af0441_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ebea1197-04bd-4896-b21a-efcbc1ce3871_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8e6384a6-06ec-4243-b568-1df737d3715f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_f48b9824-6bba-4c43-83ac-10bb9b09fbf0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_8e32f691-6310-4498-b0fc-f32453bfc0b9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_43e5fc1b-d025-4f57-af1b-dae8241c8a23_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_fe858086-6261-4f53-8869-9bcbcbcfb4bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_e57ef84c-c4af-4315-9c5c-6e8a2f8e6693_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unbilled receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_ad5451f9-276e-4c5e-845e-7f57391af00c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract assets in accounts receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b63393dc-2769-4257-8743-6fa9d811dd37_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_16faaf60-3e30-4151-ac03-bd8c7aa9e833_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_ec260cf3-f54f-45aa-9703-2fa74ef05828_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_28567744-a1ee-441f-aa04-844a1f34e1f9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating earnings</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a9856f9a-a3aa-49d5-b7f3-e59816eb4a6d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Book basis in excess of tax basis of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_3c8c9b78-d015-4b7f-8c85-ed4a8341cab7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ec1fda07-0d54-4c7c-866b-5952046b8708_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_44f60823-bd64-4ac7-9d8c-b496659c5b38_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_a6448b3a-1c34-493a-bd9e-86994b13de88_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod_18f4413a-96a4-4f0f-b62d-e43fa1e820ef_terseLabel_en-US" xlink:label="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, value</link:label>
    <link:label id="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod_label_en-US" xlink:label="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value Excluding Broker Commissions and Fees, Acquired, Cost Method</link:label>
    <link:label id="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod_documentation_en-US" xlink:label="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value Excluding Broker Commissions and Fees, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:href="kequ-20240430.xsd#kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:to="lab_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f74391e0-0159-4700-9147-46476469d0bd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_18739101-d72e-4990-9a63-5aad6c9d68f7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_d5da172b-0112-464b-a4a8-de0b9df091ed_terseLabel_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">India Income Tax Department</link:label>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_label_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ministry of Finance, India [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:to="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_8dbba693-83fb-418c-a11b-eed41022d1b1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7f31c64f-75b7-4a7d-b0bf-7a9e583e368b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_966119ae-163c-490d-b44a-9a24d37467ee_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_label_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, Term of Contract</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityTermOfContract" xlink:to="lab_kequ_FinancingLiabilityTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_40f25f4a-e8fa-44a5-9ab0-fa13c934bbae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueSegmentMember_b3a15daa-b6cd-4186-bff7-322ced3c006c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales Revenue, Segment</link:label>
    <link:label id="lab_us-gaap_SalesRevenueSegmentMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Segment Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueSegmentMember" xlink:to="lab_us-gaap_SalesRevenueSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_103e9790-77b8-46a0-a7ed-4aaf501e519c_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank Guarantees outstanding to customers</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_0d72b81f-fc65-446e-92a0-4e634da6a840_terseLabel_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation Singapore Pte. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_label_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation Singapore [Member]</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_documentation_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Kewaunee Scientific Corporation Singapore [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeScientificCorporationSingaporeMember" xlink:to="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_a9cfd56a-bbb7-4cb8-9a14-c0918b70ad80_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financing Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearThree" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9b05dc42-16ee-46c0-b7e2-cdf251e6dbcb_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_c5839d4a-9423-4c59-9b68-a90c8a3760bd_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares authorized to be repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_451d049a-f1bf-4e0f-9f57-3f7328b36283_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>kequ-20240430_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:26c5c618-095d-42fb-8b2b-083f4c1a97f8,g:047948d0-cfb5-4869-959e-a19bb6da91b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.kewaunee.com/role/CoverPage" xlink:type="simple" xlink:href="kequ-20240430.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3b3c8d12-49cc-4acd-a6db-9029a3f14376" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentType_3b3c8d12-49cc-4acd-a6db-9029a3f14376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_9a05f224-e81e-41e5-b83b-f7058540b6dd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentAnnualReport_9a05f224-e81e-41e5-b83b-f7058540b6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_206237a9-c2f9-49f1-95b9-34db8b8f1abf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentPeriodEndDate_206237a9-c2f9-49f1-95b9-34db8b8f1abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2ccb15e2-4860-4aaa-b8ed-f8b1fb960988" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_CurrentFiscalYearEndDate_2ccb15e2-4860-4aaa-b8ed-f8b1fb960988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2ef6461d-7308-4a6f-a3df-b64e8f282307" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentTransitionReport_2ef6461d-7308-4a6f-a3df-b64e8f282307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_72b340ab-dbe2-472f-8628-2c057b002ae8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityFileNumber_72b340ab-dbe2-472f-8628-2c057b002ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0fe5de0f-593a-4614-828f-996471a41193" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityRegistrantName_0fe5de0f-593a-4614-828f-996471a41193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6ed949ce-1ad8-4a32-9860-de6556c0158b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6ed949ce-1ad8-4a32-9860-de6556c0158b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_40f29802-dbcf-402a-b7db-1e9490ff32e2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityTaxIdentificationNumber_40f29802-dbcf-402a-b7db-1e9490ff32e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cb16ba63-c2ca-41e8-9140-9533a676c812" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityAddressAddressLine1_cb16ba63-c2ca-41e8-9140-9533a676c812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ff905f9b-6b28-4504-ba12-ec9a6cc2e16f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityAddressCityOrTown_ff905f9b-6b28-4504-ba12-ec9a6cc2e16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3a549e67-705f-4dcb-8edd-159b3f77d400" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityAddressStateOrProvince_3a549e67-705f-4dcb-8edd-159b3f77d400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ecbe9b48-1a14-4e6b-9407-42827684940d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityAddressPostalZipCode_ecbe9b48-1a14-4e6b-9407-42827684940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_89cf67ae-e922-4538-835d-43cd3c6ac026" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_CityAreaCode_89cf67ae-e922-4538-835d-43cd3c6ac026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99aae49b-ae9f-4901-b126-e1dd6643fbcf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_LocalPhoneNumber_99aae49b-ae9f-4901-b126-e1dd6643fbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_03160012-a150-43e8-a3e1-da280c19d6a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_Security12bTitle_03160012-a150-43e8-a3e1-da280c19d6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_697f2c6f-98df-47e9-85cf-5b16b4219bba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_TradingSymbol_697f2c6f-98df-47e9-85cf-5b16b4219bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_874fea7a-cf36-4451-afa1-0f46628d14e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_SecurityExchangeName_874fea7a-cf36-4451-afa1-0f46628d14e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_344f1199-373c-4b6d-b91b-5bcb09c6671f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_344f1199-373c-4b6d-b91b-5bcb09c6671f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_13f72db0-858f-47e1-b9b8-59971426c7c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityVoluntaryFilers_13f72db0-858f-47e1-b9b8-59971426c7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0bd46542-6cf4-4905-8be7-fdf8186c43e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityCurrentReportingStatus_0bd46542-6cf4-4905-8be7-fdf8186c43e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9566da46-1298-4f4b-8380-a9039536ec86" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityInteractiveDataCurrent_9566da46-1298-4f4b-8380-a9039536ec86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c27a64ce-d173-443e-88d1-744001405bea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityFilerCategory_c27a64ce-d173-443e-88d1-744001405bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b5e6d0e7-9df8-46c6-916f-22be32bdd8ba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntitySmallBusiness_b5e6d0e7-9df8-46c6-916f-22be32bdd8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f47b3cfa-6cc8-476f-a328-fb2a50f73d6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityEmergingGrowthCompany_f47b3cfa-6cc8-476f-a328-fb2a50f73d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_c506b676-bdee-4ba1-b9ac-f54b2411f080" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_IcfrAuditorAttestationFlag_c506b676-bdee-4ba1-b9ac-f54b2411f080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_0c7919dc-de79-44ff-905b-63074b9e5d85" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_0c7919dc-de79-44ff-905b-63074b9e5d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6aa8988d-a139-48bb-9141-a696641114c1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityShellCompany_6aa8988d-a139-48bb-9141-a696641114c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7aab7c56-625c-4600-87f2-eccdc757f7af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityPublicFloat_7aab7c56-625c-4600-87f2-eccdc757f7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bc49439d-7fe6-4500-89c5-424045f3a952" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bc49439d-7fe6-4500-89c5-424045f3a952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e5825218-450e-401f-935e-7074e6514dd7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e5825218-450e-401f-935e-7074e6514dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_953bd6ce-6d39-4328-84f7-9191931255ad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_AmendmentFlag_953bd6ce-6d39-4328-84f7-9191931255ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_07edab1d-63e8-46f6-9d1d-c0f97e645bed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentFiscalYearFocus_07edab1d-63e8-46f6-9d1d-c0f97e645bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_bdd5f64d-807f-48ad-ad13-c5552c0e42a6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_bdd5f64d-807f-48ad-ad13-c5552c0e42a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6554f83a-d4fb-4137-aab0-da59bab4555e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d1eb59c-6dca-4be1-8cb2-6ff020c5a41b" xlink:to="loc_dei_EntityCentralIndexKey_6554f83a-d4fb-4137-aab0-da59bab4555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AuditInformation" xlink:type="simple" xlink:href="kequ-20240430.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AuditInformationAbstract_f966be45-20cd-4b1d-ac63-fa70efd25f01" xlink:href="kequ-20240430.xsd#kequ_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_534f73ea-4ae0-473b-af95-04f66fb2c29e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_f966be45-20cd-4b1d-ac63-fa70efd25f01" xlink:to="loc_dei_AuditorName_534f73ea-4ae0-473b-af95-04f66fb2c29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_47362ccd-ad82-476f-a2a4-fbbfff0a67be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_f966be45-20cd-4b1d-ac63-fa70efd25f01" xlink:to="loc_dei_AuditorLocation_47362ccd-ad82-476f-a2a4-fbbfff0a67be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_bc74b5a9-6d5e-48bb-8406-102bac9b3230" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_f966be45-20cd-4b1d-ac63-fa70efd25f01" xlink:to="loc_dei_AuditorFirmId_bc74b5a9-6d5e-48bb-8406-102bac9b3230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62711628-499d-4d45-ad60-6710f81239f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_62711628-499d-4d45-ad60-6710f81239f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f9ba6f1b-50e6-4939-8730-70f5d0e63208" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f9ba6f1b-50e6-4939-8730-70f5d0e63208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a7d568a7-978b-4cbd-bdcb-43c275451b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_GrossProfit_a7d568a7-978b-4cbd-bdcb-43c275451b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_cfe2fedf-16b1-4f51-9f6b-958a913efe33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_OperatingExpenses_cfe2fedf-16b1-4f51-9f6b-958a913efe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2d676f00-3460-4cec-bd73-ec529d4d3850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_OperatingIncomeLoss_2d676f00-3460-4cec-bd73-ec529d4d3850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_d3265e11-ae2f-414b-a9d8-0d28736cc0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_PensionExpense_d3265e11-ae2f-414b-a9d8-0d28736cc0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_65ff1106-b4b1-4e0a-b5d3-6b2f2f6aea35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_OtherIncome_65ff1106-b4b1-4e0a-b5d3-6b2f2f6aea35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c2308785-15d0-40a2-a0dc-2568ebced2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_InterestExpense_c2308785-15d0-40a2-a0dc-2568ebced2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e645a3f0-1598-436a-adff-3a216676fae2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e645a3f0-1598-436a-adff-3a216676fae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cc31537b-34cf-4ba5-9715-9ba899a04609" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cc31537b-34cf-4ba5-9715-9ba899a04609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e30f2663-a18b-4f96-a0fd-58d254ee7b04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_ProfitLoss_e30f2663-a18b-4f96-a0fd-58d254ee7b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7d02d4e9-ee21-4721-95eb-0ef3be80606b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7d02d4e9-ee21-4721-95eb-0ef3be80606b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b862e33e-8e51-4858-aae1-fc1bb52c8aed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_NetIncomeLoss_b862e33e-8e51-4858-aae1-fc1bb52c8aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d022d270-ebe8-4efb-90e0-94ea4f9b9102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d022d270-ebe8-4efb-90e0-94ea4f9b9102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f7cfcfee-1865-4ed0-bc85-bd0a53e3278d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d022d270-ebe8-4efb-90e0-94ea4f9b9102" xlink:to="loc_us-gaap_EarningsPerShareBasic_f7cfcfee-1865-4ed0-bc85-bd0a53e3278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0e9e897b-5665-43ad-969e-e913ce4f790e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d022d270-ebe8-4efb-90e0-94ea4f9b9102" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0e9e897b-5665-43ad-969e-e913ce4f790e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9702d52d-e077-406c-85fa-4329f070cc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_439d34a3-505d-4701-92ec-c7a09a80bee3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9702d52d-e077-406c-85fa-4329f070cc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_56b59583-a677-4275-abef-3a1d381b470d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9702d52d-e077-406c-85fa-4329f070cc4d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_56b59583-a677-4275-abef-3a1d381b470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7320e182-ec36-4cbd-ac86-0416b7771414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9702d52d-e077-406c-85fa-4329f070cc4d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7320e182-ec36-4cbd-ac86-0416b7771414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c5955537-7b2a-4b83-868d-cc26fab4c424" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_ProfitLoss_c5955537-7b2a-4b83-868d-cc26fab4c424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c31d41c4-f05d-43c3-aa36-01ac0bfc9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c31d41c4-f05d-43c3-aa36-01ac0bfc9bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_381566c1-e244-40ba-838a-eea49d6308b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c31d41c4-f05d-43c3-aa36-01ac0bfc9bc9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_381566c1-e244-40ba-838a-eea49d6308b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAbstract_744aaae5-3f06-428a-893c-84638f63c1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_DefinedBenefitPlanAbstract_744aaae5-3f06-428a-893c-84638f63c1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_532f7989-234f-4171-9df1-9ff6848cdad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAbstract_744aaae5-3f06-428a-893c-84638f63c1c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_532f7989-234f-4171-9df1-9ff6848cdad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_b89e6809-8205-41b6-a048-a85bb9eddcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAbstract_744aaae5-3f06-428a-893c-84638f63c1c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_b89e6809-8205-41b6-a048-a85bb9eddcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d8551ad4-8c7e-4551-a600-dcb0b3a53467" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAbstract_744aaae5-3f06-428a-893c-84638f63c1c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_d8551ad4-8c7e-4551-a600-dcb0b3a53467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a7c8cae7-b3a4-45cb-ba1b-1f471aeab5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a7c8cae7-b3a4-45cb-ba1b-1f471aeab5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_93198447-73b2-44e1-bd43-816d850a7831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_93198447-73b2-44e1-bd43-816d850a7831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_66e800d9-51eb-4ebc-a248-8224d9933dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_66e800d9-51eb-4ebc-a248-8224d9933dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a4d3f472-e1ef-4313-9b96-bf48e9546b24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4c7ae1fe-cb1c-4ba8-9c9f-caf3a90e68b6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_a4d3f472-e1ef-4313-9b96-bf48e9546b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4231479-23b5-4862-b419-7bc21747b9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4231479-23b5-4862-b419-7bc21747b9a6" xlink:to="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9efd2eb0-3fd5-468f-89ec-72eda97f95cf" xlink:to="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9e3d6438-f62e-4fe4-aa5e-d93e4980e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_CommonStockMember_9e3d6438-f62e-4fe4-aa5e-d93e4980e1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7c825a4f-591a-459e-b977-c1744592feb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7c825a4f-591a-459e-b977-c1744592feb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_41d1319f-cbaa-42ed-b314-9cbefa7adc62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_TreasuryStockCommonMember_41d1319f-cbaa-42ed-b314-9cbefa7adc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_898c9bde-e32b-4ab5-828c-9974cb638756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_RetainedEarningsMember_898c9bde-e32b-4ab5-828c-9974cb638756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac994816-28aa-42e0-92e3-262999d0d551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4243d76f-ef23-46f0-8141-3c8fa354c269" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac994816-28aa-42e0-92e3-262999d0d551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ebd22762-adbc-4ee5-a3ed-8fecebb6d912" xlink:to="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78b53987-6ba7-4931-9955-3b6d57846dc8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7d19bfb8-388e-4f7e-bc95-4155be599b15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_StockholdersEquity_7d19bfb8-388e-4f7e-bc95-4155be599b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_475d7aad-b470-4409-86ae-4f991d2edb86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_NetIncomeLoss_475d7aad-b470-4409-86ae-4f991d2edb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4e561719-583a-48fc-922e-ebbca0c1dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4e561719-583a-48fc-922e-ebbca0c1dd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7e20924c-797d-4024-8144-57715ddf4214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7e20924c-797d-4024-8144-57715ddf4214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f88252cb-861e-41be-87d2-234f23133ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_f88252cb-861e-41be-87d2-234f23133ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dccdb68c-3840-4120-8fa1-aa830abc85be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f39f3ab-8118-4f32-b850-0eb2840bea49" xlink:to="loc_us-gaap_StockholdersEquity_dccdb68c-3840-4120-8fa1-aa830abc85be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8b089418-56b0-4606-a9ae-4c823ab065e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c810999d-73ee-433a-b3ae-c80124a43a20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8b089418-56b0-4606-a9ae-4c823ab065e5" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c810999d-73ee-433a-b3ae-c80124a43a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_54ad9692-3088-4251-86d7-789c4e2fde60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54ad9692-3088-4251-86d7-789c4e2fde60" xlink:to="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64194dca-7b11-4e17-b2b4-7466c0b70dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64194dca-7b11-4e17-b2b4-7466c0b70dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_408dbc5d-85a1-4f23-ae67-5426d9150177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_408dbc5d-85a1-4f23-ae67-5426d9150177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8f88b3b4-9314-47a7-b6ae-fe6b0376258b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8f88b3b4-9314-47a7-b6ae-fe6b0376258b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6cebe9e9-2789-4b76-a00b-b1d6e1badca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_InventoryNet_6cebe9e9-2789-4b76-a00b-b1d6e1badca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d3ccb5c8-a29c-4aa2-8e78-5a5b335910a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d3ccb5c8-a29c-4aa2-8e78-5a5b335910a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b5c9a8c6-acf0-4fcc-92ec-d8573d016451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef026594-e406-4589-b3e0-c97447d2f7c8" xlink:to="loc_us-gaap_AssetsCurrent_b5c9a8c6-acf0-4fcc-92ec-d8573d016451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3e2d20-561e-476a-86b1-2c2cf9dc9b16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3e2d20-561e-476a-86b1-2c2cf9dc9b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1838a306-fa55-40ac-b8ed-f0dd6c608a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1838a306-fa55-40ac-b8ed-f0dd6c608a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9a187e50-6680-4f47-b082-7de170ac83d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9a187e50-6680-4f47-b082-7de170ac83d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4cd94250-dfe3-49fa-bb76-5fd76698fb11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4cd94250-dfe3-49fa-bb76-5fd76698fb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e155bb69-7d95-4613-9de4-8cc68623b7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_7a070ca6-b2c8-48c5-8aab-948c2d04d301" xlink:to="loc_us-gaap_Assets_e155bb69-7d95-4613-9de4-8cc68623b7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54ad9692-3088-4251-86d7-789c4e2fde60" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_8e1005d7-4aef-4443-8b36-0eb97c109636" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_ShortTermBorrowings_8e1005d7-4aef-4443-8b36-0eb97c109636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_ac52d635-0acd-4933-9f95-0f29aa7424ae" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_kequ_FinancingLiabilityCurrent_ac52d635-0acd-4933-9f95-0f29aa7424ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_aca7196e-7009-4b1e-8b4f-81f7be9e68b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_aca7196e-7009-4b1e-8b4f-81f7be9e68b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_49f12f89-9f80-4199-8cae-574a632fe1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_49f12f89-9f80-4199-8cae-574a632fe1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4352e60c-10b2-4ffc-ad2a-f931d69deb03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_AccountsPayableCurrent_4352e60c-10b2-4ffc-ad2a-f931d69deb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0176be98-592c-4ccf-8ac5-28459bb9be4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0176be98-592c-4ccf-8ac5-28459bb9be4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6e935083-b462-4120-94d6-0012308a49f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6e935083-b462-4120-94d6-0012308a49f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ae75c79f-6d49-42b2-b5ee-f99344d21279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ae75c79f-6d49-42b2-b5ee-f99344d21279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6e4e7196-e806-48f6-9e5b-424234a76305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85d0df14-29b9-48ff-b4dd-9df02d361f84" xlink:to="loc_us-gaap_LiabilitiesCurrent_6e4e7196-e806-48f6-9e5b-424234a76305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_bd7f9200-a971-4051-805e-9bd0056e5194" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_bd7f9200-a971-4051-805e-9bd0056e5194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af88363d-d097-403e-bdaf-8e29a1f7b4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af88363d-d097-403e-bdaf-8e29a1f7b4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dca59d77-96b6-473e-b834-1f2e8b17f0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_dca59d77-96b6-473e-b834-1f2e8b17f0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts_7a625ac1-ccf8-4553-8c6b-fdc5371e855c" xlink:href="kequ-20240430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_kequ_AccruedEmployeeBenefitPlanCosts_7a625ac1-ccf8-4553-8c6b-fdc5371e855c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3086f7b4-3017-4f0a-8721-383a4a51690f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3086f7b4-3017-4f0a-8721-383a4a51690f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_23b46c16-0870-45ef-a813-fd17bb0a84f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_23b46c16-0870-45ef-a813-fd17bb0a84f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_aae35ae1-a823-4f49-8d9d-205727268f86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_Liabilities_aae35ae1-a823-4f49-8d9d-205727268f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0b85bc66-b057-4eb1-bf23-3a7bccd1820d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0b85bc66-b057-4eb1-bf23-3a7bccd1820d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ae368c07-1712-46e0-94f4-5711c1233e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_CommonStockValue_ae368c07-1712-46e0-94f4-5711c1233e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a3cb2c44-7033-40e4-ad87-7a07ddd5e8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a3cb2c44-7033-40e4-ad87-7a07ddd5e8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bad7bc9-23f8-4da2-a7d0-c706bd0994c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3bad7bc9-23f8-4da2-a7d0-c706bd0994c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94b07365-27aa-42ba-8dec-b778789ed5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_94b07365-27aa-42ba-8dec-b778789ed5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_036d34e4-e11d-4de7-b33e-d2b80399f60a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_TreasuryStockValue_036d34e4-e11d-4de7-b33e-d2b80399f60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c11a0d97-36fb-466a-a01a-fbb0c3613fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_StockholdersEquity_c11a0d97-36fb-466a-a01a-fbb0c3613fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_82fc1af1-79b3-430c-b3cc-3b72ea628cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_MinorityInterest_82fc1af1-79b3-430c-b3cc-3b72ea628cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a5b54f2-dcdd-45be-af66-a650dc53596b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_bb3e0b5c-735c-48cb-9ea1-df63789699a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a5b54f2-dcdd-45be-af66-a650dc53596b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e80b6156-94cf-44a4-9138-5f59f8cb7667" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_02c9f56f-26e8-4fc1-8713-11022ecd0c33" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e80b6156-94cf-44a4-9138-5f59f8cb7667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_40148bbf-344c-43cb-af2d-d7fbfce87840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_54ad9692-3088-4251-86d7-789c4e2fde60" xlink:to="loc_us-gaap_TreasuryStockCommonShares_40148bbf-344c-43cb-af2d-d7fbfce87840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_424f7f8d-7741-48c3-be37-cdd280831988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_424f7f8d-7741-48c3-be37-cdd280831988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c6222fff-bab4-41e0-8921-f0d74f8cb0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c6222fff-bab4-41e0-8921-f0d74f8cb0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cd878abc-2b24-4289-be3f-ec4da41fbcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cd878abc-2b24-4289-be3f-ec4da41fbcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3856913d-5e47-4373-a135-dd71b2b3f5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_CommonStockSharesIssued_3856913d-5e47-4373-a135-dd71b2b3f5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_16667a1a-7749-4033-a023-3c65ea2aa48e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_16667a1a-7749-4033-a023-3c65ea2aa48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_93faadbe-e165-4c36-8983-eba3ad37496e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0ec4a1b5-b60b-40ab-9f3b-8bdec306ff3d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_93faadbe-e165-4c36-8983-eba3ad37496e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="kequ-20240430.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1c1bce32-fec6-4cf0-8fb3-32ef5ae01a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:to="loc_us-gaap_ProfitLoss_1c1bce32-fec6-4cf0-8fb3-32ef5ae01a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1be6cc2d-f3fd-4ba7-90dc-b9d3278bc4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:to="loc_us-gaap_Depreciation_1be6cc2d-f3fd-4ba7-90dc-b9d3278bc4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_264a486a-8ff7-4ef9-8b20-bcce648e5ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_264a486a-8ff7-4ef9-8b20-bcce648e5ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a6a912b6-f3ac-43a1-a222-5063125933bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:to="loc_us-gaap_ShareBasedCompensation_a6a912b6-f3ac-43a1-a222-5063125933bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_ac271b78-6262-4aa2-b29f-2eae5433c96f" xlink:href="kequ-20240430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e70b77ce-192c-408e-9bdd-08813174f7ff" xlink:to="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_ac271b78-6262-4aa2-b29f-2eae5433c96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_14a59f85-44f6-49ce-8231-2eebd13313c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_14a59f85-44f6-49ce-8231-2eebd13313c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_226641a9-7b21-4c6b-ab49-a95d740034bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_226641a9-7b21-4c6b-ab49-a95d740034bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_34724d6b-b532-4df1-b7a6-1e0f7709e760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_34724d6b-b532-4df1-b7a6-1e0f7709e760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_6d7bd782-dba7-4f92-a87b-63d492baf5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_6d7bd782-dba7-4f92-a87b-63d492baf5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4e2a969b-6bd8-4630-9750-93cd989ae75e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6f4d14f7-4c81-4b73-8432-ae4508cf4062" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4e2a969b-6bd8-4630-9750-93cd989ae75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fec19883-3db6-4177-923c-47cc5b8d5aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_03778ecd-416c-4ed6-a30a-060484f030bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fec19883-3db6-4177-923c-47cc5b8d5aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f2e89535-d602-4d09-8896-75c991cd2853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f2e89535-d602-4d09-8896-75c991cd2853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_7161d9e1-357b-4c34-9777-5e18ed9a8860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f2e89535-d602-4d09-8896-75c991cd2853" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_7161d9e1-357b-4c34-9777-5e18ed9a8860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4bed135-6980-485e-b937-f2895147ff68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f2e89535-d602-4d09-8896-75c991cd2853" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a4bed135-6980-485e-b937-f2895147ff68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_26bfea23-01ed-4e5c-b8f1-2d3c7e9821cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_26bfea23-01ed-4e5c-b8f1-2d3c7e9821cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_9650fb79-389a-49fe-bde3-9868847111cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_9650fb79-389a-49fe-bde3-9868847111cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability_527e38e8-6f27-43e8-a08e-5d4e04fa8687" xlink:href="kequ-20240430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_kequ_ProceedsFromFinancingLiability_527e38e8-6f27-43e8-a08e-5d4e04fa8687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability_d80813eb-da86-48cf-9081-2d8a58268eda" xlink:href="kequ-20240430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_kequ_PaymentsOnFinancingLiability_d80813eb-da86-48cf-9081-2d8a58268eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8ad454a1-aebd-4a20-a949-b59039df56af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8ad454a1-aebd-4a20-a949-b59039df56af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b51c108b-29d1-44fa-b3e5-bbe1e446f784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b51c108b-29d1-44fa-b3e5-bbe1e446f784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c5182b2e-5a8a-4a72-9eae-5fbe09ab97be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c5182b2e-5a8a-4a72-9eae-5fbe09ab97be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3cad3761-3cf3-4dc3-b5f9-86a033452c03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b579129-c354-4819-bdf6-5a000694b7af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3cad3761-3cf3-4dc3-b5f9-86a033452c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6fb38522-d71f-4655-8b48-2ec05e176afd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6fb38522-d71f-4655-8b48-2ec05e176afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6d939da-8901-484d-aa09-62fde8a1ee66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c6d939da-8901-484d-aa09-62fde8a1ee66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_387d8bb3-1df6-4239-89eb-4dfdbb1de952" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_387d8bb3-1df6-4239-89eb-4dfdbb1de952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d312ac5-2a21-44c0-8f8e-2842adaefd81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7d312ac5-2a21-44c0-8f8e-2842adaefd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_41344714-665c-4434-96f3-bb09ad81b6a7" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_231d339b-8015-4102-ab73-1175727208c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:to="loc_us-gaap_InterestPaidNet_231d339b-8015-4102-ab73-1175727208c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_420a23e6-499d-4698-83c1-4aff91aca2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_420a23e6-499d-4698-83c1-4aff91aca2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c8697593-62d8-4a9d-82ba-0000194b1c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c8697593-62d8-4a9d-82ba-0000194b1c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_18041ca8-9b37-4428-b2ff-c9c160381bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_1a8b246b-fc3f-46cc-a521-012ce835fbcf" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_18041ca8-9b37-4428-b2ff-c9c160381bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d5561b32-e3d0-4149-99fc-d66f22b87209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e832961b-5448-4c1f-8564-f4fbdd7c72f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d5561b32-e3d0-4149-99fc-d66f22b87209" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e832961b-5448-4c1f-8564-f4fbdd7c72f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognition" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dbf04f5-2f62-43f2-a9a6-dfca657e4dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6c2ee14a-5a2a-4ae9-be35-009294249019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dbf04f5-2f62-43f2-a9a6-dfca657e4dd5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_6c2ee14a-5a2a-4ae9-be35-009294249019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/Inventories" xlink:type="simple" xlink:href="kequ-20240430.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_ca097c3f-a12c-4afc-b1e6-8bd900b97b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_fcea2d41-3b22-4b84-9f40-594e346b576b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_ca097c3f-a12c-4afc-b1e6-8bd900b97b9b" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_fcea2d41-3b22-4b84-9f40-594e346b576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements" xlink:type="simple" xlink:href="kequ-20240430.xsd#LongtermDebtandOtherCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_93a42174-26ad-4770-aafe-9458ed6e1d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5392e5e6-7a30-488e-bb14-768c534a399d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_93a42174-26ad-4770-aafe-9458ed6e1d6e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5392e5e6-7a30-488e-bb14-768c534a399d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransaction"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_25eabb28-d093-4a5a-8013-4b00bf130c5f" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_b54e48ad-456c-490a-9170-bc0ab4dbe4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleLeasebackTransactionDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_25eabb28-d093-4a5a-8013-4b00bf130c5f" xlink:to="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_b54e48ad-456c-490a-9170-bc0ab4dbe4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxes" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b4536d64-df0a-4a75-928e-5385b166422e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_30d5e759-eeb5-4eab-8947-2d71ebdd7330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b4536d64-df0a-4a75-928e-5385b166422e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_30d5e759-eeb5-4eab-8947-2d71ebdd7330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4ce5bb34-5a04-4642-bec1-8bb9caf00999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_cb0e6824-4317-410e-9d32-afdfc7ef41ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4ce5bb34-5a04-4642-bec1-8bb9caf00999" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_cb0e6824-4317-410e-9d32-afdfc7ef41ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockholdersEquity" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_052fb5e1-f775-4a6f-80b4-87328c40f0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6382821f-f7c9-46cf-82ad-b22bb1238563" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_052fb5e1-f775-4a6f-80b4-87328c40f0f1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6382821f-f7c9-46cf-82ad-b22bb1238563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="kequ-20240430.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_868c9913-c038-4662-bed1-24d51788934b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a9534bf5-00b4-49b4-aa96-ccb2a3297b91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_868c9913-c038-4662-bed1-24d51788934b" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a9534bf5-00b4-49b4-aa96-ccb2a3297b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0af2bda-19c9-4914-b882-7c00c3849a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5062e332-a4ad-4bdc-9b5d-58d15936b064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0af2bda-19c9-4914-b882-7c00c3849a3f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5062e332-a4ad-4bdc-9b5d-58d15936b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefits" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefits"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e5cef300-b085-44b7-a753-3a6c6cdd092c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_444b1a84-03a2-408d-a85f-04f01d1d3c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e5cef300-b085-44b7-a753-3a6c6cdd092c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_444b1a84-03a2-408d-a85f-04f01d1d3c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformation" xlink:type="simple" xlink:href="kequ-20240430.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_db4a1d0b-417b-48b8-bc38-b3241cce2260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_30ae21c5-71ad-4080-87cb-428bcf8b0fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_db4a1d0b-417b-48b8-bc38-b3241cce2260" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_30ae21c5-71ad-4080-87cb-428bcf8b0fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7d32a3fb-63c4-4698-9497-9e97e5ae7f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7d32a3fb-63c4-4698-9497-9e97e5ae7f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_31bddb2f-b156-431f-8611-4eab2c001d34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_31bddb2f-b156-431f-8611-4eab2c001d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3940c3ed-0eee-42dd-95f4-edeefa6d0703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_3940c3ed-0eee-42dd-95f4-edeefa6d0703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_2876f5b6-c40a-4c45-ac8f-cdbaae1e968d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_2876f5b6-c40a-4c45-ac8f-cdbaae1e968d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_ce55adbc-7a21-432f-9392-904a02a8c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_ce55adbc-7a21-432f-9392-904a02a8c05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_4adb707e-defd-4ed1-b6ee-82bffb1a38d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_4adb707e-defd-4ed1-b6ee-82bffb1a38d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_bc071591-0490-4be1-81d5-a2a5230ee0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_bc071591-0490-4be1-81d5-a2a5230ee0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentImpairment_cf382248-8b82-49f5-9678-5f21685d1bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentImpairment_cf382248-8b82-49f5-9678-5f21685d1bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OtherAssetsPolicyTextBlock_c990ec0c-db4e-484d-a94f-349306e05149" xlink:href="kequ-20240430.xsd#kequ_OtherAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_kequ_OtherAssetsPolicyTextBlock_c990ec0c-db4e-484d-a94f-349306e05149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c4824f8b-26fd-42af-a939-eec4c552ad5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_UseOfEstimates_c4824f8b-26fd-42af-a939-eec4c552ad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_909fe45f-900e-4124-9f47-43771d0dd8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_909fe45f-900e-4124-9f47-43771d0dd8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_fa5044ce-546e-4e91-8774-98f5af86acf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_fa5044ce-546e-4e91-8774-98f5af86acf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7610e3d4-94de-4ef5-ab0e-1e64cba80037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7610e3d4-94de-4ef5-ab0e-1e64cba80037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_9d5a0af3-3b0a-4857-b08d-a7dc60cd3282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_9d5a0af3-3b0a-4857-b08d-a7dc60cd3282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_5de46477-768c-4b49-84d9-ba66606f8795" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_5de46477-768c-4b49-84d9-ba66606f8795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_bf91fa06-49a2-4c65-baa3-d8d885657d74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_bf91fa06-49a2-4c65-baa3-d8d885657d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_958c6790-6f7b-4cac-b6cf-8956c7ef7a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_958c6790-6f7b-4cac-b6cf-8956c7ef7a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_bc54facd-fbf9-4a5c-adf8-4ff066840594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_bc54facd-fbf9-4a5c-adf8-4ff066840594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_473be715-c153-49d5-a760-5d35c9101dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_473be715-c153-49d5-a760-5d35c9101dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_c732c9cc-c01c-4b48-9650-7354084b1bab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_c732c9cc-c01c-4b48-9650-7354084b1bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5a1e3279-9370-47f2-bd63-13858540945b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5a1e3279-9370-47f2-bd63-13858540945b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6cc42883-4bc7-41fe-9722-ad0fea1a1474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21ad62df-e5db-48f7-8c71-615e3de8932c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6cc42883-4bc7-41fe-9722-ad0fea1a1474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_2b7e5241-a973-4de2-82b5-93f3365c4e32" xlink:href="kequ-20240430.xsd#kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:to="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_2b7e5241-a973-4de2-82b5-93f3365c4e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_f06e74b2-79f7-4afe-a25f-9195eb0135dc" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:to="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_f06e74b2-79f7-4afe-a25f-9195eb0135dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5d570c11-85e7-4a11-a6ca-a4b29c0b0156" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5d570c11-85e7-4a11-a6ca-a4b29c0b0156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_354b270e-7696-4f0c-b95a-b5fe5daecfca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_354b270e-7696-4f0c-b95a-b5fe5daecfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e6b0a528-19f8-441d-8b01-f155da5edd96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ee0a02ff-b813-42a8-927c-723e1c94b3e7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e6b0a528-19f8-441d-8b01-f155da5edd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_52734af2-10b0-4b1a-a742-dfbf5ed61e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da08b23f-b858-4daa-880a-b64d1537511d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_52734af2-10b0-4b1a-a742-dfbf5ed61e1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_da08b23f-b858-4daa-880a-b64d1537511d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e4034625-5d57-4a34-af78-6351beabd148" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dd97de35-e0a2-45c1-af9c-e561d7cd410f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e4034625-5d57-4a34-af78-6351beabd148" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dd97de35-e0a2-45c1-af9c-e561d7cd410f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_9d994047-6f8f-4178-b842-55c52a78a9f7" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_507ea79e-7089-41ca-8a7c-83c14369f169" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_9d994047-6f8f-4178-b842-55c52a78a9f7" xlink:to="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_507ea79e-7089-41ca-8a7c-83c14369f169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_73486ba7-c386-4c2b-b872-1047980227e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ba3823c5-ae8b-4cbb-ab5a-a898db38893f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73486ba7-c386-4c2b-b872-1047980227e3" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ba3823c5-ae8b-4cbb-ab5a-a898db38893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_46626528-e996-4293-9e53-512ec4bb4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73486ba7-c386-4c2b-b872-1047980227e3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_46626528-e996-4293-9e53-512ec4bb4c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3f10ee00-15f4-4b4f-bb88-bd396e9a4631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73486ba7-c386-4c2b-b872-1047980227e3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_3f10ee00-15f4-4b4f-bb88-bd396e9a4631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9fd61242-5f48-480f-99ee-24a873924cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6312a725-d4e0-4cc7-bd2f-01ed6a8d9086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9fd61242-5f48-480f-99ee-24a873924cf4" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6312a725-d4e0-4cc7-bd2f-01ed6a8d9086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ce1733ff-ca1a-4b61-a40c-79290d052b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9fd61242-5f48-480f-99ee-24a873924cf4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ce1733ff-ca1a-4b61-a40c-79290d052b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_05fca9cd-b578-42a8-bfa7-c1daf8887489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9fd61242-5f48-480f-99ee-24a873924cf4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_05fca9cd-b578-42a8-bfa7-c1daf8887489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f3a1b151-d2be-40a3-91fb-1c394d15df65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_e7233ff3-a500-4d32-bd4e-15888d41a76b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f3a1b151-d2be-40a3-91fb-1c394d15df65" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_e7233ff3-a500-4d32-bd4e-15888d41a76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2aa3c22e-ac02-46fc-9959-39b746098e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_f49d4319-b007-476f-bd15-ae830e40a75c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2aa3c22e-ac02-46fc-9959-39b746098e7c" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_f49d4319-b007-476f-bd15-ae830e40a75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64dce243-85d3-466c-a0e0-dc3e758998dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ad35b945-4d8d-4d37-8e56-63c74a99f247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64dce243-85d3-466c-a0e0-dc3e758998dc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ad35b945-4d8d-4d37-8e56-63c74a99f247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e52a1de8-f1df-4cc2-afe1-a5e1caec241c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_64dce243-85d3-466c-a0e0-dc3e758998dc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e52a1de8-f1df-4cc2-afe1-a5e1caec241c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3346b0f-15bf-40ca-b79f-eca6a8d31449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_fe3b5502-13c7-4915-afa2-a63840458437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3346b0f-15bf-40ca-b79f-eca6a8d31449" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_fe3b5502-13c7-4915-afa2-a63840458437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8ce944f8-2655-4efe-b6be-84cf4cebd224" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3346b0f-15bf-40ca-b79f-eca6a8d31449" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8ce944f8-2655-4efe-b6be-84cf4cebd224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_f48ed59e-28b2-4392-ad18-f70b5eb33267" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3346b0f-15bf-40ca-b79f-eca6a8d31449" xlink:to="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_f48ed59e-28b2-4392-ad18-f70b5eb33267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_ff5bf5be-fd0d-4875-91e6-b79d2a29af56" xlink:href="kequ-20240430.xsd#kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a3346b0f-15bf-40ca-b79f-eca6a8d31449" xlink:to="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_ff5bf5be-fd0d-4875-91e6-b79d2a29af56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="kequ-20240430.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ff51b816-eaa5-4517-86a1-f5706f0078d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_756eb114-aacb-4666-91f2-d4622a085587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ff51b816-eaa5-4517-86a1-f5706f0078d8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_756eb114-aacb-4666-91f2-d4622a085587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_19ccd1a8-a674-4e7a-98a1-e588ab9ed477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_19ccd1a8-a674-4e7a-98a1-e588ab9ed477" xlink:to="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_71c954cb-56ab-42c1-9ca3-c4a85bc82383" xlink:to="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember_28222057-3755-4f39-b137-ab2d20b8ec9f" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:to="loc_kequ_KewauneeScientificCorporationMember_28222057-3755-4f39-b137-ab2d20b8ec9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_1878fd6e-273a-4b08-9f4e-65ef507fb667" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_84d3aef2-3dc3-4331-b2a5-04d2de537fbb" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_1878fd6e-273a-4b08-9f4e-65ef507fb667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b0c70119-6fc7-48e4-8c67-2568018e3f41" xlink:to="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember_f61149d4-8c0b-4678-a426-455b6f39803f" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeLabwayAsiaMember_f61149d4-8c0b-4678-a426-455b6f39803f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_dfc440de-4bfa-41d6-94c1-0aa1dbfeb2b7" xlink:href="kequ-20240430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_dfc440de-4bfa-41d6-94c1-0aa1dbfeb2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember_4234b873-b92b-40b8-bd2a-147eb9ac1d07" xlink:href="kequ-20240430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KewauneeLabwayIndiaMember_4234b873-b92b-40b8-bd2a-147eb9ac1d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember_7291affc-3fb0-4e69-9045-22fc0c9d6599" xlink:href="kequ-20240430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KoncepoScientechInternationalMember_7291affc-3fb0-4e69-9045-22fc0c9d6599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember_dfcada32-a67c-40d0-ae26-e588f02e22aa" xlink:href="kequ-20240430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d12a2e5c-a864-4d6c-b87c-c07468d94e46" xlink:to="loc_kequ_KequipGlobalLabSolutionsMember_dfcada32-a67c-40d0-ae26-e588f02e22aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e63e6a44-a3e0-4e97-a72a-84f8d0ba6ec9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_913133e8-c625-4439-8625-5c2252707918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_913133e8-c625-4439-8625-5c2252707918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_06e4dcfa-ced7-4480-9f94-4a79a0d2eecf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6520b26-4c46-43e8-ab04-bb01460db6bd" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_06e4dcfa-ced7-4480-9f94-4a79a0d2eecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_d2bafa12-c559-4de4-a4fd-ba3a0b3d5e2e" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_e747bd24-7868-4059-b498-84324a87cf8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c21d9c51-2bf5-4190-99ea-6d0113a318e1" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_e747bd24-7868-4059-b498-84324a87cf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2008a60d-9510-4c72-934e-a93cb12fba64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7ff889db-a4c7-44a3-8595-9386ffb35064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc9061cc-1f5d-4c52-ba1f-1270d4f47a92" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7ff889db-a4c7-44a3-8595-9386ffb35064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9da3ee0b-65d3-400b-b943-e99202ac5596" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember_581da3a5-a44c-4885-b851-a316d369c23e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:to="loc_us-gaap_SalesRevenueSegmentMember_581da3a5-a44c-4885-b851-a316d369c23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_5f84d113-bcce-4803-a81e-d3413fc8a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_edd32960-da9d-483a-af74-80ba90d61767" xlink:to="loc_us-gaap_AccountsReceivableMember_5f84d113-bcce-4803-a81e-d3413fc8a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6277e40d-c80d-4cd4-838e-496184183ea6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_9026446f-58e1-4889-a85a-aacde983bf8c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1ff10022-d891-42f0-bc08-37c8f0458d4b" xlink:to="loc_srt_SubsidiariesMember_9026446f-58e1-4889-a85a-aacde983bf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_1dfe6a27-bee1-4eeb-ae52-5ee26841aee7" xlink:to="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_e1f5f65f-55a7-46e9-aae6-cfcaf8b3978c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_9e051a78-8532-401e-9c89-b2d323203a0a" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_e1f5f65f-55a7-46e9-aae6-cfcaf8b3978c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_03779bcd-52f1-4737-a574-05a281a86ce3" xlink:to="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d433fd06-d3b0-418f-aea6-15ae314e4ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5d55f7b3-dc32-4e8b-aa69-4c5c738affa7" xlink:to="loc_us-gaap_OperatingSegmentsMember_d433fd06-d3b0-418f-aea6-15ae314e4ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51043d92-4d6d-4934-87f7-90203db171ee" xlink:to="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_0efddb68-497b-4be0-a2f1-cfedf298786d" xlink:href="kequ-20240430.xsd#kequ_InternationalOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_65397327-e611-488c-a399-d62b830287b0" xlink:to="loc_kequ_InternationalOperationsMember_0efddb68-497b-4be0-a2f1-cfedf298786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:href="kequ-20240430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_d026152e-6357-4dbf-9fc0-d84cb3003b65" xlink:to="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d227b8d5-5334-4960-b7b9-c6fa41a2f34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_d227b8d5-5334-4960-b7b9-c6fa41a2f34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_2d2ff5be-39ad-408c-879d-df1de31a0b39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetsNet_2d2ff5be-39ad-408c-879d-df1de31a0b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_102b1e1e-0ce3-47bb-ad2a-6104baa3fba4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_102b1e1e-0ce3-47bb-ad2a-6104baa3fba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_66ce7cef-4205-442d-99ea-b9e5bfd7c796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_66ce7cef-4205-442d-99ea-b9e5bfd7c796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5fb168e2-919a-4e07-ba9b-2888562dcd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetImpairmentCharges_5fb168e2-919a-4e07-ba9b-2888562dcd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_230166fd-735a-4e28-b673-72e76df4bc88" xlink:href="kequ-20240430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_kequ_UnbilledRetainageCurrent_230166fd-735a-4e28-b673-72e76df4bc88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_7c902187-f2e3-4539-a6e5-eb356d9fb8de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AssetsHeldInTrust_7c902187-f2e3-4539-a6e5-eb356d9fb8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_9dbd902f-e8d4-4dc4-871b-07b2be9ab3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_9dbd902f-e8d4-4dc4-871b-07b2be9ab3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9a6af223-e888-409c-b9cb-617238db7816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_9a6af223-e888-409c-b9cb-617238db7816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_a9058b39-16e0-4c40-88e0-6efc0facbbb1" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_a9058b39-16e0-4c40-88e0-6efc0facbbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage_f60e8337-aaba-4d89-9a35-481f66788503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ConstructionContractorReceivableRetainage_f60e8337-aaba-4d89-9a35-481f66788503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7425a41b-a7e2-472f-81a2-e233aba34b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7425a41b-a7e2-472f-81a2-e233aba34b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_669ec194-51f2-41ad-83c4-1c6625676ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_669ec194-51f2-41ad-83c4-1c6625676ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_5cd6f9c8-4ff4-4a02-b165-7595d167b5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AdvertisingExpense_5cd6f9c8-4ff4-4a02-b165-7595d167b5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5193e60d-246b-41ee-b874-570c7a049c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5193e60d-246b-41ee-b874-570c7a049c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_afdcb52e-a075-4402-8634-7c3caf5503c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_afdcb52e-a075-4402-8634-7c3caf5503c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_52754e6e-bb37-4e1e-a7a2-c8699d98f226" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_ee9bcf96-b8c6-40e2-a82c-bcaee6d91ad1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_52754e6e-bb37-4e1e-a7a2-c8699d98f226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c2492da6-53bd-4bbe-8a86-f5c86acb45d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21f214c1-8231-479c-acfc-21ef50275174" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c2492da6-53bd-4bbe-8a86-f5c86acb45d5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_21f214c1-8231-479c-acfc-21ef50275174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_e40521bb-e610-4853-8016-b05205e737d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c2492da6-53bd-4bbe-8a86-f5c86acb45d5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_e40521bb-e610-4853-8016-b05205e737d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c2181334-1e1f-4c52-adb1-c6bbecc6a3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c2492da6-53bd-4bbe-8a86-f5c86acb45d5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c2181334-1e1f-4c52-adb1-c6bbecc6a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8534bced-8f4b-4019-81ab-459b2659a5da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8534bced-8f4b-4019-81ab-459b2659a5da" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b087a66c-0d1d-46f3-a246-4325e9f4f21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b087a66c-0d1d-46f3-a246-4325e9f4f21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ca6e2522-44be-42d9-9e9d-e7f437c081d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ca6e2522-44be-42d9-9e9d-e7f437c081d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_bbe667d5-2cb3-46bc-b3ca-f5ac4b99ed7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_bbe667d5-2cb3-46bc-b3ca-f5ac4b99ed7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5052430-2126-4e96-8b2f-d60fb0703fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_7cf763e3-5a78-4e20-86ea-c1610d5a0d14" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e5052430-2126-4e96-8b2f-d60fb0703fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_014830c7-61f1-4f90-9952-c9d7f80e9abd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_014830c7-61f1-4f90-9952-c9d7f80e9abd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f7705fd1-f696-439f-8129-2fbe42db5e98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_112d33e3-76bf-4ec6-b531-b3915d238ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_LandMember_112d33e3-76bf-4ec6-b531-b3915d238ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_58543127-449d-4e5d-b799-3f115170ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_BuildingImprovementsMember_58543127-449d-4e5d-b799-3f115170ad10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_0ab77fe0-5e72-4ec3-bd16-02492eb45256" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cc759f71-0667-4c42-a87b-9bdcdd8202b5" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_0ab77fe0-5e72-4ec3-bd16-02492eb45256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:to="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c2939695-aff5-4c4f-a57b-f1aa6f313b1a" xlink:to="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0d52b22b-719b-4494-b6a8-be2ac45e4159" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:to="loc_srt_MinimumMember_0d52b22b-719b-4494-b6a8-be2ac45e4159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bac8e6bc-e75a-479a-9da5-3ba00c3c7f15" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55f3ee88-add4-4657-ac26-272f5f198502" xlink:to="loc_srt_MaximumMember_bac8e6bc-e75a-479a-9da5-3ba00c3c7f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_912b60ad-7129-4c16-8b4e-25b3d4665b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1f442f85-57ff-409d-a46a-a70874b66290" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1f442f85-57ff-409d-a46a-a70874b66290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_802f294d-c02e-4404-b32c-9dde3812346c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_802f294d-c02e-4404-b32c-9dde3812346c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52db8638-7e83-45d4-8691-eb11d10ade1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_52db8638-7e83-45d4-8691-eb11d10ade1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_efd0e5b6-6859-4f49-aa81-f55d2108fabe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c4d2694e-f39b-464e-973e-edd4affe5c14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_efd0e5b6-6859-4f49-aa81-f55d2108fabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_992a2d58-da38-46f7-b131-9af2e53af8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_992a2d58-da38-46f7-b131-9af2e53af8a8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_196040b3-bf6e-49d4-a5f0-3cbe719ad44d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b13d3140-b100-4d01-9ed6-3c1826f03d61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b13d3140-b100-4d01-9ed6-3c1826f03d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_55a7b1fd-e9e1-4a20-a7d0-e3b2fe2715c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9109e3e1-976f-40e4-9e0c-c3da5fbfa787" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_55a7b1fd-e9e1-4a20-a7d0-e3b2fe2715c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b2a429bd-f211-4353-98cf-5cb0d8d9a693" xlink:to="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember_a31f42b4-a253-493a-9b86-5bd3cbc86fa5" xlink:href="kequ-20240430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1501f15-4e29-4068-94f3-87b2ff49eaae" xlink:to="loc_kequ_NonQualifiedCompensationPlanMember_a31f42b4-a253-493a-9b86-5bd3cbc86fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_28d3bcdb-82d8-4b44-8e70-1ba6466b2f09" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember_6b10099e-e2b0-41cf-8459-c569e5f201f5" xlink:href="kequ-20240430.xsd#kequ_TradingSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:to="loc_kequ_TradingSecuritiesMember_6b10099e-e2b0-41cf-8459-c569e5f201f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember_617f893e-5622-4ca7-8a95-d5d04ee4f312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_38ecadfe-1107-4830-9784-6ccc4d8fa549" xlink:to="loc_us-gaap_CashSurrenderValueMember_617f893e-5622-4ca7-8a95-d5d04ee4f312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_ca9fc35c-1f37-4a62-91d4-90f8a247f79e" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_069de521-c9e5-4c66-acd9-668ceca055c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_us-gaap_DerivativeAssets_069de521-c9e5-4c66-acd9-668ceca055c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d61c9c8d-7f54-4f30-9de2-ab02cc760a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_us-gaap_DerivativeLiabilities_d61c9c8d-7f54-4f30-9de2-ab02cc760a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1c4fa6ab-0981-4efe-a482-26631bb2d310" xlink:href="kequ-20240430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1c4fa6ab-0981-4efe-a482-26631bb2d310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans_3dda1efa-7166-4d72-9ba1-a0627eff0047" xlink:href="kequ-20240430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_NumberOfNonqualifiedCompensationPlans_3dda1efa-7166-4d72-9ba1-a0627eff0047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1d38e70e-e760-41e4-961f-579d56c373fc" xlink:href="kequ-20240430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_efef2ab1-99fc-49ce-b2cd-647040adc966" xlink:to="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1d38e70e-e760-41e4-961f-579d56c373fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_19ee83d9-7afe-4ba3-8bbd-5e2a1435b402" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dac23ed4-78de-4dc4-990a-80923cd5379a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_19ee83d9-7afe-4ba3-8bbd-5e2a1435b402" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dac23ed4-78de-4dc4-990a-80923cd5379a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4d68abb-f187-4475-a980-95a2c3e5f5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dac23ed4-78de-4dc4-990a-80923cd5379a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a4d68abb-f187-4475-a980-95a2c3e5f5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_76cb7c4e-d104-4b8a-913e-92d605086272" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dac23ed4-78de-4dc4-990a-80923cd5379a" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_76cb7c4e-d104-4b8a-913e-92d605086272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c69bd50b-a0d9-43d9-8b5e-5172bf27ea43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_dac23ed4-78de-4dc4-990a-80923cd5379a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c69bd50b-a0d9-43d9-8b5e-5172bf27ea43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1aaf9f4f-545c-48fd-adca-99153cf02d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1aaf9f4f-545c-48fd-adca-99153cf02d3d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:to="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_0b99b6e9-6b3c-4f82-8240-7e718fbf635f" xlink:to="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_bb7efdbb-f1f7-4cb2-bed7-d6ce22c0cce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_bb7efdbb-f1f7-4cb2-bed7-d6ce22c0cce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_eb8fc768-9d56-491d-bed1-62312cfbc13a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_ca6f00b5-29fa-4cc4-b59c-a229426f0ae4" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_eb8fc768-9d56-491d-bed1-62312cfbc13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_f255554e-a1c0-45de-983f-9ce6fbc41af6" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3447f478-7276-4bc3-889c-17dc900feaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:to="loc_us-gaap_TransferredOverTimeMember_3447f478-7276-4bc3-889c-17dc900feaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_751f85d0-9b62-4358-989f-0539ab5143b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d121bee5-d337-4b92-8c57-bbef35ac1d84" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_751f85d0-9b62-4358-989f-0539ab5143b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_a76cad45-f648-418c-bd48-e7a77f402233" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cabe3302-bddb-4a1d-b80d-f5cb243fbecc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8e4ab515-fa40-4699-886a-865396fa89b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cabe3302-bddb-4a1d-b80d-f5cb243fbecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RevenueRecognitionAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_794158b2-ae39-48c1-9065-70e74cd08168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_794158b2-ae39-48c1-9065-70e74cd08168" xlink:to="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9dff763e-a9b2-4a13-b20e-ea79938a21a0" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember_ad70f4ce-d646-46cd-b07c-9058eec4013f" xlink:href="kequ-20240430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_16997131-8269-4948-84b5-cee7345470af" xlink:to="loc_kequ_FiscalYearTwoThousandTwentyFourMember_ad70f4ce-d646-46cd-b07c-9058eec4013f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c51e7164-3651-4786-b754-5f33cb957b84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f7cc2cb-e78b-482c-a870-f2cd5659a579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b5789a8f-32e2-4fee-871f-7adf261ed024" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9f7cc2cb-e78b-482c-a870-f2cd5659a579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:href="kequ-20240430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_270f8b30-53e7-4482-badf-40a2055dbd01" xlink:to="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_44c5c3ff-dda7-4d01-b93e-770eac86da51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_44c5c3ff-dda7-4d01-b93e-770eac86da51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_2b418c98-1ac1-4de7-b1bd-87748d745943" xlink:href="kequ-20240430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_kequ_UnbilledRetainageCurrent_2b418c98-1ac1-4de7-b1bd-87748d745943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_557a3117-7a13-4812-a1a8-e8065c7da314" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_us-gaap_ContractWithCustomerLiability_557a3117-7a13-4812-a1a8-e8065c7da314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_6255092b-84e4-42de-9252-3c9ae6ec1b94" xlink:href="kequ-20240430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_3d26b59a-b6b3-425f-bb91-82997612e51d" xlink:to="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_6255092b-84e4-42de-9252-3c9ae6ec1b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#InventoriesSummaryofInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0c14edef-5d7b-4983-85e3-9d8599e93db1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4e218367-c167-4309-8580-7107c0b4e76c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0c14edef-5d7b-4983-85e3-9d8599e93db1" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4e218367-c167-4309-8580-7107c0b4e76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d879aa26-1806-45b2-b9ce-7512c75e3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0c14edef-5d7b-4983-85e3-9d8599e93db1" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d879aa26-1806-45b2-b9ce-7512c75e3e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc630168-5516-4390-8606-93208983c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0c14edef-5d7b-4983-85e3-9d8599e93db1" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc630168-5516-4390-8606-93208983c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8d857759-85ef-49dc-a2e7-48c29ae06423" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0c14edef-5d7b-4983-85e3-9d8599e93db1" xlink:to="loc_us-gaap_InventoryNet_8d857759-85ef-49dc-a2e7-48c29ae06423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#InventoriesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0e1f140e-58b6-450a-8a72-19216c558aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0e1f140e-58b6-450a-8a72-19216c558aa5" xlink:to="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:to="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_beaca0d5-df58-4504-bffe-0601e73798d0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember_61c5caaf-9ae9-4e65-8c98-25118134877b" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c909d97d-0e54-49cc-917d-cf33d9d01962" xlink:to="loc_kequ_ForeignSubsidiariesMember_61c5caaf-9ae9-4e65-8c98-25118134877b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_3a63761a-10b2-494e-bd96-dce6e92e14df" xlink:to="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount_e03e46a9-812f-4b90-b1fc-35d64d83e292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_096d753c-23b5-47af-b919-10eef6eb8a0d" xlink:to="loc_us-gaap_FIFOInventoryAmount_e03e46a9-812f-4b90-b1fc-35d64d83e292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_712f563e-a688-49aa-ae30-cf2e3d498e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_712f563e-a688-49aa-ae30-cf2e3d498e06" xlink:to="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_94e8918c-36b3-45ca-99f4-04e722ea8a13" xlink:to="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d44a2669-427b-4de4-bbd9-044a18070c30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_us-gaap_LineOfCreditMember_d44a2669-427b-4de4-bbd9-044a18070c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember_0992f24a-3a9b-46a1-894c-796818fe3a84" xlink:href="kequ-20240430.xsd#kequ_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_kequ_TermLoanBMember_0992f24a-3a9b-46a1-894c-796818fe3a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1cf3c982-fd9d-4388-8d99-2d96c90d9775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_eb60a35c-3551-4a71-8ac2-0cea743455d6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1cf3c982-fd9d-4388-8d99-2d96c90d9775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_72be452f-0090-44a4-9b68-902a491ca38f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6920add2-646d-49a8-af10-c66bf4808a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6920add2-646d-49a8-af10-c66bf4808a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d75bcf50-c2e6-43c4-a6ef-8e3e0629e53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d75bcf50-c2e6-43c4-a6ef-8e3e0629e53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57982d9e-fbc8-4bad-a0c9-049d96a69abc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_57982d9e-fbc8-4bad-a0c9-049d96a69abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_5d831af9-3ee2-4939-ad16-1c46736f883d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0e9c9492-da6c-4de2-9201-48c263ebfb3d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_5d831af9-3ee2-4939-ad16-1c46736f883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_cb80d520-5781-4e17-8602-19b33f937578" xlink:to="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember_17b66c68-ad73-442d-af3b-a240d82e2485" xlink:href="kequ-20240430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9c352a3c-3147-498c-b670-09229923649e" xlink:to="loc_kequ_SecuredOvernightFinancingRateSOFRMember_17b66c68-ad73-442d-af3b-a240d82e2485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bdcbcc23-4292-4dab-9644-b46bb5fd16bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_a43caab6-e3b5-474a-847f-cb1ae7e0dfd5" xlink:href="kequ-20240430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8cbba6db-ca76-49a2-b9df-7844b2426e74" xlink:to="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_a43caab6-e3b5-474a-847f-cb1ae7e0dfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6a39da2e-9b92-4654-9c9c-a16108967045" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3b9fce29-f2ad-4521-a864-5488b6836321" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_48eaa4cb-4a96-4ba5-aaf4-1accfe5c8d86" xlink:to="loc_us-gaap_LineOfCreditMember_3b9fce29-f2ad-4521-a864-5488b6836321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fc1c528c-fa26-45e8-8a86-569d34542844" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember_ae62a294-93f4-4f3c-a62e-7e2ca370d0ae" xlink:href="kequ-20240430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3a9c3ffd-b353-45cd-a24d-f7224b8c9a02" xlink:to="loc_kequ_InternationalSubsidiariesMember_ae62a294-93f4-4f3c-a62e-7e2ca370d0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eefac6bb-62a7-4f03-b119-623a62105f8a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28b3c630-03ed-4344-92ce-7da42a30c251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_28b3c630-03ed-4344-92ce-7da42a30c251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_68dc126c-cbce-418d-a920-ed56246a3f44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCredit_68dc126c-cbce-418d-a920-ed56246a3f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_437596de-c465-4156-91df-529577ed2170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_437596de-c465-4156-91df-529577ed2170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2bedbc3f-d846-4675-b2b8-54c454b26d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_2bedbc3f-d846-4675-b2b8-54c454b26d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0d95c818-82c7-48df-87ef-f0cd42099c96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0d95c818-82c7-48df-87ef-f0cd42099c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_3b09f282-bbb0-4ed0-a718-1588cc57e415" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_3b09f282-bbb0-4ed0-a718-1588cc57e415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_5f8ff774-81fb-4961-95c6-5448f7727b6d" xlink:href="kequ-20240430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_5f8ff774-81fb-4961-95c6-5448f7727b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_42e85194-78f8-4915-8d32-6d3775d6a19f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_ShortTermBorrowings_42e85194-78f8-4915-8d32-6d3775d6a19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_a356448a-0466-42a4-a982-ecc0826279df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_03e6f647-c7dd-4f88-a654-908e0390af9e" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_a356448a-0466-42a4-a982-ecc0826279df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_8706eb3f-20b9-4360-8bc7-aa1b8a9829ba" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_8706eb3f-20b9-4360-8bc7-aa1b8a9829ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNumberOfRenewalOptions_354cd922-51b5-411f-ae87-f3d487767bca" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityNumberOfRenewalOptions_354cd922-51b5-411f-ae87-f3d487767bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityRenewalTerm_f5cd7004-3e43-49f3-a9c8-e2944f70f373" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityRenewalTerm_f5cd7004-3e43-49f3-a9c8-e2944f70f373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityBasicMonthlyPayment_70d4958e-dac6-489b-aec6-9cb7671ccc25" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityBasicMonthlyPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityBasicMonthlyPayment_70d4958e-dac6-489b-aec6-9cb7671ccc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAnnualIncreasePercent_27dcab1e-1e6c-4acf-b3fa-6b7965357639" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAnnualIncreasePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityAnnualIncreasePercent_27dcab1e-1e6c-4acf-b3fa-6b7965357639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate_ce9e2f29-2e01-42d2-8293-2574012529c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_us-gaap_LesseeFinanceLeaseDiscountRate_ce9e2f29-2e01-42d2-8293-2574012529c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_3227e1b0-77bc-4f14-9479-35342649fc69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_3227e1b0-77bc-4f14-9479-35342649fc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_11b6aa09-b367-4f4e-beac-058ea3bd3898" xlink:href="kequ-20240430.xsd#kequ_FinancingLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiability_11b6aa09-b367-4f4e-beac-058ea3bd3898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_3825cae6-0d71-4c2e-a66e-4dc7b0ca63d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_3825cae6-0d71-4c2e-a66e-4dc7b0ca63d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_5e59a401-4584-495c-9cb4-70838d229524" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityCurrent_5e59a401-4584-495c-9cb4-70838d229524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_923bb567-0566-4f74-84a1-81104e733409" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_923bb567-0566-4f74-84a1-81104e733409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InterestExpenseFinancingLiability_d2724e44-1275-42a4-89ff-0b9490de77e0" xlink:href="kequ-20240430.xsd#kequ_InterestExpenseFinancingLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_InterestExpenseFinancingLiability_d2724e44-1275-42a4-89ff-0b9490de77e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityTable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_3c29b9c3-7698-4121-a251-ce4f1e5300cf" xlink:to="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f114879-59af-4091-9cd0-42f89d84ab29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_0b80f84b-ad96-4626-ab2a-7b5fb41af64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:to="loc_us-gaap_BuildingMember_0b80f84b-ad96-4626-ab2a-7b5fb41af64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_432a2cd4-94b5-4acb-a395-7812cb24bb52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_496e5350-2e85-4efa-92db-0407286b2632" xlink:to="loc_us-gaap_LandMember_432a2cd4-94b5-4acb-a395-7812cb24bb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityTable_dd9f08c7-4d89-4cdf-898c-70582517b0ca" xlink:to="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1b56f032-1085-4716-a5d3-4d4adc59cbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1b56f032-1085-4716-a5d3-4d4adc59cbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_be55ef59-38ee-4065-a99e-ae3b8a14c692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityLineItems_a755776b-469e-4f48-adf5-018f34b53129" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_be55ef59-38ee-4065-a99e-ae3b8a14c692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne_d43d8b92-db0c-480f-a663-4f81d88b11b9" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearOne_d43d8b92-db0c-480f-a663-4f81d88b11b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo_55c31da4-d1c0-462a-a9a2-75b98e43cebf" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearTwo_55c31da4-d1c0-462a-a9a2-75b98e43cebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree_7827816d-4967-499d-8d2e-3ec137ad97f4" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearThree_7827816d-4967-499d-8d2e-3ec137ad97f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour_db0dcf2b-2474-4ca8-baf4-151f51f0a9fb" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFour_db0dcf2b-2474-4ca8-baf4-151f51f0a9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive_2017ed75-ee6a-4e50-925b-28621594888d" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFive_2017ed75-ee6a-4e50-925b-28621594888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_d80cc9b7-5a69-4af4-8194-39d95eac8cc1" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_d80cc9b7-5a69-4af4-8194-39d95eac8cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_2cf00f86-40d1-4b04-bf1e-a2159128de09" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityToBePaid_2cf00f86-40d1-4b04-bf1e-a2159128de09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_1c70bcff-48dd-4c61-8e85-91153660055f" xlink:href="kequ-20240430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_1c70bcff-48dd-4c61-8e85-91153660055f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_3abc9446-7441-4bda-9b27-9ee92d8a745c" xlink:href="kequ-20240430.xsd#kequ_FinancingLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_0e02756f-f15e-41e0-96fb-de04b514124f" xlink:to="loc_kequ_FinancingLiability_3abc9446-7441-4bda-9b27-9ee92d8a745c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2c9e78ec-e453-43b8-93a6-f485566e3f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c9e78ec-e453-43b8-93a6-f485566e3f9b" xlink:to="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_2294c8af-1d73-4777-b85b-459849bd8a4e" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_cc102fb3-b318-4871-9008-2b64841d9b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_5bea0749-3961-4ec9-a1bd-137e9bb6b96a" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_cc102fb3-b318-4871-9008-2b64841d9b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:to="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_19e174cb-192e-4f71-81ba-98627595946a" xlink:to="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0a109947-4b81-4b3e-ab4b-ec0bea3d8be3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:to="loc_srt_MinimumMember_0a109947-4b81-4b3e-ab4b-ec0bea3d8be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a4d66b0f-e44b-43e3-bc80-4930c26aa018" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_287021bc-7c6f-46fe-a9a8-a1096dbaaf6a" xlink:to="loc_srt_MaximumMember_a4d66b0f-e44b-43e3-bc80-4930c26aa018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_4d8e7966-d16f-4f70-8c93-122ee3edd4fe" xlink:to="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense_88fa7d97-5069-428a-b730-b72733306065" xlink:href="kequ-20240430.xsd#kequ_TaxWithholdingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_TaxWithholdingExpense_88fa7d97-5069-428a-b730-b72733306065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_0640defa-3ad8-483a-a294-d8c648d0e7b7" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_0640defa-3ad8-483a-a294-d8c648d0e7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_befcc124-f3a4-4fe6-8ed3-e90be08ba919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_befcc124-f3a4-4fe6-8ed3-e90be08ba919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_bd427a6e-654e-4fca-9da7-ac111aecf15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_bd427a6e-654e-4fca-9da7-ac111aecf15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_5c2d7b7c-fb8e-4af0-b655-3e7a50ee91e8" xlink:href="kequ-20240430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_5c2d7b7c-fb8e-4af0-b655-3e7a50ee91e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_5005faa4-e6ef-434d-bf99-79f6338e5daf" xlink:href="kequ-20240430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_bf3db317-14e4-4bc4-916d-9dd2feef3060" xlink:to="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_5005faa4-e6ef-434d-bf99-79f6338e5daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesIncomeTaxExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_652de952-faa2-4641-b537-2f4ada4edf82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_652de952-faa2-4641-b537-2f4ada4edf82" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_647e5d0a-32ec-43e5-9d5d-d9009dd73c13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_647e5d0a-32ec-43e5-9d5d-d9009dd73c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_278d6729-9ae8-4c7a-93dc-f571a9244bff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_278d6729-9ae8-4c7a-93dc-f571a9244bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_205ba81a-b3fd-44dc-ada9-45727f31bd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_205ba81a-b3fd-44dc-ada9-45727f31bd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa5cf1a8-2de0-4f4f-a452-1a4001f1f87a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2cc25d2e-4381-4378-a82b-c834fc89084c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_fa5cf1a8-2de0-4f4f-a452-1a4001f1f87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_652de952-faa2-4641-b537-2f4ada4edf82" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c3f85f3b-18f1-44f8-a877-b7e4bbfba195" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c3f85f3b-18f1-44f8-a877-b7e4bbfba195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2a7fd901-b1c2-4873-aed7-84d6d6a40932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2a7fd901-b1c2-4873-aed7-84d6d6a40932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_192f76e3-13a6-44a5-b621-fb6f4d243880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_192f76e3-13a6-44a5-b621-fb6f4d243880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae8f70b9-5b6c-4742-993b-5c604a645285" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_1cd2ce21-c677-4457-9aaf-0750c2f2faba" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae8f70b9-5b6c-4742-993b-5c604a645285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97d999f3-a6c6-42c4-abe4-58f2b5131441" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_652de952-faa2-4641-b537-2f4ada4edf82" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_97d999f3-a6c6-42c4-abe4-58f2b5131441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesScheduleofIncomeTaxReconciliationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6b96c1dc-8d83-4ad4-877f-32eeb6baa7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6b96c1dc-8d83-4ad4-877f-32eeb6baa7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_962756e8-fe9c-4d78-b10e-edd04a340c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_962756e8-fe9c-4d78-b10e-edd04a340c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_3335f176-a172-4374-a47e-b7439bd778fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_3335f176-a172-4374-a47e-b7439bd778fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9d48aae0-b180-42c3-9b2e-086a35d759e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9d48aae0-b180-42c3-9b2e-086a35d759e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_a4c95294-1722-4ae7-85a7-33abff29f6a5" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_a4c95294-1722-4ae7-85a7-33abff29f6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_fc0cd0a9-87c6-4af0-9ba2-4cce1c3aa232" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_fc0cd0a9-87c6-4af0-9ba2-4cce1c3aa232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_9ccaeb2f-4f1a-46cb-af75-80b983db96f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_9ccaeb2f-4f1a-46cb-af75-80b983db96f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a8aedd61-757c-4ee6-9aea-f1270a780b68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a8aedd61-757c-4ee6-9aea-f1270a780b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_ad668384-916f-46ff-b88a-2c79a282a21c" xlink:href="kequ-20240430.xsd#kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings_ad668384-916f-46ff-b88a-2c79a282a21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_73cabbc5-8dc3-4e36-8d13-38b408df8af0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_73cabbc5-8dc3-4e36-8d13-38b408df8af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_79afc617-cb9d-466f-b343-bd16a1b1ba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0aa9e99b-a757-40a8-a364-701ceb0b1a69" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_79afc617-cb9d-466f-b343-bd16a1b1ba3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d9485cf5-246d-433c-bf08-7f18413a89a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d9485cf5-246d-433c-bf08-7f18413a89a7" xlink:to="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_88620276-6d0f-4358-9c5e-d55f8758c67e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e2962429-7bba-4355-a3a5-f80b84b3d90d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f1a19338-89e5-4180-b06c-82f68d623c31" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e2962429-7bba-4355-a3a5-f80b84b3d90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:href="kequ-20240430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_8ee4ae33-ac12-488f-bc71-74c6a81a487a" xlink:to="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_5d0b1161-d8c0-46c5-8b46-745f110a0967" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_5d0b1161-d8c0-46c5-8b46-745f110a0967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7b2c51f8-2d4f-4dc8-a5cd-d570fad835ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_7b2c51f8-2d4f-4dc8-a5cd-d570fad835ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_2d071eb9-ce0d-41a2-9e32-81c3343b364d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_2d071eb9-ce0d-41a2-9e32-81c3343b364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0bc31d3c-73f9-43cf-a6ee-f442c9382175" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0bc31d3c-73f9-43cf-a6ee-f442c9382175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_32c72875-5f64-47f0-a7a4-86c0cae9e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_32c72875-5f64-47f0-a7a4-86c0cae9e9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_55f4f988-01a3-4810-886d-60aff756cdd8" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_55f4f988-01a3-4810-886d-60aff756cdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_2efc72e5-7bad-450f-af2a-d3c349d080f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_2efc72e5-7bad-450f-af2a-d3c349d080f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_2d2a7f55-9fc2-4dd1-a4eb-12d9a078ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_2d2a7f55-9fc2-4dd1-a4eb-12d9a078ac30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_71e536b9-29c5-4d41-880d-c5c88e5edce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_71e536b9-29c5-4d41-880d-c5c88e5edce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_84733479-15e3-431f-9e54-d94039d783d7" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_84733479-15e3-431f-9e54-d94039d783d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_11075ef5-1265-4540-8831-be7d19e884f8" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_11075ef5-1265-4540-8831-be7d19e884f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_26c2b0f4-c657-422e-9e79-574039c1ff41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_26c2b0f4-c657-422e-9e79-574039c1ff41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a440fb2a-5408-488b-91b2-69e32413a3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_9b6a0570-81b6-4fe1-834b-6879ed508969" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a440fb2a-5408-488b-91b2-69e32413a3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_edb18df7-8767-44db-a12b-a416eae49d59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_edb18df7-8767-44db-a12b-a416eae49d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_af42fdd9-9e72-4a14-8525-78934b190edf" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_af42fdd9-9e72-4a14-8525-78934b190edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_404ed020-c963-4a41-9bfb-3011bc9be563" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_404ed020-c963-4a41-9bfb-3011bc9be563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_0344d72c-8b3a-4e5b-b654-2f36264fa77b" xlink:href="kequ-20240430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_0344d72c-8b3a-4e5b-b654-2f36264fa77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4711866a-7b1d-4fb3-81d0-89ace0f9aa06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4711866a-7b1d-4fb3-81d0-89ace0f9aa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_d4116f2d-c7b6-402a-a032-7fa0a02dbd93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_d4116f2d-c7b6-402a-a032-7fa0a02dbd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b064a877-c228-43b8-9f27-77549752ae26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dbac21c-e0eb-4696-a94d-ddd314770e6a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b064a877-c228-43b8-9f27-77549752ae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8d03e470-9c95-4923-a3d2-6ed3638a07d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8d03e470-9c95-4923-a3d2-6ed3638a07d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_54408c87-b37b-4112-8033-a73264c2810d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_54408c87-b37b-4112-8033-a73264c2810d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_f8c7c36a-5184-487c-aa1e-8538e62621b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_DeferredTaxLiabilities_f8c7c36a-5184-487c-aa1e-8538e62621b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_7060ca99-e27d-44be-9473-279e669cb3f9" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e309bb64-ecf8-4e85-9cb6-2ea557ac78b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e309bb64-ecf8-4e85-9cb6-2ea557ac78b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_402f1872-2adb-4cd0-be1d-8b2ec05776ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_402f1872-2adb-4cd0-be1d-8b2ec05776ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a8e64896-b57e-4ba5-91f8-4b17b171b719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a8e64896-b57e-4ba5-91f8-4b17b171b719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_aa871f25-5eea-4e4c-870d-bbace028e64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_5aa7c930-220a-47df-a2d6-b7a37b80e860" xlink:to="loc_us-gaap_DeferredTaxLiabilities_aa871f25-5eea-4e4c-870d-bbace028e64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd3d4e78-7142-46fe-b0d8-c23da7477167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd3d4e78-7142-46fe-b0d8-c23da7477167" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5b247020-2f48-4879-9b77-3865340787a5" xlink:to="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_431ffe35-4b6b-410a-bbca-d0e3308d2f06" xlink:href="kequ-20240430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_431ffe35-4b6b-410a-bbca-d0e3308d2f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember_b5ab0abb-e6b8-4079-a478-fbb69c48ca82" xlink:href="kequ-20240430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandAndEightPlanMember_b5ab0abb-e6b8-4079-a478-fbb69c48ca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_ad20cf52-5845-4a90-ac06-8a63995f7d11" xlink:href="kequ-20240430.xsd#kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_504803e0-136b-41d3-83a5-125d1febd780" xlink:to="loc_kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember_ad20cf52-5845-4a90-ac06-8a63995f7d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3d98c83f-ee5c-4af7-bfb6-8962690508c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e4dcb65b-dca9-4f91-8f39-a3e26993a0b6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_5cd73de1-f20a-47f6-8c2d-31e404feb6df" xlink:href="kequ-20240430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_cf4bda5b-6ae8-4f7b-96a8-38eed1c5ad63" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_5cd73de1-f20a-47f6-8c2d-31e404feb6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_45851c01-dcf8-4551-bc90-24f5d1024b57" xlink:to="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0c595169-c470-4d91-b732-03aef2b6b02a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:to="loc_srt_MinimumMember_0c595169-c470-4d91-b732-03aef2b6b02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7b5b971f-1530-4a50-8e70-9bbbbe8236f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e35f3c41-02ab-4ac5-a902-0f122dce0142" xlink:to="loc_srt_MaximumMember_7b5b971f-1530-4a50-8e70-9bbbbe8236f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_66f8ab7a-ab36-4bd0-a7e5-5fc0cec50274" xlink:to="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_a28d79ae-4f7e-45ac-97f4-c1761fb43dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_674f7231-a950-42e1-89a2-e9628f74221a" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_a28d79ae-4f7e-45ac-97f4-c1761fb43dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_966e5c21-d295-4a11-99b0-3fa92150184e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d44b9f98-71ef-40b1-9ce5-1e14047e0785" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d44b9f98-71ef-40b1-9ce5-1e14047e0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_36822af5-468a-46a8-b2cf-341232740719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_36822af5-468a-46a8-b2cf-341232740719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_273c5982-7ace-4de7-a88f-50d65412f745" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_273c5982-7ace-4de7-a88f-50d65412f745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_95a8dc16-e5ef-478c-b57a-0840fef7fbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_95a8dc16-e5ef-478c-b57a-0840fef7fbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58aa3bdb-cf92-4f89-b777-af5d45494858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_58aa3bdb-cf92-4f89-b777-af5d45494858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_50fed401-cf90-4feb-adc9-22ab4a7f8e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_50fed401-cf90-4feb-adc9-22ab4a7f8e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4c5feeaa-7630-4083-be9f-a848c86fdb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4c5feeaa-7630-4083-be9f-a848c86fdb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_43186093-a100-48fb-b2db-4c39219b3c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_43186093-a100-48fb-b2db-4c39219b3c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c2759269-2576-4aa0-8f1b-44f63f0b845c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c2759269-2576-4aa0-8f1b-44f63f0b845c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1e5f2f8e-90ad-4b3e-9362-e0c58b4f7ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1bb47a37-cc1d-42de-9f81-f0745d5a20f8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_1e5f2f8e-90ad-4b3e-9362-e0c58b4f7ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb9decd7-31b9-4344-b4ed-f773e6545caf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb9decd7-31b9-4344-b4ed-f773e6545caf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:to="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4825add9-f336-41de-ad56-70465471bfdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_70d47dfa-8ded-4653-97b8-9dcdead211e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b98e7711-4b72-47a1-89cf-0748ee6442e4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_70d47dfa-8ded-4653-97b8-9dcdead211e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0b6a0c6d-54c9-459e-a3d2-d46b4bc86cb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_697ab5f2-b672-470b-b6df-da0daadfcbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_697ab5f2-b672-470b-b6df-da0daadfcbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c00d9882-a54b-4b34-aa4d-03f2735e105b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c00d9882-a54b-4b34-aa4d-03f2735e105b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36694768-dc62-4f00-9223-13d36cd000f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_36694768-dc62-4f00-9223-13d36cd000f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6f28256d-52a1-443a-a728-cfa960c77a15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6f28256d-52a1-443a-a728-cfa960c77a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7801923f-bd60-4459-9a7c-1f34f0d5bf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_36ba4b19-bfac-45db-9974-a94469a3dbd8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7801923f-bd60-4459-9a7c-1f34f0d5bf0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c4c36b99-56a7-4b39-a63a-0a5a9d27b98f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d19e5d6c-dd46-4c89-8bfc-2d204b3e4ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d19e5d6c-dd46-4c89-8bfc-2d204b3e4ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fa12126e-76c4-4930-b3f3-54813a8f64cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fa12126e-76c4-4930-b3f3-54813a8f64cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87b40dd2-3628-4fc2-8dfc-09f2392850c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_87b40dd2-3628-4fc2-8dfc-09f2392850c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_335f846e-59ad-4c94-9906-30ee28a5d20a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_335f846e-59ad-4c94-9906-30ee28a5d20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1deb7f23-45e7-45df-ad80-46ca808e34fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5684007d-3cab-41fb-bc08-cda2c0ab1d24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1deb7f23-45e7-45df-ad80-46ca808e34fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd17165d-064f-4496-8753-550aae70dc78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd17165d-064f-4496-8753-550aae70dc78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a4c82f90-2c27-4850-bb6c-1f3ed429a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a4c82f90-2c27-4850-bb6c-1f3ed429a6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_25a8a06e-7ad8-4e4c-a43f-51f8b47259f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_25a8a06e-7ad8-4e4c-a43f-51f8b47259f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e2c0e185-f7e2-4bc2-b8af-a3ffb0e63756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e2c0e185-f7e2-4bc2-b8af-a3ffb0e63756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1af7357f-45d5-459a-8805-ed1b18aed6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1af7357f-45d5-459a-8805-ed1b18aed6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39ce00b4-1bdd-4c0b-93ad-5b9b14cde6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4cea30df-7754-429f-b20b-6bd47a68cb4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39ce00b4-1bdd-4c0b-93ad-5b9b14cde6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd17165d-064f-4496-8753-550aae70dc78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c73d518d-1814-459b-abf2-aa29468860a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c73d518d-1814-459b-abf2-aa29468860a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_72bf3544-bf69-4ee8-a607-0228193c0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_72bf3544-bf69-4ee8-a607-0228193c0ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41fdf696-6e94-4d6a-9218-859024d3b184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41fdf696-6e94-4d6a-9218-859024d3b184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f85cf4c3-cac1-43f8-9b03-feb51bef59b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f85cf4c3-cac1-43f8-9b03-feb51bef59b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6f18b1d7-69ab-4055-97b3-4913e9b1283d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0bd44ee5-4969-46a4-9106-77eecfe9c9e5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6f18b1d7-69ab-4055-97b3-4913e9b1283d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1025c3ba-0100-48a7-85aa-3c82ff7dd53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1025c3ba-0100-48a7-85aa-3c82ff7dd53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_4c436562-f4a7-434d-b2ab-ad4aa31ee06d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_4c436562-f4a7-434d-b2ab-ad4aa31ee06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9f94716b-15a2-415f-b14b-aa25e8c116d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9f94716b-15a2-415f-b14b-aa25e8c116d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b15022e3-4a78-42b6-bbdf-0a83087c273d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b15022e3-4a78-42b6-bbdf-0a83087c273d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_aba12109-e309-4164-afd1-e36cc0c2f4af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_aba12109-e309-4164-afd1-e36cc0c2f4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_015d972c-ae94-423b-8513-a7a3c2b42eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_015d972c-ae94-423b-8513-a7a3c2b42eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36e939d6-f354-47a2-94db-169a0e2c762f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_36e939d6-f354-47a2-94db-169a0e2c762f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_7b6aa884-e401-48e4-9384-2dd1edd66b65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_7b6aa884-e401-48e4-9384-2dd1edd66b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ad4bb189-e5f6-4539-b1eb-d4cdbafebd31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_23758c93-c0c7-4db4-a5a5-aeb8ba3e8222" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ad4bb189-e5f6-4539-b1eb-d4cdbafebd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_536230f6-5a67-4a59-a83d-153f979edd61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_536230f6-5a67-4a59-a83d-153f979edd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8977035e-1269-40c3-b6d9-dba56da261ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8977035e-1269-40c3-b6d9-dba56da261ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_39b3a9de-7332-416c-9fea-e0d282bd9789" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_39b3a9de-7332-416c-9fea-e0d282bd9789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_9193f0ab-b074-4d71-b84a-b4c18180d8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_9193f0ab-b074-4d71-b84a-b4c18180d8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e19ddf45-ee69-48e1-a75a-aa4c69d65e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e19ddf45-ee69-48e1-a75a-aa4c69d65e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod_ad31082e-0784-4f04-992d-219cf9b73893" xlink:href="kequ-20240430.xsd#kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod_ad31082e-0784-4f04-992d-219cf9b73893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_56b0d903-f54c-4195-aa20-dc31939fc034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dccec162-2f5d-43d6-9209-503e7d63a3a2" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_56b0d903-f54c-4195-aa20-dc31939fc034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#StockholdersEquityShareRepurchaseActivityDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_63ee6e1a-7cbf-4bb6-a79d-858d3854ddc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_63ee6e1a-7cbf-4bb6-a79d-858d3854ddc4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4e4d4a62-ca17-4595-ab7f-2268b67a82af" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PubliclyAnnouncedProgramsMember_935975ea-0f39-44ba-bb51-5007b22bbb82" xlink:href="kequ-20240430.xsd#kequ_PubliclyAnnouncedProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_76329462-940e-4d7f-a5c0-7af1eca7b0df" xlink:to="loc_kequ_PubliclyAnnouncedProgramsMember_935975ea-0f39-44ba-bb51-5007b22bbb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04e4a3ba-5af1-4dba-955f-319eada3ab10" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dc76baa4-e093-40d6-8e63-3960ca5cf72d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dc76baa4-e093-40d6-8e63-3960ca5cf72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_cef8ba52-5d87-4d85-b260-e5025116c7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_cef8ba52-5d87-4d85-b260-e5025116c7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_5e3e8d43-0123-4fb2-b15a-91c5418674d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_15b6f6bd-7dc4-420f-a2b0-b5d8ed2798c4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_5e3e8d43-0123-4fb2-b15a-91c5418674d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_aef650e4-fb99-44ed-bd88-c1b895393902" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_aef650e4-fb99-44ed-bd88-c1b895393902" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86c5e5dd-df77-4570-b9e9-7321628765ec" xlink:to="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f4bac3e4-201d-4917-9197-87cf409ce4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_f4bac3e4-201d-4917-9197-87cf409ce4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_89b117fb-98a8-4998-a690-ffe9acbf13cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1fc5773b-30d1-4bc4-9133-de7cce5aa2ef" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_89b117fb-98a8-4998-a690-ffe9acbf13cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0e85b570-2051-4de5-b66b-2fe135ae72aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7d29a75c-2ec3-4002-afc0-a6b656ca817d" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c28fb05-bb92-4a9e-9376-72f792a0b707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9c28fb05-bb92-4a9e-9376-72f792a0b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fcdb799f-965b-4fc7-9642-e3bc23826683" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fcdb799f-965b-4fc7-9642-e3bc23826683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5b894c1a-20a8-4fe6-a0be-2d553a0e695a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_5b894c1a-20a8-4fe6-a0be-2d553a0e695a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_881f2268-9340-469c-b8e9-b87122501b84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_881f2268-9340-469c-b8e9-b87122501b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_61bce5c3-481d-4b22-b4a3-0e88319e9690" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_61bce5c3-481d-4b22-b4a3-0e88319e9690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bfb938c5-6fd8-4ea1-ae85-dc8449739862" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_95c07da8-3aaf-4d8b-bb57-771d0e7d8d23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bfb938c5-6fd8-4ea1-ae85-dc8449739862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c231b871-89df-49e3-a1f6-74fa2821ca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c231b871-89df-49e3-a1f6-74fa2821ca0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_092e5039-9196-4a01-aa5d-8293109f2c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_OperatingLeasePayments_092e5039-9196-4a01-aa5d-8293109f2c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeRemainingLeaseTerm_f39df4ae-2a71-4c0d-b0a7-cad4f019dcc2" xlink:href="kequ-20240430.xsd#kequ_LesseeRemainingLeaseTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_kequ_LesseeRemainingLeaseTerm_f39df4ae-2a71-4c0d-b0a7-cad4f019dcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoExtendTerm_61867c60-c204-4db2-8024-2c27c4943584" xlink:href="kequ-20240430.xsd#kequ_LesseeOptiontoExtendTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_kequ_LesseeOptiontoExtendTerm_61867c60-c204-4db2-8024-2c27c4943584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoTerminateTerm_07252013-4151-4fe6-8d92-e929775ed1a0" xlink:href="kequ-20240430.xsd#kequ_LesseeOptiontoTerminateTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_kequ_LesseeOptiontoTerminateTerm_07252013-4151-4fe6-8d92-e929775ed1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_af2d3937-785e-43c2-b963-b22c0458a438" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_OperatingLeaseExpense_af2d3937-785e-43c2-b963-b22c0458a438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OperatingLeaseShortTermExpense_fb6d7ee0-403b-40fe-b37f-ea439657900e" xlink:href="kequ-20240430.xsd#kequ_OperatingLeaseShortTermExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_kequ_OperatingLeaseShortTermExpense_fb6d7ee0-403b-40fe-b37f-ea439657900e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cddee952-95af-4acf-b02a-ccedbe6c3107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cddee952-95af-4acf-b02a-ccedbe6c3107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea8a4bf7-dc11-488c-96e6-016cc429a9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ea8a4bf7-dc11-488c-96e6-016cc429a9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_2e09f51f-a281-4b8f-9023-1d118714b7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_2e09f51f-a281-4b8f-9023-1d118714b7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1c4ae622-a441-4817-a751-4f9f153a551f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1c4ae622-a441-4817-a751-4f9f153a551f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a1a607eb-531d-4b56-991a-fff7b35ff1b1" xlink:href="kequ-20240430.xsd#kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_a1a607eb-531d-4b56-991a-fff7b35ff1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_318701c2-981e-41c8-9bcd-7b1105ccb8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2f8ec832-20c6-4cf6-aa16-172d24847360" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_318701c2-981e-41c8-9bcd-7b1105ccb8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="simple" xlink:href="kequ-20240430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_42a5f6b2-612b-437b-bfde-ac79a7d070b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42a5f6b2-612b-437b-bfde-ac79a7d070b5" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_62681166-1ee0-4f46-85ae-e1f428f4bdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_62681166-1ee0-4f46-85ae-e1f428f4bdf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a1c358d5-4e97-4108-a9a6-66eee66a5490" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a1c358d5-4e97-4108-a9a6-66eee66a5490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b6e962cc-7051-4942-83e8-e5d52e67b31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b6e962cc-7051-4942-83e8-e5d52e67b31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_37b60b22-039c-4660-9d19-2f80c9856b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_37b60b22-039c-4660-9d19-2f80c9856b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fb2110e0-9569-4e11-90b0-c8d7277b9d88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fb2110e0-9569-4e11-90b0-c8d7277b9d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0fe8d527-7d89-46ea-8ffc-decca2d4ccea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0fe8d527-7d89-46ea-8ffc-decca2d4ccea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e74f2ee1-6d7d-41a0-a469-21215a744453" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e74f2ee1-6d7d-41a0-a469-21215a744453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6221df27-f678-4aac-9460-91abfb2a2da7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6221df27-f678-4aac-9460-91abfb2a2da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_29f1d916-c2f3-4a8a-afe4-b55c69498d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_29162a03-d0bb-491c-8738-470e41c40925" xlink:to="loc_us-gaap_OperatingLeaseLiability_29f1d916-c2f3-4a8a-afe4-b55c69498d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_42a5f6b2-612b-437b-bfde-ac79a7d070b5" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_84323378-5fa3-4005-a9df-4115c4f987e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_84323378-5fa3-4005-a9df-4115c4f987e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7b012faf-b716-4f84-8ec1-9f36d7fb164a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7b012faf-b716-4f84-8ec1-9f36d7fb164a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_be74b6ef-3403-412a-928e-f7c8afbff421" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_be74b6ef-3403-412a-928e-f7c8afbff421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0c5f6133-2308-40bd-95ff-1ef77d34abf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0c5f6133-2308-40bd-95ff-1ef77d34abf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2e5171f2-d958-414b-b4fa-229fbf70acd6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2e5171f2-d958-414b-b4fa-229fbf70acd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ec2a54a4-1525-4fbc-9d64-d2d8f8fd1b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ec2a54a4-1525-4fbc-9d64-d2d8f8fd1b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_264a2f14-0edf-411d-a81f-e6675f5bb2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_264a2f14-0edf-411d-a81f-e6675f5bb2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f8188c9a-91c2-428e-a10e-686193b7bbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f8188c9a-91c2-428e-a10e-686193b7bbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9115f57f-35cd-44df-a681-24d7b45a4c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_3ba86c4f-6cb4-422f-8366-6aed83ce62e5" xlink:to="loc_us-gaap_FinanceLeaseLiability_9115f57f-35cd-44df-a681-24d7b45a4c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_176fa38f-6e3b-4f1e-a3f4-cd0fbad673de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_176fa38f-6e3b-4f1e-a3f4-cd0fbad673de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c25093df-d797-4b88-afac-72f5b0e2b0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c25093df-d797-4b88-afac-72f5b0e2b0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_91a26b45-52c0-42ac-b007-0fc520c3c5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_91a26b45-52c0-42ac-b007-0fc520c3c5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5f55ed77-3b14-48ad-a366-4294c1f85cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_5f55ed77-3b14-48ad-a366-4294c1f85cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_3d306d5f-18dd-46c7-9d5d-1ed147ab9954" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_3d306d5f-18dd-46c7-9d5d-1ed147ab9954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_f5c6e2e2-6a55-4fb1-8915-4c722376b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanSettlementsBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation_f5c6e2e2-6a55-4fb1-8915-4c722376b05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_68a5a6f6-6efb-4e38-b750-24b0e9c8d9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_18ecddf5-9e90-4316-9f82-f25e2abc70ae" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_68a5a6f6-6efb-4e38-b750-24b0e9c8d9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1a27b264-33d1-47e6-9be2-6f158579a40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1a27b264-33d1-47e6-9be2-6f158579a40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_56bcd4e0-961d-4320-9c1d-0112a5030f99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_56bcd4e0-961d-4320-9c1d-0112a5030f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_127f7167-7913-483f-b776-548c5dd6fe49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_127f7167-7913-483f-b776-548c5dd6fe49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_ffa62806-f8da-46d4-acac-50e69c9b9c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan_ffa62806-f8da-46d4-acac-50e69c9b9c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_88e312cf-ddf5-4eeb-bbf4-b1bec94277f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_88e312cf-ddf5-4eeb-bbf4-b1bec94277f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_38a2bff5-4fcc-435b-86ec-b7cb677fed8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_e1ef3c10-07d4-4fa7-8923-028a96a0b3f0" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_38a2bff5-4fcc-435b-86ec-b7cb677fed8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8b380083-e602-4cd3-b4cd-5bc19a41da3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8b380083-e602-4cd3-b4cd-5bc19a41da3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_7b02994e-947c-4964-bd2d-6698dd315cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_7b02994e-947c-4964-bd2d-6698dd315cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_670b9796-1e5c-4105-a4e4-cf3c9f6ec85e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_7b02994e-947c-4964-bd2d-6698dd315cb5" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_670b9796-1e5c-4105-a4e4-cf3c9f6ec85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_7e09bed7-b4c2-456f-910f-34e3b0e78702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_7e09bed7-b4c2-456f-910f-34e3b0e78702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e775f625-839e-4e33-b2ce-50c47fbfe5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_7e09bed7-b4c2-456f-910f-34e3b0e78702" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e775f625-839e-4e33-b2ce-50c47fbfe5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_40d2cfbd-27c1-426e-8425-7faade4aa4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_7e09bed7-b4c2-456f-910f-34e3b0e78702" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_40d2cfbd-27c1-426e-8425-7faade4aa4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_ea844d03-e22e-4a7d-871c-10d0f74c84e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_7e09bed7-b4c2-456f-910f-34e3b0e78702" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_ea844d03-e22e-4a7d-871c-10d0f74c84e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_ea6076d0-8400-4726-9764-8e41a6f35518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_ea6076d0-8400-4726-9764-8e41a6f35518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2921bc4c-22aa-4a16-989d-bae2a5a1c66c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_ea6076d0-8400-4726-9764-8e41a6f35518" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2921bc4c-22aa-4a16-989d-bae2a5a1c66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_8799a6b2-a31e-4cce-8703-a991afaca403" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_59eddf10-f7f1-4d96-9c07-272f584ad016" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_8799a6b2-a31e-4cce-8703-a991afaca403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e8e23fc7-37cf-42a4-b919-a1c317fb8f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_8799a6b2-a31e-4cce-8703-a991afaca403" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e8e23fc7-37cf-42a4-b919-a1c317fb8f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f6a9c860-a245-4286-a042-37f3415f0f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_8799a6b2-a31e-4cce-8703-a991afaca403" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f6a9c860-a245-4286-a042-37f3415f0f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_143650a2-0eb5-4773-830b-b07dc11f0e89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_143650a2-0eb5-4773-830b-b07dc11f0e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_078acc3e-3753-45c1-86a1-374ee06cfd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_078acc3e-3753-45c1-86a1-374ee06cfd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_5abae234-57c2-4c29-abec-692bc1452e11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_5abae234-57c2-4c29-abec-692bc1452e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8f67f15f-996b-4301-83a5-45c74ff632ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8f67f15f-996b-4301-83a5-45c74ff632ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_59f2349f-d7ad-494e-917f-1253af1f0bf8" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent_59f2349f-d7ad-494e-917f-1253af1f0bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_e2f3970e-981c-4c65-914c-4b05fc64fb12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_e2f3970e-981c-4c65-914c-4b05fc64fb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_ccf83a86-862e-4dc6-99bd-fbfdaa4a80e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_ccf83a86-862e-4dc6-99bd-fbfdaa4a80e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_92863a36-e16b-42aa-97cc-b2ec17c0a6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_92863a36-e16b-42aa-97cc-b2ec17c0a6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_078ef064-cc64-44a9-b04a-a744a874b00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_078ef064-cc64-44a9-b04a-a744a874b00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_e2872b5a-1224-4120-b81e-5b0883276efb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_e2872b5a-1224-4120-b81e-5b0883276efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2f7f044-265b-4366-8d57-524071b5a464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4104ba9a-cdc7-4dbc-9591-bc8c1c73c0b4" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d2f7f044-265b-4366-8d57-524071b5a464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce7db859-f1ef-4318-93b6-33b8d1a983f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce7db859-f1ef-4318-93b6-33b8d1a983f8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c233f238-ce42-42fd-8dd5-cb4b7281f1e5" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_32308719-0731-4994-87f9-be25c9ea4fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5cbbe627-302f-4456-acb0-7d2dc02ce6f3" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_32308719-0731-4994-87f9-be25c9ea4fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:to="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_832c2992-e6cf-4c96-92cf-d4c9b9029f25" xlink:to="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e084f171-c9a4-4aeb-a283-be4047ade89c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:to="loc_srt_MaximumMember_e084f171-c9a4-4aeb-a283-be4047ade89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0ffc217e-1893-4b3a-a87b-c5a6c4d882e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_415a96ce-c1ba-4508-a6d4-3bbdd1ef6a87" xlink:to="loc_srt_MinimumMember_0ffc217e-1893-4b3a-a87b-c5a6c4d882e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7273ac0c-2898-4466-a540-21898e0d3179" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_a6771353-81e3-41c1-98e7-9b76384056ce" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities_a6771353-81e3-41c1-98e7-9b76384056ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_cd635c27-1ecb-47db-912b-e5887954cd30" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_cd635c27-1ecb-47db-912b-e5887954cd30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_4b60c679-1b71-4d6c-bcfe-bfd9f5b232f4" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_4b60c679-1b71-4d6c-bcfe-bfd9f5b232f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_21f1d5aa-2bb1-4bb4-a1dd-53c7d0127642" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_21f1d5aa-2bb1-4bb4-a1dd-53c7d0127642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_6a517b2a-40db-4df2-9966-873f3d8b70a5" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_6a517b2a-40db-4df2-9966-873f3d8b70a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_68ec121e-d3f0-400e-b1ea-2d7edb9ab34f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_68ec121e-d3f0-400e-b1ea-2d7edb9ab34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_0bfeeb5e-951d-4ac5-b7d8-a9f2a39f42ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_0bfeeb5e-951d-4ac5-b7d8-a9f2a39f42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_c5d1213d-63c5-4ab1-a181-2280543a322c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_c5d1213d-63c5-4ab1-a181-2280543a322c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_75a37f2c-af94-4284-9381-06293974ade6" xlink:href="kequ-20240430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9bf95700-dbfd-4aa7-aa73-491e7cece69e" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_75a37f2c-af94-4284-9381-06293974ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_478f51dc-5f64-4026-a282-3f66d335025c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_478f51dc-5f64-4026-a282-3f66d335025c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_41603651-fad4-4ba1-a48f-c45b03c99eb8" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_7d8425e1-40a7-4e38-8eaa-4abffc966bea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_7d8425e1-40a7-4e38-8eaa-4abffc966bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_65da08b3-429a-410b-85db-aedf909e034b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_65da08b3-429a-410b-85db-aedf909e034b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_707fde5c-865b-4b03-843b-f80c6d4dc20a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_7fc220ae-c965-4632-a4d8-fbd74d160777" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_707fde5c-865b-4b03-843b-f80c6d4dc20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_e1caeeb5-41dd-44d9-8ac8-5b53948c6a74" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f1e3232f-640f-4c35-8585-c1ef58c8bd23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f1e3232f-640f-4c35-8585-c1ef58c8bd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_f4d49dd3-1cc3-49d7-9951-9d03070da5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_563cf445-beac-4a0d-ad4d-a2821c856a05" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_f4d49dd3-1cc3-49d7-9951-9d03070da5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_70879d4a-b1ed-4839-b443-d609f97bb907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_70879d4a-b1ed-4839-b443-d609f97bb907" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_54239fb7-183c-4b54-92d1-3f7c246f6da5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1dc0c54f-1482-4c42-bd65-466011942485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1dc0c54f-1482-4c42-bd65-466011942485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_04dbe361-fafc-4c5e-9f11-4271ab2b0f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_04dbe361-fafc-4c5e-9f11-4271ab2b0f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ac050b5f-2ed6-420d-ac01-6efe024c766c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e62e4c4c-be52-4035-ab11-815ee2d0a706" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ac050b5f-2ed6-420d-ac01-6efe024c766c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d7009a9b-b55e-46f7-9c27-cb376d250a27" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_bdaae05b-297c-4d3e-af30-4fac3a436c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_bdaae05b-297c-4d3e-af30-4fac3a436c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_b0424374-375e-40a3-b850-a1604076df6f" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_b0424374-375e-40a3-b850-a1604076df6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_1fa3ec08-66db-4ef1-9a11-15ee17638840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_1fa3ec08-66db-4ef1-9a11-15ee17638840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_b1cf40c6-8042-4f32-a392-871a2139d159" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_b1cf40c6-8042-4f32-a392-871a2139d159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_964b449f-11d6-4298-8ef0-036360931a41" xlink:href="kequ-20240430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_2cb4e871-134d-41f0-a0f9-87ea569956a2" xlink:to="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_964b449f-11d6-4298-8ef0-036360931a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_e2105353-3160-451f-91e6-911a77e91539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_e2105353-3160-451f-91e6-911a77e91539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_ecc393e0-e312-440f-ab5d-91ebd22166ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0c8490d9-1bb9-47dc-9093-ca036ccffaa3" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_ecc393e0-e312-440f-ab5d-91ebd22166ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_fea513de-6b24-4a55-8729-bd66f84278ed" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_338d8954-e25b-4bb2-92d5-00981e372fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f07c4a71-629f-400f-bbe5-b48073b0bb87" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_338d8954-e25b-4bb2-92d5-00981e372fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SegmentInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a3478443-61c7-4465-a642-e0e8daae2266" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4b51d2c2-d87c-4e36-9c31-2c54d84cd70b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a3478443-61c7-4465-a642-e0e8daae2266" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4b51d2c2-d87c-4e36-9c31-2c54d84cd70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="simple" xlink:href="kequ-20240430.xsd#SegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fd10de34-fcc7-4037-bd57-307e08dd18be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fd10de34-fcc7-4037-bd57-307e08dd18be" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8b2020a9-0572-4e1c-a52b-8f5d7df74949" xlink:to="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember_31bdfc19-5302-4d8f-bd15-cf6b6385514d" xlink:href="kequ-20240430.xsd#kequ_DomesticOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:to="loc_kequ_DomesticOperationsMember_31bdfc19-5302-4d8f-bd15-cf6b6385514d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_5ef102a1-6136-4ad9-93b9-d8b6ea408cb3" xlink:href="kequ-20240430.xsd#kequ_InternationalOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8bc4ff21-6177-4e56-ba6d-dd9334c4007f" xlink:to="loc_kequ_InternationalOperationsMember_5ef102a1-6136-4ad9-93b9-d8b6ea408cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ec431752-f91b-4f59-8d6d-ac1d641594b5" xlink:to="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d16d6ea1-98bd-4d64-bc45-b1d3e1e8b98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_OperatingSegmentsMember_d16d6ea1-98bd-4d64-bc45-b1d3e1e8b98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5abae19e-6c76-452c-b827-481b266bfe42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5abae19e-6c76-452c-b827-481b266bfe42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_43f803eb-fab8-4991-90bd-74cd77d030da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7479e987-8467-4b2a-b326-9b0e851d569c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_43f803eb-fab8-4991-90bd-74cd77d030da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_78828eb1-d3c6-4310-a7f0-d93e84b5b572" xlink:to="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4056886b-532d-4f75-a768-ef024f825bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b6535ead-5584-4276-9494-73ec3cae9999" xlink:to="loc_us-gaap_NonUsMember_4056886b-532d-4f75-a768-ef024f825bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0fa00713-7261-4f5d-b96e-b9c748a44736" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52ed7d8f-f966-4baf-ab0a-d11ccb66ee9b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_52ed7d8f-f966-4baf-ab0a-d11ccb66ee9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup_9727eccc-d8ca-4ff3-925d-195c20ad03b1" xlink:href="kequ-20240430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_kequ_RevenuesIncludingIntersegmentMarkup_9727eccc-d8ca-4ff3-925d-195c20ad03b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_91133c07-fae6-48fa-baa9-30134e5430b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_Depreciation_91133c07-fae6-48fa-baa9-30134e5430b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db540270-9273-4298-8a1f-ab71112df88a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db540270-9273-4298-8a1f-ab71112df88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6b9d23ff-c23c-4b84-beb4-c8570a349dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6b9d23ff-c23c-4b84-beb4-c8570a349dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4a3e3516-1f0d-40ad-8c3c-926a0150e409" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4a3e3516-1f0d-40ad-8c3c-926a0150e409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a4fb24a-6e80-40a1-8a85-e2c0f3a8bd34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_NetIncomeLoss_3a4fb24a-6e80-40a1-8a85-e2c0f3a8bd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_541103c7-958a-455e-94ab-56c269fcef39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_Assets_541103c7-958a-455e-94ab-56c269fcef39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_85768d67-d9a2-4efa-9c8f-20cd295badab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1eb7d192-66c2-471c-ab86-cafdc04663df" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_85768d67-d9a2-4efa-9c8f-20cd295badab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:href="kequ-20240430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>certification311001.jpg
<TEXT>
begin 644 certification311001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 _\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'NJM'(\898XY70X*Q-(JR'/;Y"U &K:>*_#U_J)T^SUS3KB\!(\B*Y1GR.O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *BN+>&[MI;:XB26"5"DD;C*LI&"".XQ4M% '+6GP_P!%M9K8F34+
MBVM7$EM9W-[)+!"P^Z51CCCMG..U.F\"Z?)?WEY#J&LVCW<QGF2TU"2)&<@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/UW5%T/P_J.K-
M$9ELK:2X,8;!?8I;&>V<5)I-^-5T:QU%8S&+NWCG"$YV[E#8SWZUE^/$:3X>
M^(T12S-IER H&23Y;4SPSJ%M:>'O"^FSNR7=UIL9BC*-SLB3=DXP,9'6@";Q
M%K&K:/ ]S8Z*E_;10M+,YO!"4VC) !4YX%88\;ZQ_P (FWB&;P]%;6CVT5Q
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MIU".%&6P<\XP<UP6OW^GZG=V6M:,[V=C;ZL&O-5^R"2)W^SNBRX/WE4E4+$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH KWR7<EE,EC-'#=,N(Y)4WJA]2
MN1G'IFL#P%=7MUX<D-_>2WD\5_=P&>4 ,RI.Z+G  Z =!6]?M>K8RMIT=O)=
M@#RTN)"B$Y[L 2.,]C7*^&=+\6:-I&HVD\.B^=))<W5JZ7$KKYTLC2!7!1<(
M"V,@YXZ4 =G138]_E)YNWS-HW;>F>^/:G4 %%%% !1110!Q[:I>CXQQZ3]I?
M[ = :Y,'\/F^>%W?7'%'BC4=2LO&?AJ'3H7N6GAO ;8SF*)R!$07.#P.><$\
M\#FK;>'KL_$Q/$OF0_8UT<V!CR?,\PS!\XQC;@>N<]JMZAI$]WXKT754>,06
M,5RDBL3N)D";<<8_@.>: ,R#Q??W>C)<VVBI]L6[FM+F*>\$<-N\18,6EVG(
M) QA><CI3]%\;1ZO?Z7;-8M;KJ-K-+%(90P\V&39)%P.<=0V>1GBL>;P3JBW
M45P(-*U!$U*^NOLEX["(K.P*/]QOG0 C&/XC@TT^"-=@\&V=C97.GPZUI=_-
M<6%RI98V21GSN 7*965AM&X94<^@!H+X]>[\N/3],CEFN+NYAM3/=B*.2* A
M7F+;3@;CM  .>OTZ'0M:CUS0XM2CB:(L71XF8$I(C%'7(X.&4C/?K7,ZAX$2
M*R\/)8V&F:B-'MWM?LNI#$<RN%R^[:^'W(#G:<Y;UKIM$T^33M#@M)(+&WE"
ML6BL(O+A4DDX4?CU[]<#.* .8T_X@W=_X=LM8.A"!-2DBATZ.2\ ,SL&+[SM
M^15",<\D@=.@JW9>.?.U"QLKK3Q!)->RZ?.Z7 D2&=8Q*@!VC<KH<@\<\8JB
M/ MT/ 'AW1YH].O+W1WCE\FX!:WG*JR,I)4D JYP=IP0.*LS>$KJX\(W%G%9
M:-I>I"Z2]M$L(RL,,L;*R;F"@L?EP6VC@XQQR 5O$GC"#[+J(-E=/:V&JVMB
M)K>\:$RRL5+<J,[5+ $?Q<BKU[XX-IJ-T%L(Y-,LKM+2YNC=!9%=MN2L6/F5
M2ZY.0>N <50O? M]/X"L=%CN+8Z@M]%?7D[E@LDOF^;*0<9.22!D>G2GR>"I
MX_$5[<1:1X>N[>]O5NS>7T.^X@&%WH%V?-G:2IWKC=T..0"6\^(L-EH5KJ$N
MG/YLFH2V,]N)1F 1,XDD)QR J;NWWA5G4_&XLM7N]+M[ 3W$4\%K"7N!&DDT
MD;2E2<':%C7<3SU  JF_@2:Y\4ZU<W,T+:/?6\ZPP#.])9XXTE8C&,8BXY_C
M:J4/@#43X9LQJ(TS4=:BU(ZA<1W +6UP2ABV$E21^[*X.TX91Q0!J+XYFGCM
MK2VTI)=:FOI+(VAN@(D9$\QG\T*<IL*D';D[@,5+X&U"]U";Q,U\LL<D6L-$
M(9)?,$0$$/RJ?[N22.G7.!FJ7_"*ZK;)I6HZ?I^A6FH6-W--]AM@T-N\<B;"
MI<)DN %.[8,XQBMCPGHVI:3_ &S-JLEL\^HZBUX!;%BJ*8HTVY(&<%",]Q@\
M9P #CM:\4^()M+\6^9 ((=.U2U@MWM;C]X!OMR4&%7.X,QR3_%MZ<UMZGXLN
M8M-\1VFL:2]I/8Z8;X+:7Q)EA(<<2!5*."A' .."":AOO!^M7$OB.VB:P^Q:
MI?6]_%*TKB1&C:#<C+L(QB)L$'J1QW%WQ-X3OM9NM>EMYK=%U#0_[-B\QF!6
M3=(<M@'Y?G'3)Z\4 -@\7W)DLK#3-(^ULNG6]Y*DM\%F\N0$ (&!\UAM.22O
M;G)K9\4^(!X8T-M3-H]T!/##Y4;88^9(J<>XW9QWKF=9\'ZOJ&D66EBUT:;R
M+**"&_D=TN+&95PTD9"G=T! RG(YXKH_%NB7.O:&EC;21+*MW;3EI20-L<R.
MW0'G"G'O0!F7?C#5+65;/^P[<ZC%:_;+NW;4 JQ1EF5%5]GSNVQCC  QUZ4S
M_A.+N_NY8-!T/^T%2P@U 2270A#1RABJCY6^?Y>!T/.2,<IXD\)SWWB)M8M=
M*T34VFLUM7BU5>(2C,RR(=C9^^05XS@<UFV]OKEEXWUNWT.'2V=-)L(6CE+6
M\2']\%9 JMA1@_)Z$<\<@&K!XWGUDP+X<T@7[-817\WGW/D"-9,[$!VMESM;
MC@#'6F1>/7U*\TBVT;1WNWU*P^W*99Q$(E#A6#\'D9QQG)X]Q6TKPCK7A$PG
M0#87F_3;>RN%O)7BQ)#NVRKM5L@[VRO'0<U;\.^"Y] UC2)Q<QS6]EH[V,C'
M(=Y6E20L!C 7AN_<4 3^"]=UC6Y-:_M.U@ACM=1EMHC'-O(V$ KC:.!UW=\]
M!BHM2\;75J=7NK31OM6E:-(8[VY^TA),JH:3RX]IW[0PSEER00,U<\,:/J6B
MW^MQW(M7LKN_EO;>6.1O,_>$$JR%<#&.H8Y]!63J/A;7C#XATG3GL/[,UV5Y
M)+B:1Q+;>8@24! I#]"1\RX)YZ4 2ZEX[N[9]=>QT,7=IH@22YG-V(]\;0K+
MF,;3E@K'@D#@<\X%_P <:G/9_#O6-3T^=X9DLFEAE7@J<9!JI-X0NCIOC*S@
ME@"ZS!Y5IN8_)BU6$;^./F7/&>/RK0\1Z#<ZQX"O="@DB6YGLOLZO(2$#8 R
M2 3C\* ,71[SP]!>I<Q?$"XU)X8WE:T?4H90ZA"6)15R<#)X]*NZ9XQO+FYT
M=K_1?L5CK.?L,PN1(^=AD594VC86521@MR,&MVXT6QN-/GM#;0QB:%H6>.,
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M+N,C/7;T':L6_P#"6LZW8>)Y[XV-OJ.K:>MA;PQ2O)%"BAR"SE 22TA)PO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<'H<'=UJ*S\#ZCHL=NVBZI9QSFS%I<&YLRZ8#NZO&H<;=ID<!22,8':M&_\
MB#X;L='74UU&&XMVN8[7]TV2'9@.0>F =QSV%;TVIV5OIPU":ZCCLV56$S-A
M<,0%.??(_.@#F;WPEJO]H7\VFZQ!#'JEI';WIGM=[[D4KYD>UE 8J<8((! /
MM6K;^'(O^$'B\,W<IEA&G+82R(-I8>7L+ <X]:FL?$VAZFEV]EJMI,MHNZX9
M9!B-<$[B?[O!YZ<4EIXFT._L+F^MM5M7M;49GE\P 1#&<MGH,<Y[T 8MOX3U
M:XN;*76=5MKE=.MI8+3[/;-&69TV&23+G)VY&!@?,?:K-IX3>VM_",1O%;^P
M(PC'R\>=_H[0\<_+][/?TJ_!XJT&XTN?4XM6M6LK=MLLOF !&., YY!.1@=\
MC%#^*]!CTJ/4VU:U%G)(8DEW\,XSE0.NX8.1U&#0 NH:*U]XBT;51.$&G>?F
M/;G?YB!>N>,8K);P8[:-/8?;ES+K7]J[_+Z#[0)MF,^V,_CBM2Y\6^'K1+1Y
M]9LD2[020,91AT)QNS_=SQGI4LOB318-832)=3MDU!R%$!<;LD9 ]B1R!U-
M'(1Z=;Z_\5CJ5DTS:?8Q*U[F,K%+>)O2( D?,RJ[DXX&$KJ?%F@#Q/X>ETII
M4C626&1BZ;P0DJN01WR%Q^-)/XP\.VUU);3:S9I/$2LB&090A@IW>G) YK3F
MOK6WN[:TFGC2XN=P@C)^:3:,M@>PH Y2]\"NT>J6>GWR6VEW\T-U]E,61!.D
MJN[)@C"N%Y7LW(ZD5:U[P8NO:AJ-Q+>&%+O3HK-=B9:)XY6E63KSAB./:KMY
MXLTJQ\4V?AZ><+>W432H">!AE"J?=MQQ_NFIK3Q1H5]J;:;:ZK:S7@+#RDD!
M)*_> ]2.X'2@#-M?#-]>:K+J/B*\M;J0V+V$<-K T<8C<@R,=S,2S;5'H .^
M:PC\,;AO!4>BMK9-^+EII+\0\LK1& KC/_/$[<YZC-=QJ.L:=I"1OJ-[#:K(
M2$,K[=Q +$#WP":SHO&OAF9K58];LF:[;9"!*,LV2N/8Y!&#CD8H IW_ (*@
MO_$PU%Y@MD=&DTEK54YVNP.0V>, 8QBH!X1U2^T.[T76-6MI;*2Q:RC^RVGE
MN20 )7)8_,,=!@<GVQNOXDT6/65TA]3MEU!B%%N7&[)&0OU(YQUQ6?H_BN&Z
MTZ^O-2>"T2WU2?3T);ARDIC3KU9L#@4 9<_A#5=2NOMGB#5(+M4TNYT]H+*U
M,>]90N7&YC\YV].G3\>>T9+GQ'X@\/V\]^VH6UC8W,5P%L)+7R4>,1@2[R?W
MK>@QC:W%>C)XBT:36#I":E;-J )!MPXW9 R1]0.<=<<U6\1>+-*\,/IZ:E.(
MS?3^3'D]."2Q]A@?F* *FBZ)KFE0)!<:M:RVUI:&WMQ#9;7D( "O(2QR0!T7
M ))/H!K:?'>77ANUBU3"WTMHBW6T 8D*#?@#CKFL73O'6ERW][9:E>VEI<QZ
MC)9P1M)@R $!2<]"22!ZD<5L2^(M&@UA-)EU*V2_<@" N-V2,@?4CD#J: ,'
MP]X/O]*/A[[;J-M.-%MIK2+R8&3S(V6,*3EC\P\LYQP<]L<QR> Y)'T]O[04
M?9-?EU@_NOO!V<^7UX(W]?;I74ZEJMAH]H;K4;J*V@W!=\C8RQZ >I]A6/+X
M[\/QZKI-@E_%*VJ(SV\D;@J0#M'/NV5'N#0!#%X:U.;Q+8ZEJ6H65Q'82RR6
M\D=IY=PX=64)(X;&T!^P&2JGC%:-UH;7'B[3M<$X5;.UGMS%MY;S"ASG/&-G
MZTL7BO0)[JZMHM6M7FM4=YD60$JJ??/OM[XZ=ZHZ;X]\/:CX>AUO[?%!:R2>
M4!*WS!^NW ZG'.!VH 98^&]4TS4G2TU*U327O9+PQFTW3@NQ=HPY;&TN2<[<
M@''O7-^&?#>JZOX=M[:XOX8](&KSW<ENUN?./EW;NJ!MV-I95;.W/:NVN?%.
MA6=M;W,^K6B0W$1F@?S 1*@*@E<=>67IZTRV\7>'KR\M;2VUFSEGNEW0(DH)
M<8SQ[XYQUH PY_!%_)!=:.FIVZ^'[J]-Y)";<F<!I/->)7W;=I?/.W(!(]ZU
M+7POY$7B6*2ZW+K5P\N53!B#0I'CKS]W/;K5^+Q%HT^L/I,6I6SWZ$@P!QNR
M!DCZ@=1U%0VWBWP]>7\5C;:Q:2W,P)CC60$M@9P/?'..N.: &:)HES:>$8=#
MU6X@N?+MA:>9;QF,-&$V#()/S8Z]O:L33_!FKQW7AX:CK%M<6FA;TACCM2C3
MH86B!D)<_, PZ #KZC%_3OB#X;U&QO;Q=1AB@M+DV[M(V-QR0I'KNVG'?BN@
MLK^TU*RCO+*XCN+:4926-MRL.G6@#DM/\%:A;QZ/IMUJD$VBZ/.LUK&MN5F?
M8"(ED?<1A<CH!G:.E6='\,ZOI BL(=6MDTJV\P6XCM!Y^UL[%9V)7"9X(4$[
M1GN#=3QOX7D?8FNV!/E></WPY7 .0>_!''7FI_\ A*M!_L==6_M6U^P,_EB;
M?P7SC;Z[LCIUH H:+X<U&V\0-K.JWEC/="T^R;K2U,)F&Y6WR98Y;Y1@#@9;
MUJU_PCS?VQKM]]I&-4M8;<)L_P!7L$@SG/.?,_2IYO%&AV^EV^IRZK:BRN6V
MPS;\B1N>%QU/!X[8/I6;I?C33[G3-0U*^NK6WLX-0DM()A)E9@,;2/4G/04
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MM.3QGHL?B2ST/[7&UQ=VQN8W5@4*Y4*,]RP8D>RFKNE>(M'UQY4TO4K:[:(
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MC@YSG/L!C%='+=6\-F]Y),BVR1F5I=WRA ,EL^F.:QO^$V\,;IU&N61,"AW
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M7H&F,GA[X81O9,I@G9Y%,1'EG[/,<MZ?-CKWQ2237&FW=]OW6-M+XFN':_\
ML?G-;C[.NUD!4@%CE=V#U([UZK4$U[;6]Q;6\TR)-<L4A1CS(0I8@?0 G\*
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M:1J%K:6^LK?J[W\<EG&BR^86C4$/O?IM*X4LV#CKZ!K>CVNOZ/<:7>^8()P
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M#@$+@#)P ,MDX&,T 9'B"WN9OBIX6\O4KJ"+[)=N8HQ'M.PQ9'S*3\P;!YZ
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MC:6E]%I.IWUO]LOTO&0W&U8CYH>4)M&<,-V5)(/3@4 =31110 4444 %%%%
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M45F("?*I);(P :XRRU+6;T:5I;ZAJ-IGQ!<6,A>5'G\E;=Y-C.N02#QNR2,
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MU"YL(W8W%LJ-*IC8 !@2N&(P>G8G'>F:MJUCH>ESZEJ4X@L[==TLI4MM&<=
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M/H;;49HA96^G-: 'B%G/S$#W[T >JU4U34[/1M,N-1U"80VENF^60J6VCUP
M37GFOZCJGA&\UR&TU6\N0=&6Z1KQQ+Y4QF\LNO& ,-G;T^7I3O'>D2Z1\/\
MQ/&==N[V&33@WV>\D$DB.&YD#=0IX&W& 1QCI0!Z5%(DT22QG<CJ&4^H/2G5
MQ.E:C=#6-;MVN7\BVT6REB0GB-F6;<P^NU?RK)\-W.I>)Y],MKK6;^W6W\.V
M5YN@EV-+/+NW2/Q\P&P<'CDY% 'H6G:C::MI\%_8S":UG7='(%(W#Z'FK1(
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M@Q211S!DWAX,L3M;<GWNG'7F@#L-1\&:+JE]/=7,,^;DJ;F&.YD2*YV\+YB
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M#RS<R&-)\L2ZJ3A<EB2!P?P%8K^.KRUU?Q0+K2)AINC6<=SO#('.49^03G+
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M0LDT:%R"V[;M(&=V>AH7QU&UBI&DW7]J-J#::-/WIN\X+O/SYV[0GS;O3WH
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M@&68$-M(X.1G&*]%9U4J&8 L<#)ZFL_0-8B\0:#9:M!$\45W$)%1\;E!]<4
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M6SI$L;!EQEDPH(QSG(XZUV7BG2IM4\&:OI-DJ>?<V,MO"K'"[F0J.>PK:HH
MXE_#&HMKW@2\"Q>5HMM/'=_/R"\"H-OK\P-1VGA74X?"GAS3G6+[18:HEU.
M_ 02.QP>YPPKNJ* /,=.\'ZS:ZUH^H2Z19-=V.H2RW=^;C=-=I(LB;@2,@*'
M!VD]L#ISJ6'A74[?POX0T^18O/TJ^CGN0'X"A9 <'O\ ?%=U10!QGAK3_$NA
MQ6.@K:V8TVSFDW7[3;FF@)8HJQX!5_F4$DX^4XSFL#3_  3K-AX<T6QN].MM
M2BM;J\DN;!KG9')YCEHG)P0VW)X(_BR,D5ZE10!YII7@O6K2?PFDMO:1Q:+J
M-[+(89/E:*7>4*+CC[^-O;%=3XGTS4)[W1M6TR&.XNM,N'<VTDGEB6-XV1@&
MP0&&01GCC%=%10!Q,UAXGDU+2_$4ME9RWML;F%]/BGV[;>785 D(PSJ8U)Z
MY..G,.E>%-5AUO3=6NE@25M3N[^[B23<(1+#Y:(#@;B %R<#G-=Y10!Y]+X7
MUJSU0ZS:6\-Q<0:[/?1VS3;/-@E@$1^;& P/.#Z52U+P?XBU;1]<$T%K%=ZA
MK-K?1QK-N58D6($%L#Y@$(]S7IU% ' ZOX<UJ>]\;0V]K#);:]IXC@G,X79(
ML!CVLN,\D@YI]CHFN^';JQO[*PAOW;1K;3[F W(B,<D.2K!B""IWL#WX!YKN
MZ* .(\+>$;_0M5TJ:=X9$M]+G@G=#QY\LZRD*#SM^]S["K/AJ'4O#UKI&B3V
MT;B>6]DGD63/E RM(F..<AP#Z'%==10!S^KZ1=7OB[PYJ4(0V]@;DSDM@C?'
MM7 [\US;^"7C\27LC>'M.OXKS4!=K?W$Q!A0[2ZE,9+ AMN..1G&*]$HH X#
M_A&-3N?$S72Z7:Z67><7E[:W)V7L;(ZH&A_OY*,2>A4X)S3=%T/Q(+CP?%?V
M%K;6^@HT,TB7/F&;_1VB#J,# SC@\_-[<^@T4 >8V'@_7])\,:!'':P7%[IF
MM37SP"<*'C<R@88C&<2 X^M:NG:!J:>,8=3_ +)M=,Q+*U]<6ET?+OD*L$!B
M_O9*L6/(*GDYKN:* .8U?3]4M/%EOX@TNSCO@;)K*>V:81,!O#JZDC!YW CC
MJ*PU\&:JMIX:WF!KFVUR35;X(_RIYAD8JF1S@N!VSC->AT4 8/BW2+K5])A%
M@8_MEG=P7L"2MM21HW#;20#C(!&>V:XKQEIVKW.D:_K]_:PV,LEM:65M;^:)
M2 MR'+N0,<LP  [#WKU.HKBV@O(&@N8(YX6P3'*@93@Y'!]P#0!P.M>%=:\6
MW.I7-_9VU@?[-%G;1&?S5ED\U92S$ 83,:#UP2<#I4%SX,NKSPYJ]O9^&]/T
MBXN1;I&J7'F/)LE#ON;& N!P.O7.,UZ510!Q?BOP[>ZOKT$W]FVNIV)LV@2*
MZEQ';3%L^:4P=_&!QS\N.,YJEX;\/Z]H^J^'+B:QA>.VT1=)NMMR,Q%'4B0<
M?,"%Z=1FO0:* /,_#GA#7O#>@^%IEMH+G4-)6[AN+43A0\<\F[*N1C(VH<''
M!/-:&E^%=6CUS3]7NT@25]5NM0NHDDW"%9+<Q(H.!N( 7)]2:[RB@#@KKPS?
M>3JZ7&B66K6MYK#W?V>2;8X0Q(JNC?PL&4^AP>#6UI>E:O;^!&TR6[*:H;>9
M(IC,TAA+%O+!<\ML!4;N^W-='10!Y./ ^KF*Y-MH-A8&ZT*ZTR4+<AY&F=5*
MRN^/F!92.Y&<GK@=+KOA2[UF?3XMR) NCWEA,^[E6F2-5('<?*U=G10!PFG:
M7XENM;\,7&I:?:VD&D12Q3%+GS#*S1; RC PN1T///;'.KKNGZI#XET[Q!I-
MI'>O!;36D]J\PB+([(P96((R&3D'L?:NFHH \YU?PQX@UNYCDU?3M,U!Y]/,
M 5I2(+&8NY+A"#O^5D&1@DQ_P@\03^%]=N=-TN Z):0:G:V<$$&JP7I26U*8
M#;\#,B\;@O0[L$#K7IM% '#7?A74YO"GB/3D6+[1?ZH]U "_!0RHPR>QPIK7
M\=Z-=^(/ ^K:38A#=74&R,.VT9R#R?PKHJ* .-U/PO>7_C'1;\A!96VFW-I<
M'?\ ,&D"@8'?H:I:;X?\02VWAG1M0M+:&ST&6.1[R.?=]I\J-DCVIC*YR"<]
M,8&:[^B@#S.+P'JT<'B"/,'[L :&-_W,7#W*[O[OSF-?H@JT_A6]C\,:78WF
M@V>KRYEN+O\ TGR98KJ1MY>.3TRS@D8/W<>E>A44 <Q<>'+[4_AN_A[4+T27
M\VG_ &>2Y)+ R[<;B>K#/?J:@L[#7=5\2Z5J>KV,%A'I=O,H6.X\TSRR!5)&
M ,( IZ\G(XXKKJ* .9^'VAWGAOP/IVDZ@$%U!YN\(VX?-*[#GZ,*P9?"^N%M
M9LA:PFWN=?M]5AN?/'*+)"S*5QD$"-OKQ7HE% '!^)_!U[K>IZS<)';R13V]
MAY$<KD+*\$TDC(V!D*P8+GW]JU_"6C#3/MLW]@V>C^>R!8H)?,=U4'EVZ=6.
M .WUKI:* .,;PE=7=GXWL[ATB37)6^SR YVJ;=(\D>S*>*P+SPD5\,ZQ)-H>
MDZ Z6('VL7!DW.KK(22!\L68UZ\^W'/J5(RJZ%'4,K#!!&010!YHL^I>(O&U
MR)(+2&1_#<\2107(G"F21-I9P !NP<#T7/? 1_"&JIX0T/2I=#L[VZL].6&.
MZCO#!-9W &"RR 9*?=/R\_+T/;T'3])TW24=-.T^TLUD.YUMH5C#'U.T#-7*
M /.-0\+>(9/^$IMA%#=#6M(BMQ=F8)B=(60[EQT8L#D=*T_$/A^_O9=#_P")
M;;ZI9VMO)%/8SS^7'YI"!)#P0P7:XQ@D;L@5VE% ' ^#_"NK:/J.D->0VZ1:
M?87=F6B?AR\\;HRKV!53QVJ&V\+ZYIA\.W4-K#<RZ=J.H330^>$S'</)M8$C
M' <$BO1** .7\8Z1>:K_ &68;*/4;2"X9[JPDF\I9@48*23P0K$'!_H*YJV\
M):E:Z&-,O/#&F7]M'>W,\:077DM"9'WHT+8!0#<RD<'@$>E>FT4 <Q<>'+[4
MOAN_AW4+T/?S:?\ 9Y+DDL/,VXW$GEN>_4U!9V&NZKXETK4]7L(+"/2[>90L
M=QYIGED"J2, 80!3UY.1QQ7744 <1X5LM5\&>!-#TN>UBFNQ>>1.JR9"I),Q
M+ @<D!@<?7TK3\9Z5>:K86,=K;+>0PWBRW5DTWE"YB"L-A/3ABC8/!VXKI**
M /.- \'ZMIVLV,CV%E:VEMJL]\$MI/D6.6V*!%&!RK8&<#/7CI4]QX7UFUU2
M76+2"&>X@UY]0BMVFV>= ]L(6&[& W4C/I[UZ!10!S/A73=5M=3U_4-5AAA?
M4;J.>*.*3?L40HF"<#D;>:;IF@W=OX\\2:M.$^Q:C;VL4)#?,3&KALCM]X5U
M%% 'GNG>&M?&F^'O#MW:V\=CHMU%,;]9]QG2$DQA4QD,?EW9.!@XS6CIEOJ?
MA'P3J3FUBN+R.[NKJ.$2<2*\S.HR!U*L./7BNQHH Q/&.DW&O>#=7TJT*"XN
M[5XH]YPNXCC)[52T;3M4;Q2VM7]HEHLFDPVK0B82%9$EE8\@<C#*<^]=110!
MY5;> +VQL]'ENM#LM8GATI+"6"2Y\ORI$=F5@V.5.]@>_ QFO2M*LQI^DV=F
M(8(1!"D?EP B-<#&%SSM]*MT4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!Q_Q2,8^'NH&9VCB$UKO=3@J/M$>2".E<;XH
M@L]+OM>@\,):V]D^C6[WJVIVQ#-R%W-LZ$Q&7)Z[1FO3/$NC'7]#DTY9Q"7E
MADWE=V/+E23&,CKMQ^-6[32M.L(I8K.PM;>.8DRK#"J!R>I8 <_C0!Y'KNEF
MT\->(HXIM&MX)3INZST9F"0O]I&).@"LRX'']P&N@U?3;31_B5X'LM*M(;:&
M.VU'RX8E"J"8U/ZGDUW,&C:5:V;6EOIMG#;,P=H8X%5"P(()4#&<@'/M5E[6
MWDN(KB2")IX@1'(R L@/7!ZC/>@#R/1H--CT'P1J-DL/_"1W.HQ"\F7'VB5B
M&^TB0_>('S9!X&![55M8-'/A[PK?2"W'B&?Q%%]JD&//>3[0V]7/WB!@<'@8
M7VKU^+2=-M[^2_AT^TCO)?\ 67"0J)'^K 9--&BZ4MY)>#3+,74C!WF$"[V8
M'();&200#0!P/AV"QTOQ?9E8M+OS?W%W]GU2TD*W6?G=DN%_C P5R3@%5^4'
M%7O$%IH]]\4]*M]:CMI;=M(N"D-R 8W<2QXR#P2!N(!],]J[*#2=.MKZ6^@T
M^UBNYO\ 6SQPJLC_ %8#)_&LZ_\ #%KJ?B6/4[U(+FV6Q>T:UGA#JQ:1'#<\
M<;.F.] 'FNCZ;9ZQ>>"[&\B6ZTH3ZPMO%)\R26Z2CR@<_>4 +@=, 582PGNM
M>U"Y>70[2]@U]4BN;AF%XBJZ>7$F!]UH\*%Z$,3ZUZPME:H8"EM"IMU*0D1@
M>6I&"%]!@#IZ5&^EZ?)J":@]A:M>H-JW)A4R*/0-C(H \JE1-&DO)=/BTZ_O
M;V+46L-5LI"MV)=DDA2=?XP"-H.< JOR@XJE/IR6WA/5KBUFT&&&7PQ<%[?3
M78O<+M4I+)D<D'<-QY.\U[##I.G6U]+?0:?:Q7<W^LGCA59'^K 9/XTV'1=*
MMDN4@TRRB2ZS]H5(%439Z[\#YNIZT >>ZIH.EZ?KEO;VMA D=[X=O?M2^6#]
MH9#"5:3^^V68[CD\FL33;&UN+'P?9P6F@R6+Z"9S#J Q ]QB+S&PHP90I')Y
M +'UKV8V\!F28PQF5%*(Y4953C(![ X''L*I-X>T1K(63:/IYM1)YH@-LFS?
M_>VXQGWH \VT.STN75E@\3W=C?PVF@0/8W$C;H]ADEWR1EN=P B&X<\#FNP^
M&?\ R33P_P!?^/-.M;]SI6G7C6[76GVL[6QS 9858Q'_ &<CY>@Z58A@BMH4
MA@B2*)!A410JJ/8"@#Q7P1I]KJ?AWX<6M["D]LQU(O#(,H^&8@,.A&<'!]*]
M \ 0QVEEK=E;HL=M;:S<QP1*,+&F0=JCL,D\5TL.G65LL*P6=O$L&[R0D2J(
M]WWMN!QGOCK4L4$,&_R8DCWN7?8H&YCU)QU/O0!XQ#I.D#3=0M8;2UA>3QHD
M$JPJJ/Y0N%VJ<<A<$X],\4_QK86FE:#\2+#3[:*ULQ:6$JV\"!(U=F8,0HX!
M(5<_2O7/[(TT74ET-/M/M$C*[R^2N]F7[I)QDD=CVI\VGV5P)Q/9V\HG"K,'
MC#>8!T#9'(';- 'G&N06-IXCEUB>+2]41);-)HI)#'>V+_($\EAU4[@VT;<Y
M89.<5M_$FUBOK'P_:S@F&;7+6.0 XW*=P(S[C(_&NIETG39[Z*^FT^TDNX1B
M.=X5,B#V8C(_"K$UO#<;/.ACD\MQ(F]0=K#HPST(]: /)/$6CPMK^O6(CT&S
MM+/3H!9O?%HS9Q$.?,@"C"D.#R.<JH]*2^L=#N=1\?/K[6DU[;V=NZ22XS&W
MV5<R19Y5BP'(YX7VKU6[TO3[^:&:\L+6XE@.Z)YH5=HSZJ2./PK*A\)V+:]J
MFIWT%K>_;)HIH4FMU8P%(U3()SR=N<C% '!6L&FZDOB";QBEN][;Z3:-$UYC
M?#&;8,SQYY4^;OR1SD#T%6/#NDQ:[XPTZ3Q#:K=W,7A>PFDCN5W 3;Y,N5/&
MX<\]LFO2;S2=-U":&:]T^TN983F)YH5=D/\ LDCC\*L"WA%P;@0QB=D"&7:-
MQ4$D#/7&2>/>@#SGX>Z=X:3P19"ZATZ&0:I(PR5C)N%N)!"#C&6  "@_05Z5
M65<>'-*N!Q90PDW4=X[0Q*IDEC;<K,<9)R.O7KSR:U: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<.8XE)Y=@I8@?\!5C^%35X[I,NGSVO@.ZOI89H8-1O[7SIGW[0!,(D+'_=3
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MC/J<?6FB>UB8QB6%&SRNX Y^E<=%ID%C\88[B-I7FN]'N7E>60L>)X,*,]%
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M)^Z W/J<XXQRFE:[K\5YX9N-3U&VGM];LWEDA$ C6W981*"'SDC&0<_48Z4
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M\2:F/%44-QJ"Z9:RR6XLXI[,M#>(ZJ7'G_PR;BRA<CHO!S7>4 (JA5"J  .
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M7CL[.5)6X.-I:5AUQVJ:V\5Z1>II1MKAI6U3=]F18SN^0?.6'\.WH<XP>.M
M%?3_  L]IJEM>W6LW^H+9JZVD=SL/E!\ DN%#.<#&6)]\GFGZKX9-_K2:M::
MK>:==&W^RS-;A#YL6[< =ZG!!)PPY&358>.-*NVE@M'N!(\<WV6>2W=8;AHP
M2PC<C#8P3[@'&:K^$_'%IK-AHD%T;A;^^LTE$K6S)#-($#2!&(P2.>GH<=*
M'VW@2+3;+3H=)U:]L)[&W>U6X18W:2)FW;6#J02#R#C(Y]36A_PBUL=9T74V
MN[J2?2;:2WC,K[S*'"@L['DM\H.?<U!:>.=%O/-*-=)&MO)=1RRVSHEQ%'C>
M\9(^8#(Z>H/2GZ=XTT?4[V&VA:YC\^!KBWEGMWCCGC7!8HS !L9!^AR,B@"O
M;>!K&V\[;=7)\W6SK1SMXE./DZ?=X^OO4]_X/M+^ZU&Z-U<PW%Y);S)+&5S!
M)"/D9<@CZ@Y!Y%,T_P =:)J5[8VL+7:/J!;[&TUK)&MPJJ7+H6 !7"]?<>HJ
MQI?B[2M8ODM;5K@&9&>WEE@=([E5(#&-B,,!D=.H.1D<T 5;CP?)=VD)GUW4
M'U*"[^V0WYV;HGV;-JIMV!"I(*XYR3UYJ[X?\.1Z#)J,PO;F[GU"<7$\EQMR
M7"*AQM  'R].W;BG^)]<3PYX;O=49/,>&/\ =1=Y92=J(/JQ _&J/A#Q!>ZK
M:7]MK<5O;ZQIMP8;R.#(CP1N1UR2=I0CJ>H- $=UX&L;NXU^9[JY#:U+;2S
M;<(8-NW;QWVC.<UL#1X1XD?6_,D\]K1;0IQMVAR^?7.36*?B%HKVT\T*7KA;
M9[FW+6DBB[C3&YHB1\P&0>.QSTYK6\-:U_PD/AVQU3[-+;FYA20QRH5P2H)Q
MD#*\\'O0!0U7PI/?>(3K5CKU]IERUJEJXMXX75D5F8?ZQ&YRYZ4?\(I-=):Q
MZOKE]JD-O="Y\N:.)%D91\BL$1<JK?-CUQGI7/:=XA\:7_@\^)EF\/" 12SF
MV>VF0E4+9'F>:0#A>NVNLT?Q)9ZP+=(Q)'<RZ?#J#0LI^2.7.W)Z9RK#\* ,
M^3P/:?9IH+:]NK51??VA9^5M_P!#FYW>6""-K$ME3D?,W3-2V7A"*VOK*_N-
M2O+R\MIYKAI9BO[QY(_+(P  JA0,!<=._-9S>+Y+WQ=X3ATV8-I.L6=S<-OC
MPS!%4H>>1U-:-OXZT*X$KF:>&W6"2Y2XFMW2*:*/[[QL1A@.O'4'(R* (IO!
M,7VEKNSU.[L[S[?+>K.BQL5,B!'3#*01@#J,@TND^"+72+ZTN([Z[F%I-<S0
MI,5.#/@N"<9/S9.3SS6GH^OVFM//'#%=P30A6>*[MGA?:V=K ,!D':?R-9NI
M:]JUGXTT;3%LK==+O99(FGD<F1V6%Y/D4<* 5 ).2<G@=2 9FO>&UTR&"]L%
MU62X759;W[18B-Y;?S5(?$; AT/ (QGD'M4'ASPA<7&EWEQ<RZAI]Y)K#ZE9
MSR[#<)F-8]SK@K\X#Y7& &Q@8XT_$^J^)]-35-0LQI=KIFG6_G*;U6=KLA2S
M %7'EC^$$@DGMCK9N?'&EV*0_;([N-S;17-SLMWD6T23H96 PO(;\B>E &OI
M=A)IUCY$M_<WLQ9G>>X(+,Q.>   H'0   "J_AW0+?PWI(L8)99RTLD\T\V"
M\LCL69FP ,Y/Y 5K5S&B:]JU[XMU;2M1LK>UAM[:&XMU1R\FUWE7YS]W/[L'
M Z9ZF@"%O 5K')--9:A=V<YU!]1MI(PA^S2.NV0*&4@HV22I[GC%/;P2N-,F
M36=0%_8W,MS]L?8[2M*") 5*[0"#@  8P,5G^&?$NLZ]=QN^K^'8XWGE!L%A
M?[5Y22,H.?-ZD*#G;CGI3KWQA>PVGBG68(C)IVD+):V\20ES-<1KEW8CD(&P
MOX,3VP =-K&BP:R=/,TDB?8;R.\39CYF0$ '/;YJ9<Z%!/XCL]<262&Z@A>W
M<)C;/$W.U^.<-\PQT.?4UQ^A^*M932O#VL:I</<6>I3);7*R67V<PR2JIC=,
M_>3<=F>^X'L<]QJVJVNBV#7EXSB,,L:K&A=W=B%554<DDD#% '.:?X AL'TE
M3K%_/:Z1.9;&V<1A8AM9=I(4%L!^"3D8^N9(? =I:6+16FH7<%R-3EU.&Z78
M7BEDR& !&"I#,,$=#Z\U9;QQHJ6,5U*UU&9+LV/D/;/YJSA"_EE,9R5&1ZY&
M.M"^-]'.ES7S&Z0PW0LWM7MG$_GG!6,1XR20P(QQ@YH 5O#5\+:W$'B;58[N
M,R&2X8QN)=Y!(,;+L&,#;@#:,CN<Z-AI$6E:!#I-C-+$D,'DQ3'#.IQC=R,$
MYYZ8]JR?#7B.37?$&O6X\Q;:R-NL<4L)CDC+(2P8'G.?TZ<&C4]>U:R\9Z+I
MB65NNEWTTD+SR.3(["!Y/D4<* 4 ).<Y. .M $6F>"9+&YU%[GQ!J%_!J18W
MEO-%"JRL8Q'G*("/E4#@CI26O@1%FM?[2UK4-3M[*)XK2"X\M1$'0QDDHH+M
ML) )/<]^:IWWB76'\6:EI5IJWA_3XK5X8XEU")VDF=XPYQB5<XR. .]:FN>+
M[/1_M5F3/)>V]IY\S06SR1VX(.UI" 0H)4]>P)/'- $6E^"O[-U#3+U];O[J
M73H6M81*L87R"%&PA5'/RJ=W4X].*W-6LKG4+(P6FI3Z=(6!\Z!(W;'IAU8<
M_2H?#=]/J?A;2+^Y(,]U90S2$# +,@)X[<FLRPU[5I_'5UHUY96]O9+9FXMR
M'+RN!+LW,?N@'J%Y(&,G/  (+#P,UCX<CT4>(=4>*V,1LI0(D>V,?3&U &![
MAPV145_X#^V:%KD,VJ7%YJVIPHGVVX55V&,[H@%0 *JMSP,G)J#2?$NLZOK=
MQ NK^';>*+49[=+*2%S<R112E"1^]')"GG;CVJ_+XEN6U[63"COIFBPJDRPQ
M&22XN' ;:,9.U%*YQW;T% "KI5WX@AL=:^T7V@ZP+8VURL:(QQGYEPZL" P)
M5AV/H:9<Z3<WWBG0K7;<MIFAH;E[FX8LUQ.4,<8W'EB%+LS>I'O7,^'?&VNS
M>&=,\4:E.9+*:X2.]@-B84A25MBO&YY<*Q7)YX)[BNRM=7NX/&EUH5\RO'/;
M_;;"4+@[ 0LD9]2I*D'T?VH L:WH!U:[L;R#4+BPN[,N(YH%1B5< ,I#J1S@
M'.."*HZ/X)M-&O+*>*]NY5LFNC DI4[1<,KN"<9.&4D$G/S'.:S?'WBS4-%U
M+1-*TU9XI=0G(DN4LFN-J!6.$ X9\CIV'.*U#XWTB"Y-O*]T5BF6VGN_LK^1
M',<#8SXPIR0#V!."10!#)X&A22*YL=3N[.^AO+F[CN45&(\]MTB%64@KTQQD
M;1S6IX=\/P^'+*XMH;FXN/M%S)=227!!=G?EB< #KS^-1VWBK3;SQ!/HEL+F
M6\MY#'.4MV,<)V!QO?&!D'CGDY':JM]XM6T\90^'1973O)9/<F=86*J0R@=!
MC;\QRW0$ =Z (9O!][+XF&N#Q1J23*KQ)&L-OL2%G5S'S'DC*KR3GCK1>^!U
MOIKF&76]2.DW5Q]HGTTE"CMD,5#E=X0D9*@XZ@8!Q5;P=X[MM9TK08KXW U#
M4+56$QM62&:4)N=4?&TD8;CV/I6OIOB[2M5OTM+9K@&4.;>62!TBN APQC<C
M#8]NHY&1S0!EZO\ #^#55U>W&L7]KI^K-YEU:0^7M,NT+N#%2PSM4D X)'H2
M#V!!V%02#C ([5C:YXITWP_<VMK>?:7N;M9&MX+:!I7EV;=P55!)/S@_3)[&
MHSXOTD:M_9Y:XW>>+4S_ &=_)68C(C,F,;N0,>IQUXH IZ7X/N].UR?5)/$V
MHW;W(07,4L, 68*I"@[8P1C<>A%)9^"1;W5B;K6]2OK'3I?.L[.X*%8W (4L
MX4.^T$XW$_C4LGCW0HKHPM)=;/M8LDN/LK^3).7";%?&"0QY^A]#3(O%5G:W
M6N&YU&2Z%G=QVXMXK,[XW=1MC7&3(23G/;\* *.E^&9!8:GX8NUN(+:"]-]I
ME[#CY%:0RK@D$;TDW @CD8Z@FIM=TG5HO"][I5O>WNIZCK#_ &9KF8*$MD9=
MK-A0%150$@#DL>^:6[^(%G#>Z-;P6&H2G4+F2WD4VL@>$I&S$%<9W9"\?W26
MZ"KB^.M#:345$ESY>FF47<_V9S'$T;;2A;&"Q/11R1]10!6FT>6Z\5:%:16\
MD>D:!$9A(XXEF*&.-5]=JEB3ZE1ZUJZWH)U:YL;N#4+BPO+)G\N:!48[7&&4
MAP1S@=N"*J?\)QHT>G7=[=-=6:6<L45Q'<VSQR1F5@J$J1G!)'(]_0U1U3XA
MZ?8Z#K5]#9WS76F0B5[2>V>)R&!V,01D(2I^;M@YH M:-X)M-%O[6YBOKN86
MANO)28J=HN'1W!.,GYE)!)S\Q]JC?P/ GD366IW=G>V][<W<5RBHQ'VABTB%
M64@KR.V?E'-;L6JV[:-_:DPEMK=8FFD^T1F-HU4$DLIY' )K(C\<Z,]C?7<O
MVNU2R@6YE6YM7C<PMG;(H(R5.#T].<4 7?#OA^'PY:7,$-S<7)N;I[J22X(+
M,[XW'@ =1GIWK.C\#6,;7C"ZN3]JUB/5V^[Q(A4A1Q]WY![^]6;;QGH]Q-=Q
MN]Q:_9;8WC-=6[Q!X!UD7<.5_P 16=:>,O[5\8:1I]G'<PVUS9W%Q+'=6K1.
MP4Q>6R[AT.Y^GXT 7=7\&66LC6_.N;B,ZM#!%(8R/W?DEF1ER.N6YSGI4<OA
M">2X>XC\0ZE;S7,217SP+$AN=F0&SM_=M@XRF.,=P#4>K>*7TCQK#ITL<\]M
M)IK3K!:V[2RM() ,@*,X"Y]OTJS+XWT9;"PNX#=W:WT33PQVMJ\DGEK@.Q4#
M*@$@'/<XH LKX:MENM=N!--NUE$289&$"Q^6-O'ISSGFH9?"-C-;Z-!++,T>
MEV[VR#('F*T7E'=QUQZ8YJWIOB/3-7O&M;*X\R06L5VORD!X9<['4GJ.#]*S
MSXZT4VT$]O\ ;+H3^:8TMK5Y'*1-L>3 &=@;C/?MF@"M:>!!;SV<TVN:A<R6
MEK)91^8L8'D,H&S 4<Y53NZG'/'%;?A_1+?P]X>LM&@D>6"TB$2M+C<P]\<4
MZVUNQO+BTBMG>9;NV^U0RI&QC:/CG=C )W# ZUHT <II_@6WLO*MY=4OKK2[
M:*2&VT^4J(XD<%2I*@,X"DJ-Q. ?7FGZ9X,2QN[&6YU:^OX]-B:*PBG$8$ 9
M=F254%VV_*">Q/<YKJ** .>M?"-G:Z;X=L4N)S'H;J\#'&9"(FC^;CT<GC'(
MJG8^!+>RDLP-3NY+:RU%]0M8'5,1,_F;ER%R5)E8\G/ KK:* .9U7P>M_?W]
MS;:M>Z>NI1+%?Q6XC(F"KM!!924;;\N1V [C-6;7PI8V7B:#6K=I(W@TP:7'
M;C'EK$'#@^N>,=>E;M% &'J_ATZAJD&J66I7.FZA%"UN9H41Q)$2#M974@X(
MR#VY]:I7W@/3;SP?#X=2XNH(X9!-'=(X,PEW%F?)&-S%FSQ_$:ZFB@#!O?"T
M,L&EC3KN;39],C,5K- JMMC*A2A5@05(5?Q4&EM/#$-KJNGZB]]>7-S96LML
M'N'#&42,K,S''7*C & !QCI6[10!D>)_#]OXI\/76C74LL4-SLW/%C<-KAAC
M((ZJ*BO?"]K?>)!K;SS+.-/DL-BXV['8,6Z9SQ6Y10!SP\(6/V/0+5YIFBT:
M$PQ D?O5,!A.[C^ZQ/&.:S8OA\B):+-KNHS_ &2UDL8=ZQ +;N@4I@*.>%.[
MJ=HKLZ* ,,>%K/\ XD8>25UTB!H(U;&)%:/RSNX]!VQ5'3O!"6 CA?6=1N;*
MVMWMK.VD9 L",-O55!<A> 6)P/?FNJHH Y"T\ P:?;:9!8ZM?6PLK,V+NFPM
M/"6#8)*G:<C[RX/)_"72? UII-]HUTE[=3-I-I)9VZR;<&-B,!L 9(  !_.N
MJHH S+O1(+S7],UAY9%FT^.:.-!C:PE"@Y[\;!BJ*>%3!JTES:ZQ?V]G-=?;
M);&(H$>7@GYMN\*Q&2N<$Y[$BNAHH \]T'P7<7=G<IJ5[?06;ZS<WCZ<50)+
MBY9XSDKN"G"-@'!Q[G.O=^!;>ZFO(O[3O(]*OKG[5=:<H3RY9,@M\Q7<%8@%
M@#SSTR:ZNB@#(M?#UK:W>M3B25_[7D$DRL1A<1K'A<>R_G61I_@."R'AX2ZI
M>77]@L_V3S%C7Y&C\L(VU1D =^N>M==10!SL?@^SCT2RTL7$YBM-0&H(_&XN
M)S-M/'3<<?2N+N/#U_-J-OI%K::W%:P:VEZD,OE&SAC6;S6D60 ,P89PA)P7
MZ< CU:B@#!\8Z/<:UX=DAL2HO[>6.[M-QP/.B<.H)[ XV_C6?<^%X_$JSW[W
M>I:=%JUFD-_8[45G #  DJ64C>0<'! _/KJ* .5;P9+*L4%QX@U*>Q#0R2VL
M@C*R-%M*X.W* E%)52!G/3)KJJ** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F_'-A=ZAX:(L8&N+BVNK:
M[$"D RB*9'91GC)"G'OBN1UW2]7\5:CK=Y;Z1?6D4FEVL=N)B(I)GBN6E91S
M\I(X&<>O2O4J* /+[_09=0\)>*WL-,UTWEWIZVL3:I.7EF(WG:JDD@ L>3U+
M''3)UKG1]0?QKX&O%M)#;V-E=1W,G:)FB0*#]2"*[JB@#SK3M"U.'P?X)M'L
MI%GLM2CEN8\#,2@2Y)_[Z'YU0\/^%)HDL-(O+/73<V)F'VB:[/V.,['59$&?
MFW!_N@9&XYQCGU2B@#S'2[?6)K?P+IDN@7MNVB3HE[/(JB,;+>2(%"#\RDG.
M1ZCUK?\ '>F7NI3^%39VSS"UUZWN9]O_ "SC57RQ]AD?G77T4 >=7FA:D_@S
MQ+:)92&XNM;>XAC &7C-Q&P8>VT$_A6S\1].FU3P=);0V,E]_I5L[VT:AC)&
MLZ,XP>#\H-=910!P>@1Z#IVJ";3?A_?Z7.8W'VD:?$F%QDC*N3SC&/7%4_#N
MA:OI/B8^(+G3\#7]ZW-O$ 6TPD[DP>X;_EIC^/!Z5Z110!Y]X>.LV7ANP\+R
M>'K@2V5K);W%W(5$.%1E1HSDERYV\<8!.>F"ZUT;58=,^'R1VC+/IUN5N PX
MA;[&Z#=_P,@5W]% 'CPTO7;I;*YGTW7IKLZ7=VMY)>3;A]IDB'^KCW;53<I&
MY0 <KUKHM0\/ZA>6WA6V2!HQ!I5S;3N>! SVZH,_C_*N_H(!!!&0>HH \IAF
MO+Z\\ :;/I5Q8M;I-!)+*4P7%G(O[LJQW+QG=P.5]\7?!6@2V=SHL%[IVNK=
MZ5;F-Y;J[+6L;A/+_=+D[@P)(P.!UP>*Z[2_"&A:->K=V%@(ID5DCS*[K$K<
MD1JQ(0'T4"MN@#B_%FBZEXG\3:1IT<ES8Z78YU"6]B5#NG4XB10X()&68Y!'
M3O6==^%-9TWQ/]J@U&^U2#6;.73[^69(E,!"DPR8C5<@$LI."?F%>BT4 <#I
MDNLW7AB'PZWARXMY;?27M;BXN&54$HC"*L1!.\,<G/  Z\\5O^"FG'@W2;>Y
MLKFSGM;6*WDBN$VMN1 I(Y/&1P:WZ* /([3X;!OAU:R_V:PUZW8W!M;B5S'<
M%9&;RG0G;AEXZ=2#72237]GXO&KQ:%?RP:AH\-O''$BYAE1Y&V29(V<2#GIP
M:[BB@#RK2/#&KK<> DGLY85LM(NK:[?'^H=XU !]\@_E2:'X<DCTVTL[[0-<
MO;G3M.DAEAN[[%JS>5Y92+)((<$XQ@*,9Q7JU% '(>#(]0AO+Z/;JZZ,L<7V
M9-7(,R29;>JG)8H!LY8GG.":J^*;^]'B[0I(/#^KW4&F7,DLTT$*LCA[=U&P
MEAG!< ].AKN:* //_%_G:K]IM-0\(WE_MC$FD7-J!OCD9!G<VX&)U<#GIC'T
MK&\2:3XHU'2=1TN^AU:]NWTF**U-I<>5;/+Y1$QD(8;F+Y^5L@C: .37K-%
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M!>:$6BQ,4!/)!8G'^R:])HH Y'PK'?3>)_$NJ7.FW%E;WK6QMQ. '=4C*DD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J&[F>VLIYXX'GDCC9UA0@-(0,A1GC)Z<U-67XDTN76_#6I:7!/Y$MW;/"L
MASA2PQSCG'K[4 <]:ZQ<>+$U/P_=B"POEM4N(KC3;_SQ$69@N6"J0ZLHR.00
M>X)K9\'ZS+X@\):=J=P@2YEC*SJO02H2CX]MRFN>M["[\)WUWXFU*'2;2R33
MA!)::>&&PHQ*!/E&]F+$=!_" #U.YX&TJYT7P7IMG>KMN]C33K_=DD8R,OX%
MB/PH YCPII&H>(M#N-2D\4:Y;WAO;J-#'<!HT"3.JCRV4@@ #BIM,\>W\FEV
M-G+!8RZXT]U;3-/<?9[?_1WV/)NVL1N+)A0.K'L*ET?0?&FAZ;/IEC/H20O<
MSS)<R>:[H))&?[F "1N]<<42?#[[!::,=/CL=2N+!9UF755^2Y,S*[N2%;:V
M]01P>"10!(GC^XOQ81:5IEK+=W%O+,\%S?B'+1R&-XXF"L)&W*?08P<\TV[\
M6V>D>)/$<T]A<K)I^EPW4A^TLWF;MV(Q']U6SQN'7-.U;PIJU]H<&F&R\.7,
M+0,LD4D#0I;3$D^9#M!/&>GRG*YR,U2U;P/,%\1WE[J6;:ZT6&U\Y8VDE5X0
M29"H'S<X.!DF@#1F\::KIMY-9ZMH,,$\>E7&I@P7OF(PBV_N\E =WS<\8'&,
MYX=;^-[J&XM7UC28[*QO;"6^MY8[GS758U5V61=H"G:V>"W3%<U;S7GC7Q+,
MJ:EI5V6\.75JSZ<[200O*T87>Q&0S88[<9 7O75ZAX0DU(:+#-/&+>TTZXLK
MC;G<WFQ(F5X_V3UH H1?$<6]M-<:M96\$9TZ348%M;P3L53;F-QM&V3YUZ9'
M7GBEM]3URX^(.@0:I9)8"33KN7RK>[,T;_-!@-E5^=>>Q'S<'DU%#X$O;K0[
MW2;ZVT*T233WLUN;"W/FRN0 )6) VCC)0%LD]>*TK#1?$=QXITS6=:ETU5LK
M.:V\JT9VW,YC._+*.NS[O;CDYX +&N^)KW3]<ATC3M/M;JZ>V-SLN;S[.9%#
M;=D7RMN?V. .,GFDN/%Q@LO%5P; YT&/?L,O,W^CK-@X!V_>V]^F:C\8Z!J6
MOQ-:PVNCW=G)"4 OU8/;2<_O8V53DX(X^7E1SS65J'@WQ 8/$-A8WMB]KK=J
MD<EQ=%_-C=8!"?E (8,%!SD8R>#0!I7'BW4Y;RZBT?0UOTL(8I;P&Z\M\R+O
M$<2[2'8+@\E1R!6(WB?5]&O_ !G?Q:<+W3]/NTFF\^[,;1Q_9H2RQ+M8$CYF
M()4<]R3C5?P[XCTZ_OIM"O-/C&I00I/)<ABUM+&@C\R-0"'^4+\K8Y7OG%27
M?A&]N-'\968NH3)KF[R7;/R9MTBR^!ZH3QV- &UX@UV/0O#T^J^2UQMV+%"I
MVF1W8(BY/3+,!GM7&7^LZI!X@UTZS9");7PU)<-;6E\YCE 9SE7VJ5; *YVY
M'49KK/$FA2ZWX6DTR&=(;D>5)#*P)421NKKD=<;D&?8UA77A;Q!K%SK5YJ4V
MG0RW^B2:9%#;N[)&S%B&+%02,MSP,<#!ZD 2T\8W7V?1[+2=)AFDDTBWO_(N
M=1*2LC@@)$64^:XVG)8KU7)YK1;Q3J<^I7BZ;H8O-.L;I;2YE%SMF+D*6,<>
MTA@F\9RPS@XZ<Y.I>"]7N_#&G:$8]%NH8--AM1/<JXDM)E3:9HB%)/8@94@K
MUYJ]#X>\1Z7?7T.D:A9)87]VMW)<3 M<0DA1(%7!5MVS@DC&X\' H QM)\2S
MZ3J'C*6037TQUV*SLK9I2 7D5 J@G(5<DD\< 'BM:[\<7>DQZC;ZMIEM!J-H
MMLZ*EX3;R)/)Y:N9"@**K [LKP!D9JN_@2_+Z[<1WELMS<ZQ#JMB2&*JT87"
MR#T."#CL<U;&@>()[S4M9N6TH:E<P0VL5I\\MOY".S,K,5!)?>W.WCC@T 7+
M?Q-?+?:19:AI<,,NHW$L(D@NQ+$52(R"1#M!8'&,$*0<]1C-'4?'<UFDPM](
M-S,NMC1XXQ/MWL8@X?.W@9(!'8<Y[51M?!.KZ=]DO]/32K>[MM2DO(].1W6U
MCC>#RF16"Y!SE\A0,D\5/!X+U8^7+=W=FT__  D2ZQ)Y88+L\H(4&1U!Z>HH
M ?J?CN\TN2[CETZQ+:9;I-J2F_VL"R[BD(*?O"%YYVYR!UKHM<UV'1= DU41
M-<#]VL,2'!E>1@J*">F68<]JP-7\(7DWB&_U"QM-$N1J"1B1]2A+O;.B[=R#
M:=X*[?E)7D=>:W/$NAMKGAV73K>5+>96BEMY"N522-U=,@=LJ ?:@#+N?%6K
MZ7:2+J>@HE^UQ#;V:076^&Y>4D "0H"NW!W97@#(SFJ]YXYO-(M=534]'0:C
MI_V5_(MKG>D\<\GEJR,RJ<@A@00.0.><TZ^T'Q-K5L9]0O-.@O+:ZM[JPMX
MSPH\1);>Y4,=X8@\?* ,9YS7O?!^KZRNJWNH36,6H7ILXXXH'=XHHH)O-QN*
M@LS$M_".WUH A\0^,]>T[1_$D#Z9:6FJV&FB^@>.[,J>6Q==W,8^=2A.TC!X
MYK03Q5K7]N6&A#1;:2^FL5O9Y!>GRHD\PH>?+!)Q@@8')QT&:7Q+X0NM=NM<
MDCN88DU'11IT>[)*N'D;<?\ 9^<>_6K&DZ%JJ>)K?6]2:S61=*%C)%;.S#>)
M2P(+*.-N/Q_.@"E'XYNWAAU8Z3$/#\U\+-+K[4?.YE\I93'LP$+X'WLX(..U
M8VF>)[G1[OQ?-(PN#_;Z6EN+JY,<,6]%QN<@[%Z]!U('>M*+P;K"Z?;^'7N+
M'^P(+\70F!?[0T:S><L17&T?-@;MW0=,U-;^%-7L&\12V[:9<_VIJ7VH6UVK
M&.2+8%,;G!VGC.0&Z=* .HTBZO;RP66_LDM+C<5*1S"5& /#*V!E2.1D ^U<
MY;>-+K^VUT^_TVUM_/2=X$COA+,AB&<2H%PFY>1@MCI6EX3T*;0=&EM)?L\1
MDN))E@M23%;ACPD>0#@=>@Y)X%<MI7@36=/;1LC1D&FI+ [PAP]TLB%3*[;?
MOYP=O(R6^;I0!IZ/XWO[Z30)[W1HK33]<B+6THN_,D1A$9?G78 %*JV"">@R
M!G R[CQ/JVLMX2O_ .SQ9:9J&JQM;R1W9:1X_+E($J;0!N&& !8<<UM6OA&Y
MBTWP9:2SPM_8:!+G!.)/]&>$[>/5L\XXK.L/!_B*"W\.:;<76G'3M"NTDBDC
M+^;<1HCHNX$84A6Z G)[CH0#H?$7B"ZT>^TFQLM.6]N=3FDAC#S>4J%8R^6.
MT\84YP,^QZ5B3^/[RVLE231 ^JKJZZ3+:1W7R"1HS(CJY494C;U QD^G,WC(
M7I\4^#SIYA%TMW<%!/D(W^COE21R,C(S@XZX/2H8_!FIS2P7UY<6@OGUY-6N
M5B+&-42+REC0D L0 O) SS0!;F\4:XUW=65CH=I<76G6T<U^K7Q15=P6$<1\
ML[S@9R0HY'KPP>-KO5?*_P"$:TE-0QI\6H3">Y\DJDNXI&N%;,AVMP< 8Z\U
M+J&AZ[;:YJM_H4NGE=5AC287C.I@D12HD7:#N&TCY3CE>O-4K;P?K'AMH_\
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M>RT31VNM.&EZ/J$=S#(I?SIHD8E588PI ;L3D@=*]"H **** "BBB@ HHHH
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MN/M%Y;PY (\R4+D$X!Y/J0*\9TM7B309);S2;+2FMM0^POK%L98-AN<J%&]
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MC@$2B-3YT0R%QCH3^= '8)J5C+<I;1WML]PZ"18EE4LR?W@,Y(]Z!J>GM//
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M/O0!Z7%JFGSW*VT-]:R3LF]8DF4L5]0 <X]Z4:G8&X>W%];&=&"O%YJ[E)Z
MC.037EF@Z?9VOA#X=WD%M%'=/J:;YU4!V#1S;@6ZD$8&/0#TK/LI-%.@^$;<
M_9SXBBU^+[8J@>>DGGMYAE_B )Q][@_+[4 >N:QKNG:%%;R:C<I MQ.D$>X@
M99B .O89R3V%3R:GI\5S#;27ULD\P!BB:50T@/\ =&<G\*Y/XEK:+8:#<7JP
MBWAUNT,LDP&U$+88L3P!TSGBN4U671!HGCR&_:T;6;B=S8*=IFE4PH+4P]R,
MXQMZ$&@#U/6=8LM!TBYU34)A%:V\9=V[G S@#N3V%9P\7::-<FL);BVBMH[.
M&Z6\>X41OYCR(%';/[L]^_M65\1H))?A+K*W*"2=+ L_&<. ,G^=4K&RT/6/
MB#=RQ06-Y9#0+=82BJ\6#-.&VXX[8X]Z .XN=0LK-8FNKRW@64[8S+*JASZ#
M)YJ>21(HVDD=4C0%F9C@*!U)->&:82VG:(VI:CHUI9R>%X(XGUBV,R, S^:L
M?[Q,-CRLCDD;?2O1M4@:V^#U];O=-=-'H,B&X="AEQ 1N*GD$]<'F@#HWU;3
M4@EG?4+1886V22&90J-Z$YX/(X/K3Y]1L;:".>>\MXH92!'))*JJY/3!)YS7
MF.HZ?#IECX'-LVE:?9&%WEFU"V\R W#0KM9\,F7(\S#$]3ZFH-'31M-US1WU
MK4=.NM&>QOC97$L/DVHD:X#,D8D)& N0O)RHXR* /3;K5#'<V*6R6\\5Q,T4
MCFY5"F <[1_&<C!4<BGR:SID7VD/J%J&M5+SKYRYB'JPSQ^->0:.(19?#X6Z
MND(\0W_EJX(8+YD^ 0><X]:OVW]FQ3S:;:2:3K$-Q;WYADCAV7MJ2&9EG7^(
M;OER0ISMXS0!Z39>)-'OM(MM4CU"W2UN(1,K22JN%P"<Y/!&X9],U<_M"R^V
MBR^V6_VLKN$'FKYF/7;G.*\IT&UT;5[GX:Q+'9W=O'I%QYL:A73SA%;Y#CIN
M!YP><X-1:EJ5H=?CNO.TBR:'Q*BRVZPDW2A9!&9I)2_R(PQQMQAE&>: /61J
MFGFYCMA?6IN),[(O.7<V"0<#.3@@@_0U!IFOZ9K%U?6UC=QRRV4WDS*K X;:
MK9'J/F SZ@CM7FB:?9Q^##J"VT0O/^$MW"?:-X/]I;.#U'RY'XFMOPGJ&BZ+
MJ?C1KJ:TM9HM8=W!P'6)HX0IP.=I8]>F30!W&IW4ECIES=111RR1(65))A$K
M$=BYX4>]1OJUE;6R2WMY:VI*(S"2=0%W=.3C.2#@]\&L/XF?\DS\1_\ 7C)_
M*L+1],L=1\8/]MM(;@+X8L542H& #--G@_2@#OKK4;*RCCDN[RWMTD.$:654
M#'T!)YK);Q)#'XY;P\]LJD:7_:+79D  42;-I&/QSFO.?#-SH\,.A2^*I+46
M#^%8$M7OL>62&;SE4MQNV^5P.2 *GNHX)O&-Q%ID$ZV[^ W6VAE#>8%,A"J=
MV6SC'7F@#UH7$):)1-'F49C&X?..N1ZUCW7BBRAUC3-.MI(;I[RZ>VD,4RDP
M,L3R?,!GGY",<=:X/^V+;59?!T.BWL5S>1:/=?ZAPQCD-NH4-C[K9!X//!JO
MH<_AV6\^&D>E&T-]$KK<"'&^,_9)-PDQR&W@_>YR&]Z /3+#6$FL3<7YM;,^
M9(H NUD4JA/.[@=!DCM5K^T[#[!]O^W6WV/&?M'FKY>,X^]G'6O'O"=I;WJ>
M%8+J%)H3X@U-BCC*DA)2,COR ?PJVR6-EK 6^6"'0K?Q=/YRR "&-C: QENP
M'F-GGC)% 'K<%S;W()MYXI0,9,;AL9&1T]00?QK'O_$]OI":Q<ZH(;>RTX(1
M*MPKO)E<D%.JG/ !Z]:POA\VGOK'B]]*""Q;4T:+RQ\AS!&25[;2<D$<$'CB
MN.\3Q+*?B[NC#[$L7&5SC$(Y_ 9H ]?_ +6T[? G]H6N^XYA7SES+_N\\_A5
MF::*WA>::1(XD&6=V 51ZDGI7EGB&[T&VU6XU+3;O0M0B>*V633)D >158[#
M:R*>3DG@ C<.H.:Z?X@F)+#1I+S;_9<>K0-?F3_5B+YL%\\;1)Y9.>* .E&I
M6!L/MXO;8V>,_:/-7R\=/O9Q2IJ%E);1W*7=NT$APDHD!5OH<X/0_E7F^H3^
M%WUC2;JQ6W'A]-:D-_,/^/1KG[,1&V<[,;L#(XW]>:SY[>QO]0G%I'#+H-QX
MKM?(6, PR,( )=N."I<$''!.[WH ]635=.EL6O8[^U>T3AIUF4QK]6SBB35-
M/AL5O9;ZV2T;&V=IE$9STPV<5YKJ5EIL6M^);=[RTTJ)-1L)H&F@#6WG>3G$
MB\#:V.I(YV\YQF'3;[39=<T*YU6WTNVTJ)M0B66%A]BDN]T>)$+<#<OFX]]P
M!- '>:[XHAT9M#\N$7<>K7\=DDB2@!-ZL0_0[A\O3WZU>M=4,CZB;M+>W@M)
M=@E%RKY7 .YAQL^AKR=PGV7PV]J --D\;L]AL&$,)\S!3_9+;R,<8/%)<&-9
MO%;W6/[.3Q;:-?;_ +GDCR\E_P#9SMSGC% 'I]CXFL[_ %K4+*)X6M[.UAN?
MM:S!D=9#(/H,>6><]_:I+_Q/HNG:4FIS:C;M9O*D*2QR*P9F8* "#SR>?0 G
MM7FE_?Z(FM^+Y=-ATZXL9TTJ&1V/^BAFFD4R,4(!1>"V#@E2">M9]_-8MI_B
M(37>FW4,6LZ9<&6VMQ#!LWQ*\BJ6;Y>"I;.#@T >T'4K 3P0&]MA+<+NAC,J
M[I!ZJ,\CZ5E^(_$FG^'-.OKPFWFO+>'S3:B55E=<X]SCWQ7G.IQ07FL>(8&U
MO0[%;BYM6L6ELVFN&B\J+R6MV6094.&P%4X.[UJOXEFT5/"_CBWU(VW]N-JL
MC1QOC[04RAB91][:(^XXP&]Z /;**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *C6W@1V=88U9FW$A0"3Z_6EF9T@D:)-\@4E4SC<<<#->9P^-M83PWJ5\^
MI6,U_;V\4DUC)9O;S6DK2*K*48Y9.2 WJ.^> #TJ4V]O 7E\J.&+YRSX"ICG
M/M]:/(@,AE\J,NV,OM&3CIS7!?$75KG[#XCT?Y/LO_"-SW73YM^XKU],5)<:
MWXHT.YBM9OLFI37VEW-S9V\,!0QSPJA$>=QWJ=^,\'(]Z .VG:SM=UY<&"':
M K3R$+@$\ L?>I28H(F8E(XU!9B< #N2:\NUKQ;=#X=Z[?\ V_2M:-JUL!%/
M8-$T3-*H9)H'/&,@J3WSZ9.EXFU/6]4@\96]C<VL%CI-HT+0R0%VN&:#S'^;
M<-N%< 8!YR3GI0!W)DL;BYB0O;RW"IYT:Y5F"GC<.^/>I7@BD='>)&=,[690
M2N?3TKSS2M:DM?$UG9"'3T2+PA'>"YG3:P8/C:TG41\9(^IJLOCK5K?3=<;[
M=;W\MKHS:C!.-/EMT61<@J _^L3H0P]Z /27DM;:2)7>&)Y/W<88A2W?:/7Z
M"I)88IXS'-&DB'JKJ"/R-<#J.J:O9S>$3J?]G7<^I:H/^77'V9&B+!4)).X$
M'Y^,YZ"H-+\>7U_K-JZ3++;W-_):&P2PE!AB#,JR>=]TG*J2.F&QU'(!Z(\$
M,FS?$C>6<IE0=I]1Z5ES:#:MX@&L2LGEI8M:&!D&S:75]Q_[YK"\&^(M2U>_
M>'4=0M/M0@+W.F-:O!/:2;@ !N)\Q.2-WJ 1UP.JU64P:/>RA58I;R,%<94X
M4G!'<4 2*+2^M491#<6[ ,A&'0^A':IMB[]^T;L8SCG'I7EMKXNU.+PMX;N?
MM%AHEG=:=YQNC8,]L)L@+$=I B7&3D]>QXKLO%FM7FB>"+W5[40/=P0+(HSN
MC+$@<'N.>M &_L3S-^U=^,;L<X]*0PQ,'#1H1)]\%1\WU]:X=KSQ>?$]UH(U
M73@QL%OTN19']V2[(8@N_D9 .XG. 1CG(S[GQOJ=QX;T?48=0LK&XN=+^VO;
MI92W4DDF!QM3[D6<_,3G\J /1Q##'&BB.-4CY4;0 OT]*;&MM.4O(A#(70;)
ME .5/HWI7#IX@USQ)-=+IDMK9P6NE6]U)'+"9#-).C/LW;AM4!0,C)R?;%<]
MI/BZ\L/#>@:59WL5F;;P_:76Y["6Y\^1U(5/D^XO[LY/7YACH: /6I?(B@E>
M;RTA +R,^ H Y).?YU';VEO'=7%[$,R76PN^<@A1A<>W7\ZYOQ-?-J?PBU>_
M>!X'N="FF:)QAHRT!)4^XSBLC1/%UWJOA^_U#2)+<:7H^GM&&==SW%PL0;.,
M_+&./=LY''4 ]!,49E$IC3S -H?;SCTS21010 B&)(PQR0B@9/KQ7!P>)]<T
MV;2;O5Y[2XM-2TV>[:"" HUNT<:R8#%CN!!(.0.>1CI1%KOBB"UT&\NKJPE&
MO*8XX4MBOV29X6ECPVX[U&W:<XSU&.E '>R0Q3;?-B1]IW+N4'!]12[%RQVC
M+#!..M>>0>/K^ZG\+/'%"+:ZMXGU;*G,3RN(8U7GC]Z'!SGI3H/%'B'5M6L;
M6RFL[>VU&ZU!89G@+E(;=D16 W#))W^V&![8(!WQMX&:-FAC+1_ZLE1E/IZ4
MK6\#2&1H8RY7:6*C)'IGTK$\(ZK>ZKI-S_:#1/=VE[<6<DL2;%D\N0J&VY.,
M@#C/6N+T36_$<%M+:?VG!<7FH^(KG3X99;<[;=8VD9WQOY^6/"KD >IH ]2"
MJI8A0"QR2!UIL<,4.[RHD3>=S;5 R?4US_AS5-0FU;6=&U26&XN-.>(I<Q1^
M6)8Y$W#*Y.&!##@X/'2LO4/%>HVWAWQK?1B'SM&N)([7*<8$,;C=SSRYH [1
MX8I'5WC1F7.TLH)&>N*:S6\3PHYB1F.V)20"3@\+^ /3L*XV7Q'J:>-6TV>_
MM+"/[1'';6MU:N!>1%%+,DV=N_)<!0/X0#US4GCA;QM<\(+8211W+:E($DE0
MLJ9MILG (S@9(&1S0!URV\"8V0QKABPPH&&/4_6G1Q1PJ5BC1%)R0JX&?6O/
MSXMUO2KJ:'49+:XATS5HK._N$A*;H)XU,<F,G:5=U#=L>E=+HNKW>K:_KBCR
MQIEC,EI 0OS/*%W2DGT!95^JM0!N"*,!0$4!3E1CH?:HKE;1+>1[H0K!]^0R
M@!>.YSQ7#:CXEU_[#XCUVQGLX[#1+B6(64D!9KA80#(3)N&TGY@N!Q@9SFL#
MQ+<ZI=P?$<RZB);"'3X3%;F+& \99<'=QC//'/MB@#UI[>"0,'AC8.06#*#D
MCIFG>3%YWG>4GFXV[]HW8],UP6I^*=<\+75^NIRVE\@T>7484B@,?ER(ZKY>
M=QW*=XYZ\&LZY\>:O8:-KDJ746H26FG?;(KDZ=+;(D@8*T9#_>'((.<]<T >
MG>5'L*>6NPYRN.#2&"(NKF)"ZC:K%1D#T%<+K>M>(=#6Q34=6L[.*=)99=0_
MLYY(87RFR%L-\JX+G>Q&=O:MSQ%K%_I?@J36;;[-+/;11W,WEY>-XP5,NP]<
M;-Q!^E &^D,49RD:*0-ORJ!QZ4PR6QO/)+PFZ$>_9D;]F<9QUQFN,D\<36WB
M[4HI_)_L*VMI?+F4?,9XHHYG&<X(V2'\4-9-MKVMSZZEO<QV%OJ4GA(:@]RM
MKF2.4R_<SG.P?W<]>: /2BUNDL4),2R8)C3@' X) ]LCIZTV1[6#;%*T,?GL
M55&('F,>P'<UY7HJZY=2_#\KJD37EQHEPYNI8"YC0K;'D;OG;MDD=<X['0;Q
M1J$Z>%UO8+"XNG\03Z=/*;?C]TTB^9&"3L8[!W[F@#T=;>%(1"D,:Q#H@4!1
MWZ4_:N_?M&[&,XYQ7G3>)_$BV-QK37-D+*UUQM/-H+<EI8OM7D[M^[Y6 8=L
M?+SUP-;XDSZC;^&(7TV^^R2-J%I&SA-Q*M.@QU&.2,^HR.] '5(;=W:%#$6A
M(+(N,H2,C([<&E%O "2(8P2V\X4<MZ_7WKS2>7Q!I^L>.+ZPU"SCDL(;>XE,
MMJ7^TNEJ"5QN&Q3@^IY]N=3_ (2#7]<FU631[BSLHM,MH9/+FMS*;B5X1,5)
MW#:H#*..<DGVH [<6\"DD0Q@EMY(4?>]?K[TI@A,PF,2&4# ?:-P'IFO/AXU
MU&\OM,F%Y::3:7MK:W%JEY;.T=V9!ET\X'",,@ 8SG!Y!Q3+;QW?7.NH8IED
MMWU5M/\ L"V$I98Q(8O-\[[N=PW$= O'49H ]&,<95E**0W+#'7ZTK(KKM=0
MRGL1D5RWC/Q'+HC:7:07"VKW\SJURUL]QY2(A8D(O)).T>@R3VK%L_%>OZK+
MHMA;26\,UW->037<MFZAEAVE)4C8@C<"."< GN!@@'H,L,4ZA98DD4'(#J#@
M^M,CEMIIY!&\3S1?))M(+)GG![CUQ7F5]K/B/4%T* :I#;W,7B.;39Y8[8[9
M]B2%7*[^!@<KG!/.>,57\1:WJ3Z;X[6Q>VL)+'4;6(3P08DE5]@.Y@02WS=?
M08H ]2064=PMK']G69%,@B7:&52<%L=0">]2QV\$041PQH%SMVJ!C/7%>>ZM
MXGNO#OBS5%N8+.ZDL/#/VUKA;?RY)9!*PV[LDA"0/EYP3FHX/&6N^1J,-M(-
M5G2R6Y2:/2YH1"WF*LB[&YDPK;U .3M(H ]($4855"+A3E1CI]*Y@>#YI=4@
MGO-;N;JRM[O[9%;/$@;S!DJ&D W,JEN![#).*L^$=5DU;3IYFU:SU-$F*)/;
MPF%@, E9(R3M<$GCTQP*9XPU;4M*L]-_LOR!<WFHPVF9U+*JOD$X!!XZ]>U
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MO.^-8BN.>!ES0!TLTEK;1 SO#%&S@#>0H+$\=>Y-1WNF6FH6\T%Q"I6=0LA
MP64'.">N*\XN?$.N-X T/7M4_LRZ?4[NP*6YM,I '(RP)8Y8Y# \;3QSUJYJ
M?B?Q)#9>)-6@N;)+31+\PK;M;EFN$ C+ MN&WAS@@=>M 'HK*KJ590RG@@C(
M-($0'(50<8R!V]*\_P!;\2^(ULO%FK:7-91VNA%X8[:: LTS)$KNY?<,8W\#
M'.WGKQL>.;N]B^&>L7EG<_9KI=/>3S%7)'R9..1@]<'MUH Z)DM)'6U=8&=
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M\5:]_8I\5B>T_LG^T/L_V#[.=_D?:/(W^9N^_GYL8QCCWK-\3ZGK>M^$]:U
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M<26. ,#/WA0 VX^']C=74LTUW.5ET+^PW10!^[SG>#_>Y^E077@&;4%NFO\
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MFWTK5)?.O;)(U/F,0 X5R,J&"C(Y[XQFDU7P*FI7>N.FIS06VLVJ6]S;K$I
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M1)#'I6-DI"LC1R$@A.H.6P,,>>*]*HH \G>62RG\?:/:Z1?WDETL5K;F&+S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?7Z,T$) RJMM*X+'H20.#UI^DZ_?7GB!M,NX;5=FE6]ZSV[EU+R/(I"MW7Y
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M;.S(X'7GK0!Z-17!7OC/6- DDEUJVL9+>32;C4H([4.KQM%LS$S,2&SY@^8
M=#Q5VQUSQ'!XFTC2=9ATUDU"UFN/-M5==C)L^3#,<XW_ 'N_H,<@'845%<SI
M:VLUQ*2(XD+MCT R:XO3O%6NE/#VI:E!8+INNR+'%# KB:V,D;21[F)(?(7!
MP%P3WH [FBN5\#:YK7B32$U?48K&"UG!$$4 ;?E792S$G&#C@#\^<"--=\0Z
MEJ=_)I%K82:=I]\+.2&4L)YR-OF.KY"KMW' (.=IY&10!UU%<*WC6[@\7P:;
M+<Z1)#/?M9?9+=V>XB&UBLCMG;DE1E, C<.35BW\87DWAC1]4-O );[55L74
M [50SM'D<]<*#]: .RHK@+7QW>;]7NKM],\C3H[J2?3E+)>0+%NVL=QPX8*.
M0H W#DU0A^*$EO:WLEQ<:1J4J::U[$FFNV(W5E7R9"2<Y,BX88SAN.* /3L\
MXHK@[/\ MH?%#2TUHV+R_P!C73+)9HR+S+!E=K$GC'7/.>@JWXF\47^E^((-
M,MIM+M!);B6)]2WJMW(6(\E'! 5@ #D[C\XP#S0!V-%<=>^+KVUT3QE>K;P>
M9H3NL"G.'Q!'+\W/JY'&.!2S:]XBO]5U.'0K6PDATMHHY8K@L)+F1D61E1@0
M$PKKR0V3Z4 =AG-!.!DUY;_;.MZ"/&VKV,5BUE9:L9IXYPQDE'D0;E4@@(0.
M<D-DGH,<]CXZO$L/ FM7;VD%VD5H[F"X4F.0 =& [4 =#17#IKVO76HC2=%@
MTN!8='MKX27".R@N7'EA58<?(,'/&#USQFV/BS6-3\2:%?B:WM]+N/#[ZE/:
ME&8_>BW\[@"PS\IQP">.: /2J*\TTCXE37QC+7.CW+75A-=Q6]F[-):.B;Q'
M+\QW9&<D!<%2,<YJU:^*_%$^F^&[EK72EEU^11#'B3$"&!Y-S'/S'Y0<#''&
M<_-0!Z#02!U-<+_PENK0Z1J*WDVC6M]8:H+"6[F+);[2BR!PA;<6PX&P-U[U
M@:QK\GB*P\'74I@:6+Q9';M);Y$<FSS '4'D C!P2<>IH ]9HK#\3:S<Z3;6
M,5C'"]]J%XEG;^=GRT9@S%F Y("HQP,9X&165<Z[XELY+#2)[;3AJU]>/#!<
M@,;<PI'YC2F/=N!_AV;NO.<4 =C17 S^,M;MMVG-:V,FKPZQ%ILC#>L+K+%Y
MB2 9)7@C(R>A]16?XA\2^)HM'U:R^T6,.HZ?J=E US;Q.J213-&1A2Y*G+8/
M)R,XQG@ ].HKB?\ A)]<C\1:M92QZ>+'1;6&YO9PC[I T;,RQKNXY4D$YP,#
MG.0NG>)M>6?P_/J\.GBRUT[(H[=7$EJYB:5 S$D/D*02 N#ZB@#M00>AS17"
M_"/_ )$;_M_N_P#T<],_X3'6O[-_X23R+#^P?M_V7R-K_:/*\_R/-W[MN=WS
M;=O3OF@#O:*X>3QK?Q>&+Z1K6W.O6^IG2DMAN$;S-(!&<9SM*,KGGIFJ,OQ(
M,>O2P_;-)^SPZFNG-8EF^UO\XC:4?-@ ,2=NT_*"<T >C4$@=37*^%M<UK7M
M1U22XBL8=-LKVYLD"!C+(T<F V<X V\$8R3Z"N<\16-]JGQGT:VF_L^>TAL)
M+J"&Y@9PF'0,V-V/,S]UL<>AH ]-!!Z&BO,M'\4WD6D6PTG2M-MYKWQ'<Z>4
M"LJ# E8RG!R6R@)]>1QU&H?%FKVVGZO#>RZ-;WVG:A':/=REH[?8\:2!]A;<
M6P^-@;D]Z .YHKSRR\<ZMJ2:7;6*:;-=76H7-B]P XA(CC,@D5<YQ@#Y2>O&
M1UJ>'QAK4J)I0AL#KCZO+I@EVO\ 9\)%YQEV;MWW,#;NZGKB@#O,@=317!:S
MJFI6UUX7AUS2=.EO)=:^SK*N64+L8K-&,Y1B.,$G'-/7QK=Q^,+?3)KG2)8;
MB^DL_LML[/<0@*[*[MG;SLY3 *[AR<4 =T"#T-%<+\*_^0+K?_8=O?\ T943
M^-M7@@\3:I-;6*Z7HEQ-;!<L)9W4+LYSA1E@"<'J>!CD [^BO,W^)-W!IVK&
M*?1]7N[2"">*2P9A$V^41M&P+$AAD$'/.1P,8K0U#QEJ_AN?4[?6K>RN98M.
M^W6ILP\88^8(_+;<3_$Z?,.Q/ H [RBN$U+Q3K_AP7L&K1Z;//\ V1=:A:26
ML;H@>  M&X9B2/F7Y@1WX%4K_6/%\TOA*3[1IMI_:=Z6\E(Y&Q&;=W5)#O&[
MH<XP,A?3D ](R#T-%>:IXJGTY_$\NG:38+<Q:_;V7 9/M!D,:[G.?O?-U]AP
M:NW?C#6](?6+"^@T^YU&W-F+-H%>..0W,AC4."6(VLI)(/(]* .]HKE]'UG6
MF\6W>@ZO'9,8+&.Z2XM591)O=E^ZQ.W&W&,GUSS@96I:_JVE>/\ 6))KF!M%
MT_1!?O;!&WD R9P=V-V4ZXZ8&,\T =[1GG'>N.T[Q!KT.JZ'!K46GF'6D?RA
M:JZM;R+'YFQBS$.-H;D!>1TYJ#Q =3_X69HZ:2;5;A])NP9+E69(U\V YVJ0
M6Y &,CKGMB@#N**\VD^(]P(+&TGN-(TO47DNXKJ>]+&W1K>01D(-RDER01D\
M 'KBNQ\+:V/$?ANSU78B-,&#B-MR;E8HVT]URIP?3% &Q1110 4444 %%%%
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MFMN8@YPHZ@+@X&.>*[2N4NO'.FOJVE6&E7EI>275_P#9)PKY**(Y&++CKAD
MSR.: .1T"&]O-=\(V:7=]<PZ,TN^*?3'M3;1B!XU$S$E7DR5 VD C<<'K77V
MO@S[-H/A[3/M^[^Q[M+GS/)QYVT.-N-WR_?ZY/2M:U\2:+>ZC-I]MJ=M+=P[
MC)$L@R-IPWUP>#CIWJC+XOTF[T?4;K2-7TV62SB\QGFE/E(.S,1SM.#R/2@"
M'2?#&HZ8(]/_ +8C?0H/,$5H+7$C(V<(\A8@JN[C"J>!D]<T-/\  ^I6SZ!#
M<Z\D]CH4NZTA6SVNZ"-HU$C;SDA6 ! '0Y!SQOS^)M(T\V4.HZI9P7-U&KHO
MF8# X^89_AR< FF7'B_P]:6\-Q/J]JD4T*SQ$OG?&V<,HZD<'IZ&@"76K#5+
MP0MIFHV]L5#++#=6OGQ3*V.H#*01CC!QR<@]L"S\#7ND36DFD:TD&S3UL+DR
MVF\NBNSAH\, C NP .X $<'%;UYXHT+3[.UO+K5;6.WNUWP2&0$2+C.X8ZC!
M!)Z#-.OO$NBZ9);QWFJ6L+W*[X0T@^=?[W^[R.>E '/6?@:_T:UTLZ-K44%[
M9Z<-.EEGL_,2:,'*ML#C:P))')')R*U=,\,/IVI7%Y)J4UT\VG063-,N78QF
M0F1FSR6\SI@8Q4_AC6VUOPCI^M721P-<VPGD52=J<9/7M5U=7T]TL76\A*WX
MW6I#?ZX;"^5]?E!/TH J:1H7]E>$+/0?M'F_9[);7S]FW=A-N[;DX]<9K*\/
M^"?["'AT?VAY_P#8]C/9_P"IV^=YC1G=]X[<>7TYSGK6I8^+/#^I7T5E9:O:
M3W,R>9'''("77&[CUX.<=<5FZCXYTR+4+&QTV\M+NYFU%+.:,/DH#D,1CJ00
M ?0GF@"NW@>YA^P36.K1QW=EJEUJ"/-:ET(G,FY"H<'@28!SVZ5>TKP[JFDW
M:06^LQKHL=Q+.EJ+7][\Y9C&9"Q&P,Q(PH/ &>.=*#Q'HUUJTFE0:E;27\98
M- K@ME?O#W([CJ.]&F^(M'UF>2#3=1M[J2) [K$^[:#TS0!C0^"O*\%P>'?[
M0SY5XMUY_D]<77VC;MW?\!SGW]J77_!K:SJ%_>I?B"2XM[2.-6AWJCV\[3*S
M#<-RDD KQP.O/&I>^*-"T[45T^\U6U@NSM_=/( 5W?=S_=SVSC-6WU6PC%\7
MNXE%@NZZRW^I&W?EO3Y>?I0!QNK?#W4-;T[7K:]UZ(OK45N)G2R($3Q/D%!Y
MGW=HQ@DG/.>U=9K^CP^(-"N]+GD>-+A-HD3[R,""K#W! /X4R7Q-HD%[!92:
MG;+=3F,10E_F?S,[,#WP?RJ75M=TO0HHY-4OH;59"0GF-@L0,G Z\#KZ4 8%
MSX2U?5;:4ZMXA$MXKP26;VUKY<5O)$^]7\LNVYB>&Y'' QUJ.Z\$7>JQ:G-J
MNJQ2:C?);PB6"U*1PQ0R>8%5"Y)));)+=QZ5T\&JV%R\B07D,K1PI.VQP<1O
MG:W'8[6P?:L^Z\8^'+*&*6XUFTC26%+B,F3[\;YVN!W!VGGV- %;7/""ZY>:
MI,]X8EO](;3"HCR4RS'?G//WNGMUHT;PS>6.M0ZM?ZC#<W*::NGLL-L8E8+(
M7#<NV."!CVS[5?O_ !/H>F06T]YJMK#%=+O@=I!B1, [AC^'!'/3D47OB;1-
M.NHK6[U2VBN)?+\N)G^9]Y(3 [Y*M^1H P8? ]U'';:6VK1MX?MKT7D5H+7$
MV1)YJQM)OP4#X/W<X &:U_#WAS^P;[7+G[5Y_P#:E\UYM\O;Y655=O4Y^[UX
M^E7CK>F#2HM4-]!]@FV>7<;_ )'WD!<'ODD ?6L^#Q-:06^IW.IZEIJ06M\U
MJ&AD)V=,(^?^6G/(&>U &;J7@R]N7UFULM82UTO6G+WL#6N^12R!)/*?> NY
M5&<JV#DBI=>\#6^M:MI5VET;:"T58KBW6/<+J))$D1"<\ .@/?@D=ZOGQ#;W
M-[HO]GZAILMIJ#2@%I#YDNQ2<18X)!!W ] #WJ:/Q1H4VKG2H]5M6O@YC\D2
M#)<<E1V+#N.HH HW_AW5#K%Y?:/K,=@+](TN@]KYS H" \9W *VTX^8,. <>
MMW2]"_LW7=;U/[3YO]J2PR>7LQY>R)8\9SSG;GH.M-3Q;X?DOXK%-7M&NIG,
M:1B09+@D%?\ >RI&.O%;5 &'K'AW^UM?T'5/M7E?V3-++Y?E[O-WQE,9R-N,
MYZ&LF7P'YDNN/_:6/[4U*UO\>1_JO)9&V?>YSLZ\8ST-:%CXVT*^U#6+1;V*
M,Z2V+AY'"J%"J6;)Z %MISW!K1TG7]*UQ93IE_#<^40) C<IGID=1GMZT 8N
MO>#6UG4+^^COQ#+<06B1JT&]4>WG:92PW#<I+ %>.!U]*K>![^YOY[R]UN*5
M[FZL[N94LRH#V\@8!/G.%*@#!R0><GI6]J?BK0M&F>'4=5MK:5%5F21\,%;.
M#CT^4\^U.NO$VB65Q;V]QJEK'-<",PH9!F0.2$*^H)!Q]#0!EZOX,35KW5[E
MKYH7OHK00E(P3;R6[O(C\GYOF8<<=.O/%35O!>J^(= U&PU?Q LD]Y) RM#:
ME(8%B</A8RY.6P<DMZ>E;L?BC0I=7.E1ZK:M?!S'Y(D&=X&2OH6'IUJ?^W=*
M_L8ZO]O@_LX DW._Y!@[3S]>/K0!S6K>"+^_DUF*WUJ.VLM3N$NV0VF^19D5
M H+[QF/,:G;@'J-V*UM$\-OI/B'7=7DO%G?5F@=HUBV",QQ[#@[CG/7VZ<]:
M?#K\$4^M/?:AIL=IISJ&9)"&A4J#^]SP#SQCM5.Q\:Z??Z]?V\-U:G3+33XK
MQ[K?C86>16#9^Z $!Y]: +D'AN--:UZ_FF\V+5XH8G@V8V*B,IYSSG=Z#%85
M[H.MZ=X-U6TN-96]M+?1Y[:VMXK/8\G[O"F1MS;F &/E"@Y)QZ=5I6M:;K<#
MS:;>17,:-L<QGE3C.".HX(/XU&WB/1EU<:2VI6XU L4^S[_GR$#G([?*0?QH
M YK2/"-Y?6^D3:WJ*75K::>T%O;+;&)QYL81C(VX[F"Y7@+U)Q5K3/"%_;W.
MCC4M8CO++10?L426OENS;#&K2MO(8JC$<!<DYK8L?%&A:G'<R6>K6DR6J>9,
MRR#")S\Q/]W@_-TX/-,M_%F@7>G7.H0ZM:M:6N//EWX$>>F<],]O7M0!CGP,
MP^'D'A:/4@);=XY([LP9&])A*,INZ9&,9IM[X%GU*ZUN[NM5C^T:MHZZ;(8[
M8A4;#9D +GCYONY[=:V_^$KT'^R?[4_M6U^Q>9Y7F[_^6G]S'7=[=:</%&A?
MV9%J7]K6@LI7,:3F4!2X!)7/8@*W!]#0!E>(_"4.K1K-<2S20P:5=6+P0Q@R
M2B4)RI)P&'E\ ]2>HQ7.^'6U'6?&6CWCWUS>I8:=<1RRR:8]HL+.8PJE7)W2
MG:Q;!Q\HX'?M8O%6@S:3+JJ:K;&QA?RI)M^ C\#:>X;D<=>1ZUG:GXVTZTBT
M6\MKNTETV^O'MYKDOA8PL4CGZ',8&#ZT :VD0WLWANTAULB6]DMPMU\H7<Q'
MS<+P/PXK!TWP9>VS:-:WVL)=:7HKA[*!;79(2J%(_-?>0VU6.,*N3@FG>(?'
M%M9>%!K>BRVVH)]LBM3\QPI:158''((ST-;EQXCT:UU:/2I]2MH[Z0J%@9P&
MRWW1[$]@>O:@"/POH?\ PC?ARTTC[1]H^S[_ -[LV;MSENF3CKCK67)X4U*+
M4[UM-US['IM_=K=W,*V^9@XV[A')N&T/M&<J>IQUKHM0U&STJRDO+^YCM[:/
M&Z21L 9. /J20,50;Q7H*:5'JC:K;"RDD,22[_O.,Y4#KN&#QUX- & G@?4H
MFMHX]<A6TLM2?4;6(V9+%G=V82MO^?B1@"-O8G.*2'P)J$:6=D=<C_LNQU,:
MA;PK9XD/[TR;'??@CYB 0H[$YQBMZX\7>'K2.UDGUFR1+M!) QE&'3.-V>RY
MXR>*N2:QIL5O?7$E["L-@2MTY;B$A0QW>GRL#^- '.77@J[U>]7^V]5AO+.)
M+B.():".<I,C1E7DW$$!7/ 5<D GI4C^%-5U+1+W2-;UY;FUFM/LL0M[01%3
MQB5B6;<XP.FU>O'/&S-XCT:#5$TR74K=;YV"K;E_G)(W#CZ<U%:>+?#]_%=R
MVNKVDL=G&9IV63A(QG+^Z\'D<<4 4--\-:K'XFM]=U?68;R>"RDLQ%!:>2A#
M,C;^78[ODY['(P!CF3Q-X>U/78[BU@U6VBT^[M_L]Q;W-D)MO7+QG<NUL'^+
M<. <=<W]/\2Z+JM]-96&IVUQ<PKO>.-P2%S@GW /!(Z&FV'BK0=4>X2RU>SG
M-LADEV2C"H.K9[K[CB@#G-3\ WUW!KMA9ZXMKINLH//1[7S)4<1+'E7W@8(1
M<@KGK@C.1=O/">I?VC?SZ3KO]GP:F(_MBBVWR!D4)OB?<-C%5 Y#8QD5N:3K
MVE:ZDCZ7?P70B(#^6V2N>1D>A['O3;GQ#H]IJ::;<:C;QWTCHBVY?YR7SMX]
M]I_*@#(N_!GVK0_$^F_;RO\ ;D[S>88L^3NC1,8W?-_J\YR.M:GB;1?^$B\,
M:CHWVC[/]L@:'S=F_9GOC(S^=.L?$FBZG>S6=EJ=M/<0@EXT<$@ X)]P#P2.
MAJ+3_%F@:K<I;6&KVEQ,[%42.0$M@$G'J, \CC@T 1:=X;_L_5Y+_P"U^9OT
MVWL-GEXQY1<[\Y[[^G;'4UD6/@.;3GT$P:G$Z:?IK:7<K+;$BYA8H3MPXV-\
MG7YNM;UEXJT'49+E+/5;69K9#)*$DSM0<%O< ]QQ4/\ PF?ALV<MV-9M&MXG
M2-I%?(WL,JHQU)'84 4M/\,:O;::=*N=>2;3HK)[.WC2S"N5*A5:5BQW%0,?
M*%SR34T'A3R;7PK#]MS_ & %Y\K_ %^+=H?7Y?O;N_3'O5&#QI]NMM2N+:YT
MN."VU6.RAGGD;RY4:.-N",_.3(0!TX%;-YXM\/Z?=-:W>KVD,ZRB)D>0 JQ
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M[9]04E3 '^;(&2/<@=1U%0V_BWP_=ZA#86^KVDEU-D1QK("6(&2![X&<=<4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKZ(371MA.;1.3YJJ01D,% )!QNS7#V,D,:W\UYJ6L65Y%K3W-KJ<E@#A9+=
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M-YR*[.$W,SEE.=V#O)Q5O3K"6+P+X1C6T=)$UY)77RR"N9I<L?3@]?>O4:*
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MXZ?=K.E\#:7<Z%JFEW4UY<?VJ0;RZEE!FE(P%Y P  H    ]*Z0(!&$'0#%
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M$C?#*0A96!(QCDX X(O>'O _E>&[2.\:YTW4(KNYNH6M9PTEL)G8^66(8/\
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M[NTU#3K=+1KZ.6\A"K- N,LNTD]U^4X;D<4+XZL(K6\FU"QU+33:PI/Y5W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH ***:9$&<NHVG!R>A_P F@!U%%% !12!@PRI!&<<4M !1110
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M4(-O'4@<Y!Y]*DF\'LVN3ZG:ZU?68O507]O $V7)5=H;Y@2A*@ E2#@#H>:
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M(K9D554 ')')X';FLF[\!+?QZNMSK=[(VK6T5O<MY<0_U9.&4!1@_,1Z?4T
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MD 4[9)!GC"MGY>I R/2HQX*M%CN[,74O]E7=Y]MDLBH(\S>'(#=0A8;BOUY
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MN69XY$5WY&T#:0A'KT/M4>A>+M1;0;&34%BEOM0O[J"'RD=@HCDER2J@G "
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M,*DDBPA%)[9P?R-6/"-DLFM)?O;^(EG@LC SZJ0$0LREHT&!NY0'<,KQUYH
MW]6\4Z7H][]BN))C<^3Y[+#;R2B*/)&^0J"$7(/)QT/H:Q/#WBN34+?PO)?Z
MG;PW&I:8UW+:BU;]Z0JDL),X0+GH<YS[4V]:\T;QKK-U_9-[?0ZK86\=N]O%
MO421F0&-S_ #O4Y.!UYK T30=4@O? KSZ5.R6>@3P7*.N LA1 (V)X!.".:
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M(2PCG7)*/C[O7O4UMI.H:?X*\!W!TZXDDT8PR7EG&F90# \;$+U+*SYP.>M
M%_Q5XZ6U\#ZAK&AO_I=G<PP2174#H\3-(BD,C $':^1]0:WF\5Z2FL_V699_
M/$H@,@MI#")2 1&9=NP-@CC/<#K7GWBC2-5UW0/%VH6FEWB_VE=6"VMM)$5F
M=873=(4ZJ.O7G"YK=N([VU\9;](M-9M9I[^,WD3)OL;B'"AYMQ&$?:.Q!)4
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MNEMUL97N#*) I 0+N*@9.=N",'."*Z'Q;9SZAX,URRM8S)<7&GSQ1(.K,T;
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M@C;UX&.M>L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445C>+8]2E\(:Q'HY8:BUI(+?8<-OVG&#Z^GO0!#/XB<>+
M+?0[:*WF$UI/.)A/RKQM&-C*!Q_K!SD_2M+2M3AU:S,\0*,DCPRQ-]Z.1#M9
M3]"/Q&".#7#:1/87?CCPY=Z;IUS!"NCW%M)NLI(_*8-"5C<E0 1A_P#)K9\&
M1R#5?%LXR+:;6&\KT)6*-'(_X$I'U!H FM_$NJ7NOZUI5II%J[:4T0=WOBOF
M^8F\;1Y9QQQR>M2Z=XH_MO2+BYTZV6.]M;H6MU:7LGE&!PP#@L P/RG((R#Q
M6+H]_%I_CWQE<W$5T(9WM#"Z6LCB7;" VW:IW8/'%<_J&B7C:!X@UJ\T^6*?
M5M:L[FVM#%OEBBCEC4.0,[6*!V([#KWH ]7-Q LX@,T8F(R(RPW$>N*/M$;2
M/#')$TZ+DQ[QD>F>X'X5P4ZW<'C7SK';?6]QJ*&>SN;<B6V?R@OVB&0=8]H&
M0<CJ <G%-\%26D\.DV^I:5>)XCTKSENII(9$5&8$22&3 20/P1R<Y!QQD '4
M^&]?&M^&8-8NHX[,2-('0R[E3;(R?>(']WT'6M9[F". 3231I$<8=F 7GIS7
MEV@"ZL['PA<7=M.-+@N+];M7A;]S*[L89'4C(&"PW8P-X]:ECTN[MK21K>\?
M34_MFYNM),]L9+=8BF"DB<;$8F0J>,9&.H! /3)+JWB1'DGB1'("LS@!B>F/
M6J>MZHNCZ1=7N(GEBB>2.*27R_,*@G:#@\\>AKS<R-OLX_$6EWUCI=_HT=K%
M#96AN(X9 SAX\>6S)O4QD<#A0#R.)KN/[#)X@TW5;&]DBN-$A@TLS0M<$JL3
M!XRR@CS-^"?7@]J /1M)OFU+1+&_,81KFVCFV9R%+*#C/XT65W(VG6\VH?9H
M+AX]TBQ3;T! R=K$#('KBL_P^L;>!M,CNH65!I\22Q3Q$$8C 8,I&?7C%<#X
M>TR&6+X=1W^FLWD:;<17*SVQQ&=J;5DR..0< ]QQ0!ZRCK(BNC!D89# Y!'K
M7.7WC"W2#3[C31#>P7.J)ITD@FQY9+E"PP#NP5/<5#\.HC#X*@MGA>+RKFZ0
M121E"J>?(4&".FPKCVQ7'1V2)X=L]/DTV=9(O%1>X0VC@&+[3(P8G&&380<\
M@ CUH ]/O+R4:<]QIWV6XD! 7S9MD9^8!LL <8&>W48JPUQ DPA::,2L,A"P
MW$>N*\IU:PCCT#QG9V^GN(O[:MIK2&.V..EON:, >JR9(]#6U>BZA\:&>QVW
MUO<:C;FYL;FW(>(^6@^T02#^$+C<#D<,,@G% '?O(D8!D=4!. 6.*C-W; Q
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MI-Q$(,9\TN-N/KTKSZ]L=,GO_"_V'2YTTV75[BYD26&3:0\$N79&&44NV "
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M1:/8['O(?,_>QM)DER,-(HV9/6L?0--ALM/\%7$6G/!=QZQ<B=Q;,KI"PN
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MNEW&HSN/L\$+3,P.<J!GCUXK'TK6=9U"[LY'T^P33+F)91.MX6D&4)V!-O+
M@9.<8.>V*=XKL[>/P%JUE!:KY2:?+%!!'%G!$9"*J@>N  *YQ;6W75O ,L=G
MM$5O,L["W(\O=;XP_'RY;C![T =\+F!I!&LT9=LX4,,G!P>/8TJW$#SO LT;
M3(,M&&!91[BO)M'TV"STOPK<0Z:T-Y%XBN#(ZVS*Z0,]QC)QD(0R>W(J73I%
ME\1>'ISIEW:PI>ZA'<V[6<K"+S Y_>2,#OW'YLYV@8],T >IK<P/((TFC9R"
MP4,"2 <$X^O%*L\+3M LL9F49:,,-P'J17D_AG38[&V\!3Q:<\%TEU=)<O\
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M)XX4C.Z(/:RL@+;OF^4\\#GIB@#TBHYYX;6WDN+B5(H8D+R22,%5% R22>@
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M)<W=W-*<O/>3&60@9PN3_",G ]SW)K3KSS2?%?B348?"LS/I:C7K>0[1;O\
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M9&W@_*<,=HP?N\]>*;^*=2A\1V%J_P!DEMKK5);!EA1F\M5C=E/F9P7^3YE
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M9LJ(U.2&R>JG!P1D'%5-3\9:3INC:AJ.^:7["526 0N)%=@-@92,J#D<D8H
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MAF0X^< D#Y<]1ZT 1GPU9O=QS3RW$Z17+W<4$K!DCE8,"PXST=N,XYZ51LO
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M0M_$]FMS.L.DW&DR7>QK=_,$BR1KZ;CPS<!>@S0!<L? FE:=)826T^H*=/\
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MM%O]0O/M6E0WL&HPVA6VO+:6/8[$G,,T;G#(<*>AQSR.^IXKLK_4O FK6$$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !15/5M3M]&TB[U*Z)$%M$TKXZD =![GI61X
M0UG4->L9+^YN=%N+5R! ^ES/(,\[@Y8#!''&* .CHJM?M>+9.;!(FNN @F)V
M#) )..< 9/X5RUIKGB2\U[7=+A&F/)I0@/,3KY_F(7P/G.W&,=_PH [*BN6T
M/Q;#<WNH6.K7MA;W<>J265K&'V-,JJA&%9B2WS'I6Y+J^G07L=E-?6\=U(P1
M(FD 9F(R !ZD<XH NT54OM3L-,6-K^]M[42-M0S2A-Q]!D\U7/B/1!;6]P=6
MLA!< -%)YZ[7!. 0<]">/KQ0!IT51O-9TS3Y"EYJ%M;L "PEE"[03@9STR00
M,]<5!'JT,FK3(NJ:<]I':+.8E<&5,DGS&.[ C*XQQZG- &K16'J'B[1--LQ<
MRZA R&XBML(X)#R, H/IP<\]N:L?\))H?VM+7^V+ W#NJ+$+A-Q9@2!C/4@9
MQ0!J45FQ^(-&FCFDCU6R:.",2ROYZX1#T<G/W3@\].*;%XDT2<SB'5K.4V\(
MGF6.96*1D9W$ ]* -2BN;7Q'<:MI&CZIX=6UNK:[N(A.LK-O6)N3C;D!U!!(
M;C /?%;)U2P%\MB;R 73-L6'S!N+;=V /7:,X].: +=%075Y;6,0DNIXX4+;
M078#)]!ZG@\5F7WBO1;"'3II+^!HM0F$-O(D@*.<$D[NF  >?PH VJ*Y71_%
MT,NIZI8ZM>V%O-#J9LK- _EM,/+C<<,QRV7QQ[5NSZOIUM>1V<]];Q7,C!$B
M>0!F8]!CU/8=Z +M%9T'B#1KJ^%C;ZK92W9+J(8YU9R5QN& <\9&?2I;[5M.
MTP W]];VP(R/.D"\=SSVY'/O0!<HJE=ZQIMC+'%=W]M \A4(LDH7.XX7KZG@
M>IJI=>*_#UF\D=QK5@DD9<-'YZEP47<PV@YR!SCK0!L45@6?B.VU;^Q)[#4;
M!8;]#(;>5@9I!Y>[" -P5."W!X!Z5E1>-HKS4KEX=6T6VT^RO_LDPNIMKRIL
M4[T?=@'<V ""#@\^@!VE%9>K:O;6=E=JFIZ?:W<=N95:[D&R,'A7<9!V9]Q3
M;CQ)HVGH1J&LZ?#*D2R2;YU3 /1L$Y /;- &M15.YU;3[.));F]MXHY$,B,\
M@ 90,EA[ $$GH,U-:W=M?6ZSVEQ%<0MG$D3AU/XCB@":BJ46L:9/=-:Q7]L\
MZAF,:R@MA3ACCV/!].]<9=_$!TL-6UFTN=+DT_2YKB*6V=SYTPC4[61P<?,X
MP 5Z<YR* /0**YG2]5U&XUN*&?5]!GM)X6EABM@PN'Q@$@;R-JMD$\YR!QCG
M9@U?3KJ\:T@OK:2X4%C$D@+8!P3CT!X/H: +M%9@\1:*4N'_ +6L@EN@DF8S
MJ!&IZ,3G@'UZ58L=4T_5%F-A>V]T(7\N4PR!]C8!VG'0X(XH MT50CUO2Y;E
M[>/4;5ID5V9!*N0%.&/7^$\'T[U':>(M%O[J.UL]6L;BXE0R1QQ3JS.HZD '
MD4 :=%<QK'BE;37M#T^QNK*8WE\UK<1D[I% C=B5P>""@!R#C=VJ;QEKEYX?
MT>&]LT@=FNX+=EF4D8DD5,C!'3=GWH Z&BL+Q?JU[H/@W4]5M/(>ZL[9I@)4
M)1BHR> 0?UJ[;:[I5V+KR=2LY&LQFZ"3*?(X)^?GY>AZ^A]* -"BLP^(M%6U
MFNGU:R2W@8+-(\ZJL9/(#$GC((QGKFK;7]FLHB:[@$AB,VPR#/ECJ^/[OOTH
M L454LM4L-2,HLKR"X,) D$4@8H2,C('3(Y'K6-XT\3)X;\.:E=P75FNH6UL
MT\4-P<AL9P" 0>2,#WH Z2BLF'5 VJO%)J&GB*.S6:6WW8FC.>7;YL!,8ZCK
MGFK,>L:;+#-,E_;&.#'FMY@Q'GIN],]L^M %VBN:USQ-]GLM.N](GM+F*;5;
M>QG/W]H>548#!&&&>_Y5L3:OIMM=K:3W]M'<,P41O( Q8_=&/4]AWH NT54?
M5+".\6S>\@6Y9@@B,@W%B,[<>N.<=<<TV/5].EOS81WUNUWACY(D!?Y3AN/;
MOZ4 7:*YB]\4JGB[0M)L;JRGBO9)X[A0=TB>7&S94@X^\N#P?2NF.<''7MF@
M!:*Y3POXQMM4A6UU*_T^+5WNKF%+6.0(SK%,Z A"Q/(3/YUO)K&FR7_V%+^V
M:ZRR^2)!N)7[PQZCN.U %VBJ<.K:=<3O!#?6\DJ*79%D!(4'!/T!XSZTVVUG
M3+Q;AK?4+646X#3%90?+!&06]!@$YZ4 7J*YK3?$IU+QK?:3!/:3V4%C%<H\
M62X=W=2K'..B@C@<-6S?:KI^F &^O;>V!!;][(%X'4\]AD<].: +E%9MYXBT
M73F=+W5K&W9(Q*RRSJI"$X#$$]#GK5^*6.>%)H9%DBD4,CH<A@>00>XH ?15
M&+6M+GG>"+4+5Y44NR+*I(4'!/7H#P3VHCUK2IA:F+4K-Q=AFM]LZGS@H))3
MGYL $G'I0!>HK.L=>T?4[G[/8:I9W4VPR>7#.KMM#;2V >FX8SZTRZ\2Z%8R
M2QW>L6$#PLJ2K)<*I1FSM!R>"<&@#4HJE:ZQIM[>7%I:W]M/<VW^NBCE5FC_
M -X \=#^5%KK&FWTKQVM_;3.B"1ECE!(4]&^GOTH NT5AZCXOT/3=*NM0DU"
M"2*W52PC<,V7)"#'^T0<'IP3T%:<NHV4%@;^6\@CLU7>;AI (POKNZ8H LT5
MF1^(M%F@EFBU6SDCBD\J1DF4[7QG:<'KCG%2/K>EQV,5\VHVHM9ANBF\U2KC
M&<J>_'/% %^BJ%SK>E6=K%=7.HVL5O*GF1RO*H5EX^8'.,<CGIS4-UXFT&Q:
M1;O6=/@:+9Y@DN$7;NSMSSQG!Q]#0!JT5E?\)%IG_"1C0A<I]N\CSRFX?=)P
M![D\G [#Z5;OM2L=,B\V^NX;9#D[I7"C ZGGT[T 6J*IQ:OIL]W]DAU"UDN?
M*$WDI,I?RST? .=I]>E0R^(-&@@CGEU6R6&12Z2&==I4'!;.>@/&>E &E17/
M3:_+:^-&TRXDM8]-&EM>F9LJRL)%7EB<;<'/2M:+5=.FEMXHK^U>2YB\^!%F
M4F6/CYU&>5Y'(XY% %NBLO\ X2/13;W$ZZI:O';1>?*4D#;8^?FP.HX(!'6J
MMGXCMM6.B3V&HV"Q7Z&0V\K S2#R]V$ ;@J?O<'@'I0!O45275]->^%DM_;&
MZ)8"$2C<2OW@!ZCN.U01^)="FNHK6+6+!YYG:..-;A"SL.H SR1@_E0!J45'
M<7$-K T]Q*D42_>>1@H'XFL76O%FFZ5X7U'6XKF"YCLXW.U)1\TB@GR\]F]N
MOM0!O45D:1=WLL-Q=WM[IL]B0'MY[4%0  =X?+$<$=0?J!BHK/Q%81:79R:G
MK>DM-/&T@EAE"1RA<Y9 6)*@#KDT ;E%8=SXNT.V&E,=1MWCU.0I;2I("C85
MF)W=,?+CZD"K[ZQIL=^MB]_;+=,2%A,H#$@9(QZXYQZ<T 7:*QO^$N\-@L/[
M>TSY5+G_ $I/NAMA/7^]\OUXJS!KND7,=W)!JEG(EF<7+).I$/&?F.?E[]?2
M@#0HKF?$WB@6/@_5M7T6XL[F>P0LROEU5A@[6 ((."#^(KI"ZK&7=@J@9))P
M * '451@UK2[F.XD@U&UD2W :9EE7$8(R"W/ (YSTIAU_1ULY[MM4LUM[<[9
MI6F4+&>N&)/!Y'7UH T:*R)_%.AP6>HW7]J6LD>FJ6N_*D#F+KP0.<G!P/6H
MU\7^'Q9PW,^L6$"RPB?;+<H"%) R>?4@?6@#;HJD=7TT7RV1O[;[4S;1%YHW
M%L9VX]<<XZXYK/T+5[O4-8\065TL.W3KQ((FB4@LK1))\V2>?GQQCI0!NT52
MNM7TVRG6"ZO[:"5MN$DD"GYCA>OJ>!ZFG+JNG/<W-LE_:M/:J&N(A*I:$'G+
M#.5'UH MT5C:CXHTW3UM<&>\>[1I88[&(SL\:XRXVY^4;EY]QC-59O&^BI<6
M%O"]Q=2W]NMS;):V[R&2,G&[@< =3G&* .CHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"KJ-ZVGV$ETMI<W93'[FV4
M-(02 2 2,XSGUP.,USVGV@TS4->\16NEW*0W<$3?8HXPLL\L>\LX0D89@R+@
MX)V<]JZNB@!L;F2)'*,A8 [6ZCV/O7)^'[:YB\?^++N6UGCMKO[)]GE>,A9-
MD95L'V/KU[9KKJ* /,;K2K]M*UM4TRY,\WB>"]BQ"<O"LD+%P?0!']_S%68-
M,G;6M0TO5M U&]674S?6=XEPPMMI8.I?YQM9,8QMR=HQ7HM% '+^-;2:\&@B
M*TEN1!J\%Q*$CW;(UW98_3(]_2L35M,DB\2ZO:WWA_4-4TG58HE@^Q3%(TVK
MM:*4!U"C/S!N1\QKJ7\6Z''J,.GM? 7,[[(5\I\2'=M.UL8;#<$@\=\5M4 >
M6:U:%M5\0Z;]AU66POA:)<O9VOVG:T:+D(P<%3M"C!4G/S=ZU=1MAJWB'5+Y
M=.N[O2[WPXD"F)2AF)>1BBDXPVUQCW/K722>%-(DU":]$5Q'+.V^=8;N:..5
ML8R\:L$8X'.0<]ZV5544*JA548  P * /,[K3/$#:-=1.+K58+74=/N+:>:W
M$5W+%'*KR*Z\;R@'#8&<GKBM>UL[EO$OBV^.CL[7-K;FU6YC 65TB8%-W0<D
M#KWXS7;57M;ZVO9+E+>3>UM+Y,HVD;7P&QR.>&'(XYH \QMK#5I)9)GT;446
M;PQ)9;6A15CE!XB5%/"CH.I[Y(YK5TS2[R/5O#9%A/$D'AZ6SF8Q%1'*?)(0
M_P#?#^WYBNUU#5++2UMS>W"PBXG2WBR"=TCG"KQZDU<H YSP'#=6O@?1[*]L
MY[2YM+2.WDCF !W(H!(P3QD'%9$=AJ5MXR2ZTT7:VTU^[7ME=P[H0-C+]HAD
MQ\I/ *Y.=QX'6NZHH Y?Q#;WT/BOP_K$<$MQ86HN(;F.%2[1F15VR!1RV-I4
MXR0&^M<Z=!U.R2TOH["XEB;Q2^IBVC WQ0/$Z9VDC&6;<1VW\XP:]*HH \QU
M'2K^72/%:QZ9=&XN]=MKFW A.Z2-#;DL#Z#RY/\ )&;']FSOK>JZ9JN@:C?Q
M7E^+VTNH[AEMMORE?,&\;&0KZ$D 8S7>WU_;:;92WEW)Y<$6-[!2V,D#H 3W
M%6: .5\'V+VUYXAEN+)X7GU:6>%Y(MI>-D0!@?\ @)]ZIZFE[8>,=3>YT*YU
M?2M7L8;=?(5'$;(9 T;AB %829STZYKMJ* /-[S2ITUO5].U/PY>ZCIVJ+ U
MO]CN&6W3;$B-%( Z[5#)N#8/!]>*T=/TB=]0\:[K!T>]E4VDLD>!(!:I'D,?
M]H,.?7/>NWHH \\TVTU CX?>;I=Y"=.B:*Z\R/\ U1^S&/)P3P7X_7IS5S2]
M"_M;3?%VEZC;7$$.HZE-+$[QE24*1A9%/J&7([\"NWK%F31?%]E/;,YNH+:Z
M\N41R/'ME3!QE2"<9'MS0!RPM=7U;X8ZW<W\ GUC4=.>U1(/F#A49$V^S,6D
M'H)/:I6L+A_$<]TVG7!B;PVMH',!_P!;N8F/IUP1[5WD<:0Q)%$BI&BA551@
M*!T %.H \IB2^TN+PZ%T_47O(O#HL;R..U%QY6=@ 9-ZD'<C\\A@I'/4=KX?
MMX&\#6UAI<EU"L-H;.)[J,I+&R IEE/0@C_#BK5_X:TS4M0%_-'<1W801F:U
MNY;=F0$D*QC9=P!)X.>IK2M[>&T@2"",)&G11^OU.><T >?Z7I.H76F>"K&2
MPGL[[09E^V2LF%")"\;!&Z.)"5/&>,YP145QIVH3?#SQI8)IUW]KOKN]:VB,
M1!E65CL(]CGOT[UZ"+ZV;4GT\2?Z4D0F9-IX0D@'.,=0>,YJSTH XS5K.\O_
M !5H4]K!<1HFFWD+W!B8"%Y!%LSZ'*-^7N*R]/L-2U7P8NAR^'I=/UFRTF73
MUOIP@1&,6S,3@DD,0IX' '/.,^CT4 >936,FK^&-6E_X1;5+/6/[&GL";J9I
M-SNN!%%\[!E+<[L #CU..^T6%(-&LU6#R&$$89"FT@A0,$>V,?A5^J5[J^GZ
M=/9P7EY%!+>R^3;*[8,KXSM'O0!Y]I%MJXU[PW>7.A7MJEHU['<0QQH(;??R
M-@!RRG&=W.2>/0-T31M1MM,\#P_V=<6\]E<71N3Y)_<;XI5!/KEG3I_2O4**
M /+=,M-733/!>G7&AWRWFC:B!>2[5*$>3,IE5R?F#%@V??GG&>E^(=I=7WAV
M"WL[6:YF^WVLI2)"Q"),KL?P -=;2$A5+$X &2: .<\=VUQJ7@#6K2R@EGN+
MFS>.&)%.YF88 QV_&N>UZROWU?5[FPT-KR*7P]';1PS0D1RR"1R8R#C.%;..
M,],UV5OXATJ[M;2YM[L20WD[6T#JC8>12P(Z<8V-R>.*TZ . TG19M4UGQ1!
MJ=AJ']GZO8V\8GNU12^%D5AA3\K#<,# QBD.B^)+_P"'VH17B*VNF%;9%\S:
M)T@;N>WFX<Y]''I7H%% '+^%XX+J^N-670=1TVYEA2&:3496:1]I)"@%VRJY
M/S<9SQWKFO$%CJZVOCS3&TF[O7U>(RV%Q"@=&'D*@C)S\I5E) /7/'->FT4
M<#?Z?/=^(-0EN-(O);2?PV+1XU&UG?<Y,08' ;:W7.,GK6=/I_B:&W$R+=:S
M:Z;J%K=0F>$0W=S"H</&P.T.R%E96(&2/45Z?5.#5+*YU*ZTZ&X5[NU5'GB
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MR"VA4NQ P%'4G H \[M_#UW<Z(NBOILL%_'XA>_^TM'A(X_M1E$BOT),?R@
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MVVJR7UM?_:&^RE6E:19.'X<!BNW:<GV)([G4]4LM'LC>:A<+!;AE4NP)Y8X
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MI1-;1B>3$;@Y!'S=B31+X4T::"[@DM':*\N%NIU\^3$DHQAC\W4;5_[Y'H*
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M:1$E*X*LR*P4L,#DC-37'A?1[IKYIK1G^WPK!=?OI )8UR I&[H,G\SZF@#
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M0"1Z\UJV]O#:6T5M;Q)%!"@CCC0855 P !Z 4 2T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=9U)='T/4-
M3>,RK9VTEP8P<%@BEL9]\5>K!\;_ /(A>(O^P9<_^BFH SH/'1CF@.KZ3+IU
MI=64M[;3M,LA9(U#L'4?<;:<XYZ'N,4S_A.Y;:RNI]1T62T9-,EU.VC^T*YF
MBC +*<#Y'&Y..1\W4X-9R>&=8\3V^G)K"V=M96VES6R2V\S2/.TT0CWE2HV
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M[.#D[\PB0$L,8'WE[^M4=*\(ZC9:7X(MI9+<OHC$W15R0V8)(_DXYY<=<<4
M0:AXQCN-(LYKRRO;2YCU^+3)H+:[V[9=W=P/GC(()&!G.*LW_CV:S_M:X30Y
M9;#2+K[/>7/VA5P,(2R+C+8#@D<?4]J6I>"-4NX94CDM06\41:N-SG_4KLR.
MGWOE/'3WJW?^$M1N?#7B_3DDMQ-K%Y)/;DN=H5DC4;N.#E#TSVH DUCQW+IG
M]N7%OHDUY8:*"MW<),JGS-@?:JGJ &7)R,9/!Q6CXLUN[TCP+J6M6$"O<PV;
M3HKM@+\N<GCG'7'?&*X/QA<3:58^.M+M+[2VCU!3.R2SLMS'))"J>6L6W$F_
M: I##!8]<8KT#7M'GUGP-?Z-$R1W%U8-;J7^ZK%,#..V: .;CU_Q#_PE\,<>
MF/<3RZ)'.UD+P+"C><X+EB,9(VC@9YQT&:T8?'3ZE::<^C:1)>7%U9?;GADG
M6'R8\[<$G.6+!@!T.T\BI]$TC5D\0Q:OJ,-K;G^RDLGAAG,N'65FR"57(*D?
MCQ[US,/P\NK.UTF2?1M#UNXM[ V4L%^?D0B1G5T8QM_>8$8';TH [<^)=/'A
M'_A)<R?8/LGVL#;\Y7;NQC^]VQZUCS>.GTVVOCK&D26EU;VR7,4$4ZS>>KOY
M:J&& &WE5(/ W#DUH:AX;&H^!)O#Q%I;-+9>1_HT.V&-]O\ "G9=W;TKF6\#
MW5WHNI6\.@>'-"NI(X?(:P3)DECD63+L$7$99%&W!/4^U &C=^/+K2WU*'5-
M">WN+#2WU)E2Y619$#8VJV!SUSD<8[C!K9U'7X[;4X],:"0F?3I[WS$?:5$9
M0%1[GS.O;%<7J.FZSXD\4ZOIVI1VEC<7WAJ2WACAF:98\RXW,Q5<Y)Z < 5L
MQZ)XCU+7(=2U.#3[58])N+ 0PW#2DR2&,A\E%X.P\=L#KG@ D\(^+(+Z#0;$
M6]VB:CIK7=M/=7'FNY1@&1F/)8!E;/<?2IXO&%W?V9N-*T22Z0WD]O'*]P(H
MF2([3(7(. 6!"C!SCM6.?!6MVOP^\/V.GSVD?B'10/)F9V\HY5D<9QG!5L].
MJBK%_P""98(?#MK96&GZG9:9:26S6NH.5C\Q@F)\;6#,-K\$9^<X- $$_B:7
M5?&'P_N;2:XMK+48;]Y[8R8#%(EP' .&VMG!_*M*T\>>>MO<2Z5)#87T4LNG
MSF=6,P1#)AEQ\FY%+#D\#G!XK*TGP-JUI?>#VN39>1H8OXIC$Y_>I,N$95V\
M>XSQV)INA> IM*MTL1H'AR(VUK+ FJQQYN;@E"B-P@*$@_,=S9YQUS0!KZ=X
MWN[^72M^@R00ZO;/-8.]RI,C+'YFUP!\@(S@\^X'2K?@+7=2\1^$[;4]2MHX
M99BY0HX(==Q . .,8Q^&:@M?#-] /!89X/\ B2PF.YPQ^8_9S%\G'/S>N.*L
M>!=)U/0/#4.CZE%; VC,D4L$Q?S4+%@Q!4;3STY^M '%Z-XGUBWU?Q9KNKVU
MU)!I]X+5+==0S%#GRP$$>-I/S9W]>U=GXB\90^'I[^.6SDF^QZ;_ &@Q5\;E
MW[-HXZ]ZQY?!.IRZ/XQM1-;+-J^H?;+0EB5&!&5#\<<ISC/!J'6O"WB3Q&^K
MW5U%IUI)>:1]@A@2X:0(_F;\LVP<'GH.,#K0!JR^.3IT]\FM:3-8+;V#:A%M
ME65I8E8*5(&-KY91C)'/6J/B/QEX@TOPOJ]TWAU[*]MK=9HI'F66+#';]X#&
M]3C*>_!-7/%7@^Y\1ZE<.L\4,$NCS62N<EEE:6-T;&.5&SGFH-:T?Q9XH\-:
MQI]^NF61GM!#;PPS-*KRALEV<HI53@ +@]R: )G\1Q6GC/R=3ANK6:+0I+^=
M5NR]O&BRX/R  %_]KTXJ;3_&-S/=Z='J&BR6,.J1/)8R&=9"VU-^UU ^1B@)
MQDC@C-4KOPGJ>N^)YM4U)+:T@N_#LVE3Q0S&5DD>3.02JY&WOQSV[TZST#Q!
M>W>A#5X["&'18WVR6\[2&ZE,1B#;2@V+AF.,DY(';- $FD>/)M2.A3SZ)-:6
M&M*1;3M.K,'$9DVL@' (5L'/.!P,U)I^LWOC/1G6*SN=,M;ZU,UEJ-O=*S*<
MC;N"XV/R#MY!PP/<5%9>$]1MM#\%69DMO.T1E:Y.XE3BWDC^7@9^9QUQQFJV
MFZ7<^']5NO$>J66EZ/:P6<OVYK"=BEY)E6$IC*J%(VMCJQWXR>X!K>&_$5_K
M'AS1KTZ?YL\\C6]\4D55MWC+([X/)&], #GD5T]<?X+LM8TWPGHZ&V@26YN)
M;J^CG8JT2RN\F% '+ LH(..]=A0 4444 %%%% !1110 4444 %%%% !1110
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MT.R^V:G=Q6MON"!Y#U8] !U)/H*++6=/U&YDM[2Y666*..5U"D%4<90\CN*
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MT4FH0+NE@3)*#@\GH#R..M &E154:E9MJK:8)Q]M6$3F+!R(R=H;/3J,5:H
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M@!,>G0?6M(:5:C6SJ^&^UFV%KG=QL#%NGKDT <)KEI*_Q(U>3[?=B-/#9E$
M9=G+2*5QC.. W7.>^.*HZ??:IX8T;PI>+JES=Q7>D2-+9RA?*7R[7S4"  $8
MVXZG.>:[S4?"]AJ6L+JDKW,=S]F:T?R9BJRQ$D[6'?!)(^M/'AK30FD(8V9-
M*B,5LK-D;3'Y9#>ORT <MX-O]?GU*PDN5UJ:SN[(R7<M_'$L:S?*5:+8<A3E
MQM/;;[YT=1>_U;QX^CPZK=:?;6FFI=C[-LW22O(Z@MN4Y51'T[[N:T]&\*V&
MAW"RVTU[*(HC!;QW%RTB6\9(.U >@^5>3DX &:=JWA>QU?48K^2:\MKJ.(P-
M):7#1&2(G)1L=1GGU'."* /,_#VJZDVB>'](@;5Q$--ENI&TA(R[2&=E4DR'
M[HP3@=21FMB\U3Q)!;V.H:]/JNEVXL(B]Q901R107 9O-:X3EMA&P\?*!GD=
M:ZD>!M)AL;"ULY+VR^PQO##+:W!CD$;G<R$CJN0#[8XQ2W?@?2;M%B\R^AMO
MLZ6LMO#=.L<\2Y 609YX)!/4@\DT <GJ?B?68-6\;VL%\R"WN],M;-BJD6PN
M-BNPR.?O$\YYQ3?$>I:YX:G\16EOKMU<QVNA+>6S7 0R1R&5E))"C/W>X[^U
M=3K/A&SDLO$,]I8BZO-76)IH9;AHU=H@ FUARA&.".X!K$TGP7)J5_J\^L65
MY;6M[81V+)=7HGN)<,S,Y=20HY4  ]B<#- &KIIU'3/'RZ5/JUU?V]UI;W;"
MX"?)*DJ+E-JC"D/TYZ"B_:^UKQO<Z+'JMWIUI9Z?%<_Z(55Y9)'=0264_*HC
MZ=RW-=$VE6K:W'JY#?:X[9K53NXV,RL>/7*BJ6K>&;/5KV.^,]Y:7B1& SV<
MYB=XR<[&QU&>1W'.",T </I6L:[XFOO#-G)K$]FESI]V]Y):JBM*T,R1AER"
M%SUX'1B!VQUOB^]O(6T73;*Z>T;4]06VDN8P-\<8C>1MN00&.S&<<9-7;/PQ
MI6GW>GW%I 83I]H]G;JK':L;%20?4Y0<GGKZU8UC1K37+-;:[$@\N19HI8G*
M212+T96'0CG\R.] 'G^IZMKFFW.H:%;:S.S0:IIL4%Y,J-(L=PV&1N &P02,
MC." :-8UK6?#=_JNB0ZC?WP<V#6\[+&]Q")Y7CD5> I.$RN>A;TK9UWP1%)I
M$-I9)<74MQJMK=7T\]P3+(B.NYBY((VH. N,8X&:U4\%:4+2_AG:[NI+]HVF
MN9[AFFS&<Q[6&-NT\C'?F@#C[W5?$]II;01S:I9I)J]E!9W.I1Q&;9*P613M
MR& /()Y^;':I_%EYJ&D17=OI^LZ]=7&E:8;@^1'"0C_.RR7#O@,"%QL49PI.
M#D5U:^#].^S+%/+>73B\BO3-<7!=VEC(*9/H-HX  I=5\'Z7K-]/=71N@+F%
M8+F&*=DCN$7=M#J.N-Q_/G(H Y"%[L^,O%&JKJ-VDD6@VTZ1!EV LLY QMSA
M3DCGJ3G-.\/:IJ_B>/PUI]QJ]W;"70AJ-U/;;5EGD+*@&2IP!R3@<DBNI3P5
MID=T+E9[[>;(6,H-P<3Q ,%WCN1O;!H/@G2TL=,MK:2\M'TV V]M<6TY241'
M&4)_B!V@\CJ : .3TO5=<UO5-'TB;6;B%0-3@NKB!45[C[//'&C@[2%)!Y('
M=L8XQUG@B]O+WP\XOKE[F>VO;JT\]P TBQ3.BEL #.%&:M6'A;2M,FT^6TA>
M-K"&6&',A/$K*SEL\LQ90<GN3ZU<TS2K72+>6"T#!);B6X;<V?GD<NWX98T
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M3W$DIEOE!NOML<:W+!()]^\NB] 2<YZ_>;&,F@#,^&O^O\9_]C+=?R2GV/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(!&T-PH5U(&.1D^E &+I7C?3ET#19Y[ZYU*?4HY6MGALF5[C8WS8C7.",C\
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M(RR+)&69=Y&<9P0>O%'B^":;Q9X.$=[/ &OYAB,(<$6TQW?,IYQQSQ@],\T
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M1>9:SH8Y8]Q7<IZ@D$'!JE_PC6E?:&N/(D\UK46;/]HDR81T3[W3D^_-:U%
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M*5*[2K@*!R"#U^4=*ZVPL+;3-/@L;./R[:W01Q)N+;5'09.2?QJQ10 4444
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MWHHEAA2).$10J_04 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\\%Y*BF.2,;G&<X8!?FR#TYJ\?$&BBZM;4ZM8BXNT#VT1N$W3*>A09RP/;%
M&C15%=:TI]5;2EU.S;45&XV@G4R@8SG9G/3GI5*T\1VB:$-3U:^TJTA\UHS-
M'>J\.0Q 'F$ ;N.1V.1VH VZ*YW3/%VGWEKJU[<W%I:V-A>FV6Z>X7RY%\N-
MP^XX SYF.O;WK2?7M'BLHKV35;%+69"\<[7"!'4=2&S@@4 :%%<_J'C;P[IM
MII]W-JUFUMJ$WDV\R3H4;U;=G&U>Y[9%;%W?6EA9O>7EU#;VJ#<TTT@1%'J6
M/% %BBL\:]H[6$5\-5L39S9\N?[0GEO@$G#9P<!6)] #Z4B>(-&DTEM535K%
MM.7[UV+A#$.<<OG'6@#1HK#T3Q);Z[JNJ6UH89;:S\GR[F&4.LPD3=D8XXZ=
M35;4/%-RNMSZ/HNCRZI=VJ*]TWGK#%!N&54LW5B.< =,9H Z6BN1;QPL4.GO
M=Z=-I[S:BUC=I>,$^SE8GD+AN5=<(,$'&#[8K3NO$=H^B#4])OM*NX3,D8FD
MO52'E@"-X!&[G@=S@4 ;=%49M:TJVU*+39]2LXK^89CMGG42./92<FN<L/'E
MOJOCV[\.63:<\-F%$D[7P\R5RA8K%& =^W&&^88Y]* .QHKF]8\37MCXBAT7
M3M$?4;E[0W;$7*1!4#A/XNO)%7=/U>Y>)3K5C'I$LDPA@CENTD,S$9 4COP>
M.O% &O15275-/@-R)KZVC-J@>XWS*/)4]"^3\H.#R:B37=(DTIM535+)M.7K
M=BX4Q#G'+YQU]Z -"BJ5KK&F7L=M)::C:3I=;O(:*96$NW[VW!^;'?'2L_6/
M&&@Z']G^W:G;)Y]U]E'[Y!L<?>W9(P%R,^F1ZT ;M%9%OKD)U*]M[JZTV..*
M:*&#9>!I'9UR%=2!M8_PC)R.:OS7]G;S>3/=P12^6TVQY K;%^\V#_",C)Z#
M- %BBJ>G:KIVL6YN-,O[6]A#;3);3+(H/IE2>:Q]2\47$>M2Z/HVD2ZI>V\:
MR7.)EAB@#9VAG;^(XR  >.>* .DHKCY/B#8V>A:Q>ZG;/I]]I*_Z18W$J!F8
MJ60(P.&#X.TCK@\<5BS?%>*+2]'<G0CJ&J28$0U<>3;1[=VZ639E3D%<;>O>
M@#TJBLBRUD2R:D;J?3HX+,KF2&\#[%*AB9,@;/;U'-2Q>(=%GTN35(=7L)-/
MC.'NEN4,2GW;.!U% &E16?\ V]HXL(K\ZK8BSFSY5Q]H3RWP"3ALX. K$_0^
ME7+>XAN[:*YMY4F@E021R1L&5U(R"".H([T 24444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5Q_@-2+KQ=D$9\03D9_ZYQ5V%% 'D^E6<4'@?P7)';JDIUY'9@OS9,D
MH))^G'TJO%-:GPG:>'E*?\)6FNK*\&/WZR"[WM,>^WR\G?TP<9[5[!1CG- '
MD5]IUM-X.\1F2U1WE\6*6)3)8?:XU_D2/Q-7/$<J:;K_ (L<6UKY$D&DK(UQ
M%NAB!FD4RNH(R$&#U'W1GBO4:* /&XKK3YKW6GO/$20.-0M;RTU+[(HA+"$H
M)&3H8B0R;\@$[>>AKT'P1>F_\/&<P6B9N9AYMG&4AN?G/[Y >S=>IYSR:Z/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* (7M+:03![>)A.,2AD!\P8QAO7CUHMK6WLK=;>UMXH(5^['$@51] .*FHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>certification312001.jpg
<TEXT>
begin 644 certification312001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 _\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ***\<\->(=/U/1+.?5?B5J=MJ4V1+;I+ H1MQ  !B)].] 'L=%<MJ
MOC6WT.\OK&]M)OM<4:/8Q*P+:AN(4"/_ &@Y"D=L@]#61)XCUNP\5^(O*TR6
M^2VL;2X>W^UA([?Y9"X4D<L<=@,[>2.* /0**X6Z\36][KD"VIOD>[\.2:A"
MPN"L2H2,9C'&_D?-VZ4GA+Q=?2:=X7MM5TV>./4[1$M[Z2X#M-*L.\[UZKN"
MLP.3GO@F@#NZ*\PL_&>H?V+X:DT6QGGCU'59[:3[=>[Y#M\T[=Y!X)3(/8+C
MO7=>(8;V?2REGJ0TT!PUQ=!072$<OLR" V!C)!QS0!JT5POA34-3U6SUV+2=
M:^WV4<Z1Z=J5Y&'/*CS1\H7>%.<'C)XR0*UO 5[>:AX/M;C4+I[JZ\VXC>9P
M 7V3R*"0 !T4=!0!TE%<1XSBU:SM-5UD^([BPBMX0--MK5$/F38X$@929"SX
M4*,<>YKL+)YY+"W>Z01W+1*947HKX&0/QS0!/1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6M?%7@>+5_(3=/:.71UR8I "'7GIA@1^%8WA:")/@M8R+$@<Z'RP49/[KUH
M[$ZMIRZ6-3:_M1IY02"Z,JB+:>AW9QCWJ'2O$&C:ZLC:3JMG?"/[_P!FG63;
M]<'BO-/#T45[IWPNL+Y5DL'LIIO*<91YTC7R\CH2 TA'N/:NI\56\-IXQ\(W
MMG&D>HS7SVKE!AI+8PNSAL=0"J'GH: .KLM0LM2C>2QNX+E(Y#$[0R!PKCJI
MQT(]*?:W=O>VXGM9XYX6) DB8,I()!&1Z$$?A7E'A!CX4L[;Q"I(TG4;VYMM
M4':&3[3(L4_L.B-[;3VKL?AK_P B+:?]?%W_ .E,M '64444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH/B'^SGV:O=PVRP^:,Q&1RN2<<XQZ"NKOE_XEMRJC_EB^ /H:\>BMY_^%-^
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M'<5Y)H%Y%8S^"YKUY(DM;_5;:=IHBACD=V**P PI((P.G/%>J:9=V%V+LV
M$5S)%/B(IF4'YNH&[_>Y!]: +U%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %0R6L,MU#<NFZ:$,(V)
M/R[L9XZ=AS_B:FHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *AM+6&QM(;6V3RX84"(N2< =.3R:FHH **** "BBB@#'N_#\5_KUKJ=
MW>74R6AWV]F2HACDP1YF NYFP3C)(&>!6Q110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI#*&'FPR;)(N!SCJ&SR,\5CS>"=46ZBN!!I6H(FI7UU]DO'81%9V!1_N-\Z
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MKZ\G<L%DE\WS92#C)R20,CTZ4^3P5/'XBO;B+2/#UW;WMZMV;R^AWW$ PN]
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M<1UJRU#^S4M Q"RRLX$1'?:RNC?3/I0!VM%8WB+6)M$T^SG2..5YKZUM6!R
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M,?NG)VY4= W4XJO)XW\0K;'4(M,T][-=8?2A$97621O.,2.#@A1G;D8/<^E
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M],]KO?<BE?,CVLH#%3C!! (!]JU;?PY%_P (/%X9NY3+"-.6PED0;2P\O86
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MVM+0V]N(;+:\A  5Y"6.2 .BX!))] -;3X[RZ\-VL6J86^EM$6ZV@#$A0;\
M<=<UBZ=XZTN6_O;+4KVTM+F/49+."-I,&0 @*3GH220/4CBMB7Q%HT&L)I,N
MI6R7[D 0%QNR1D#ZD<@=30!@^'O!]_I1\/?;=1MIQHMM-:1>3 R>9&RQA2<L
M?F'EG..#GMCF.3P')(^GM_:"C[)K\NL']U]X.SGR^O!&_K[=*ZG4M5L-'M#=
M:C=16T&X+OD;&6/0#U/L*QY?'?A^/5=)L$OXI6U1&>WDC<%2 =HY]VRH]P:
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MM%NGE\@1&09\S.W:?0Y&!GJ:@\;^()O"O@W4=;MX8YI;5598Y"0K9=5YQ]:
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M^&'BG\,2?:E/]BP-$PV?ZW,0CR.>.F>]7+WQ1H6G/;)>:M9PFY020[I1AT/
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MO( #$H!9\_W0&&3[T <G'X)U:9XS?:M9[!I4^DM%;6A15B<+AURYPV4!/;'
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M<CJPZ=:Y.SU"?^W_  ?J>HVXCB+ZE;_:8;-XDF9W01R%,$H9-I;GKR:]2HH
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M"(R2'RW( )"G##=C'S^]/O)XUUW3]<M7O/#^E3VMU'',-/5]TAF#$E"K%/-
MW D G'X5ZI10!Y'=PP^'M*MCIMUJ$=\=)2-+._TWS8M2C#2,D#*H^5P7*D C
M <9!%=CX]65_!PF%O(Q@N[.YECC4NRHEQ&[X ZX4$\>E=710!Y'XFF7Q!-XM
MN+*VN)[2;2["*-S P6;%Q(6VY'(&<5?\?:9>7FJ:S'96DLI?PYL"QH?WFV?<
M4'J2NX >]>FT4 >3>(YE\6:S>OX?M[B3S/"]Y;)-]G:,.Y>,B(%@.<9X_P!K
MZU2UR!-6\,:_=VNI:EJ<Z:/]FV/IX@5 9%8)\JJ2XVGY>< GUKV:B@")+>%;
M1;81*( GEB,#Y0N,8QZ8KQRSL-1CM)IY;6X+^#EBM[4F,DS*ER6D*>H,"1#C
MU->T44 >8^'-+G77O"6HW5JXN+N#4]0G+H<Q23O$R@^A"';_ ,!-9\EE="3P
M^%M9ML?C2[D($9PJ&2;#>R\]>G->O44 >=>'[VRL%'A_4M,N+K5QK<\VS[,6
M W3/(ESO(V[0C [LYXQUXJGI]A+%X%\*HMHZR)X@65U\L@C-Q)EC^!Z^E>HT
M4 <MXV^RQPZ;<S7UYIT\%P7M[^"W\Y(7*,I$BD'Y64D=.N.17,Z/K#V'B#2M
M7UFU:UBN=+N+=)+>RD5)9!<Y4A "5,BX<*>?F/>O3Z* /)/#$YT%O#FKZQ;W
M$%C]AOK?<T#-]GF:Y#@,%!(W*I /?&.];_A^&";QO:7UMH\FGVIT+$,,D(C,
M6ZX)Q@<*2,''7GFN\HH Y'P/;F+X9V5O<VTI @E5X N'*[G^4#CDCI7#W[W%
MWX/U[2M-EGU>RBT1E@EFL#%<VQ!4"W9@HWG:"<8R-G.<BO9J* /)?%>JOK,6
MLQ6,UQ%'=:,$LUM=.#R:CD2AE9W0D*I[<$;B<\BHM1\V_F\46MJEPT^K^'K3
M[$!"W^D;%F+J"1C.#C!QUKU^B@#Q[6;>/6/#WB"\M]2U'5IO[-CMB'T\0( 9
M0P3A5)<8.1@X#>]=D;%?^%I3S_9AY8T%(5?9Q_KGRN?ICBNOHH \5T>&ZTRP
MT&YOM0O=+MI?#<%J&2Q$^YU9R\1!5MI(9,#C./:NH\-:.+'7[N+R;AXX?#=C
M;1R74>)" 9LJW;=PN1]*]"HH \CT#&GW'A$ZE:W7DS^%#9;5B8EI28CY?'1B
M >N*WO ]VQU86%K=2:EIMO8 17-S8F&>UPP"P.V &XYZ C9SG(KOJ* /-O$.
MFSOX]&D+:R2:=K\EK<W+A"47[-N,@8]!N"0+[\USR:3JVI^'M85[>Z$VB6D&
MD0_NMS2K%<;Y64$?/NC2+ YSTKVJB@#Q_7+./5_#GB"\@U"_UE[@Z=;RO)8B
M&-PMR&PH"C<0&;<<< @=N-WQ6LMAXUCOI=2N--L)=+^S)-#9+<*SB0LT9!5L
M$@K@=]OM7H=% ')R:?\ 8OA/-I\ NG$6C/%&LZ8EQY) 5E'1N@Q698Z=Y?B+
MP&PM"JVVC7"Y\OB,[( !['[WZUW]% 'DFG7%SIMII-O*\^F0&YU5EO(K 3S!
M_M1V0IN1@N]26Z?-M&*B\&WL>A7NF76KPW4<1T=K%2UL[%)TN'9XB%4X8ADP
M!P=O'2O8** /%=#@NM)LO#E[<7=WHEJ-.NK<.MD)O*?[06\M@5;;N7&..=F*
M]%\+36>EZ9H^@1M>&4V!N(A<P['\I6488#A2-ZC;VKI:B-M"UVET8P9T1HU?
MN%8@D#ZE5_(4 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!SOCK4;[2O"-U=Z;.L%XLMND<C(& W3(IR#U&&(KF-:
MUS6_"MUKMHNJRZ@5TZWN;:6[BCS#++.T)^XJ@J/E;!].M=WK&DVVMZ:]A=E_
M)=XW.PX.4=7'ZJ*J:EX7TS5KN\N+V-Y3>60L94W84QAF88QR&RQYSZ4 <=XD
MEUC2%U31GUZ]NXKK0;J\2>6.$2PRP[<@%4 V,'Q@@D8X([=3X8BFL_ >G;KN
M:XD%@CK)*%W#* @?*H&!T'&>.<TEMX-L8S>/>7=]J,UU:-9-+>2AF6 ]47:
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M@*H8$ $R DX[8[UZ9'X2M(]6COFOM0ECBN'NH;.68-#%*V[+ 8W?Q-@$D#/
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MF,WEEUXP!AL[>GR]*=X[TB72/A_XGC.NW=[#)IP;[/>2"21'#<R!NH4\#;C
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M3H#4=_K%AI<]E#>7 BDO9Q;VX*D[Y""=O XX!ZUY]K^O:I!K'CV.&^FCCLM
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M9 I1@P.T+ALDDC&#F@"?3_!FC:;+YD,=S(5@:VA%Q=22B")L92,,QV@X'3G
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MSTH M2^"=$D2!5BN(3#)/(K074D;'SGWRJ2K E6;!QTX%)%X(T2W?3VMXKF
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M 0,[FR#C '&.>HIA\=0V=M=RZQI5YIS06?VV.*0H[319"X7:QP^XJ"I[L.:
M.@T_2K/2](@TJTC*6<$0AC0L3A ,8R>:IZ;X5T?24TM+*V:-=,BDAM,R,VQ)
M""PY/.=HZUE?\)@TEU=:5?Z1?Z;>)IDM^<R1M^[4A?E921NRWX$>F,U]-\9@
MZ-I"Z=IFIZK+/IRWS!Y8_.$73+$D!W)[+Z=N* .KT_3+32XYX[2,HL]Q)<R
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M >>^'/"6LV&L>$[F[AA2/2=)EL)]LH;+94*PXZ$+GVS6Y\/="O?#?@NSTO4
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M/<@/P%"R X/?[XKNJ* .,\-:?XET.*QT%;6S&FV<TFZ_:;<TT!+%%6/ *O\
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MEG64A0>=OWN?859\-0ZEX>M=(T2>VC<3RWLD\BR9\H&5I$QQSD. ?0XKKJ*
M.?U?2+J]\7>'-2A"&WL#<F<EL$;X]JX'?FN;?P2\?B2]D;P]IU_%>:@+M;^X
MF(,*':74IC)8$-MQQR,XQ7HE% ' ?\(QJ=SXF:Z72[72R[SB\O;6Y.R]C9'5
M T/]_)1B3T*G!.:;HNA^)!<>#XK^PM;:WT%&AFD2Y\PS?Z.T0=1@8&<<'GYO
M;GT&B@#S&P\'Z_I/AC0(X[6"XO=,UJ:^> 3A0\;F4##$8SB0''UK5T[0-33Q
MC#J?]DVNF8EE:^N+2Z/EWR%6" Q?WLE6+'D%3R<UW-% ',:OI^J6GBRW\0:7
M9QWP-DUE/;-,(F WAU=21@\[@1QU%8:^#-56T\-;S US;:Y)JM\$?Y4\PR,5
M3(YP7 [9QFO0Z* ,'Q;I%UJ^DPBP,?VRSNX+V!)6VI(T;AMI(!QD C/;-<5X
MRT[5[G2-?U^_M8;&62VM+*VM_-$I 6Y#EW(&.68  =A[UZG45Q;07D#07,$<
M\+8)CE0,IP<C@^X!H X'6O"NM>+;G4KF_L[:P/\ 9HL[:(S^:LLGFK*68@#"
M9C0>N"3@=*@N?!EU>>'-7M[/PWI^D7%R+=(U2X\QY-DH=]S8P%P.!UZYQFO2
MJ* .+\5^';W5]>@F_LVUU.Q-FT"174N([:8MGS2F#OXP..?EQQG-4O#?A_7M
M'U7PY<36,+QVVB+I-UMN1F(HZD2#CY@0O3J,UZ#10!YGX<\(:]X;T'PM,MM!
M<ZAI*W<-Q:B<*'CGDW95R,9&U#@XX)YK0TOPKJT>N:?J]VD"2OJMUJ%U$DFX
M0K);F)%!P-Q "Y/J37>44 <%=>&;[R=72XT2RU:UO-8>[^SR3;'"&)%5T;^%
M@RGT.#P:VM+TK5[?P(VF2W935#;S)%,9FD,)8MY8+GEM@*C=WVYKHZ* /)QX
M'U<Q7)MM!L+ W6A76F2A;D/(TSJI65WQ\P+*1W(SD]<#I==\*7>LSZ?%N1(%
MT>\L)GW<JTR1JI [CY6KLZ* .$T[2_$MUK?ABXU+3[6T@TB*6*8I<^896:+8
M&48&%R.AYY[8YU==T_5(?$NG>(-)M([UX+::TGM7F$19'9&#*Q!&0R<@]C[5
MTU% 'G.K^&/$&MW,<FKZ=IFH//IY@"M*1!8S%W)<(0=_RL@R,$F/^$'B"?PO
MKMSINEP'1+2#4[6S@@@U6"]*2VI3 ;?@9D7C<%Z'=@@=:]-HH X:[\*ZG-X4
M\1Z<BQ?:+_5'NH 7X*&5&&3V.%-:_CO1KOQ!X'U;2;$(;JZ@V1AVVC.0>3^%
M=%10!QNI^%[R_P#&.BWY""RMM-N;2X._Y@T@4# []#5+3?#_ (@EMO#.C:A:
M6T-GH,L<CWD<^[[3Y4;)'M3&5SD$YZ8P,UW]% 'F<7@/5HX/$$>8/W8 T,;_
M +F+A[E=W]WYS&OT05:?PK>Q^&-+L;S0;/5Y<RW%W_I/DRQ74C;R\<GIEG!(
MP?NX]*]"HH YBX\.7VI_#=_#VH7HDOYM/^SR7))8&7;C<3U89[]34%G8:[JO
MB72M3U>Q@L(]+MYE"QW'FF>60*I(P!A %/7DY''%==10!S/P^T.\\-^!].TG
M4 @NH/-WA&W#YI78<_1A6#+X7UPMK-D+6$V]SK]OJL-SYXY19(692N,@@1M]
M>*]$HH X/Q/X.O=;U/6;A([>2*>WL/(CE<A97@FDD9&P,A6#!<^_M6OX2T8:
M9]MF_L&ST?SV0+%!+YCNJ@\NW3JQP!V^M=+10!QC>$KJ[L_&]G<.D2:Y*WV>
M0'.U3;I'DCV93Q6!>>$BOAG6))M#TG0'2Q ^UBX,FYU=9"20/EBS&O7GVXY]
M2I&570HZAE88((R"* /-%GU+Q%XVN1)!:0R/X;GB2*"Y$X4R2)M+.  -V#@>
MBY[X"/X0U5/"&AZ5+H=G>W5GIRPQW4=X8)K.X P660#)3[I^7GY>A[>@Z?I.
MFZ2CIIVGVEFLAW.MM"L88^IV@9JY0!YQJ'A;Q#)_PE-L(H;H:UI$5N+LS!,3
MI"R'<N.C%@<CI6GXA\/W][+H?_$MM]4L[6WDBGL9Y_+C\TA DAX(8+M<8P2-
MV0*[2B@#@?!_A75M'U'2&O(;=(M/L+NS+1/PY>>-T95[ JIX[5#;>%]<TP^'
M;J&UAN9=.U'4)IH?/"9CN'DVL"1C@."17HE% '+^,=(O-5_LLPV4>HVD%PSW
M5A)-Y2S HP4DG@A6(.#_ $%<U;>$M2M=#&F7GAC3+^VCO;F>-(+KR6A,C[T:
M%L H!N92.#P"/2O3:* .8N/#E]J7PW?P[J%Z'OYM/^SR7))8>9MQN)/+<]^I
MJ"SL-=U7Q+I6IZO806$>EV\RA8[CS3/+(%4D8 P@"GKR<CCBNNHH XCPK9:K
MX,\":'I<]K%-=B\\B=5DR%229B6! Y(# X^OI6GXSTJ\U6PL8[6V6\AAO%EN
MK)IO*%S$%8;">G#%&P>#MQ7244 ><:!X/U;3M9L9'L+*UM+;59[X);2?(L<M
ML4"*,#E6P,X&>O'2I[CPOK-KJDNL6D$,]Q!KSZA%;M-L\Z![80L-V,!NI&?3
MWKT"B@#F?"NFZK:ZGK^H:K##"^HW4<\4<4F_8HA1,$X'(V\TW3-!N[?QYXDU
M:<)]BU&WM8H2&^8F-7#9';[PKJ** //=.\-:^--\/>';NUMX['1;J*8WZS[C
M.D))C"IC(8_+NR<#!QFM'3+?4_"/@G4G-K%<7D=W=74<(DXD5YF=1D#J58<>
MO%=C10!B>,=)N->\&ZOI5H4%Q=VKQ1[SA=Q'&3VJEHVG:HWBEM:O[1+19-)A
MM6A$PD*R)+*QY Y&&4Y]ZZBB@#RJV\ 7MC9Z/+=:'9:Q/#I26$L$ESY?E2([
M,K!L<J=[ ]^!C->E:59C3])L[,0P0B"%(_+@!$:X&,+GG;Z5;HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C_BD8Q\/=
M0,SM'$)K7>ZG!4?:(\D$=*XWQ1!9Z7?:]!X82UM[)]&MWO5M3MB&;D+N;9T)
MB,N3UVC->F>)=&.OZ')IRSB$O+#)O*[L>7*DF,9'7;C\:MVFE:=812Q6=A:V
M\<Q)E6&%4#D]2P Y_&@#R/7=+-IX:\11Q3:-;P2G3=UGHS,$A?[2,2= %9EP
M./[@-=!J^FVFC_$KP/9:5:0VT,=MJ/EPQ*%4$QJ?U/)KN8-&TJULVM+?3;.&
MV9@[0QP*J%@002H&,Y .?:K+VMO)<17$D$33Q B.1D!9 >N#U&>] 'D>C0:;
M'H/@C4;)8?\ A([G48A>3+C[1*Q#?:1(?O$#YL@\# ]JJVL&CGP]X5OI!;CQ
M#/XBB^U2#'GO)]H;>KG[Q P.#P,+[5Z_%I.FV]_)?PZ?:1WDO^LN$A42/]6
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MSM>-@RG!QP1[U)7FWPVU6\$.A:2Y06[Z5<73J!G]X+D+P?3#&DM_$OB/5O\
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MD2%BJA3$[0L,HK!FW-C *=LUWFG2OJ&@VTKW<,SSVZDW-F<(Y*_?3.<#N.M
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MSC>RCJ0.I'3-><6'B;4+GP?X9DCU)+"XO+%IY(K'2VN96(P!MB12$C&3D^N
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MYKO* $50JA5  '  [4;0.P]:6B@ INQ=Q;:-Q[XYIU% !1110 4444 %%%%
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MQ6QB-E*!$CVQCZ8VH P/<.&R*BO_  ']LT+7(9M4N+S5M3A1/MMPJKL,9W1
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MD+.KF/F/)&57DG/'6B]\#K?37,,NMZD=)NKC[1/II*%';(8J'*[PA(R5!QU
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MU=/;&YV7-Y]G,BAMNR+Y6W/[' '&3S27'BXP67BJX-@<Z#'OV&7F;_1UFP<
M[?O;>_3-1^,= U+7XFM8;71[NSDA* 7ZL'MI.?WL;*IR<$<?+RHYYK*U#P;X
M@,'B&PL;VQ>UUNU2.2XNB_FQNL A/R@$,&"@YR,9/!H TKCQ;J<MY=1:/H:W
MZ6$,4MX#=>6^9%WB.)=I#L%P>2HY K$;Q/J^C7_C._BTX7NGZ?=I--Y]V8VC
MC^S0EEB7:P)'S,02HY[DG&J_AWQ'IU_?3:%>:?&-2@A2>2Y#%K:6-!'YD:@$
M/\H7Y6QRO?.*DN_"-[<:/XRLQ=0F37-WDNV?DS;I%E\#U0GCL: -KQ!KL>A>
M'I]5\EKC;L6*%3M,CNP1%R>F68#/:N,O]9U2#Q!KIUFR$2VOAJ2X:VM+YS'*
M SG*OM4JV 5SMR.HS76>)-"EUOPM)ID,Z0W(\J2&5@2HDC=77(ZXW(,^QK"N
MO"WB#6+G6KS4IM.AEO\ 1)-,BAMW=DC9BQ#%BH)&6YX&.!@]2 ):>,;K[/H]
MEI.DPS22:1;W_D7.HE)61P0$B+*?-<;3DL5ZKD\UHMXIU.?4KQ=-T,7FG6-T
MMI<RBYVS%R%+&./:0P3>,Y89P<=.<G4O!>KW?AC3M",>BW4,&FPVHGN5<26D
MRIM,T1"DGL0,J05Z\U>A\/>(]+OKZ'2-0LDL+^[6[DN)@6N(20HD"K@JV[9P
M21C<>#@4 8VD^)9])U#QE+()KZ8Z[%9V5LTI +R*@503D*N22>. #Q6M=^.+
MO28]1M]6TRV@U&T6V=%2\)MY$GD\M7,A0%%5@=V5X R,U7?P)?E]=N([RV6Y
MN=8AU6Q)#%5:,+A9!Z'!!QV.:MC0/$$]YJ6LW+:4-2N8(;6*T^>6W\A'9F5F
M*@DOO;G;QQP: +EOXFOEOM(LM0TN&&74;B6$2078EB*I$9!(AV@L#C&"%(.>
MHQFCJ/CN:S286^D&YF76QH\<8GV[V,0</G;P,D CL.<]JHVO@G5].^R7^GII
M5O=VVI27D>G([K:QQO!Y3(K!<@YR^0H&2>*G@\%ZL?+EN[NS:?\ X2)=8D\L
M,%V>4$*#(Z@]/44 /U/QW>:7)=QRZ=8EM,MTFU)3?[6!9=Q2$%/WA"\\[<Y
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MRV+KNYC'SJ4)VD8/'-:">*M:_MRPT(:+;27TUBM[/(+T^5$GF%#SY8).,$#
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M(C+\Z[  I56P03T&0,X&7<>)]6UEO"5__9XLM,U#58VMY([LM(\?ERD"5-H
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M9+LK(D>R/(B3:0=H.X@E1SQ76>'-&O+"ZU74M3D@:_U.=9)$MR3'$J($1 2
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M7+W%MY.D?;O-A0MA1<?<CCR/NH/EYQP!]*YC39Y))/"7ARUU;3[V+2]5"K#
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M^)UY9VP?5E)CM90N9$)LTX0]03GMUXJWX&AM)/$$-U9ZUHERJ:4(C;:39-$
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M]2/E7@\8 ':K,TMII]UJUCY6FV]M)XIVQS7R$VUJWV-)-Q0,H))! !(&YLT
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MS';$I(!)P>%_ 'IV%<;+XCU-/&K:;/?VEA']HCCMK6ZM7 O(BBEF2;.W?DN
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MD)>13QO(!RN<\\<>]4O"WB/5M:T'PMI^FFPTRXOK">]GDCM,QQ)'(J!8XPP
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M2WW1*G[IQ& #CJ0(ASWR:8? MJ9-/?[9-_H6KS:JORCYGD9V*'V&\_E7644
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MOJT4PC5]DC!@5*G@KAC3;KP#;7=KXDA:_G5M<FCG=U5<PO&%VX]>5!YKKZ*
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M"ZL=?OH;RWMGM9KF54F>='<.2=PP&#<C' SC&*;8^ K2Q?PVR7L[#07N&B#
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M)2X<_/C.TL-VWU/7'%=I10!C^*O#\7BKPS>Z)/.\$5TJJTB $KA@W&?I3?\
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MEAB@,3N(SSG+Y /)"=.E>C7NF6NH364MS&7>RG^T0$,1M?:R9XZ\.W!]:MT
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M<9(ED&1M.&^N#P<=.]49?%^DW>CZC=:1J^FRR6<7F,\TI\I!V9B.=IP>1Z4
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M2&_UPV%\KZ_*"?I0!4TC0O[*\(6>@_:/-^SV2VOG[-N[";=VW)QZXS65X?\
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MM-O(KF-&V.8SRIQG!'4<$'\:C;Q'HRZN-);4K<:@6*?9]_SY"!SD=OE(/XT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY3Q9-/;7L%OYGD-Y8"R,I!!C(++G!'S#IU'K=% 'E,#ZAJ/B7P'=SVH(CO\
M4MUS#:M"LR^6P68H?N;^O/4G(ZU'8[G\*Z#X66VN!KUIJ\4DZ&!QY>RX,DDQ
M;&-K+D@YYWX[UZU56TU&SOI;F*UN8YGM9?)G5#DQOC.T^^"* /.(+"5/ =BJ
MVCK,?%0F8",[L?VB?F/MMQSZ5Z+8ZG;:C)>1VY?=9W!MI@R%<.%5N,]1AAS3
MK[4K+3$A>]N8X%FF6",N<;I&.%4>YJ6&VAMWF>*,*TTGF2$=6; &3^"@?@*
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MD+6Z9&N;%+C]Q,5P!D$$@$ 9"D XYKHZ "BBB@ HHHH **** "BBB@ HHHH
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M%&]P+J2SCGVP/-Q\Y&,]0"1G!/)%5O&&AW&N7GAU81,(K;43/-+#($:%1!*
MP/LS+QS[C&: .6U#7/$.G->:)!K#R7%OKME9Q7TT,9<PW"*Q#@*%)4D\@#(Q
M4FL:KK]MJU_I-C?:Y/+IEG$T,EO9Q2_:)W#-F<[<;>%7"[?XCGICJ8O!.F)
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MBDV+>69<$.RXSG*J< @$@$@T <O_ &WKG_"-CQC_ &O-L.I"+^S/+C\G[/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4TR(,Y=1M.#D]#_DT .HHHH **0,&&5((SCBEH **** "BBB@ HHHH ****
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MTT:GY]NT@(<'(X^O;'.99^.]3UK^QTTC1[8R:E8372BZNF3RWB=$=&PAXRQ
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M'E3DX Y^1>GIWZT =)1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&[)0?,,J !SS6QXEN]0\6>$=>L[+PU?0.=,95DNH_+D>4G/DHI&6  SN!QG
M&: -F7Q=90ZK&\U_)!;#2Y+Y[&73I5FV(V#)D@$8Z;-N3UK8GU_3+:+3I9+D
M;-2=8[0JI;S"REQT' V@G)X%<I#:W.J_$O3=7.FW<>G/H,MO(;F IM<RK\C
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M(526$F<(%ST.<Y]J;>M>:-XUUFZ_LF]OH=5L+>.W>WBWJ)(S(#&Y_@!WJ<G
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M-O[:2+48+*WN+E@!Y1:3<"$.><,C?IUH CU7Q=H^BWIM+V:82(BR3-';R2)
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MNFMK9IGQ9R0.Y&>L1!9!ZYZ#D\5C1_$",ZU8B2WNUL[O2C=+;K8RO<&42!2
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MP!@#GYN0,&H+6UU2/0/#OAQM#U W6F:U#)<SF']SY:SEO-5^C9!!XY&3G&*
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MBS'GU)/%6Z** "BBB@ HHHH **** "F"*-96E$:"1P%9P.6 S@$^V3^9I]%
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MWD,5FZO;&*>2)XBJE00Z,&'!(Z]ZUJ* ,_5]$T[7K:*WU*V$\44HF1=[+M<
M@,"I!R,FL\>"M"&GS6?V:=EFG6YDF:[E:<RKC:_FEMX(  'S<#BN@HH YO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU.VU--!U+28[>V:VT\R /N?S(V3RV9&8,A!P,[1SP* /3'GAC<(\J*Q( 5F
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M9E09:,,-P'N*\]\-&&X:'3M3TN[_ .$FL+ZXF\]X)%3+,^)O- VLA1@ I)Z
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M0N3'C/'3%:_@PV=S;:7:ZKI-V/$6F"9;N66"155F!$DADP$D#\$#)SD''&0
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ML4D*WE%B%YVCKM-=#X-\H^)O%LMM;316UQ>0S1.UN\:2 V\88C( /S _S[T
M=G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% #74O&RAF0D8W+U'TJ.UM8+*
MV2WMXQ'$G11^9)/<DY))Y)-344 %%%% !4$M[:P7,%M-<PQSW!(AB=P&D(&3
MM'4X )XI]Q.EK;2W$A(CB0NV/0#)KSN2_O\ 6]2^'^LS/;)#?7,D\<*1G=$'
MM960%MWS?*>>!STQ0!Z14<\\-K;R7%Q*D4,2%Y))&"JB@9))/0 5Q5EXNU2?
M2O#]W(EIOO\ 6)M.N L; ;4:8!E^;@_NAUSU-0?\)!XDN- \2:G(VD-;Z6;^
M$0-:N?-,.=I/S\ @$$<]<Y[4 =]'(DL:R1NKQN RLIR"#T(-.KB)->UZ?5(M
M.L)-.@5]$74%>6W=]KY VX#C(_+'O20^,[N\M-!D)M=/74](:_-S< M&)0J'
MRAR/[S,><X7CN0 =Q4$U[:V]Q!;S7,,<]P2L,;N TA R0HZG@$\5F^'+[4M6
M\*V5_?QQVM]=6XE,8B8"(L,@%2V3CZC/M7 6-UJNHZ-\/KVXNX9K^XU&5Q-)
M$< FWGR6 ;YO7 V]AQUH ]8HKA;+QAJ<L5OI\L4,NJ2:G=6!EACPC+"&8N$9
MQR0%XW<<GG&*Z30+C6+C37_MJUBMKV.9T'ED%9$!^1\!FVY&,KDX- &M17G]
MIXMU\:.^JW?]GO$U_)ID4$,+*QE^U>2CDL^-N,DKQD@?,,\7+OQ%XBTFVN7U
M&PACA^VVT,%XP4!89&"N\B*[8V'/.X Y'3!H ZZZN[:QMGN;NXBMX(QEY97"
MJO;DG@5-7GVH^)]9C\,^)KXKIUQ#IMR(+9VMF,=PGR$L?GP2"^WCC*'Z#3U#
MQ1<67BU=(N'CL8Y9H4LY+BW8QW:MC>JR@X60'("D<X'7/ !MZ;HD.F:CJ=[%
M<7$DFHRK-,LA7:&"!!MPHQ\JJ._2M.O-;;Q#XALM%N[S[7:74S>)#IX$T# !
M#<B'@A^,#&.#C'>KOB+Q-X@\.:;?2SS:9<W%C9"Z98+>3][\[YW+N/E+L48)
M)RV[&<8H [VBN%USQ+X@M;[Q1'8OIRQ:/I\5_'YT#LT@*RL4.''7R_O=O0]K
M-AJ6I7WQ"$?VI%T]M&ANEMC'G:7=@?FSU^4<XZ<8[T =9;75O>0+/:SQ3PMG
M;)$X93@X."..M2UR6IO'X'T2W&FV12Q:Z9KN2WM?,^SHP9BXB3'RAMH..@.>
M>M;6E7\FI>'H+V&[M+B2:(NEQ I,+GG! SG'MG/;- !H^B0Z-'*$N;N[FE.7
MGO)C+(0,X7)_A&3@>Y[DUIUYYI/BOQ)J,/A69GTM1KUO(=HMW_<.L>_=G?\
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M@BC=XRX8'&\LH(7&,'&<\U4TCQ#X@UHZ9J-I81?V3>[][.$!@7!\M@?,RYR
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ML42_Z1=+(UP8YDE,2NK'$9VD?-CEAQUK2C?6AXKOO$/_  CEW'&=%2%();B
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MN 5/EGH2>1D#G'I5% 'GVG^%]3TN;PHJV?F)::A>7EUY4B!+<3++A!D@D R
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M:5]1NYU5G1LI),[J?E)[,*Z2BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;
MMY8[.=X%W2K&Q1?5L<#\Z\LTNUM8=$\"ZQ:RR2:MJUQ$E]*969KI9(G,ZN,\
MA2"?]G:,8KUFLNT\-Z)8:E)J-II-G!>R9W3QPJKG/WN<=^_K0!Y[ILUU=OI/
M@*2>5I]-U.0WCECN>S@VR1%N^'\R!??#4WPQ;:M=WVEZT\>G6]S+J4ZW-W)J
M<AGN5#2*T!A,>WY0.%W<>6#ZUZ='IMC%J4NHQV<"WLR".2X$8$CJ.@+=2!5>
M+P]HT&KOJT6EVB:@^=URL*AR2,$Y]2.I[T <O\+--@3PG!JK&26^NC*DLTDC
M,=BS.%4 G   [>Y[U1M=%TX_&_59C:KYB:5#<JV3Q(9'!;K7H-G9VVGVJ6UG
M;QP0)DK'&H51DDG 'N2?QI%L+1;^2_6VB%W)&(GG"#>R Y"D]<9)XH \=\$V
MJZWI'P_M=0DFFMY;'4FFC,K8FQ*F _/('I[5?LT2ZLK3P\+,7XBU/4Q;P7=Z
MT5ND$,I4;R%9GVAU"KCW[5Z;::+I=@MJMII]M +172W$<07RE<@L%QT!(!/K
MBH+KPSH=]$L5UI%E-&LS7 62%2!(QRS=.I)Y]>] 'F_AN!/$,_A&VU&5[FU.
MFZCOC$[,DH2XC1 QX+@#&,^@IVBPQZC-X=T'47DETD7.K(L,DK8D:&?;$C'.
M6"H7(!_N^U>F6NB:78W'VBUT^V@FS(V^.(*<R$%^1_>*J3ZX%1W7AS1;ZP-C
M=:5:36OFM-Y3Q J)&))<#LQ))S[F@#@Y'M+3QMX!M],U*XN]/3^U$#O*9,[$
M^[G^(*<J,YX'4]:K>%Y2OBOPW?6]M':PZS;W,^YK]Y[BYC*AU:92H4$'&,$X
MY%>E1Z+I<+V+Q:?:HU@K):%8@/(5AA@G]T$<'%5K;PKX?LY5EMM%L(9%F\]6
M2!05DY^8''!Y/YF@#G/@W_R2C1/I-_Z.DKE;>T>#X?7>JPEY+Z[UA[*666Z>
M,+;-?[6CW#/EJ>A8#(W$UZW86%GI=E'9V%M%;6T>=D,*!57)). /<DTQ=)TY
M=/ET\6-O]CEWF2W\L;'WDELKT.223ZYH \LU.PNM-M'M+J2STVQEUK3E^R6&
MHO*;8,V),L50QAAM.![FEUB)-'US5M#TZ66VT26ZTI;M(Y6"P^;*ZR '/R;U
M6,'&/O>]=MJ?@K3IM+L].TVRLK2UBU"&\FB$0"RA&RP( Y) QS6I;>&]$L].
MGTZWTFSCL[@DS0+"NR3/]X8Y[=?2@#S/Q="NB0^+]+T5WMK%--LK@QQ.2MO<
M-.RY4?PEE521WP#WK9O_  OHUA\1O"$$-I\H@O7R\C,S.OEL&))R3EF/XUV5
MOX:T.TTV;3H-)LX[.=MTL*PKMD/'+#N>!U]*L7^CZ;JLEM)?V-O<O:R>9 TL
M88QMZJ3TZ#\J /)M+5]0TRSMI[B?RY?&MU$^V5E+1[)LID'.#C&*LW=O%9:G
M?>'HGDAT1_$EI#) LK!5C>V$A0'.0K2!>.GS$=Z].BT72X HBT^V0)<-=*%B
M Q,<@R?[QR>>O)JCK_A]-3TR\ALX-/6XNI(Y)_M=J)8[C9@8D'4_*H /48&.
ME '+Z+IND/KOC;1Y;AO[(C-HAC-RRK!\A)16SE1N[ \=/:NI\8W<5EX2U&65
M9V1HQ%MMY?*<EV" !_X>6'S=AS6/IO@.,:1K5IJ(LT&K!(W@L8=D,$:+A50'
MOU;=ZGIQ777=I;7]I+:7<$<]O*I22*10RL#V(/6@#QV[BN+)?$.CJL.G)'=Z
M,?L^GWDDBPM)<X8AF52K%0N<#T/>KGB.!/#UWXFT[3'EL["6UTQYECE8",27
M+QRN#GY24')'IFO18?"OA^#R_*T:Q3RU5%*P*,!7\P#IV<;OKS5R?2["Y>X>
M>RMY6N81!.7C#>9&,X1L]1\S<'U- '&Z-ING:3\5KNSTQ1%$NB1LT"N2L9,S
M= 3QD ''X]Z[VLW3/#VCZ*=VF:9:6C;=A:&(*2N<X)'7FM*@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **IZMJ
M=OHVD7>I71(@MHFE?'4@#H/<]*R/"&LZAKUC)?W-SHMQ:N0('TN9Y!GG<'+
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MJ"H  .\/EB.".H/U Q45GXBL(M+LY-3UO26FGC:02PRA(Y0N<L@+$E0!UR:
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M-"L/F^7Y=U*I'F$-(,ALX8@$CUYK5M[>&TMHK:WB2*"%!''&@PJJ!@ #T H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "FR1I-$\<J*\;@JRL,A@>H(IU% "*H50J@!0, #M2U6O]0M=+LWN[V98
M+=" \C?=7) !)[#)'/2K- !15:XU&RM+FWMKF\MX9[EBL$<D@5I2.H4$Y8\C
MI3+W5+'3I[2&[N$BDO)?)MU;/[Q\$[1^ - %RBJ=CJECJ4EW'9W"3-:3&WG"
MY_=R  E3[X(JY0 455T_4K/5+=I[*<31+(T98 C#*<$<^AJU0!!+96DUQ'<2
MVL,D\?W)6C!9?H>HJ>JNHZE9Z38R7M_.(;:,J&D() R0!T]R*KWFOZ58:I:Z
M9<WT4=]=<PV_)=AG&<#H,\9/% &E1573M2L]6L4O;"<36SE@L@! )!(/7W!J
MU0 444A90P4L 3T&>M #?)B\[SO+3S=NS?M&[;G.,^E/HJO:7]K?&X%M,LAM
MYC!+C^!P 2I_,?G0!8HJCJNL:=H=E]LU.[BM;?<$#R'JQZ #J2?0466LZ?J-
MS);VERLLL4<<KJ%(*HXRAY'<4 7J*K:AJ%KI5A-?7TPAMH1NDD()"C..WUJP
MK!E# Y!&0: %HHHH **JP:E9W.H7=A#.'NK0(9XP#E-X)7VY -6J "BBB@ H
MHJO=7]K9-;+<S+&US,((0?XW()"C\%/Y4 6*9+#%<1^7-&DB9!VNH(R#D<'W
MI]% !112!E8D!@2IP<'H: %HHJJ=2LQJHTLSC[:8?M BP<^7NV[L].O% %JB
MHKFYAL[6:ZN)!'!"C22.>BJ!DG\A3;.\M]0LH+VTE$MM<1K+%(O1E89!'X4
M3T444 %%%5HM0M)M1N+".=6N[=$DEB'5%?.TGZ[3^5 %FBBB@ HHHH ****
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M %JBJ>H:I8Z4ML;ZX2 7-PEM#NS\\K\*H]S5R@ HHHH **** "BBB@ HHHH
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MGA(Y\N08'(SUQR,'GJ>.TOQ!J1UFPECO]6NK/4[>Z<3W<,4<$FU=\;P("74
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MQV..1W%<Q>Z7>76LZ])"FBVLNG:A!!9WEY=O%+9QJD1C6-0A 1LGC(W%F!H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %9,/A;P_;H%AT/38U#M(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMU5G215E 5@2."<C/08YINF^"]7MM0\-V<T3*EOX:GL;BX4Y6*9]ORY_/\J
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MHH HZMH]CKEB;+48FFMBP9HQ(R!O8[2,CGH>#5R**.&)(HD5(T4*J*,!0.@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,YWB,Y3^+@J>01@@DU&W@SP^\-["VG@I>[/M/[U\R[<8+'=G/ R>^!G-;U%
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M=".XH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.?F!K!L@+;3;#^TM7M=,M+SPK801&ZLO/\]0C^9''\P^?+*=HR3E?2O<*,4
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MPK2O[S3O[:TG6-+NX-&T5A?*M[=VF^!YV>,EU!8 !PK[6R,X; ^:O6*,#&*
M/+?#^D6B^*_"<1?[=;Q:1>RP2RVQB'S3QE<(<[0%; ]L5ZE110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[P-Y&F*1#;OY:[E&>!GAB!W8]Z );SQYI]E>7*-8ZC)96EPMM<ZC'$I@AD)
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MEB#_  UL_#2:6;X;Z 9;62WV6,**'93O4(,.-I. ?0X/J!0!U=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex1022001.jpg
<TEXT>
begin 644 ex1022001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7V7-S+FY>:W)&UKVW[]=OF6/^$6U'_H;-7_\A_\ Q-(OAB_897Q=JQ'L8_\
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MBM/91_ILX_K]?R_\!C_D<S_PBVH_]#9J_P#Y#_\ B:/^$6U'_H;-7_\ (?\
M\37344>RC_38?7Z_E_X#'_(YG_A%M1_Z&S5__(?_ ,31_P (MJ/_ $-FK_\
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M_$7H_P!#JBFL)._\T?RF=%1116AQA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%)D9Q2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4 %%%% 'F?QB.-/TT>LDG\A7CA W5[#\8C_H&F#'5Y/Y+7CKJ <Y.: &[LG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6O;*\5^$]K<67C2]MYXGC=+1PZLN"IWQ\&O:J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXM\.6MK'<SZYIT<$A(21KE K8X.#GFM&WO;6ZM5NK>XBEMV&X2QN&4CUR.*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?/Y7F<^40JOE?0Y/)[X%=O?^#=7\4ZE93>*+VT-C82^;%962,%FD'1I"Q/\
MWR/SIGA3PO=>!?#GB(WMQ%<I-+->J(@00NSH<]\+0!C?!/0M.E\"1W]Q!!<S
M7$CK^\0/Y:*<!!GH,Y;_ (%7!:[)-I?BS5/!>G736VC7VKVXD6-MHA#XW(,=
M =PXZ?**ZOX5:;XHA^']I=^'[_3_ "[MI&D@OT<B-@Q4,A7ID*,@\=_6N@C^
M$EI+X>N[:_U":;5[NZ^W/J"* 5F'3:/[HR>,]^W& #9\6>%]%;P)J-M'I]K
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,CUH
M **** "BBB@ HHHH **** "BBB@ HHS10 4444 %%%% !1110 4444 %%%%
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MXHE\.Z/;P/=6D*S7MQ.6\J'=]U !R6/7MQ7&>-KGPWJG@^UT+0M?T&%4NEN
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M:I(?*N(AUP<94YXP16)K,]K?:GX>\0G7]"?5=+E<RP)=JL<D3\%58G[P'0G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;U75=<\/2"'Q#I5Q$\.#@R)Y*%H7]CD_C]: .[D\6^'X5=I=7M$5 2Y:0#:
MQ4D^GS CZBAO%OA];1[IM7M!;QJCO(9!M56^Z2?0X.#WKS_4)8;_ .!&JZG<
MVR075Y#.\@(PRL;AV"$GGAF(Q]:C\4I;+^SO;S;8Q*VE64?F<9.-F%S]2>*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%!( R:0$'H: %HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XRTNX&^+>I1"
M9-XTJ!-N>=PDD./K@@_C73V&JV>IO=+:2F0VLYMYOE(VR  D<CG@CD<5:"*&
M+;1D]\4H '0=: %ILCK'$[N0%4$DD]!3JJZA:?;[":V^T36WF+M\Z$@.GN,@
MC]* /#=%1X_#FE^(6GDU+0K/5+B2]T\-E8@9F*3!0,L5R&P<]<BMWQ7J6A:I
MXG?^U]86'2+O3HQI]PD(F5GW/Y@0[6VORG3G@>E=;%X,8^;%#XRUW*G:ZI+!
MP<9P1Y7H:1_ ;2;4?Q9KS*IW*HFB7!]?EC!H Y8_9;/QM\BLVHS^&XQ8/>1@
M333J7 8_[> ,]Q5+PVVA74"7,6I.UW'IDL5_;+;>6579\QN&SR0PX)YR:[H^
M"[A&4IXNUV-AT9I(7;\WC)%1_P#"#W(WX\9:X/,^_P 6WS?7]US0!Q7A>.PM
M9/AX\;QB?4M/GAN]S;C.@B!"MGJ P  [=!38'TF#X:P10BUCNX-;C$H7:K*?
MMIP#_P  !_"NW'@6[#*W_"7ZX"OW<"V&/I^ZI#X$N2"/^$PUT@G<>+?KZ_ZK
MK0!R.LS6=S;^-DUJ58M9AG+Z8^?WJQ>6OD^2>O+ YV]R<]:2XM+>_P#$NNQZ
MN$^UQ^&X)YLR';'. VYL9ZCY?IQ78GP/<LZN?&.O%TZ,3;DC_P A<4P^!;MG
M9I/%VKN[ ABT5N21[YB]J -;P1>S:AX&T.[N)#+/+8Q/(Y/);:,D_C7->/I;
M;_A./!L,NHFQ;S;EO/1U5HU\HC.6! R<#D=ZUH_!VHQ1B./QEK2(.@5+<8_\
MA5%+X'O+AA)+XOUAV QN:.V/'_?J@#BS<7NG7/CA=!OI-7=[))SJ2D-+'(,K
MY6Y<*Q"@L,#CO6GY6DC7M-?09U6QN=)N&U%(&PK)M&V1R/X]W&>O7TKHXO!N
MI1)LB\::TJ_W5CML?^BJB7P)>6T<RP>*]043D^:LEM;,KYZY C&30!R7@](+
M4> ID=C-J=G<0W6^0MYR!-P!!/8@8^IJGI6J16^A^";&:_4:C;Z[+#/&9LNJ
M"64;6Y^[]WKQTKMD\"W\;Q,OB:53%_JB+"W!C_W?EXJ1?!&J+*TG_"57&]GW
MEA86^2V,9)V=<=Z ,309X[;QY:I(\5\EY-=O:W]O(1)D9+QW"?[/13VP!Q7H
MVHP276FW,$3E))8G16]"00#7+P^"=0@FDFC\4WL4LAR\D-G;(S?4^7S4K>%=
M7_Z'?6A_VSMO_C5 %+P+K>GZ?\/;2WOY4LYM+@^SWL4Q"M&Z#!R/?&0>^:XK
M2M.-I%X*M-4-U;0ZA=W[>1YS1!8W!=%8 \9';K\V*[6?P%>SW:73^)99IX_N
M37&GVTDB_P# M@JIJW@'Q!JNI:?<3>+&FBM2YQ-91$C<,' QM/XB@#F)4>WC
MTZR6\NO['B\3_8[:87;J3 T;!E+ \J'X!]N/6K5[<S:$=8LK2]N6T"+6+*.>
M5YV8P(_,R!\Y Y3OQN-;6K_#S7=1BT^W'B@/:VLPD\F2PB"C (X55P>O0\5I
MP^"]9M[/['%XJD2VQCR5TZW"?EMQ0!QGBT/IR^)K;3+J1-*B@M)T\N8A;>X:
M7:50YZ%>2!QR*W-4\/:)I?CKPV9&D\N9;MV>XNG;<V$(&6;USQ6H? NI_8C9
MCQ)FV)W&%M,MBA/NNVGR^$M=E6!)?$T#"!@T/_$KB)C(X!7).#0!R,FIV]KH
M]I;-J+K=1^+/)C5IVWB/[1RIYSMV^O'2F:H7AT_QGJ<%]=BXTS6(C:-]I<K'
MD0Y&,X(.2,'MD5U'_"":G)++--XB@DFE8-)(=)M\L1T)XY(]Z<? 6IF*>/\
MX2"';</OF!TFWQ(WJPV\GW- &+XL=Y?%?BBS-Q.UNWA4SF$2MM$@D?! S@'
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M%VFP %DC+!AZ'(KTDD $DX KEK#X>>']-O+*ZMXKH26+N]MNNI&6+<""J@G
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MHOG>0R'^(L#WP3E>N.G'O6/X!\0:AINA>#]/NH8&L-1M72&1"?,1T0OENQ!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKYUO;QZB;:6TER7*20XQN4C&"5'>MWPW9:U%++<:Q'IT+-&$6*R0X."<LS$
M_0=!SZ\ &-X[\4F+0/$%KID-])<V5HS2W5L0JVSE-RY)8$G&"0 < \U/=^/-
M/T*PMX[H37$L-E%<7)C9,HI'7#,"QX)P,FL[6/"GB//BBST[[%<6&NHS!IYV
MC>WD,6QN I# XSU&*>GA?7],U1;ZPM=)NOM=K##=1W;-B&2--H=#MY4C&1@=
M* -'Q)XKB_LN^BTRWO[N1+#[2T]EC$*L"4.21R<9P,G'UI/#WBI3;:=I,L-U
M-?G1(]1\SY2)5P 1DG.[)[_G52?PUX@L;G5QIYL;V#5K5(Y3<2&%HI5C\LL
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MAO??V;=2V8T:2W\U4W*9"X;:![@?RH W9_%&D065I=_:3+'=Q>=;B"-I&D3
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M[TFPO-973Q<:!#=QR-(Z"29L[V!5ERRX4X)_B/%>D:%)))H-DTUV+N3RE#7
M0H)3C[P!Z9Z_C0!H9%85SXJM(-3DLX[>ZN!!*D-S+#'N6W9QE=W.<8(R0"!G
MG%<'9WNKZEK;:@^MVMI-:ZNUO-;&ZEWM'YFP1>3]WE<$,!GOGK5G1]$M)-<\
M=A[J]5(IU&5O95ZPJQ+8;GGUZ#CI0!VVD>)8=9N52"SO%MY8?/M[IXOW4Z9
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MKZPOBZRL+S4S?6M_HXOE#0JAB<,H^4CD@AN_>KGQ10O\-=< QGR >?9@?Z4
M;.G>)]#U:X:WL-4MKB=5W&)'&['KCKBM:O+==;4X?%_A+4-:L;:"QAN3#%-9
M3&5S+(NQ0^Y5PI]L\T^?Q=K+^'-4\56]V%@L-0>W%@8EVO"D@0Y/WMY!R"#C
MMB@#T^BO,=7\1>)+5/%=]!J48AT:6&2*!K89="BNRD]>A/OFKFI^)M7@O_&L
M,5TJII>F1WMI^[4E&*.Q!]1E1UH ]"HKSB[\7:M;W&E7%W<?8=.O;2VDBN1
M)(6E;F1)6ZQ\$;3TZUZ*IR@- $;7=NEW':-,@N)$9TB+?,RK@$@>@R/SJ:O'
M?$&O%=<3QC%'>%-.O1;K^X?RGLQE)'#XVY+,3UZ**[;Q-XAEL-2T:U2\CL;*
M_P#,+W[!2%*KN1?FX&[GD^E '645YA'XD\72:)X9N)+FS@N=5OVM7#6C *A5
MRC8+9_@W=L[@.*LW>O\ BTWE_IFG"*[O=+BA#ND:*EQ*Z[B6#."BXX&,\Y.>
MU '91Z'!'XBEUL33FYEA$#*6&S8#D#&,]23U[UJ5YY/XI\2:C>:FFAV0D;3I
M(HS$?+*2,45V#.7! PV 0.V>:AUGQ1XDM[;Q1=6ES9*FBF.54> GS$,8<ID-
MP>3S_*@#TFBN!E\6ZKHNLZM:ZHUM=1V^C-JT(@C:,@*2&0DDY[<\?2JW_"1>
M,;?3KR^EM(C;'39+J*:5$58IE7<% 60ED(SR<&@#T>D&#7GVE^)/$%U?:7:7
M-S9?\3?1VOH9(H&'V=UV<$%OG!#CTZ5L_#R>]N_ ^EW=]=?:))X%DW%-K#(Y
MR<G)SGGB@"]XCTZRU6&UM;S4;FS#3C8(+DPF8X/R$CD@C/ ]*OB>PTQ+6R,T
M%N&Q%;PE@I; X51WP/2N7TR9]6\;^)9O,Q)IJ1V=KO7<(MR;V;'J21GV45Q%
MM/K-]X<\%WT]W!=7LNN.(7FC(VG]_G<022.,X&.@'O0![5B@* <UY[_PG6H6
M^G36]Q#%)JL>KG2U,$+LCG ?>$SN^X?NYZCK72>%]4U34[6X_M6Q:VEBG9(V
M,9C$T> 0^TDE>I&,GI0!MM)$&(9U! R03T'K33-;@\R(".Q-<OK7A+4M2N-5
M>WUI8(KT0LB/:A_+>,J>3D;D.WE#Q\Q/>N;U.S@3XPI]HT9=6D;0=TD:1Q?.
MXF WXD('3CKGF@#TTR0F+?O4H.=V>!4/]H:>L F^UVXA9MHD\P;2?3/3-><^
M(;:>V^'7F:=8Q:6EWJ,33V$J<*6G1=HVG"@X&X $')]:K7&AL/B/;6%UIVC+
M;3Z;)<36ZQL8WR\:RL!TW8 P<?SH ]76-!DJ!\W4XZT>4G]T?E7GWA[QO=74
MVGK%H\BZ-<0LR.D,P^S(JY0L[*$8$#'!X/K6CI>O^)-6TZ'4X].L8[&]LWN+
M9O.8O$< QB08&=P/.WI[T :7B'0FU&>RN;;5I=-N;<LL;(B.K[\9!5P03QP>
MO7UJ;1O#D.F?:);B9KZ[N2IFGE15SM!"@*H"J!D]!WYKAM-U[4[GPEX.U#5[
M.RU!KW48569V.^)FSB0#&-W4<'CBMM/&>IQRZ[93V%O_ &C87<-O;0I(V)UE
M(".3CCJ<X'&#Z4 =KY$6]7,:EE&%..1]*DK@[SX@3Q:O-#::7+=VMI=K:7)B
MCE:3=QN9 J%2JY'4@GGCU[M3N&: %HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D) !).!2TR5$EB=)
M%5T8$,K#((H 021-P'4^P-.VCTKS/P1X0T'5O $)GTVW2=Y9\742!)D(E< J
MX^8$8'>DT#QCK;^#]'E+VK2.+B.2\NV+>:8GVJ%1/F=F'.1TP: /3=JYZ"L2
M/P]Y7B^YU_[43YUJEJ;?RQ@*K%@<YZY9OSKD[7Q;K>M:YX3DM/LUO:ZC9374
ML#ELDIM##..@W9'';FK>F>.;W6KNSDMM+DN-)O)V@W1Q2;HUR0)&?&PJ2IR
M<C(Y/- '>"1&QA@<],&E"@'( SZUQ^E> [736T1T*QMI<T\L?ENY"K)G]VN3
M]WD9)Z[>V:T_$FMW.D/9+!';A)W97GN'PL>!D */F8L> !F@#=VC.<4AC4]5
M!_"N!M_'VHZ@/#266F6YEUD7 (EG91$T0.?X<X_#-6;3QS<W6DVP^P1KJ]QJ
M4NFK!YW[KS(]Q9]V,[0JD],]J .S1HFD=492Z_> /(^M.=E12SL%4#))/ %<
M+X'2XC\9^,Q=0P13F>V9Q 3L8F+.X9YYZGW/?K69XEU+5KT^/]/N3;O8V.F*
M8DYRNZ)VSTY)(&?3 Q0!Z:NU@'4@@C@CN*0Q(5*E1@]1CK7#:3XOFTP0V&L6
MD4$$6B_VA'-%-OS&FT,&!48/(/&1^56O#_C"_P!6UB&UN-)EBMKB S1SI'+B
M,\?(Y9%&2,\J2.,>E '6&V@).8D)/4E1S1]F@X/EIP./E'2N?UC1-:O=6O9[
M/4+>&VGTUK:(.K;X9B2=P(.,'C/?Y14.M7DVB>#[2QNKJUM[^Z5+)9(CLC1R
M,,R[N@50S<^E '3B"+C"+QTX'%2UQ7PYU@77AR?399Q/=:/,]G)(KA_,5?N.
M".H*X_(TS3_'%]J%WH2Q:9 8-:262%OM)W0J@R=X"'G![<9XS0!V:6\49)1%
M4GJ5 &:6.&.(L8T52QRQ4 9/J:X6W^(%[_8L^L7FD1PZ?%)) '6ZW,TPF\I5
M V]">I[<\5(OQ">W@OOM^FM'+#+#%;O'YAAN&E. %9D!R#G/RG\>E '<LH=2
MK $'@@BHOLMOY'D>3'Y0_@V#;^5<0_Q"NXH26T5F=;^WL]ZR,L<@F.%=&9!N
MP<@C P1UJ*\^(>IV(UWS= 0G1'0WA6\!7RW *[/ER6P>00!QU- '=O9V\BLK
MPQLK'+ H""?>G-:P/*DK0QF1.%<J,K]#VKD-?\=MI5Y-!9Z>;PVUNEQ-RX)#
M9(5=J,"V 3R0.1SZ17?CV\6ZO8K'0VN$MM.CU$L]QY9,;!CM*E<AOE/'YD4
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M?6LMPEO<SB%B8R%,:Y!#/DG X! SF@#>U#1<:<\>B_9=.O539!<"V5A$-V2
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M5B )9V7RQ&GJ!N.?]K '>NO21),[&#;3@X/0^E #JCGF6"!Y6#%4!8A%+'\
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ML7$,X&Y3NQDA@& &>M '945P<.I:S<:OI&AW5_):RW5I->SR+&@D^\-L2Y7
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M0^S7=T?$6V/:"G(DF!&3G"\#'L!UH ]=HKA9/'=W8Z=J?VZQA.H6FI1Z=''
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M:_$?P_=6*7Z?;DT]O^7R2QE6$<XY<K@#/?I74Q313PI-%(CQNH974Y!![@T
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M2Q$F0JBY #\@[>._M7H::S92:U+I"R'[;%")W0J0 A. <]#R#^57N/:@#G?
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M<>HKUV+3[*"U:UAM((X&SNB2,!3GKD8Q4*Z+IB6/V)=/M!:YSY(A79GUQC%
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M3"":]VJKKL_U>T 8 4C.._>@"GK7C'4=,N?%4<5O;.-'L(KR'=N&_<')#?\
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M1)-;RQ7 E#*PSM88!##C.,CT)JKJ'C2V@ATZ;3XA?0WFIKIQ=) H1BQ5F'J
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M[WQG!./0=3[ T :-%9>G:[;:EJ=[8117*2VBQNS2Q%4D5P2I0_Q#@CZBM2@
MHHJ&ZN!:VLUPR.XC0N53&3@9P,T 345F:3KEKJWAZWUN)9(K6>'S@)1AE7W
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MAY9YSR.F<]Z .:\&6]O9^+/%5M;3/+%'); &28RL/W(X+,23CW-9'B?^U_\
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MO?+O+FY-Y.;B1IRI.\]<8 ZUD:I\/K;4FUT#4KV"'6547$$94H& 4%AD=2%
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MVO@[SN^WYAQPOR\#MGMBIM-\*:W::;X'MI;/YM*:87C)*GR!XW0$<\\L#^%
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ML>I:)K6HV^JB*6T-K<21P'$87RY@& 7!7.2._P"%>I)F*V!D'*KR%R>W;N:
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MT[59+:2_LH+EK9_,A,J!MC>HJ]10 =**** &O&DD;1NBLC##*PR"/>E "@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *1W6-"[D*H&23VI:KW]E!J6GW%C=*6M[B-HY%#%25(P1D$$<>E '
M$)KFHW_Q'T?9,R:/<VMTT$2_\M0FP"5O8Y.WVP>]=_7"I\/;6S\7Z5JEE).E
MI9PRJT<E[,[%R5VXW,?EP#D9P>.*Z[33J!BF_M$6X?SG\GR"Q'E9^7=G^+'7
M'% %RH;I!):2J9&C!0C>K8*\=0:FJCK-U%9Z/=S3/&D:Q$%I7VJ,\<GL.: .
M"^&WBZ]D\/W,/B:[WW5I;1W_ -I?&7MI$WAC_N\C\!2>&=8U'4M2\57FK7-T
M8H(HGAM8GV&WCD1FQC(&\+M))Z'-94<'A^XM_"INO$FEQ2Z;;+9WZ1W(9;J%
M5&%SQD;U4\XX)J6UU;38=5\8W$FM:0$UJ-!;A+DML*Q>7AOEZ'KQ0!U%OXRL
M]/TC2H;:TU749)=,6]5/D:?R0%&Y]S+N;GH,D\U?U'QG::?/<Q"ROKH6:H]V
M]O$&$ ?D @L"3CG"@D"O-M0OM+O='T[3YM5\/>=9Z?'%!>+JODS6UPN06!QD
MH0%...AXJZFO1Z3KVH7&D^+?#5Q!JD<9GEN+P*\$ZH$,BJ,A@0,[<CF@#M]5
M\>Z5I-[+;S+.R0/''<3(%VPE\;<@L&/4$[0<9YK&N;BY76O',2:G=+#%I\$L
M+"3BV<K*3M].BG\?I6 -6T^P\1:E)8>(?"]U8ZE(LQN+JX3S;5]H5B!C#YQD
M#( -/N]7TF:\\9M'X@T-DUJU2"TS?KD,L10[N.!SGC- '36/C(:3X6TAKVSO
M[NX_LF*]NY(U7Y$VC<S%V&3G/ R?:KU[X\L+74%LHK+4+N=[$7Z"WA#!XCW!
M)&/QQ7GNKW-MJ%G#;OK'A^>!=&%HJSZCM2VN-K!I  I#Y!4 G&,5HZ5J5I#K
M$-]<ZQH6P:"M@WE:@I_>@DY&<?+@]: .XF\;:8NGZ==VZ3W7]H0&X@CC"JQC
M !+'>P QN QG.320^-=.O+2QGT^&ZOGO8&N(X($7>L:G#%MS #!.,9SGI7F5
MK<6.FZ9X;N8M8\+W=[IUF;&[M+F_0I(F059'P<$%<].];,>O:9IFN6.LP:_X
M?NI39-:7EM'?)$J N74QYXPI)4YY(YZ\4 =M:>--+OKG2(K<S.-521K=]@QF
M,9=6YRK#ITZTR+QMI]Q9QSP074DDMY)8I J+O:6/=O RVW "L<Y[5Y[%=:+I
M4OA_4+7Q'H%U=V$UY+/ VI*B_P"DG)VM@_=.!TY&:@T^736\-?V9?W6@:C"V
MH7%S(+;5562+>=R-&_&&!+#Z?E0![+IM_%J>G0WL*R+',NX+(NUA[$=C7)_$
M34[K1QH,]OJLFGQ7&IQ6MPRA"#&^<D[P0,8SFKG@Z?4O['TRWDO+34XDBD6Y
MOHKG>0X;Y5&!AN#@G(/'3FHO&^CZCJ]SH$NGVR3?V=J*7DBO($#*JL-H]^:
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MS#YHDZYZX&,4 =%/XJTW2=2\07%Y?7IBT](#/"T&4A#9P4P,MGJ3R.E7=/\
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M@2Q^5LCKZYH ]MR*7->7>(+JYU/Q7J.FW.M1:8D%E#+9M+,\6,@EY5PP#$'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS6W$%F+'G'J2?QK'F\ :/,+A!+>QQW%V+QXDN#L$H;?D*>!\W)_PXJ@_B_\
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MNM:-<:7?J9;>XC,<F#@GW'H>]8$/P^TXZ1=Z=?WM_J*7$2P^;=2AGB13E0A
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MHO-N5G0V]Q; #<)$W$AQE@"!V'.*]%HH X_Q?IVL)K>C:_H]J+^2P,D<UD9
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M#P">?K50:3<>*-?UF[NY=3L+=4%C#$8%4308RQ^="?F8D<8X45W=% 'D,?\
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MRS?ZU3$I$G^\,<_C4<VB:5<00P3:=:20P?ZJ-X%*Q_[H(XZ#IZ4 <RKQ:O\
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M+6TM9=*M'@LV#6\9B!6(^JCM5Z^L;;4K&>RO(5FMIT,<D;=&4]10!PL:O?\
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M^8>84]AQD\#)S@9K<UJXL;K6[S37\0V^D:>NGQOI<_FMMZMODC(=075AC'/
M'O0!Z]17E-S>2VOB"SU":ZEU2T$EG;2/'*\5Q:2D#&8NC*^X$CJ,GTKU5>@H
M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>]O2K>:\ZU.[O9OB MJNHW<5O/X<EG,<4I4)()%&]1Z^]9VAW&LVEKX)U?\
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M[/>KT]Q/8Z_\1KNT\CS8+2VF59H]Z-B%B00",YQ0!T>B^$=*@6WNH;_4+ZT
M66VBN;MI8D[JR@^G&,YQ74\9Q7F^N^,=6TVQ6XM9K11'I*WRVR0-*[L 2V\
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MCD#H=N: *WB'P\OB"&SC:[EM_LMTETIC"DEEZ Y'3FM1YH8#%'-*B-(VQ Q
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MXZ_L\:I%?Z7-!>:?9F_,'F*PFA'4HPZD="#CFK-SXM:*Z-M#8O)*^FG4(<R
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MOHUS<WMQ-9*\M]$(;EBQ_>H.BGGI4VLZO'HUBMR]O<7#/(D4<,"@N[,< <D
M?4D 5@/\1--BLEN)K+4$;[?_ &=)$(@[QS8! .TD'((Z9H TCX+\/$0@Z9$1
M#&L2 LQ&P'(4C/(!['-++X.T";[<)=/1Q?D&Z!9L38Z;AGG%9LOQ#L+?2KN^
MFTW4U^PW @NX/*7S("0"&8;L;2"#D$]:WXM7AFUAM-2.4NMNMP9 !L"L2 ,Y
MSD[3V[4 5+KP[8H'N[2S1M02T:UAD9SD(1]W//&:S?!G@VU\/:3IIN+6/^U+
M:U6!YED9P#C#%,\#/7@"K>N^,+30-2@T^:QU"YN)X7FB6UA\S>$^\!SG/(X]
MZJWGQ"T>RNA%.ERL2R)#-/L79!(X&$;G.?F&< @9Y- '5.BR1LC@%6&"#W%4
MXM'T^'[%Y=K&IL4,=L0/]4I&T@?@,5DGQKIZZM%9-;WBQRW1LX[IHP(GF )V
M#G=V/.,<=:EM?%UE>:A]FBMKORO-EA%T47R2\>=XSG(P5(Y SCB@"S-X9TB>
M_NKZ6T#W%W#]GG9F)\R/^Z1G&/\ $^M06G@[0;&2WDM;$1/;Q-#$RR,"JGJ.
MO?U]AZ5#;^-=-N+RT@\F[CCO@QLIY(L1W.!GY"#GD<C(&1TS5;3?B%I&J7-G
M%%!?QQW<SV\<\UN5C\U2PV%L]3M)'^/% &WHNAZ?X>T\6&F0-!;!BPC,C. 2
M<G&XG'-4[WP=H.HW=[=75@KS7L8BN&#LOF*,<'!]@*UKV]M].LIKR[E6*WA0
MR2.W15')-8</C737EGAGM[ZUFCMS=+'/ 0TL0ZL@&<XXR.HSR* +<7A?28=0
MAOTMW^TPP?9D=I7;$7]W!."/K4>B>#]!\.W,MQI6G1V\LN=S DX!.2!D_*,]
MA@4_P_XFL?$D!GL8KM8_*CE#SP-&&5QD;2>&Z<XSBJ6I^.M(TJ[OK69+R2>Q
MC6:X2&V9]D;9^;(XP,$DT ;6IZ78ZS8O9:A;1W%N_P!Z-QD?7V/O5#3/">D:
M3="ZMHIFG">6LEQ<23%%]%WD[1]*6Z\4Z;;-!&C37,T\!N4AMHS(YBX^? Z#
MD8]:O:9JMEK&F0ZC83B>UF7<DB@\CITZYXZ4 9UGX/T.PO5NK>S*2([21J97
M*1LWWBB$[5)R>0.YJ)? ^@I:BV6VF$*W?VT+]IDXFSG?G=G.>:CA\>Z%/<7$
M2R7(6V:5+B9[9UCA,8RP=B,+P>,]:(_'FB,E\T[7-H;.'[0Z7,#(S1$X#J.I
M&>/7- %'Q7X/6?PWK\.C6S/J.K1A)#)<-M8] 3N) P/0>U:5IX.T=;.X6:TE
MD:\MA;SBYG:5O+Q]P$L<#Z&DB\;Z0;._N+C[39FP"M<0W,)610QPA YR&[8^
MG6IE\6Z9_9[7DWVFWVS"W,$T#+*92 0@3&6)##IF@"A_PK?PSL96M;AR\'V=
MW>[E+/'Z,2W-6;KP['I\IUC2K:2YU:WM/LUO'-=LJ,@Z*>H]\D&DE\=:%!97
M%U-//&MM,L-PC6[[X7;[H=<94'C!/!R.:O:1XCT_6[B[M[0SK-:%1+'/"T3
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MO$E@>WLK&:"4\AY))7#LP&, 9' SWKN*0-D#(P2.E+0 4444 %%%% !1110
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MG<R[DF(/4K@Y!YQ7I6T"L>/P["OB-]:EN[R:3;B*WDES# <;247'!([^Y]:
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MA"H19)R-VT# '  P !0!S]IKVN:Q>75QI:636%KJ1LI(9=RR%48+(^[.!CG
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MLK,7,SV:WK)),8\(WW5&%;+'#<<#CDU+=>*Y=3M_LVDZ7-<2O8+=W"2S?9S
MC@[5S@GS#AN..G4<573P9K%A/I]YI.MP6]Y#I\=A<B6T,D4ZQ_=8*'!4C+=S
MUJ9_"6JVFKC4-,U=/,GLTM;S[7$9/-*9VR####<GCIS[4 3_  YD>X^&^AR2
MN[N]J"S,Q))Y[US'ASQ;=Z%HX^U:5=S:6-5N;>746G5O*W7#JAVDEBHR 3V]
MZ[CPIHDOASPO8:/+<+<-:1^7YJIL##)QQDUA0^"KY;&71I[RVDT>2^:\;$1$
MK@RF7RSS@#=CGN.PZT 3P^-)7B\0++IGE7FD2+&+;S\FXW %"#MX#9 '7FM_
M5+^ZT_0Y;Z&Q:YN(H_,-LDF"V!D@$]3U^M<K;Q:;XH\=PZEILLK1:>CP7W[M
MD2216_=J<@;BIWMGMQ77ZKJEGHVFRW]_,(;6$ NY!(&2!V]S0!DVOBVUNK?3
M;B-08+RS>]D?S 1!&H!);UY./P/I5.T\;>;/IC76F36MGJV18SM(&W-C*JZ@
M?(6'(Z^^#53P?X;L7T;5IHUF^Q:J\JVRR J4M6R0J@\JI9G8#T84_3_!^HK#
MH=CJ=[!<6>BR"6!XT(DF*J53?DX& W.,Y('2@"S;>.(KBST.Y^PR*FJWKV0'
MF F)UW\GU'R']*W]8OY-,TR2ZBM)KN12JK#%]YBS!1]!SDGL,FN,A\#ZQ VE
MVZ:A9_8M,U1[Z &%C(RL7.UCG&1YA''U]JZ7Q9H]WKN@R6-G<I!*TB,=X)21
M58$HV"#M8#!H YX_$N"'3+JYDTYYI;74(["5+2X25=SXVLK<9!W = <\<5H6
MOCNU^SZP=2LI["YTMD$UL[H[,) #'M*G!+9QC/6L&Z^'^M31:@BW>FJ+J_M;
MX)'"\:QF$(-HY/'R #ZU>U/P+>:M?^))I;B"!=36V:W= 6:&6#E&(P >?Y4
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MA(]:OQ'>/.;])EE"N@^=E5=G"X VX_6@#NCXTT[ 46U^9VD=$@-LRR.$ +.
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MGGBN9M/#&K7?A?QAIDMN;.?4;ZXN+5W92'5R"N<$XY&"#V-0VFA7\VCW@NO
MUA!*8$@EA2X4O=_."VUQC8  2,GKCICD [$>*=+-I+<,TZ+%.+=HWMW63S"
MP4(1N)(8'@=*K2>.= BM8;B2[D1);DV@#0.&6;^XPQE3]>O:N-N/"GB&71@?
MLTE_'8ZFMU:6.IS*998?**,C."1D%CMR>W-6Y- U.:WT>2W\,0Z=Y>M17LMM
M!)&2D:J5+.<@,Q)X SP!0!OZCX^TNTT7^T;=+FX'VM+,QB!U=)&8##J1E?O
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M%]'K*VB6J6ZNOV7 S)R/0YSG QC'- '9ZQX;TW7'BENXY1/""(YX)GBD0'J
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MI,^MK:7=O*&9/.C9QC.1E-R9QUZ5Z3ING0:=9>1#!#"')DD6)<(7;EB![G-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "@]**PO&6JS:'X.U;4K89GM[9WCXSAL8!^@/- &LUQ:K,(VFC$N,["P
MSCZ5-M!P:X^S\#Z)?>%(K>ZMXKBZN;8&34&4-.\C+S)O/.><]?:J/B;QA?\
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M#N0!D*O & !@>E:M% #'ABE96DC5BN<$C.,]:B^PV@VXMH?E.5^0<'U%6**
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M6\=O;0I##&-J1QJ%51Z #I5*\\/Z-J%P]Q>:79W$SIY;R2P*S,OH21TK2HH
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M;\4:PQ+&N["@ ;B2?S-/HH PKKPAHUY?7-W-;RE[ID>X07$@CF*@!=Z!MIX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQMSU!8=*](!XH I)J]@\=[(+E EBQ6Y9N!&0-QR3Z @U'I>NZ=K#SI97'F/
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M %DWXGBN[6&#RWC.\&,$!B^>2<G/ KI1(A&0PQZYK.U[5O[%\/W^JI#]H%G
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MZA<);VFK64T[C*1I,I9AZ@9Y'TH X/Q#I;P>+-1COM%U;4--U*VBB@&GR,J
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M_,-V1]W..5!Q7I/A6W6V\,Z<B2RR VT;9D<L1E1QSVJ*S\%^'K!RUOI=NC-
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M6G7OB<:[.I><6AM3&0-A!)^8^X!8?1C0!AZ]XBDN/#7B"[%G9W^EVL*!4E)
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M9+S5$U.!Q"<1.I4[6&?F'RCTZUUEUIQU+0[C3KZ7=]I@:&9XQMSN7!('..M
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MC\S6(XDML3KM)\L(V2>F#GMSBG^)K2+5=5T6VL;N*'6,FTOX4D5I%M'3=*&
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M/;RQRP;'AE*'F51C(ZY!H U-8\3Q:7>_8HK*[OKM8#<O#:JI98MVW=@D9YZ
M9)P>*VT??&K@$;@#@C!%<#'8VQ^,URYEFW+HZ3$?:' #>:1TW8VX_AZ>U=U%
M<PW%MY\$R21$$AT8,#^(H ES2YXKQ?2M:N3K?AYXM2NGMM8BO%DFGNV,DX5&
M97,8.V+! "[><=<5/X4U+4T@\#:E)JFH74FIQ7*744LQ9)-B,RG;V(*]>M '
MI^IZU;Z3<V$%PDI-].+>)D4$!R">>>. :TJ\CAD&I6/@S6Y]2N)[Z[U5'GC>
M<E$8K)E!'T7;TX /K7K@Z4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%9^NW*V>@:A<O<-;+%;2.9T7<T>%)W
M=R.N* +^0: 0>]>2:;J>I17]S;IJSVD-WH7VFWFN[MIRKY 69P>$)R257(%=
M/X,U)XY;^RU1;FSOK5(?.BNKHSH0=P$D<A/1B#P<$$4 =K29!XK(\5-(OA+5
MI(9I8)8[25TDB;:RE5)!!_"O/HI]8T'^P-3MM4O]4EU'3I7N+6>7>I*0B160
M=L, OON]: /2[#2M/TV2X>RMHX6N)#+,4&-[GJQ]35W(KR+2[C5;C1[?6/\
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M:WNC*-7MK:TL5G26R5<^86;YSD\KA< =SGBNCL_&&G7K:''&MR1K,+26LAC
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M4 -"A5VJ  . !7"R?#ZZ:S>R36B+4:K_ &E#&UL#Y;>89-N0PR-Q//I7>44
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MS<")B2 ..6Y^G!KI/"UAJ-EJ/B&>_MA"E[?_ &B#$@;*>6B<XZ'Y,_C7344
M<:=&U27X@ZAJIMPEA<:8MBI,@+;PS-O*^GS8]:Q="\,>);.?P?%<V=HEOH23
M13.MQN,H*;%8#;QZXKTRB@#R_4/"6OW'@[Q!IT=I%]JU#6?ML7[\8$8DC89/
MKA.GO7H=K->R7MU'<6J16R!/(E$FYI,CYLKCY<'CJ<U=HH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMZ?X>TN74=3N%@M8OO,><GL !R3[5BGQU;1VD=Y=:/K%M9RE0D\ML,$L0%R
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M)MM,DTR#3[>.QD#![=$ 0ANOR].:+30=)L--DTZST^W@LI,[X(D"HV>O ]:
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M(D+R.J(.2S' %*2 ,GI7G_Q'\2:(^C#1I-2B\R[E$<JPD2,BC).0,XY4#\:
M/0>M%>;>&O'FH7?ANPBL?#FIZC=Q1"*67Y8XBZ?*3O8^H]*TCJOQ#N 7A\.Z
M5; \!)[TN1[DJ,8]NM ';T5Q#_\ "R&C9WG\,VP'_75@!ZY(%<S<>./%MIJ$
M=G!J/A_5K@GF"PMYI6_$CY1^)H ]=HKG/"5_XEO[>XD\1Z;;V+ CR%B;)8<Y
MW#)QV[^M='0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_#+P<XYT.#_OM_\ XJK?CRU^V>"-6C R5@,@_P" _-_2M?2;Q=0TBSO5^[/
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M-XV3<IM="F[*PGEC_$C:?RJM<^&_$>LC;JOB1K2W;B2WTR+R\CT\QLM^@[T
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M@>3^[&!_.N^KC-/\,ZS=^++?7O$5[:2M91O'9V]I&P12W!<EN<D<8KLLCUH
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MDOF$HYD8!< 8)YZ<5TNLZ)J6G/X>U6R%L-;>,:=>-M"B3S$RT@P.2C*6^F:
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M1A\QVD@9)YP:MZQ;21ZYX)T>5LP1,\DA' 9XHAM_4D_A6%XKT"\U[4/$%SI
M%U>126\!B$@7]V$RRG/'4@_4>M 'JP.1D4M>=6VJ:_H%]#K6OM)'IE_*T,ML
M[!A99.(FXZ ]&^M=7J7B6SL9(+:$->WUP,PVUL0S,/[Q.<*ON30!M5YWXNE6
M_P#B?X0TL<I \MW*., [#L_'*FM'3O&EU=6.H:W>6$=GH5M&VR4RAY)'4X.
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M#0!-!IFGVJ$6]C;1*>T<2K_(590)M!0+M/I7&&Z\4"Q2QU:.QLH8\"YU07(
M=!UV*1PQ'<\#FM+PGK[:Z+_;Y,MK;3".WNH%94F4C/ /<="0<&@#HP,=****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H$LK6.
MZDNDMXEN)  \H4!F Z9/>IZ* "J%_HFEZJZO?Z=:W+H,*TL08J/8GD5?HH Q
M%\'>&T&%T.P _P"N"TO_  B/AW&/[$L/^_"_X5M44 8W_")>'< ?V'IYQZVZ
M_P"%-_X0_P -'KH&F?\ @*G^%;=% &)_PAWAP8VZ-9QX[1QA!^F*#X0\/GKI
M4'Y'_&MO(I,CU% '/7?@7PU>PF.328 W\,B##H?56ZBN>/@NZT:=?(L++6;
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M= _Z!R?]]M_C2/X-T-EPMH\1_O0W,L3?]]*P-;U% &"/!VC@8"WN/?4+@_\
ML]"^#M$4?\>\Y_WKN8_S:MZB@#"_X0_1,@_99"?>XD/_ +-2_P#"(:+_ ,^C
M#Z32#_V:MRB@#!?P?I#IMQ?*.OR:A.A_,/4?_"$Z1_STU3_P;77_ ,<KHJ*
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MH7N[:.=()+B)9I/N1LX#-]!WH QCX0T]L[KG53_W%+C_ .+J(^"M.(8?:]8
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M_P#(=1KX[\*M*T8\0:;N4X/^D+C\^E:UAJFGZI$9=/O;>ZC!VEH)5< ^F0:
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M;)_\>IK0>*U7*:CHTC>C6,J#\_-/\JUK*Z-Y;"8V\T!)(V3+AA@XSCWZU8H
M@LQ=K:H+UX7N.=[0J50\\8!)/3'>IZ** "BBB@ HHHH **** "BBB@ HHHH
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M7W$LS-)O!Z]D1<'KR:WY$UCQG:7_ (KTDM#=64JII,8/$B1G+D]/OY(_X"*
M/6B0!S2YKS>^\2KXST[0M-T^=K;^VDF\]@3OB\M/F3C&#DX^E5)/%TWAG6=2
M>ZG>[@%@L%KAV99KF$*'5?0EG(/^Z<]* /4Z*\OGN]4\.-H?B%]<N;N#4+E(
M=0M99UDAB\S/,9'0*>./\:],AGBN$WPRI(H."48$9]* )*#THHH Y5? ^EW^
MI7FH:[I]I?7,LS&.1E)Q%QM4@\9 X_"LJ'P7X9UBUDO?#T<NCWT,CQ)=6I,;
M1NIP05S@CCH?TKM+S4;>QDMHYBWF7,OE1*JDEFQGMT  ))/I7(:9$_AWXF7N
MG1@&PUN%K] /^6<R$"3CT;<#F@"WX4U_4&U2\\-Z^T9U>S42)+&NU;J$]) .
MQSP1ZUU]<)KBJOQ>\,O$%,KV=RLN!R(P,@D_7/'UK8U35;K2_$^E1374*:=?
M$P!70Y,V"0 1T)XZ^F.] &_<0I<6TL,B[DD4HP]01@UY_P##76K#3?"YTG4-
M2MHKC3[R>S"RS*I(5^.#Z @5Z&>E>=>%?#&BZCJ/BN/4=,L[LQZS*4::!25#
MHC$ XR.30!>%PMK\6X9(ID:VU/22#L((9XG!!R/]ES79PW,%RK-!,DH5BC%&
M!PPZ@^XKA9O FE0^+;:ZL]$MX[2TLIC]T;'F8KL&.^ K_3(KFO!5IKVL^&(K
M;3IIM,%HYN&N7+*;B[+EBK 8S& 0#_\ 6H ]C/0UY+%!#?\ BE;]2\NJ7&O^
M26R#Y4,"9(7/89&3WS]*ZF'QAJ]O;F'4_">J"^48Q:*)87/J'SP/KTKD/#4]
MWX8\4:G=^(-$U(2W)::QCMX6N0OFMND7<H(W<(.W2@#T#QMJJZ-X.U&\8G(B
MV+@X)9B% 'XFH? VB3:+X>Q<+MN;J4W$B?W,@ +^  _&N9\2Z+XC\:Z%>W%Q
M"UE'$ADL=-# M*P((,IZ9(& HZ9KEAXRU#5]2CL]>U^]T<,WSP*HLUCP.F[)
M=L\?_6H N>*)=9?X@R:=J_VS4=-4&Y%G93B-3"20NX9'(QSD\X]Z?X8\0^']
M(UC4[V+2/(C98X[>W14,B =1][D]#U[UC7.GZ5_PGCQ/J/GZ;(L4C7]S(TI,
M:CYHP3U+'CV!)JQHVH3VWFZ1:QO%8B\DFFO+"U:::XC9OEC4;2$!7')Z8H Z
MV+Q*OB+QSH<\-NUO;6^\!9]OF/YBL < D!<H,'J<'\?2QTKPA]3GLO'Y73-"
MO$>Z>U>TM)T\E_*A5@RJ#T! ;GZUWH\0^/)CF/P7!$G_ $UU-,_H* .ZHKC%
MD^(L^7\KP]:+VCD\V0_B00/TIO\ 9?C^Y3]]XDTRS)//V:Q+[?IO/\Z .UHK
MB_\ A$O%$IS<>.[PGTALXHQ^E2KX'NV;=<>,?$,AQT2X6,9^@6@#KLXI"ZJ,
MD@?6N27X>V)BV7&L:]<^OFZE)S^ (%6D\!^'EQFTFD [274K _4%L&@#?:ZM
MU.&GC!]"PJ4$$9!R*SK+0-)T\#[-IUK&1SE8AG/UZUI  # X% !1110 5!>3
M2V]K)-#;O<2(,B)" S^P)('YU/37(",20 !U- &%H/BRS\2:+-?:=&YF@9HY
M;20A9(Y!U1NV??I5S0M7&M:+::GY#6\=S&)$1V!(4],XKSRSTV\TO0=+\8>'
MT,T_V<#4[*/@7:Y)+#_;0DD>H&*JW-QIW]D^%;"[DC0MHAG4WDI%NGRIR%X+
M2 GY>1@$T >O[@#B@,#WKQ[P[/!XBU+PE;W5Z]PK^'6:?;<-F24% P8@]1S^
MN:@\+R&'3_A]J1OKE[F\NYK>>22X9MZ;) $()Q@$+^(]30![1N%<]XCUF]MI
M[32M'BCEU.\8[3)]R!!UD<#G'H.YK@M%O([_ ,1+)J&OQVVM0:NZ/9+$YN67
M>0L>=^#%LP<A, #/7)KN_#NEZ3!K.M:EIUZ;J6YN-EQF4R>3(OWD'/')SCM0
M!S'BGPO%X?TF'Q!:LT^J6MU'->74RAVGC)"R @\ 8.<#H!Q79WOAC0=6C)N]
M)LYBPQO,*[L>QZCK4OB*WCNO#>I02*K(]K("#T^Z:@\)7?VWPAI-SO9R]K'E
MFZDA0"3^- &#I\EUX)U:WTB\G:?1+R0QV,[G+6[=1$Q[@\X.:VO^$NTQ9!YO
MVF*W/W;N2W=8&]]^,8]SP:P?B=*)O ^H3N?)@MGC<2LI)8[P/EQR.N,U-X9O
M]ME#X4UV/=<FVQ;R2'<M[ !U!_O 8W \]_>@#M000"#D&EKSG3==U7P]8W&@
MK;'4-1M;[[+9K)*%WPE2Z,Q]E!'Y5U6B^*+/5=#DU*4?8Q;LT=U'.<>0Z_>!
M- $/CN,/X+U.0YW01B=<'!W(P8<_A6SIUU]NTRTN\8\^%),9SC< ?ZUSLOB'
M2O%VD:UIFES&:863?>C90P=#M(R!D58\!WD=YX%T:5&RJVJ1')S@H-I'YK0!
ME_%.-X_"2ZG$I,VF7<-VF!Z. ?T8UV<$JSP1RH<HZA@?8UP?B;Q*NN>#_$*6
M6F7,NGK8R@7CX2.5L'A ?F(]P*Z#P1>_;O!6D2D$.MLL4@/!#I\K?JIH NZW
MX?T_Q#;1VVI122PH^\(LK("??:1D<]#5"W\!^%;4#RM!L>.[Q!S_ ./9KHJ*
M ."T[2-+A^(>LZ<VF68MI+*&>.(P+MZE&P,8QP*ZFU\/:;8ZH-0L[6.WE\DP
M%8E"J5)!Z#O\HK"O5:#XJ:9*6V)<Z;-%Q_&RN&P?H"2/QKL: $) &37#^$8A
MXDUN_P#%ESF2$2O;:8KCB.)>&=?0L1^E;7C:_?3/!>KW<>=Z6SA<=B1@'\S5
MGPWI::/X;L-.C.1! J%AW..3^)S0!HFXA640F5!(>B%AD_A4M<O>>!=&O+>0
MWB227;%G-[YA653G((;/&.,?2N4T'Q'JFNZ#HVA&]FBOKT3%[U"#(+>)MN[_
M 'V.%S]30!WB^)-+D\0+HL=RLEX8VDVIR!@X()['VJ#Q'XGA\/?8X_LMS>75
MW(4BMK9-SL ,L>>P_K7#>)=/AT+Q;IMMI2"TVZ7<!94)WL[L$!)ZD[G#9K0T
M73KJ/XA1V%Y=27,>DV\LMK),YDD*2E<;B><CYES[4 =UI6JVNL6$=Y:.6C?J
M&!5E/=6!Y!'<5+?P"ZL+BV)($L;1DCMD8JAKE];^'M&OM4CM4:55SL0!3*_1
M03]2!FL.XL+VVTF;7=8OKRXO$B\Q;&"8QPHXY5%"\GG )).: +'PW=W\ :3O
M&&6(H1Z;6(Q^E:S:_90ZC?V=S)]G-E"D\DDI"IY;9^8'T&"#7/\ PN$EOX3;
M3[AV:ZLKJ:*8-V8L6P/;YN*H>)].AU/XGZ19W6_['<V+B9 /EGV-N"$_7!__
M %T =W8ZA9ZG:K=6-S%<P-D"2)@RG'7D57U77=,T2..34KM+=9&VJ6SS^7;W
MKG;B&#PCXILY[6,Q:?K$@MIH4P(XY\$HX'8M@J?PK&UZZ1YO%FE-AM5U!HK2
MSBDDSO1X@ 5'8#YR<?W>: /23(IB\Q2&7&X$=Q61X6UBYU_08=3N;6.V\\EH
MT23?E.Q/ P?:M"-8['3$220"."$*SMP, =3^5<_\.(#;^ M,!SB17E4'LKNS
M ?@&Q0!%!H*ZWXNU/4=:@\^"UD2"PMYE)1 %5FD Z$DMU[8J]X@N+K3K[0I;
M69([5KP6]Q"< 2*ZD+CW!P?SKH:Y/Q[<F'3]*@7AKK5;:%7[K\^_/Y(1^- &
M=K%YKITOQ;832$&&-7L[B'Y&"./N\<Y7&,]:Z;PO=27?AK3Y)YDGG$(261&W
M!G7Y2<_45R\P,OC'Q7%)(L<;V=HB@\C!+#=CZG&*U/ A"66KVJX"VVK7**@&
M-H+[@/?[V?QH ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** ,630[QW<CQ%JB*Y)VJ(,+[#]UFHQX>NP,?\))J
M_P!3Y!_]I5O44 8RZ+>*?^1@U(\=UA_^-U2U'3&MH6:]\77\$+9!\W[,JX].
M8JZ:N.OM/L+SXCI'J5LERLNG;H%F&Y%97^8 'C)##\J *OA_3=+@M5L-$\<W
M4L:,Q$<4UM*<DY/_ "S)ZFMW^P=1Q\OBG51_VSMO_C51:EX$\-:G;M%)I%K$
MQ^[+;QB*1#V*LN"#6=X'U.\CO]8\,ZC<-<SZ3,HBG<Y:2!QN3<>[ =3]* -;
M^P-1/7Q3JI_[96W_ ,:I@T'5E0(OB6[0 _PVT(X]/NUT-% '-Q>&;R S>3KE
MQ$)F+RA+6 !V(P6/R<GI^58(^%%LMM<6L/B'68+2X):2V@D1(CGJ H7 'M7H
M5% ')VO@R6S&RWUFXB3R1 0MK;Y* 8"DF,D@#M3M-\*7^DVD=I9:_/%;1@A8
M1:0!1GTPHKJJK2:A;17\5D\H6XE5G1#W"]?YT <'<_"Z1M4_M.T\0W5I>;V?
MS(;>-1N888X ')'?\:N6OP[^S:;:6!U>6:&TD,L/G6L3LKDDELE>3DFNYHH
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M&H6-C!I=S+%$L)E/VA"[ #.>">>@K9\0>)++P[9Q2W(EDFG;R[>WA7=),_\
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MS?\ QVMZB@#$CL_$:R*9-8L'0$;E&GL"1Z9\WBMNBB@ HHHH **** "BBB@
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M2NKRK/?;6?:V=HVQMQP,GT-=K1B@#@9M'\6+KLNK:?:65E+<!1<Q#42R3;>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:$O"'YXZB'/>NUIAE13@N 3V)H P!>>+3UT72A_W$G_^,TC7?BYE91HVDCC
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDTT=O"TLKA(T&69C@
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MUZ50#_8>J$^@2/\ ^+K9HH Q/^$AEQEM"U<>WE(?Y-1_PD1_Z NK_P#@./\
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MY_\ C=;M% &(GBO2V=%(OTWL%!DT^=%R3@9)3 Y(K;!R,T44 %%%% !1110
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M0/4\T 7:#TKGI/&V@Q2O&]S/O1BI LYCR/HE-_X3OPW@[M1"X."&BD!'X%:
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MIA6Y^G% $7Q!N_LW@R_C!P]VGV5/K)\O\B:U[>*/1?#\<(SY5E;!<_[*+_\
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M&?QH ZVBLT^(M#'76=/'_;TG^-)_PDFA?]!K3O\ P*3_ !H TZ*S/^$CT/\
MZ#6G?^!2?XU(-<T@]-4LO_ A/\: +]%4AK&F-TU&S/TG7_&G?VII^,_;K7'_
M %V7_&@"W15?^T+(]+NW_P"_@_QI1>VK=+F$_204 3T4T2QL<*ZD^@-.H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ H/-%% ";1Z5DZG)JEG<+<65L+VW(VR6X8)(I_O(3P?<''UK7HH
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M83++9Z9:6\J@A7BA52 >O(%:%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !61XGUL>'?#MYJA5',"957;:K,3@
M GL,D5KU2U.P.HVR0B14"RI(=T2R A6!QAN.<=>HZB@#E(O&>H/IMNRIH]S?
M7EZ+.V6TNVDB4[2S&0[01@*> /2I8_$VO7FF74MM9Z5%=:=<2P7XNKETC38
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5** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex971clawbackpolicy001.jpg
<TEXT>
begin 644 ex971clawbackpolicy001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#?J?\ ^*HV>.?^>WAW_OU/_P#%4>T\F'U1?\_(_?\ \ $_Y*A/_P!@9/\
MT<U=-7-:1I&M)XEFUC6)M/9VM!:JEFK@8#ELG=GU/>NEHIWL[]PQKCSQ46G:
M*6@4445H<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3Q3\0D\.^/?#VAO'_H=\S1W4Y'$;M@1KGIG)!/H&!KIM5MM7N;VR33[\6=J
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MTMD[12RL"H"L<*=J[B>>KCN..$^'=CJ7@CXC:]X=:ROI="O7$UM=I9R"%)<
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MX^#O ^NRP37VMZ!)YEQ9EMTKQ>8'0#U954 CKS[5ZU:^*[34(XA8VFH2SR$
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MYS76T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX-:I?^)M MTU4AAX?<VL?.3))C =O]U#M'KDD\XKUF@ HHHH **** "BBB@
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MLA&TC./3C.,U1T+P9I'A_P /2:#;))-I<FX&WN2)%PWWATR0<]ZZ"B@#D_\
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MTOQ9=V-QJ<MWOL'\RV$,H01OP=W R3\HZ^E68_"\*ZM#J<NHZC<7,".D/G3
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M;A6$DF_!<R=.%^F.E %_Q5XJU+4/B3I?@/1KMK$2QFXU"]C ,BH%+;$R"%)
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MC>0@9V)C<?IDUYE\+='\1^$_ VM6MWHKIJ9N9KNU@DFCVS$HNU=RL<9*XYH
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M2>%O"*Z?XXUSQ-#9G3[?4(8XTM"%!+#EY"JDA<G''7[Q/6@#N**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ IKH)$9&&588/..*=10 R&&*WA2&&-(XD 5408"CT
M %/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVMXY$B9_/FC=]Z@@=?F!^AS0!V<GB;0H8;>:36;!8[B-I87-PF)$4$EE.>0
M"<].*@?QIX8CMC<OXATP0J$)<W28&_)3OW )'T->:^'?);3OA:ES"R_9S.)5
MFA(V?N7"DY' +8P>A/2M^W;0['XF>*8=0CM(H&TVS1$DC&TIB4,@&.XQ\HY.
M.G% '>3ZI86UK%<S7D"P38\I]XQ)D9&W^]QSQVIJZQIKZ>FH)?6[V<APDR2
MJQSC (ZG/&/6O+O"MEJ'A.Z\'S:VDL6FKIES:AI<XLY9)A(@D/\ #F,*F3T(
MQ5C^RE\K5KEM0N=)M;SQ#]ITJ\B3*PR"$AI64\>6[!QS@'(/0@T >D+K6F-8
M_;5O[<VN\Q^:) 5W X*Y]<\8ZYJ6QU"SU.U6ZL;J&Y@8D"2)PRY'!&1W!KRN
M75-5MX]%UC6[9SI]EJ%W!>7FEHX64,H$=T%&3M)W@D9ZG'45W7@^WTE+.]N]
M&@N4M;VZ:X:6X,@,\A W2!7Y .,=!G!/3!(!J7VM:7IC[+[4+:V; 8B60+@$
MX!.>@SQD\5C>*O%5OHMSI%@+R""74;D1-*[KF&+8[%P#Q_!M!/&3WQBL:SN(
M=,\1^,K/Q"I":@ZS6S.I(NH#$$\I/[S*01L'/S9QS63!;7>C:1\,['5G(O+2
MX#7 8Y,*^3(HW'L!N5<GC- '>V][-H?AV>^\0:G;SQV^^0W<<6S=%G*Y4<%L
M8Z<$]!6!>>-&FG\(WUC>6T>F:G*PNU?#&,>0TN"^<+C SQ^-=+XDBDN?"NKP
MP(9));&9451DL2A  KSY+JUO;+X9@JQ2VE03"6)E"%;5ER=PZ!R!GIF@#M[[
M7].O/#%UJ&F^(M/MHL,B:BS))%$X]02 2/3-7KK6M-TU%^WZC;0GRP[-(X4;
M?[Q] 3ZUY?JY1_"_Q/@C7<9[LM BKGS"88QE1_%EE/3N#6CXHD>.YN=2T74T
M2^_LR)9M-NHO,M]3BPY6-._F?,P^7GYAD<T >FR!VC81N$<CAB,@'Z5Y_P"'
M?&&M:UX/BN UE)K][+-':P1PL(T$<C(9)!N)"#&2<CJ ,DC/=QW&+%+BZ46Y
M\L/(KL/W9QR"?:O$?">GW^A>$4\7Z'(WV^U>==3TR=BHNX//D90 >5D ;*D#
MG..<\@'M$<SZ?IJRZM>VY= /,F">4A)XX!8XYZ#)JO\ \)-H7V1+LZQ8K;O+
MY"R-.H!D_N<G[WMUKB_$7B:#5M,\/>(;.*_?3K.]\S4;>.-EN+=6B= [(.<*
MS<XSZC-3C0-'\3>&/$+:"EVK:ELF2]N#(OF7,8RCJ),$!2J98  \^E ':QZQ
MILM[<64=_;/=6Z[IH%E4O&/5ESD#ZU!+XDT2&VBN9-6LQ!+&94D\Y2K(.K@_
MW1Z]*\\C?Q#=ZGI'B:*TFMY?$-M_9ES %PUJ-NY)C[@B8Y/9E%7_ !/+!;:[
M>Z3#9RV9.@F*">"V:5[E07 @7@JJKU/&?FZ@#- '>_VKI_VN*T^W6WVF6,RQ
MQ>:-SH.K 9R1SUJO_P )%HOD1S?VM8^5)/\ 9T?[0N&ESC8.>6R<8ZUYUIM]
M%8GX:ZG=+/':0Z3+:2RM _R2F*$!2,9Y*,!ZXXK.D:.?PW/'/;2@-XV,Q2:!
MAF+[3N9L$<@+G/IWH ]:T_7-*U:.>33M2M;M+=MLS0RJXC/7G!XI;+6M,U*:
M6&RO[:XEB 9TCD!*J>AQZ'L>E>;>(8+J\UOQY#I,9EN)],LO+CCX\\H9#(BG
MN=A"X_VA4LYTOQ?I>J7WAN+5)-<.D3VHEN?-C,&X9\D[L*6+>F<8)R.,@'H=
MGK>EZA=O:VFH6T]PB;S''("VW.-V.XSQGI61XR\2GP[%I:^=#:I?WJVKWMPN
M8[<%6;)&1R=NT9( )R>!BL3PM>>'_$.JZ7?6UIJG]K6$+QR)<K,@L@RX9&W
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MW\&_$Y(XD,MS?S&$*GS2@Q1[2O\ >&\-C'?-;2WFE)\58KB_DMA')X:BV2S
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M,.. 1Q]* .VHK C\3"YU&ZMK.T-PEI>)9W#+*-\;-M^8IUV#<.<YX/&.:WZ
M"BN=U#3_ !!+XAGGL[JRCT^73VAC:0,9H)_FPRC[I4Y7.>?E%<=XH@NK.'P,
MFNM:PW+:EY%X;*618GCV.0"6.XCA2<]\T >IT5YGH>M/H6N>*;OS;V7PI#Y
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MH5^MC9ZB;"[F9X_W+"01[L!B6&YATSQW[4 ;G_"-K_T%]8_\"S_A1_PC:_\
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M(8?3TSS2Z3XD77E@DMK,R:?=-+&MPDH)0ID$.HY4G!QR??!XH Z&BO,O"GB
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M'((/>@#E#I&K:SJVA:CJ]K!;OI DE*0S;Q/.R;/EX&$P6//.<<<5B)X0UY/
MEGHI@M/M<.K"]8_:#L*"Y,V =N<X..E>D44 <#XATG48]0\5:W+#$ME<>'VM
M5Q+EPR"1B2,8Q\^.O:DT72+W7] \%&[MX[>TTR.WO2XEW&9UA*QA1C@?/N.?
M3 SUKN+RSM[^TEM;J)9;>52LD;=&!Z@^HHL[.WT^TBM+2)8;>)0L<:]% Z >
M@]J .-\+Z1XM\/QQ^'R-/DT>VE/D:AYK>=Y&[(C,6W!;!V[LX YYJA>^$-=N
MO"7C#2E@M1/K.H27-N3.=JHVP?,=O!&SMGK7<:7K=AK+WJ64CNUE.;:</$R%
M9  Q&& SPPYK0H X'Q'X4O\ 7[]KM;&"SU.*2)K#5;>XVR0( N]9  "XSOP.
M00?X>M4_$'A+Q-JT>O0F+3KI[B\BN+&[GN&#1PH\;>2%V'9]QLD'G/(-=T=;
ML%U]-#,CB_>W:Y6,Q, 8P0"=V-IY8<9K0H Y6PTG6+#QKJVK&&TDM-2MK</M
MF(>.2)7!4 KR"6')(QCI6!IW@K6[#P]X7=1:_P!KZ!=32>5YQ,4\4I8.H;;D
M':W!(ZCWS7H%_J-GI=HUU?7$=O I WN<9)X 'J2> !R:I1^)=+>YM[9Y9H)[
MEMD$=S;2PF5L$X7>HSP">.E '+:]X0U/6K7Q/>+%!%J&KV,=A;PO+\L4:[B6
M=@.I+'@9X YY-:?]CZI)XST35FMX5MK33Y;68>=EM[E#D#'(&SU'6NLHH *X
MR;PW>WOQ$OM5O+.VET>ZTD::\;2Y9OWA8DKC&"&(ZYKLZ* //E\'ZZWA+4_"
M,UW$UBN/[*U R$RQJK!XTD7'.UE R#R!TJU=:/XH\6^%]0TCQ"FGZ<9K8Q*]
MG*TOF2\$2'*C:H(^[DDYZC'/;T4 <?%IOB;Q%H%YI'B:.QLXYK.2UDDLYC*T
M[,NWS,%1L R3MY)/< <UX?#FL:EIOAS3-8BMXUT:YAN)+B*7=]H:%2(]JX!&
M3@G/3! SG([BB@#EKGPM-)X\CUJ&94L)X%^W6_\ SVFB;,#?AN8_\ 6JD^E^
M*-&\7:EJ&APZ??6&K&-YHKJ=H6MYD0)O!"MN4JJY'7([5V9(! )'/ ]ZJVNI
M6]Y>7EK%YOFV;JDN^)E&64,-I(PW![9H P+/1M6A\?MK%P(9;5M*CLFE#X=I
M%=G+;,8 .[UJA?:3;:I\1K*[T^^C:)K8G5(8B&63R9 8-Q'1@Y;KU"L.U=S5
M+3M'TW2!,-.L+:T$\AEE\B()O<]2<=30!=KE/'FB:GKVG:?;:;% SV^H07;F
M:78-L;;B!@'DUU=5=2U"#2M.GO[KS/(@7>_EQM(V/95!)_"@"GXAT9?$GA>_
MTB9C!]MMVB+#GRR1P??!K"30=8UA/#D.M0V\/]C7"W,LL,N_[1*B,B;!@84E
MMQSR,8YZUV2D,H89P1GD8I: //9/"NMR>%?&FF>3;"?6[N>:V/GG:JR(JC?\
MO!&W/&>M3R:+XETGQ'!KFCVUE=?:;"*SOK*XN3$%:,G9(CA3D?,P(Q_];NZS
MM;US3_#VE3:EJ4K1VL.!(Z1M)MSTR%!(ZC\Z .<\9VS7/A1+>:_MU\002175
MB4P"+D/\@5>NTD[.>Q.:ZC2K!=+TNWLE<R&),/(>LCGEF/N6))]S22Z/ILVK
M1:K+86SZA"ACCN6B!D1>> W4#D_F?6KM &;X@TO^V_#FIZ5N"?;+66 ,?X2R
MD9_6N4FTR^\2_"2VTJW6.+5(8K:.2*=BH6:!T+H2 <9,9P<=P>E=[3%AC25Y
M5C42/C>P'+8Z9]: .6ATO6O^$\&OSVEL(#I/V-DCN"Q$GF>9QE1E>V>.>U85
MGX0UZV\)>%M+:"T-QI6K"]G(N#M:,/(V%.WD_O.X'0\UZ310!PFJ>$KS4O$4
M.JQV<-CJ<%\CIJEM/M,MJ&!:.5 !N)7*X.1T.1R*[NBB@ K@_'3QS:]X<(O]
M*@_LR^6\F2[OEA=EVLN%4]3SGG XKNP01D$'MQ2-&C'+(I/J10!Q7C*[T+Q-
MX:EL;;Q-I%O>+)'<6\CWD9598V#KNP>F1@_6JPU73-5\2Z5KNI:KHUJ^EVTZ
M101ZE'(9)90H8YR % 7 [G=R!CGLM2O;#2-.N+^] 2VMHS)*RQ%RJCJ<*"<<
M'MVJ6TDM;VS@NX$5H9XUD0E,95AD<?0T >411Q1^ ],T4ZSX?-W:ZLMZY&J)
ML*"Y,V <9S@XZ5I+JLFB>*]5N]&UGPW=:=K#I/(MUJ:QM:3! C-@9WJ0H..#
MD8R.M>E^3%_SS3_OD4@BA)($:<<'@<4 >>>-+W1M2M-'DLO%>GQ:O:W21QW2
M7,>[9(-DV<' &S<WU5:[K2KG3;BPC32;FVGM( (5^SR*ZIM PN0>PQ38]$TJ
M+5)=3CTZU6_F0))<B%?,91T!;&<<#\A5F::&SMY97!5(U+N$0L<>NU02?P%
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M_"5EJ.F:791W%U9?V7+'+9S6S*'C**5'W@01M)!!!H XZ[\7^((?!?B6[AN
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MA\KD'<S'*[3S0!SJ:IJ?B#4/AO?2:A-:MJ%O-/-%;JFSS!;D[@&4_P!YASG
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M:[JCR9XR 7Q@MC*-SSQN6VA6L.BSZ9/)->1W*,MS+<ON>?<-K%C@#IQP
M!55_"&DR^#5\+31/)IP@6'EOG.,$/N_O;ANSZT <YK>I>,-%TKQ%>+(196^G
M-=6D]XD+3),F=R;8SM*D8()'!R#FK-IJ>N0^*](T^\U-9[?5],FF"I;HAMI$
M\OE3SG(?HV>1Z<5<7P)"^AWNEWNN:Q?"[@-LUQ<S(TB1'JJ_)@9XR2"3@<\"
MKR^%H!J^E:FU_>M-IEN]O"I\O:RMMW;L)DD[5Z$=* ,KX6FZE\#6MS=WT]U)
M--<,3-MX/GR9.0 3GJ<Y]L5V=8_AWP[;^&K*2SM+FZEMC(\D<<[AA"&8L57
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M<QS:89&ACC*;&+KM;=E23QQP15:+PI;BXL7N;Z[NX["X:YM8Y]F(W(8=0H)
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M70('*]^JD _0<=L4 4-1U:>?Q?:>'+6Y-KYEC)?2SHJLY"NJ*J[@5ZL220>
M/7-4%U37+?4-#\.:C>VPU&\%S)/>6J#F.+&T*K# =@Z$\$##8'((FO/ 5K=6
MVD@:OJD-_I2&.VU&.1!/L( *,=FU@0!U7M]:EU/P/8:E96$?VW4+>]L)6FM]
M1BF'V@.WWR6((.[N,8Q@   4 4;C5]<TNYT;0K^\MY+[5-0FACO8D&5MT1I
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M'&XG: ) %(;:03VY]* -:[T72K]HFO--L[@PKMC,L"OL'H,C@>U70 JA5
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MF@">;P[H=QIR:=-H^GR6*-N6V>V0QJ?4+C -:$,,5O"D,,:1Q1J%1$4!5 Z
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M(S(5(X&X<$<@C.<B@#JK;PYH=G:3VEKHVGPVUP<S0QVR*DI_V@!@_C4@T/2
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M5P00#SG'% &Y/I.G75W'=W&GVLUS%Q'-)"K.GT8C(IL^C:7<WRWL^FVDMVN
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MJ=(\1:;K=Q>6]G)-Y]FRK/%/ \+IN&5.UP#@@'![XH U:*** "BBB@ HHHH
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MEI?L<K6\8DF\LF-'X#-C@'TYKR_2;;6)];\&7\^B:K%);Q7,-[NC6.*W=XU
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M*\+ZKIWC&1)#YNE7ZQZE>29.W[:F054=@28W'IY6*[^FO(D4;22.J(HRS,<
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M-"JMM4#(!)]*X^'X?ZA'X9M=+.I6PN-+U$W^F3K"W#>8[XE&>00Y4@8QUYH
MZ#3_ !%-)XIN?#FHVJ07L=LMY"\3EXYX2VTGD JP;@CGJ#FDUSQ/'I&M6&E%
MK6*>]CD>*2\F,4;LA4>6&P?F.[\AT-/L=$N'\3/XAU+R%O/L8LHH8&+I&F[>
MQW$ DDX[# 7OFF^(]$FUO-M-::=?Z9)"4EM;S*X?/RNK!3@@9]^F",4 1VGB
M2]F\36^B7&FQP33:3_:&[SR=CAE0QD;>Q;[P/;I5/2O&[ZMI>D/'8)'J.J3W
M$,4!F)1!"S!W+;<D?*.,9RP'J1!:>#=6T>_T*[T[4K>>6QTPZ9<O>HQWIN5@
MZX/4%>A/3O5"W^'^LV&BZ.;+5K1=9TB[N)[:1X6,4B3,Q>.0 Y.=W48QCIWH
M 9XQN[V^T;2IM2T;[->V?B6UBB <,)E$JX>-CC 8>N/>NHT'Q!>:AKFKZ/J-
MC#:W>GB&3,$YE22.4,5.2JD$;2#Q5'5_#FN:QI=@EU>V;WL.I07\NU72)1$P
M81H.3SCEB>I)QT O:;HE[:>,]8UJ5[<P:A!!$L:,2R>5OY/&#G>?ICO0!T-%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% #1(AE:(.ID50S+GD YP<>^#^1IU>:&YET;Q;\
M0]82:YG?3["WN(X7D)1B(96VD?W0>@'3)K5TNV\0S7VD:BFKPC3KNV870:Z,
MK3,R;HY(5,856!R2!\N.W% ';45XZ+SQ#_PIZX\6'Q1J7V\6DH"!8O+R)R V
M-F=V 1D'OQC KIKB+5(_B%!HXU_4/LFH:9+<2CY,HZ2(!Y9V_("'([]/7F@#
MO**\RL-9\0R^#;6=%NM6-GJES;WB02".ZN+>-Y$4J1C+ ["0,$X]S78>$-3M
MM6\.0W5K>W%W&9)07N4VRH=[?NW'9EX7\,T :5I?&[N;R$VEU!]FD$8DF3:L
MV5!W(<\KSC/'(-6Z\PU/6=:@T#XBR1ZO<B;2YR;27:F8U\A'VCY<8RQ[9]ZU
M[&XU*P\?:79RZK=7=OJ6ERSRQ3;=J2(T>"@ &T8<C'/OD\T =3JNKVVD1P&<
M2/+<2B&"")=SRN03M4?0$DG  !)(J+3M=M]1O[FP^SW5M>6T:22PW$6W"L6"
MD,"5;.UN5)Z5F^,?#Z>(;>QA@U.33-6MIC<:?=1C)60*005/#*5)R/2N3?QM
MKVA6VO6?B'3;5?$&GZ8;N"]MLF"ZA#;0Q'5=K-DCZ]* /4J*X*^G\0^'8[K7
MUO;>YTR/3)I6MI;MIFFF5"Z/&?+7 (!R <8Y XK2TNRO;J/1]37Q%,]O>69^
MU1-@BX=T#*\1Z1E?F.%'(^F: -Z^U);.R-U%;W%Z!*L1CM%#MDOL)QD<*<Y]
M,&KM>/Z7<:AI?P8TW4;/5+R.X>_C5R7#[E:\*,,L"1D,22#G-=?#>7/B+Q=X
MDT@WUS91Z4EO'!]G?8V^1"YE/][L #\ORG(.: .QHKRK2_$.O:^? [3:G-9O
MJ!OH+Q;=$"RF%7 D&5."=N?09Z<5U7@2\O9[;6[.\O);O^SM6GM(9IL&0Q@(
MRAB ,D;R,^U %C5O&FGZ1J4E@]EJUW-$JF0V6GRSJA(R 64$ XP<>A%:VD:K
M;:WI%KJ=H)/LUR@DC\Q"K%3T)!Z5G^++B2U\.W,5H=EY>LMG RCD22D(&_X"
M"6^BUKV=I#864%G;H$@@C6*-1V51@#\A0!-1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% #9(HYHFBE17C<89&&01Z$4
M(BQHJ(H5%&%51@ >@IU% !1110 57.GV1O/M9M+?[3_SV\L;_P#OK&:L44 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 V2..:-HY45T8896&01[BH[:TMK*+RK
M6WB@CSG9$@49^@J:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN0,A589/L,G%<IIVB6^J6E_=Z[:W$-Y?2R&:W^W$*8_NHN(Y-I&P*#GJ<^M
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MR0I&"3OXY4DY[5*+#Q)H?B*SUJPT9M0@N=+AL;RS%S''+!)&25<%FVLOS$$
M^] &[:^-M-O;O18((;MEUF)I;29HPJ':,LIR00P';'TS6O8ZE'?W%[#'#,GV
M2;R6=PNUVVACMP3D ,/3GCJ#7-^,K&]O/!8O)&AAUJPD2]M"A+*LZM\L8/\
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MKRUNK.=+::QN8@DZR/\ <7;D@[L\'..^0 :NZ3XDM-6U*_TT0SVM_8[#-;W
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MS%;:>0N5<$%L<@Y [Z6M:7K.K>%RMMX7BL)WO;646<4L.\+%*KLSL"%R0,
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MUBRLOM5O;07-O/B54,?F>658[CR/D.<9/M7,77AS7YO WB/35TB7[7?:V][
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M00Y+<MEP2<D8_B)XH Z6U\<V%W:+="QU***;R!:F6WV_:VE!*K$<X8C!SG
MYSCFL[PM?7%U\1_%T4JWT,<4-D5M[J7<(RPE)*@,R@'@_*<56O\ 0M=_X1GP
M==6=COU+06A::P>9 90(C&X5LE=W)().*T?#UIJW_"<Z[J]WI4EG9W]M:I%Y
MLT;.&C#[@P1FY^<="1[T =A1110 4444 %%%% !1110 4444 %%%% !1110
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M@G'49JM<>,O%%KX6US5G;2F;0+Z2VN%$#_Z6J,O*_/\ NCM8?W^?0=0#MO\
MA%/#O_0 TO\ \ X_\*/^$4\._P#0 TO_ , X_P#"LB\UC7YO'%SX?L)=/@B&
MF)>Q3S0/(RL9&3!4. WW?48SWK%L/&OB"XT3PSKMPFG+:ZE?1V%Q:QQN7#,[
M(9%<M@#<N=NT\?Q4 =/;Z/X0NK^[L8-(TB2YLR@N(Q9QYCW#<N?E[CFK7_"*
M>'?^@!I?_@''_A7,:GXBUDP>/K>*6UMY=&M5EM9XX26PT!D^;+<MQ@'IWP>E
M4TN=>74OA]:KJEN(KJWED=?LK88K;\%OWF6X8]QSS@\  '9_\(IX=_Z &E_^
M <?^%'_"*>'?^@!I?_@''_A7.7'BKQ!>P7-]H.G"[CMK][86IBYG2.3RY")"
MX"MPQ''0#.<\+>^*=?NTU&X\/:>MU]@O6M5M6B_X^-C!9/WF\!#]['!Z#.<\
M %V>+P!;+?M/;^'HQIY5;PM#"/(+?=#\<9[5>@T#PI<LZP:/H\C(%+!;2,X!
M&0>G0CH>AJ27PY874FH7$D$:RZA$D<V84.%7D9!!#-DDY.>@]*Q/$[IX:U/P
M?<6*^7$;Y-(=!_%#(A"@^NUD0C\?4T ;W_"*>'?^@!I?_@''_A1_PBGAW_H
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M8>,_"Y95'B/226&X#[9'R/7K6Q<0175M+;SH'AE0HZ'HRD8(_*N*OP!\:]%
M&!_8MQ_Z,2@#IK7Q%HU]>06EGJEK<SSPF>)(90^Z,'!8$<8R:TZX#5[6>#XG
MZ)!I'V:VD;2[U@\L9=$+2Q,3M!&[DGC(Z_A3M,\;ZA>:1I44L$7]K7E[<V;M
M#$60>07W.J%@3D*.-W&[/.,$ [VJ]Y?6FG6QN+VYAMX00#)*X5<GH,GO65X:
MOM;NX[V/6[$0/!<%+>=5V"XBQD-LW,5/4$9[9%<[+*VI?'**QN^;;3-&-W:Q
M-T\UY C28]0OR^W- '7VNN:7>SK!;W\#SMTA#@/C&<[3SC\*T*S=6BL+=5UN
M[C^?3(Y9ED4?,$V'>/H1SCU KEI/%^K6>AZ!XCNDM7TW5)8%FMHXV#VZ3XV,
M'W88J2H88&<\8H [NBO.;_Q9XGCTWQ;>P-I2CP_<L KV\C>?&L22%?OC:<,?
MFY^@[ZL.OZW'XJTNPNFL&M=8LIKBW6.)PUL\80X9BW[P$/V"]* .QJ.>>*VM
MY+B9PD42%W<]%4#)/Y5YO:^-/$\GAG0M>==*9+W41836HBD4G=.T2N'W';@@
M<;6[G/8:T?B'7;>]\4:9=OI\]SIME'>VTT=NZ(P</\CJ7)X*=0><T =?9W=O
MJ%E!>6DJRV\\:RQ2+T92,@C\*GKSA]9UK4KWX<SPWEO;+J=N]Q/$+<LAD^RE
MO[X.T;C@9XZG.!2:=XCU328/&FIZA=17B6>J_9X81"4.XI"L8!W$!<N,C!/4
MYH ](HKB+KQ1KNA-J=YJFG>?I-MI[727*Q>0PF4_ZHJ7;(/!#=N^:OZ=J7B1
MO$5O;W=BLNF3P,TEPL/DFWE'0<NVY6&>V01[T ;FHZMI^DI"]_=Q6XFE6&+S
M&P7=C@*!W.35RN,^)VX>&;,QJK.-6L=H8X!/GIU/:F+XB\0VVH^)-+F33KN\
ML+.*\LW4&WC(?>-LFYS@*4SG(R/2@#MJ*X:V\7ZF=0UZQABBU22RTM+^S,,#
MQ&=CO&P D[@2@PR]<]ZT?"/B1?$AN9H-3M+RWC2,%$A:&>"7+;UD1F)'1<=.
M_7K0!T=S<P6=NT]Q*L42XRS'U. /J20 .Y-5],U>PUB&66PN5F6&0PR@ AHW
M'564X*GV(KE?B1]M\GP\+:XAB1]<LU97B+Y;S,J>&' (R1W]15NTU344\8:O
MHA&G@QZ?#>K/';,I:5BZ'>-YW#]V.X..,\4 =!=ZMI]A=VEK=7<45Q=OY=O$
MS?-(V,X _"BSU;3]0NKNVL[N*>:S8)<+&V?+8C(!]Z\]FUFX\1:/\-]8NTB2
MXN]421UB!"@F";IDDX_&MWPQ_P E \<?]?%G_P"DRT =C1110 4444 %%%%
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M0,'MXW5&C#*"$88*\=".QKGM;TQM?\1:+&5/V/2KDWTSD<-*%*QH/7&XL?3
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MRRB!%P<G/ Y]_3I6W6-IOB!=0\2:QHWV22%],6%C([ B42!B" .@^7OSST%
M&S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@7[()OM A\Q]OF9W;\9ZYYSZ\TRZ\%>&[V:[EN='MI9+S;Y[."?,(Q@GG[W
MYZ^] &9:_P#)8]2_[ 5M_P"CI:UO%]Y%8>$=4N9M0FT]%@(^U0+NDC)X!4?W
MLD >Y[5:M]"TRUU(ZC!:+'=F(0>8K$?NQT3&<;1V':K-_86NIV,UC?6\=Q:S
MJ4DBD&58>AH \[22]MO$?B/32UQ:VYT!+I+<7KR-')ND&_=GY7(49VDCC.31
M97]U+'\+G>_NC)?6Q%S_ *0_[_\ T0L2XS\QW8.3SFNTLO"F@Z==QW=II=O'
M<1P^0LH7+;.>"3UZGD\\U!:>"/#5BUNUOHULAMI#+#D%O+;GID\#DX'09.*
M/,YK*"V^#WBPQ-*#_:UQ& TS, %O !@$D9]^I[UT6IW5YX7\6ZX--GN[D?\
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M#WS6M%X>TF)K\K91G^T/^/L.2XGXQ\P)(/''TXJC;^'K3PIH]Y_PBFBVBW;
M%86D*"0@\ N<D 9.!T^F: .>\(ZA=:V-,TF[EN4OM 9TU4B=\R2IE(PQS\ZN
M"9.<_=%>@)(DB[HW5ER1E3GD<&LK0=/GM8[J\OHH(]1OY?/N5A.Y4(4(J!B
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MW'^'(R!NYST-.]AN&\&^,[$V&IR2W&O17$0ELW+2QEK<[L;>>$8D <8Y XH
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M(ZE1D@9ZXY_Q#K\NMR^"YM*B@N=+U2[$NV:4IYN(9&".NTX (![_ #*..,T
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ME);^-7DU;2+.YTI[4:LTRVRRRXF0QAB#)&5&T,%."">U '6,RHI9F"J!DDG
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M6;W5N6F1 NU58JW7^^,G\L]*?9^.8KC1DN);!XM1?47TL67FALW"L00'QC:
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MK)$\3!E89!&*\W\%>+;C1/!OA""^T69-*NXH;1-0$RG;*PPNZ,<A2>-V?J*
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M,OE<*!\ZA^">.O0T =U17(7GC*]CU+7[&RT%[B71XHIG+W2QK*CJS<<'!PO
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MI/AC4ET]A!KTZP*#+\T+,K,,C'(PA[CM0!J^&_#Z^'+&>TCNY+E);F2YW2*
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M-@D:)UEC:-T=3AE*L 00:9?Z[I^FWNG6ES(XEU"7RK;;&S*[8+8W 8' )Y-
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M4*S,QB8)M8D##XP3P>,T 8MK;^*KS2KM-8_LN.Y>V:&*&TD<QNQ&"[,RY'L
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M@;6&XDC)&,\YZ5K2>-M#BT*^UIIYQ8V,[V\[_9I-R2*<,"NW(P3C) %="#D
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MUH^,27%M<O+]2B-&,$^Y./\ :[Y$'AS6-(O_ !"NEFSFL=9E:Y'VB1D:VG=
MKG 4[U. >HZ8]ZZ>[U&"RNK.WE68O=R&*,QQ,P!"EOF(&%& >35N@#BM(\'7
M>@^(=(GLC;2:=IVC'31YDK+*[%E;?@*1U7U[UG_\(7KO_"$#1,Z=]I&J_;M_
MVA]FS[3Y^/\ 5YS_  ]/?VKT6LZ77+&'7K?17>07UQ$\T:>4VTHN-QW8V]QQ
MG/- & OA_6%USQ5?[;$QZO:PPP+Y[Y1D1U^;Y.AWYXSTJI;^$]:AL/!-N?L!
M.@%?M!$[_O (3%\GR>^><>GO7=U6O[ZWTS3Y[ZZ9UMX$,DC)&SD*.2<*"3^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.?FR!C[HX'YUQ<%SX?U6?Q5IOBFX2'5(M68QAI-ESY*E6M_)/WN0!@+U)/\
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M_,5HU<$D@?WO_P!=>;>']0BMK#P/8W\BC0FO]2A8RG]UYB2N+=&)XP!G:#W
M]!76> SIT7BSQM;:>UN(QJ$3K'"PP,P)N( [;L_C0!O^,O$$WA;PM>ZW#:1W
M7V1 [0O*8]PR!P=IYY]*DBOM=WVCRZ;8FWE=1(8KQV=%(^\%,8!QQGD<9-8O
MQ:('PK\0$D#_ $<#G_?6K4,&GZ?/IFHOK-Q(0H@CMY+GS!*TFT#:N?O9[]@3
M0!U5-:1$QO=5W' R<9/I7D^I6.DZ+XRDU#[-$?"5[>Q1Z@-J^3'?)D(YX_U>
MX@-V#XST859UJ72=0\8>)-%\3:G;V$4EM#]B-TL8#0&/YC$S\!A)N/'/ ].
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M.ODN^6$^&/&_[@/? I/L.@6?C7P8$6)[$:;=QV\]YAFDV-%Y9W-][CE?8\4
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MGH,(K';N..F>#56^U&>QN_'ZZ1=6ANVTNUECCT[Y1D>8)"@!.6"#[PP>!P*
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M TE;>%K;4S.'F9SO0QQE\!<8YP.<_A69\+2!X%@A1LQP7=W#&,YVHMQ(%7Z
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M[0VX;3C!SP<]*%97SM8'!P<'H:\/@^Q7?ANRMC/;R_9O&PBC\EMHCC:X; 0
MY52,D '^5=QX3M+33/B'XOL+""*VM5BL9A;PJ%179) S!1P"=JY]<4 =S111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)2+6,37)BA:00(<X9]H..A/K@9QBEOO$VF6,!F:26=%@%RYMH6EV0G.'.T'
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MUIJ,>U,^:#\JE067)VL-O&:[3Q"';P[J4<44DLLEM(B1QJ69F*D  ?6M*@D
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M!F/8=^=O3;US7G&G:5J<'A'X?6<FF7@N-,OHY+Q/).856.123Z\NO3->J44
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M+GG=P, =2>.4@T_5A\/O!VG2:-?1W6F:C9FXC,88A(F^=QM)^7T[GL*]5HH
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MO-;SO!MGDM(W1M\H 'S###D D <5ZA4-U=VUC;/<W=Q%;P(,O+*X15'N3P*
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M[S;(T@7;OXY8C.3TZ4MW%HWB[QQITVGW1FGT=Y4U PY"X5E*PN<<GS55P/\
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M[2^2>S+PW CSL<*'!5ADC[V*T#X9O?\ A*=)U@ZDLJV-K+;R++$2\QD*EFW
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M4=,LO"UL=7MI1H$KNI^RD>:K(R;?O\'#$YYY[4 =IIS7KZ=;MJ4<$=Z4'G)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ'9-0NUDTVX<V;^>VZ'$". #G.-Q)QTYK7M[R;Q%XEU+0[B_N;46NEVTMO\
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M!D'W!S[X)%8UOJ.L-\,]$\3MJ%[/+I=P[7R+*P-U:QS/&^X#JP50V>^TYZT
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M4%&% '24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX.Q]QSN7!(SP>E;L_A#0;BZL[A]/59+.#[-#Y3M&HA_YYLJD!DX^ZP(K;HH
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MTV (%@CP2B[0S'EFQVRQ)Q[UHT4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EUY_9T
MWB?XD-<?9G8:9 BF3:?^6,@8#/OM!]\55L-6L_L_ARU<B"[F\+(@O2K2O-PH
M:WC7E=^Y<MD$]!CN/6Z* /);2-Y/@_X6\0V"-+?^'HHKD *0715VSQC/JA;I
MW4>E:WBDWEEX7L-:DBN51]6BU#4UA3=)'!@A?EP<F,>5GC^ FO1** .2\'G0
MK[4=4UK1+JYO?MPB^T7;\1R,H( 4;5&0,9('<=ZYCQSJ%JU[XRTX)]DO'T0#
M=L:22_&R4A4!RH1"2&(&?FZKC->J44 >43>(=/T?6_#^KSW]N([CP_\ 9RE]
MOCCX=3N5PC9)/!&.@!STRS3)]"T#1?!5I:7UE=();A5UI,F*"78=RA0<%V#;
M%W= .AZ5W-_H.J-KLNJZ7KGV4SQ)%+!<6HGCPA8@K\RE3\QSR0?2M33=.73X
M9<RF:>>3S9Y2H7S'P%S@<#A5'T'<Y- 'CQGM?^%7W$$CDS6_B7CSH]C+_IH8
M\$#!VY)  P.H%="ZZ3+XZ\;R3"S8-I-OAFVD$[9=^#^*Y^HKTVB@#QZPGD7P
MOX7O=-UZTL=7M="1&M]0 :VNX\#=&QR"K!D'(YYZ'G&QIU^B>./"EY=V;Z:M
MWX=>&*W96.R0R0MY0XSD =^<#FO2:* .1\=ZC:Z=_83W<4:JVI+LO)]WE6C[
M'P[!2,YR5 )QELGI7G=Y-9OX)\5V\\AEE'BB.13/%L8JTT!+8P,94,> .,FO
M<J* .!M8M,D^*^I6426QM;G0(8WB3&R3]Y)D$#@_(1^!':F>#K._CU$>';Z-
MVM?#$K"WG?I.KK_HY^J1LZD>NTUV^HP75UIUQ!97ALKET*Q7(C$AC;LVT\'Z
M&H='TQM+LV2:Z>\NYG\VXN74*97P!G:.  %4 #H .O6@#F?BY(B_"_7(V=0\
ML(6-<\N=Z\ =S2VEUX4M;W3+NRU)+F_(%O%!%>M.S>9M!^4L< 8!)QP :[6B
M@#RG5+FQTOQ</%EN$D\.S7B6M^J/E6N5RJW(0=0I.T^N-V/E!*ZCJ6DIXH\2
MZ3XFOKJ"SU<1-9-''OCO+<PJI1&",=P;=P#G+9'6O5:* /+XM2TWPYXJU#3O
M$J30:=J&E6MO8-=*TF^-$99("PS\^6R1U.?I5I[C3_#_ (^\.S31G3=.?0I;
M.U68'(821%8NYW[1TZ]N:]&HH \6TR[AA\+>$[J4M'!:^*;AIW="!&&:YVD\
M<?>7\Q77:4UG-\6?$$:B(K/I=J&0C&\[I=P(]<$9!YY&:[NB@#S_ ,&6-Y:W
MTOAJYA?[%X=N7:VF;I+'(,P#/?8KR ^A5*P?#MQI6I6MCH&NW&H_\)'IVHF8
MV 3:WG"1F$P8)RA#%BV[&"?:O7J* .,^)NBWNL>%X)=.A:XNM-OH=02W7K,(
MSRH]\$X'?%/\1>*-,U#PC?0Z7<)>W][:O!;641S,TCJ5 9.JX)^;(&W!S784
M8&<T >7&QB\+WGPSTB[NHO.LO.69BX !^S.I/L-QP*V;>[M3\9-31IXN=%@C
M(+#[PED)7Z@$''O7<44 >+6U\MAX>34(T,NE6/B^XGOD@7=L@+R;)"HZJK%&
M_ 'M6YXBO=-N="NO$'ARWGGM&U&TNM2N;5"3<1QD;BBL,-L 0G QQZ@X]-HH
M \@\2/X;U7P7XNUK2+N?4)+RP6.6ZE&(WD7(C51M4%P">@R,@'K7IVBVNG0:
M;#+IT%LD<T:,7@4 284 $D=>!BM&B@#R8RPMX1\<Z#K./[:GN[N2*!_]9<[Q
MFW>(=6Z(!CH5QQBM3399=)^(VG)K,V+J3PS! TK9(EF24F3![XSD^@YZ5Z+1
M0!XE9-I\7PZ\/S@VZW*^*%D9^ X'VQR6)ZXV$'/H?2M!KG2;NX\0>&/$]SJ"
M7MQJ<D\%I$G-Y&7#0M$P7.0 J_>XV\X%>NT4 >?:!::5=?%#Q<)8+2:5/L3Q
M[U5B&5#N9<]PP7)'(.*O?$:1;>T\/7<IVV]OKMK+-(1Q&F6!8^@R1S[UV=%
M'FKRZ7=^/?%LUP;=T.BVX4S <#$NX8/0X*Y'N,UF>'=7LXK/P5;3D6UR^@F)
M;]E:1C_JPUO&G*^8=H/() 7 !SQZ[10!XCX??3[C0_AA'<B)GAN)HY1,F-N(
MI  <]MQ4>F>.M=OX$DMQKOC*&W>/9_:_F*B$8P88P6 '^T#SZ@UV]% 'CWQ
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M?NX_M3MD>B[2#Z8(KVRB@#S#5KJ;3O$UY<Z5?6VHP3ZG;_;M#N0/.$O[H+-
MP.3@*C8((^5N1@XZ_P <S1P^ ]?\QU3?IUPB[CC<QC8 #U)/:N@HH XGP5H&
MCWGASPSJSJ]U=VEA"(FEN'D6!S&H;:A8JK=NF1TKDMQNOA7J_AV]/_%5I>3?
MN"<3R7+3EXI4'4C!4AAP #S@5['10!P>GS0K\5-5CO+B!V&AVR2EB-I97D+]
M?8@GV-<AH&J1Z+X6\!:I=;O[$LY[R.\=5++;2.6$3N!T RPSVW^]>UT4 <-=
MZ'I?B7PCJ1\.0B"26\.HV=W@@/=KAA*N[L6&W/0_-CU-GPWK"W.A7?C/6(7L
M5FMU+1NI+00Q*<\#)/SF5N.2"M;>MZ;J6I1V\>GZU+I@5R9S% DC2H1C:"P^
M4]P16A:VT-E:0VMN@2&%%CC0?PJ!@#\J "VN(KNUAN8&WPS(LB-@C*D9!P?:
MI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOIO&FDZ>$@%A?:5)>@;#YBN&C&-V<8^?TJKX2\73^(-16VGNH(+R*)S?:5+
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M1_%4 U"$P6]O:"&*2W)"!EE( PX[\D]_;BL^W\::V?!'AGQ-+]A2TNYXX]3
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M,O6L_P"U+&6,6 2!E29)@!$S N2<OE6P1C%%_P"(?$%Q-K%IHD"3W>E;(L&
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M69[*QUQ9#=VHA60"5TVLZ$\KD8R.<]L=NRHH J:78_V9I-I8>?).+>)8A+(
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M95+3<,F-26;COMSQGI@BH_%LUNVH:#I\CRR3W5TYBLPX2*YVQL2)20?D7[V
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MGAO3QI;R/910K!$95*N!'\F&# $,"I!!'4&L$">P^*E]=RV5X]K=:3!''/%
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M?!\:7%MHNDZIX8U:/5](V(TMT9#;1&-=OFQN6VG(' 4=\=,FNV\5?\BAK?\
MUX3_ /HMJ (+#QKX<U/4X-.L]5BENYXO-ACVL/,7&?E)&"0.H!R.XXJQ)XFT
M>*_ALY+P))-*8(F:-Q&\HSE!)C86X(VYSD$=JX?3[3_A(-#^'D5E:SI)IIM[
MN>=X&C6*-("&4,0 =[%1@9R.>@J'PS:[+:T\-ZYX;U:XU.PNMR7$AE-F^URR
MSJ^[8#@YQUSQCF@#M(O&_AN>\%G%JT+3F22( *V T:[G&<8& #]<'&<4NCZQ
M80^%["\DUI]2AF^2*\>/#W+$G 5%49/!X Z#-97@99+2/Q.]Q9W<'FZS<W*>
M;:R(9(VV[64%<MG!Z<URVA:?JNF^'? &HR:=?>5I$MQ'?VAMW$L8E5D$GEXW
M,%SV!.&..] 'I=MX@TJZLKJ\CO8U@M"RW)E!C,!49(=6 *\<\@<5SL'B.6\^
M*%MIMM>W!L7TF6X>UFMC%AQ)&%<;E#$$%NY'6N<\2:!JVIR^*=;TFTG>&X;3
MV2U9#&]Y]G?=)\K8/3"C(YVGMC.U;7[:M\3-*U2WTS4X[,Z3/ \MQ921!)#)
M&P5MP&.%//3T)H ['5=032M*N;Z1)'6",OMC1F)P/103^/:N3\,ZQ/=:7I?B
M2_UNX$-Y:1B:PDLR%:X<*R^3\H8X!88&[(YSD$GI]?)'A[4@L<LC-;2*J11E
MV8E2  H!)K@+:TU*TT+X=ZG]@O6BT6-8=0M/L[B6,M;^5OV$9;82>@)P3B@#
MMI/%NA0Z7=ZE-J*16UF_EW)D1E:)O[K(1N![XQ5K2]<TW6C<C3KI;C[+)Y4V
MU2-K8!'4<C!!R,BO.?%.D7E_:>.]4LK*\>+4[""TMH5MG\RXE0-E]F-P W!0
M2.Q[8KTZQ=9+"W9$=%,:X5T*$<="I (^E %;4-<T_2V=;N9U,<1FD$<+R>7'
MS\S;0=HX/)QT/H:%UW3GOY[%9V-U! +AXA$^[RR<!@,?,"01QGI7(^-;&XDU
MF:^TJ;4['6(+ >5-#:M/;7J[G/D2*%*Y!]P1YF:$EO\ 3_B#;ZC?Z5=G[;H,
M-MBT@:5$N%D9FC+#A1\_!8@<=: .KC\1Z3-IEIJ$-V);:[XMS$C.TW7[J ;C
MP">!T!-<WXC\5IY/AO4M)U<)87&L):77RJ%*;7+*VX;E(*<C@]<UROA]=7\/
M:1X)U>XT74I;:RM;FRO;:.V9IH#(RLL@CZD?+@D= :W]?1KN+PU/9Z#=6T/]
MOQWCQ1V;;UCVONED50=I+-GGGD9YR  =EI&NZ;KL<[Z=<^=]GD,4RE&1HWP#
M@JP!'!!Z<UA_$K5M1T#P+J&KZ7=&WN[7RRA\M75MTBJ00P/9CTQ3/#<4Z>/?
M&$SVMS%!<26K0RR0.B2[80K;6(P<$8J+XL6]S>_#C5+&RM+F[NI_*$<5O"TC
M-B5&/W0<< GF@#;NO$NCZ/=+IM]JFZ^$!FV%"TCJ"!G:B\G)' &?:IH/$>DW
M.D6^JP7J2V=R=L+HK$R-DC:J@;BV0>,9X/'%<_<,\WQ1TK4%L[TVBZ1/&TQM
M) JNTD9"DE>#A6X_QKDM.AU;2--T+6!H^HS0Z9K%^]U9K;.)O*G:0)*B$ M@
M,#QSAC[T >F6_B32+JQDNX;P/%'.;=UV,)%E!P8RF-V__9QFJ[>,O#R6#WLF
MIQQ0QW MI/-1D=)<@;&0@,IY'4=ZY7Q";FXM],\1:;X>OA9VVI&XNK2&,P7=
MPCPM&TVQ<-N&X<'YB!Z55U^T@OO"-[<Z3X>U.)[V_LI'\ZWE:XG\N9"SLARP
M4*, G&<'C&,@'9CQEH<EKJ<\%T\_]FQ^9<QQPN7"D$@JN,L#@X(R/>J$/B>S
MU?3?#EZ=3FTN2_EB=+<PG-P6CW&+YEY7YOO#CY>#69J-K=7GCG7W@LKLQ7/A
MQ;:*5K=U1Y=TIV[B,9PZ_G6=B[G\*_#V(:5J:R:?>VOVE&LI T0C@9'8C&0
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M;=PXX+8/!]:SKCXBW5OIVJZD?#[_ &/2=0:SO'-VH8*"@+HH!W$;\XR..YZ
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MBT<>T9^=NBYZ#/4T <WH'A*32_%,VMK;66FBXM/*NK6QE9HKB7<#YI4JH4@
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M7HBYVC< #CD YI:* .)?P?>7?B>PUJ>&PM;ZUNW=[^TD82W-O\P6*1-H!X*
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M]N=X@@0R2%(RY"@9)P 2>* ,[Q;I>H:SX9O+#2[M+6\EV['<D*0&!96*\@,
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MQWKGB(C_ $=H8=/M6_YZ"/<TC#VWMM'^Z:V=$US3O$VDQZCIKO-93 [)'A9
MXR0<!@"1D&M)55%"J J@8  P * %HHHH **** "BBB@ HHHH **** "BBB@
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M"\<UJ2^!=,GTC5-+DN;UK75+DW5T/,4%I"020=O )5>!Z?6B_P# NF:AK/\
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M<1K=G=NVCH"4"EL>JD]:TO&EL;S05MTU&*PG>ZA,$LR;XFE#AE1QW5B /Q%
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M<Y]#@ ]"66-Y&C61&=/O*&!*_44&:(,%,J!BVT L,D^GUKR_R[.YT;X?:AH
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M3ZU3T:RLK"X^%EY9PPQ7=W8M'-*O#3#['G#-U8!@N >F!B@#UGSHC,8A(GF
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MHH!SNYR=W ZT >L+JUD^LR:2DZM>1PB>2,'E%)P,_7!_*K0FC:1HED0R*,E
MW(^HKSAI+$_$[5KFT^Q/>SZ##+8OA"99=\PW(>YZ<CM5+P?_ ,([K,?AB_CU
MN3^W+0;9+2(1K<&0KB99AMWE<Y)+=3@YR10!VWA;7[C6X-4:]A@@DL]2GL@L
M3D@B,@9R<9)SZ"N@W+D#(R>V:\NT_P .P>+/"OC'3QY1N5\07DEK*P!\J964
MH?S !]0370^#;O\ X2B0>)KFQ^S31P"QCC=,-&ZG,^#UQO\ D_[9GUH [ D
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MP'8>A;J:L$9&#17(>)=;O'\6Z+X4TZ<VTM\DES=7*@%XH$'1,Y&YFXSV&>]
M'1_V3INPI_9]IM)R5\E<$^O2G?V;8>89/L5MO*[2WE+DC&,9QTQQ6;)HEU;7
MEA-I^IWJQ139N8)YVF6="I'5\E2"0>"!QTZ4R7QCI4(CF<S"QDN/LJW^S]QY
MN[;MW9R!N&W=C;GC- &FNDZ:I4KI]H"IRN(5X/J.*7^RM.PX^P6N'^^/)7YO
MKQS6+>>.=*L[G5;;R=0GFTM4:Z2&T=BJL"VX<<C"DY_+-/M?&ND7FHV%I";H
MKJ,9>SN&MV6*?"[RJL1R=O/X&@#8ETRPG@C@FL;:2*(YCC>)2J'U (XI]U96
ME]&L=W;0W"*P95EC#@$=P#WKEIOB9X>@CDF?[>+6&Z:UN+G[%(([=PVW]X2/
MEYXYY]NE:&J>,M*TF2^$QGDCT]8WO98DW+;K)]TMSD\<_*#@<F@#6?3;&2/R
MWLK9DWE]IB4C<>2>G4^M.?3[*1W=[2W9GC\IF:,$LG]T\<CVK&OO&6FV.JW&
ME^3?W%]!;BY:&WM7<LA) *\8(X//3MG/%+%XSTB=M$\EIY(]:7-E*L1V-A2Q
M!)^Z0 3@^AQF@#;^S0>:DODQ^8B[4?:,JOH#V%,CL;.&YEN8K6!+B7_62K&
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MFAM].MX97N7 "_,)"6)SPN$&#ZY[8JQ!XHT^ZU2VTMUNK:>^A:6S::/8+A%
M+%#V(!!P<''.* ':GI>HI%$OAR;3M-=I/])>2TW[DP?N@%?F!.1GBM.PLHM.
ML+>R@SY4$8C7<<D@#&2>Y]37#>%/%*Z3X+MKK6)[VZ,VJ7%FL[9E(8W#I&&8
MG@= ">![5VHU*(ZNVF!)3.L(G9MORJI) R?4D'CV- %RBBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#BTL=3L?&OB>Y&F3SVFI6EOY,\;I@-&CJ5(+ Y)88XQ[BJ%I9^(]
M,^%6AV%MILPU"T^SQ7ENK1^;Y2L/,,1)V[L#@Y_(XKN+_5+#2H/.U"]M[2+^
M_/($'YFK,<B2QK)&ZNC@,K*<@@]"#0!Y1?>'];ET[Q[;6^@W:C5X8?L8>XC=
MF;RE0AB7/S9!))./<UO:E8ZG-XLT[4(M&EGMX=%N;>19"FTROL*HPW9P=A!(
MXYKL/[4T_P"T7$'VZV\ZV0//'YJ[HE/0L,_*.#UJ6UN[>^M8[FTGCGMY!E)8
MF#*P]01P: .%\.:)?Z)J-RNFPZG%H#V#?\2V]=7-O<9&$A)8_+C=GG;G&">U
M#3-#US3M ^'[MH\\EQHTCI>6R21[U#0O&&!+;2,L._2O3Z* /-=;\*ZMKU[X
M[MEMGMDU6SM8[.X=EV.\08D'!R 20,D=,UJS6FH^)-5\,WMUIEQ8-I4CW-UY
MI7/F>64\M""=P);.>F!ZG%==->VMO<V]M-<Q1SW)*P1NX#2D#)"CO@<\5/0!
MY6FA:X/ %MIQT>Y^V)KPO&BWQ\1?:S-NSNQ]T],YS7J8.0#@C/8TM% '#^*[
MAK;XB^"Y5@EF 6^#+$ 6 \M.<=\>W-8VJ^$M7G_M+7[338YKF36H=0CTN=E'
MG0QPF$JV<J&8,S<].,\\5WUYH-E?ZS8ZM.9OM=CO%N5E(5=X ;Y1P<@ <UIT
M >:Z[IM]K'@O4AIO@[^S;FZDM@EN%A2>3RY5=F<JVT* , $YZ\#-;OBZSO\
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M8WD :0]<*#R?PH \]T33M;_X2SPYJMSHE_'LTZ:VO9;F>-F65C&<X#D!/E;
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M6&JSBYM[G]R3$Q14:.7?R%&W((SP>A/%=9IND:'X.TNX> K:6H_>3SW-PS8
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M 8%\=5/.!\OS_3\ZT],\/K:WVJZC>O'<7FI[%GVIM01HNU4 ))QRQ)/4L>G
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M_B"(Q[5*G(OF7&23@< #T'K7K-A!):Z?;V\LBR211JC.J[0V!C.,G'YUQ2^
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M9;@V_DX=) BH?GW8*X4'&T'W]0#?HHHH **** "BBB@ HHHH **** "BBB@
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M:L47Y0Q)W(<%@<_Q&L[QO8Q7/B_P89'N%+W\B'R[B2/ $$IXVL,'W'..,XH
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MAGE\B)_/7#R9QL'/+9XQUJ ^,/#0M)KO^WM-^SP2"*67[2FU'/(4G/7@_E0
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MU@/C!9SKY'DIH+JLH VJ?-4J >@.S<0/3/:N4\/R2V%EX0U"1'&D6&IZDEV
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M_2=+D*R%G##K'DL/F'\8P3FJGA)]*O[+1-#UBUU4^(](N4=[5_-"QRH2#/O
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M/^V7 @*B-=H4, Q."2QX'\A7+Z7X=\1VGPJ3P>^D6C736DEJT\UT/)7>6^;
M!8XW9QCJ.M65\*ZYIYT;2T6'5='M=*%H5N)_+5+@'_6LN#O&W  YVX_&@#?@
M\8V5]#I#6$,L\NJVC7EO$S+&QC7;G.XXW?.!@>_89I;CQ;;0Q6BBVD^V7-H+
MO[++)'$T:''#%F #9., GD'L,URMIX.O)O!VA:)KV@QW(L;4QB6TNE6>WE7:
M%='.W&1G.#V7K4J:!XNT6[TC5X5M==O%TU-/U*">?RRY5BRR*Y!R1N8'(YZ]
M3P ;^G^.--UC3]*N-+CFN9M361H+?A741G$A?)PH4X!ZY)&,UG_#6626+Q.9
M$N(RNO7"^7<2;W3"1_+G)S^=-OM&\10>(M&\36UM:W5S%;RVE[8QR[ (Y&#C
MRW( )4@ DXW8[=*T/!FE:KIDNOOJ=M!"+[5)+R$1S^8=K*@P?E']W]>E $/Q
M UV\TNRTK3M-E\B]UG48K!+@ $P*Q^=P#QD <>YJ[>>$K9],>"PN+NUN]HVW
M0NI"[,/^>A).\'H<YZ\8IOC3PS+XETNU^QSI;ZGI]W'>V4L@)02H> V.=I!(
M/Y\XJS:WVNW<2Q3Z.+"?I),UPDL:^I3'S-[;@M $-]XLAM1J<EM8W5[#I1Q>
MR0;?D.T.RJ"0695() ]<#)XJ&3QK:/J=E8V%A>7[WUB;ZUD@V!)4!7H688/S
M#[V!^/%9]MH>LZ)>>)K:SM4O+/69WN[>0RA?(ED0*ZR \[,J""H8XR,5'I/A
M2]T'Q!X=^SPF>PTO2)+!YMZAG=BAW!2>GR'\Z )X_B-:OIEOJ3:/J4=D;H6=
MU,XC M9?,\O:PW9;#8R5!'/KD5/?^.5M-2U;3[;0-5OKG2UCDG6!8\%'#'<I
M+C/"]/O'/ X.,"7PMKLG@/4M'%BOVRYUAKU 9TV^6;D3<G/7 QCUJ[IMU>P?
M$OQ@;73GN6>UL/E\U%V/LDP&R>G7)&2,=#0!KIXZTNZL;*XT[_2FO+7[7'&9
M$B(CSCYBY !SD8]0>PS5:W^(VFWT6AR6%AJ%TNLK,;?RT0$/$#O1LL,,",9^
M[WSBL.Q\&Z]X-DT>YT2WM-7$6G_8;ZUEE\G)\QI1)&Q! PTCC![8_#<N])UJ
MY\2>%=1FM82+!KE[L0R +'YJ%55,X+;>YP,XSCG  +%KXXLKC2_M,EK/;7(U
M$Z8UK,R!EN!_"6!*XQSD'GMD\5<D\2-']FA?2KQ;RYNGM8X"%ZJI<N6!P$VC
M(/4\<9XKFX/#=^;'7+34M!@OK/4M:DO'MY)4RUNR  @YXD#*IZCV/I#;>&?$
MVFV=A:PE[[28]0F=M.N[S$@MF0")'DYW!6W,5R000.<4 7M1\>R'2-,N],TV
M9GN=933)TD9 T+"7:Z]<$G:0#G'.21TK3CU/3?\ A.I89[*ZMM2CTD3//+(/
M*$'F=,!R,AMV3CMU(KEH?!_B"WT+[.MC9"6U\2#58(8[C"R1>:7*@[<+@'CZ
M=JW+OP_J&I^,[N[NK<1V%WH1TV22.4$K(SEB0."5PV >N>V* +B>-;/9I=U-
M9W4.FZK(L5I>/MVLS?ZO<,[E#_PDCN,XS5*[^(MO:6^K7)T35'@TBY\B^D C
MQ$ %)?[_ ,PPW1<G Y XS2M_#&LWWA;1/#&J6\<::9<6YEO4E!2:* @IL'W@
MS;5!R !SR>*BO?#.MW/A_P <V*62B76[EY+0F9,!6C1/FYX^X3WZB@#T56#J
M&4Y4C(/K7-OJ>EQ>/9X);2ZCU"'23,URS_NFMQ)T"ACSNSR5!XZXK>LA(+&
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MGALXD\XG(S)YYQ\@ZA<$9P3STH ]"HKA=?\ %EQIGB!["ZNVTF*:.+^SKF:
M-;7#G.]'DQ\K=@,CUYZ5,^OZH-2\:V@N$VZ3;0SVC^4,@M$[D-V894#MQ^=
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M#:G/K5SI1NQ'M7;#O8R;,XW%4  Z9.>G%:6H:OKWA^W,-Z\%W)>:G'::?-&
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MJILTDFM\-)%OC +*" KXD],<=* .PL/!_AW2[H7-CH]K!(K;DV)PA]5'13]
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MTAU2WTV21A=W$;R1)L8@JF-QW8P/O#J:IWOB?2-.O$M;J[*2-,EON$3LBRN
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M*-4O9&T.%H(-XCQ(K*$.["_W5 &,=.YKH[F)Y[:2))6A9UP)% )7W&>*EHH
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M:VZ%MH+D%N3@X 56/0]*ETBZU"[M';4].%C<I*T?EK,)5=0>'5@!P?0@'VH
MQ[[P<-1LKS3[S5;NXL;U46YAE2,EMH )4A1M)VC..!V"TFH>"XKS5=1O8-4O
M+1-2M5MKR"$)ME"JRJ<E2RD!B.",U+XA\6Q:/X=FUBS@2_B@NEMI )=F&,HB
M/.#G#'D>QKHZ .7T[P5#IM_HUW'JE[(=*LC8PI((\-$=N=V%!S\B\C'2HY_
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MB[U&ZAG_ +3TU;&:*9HU"3B5)4&,.IP" <]" 00:S/$OBR+1/#.IZQ9P)?\
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MCOKBX_M"Z>[E64)A9& !V[0.,*.#FMJB@ HHHH **** "BBB@ HHHH ****
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MA>^LH)WA),3N@+)GK@]1GOZTV]T32M1TL:9>:=:SV*@!;>2)2BXZ87H,=L4
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M?%:6]M]BB8D 1NK%Y4_VM_&X<C:!D5RQ$VK^!O MSK7^E73:[# )Y?O30AY
MK'UW*JG/?KWKU.^T32]3FCFO;"WN)8U**\D8+!3U7/H>XZ&EO-%TO4%MUO-.
MM;A;9@T EB5A$1T*Y'!'M0!;CBCB@6%%"QJH15'8 8Q7BUS965I\)_'0@BCB
MD&JWD8"\$(MR,#'H,BO:U4*H51@ 8 %9<OAG0IQ=B71K"07CB2Y#6ZGSF'0O
MQ\Q^M ''W2VWAWX@7^RZNK:SE\.37EVXE:1M\<@'F@,3\P5C5#0A$GB_P];#
M9'9:AH4IEC:;?)<KF+9)-C ,AW-R,]2,FO1#H6DF[%T=-M#<"+R!*85+"/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ]TD\,D;QJ>0VQE#$'!Y QQ7->(?MOB7PS=ZAHV@74$\<]K<^7<Q?9I[WR9
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M./E# <<9!IUE9O#/JGAO6_#.J:@\VH33VTXWM9SI)*9%9VW;4*D\@C/R\9-
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M2A VL5P,G@=:ZV?7[JXUG4M+T>T@N+C3HHWN#/,8U+N"5C&%/.!DD\#(Z\X
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M '>45D:UJMUIT]I%!:HT<V\S7<\FR&W50"-YQU8D #Z^F"SPIKX\3^&[75A
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M#.6 .0<KMX&=PZ<UG7_Q"GT_2-9EDTE&U'1KN&WN[87&%*RLHCD1MO((<'!
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MM?#]Q,\6HW2-);H\;!90H).&QC/!XSFIM>U[3?#.CS:KJUQY%G#@,^TL<D@
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MV BU<Q2(\L;O)#L"_N@<@>7E21Q_$>,G->A4UG1656907.%!/4XS@?@"?PH
MYQ=#U,>-HM?DEM'1=,-BT:[E+,7#[AP<#(QCGUSVJ7P;H=UX<\/)IEW)#*Z3
MS2B2+."))&DQ@CC&['X5JV=^+RXO(1;7,1M9?*+S1%%D^4'<A_B7G&?4&K=
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M#,<@W*2H"1X.#WR>!75^%K&]L=/F2[N-0EC>7= NH2K+/&FT<,R\'Y@Q R<
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MS$@ >, J ./EX9AD<\^O-0:CX%TG4K33(I)+V&?3$\NTO+:X,4\:8QMWKU&
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M[MKEHITBP!L+KU& .O\ 4UT5C90:=916ELK+%&,#<Q9B<Y)+'DDDDDGDDYH
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M]>Q[@\T:AX%T?4-=DU@O?6US.JI=+:7;PI=*O $BJ?FXX^G% '//=:]J.O\
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M*UVP;=&>JX "@'O@#.!G.!0!S-]?ZIH>H^%IEU.:^MM6G%G=)(J??:,NLL>
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M3^V0&NXTU@-]KC2<["64*Y"] 64 $]?3%2)X5LH[W2;L3W7G:5 UO:DN,*C
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ML1@0W%Z\C01\?+$2?D' Z<\#G@5K6.BV]E?RW[2S7-[+$D#7$Y4MY:DE5&T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6,QR1J\9&"K#(/X4IC0H$**5&,#' QTIU% !4;01/"86B1HB,;"H*X^E244
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M@>Q%=60""",@]0:6B@!D<4<,8CB140=%48 _"DCMX8D9(X8T5CDJJ@ FI**
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M"S,3@ #O0 ZBH+*]MM1LH;RSG2>VF0/'+&<JRGH0:GH **** "BBB@ HHHH
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MNTANHFN5D8L'5V*L 1S\F,@\?[7;-%G/::[?7>E:IKMC8:C+YUY9C0Y7S(0
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MO4[2&PAF\NS^T65X]I+!&\H.#"Z,V[)X(8'&#TXK;\1Z#;^)=!NM)NI)(DF
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M.3N7=R<9_A/;BF;I](\,^$[L:EJ3MK\VGVU_-+=NP13&6^3G]V6.%)&/SYH
M]4HKR_Q))?:1JGBC3+*\O$L#X;DU*/%P^ZUN%+*-C9RH8#.W.,J?>G)9RIKW
M@I!JFJ!=7L)EOA]MDQ*%A1UP,X0YSRFT\GF@#TZD)"J68@ #))[5Y!<W-];^
M$-8MX-4U"/\ L_Q2EG;2_:79UA:6'Y"Q)+ ;V'S9JQXATZ?2=8\0:3#?ZA<Z
M7>^'+F\EAN;N24Q3(<!E8G(#9.5Z'![<4 =WJGBB#3FT,QV\ES!J]REO%/&P
M"+O4L&.>3D ]!^5;M>8W,$=OX8^&ZQM(0VI63G?(S\FW?IN)P/8<59U&]NO"
MWBW4K)KBZN(M>MPVE":XD=8[H'8T0R3M!WJ_&, -Z4 >BT54T^W33[*VL!<2
M3/#$%WSREY'QP68DDDD]ZMT <U;>+FO=;U72;;1+^6XTQHUN"'A"_.NY<$N,
M\5M:;>MJ%DMP]I/:/O=&AGV[U*L5/W21@XR"#T(KA-"M;RY^)GCW[)J+VA$E
MD#MB5\G[/P?F%/U^.Y%UX+TY]7NS-]K^Q7[VUP\?FD6S,V<$<D@'/49X(- '
MH=%>;'P^)/'Y\/'6-;&GIH22@#49=_F"<C=NSG. /KCFJ[7MUK'@KQ;K;W]U
M:ZMIEU>" QSLHMO(Y1-N=I! &[(.[<<]L 'J-%>9V4-SXA\6W<&I7>I01S^'
M[2[DM8;R2)8YG+[MN""N,#@$ XY!JIH&O7^L67@O3K^] &H:1),SS2.INID*
M* 64@DA2S8SSG)Z"@#U>BO-4DU'2M7\,^%[[6I+ZTNKR\$UPK,C82,/' S[B
MQQN/.<G8 >XK+\2WFIZ7IWCK3[>_O5M=--G<64PN7$D!E(WQ[\Y*C&0"> V.
MF* /7JK:C=_V?IMS>>2\_D1M)Y<9 9L#.!D@5R&I7-S'\2KJU@U*2VC;PY+/
MAY6,44@E51*4)P"!WQTK-TB^NHGU+1]9LKRQUB+2)'8&Z:>VNT7 ,T;$\-DC
M((!^89SB@#NM"U5=<T#3]62(Q)>VT=PL;')4,H;!/XUH5Y7&+G3/AKX*\36\
M]WY.E6EJ][;13N$FMC& Y* X8IG>,_W37;^&V-\+W61-*\%_,6ME:5F00J J
MLH)P ^"^1U#CTH W:R)_$FG6_BNU\.22$7]S;/<HO;:I Q]3\Q'LIK5DD2*-
MI)&"(@+,S'  '4FO)O$EOK$NACQC;Z5B]L[P:O%)YPWFV"[?**XR 81R/[V:
M /6Z*X?Q;J(&D:'XQT^\N/L%K/#<7"13.J2VDG#%E!PVW<'Y_NFL33=0NFUO
M5] >YOMNN/'=Z3*UW(S+;$E9"C9^3"H74#_GHH- 'J=%>4^,[^>"P\3WVEZA
M>22Z9-;()FN6C6S8>7F- "?,)W98L #OQDXP->ZTYM7^*&HZ=-J>IQ6:Z7;W
M*Q6]X\863SG&1@\<* 0.#W% '3>*O$"^%_#MUK#VDMTEN 6CC95."0,Y)Z<]
MLGVK9KQK7;C_ (23X2>)-:O)Y_MR7<T9C6=E6W6.<*L6P'&-H!.1R3GTQTEZ
M;SQ-XG\2Z&NI?8I;**$6NV61'C5XPWG*$9=Q#DCG/W0.YR =^[%(V94+D D*
MN,GV&>*RO#&O)XF\/V^K1VSVZS-(HBD8%EV2,G)''\.:Y;2+N76_%LNB:IJ+
MW,=CI%M+$\#M +MY-V^?"D'LH'.!DXJ[\*5V?#C34W,VV6Y&YCDG%Q)R: .H
MU35++1=,N-1U"=8+2W3?)(W8?U)/  ZDUCW7BBYL]'FU:X\/ZBMG'$92 8S,
M% SDQ[N..V21W YK"^+Z2#PKI]SAC96FK6MQ? #/[A6^;(],E3^%=T\UN;-I
MWDC-L4WER04*8SG/3&* )@<C(HKA;)V\3^)/%FGWES=6W]GM##:)#.\)A1HM
MPE&TCYBQ/)[*!ZYY_0+_ %/Q%>^!Y-4O;V-M1TJ[:[CAN'B6;8T81\*1@D'.
M5P>: /6J*\:N/M=KX!UO4DU74S=:)K4EO8NU[(=D:W*J%89Q)\K$?/NXXKHI
M=*;7OB%XDTNYU;58K-+*TECBM[UXPCL9067!XZ XZ'N#@4 >AT5Y)X:UW5M:
MA\,:3JUZ-US873B25W3[8\<WEJ<J02?+&[&>=V>PJY=6.HZ?/X3TR?Q'>7;'
M5IK:6:&9T+1>5(XC<[CN*X W'GCJ"* /3Z*\OMEUA(?$VCZ1=O.UEK,7V6WO
M+Q]TT9B25X!*26&?FQD^H/!-26^MVU]IT%HKZQ87K:T()=*FE)D,@BW&'S"W
M$6,/N!Z< '.* /1[FYAL[9[BXD6.&,99V/ J%[FZ75HK5;%VM6A9VN_,7:C@
M@!-O4D@DYZ<5Y'JAGO/AYXD@OI97-AXECA@7[2[^4GG0?(&."P&]L9Z<=,"N
MPN'FT_XFV-O;3W<EO_8=S)]F>Y=U9UDC .&)^;DC/6@#MZ*\F.IW\OPLTSQE
M:7MR^MF>&211,VR9GG$;P&/.W;\Q &."H/7)I^K6\]Q-\2"VJ:HHTR))[-8[
MZ1!"_P!E\S(PW3=SM/R^U 'JU%9VB7C7FB:;-/(K7$]I'*_0$DJ"3CZFM&@"
MI:W-U/=WD4]B]O%#(%AF:16$ZE02P Y7!)&#Z5;KRO5;F\BT?XGA-1OE-DP>
MV<73[H?]&1\*<Y W$\#BM6Q2;3/'WA^.*^O94U/2IWNDGN7D5W3RBK!2<*?F
M(^4 <T =_117E5WJ-Q]KTK4]/O[N>&?Q.+5KN2=D$B%V1H5B&5,:XVY."2N0
M.<T >JT5Y)J4-Q+I'Q&N#JNJ"32IWELBE]*ODLMND@QAN1GL<CT%:Z/<Z;XR
M\,SPW=[.^JZ;<R7<4MPSI*Z)&ZD(3M0Y8CY0!S0!Z)17DIU34)OA5I_C.TO;
ME]<\^*1U$S;)6><1M 8\[=OS%0,<$ ]>:O7UW<Q1?$^,7]XJV4"RVI^U.# Q
MM=^4.<K\W.!Q0!Z944]S#;",S2*GF.(TR?O,>@'O7G-E#+JWC+2+.ZU'43:W
M/AA9YHH[R1 [^9&-V0003GD@@GOU.<:W#ZKX;^'\M_<W4\ZZ[+:^<UPX=D7[
M0HR00=V$7YNO'7DT >R45YOJU]>:/XC>?4X[J?19;^W%OJ5E=L39D%%\F://
MW&8'+<YW\\XKTB@"*XE:"VDE6)Y612PC0@%L=AD@?F:H>&];C\1^'+#68H6A
MCO(A*L;')4'L37-QW'_"0^-/%.EWL]Q''ID%NEM%%.T6!)&7:7Y2,G.%![;>
MV3GF/"-_--HO@?06N$@MKK1Y9E#NZ">560!,J020I8XS[]A0!ZU-<PV[PI+(
MJ-,_EQ@G[[8)P/P!/X5+7E-WHLMMK7@VRU'5YM2EAU6ZB$ZS2(R(8'8(6W9+
M+P-V<D#!JTWV_P 4_P#"2"+75TR\TS4&BCF\R0&UC3:5;8&"E6 ))8'.3Z#
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MY)!3;][( !STYJW7 :D]_P#\)WXAL[35);4OX>66%II6,4$S/(HD"GA?NKG
M[59\&:C*VN7^FZEI][INK1VT3R6TERT]O(@9AYL3$GJ3@]#P,Y.: .VHHHH
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M]/$&CR6US<#4[40VN/M#O*%$.>1OS]W/O4*>*_#TDYA76K RB#[05^T*"(\
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MJ%LURS,JQB099E^\H]2.X'(JM/XN\.6P8S:[IR!9O(8FX7 DXRIYZC(SZ9%
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ML+I0$6X^4$R*HS@'KQP : (;#P9X>TRYM;FUTN)9[162"1F9VC4XR%+$X''
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M:S"Y$F-N,,6SG).0,Y&;FJ:5>67C:?3+.(MI7B=/,NRIX@>+:)CCTDC(7/\
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M%$%#>F6!P#W![UZ710!Y1X0.E7]GH6C:II^K_P#"1:/+&7MY3.$BD3Y3-O\
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MVK2O=CYP(5."JJO?C/S=0!S2TAK>ZU7X;>="Q$.C30R^="PV.8HE ;<.,E7
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MZ9)- &OX>C2+XH^,0@P&M[!CSW*RYK;U+7ULM8MM(@BCFOKB![A(Y)A$&5"
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M>WS[:9F:\(&%R"H\L=R<GD= *L>!-&O_  ]X.L-)U%8!<VH928)"ZL"Q(()
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M8,L@VG"L'(XS4OA+PLWA[5-3FM8?L&EW2QF/35F,B12C=O=>RALJ,#TSQP
M8_C-+%?B9X36](2TN(+W[0"Q59-J)LW8ZX).,U'X3UJZT6UUJ6\^W3:3+JRV
MVA)<[O-EWG 52_.S/0MV!/:MW6=$U6]\?^'M:MXK8V6F1W*2[YB';S54?*-I
M'&WN:M>,O#]SKVFV9L)HX[_3KZ*_MO-)$;O&3\K8Y ()&1TS0 T:['?:CJ'A
MS4K,VU\MG]H""3?'/"<J65L \'@@@=1U%<GX>OK"U^&_@%=1TV2]$]Q;1P2!
MP!!.<[7/.3CGL?>NG71;Z\\22>(KJVBAN(].:RMK83;LEFW,S-C Y"@8SQD]
M\#$@\(ZY!X-\(Z1Y=FUSHU]!/<'SSM9(\_=.W))SW H W[[Q:8([ZXL=*N=0
MM=/N!;7+6_,F_*[A&@&7V[AGD=#C.#4]KXD\_P 3:EHD]H;:6R@2Y6224;9X
MV) 9?8$$'/0^M8MCHOBG0M;U:#3/[/FTG5+M[Q;B>5EELWDQY@V!2)!D9 R/
M<TGB[2[;6]?T6*RU!$U!)9+6\2-@S/9LF9D<#D=$P>Q8>M '5:5J$FIZ-;ZA
M]E,#7$0E2%WYP1E<G'&1CZ9KFF^(,::#'JTFF21I_:1TVXC>90UM)YGEY?MM
MSZ9X(/T[, *    . !7$7_@!=2UG7_M$R_V1JD =;<#F.[*&)I1]$"X]R3VH
M O>*=;MH=%\0QW^DR7VFV5KFY6.4#S RY9.2,$+@GGHPQGM!+X@OH_%NA:+9
MZ>@T^ZT^2X.9<-A=@QTX"A_Q]L<MN/#6K2_#"\T22:&XUJ^M'CN)Y'*HTKK@
MDG!. , <=%%/ET+65\0^'-6MXK-C9V,MG=1R3,-N_P L[D(4[L;#P=O4<B@#
MG/"_B/\ X1C2-19]+N)--7Q%<V\MRKJ!"'N-B84G<P!*YQTSWYQZ+K.I#1]%
MO=2:WEN%M86F:.(J&8*,G&X@=!7"S>#]?E\&:MI BLA<WFLMJ"'[0VP(;@38
M)V9S@8Z5VGB"SNM2\,:E8VR1_:;JTDA02/A0SJ5Y(!X&?2@#%@\<AM/AO;W2
MIK&"\\@6+W$\86X:1"Y[_(%"DG=VZ#/%10_$73Y$NXI8TBN[:\BLR/M"F!FE
M&482@8V$ \XR",8S4>H>&=;F\(^'4L9;6#7-#:&6(.Y:&4I&8V0D ':RL><9
MJW<6?B#5](V:SI6DSI-*JSZ893)'Y(#9.\IR^XJ0, #:.>IH DU/QA+H\%HU
MYHMV9+G4%L%2%T<;F&58$D9!&<<?7%5[;Q_;(^L0:SI]QI5YI:)+)!*Z/YD;
MG",C*=IRWR]>">M<OJF@WGAG1-!M(SOC/BJ"6QM)9RXMXBK;8MY!/4$]\;L<
MXR=W6_!5YXEFUJ_GE2PO+JS@M;(*V_RO*E\Y7<],F3' S@+ZG  +D7Q"TV._
MO[34!'!]DLC?F:"=9XVB!PPRO1P<?+CN,9JS/XFU"!YHI- N$D^PO>0.9,QG
M;UCD<#"/R#CYAUP35&?1_$WBKPSJ.D^(UT^P\^U: &RD:7?(<8D.X#:H(^[R
M3GDC%6])M_%E[ISV?B!=.M]ENT)DM)6D-RY7;O(*C8O?'))] ,$ M^#-5O=;
M\(:7J6H1+'/<VT<I*L"'W*#G';KTK(L/&=Q'=^*[C6;=+;3=&GV>8L@8A1&K
M=,<EMW\ASUK6\%Z=J6C^$].TO5$MDGLH$MP;>4NKA%"ALE1@G'3''K7/W_@?
M4-37QCID\EO'I^N.L\-PKL9(Y!&B@%,8P&0'.[D<8] #>3Q.T&M:?IFJ:>]D
M^I(S6C^8'#,HW&-\?=?'..0<'!J_JNJ2:>]E#!9RW4]Y-Y,87(1/E+%G;!VK
MA3S@\D"L0:+JVM:AH%UK<-M VD.T[F&8OY\VPH"O POS%N><X&.]6?%>F:OJ
M$VDOIRVUQ:P7!>\L;F8Q)<(5(7+!6R%8AMI&#CVH H'XAVXTBWOAIEU(9-5_
MLJ2.)T81R^9LSG(W*>H('/?%:VA^(VU;5=4TNYTZ6QO=/\MGCDD5PR2 E&!4
MX_A8$=L=ZY!/!GB*/3VM?*TT@>)%U=2D[*/*$F\KC9P>P'ZUT^E:1J-KXYUS
M5YXX!9W\%M%%ME)<&+?G(QCG?Z]J .EHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R)_$
M^DVVJ/IDEQ)]N1/-:!;>1FV9QNP%/RYXSTJYI^IV>J1RO9REQ#)Y4@9&0HV
M<$, 1PP/XUQ-R]ZGQQD-C;V\TG_".)N6><Q #[2W<(V?RK9O!XDD\)7ES:&S
MT_7@\T@4@20OM9@@9B 2"BK\W'8D=J .HHK@].\:RW'@?5/&+,7M8(&:*P;;
MOC>-<,)& X)<'CL,'O@32ZOXDT>:74KRWDN=%BL)KBY,ODHT<B+O'E[&)*L
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M';.,T =MHDGA^'5=6T[1[>WM[R"19;](;?R\O)DAB< ,3@\\UN5QV@?\E/\
M&/\ UPT__P! DJ]X\U6_T/P1JNJ:9+%'=6L)D1I(]XX]LCG\_I0!T=%</)XA
MU70_%4EOJEU%=V,FCS:CLB@V&%HF7*J<DL"&[]QVZ57E\3ZQ8^'?#OB>:>.>
MVU.6V6ZLQ& L23XVF-A\V5++G<3NYZ4 >@9!_"BN*\!&^EO_ !5)=ZC-<B/6
MIH0LBJ.%CBP>!Q@<8Z?C5[Q]J^I:%X4EU'2Y(4N(YX$_>Q[@0\J(1UX^]UP?
MI0!T]%<9-J.N6>M6_A^:^:\NKF.>]^T6EM%$\<2LBK&JR,5)RYRQR<#ISD16
MNN^(TFT;0M6CBM-5OY[D&Y0*V;>$ APH)4.VY!CD#DX/ H [BBO,]4\4Z]I=
MCXLQ?I-)HU[:16\CP*-Z2^62' &"<2'D8Z#BNE.JZC_PL2?1$G3[*VD"\CWQ
M E)/-*=L$K@=,_C0!N:9J5KJ^G0W]FSM;S E"\;(3@D?=8 CD'J*MUYE:>+/
M$=[X7\&WJ7=HESJ]\UK<LUOD8_>D%1GC&P<=_45J'4_$4M[>Z##=R7&H:=:1
M227EM;PH)99"Y7<DC8" *,[>22>1CD [FF22I#&SN3M4%C@$G ]AR:IZ)-J,
M^BV<NKVT=MJ+1C[1%$X95?O@@GCOUKF4-\_QAN(#J,WV6/1XYD@VKM7=,RL!
MQGG8#GK^% '4:1JUEKNEPZEITWG6D^3')M*[L$@\$ ]0:NUY%X1U/6-%\&^#
M+F*\A:PO-0^PR6GD<[9))?GWYSN!'3IC\ZZ"77_$VK6][?>'[9Y'M-0DMDMG
M\D0RI%)L?>S-O#'#$$8 X&#UH [VLC5_$^D:$)#J%RT8B57F*0O((58D*SE0
M=H)!Y..A]#6OVK@=!M;YOB/XR"ZB256S&)(596S$^T$#!P,]B,]Z .STS4K7
M6--@U"R=WMIUW(SQLA(SC[K $=.XJW7F=IXM\17?A'P5J*7-HMSK%\MM=%K?
M(PPD.0 1@#8..I]14TOC'5=#@\2VE[/#?7=A?6UK9SM%Y88W"IMWJIZ*6/3&
M0* .W.M6 UY=$,Q_M!H#<B+RVYC! )W8QU8<9S4FF:E:ZOI\5]9L[6\N[:7C
M9#P2I^5@".0>U<6;6^M_B[8K+J)N6;0;CRWEA4%&\V+/"XRO3CKUYJE;^+?$
M5QX,\*:DES:"[U+519W):WRI4R2*, 'C 0>Y]1UH ],HKS]O$^O:5;^-8)-F
MJW>BQ1SVK+#L+B2,MM95ZA2#TY(JYINLZI<^,[33[;4X+_2I-,%[-/Y"EE<L
M%50R$!0P)(R"?E/X ':45E^)-93P]X:U+6'C,HL[=YO+!QN(' ]LG%<[=:WJ
M^B77AFXN[I+RUUB=+2XC$2KY,LB%D:,CG;E2"&+'&#F@#>U#Q1I&EW(@N[ED
M;S4A=EB=DC=_N*[ $(3D=2.H]16Q7">!;>Y'B#Q>T]\\ZKJQ5E:-1O(@BPW
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M>N&/(QS^5;<^IZMK6K^(=-T>\CLY])6..+>@82S/'Y@\S()$>"H^7!^\<]*
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M3[Y+.Z$DWEN<JK.R<8^4..#UP<8XSTM &+HOAV/1+[4[J.^NIVU&X-S,DP3
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ML=-MQ;VRLSK&I) +$L>I]2:)M'TRYMX;>?3K26"#_51O K+'_N@C _"K@ 4
M   < "@!:\<MM2.G>"=-::>.'3)O$UU%?2R)OC6,RS;=XR/DW[,Y./7BO8B
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M['H]A;X4H/*MD7"GJ.!T/>E'A_15BCB&D6 CB??&@MDPC>H&.#[T >;75O\
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MF'2XMJ,"5.7;"[B-HQ\HQENN> #IZ*** "BBB@ HHHH **** "BBB@ HHHH
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M)!^G?%4-$TJ_T_Q+8W&CQZE:6-Q-*^IZ7=QEK> E6/F0L1P2Y'RJ3D,<@8-
M$2>*([]];U:^U+5]-M]'U38K06LIC^SHL>Y9$VD$L68G(W+D'@"N\.LV8EL(
M]TI:_!:W A<Y &XD\?+QZXKF_!]B[?\ "56NHV$\<%_JL\R+/$56:!T1<_C@
M\'GVJ/P#I=_:BXCU"43Q:2TFEZ?+G)>%7R6/O@1H?>(^M ':2R"*)Y&#$(I8
MA%+$X] .2?:O-M6\:S:OX&L==L9KO31_:L,;AD*!HC<^7@L1@_*.=IX/!KTR
MO)8M,U>+X:Z?HLFC7PO++5XY' C#!T6[,K,N"<@+@Y[YP,T >@67BO1[YM15
M9Y(&TY0]RMU \!1""0^' )4@'!]JELO$6G7^JR:6C317R0B?R+B!XF:(G&]0
MP&1G@^AZXKA_$NA:KK6N>*186LJ_:]*M4M998RL<LL4K2%"3TR"!SQS6YX7:
M+4;]+X^#Y]'N883'+/>1H'R<92,@DLN<DG@<#UX .DU?4X-%T:]U2YSY%I \
M[@=2%!.![\5@>&HM5U_P_::UJ6J75O<WT2W$4%J56.W1QE% *G<=I&2V><\
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M[C49_#WV53 NIQD36TN[_5*S ,R!?7('&">: .WHHHH **** "BBB@ HHHH
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M+2!ASV0>IK"@T72_[ ;7+?3K2SL]:U6U@:.WA6-!8B<*JD* ,2<,WJ'QT H
M]8$L9C\P.OEXSNSQCZTX,"H8$%2,@BO*-5M(UUJ[T+3;:U%K)K=J8;65<6GF
M?9VDD1U'8A0VT#[Y!QUJ-;VYM/#5[X>^R7L<0O;Q+Z73;626&%!A_)BV E5;
MS%'.-H#]#B@#UL$,H92"#R".] ()(!!(X/M7/>";A+OP%H7EF6)CIT*C?&4<
M;4"E@&'3/(.,'@]#5/P39#3M2\56JSSS[-40F6XDWNY-K 22?J3P, =  .*
M.NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-UO0K+7[6*"\\Y3#*)H98)
MFBDBD (#*RD$'!(_&DTS0X--?S?M%Y=S[2HFNYVE8*<9 SP,X&< 9P,]!6G1
M0 4444 %%%% !1110 4444 %%%% !1110!%+;Q3F,RH'\M@Z@] PZ''J.WI4
MM%% !1110 4444 %%%% !1110!EZ_H-MXCTW[!>2SI!YB2$0L%)9&#+R0>C
M'\*TT4JBJ6+$#!8XR??BEHH **** ,G1_#MEHDMS-;O=337#%FDNKAYF49)V
MJ6)VJ"3P*UJ** "BBB@ HHHH **** "BBB@ HHHH HZQI4.M:9)8SS74,<A4
MF2UF:*08((PR\CI4UC96^G645I:H4AB&%!8L3W))/)).22>23DU8HH ****
M"BBB@ HHHH **** "LF_T"WU#6].U:6>X2XT_?Y"HRA1O&UL@CG(X]NV*UJ*
M "BBB@"&\M4O;*>TD:1$FC:-FB<HP!&,AAR#[BJNCZ/:Z'8"TM#,ZYW/+/*T
MLDC8 W,S$DG  ^@ Z"M"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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@H **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex971clawbackpolicy002.jpg
<TEXT>
begin 644 ex971clawbackpolicy002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>(_%"W?A[1M7\.:MNMKC5K6W=XE4B1'E571@PRI_(UT6I^(]*T?S/MUT8UB
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M#W[&@"U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHK(U[P_!X@2R2>[NH!9W4=W'Y!09D0Y7.Y3QGM0!PGBZP>\?QGXAA@EAL_\
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M#>JQS7T]D'-Q;RM<7/ES*QW(<L%5 <$XSR!VSZI3)9HH IEE2,,P12[ 98\
M#W- "HXDC5U! 89&Y2I_$'D5R&N)+:?$71-6DM;F2QCL;FW>:"!Y=DC-&5!"
M D9"GG&*[&B@#SZS\&R:EX9\3P2HUDVK:E+?V08;7MV 3RY"/X6+('(Z\X/.
M:V_!#WVH:*FNZK$L6H:DB.Z*<A$5<* ?0_,__;0UHZWH4>NI;QRW^H6L<3EF
M2SN#$)@1@H^.2OTP?>M"%K=#]EA:,&%%'E(1E%Z+QV'!Q]* ):*** "BBB@
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M>(=3L+B&!"B/:1.LDYQ@-)N.!QSA1UYSQBL6#P3K</@[0M":[L)&TF^MYTD
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MENH;)K2U@CD9D&Y@S,SE0>=JC ' !ZYXPK7P3JMMX6\*:0)[)I-#O8[EY-[
M2J@8  ;>"=_OC'?/ !L0>+&O==O--LH+:22RNTM[B%[C;.J';F4)MY7YO7D
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MIHCW%UY21Y,BI$=P)7@DN?4>@'6@#TBLNQUZTU#7-3TB*.=;G3A$9C(FU2)
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M6&J7%O)9>))F6! OER@S1JP?().0Q'!&* /864,I5@"I&""."*KVFG6-AO\
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M>(+ VK2PV-Y%-<1Q3&!7C:!68 L 2V\#/^SCK0 ^/PM8P06D=O->Q26K,Z7
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M=@"L32 ,<\<#K0!/6'+X0T.;3;_3GL4-KJ%T;NY3_GI*6#;C^*BMLD*I9B
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MA\>+H\QM$TQM*>_$Y8A@1(B<DG;MPQ/Y5OR7EK#;"YEN84MR 1*S@+@].>E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKR.V%];^'WMT,%C?3+*T$V3N$9#,0FW'!/7I0!V=%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !17'2^+YF\77&A)/96MU#<0K%:W<;*]W P0O)$^X*2,N H!.4YZ\07WC
M'5I([VZT33C>I97K6IM!:REYPC[)"LH(12#NP"#]WKS@ '<45QL6O>)=0\6Z
MOI%C;Z5'!ITEJ6EN#(6:*12S8 _B '';C'.<A-,\4ZK>:?J5O.EG'K=IJ7V
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MF\U"KC;D!>/N]0,#(-=110!QT/@O4;#6+^33?$4MKI&H3M<W-A]G5F$C??\
M+ESE Q]CCG&*TM*\/76F:[KNJ?;XI#JKQR"/[,0(F2,1KSO^8849Z<^E;]%
M'$0> ;F#POHFBKK$1&E7Z7JS&S/[PK(7"D>9QR3DYZ5H/X5NFUG7]174H0=6
MM([78;4GR@@8!L[_ )OOGT[5T]% ''VO@NYM1X4 U6)AX>C,:_Z(?WX,7E<_
M/\OR_7G\JK7/P\ENK74U;66BNKG51JUK<P6^UK6<*%'!8AUVK@@XSDUW-% '
M.6^B:\ECFX\1";4O,1C/]C"P[%S\GE!N^3D[L].F!B?P[X;A\/OJ4L1B#ZA<
M_:9(X(O+B1MJK\JY.,[<DYY)/TK<HH YF3PK<KKVM:E:ZHL4>K6Z1RP/;;]K
MHA0,&W#C!Z>H'.,@U+;P1<VUIX5MQJL3+X?(*'[(<S 1F/GY^/E)]>?RKL:*
M ."B^'E]#::?:#Q$3#IVJ'4;;-FI<[BY978M\S?O#AN/<'MOZ'X>FT35=7N$
MU#S;34;IKL6YA ,<C*H;Y\\CY!@8&,GK6]10!SOB+PW<:^E[:RWEL=.N[40-
M;7%IYOEN"W[Q#O&&PP[=5!JN?"%Q;:_;:EIFK&V5-/CTZ=)8!*TD:,2K*V1M
M?YCR0P]JZJB@#S^T^&]YIFF:"--\0FWU71X7MTNS:!DFA<Y*/'NY&0"#NXK8
MO/"EY>3:)/)K&^?3;LWDDDMON,[E63& P"* Q  ST'7G/444 86B:!-I.LZW
MJ$EZDXU2=9S&L!3RRJ! ,[CGA1V'-"^'YU\;R>(OMT91[%;+[-Y!SM#EPV_=
MURQ[=*W:* ..TWP7J&D:A<16/B*6/09[AK@Z<;=2Z%FW,B2YRJ$D\8SR<$'F
MBW\%WVGZQJ$FG:_);:1J-PUU<V/V<,XD;[_ERYR@;OP<<XP>:[&B@#E_^$3N
M;/5-8NM)U-+6#5\/<PR6_F;)=NTR1G<,$C&001D ^U/U+P787G@ZV\.6TDEI
M#9B$VD\9S)"T9!5P?[W'7W-=+10!S?B+PFNL6&G1Z=>OI5[I<BR6-S$@?RL+
MM*E3]Y2IP1FJE_X1U35-,M(;W7UEO8;Z&\><V>$)B8,B+&'&T9'))).3STQU
M]% '&^.+C3M4LV\)O+*=:O(TEM5AB?,;!QMF#8PH1EW'G.![UU=E9PZ?8V]G
M;KMA@C6) 3G"@8%3T4 8>J>&+;5/$6E:S)(Z2V =2B])E)5E5O9716'N*K:9
MX)TW3M)UG3&+S6FJ2S,\;<>7')D^6OHH+.1[L:Z6B@#E++PA<);:-9:GJ:WU
MGH\JRVH%OLD=D4K&9&W$-M![ 9(!]JSM0^'MY>6&N:9#KP@T[4[W[<(_L8:2
M.0NKL"V[YERN0, C/4@8/>44 <U/X4>[\37&JW=['-!<:7_9LUMY!7<A8L6W
M;N"2Q[=/SK(A\ ZK'IVC:;)XD22ST:]CN;/=8_O=D88*CMOPV V,A1T[UWE%
M &1XFT)/$OAV[TB2X> 7 7$JJ&*E6# X/7E1Q5&X\)C6)WG\07$5XYLI;)$@
MA,*(DH D8 LQW, !G/ 'U)Z6B@#E_#?AK6-&\B'4/$LNI6=HNRUB-LL3 8VC
MS'!.\@'';U.3C%OQ-H$VOIIJQ7J6OV&_BO?FA,F\QG(7[PP/6MVB@#E'\(W3
M7/BB;^TXA_;T2QD?93^XVQ^7G[_S?+].?RIJ>$;B&3PM,VJP[?#T3(,VI'G
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MH*XNR^'E]9V^C6__  D1>+2+U[FW/V-=S*P<,'.X[G^<_-P/537>T4 <1<^
M;FZ\.^(M(;6(@NMWCW;RBS.8MVW*@>9S]P<_6K+^$+^'7M0U/3M9BMAJL*)J
M$#VGF*[JNT21_.-C8XP=P^M==10!S>A^'-1T+2-!TR#6@UOIJ^7< VJ_Z2@7
M"CJ2F#@Y&<XKI*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHYW,=O*Z
MQF0JA(1>K<=!]: *=MKFE7EY]DMM1MI;@AF$:2 E@IPQ'K@\''2M"O'M#OHY
M]9\ W,4%S!#$+J%[.*SD$5DS18$62NXMD8))(XSA0:]4TS5;75XIY+0R%8)W
MMW\R)D.]#@XW 9'N.* +M5=2^W'3Y1IIA6\.!&TRED4DCD@$$@#)QD9Q5JB@
M#AH]6\3R>.[GPV-2TP+#IJ7HG_L]R2S.R;=OG=.,]:6'Q5>Z5XL>Q\2ZA86U
MI'HT-W*P C19V<HP#,QR,J<#WJ*UGC/QNOW#?(=%B@#_ ,)D$S$H#TW $''6
MI&>U'QBNIKCR_+304C\QP-H;SG9ER>^T@D>E '6R:MI\5C%?/>P"UF ,4OF
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M-K%V"+<K,IC9B< !LX)SQ]:YCPIK.B>(/[',&E3+J>GVQAE$UJ\9L?D 9"S
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M]"\77%QX8\.SWUMNU36(D\B%' $I\OS&<G^%0,D]3TZDBM?1?$,6K7VHZ=)
M]KJ.G.JW$#,&&&&4=6'WE89P>#P00* -FBN(^)6([7P[<^7)(\6O6958_O-\
M_0#.#G ZU8A\?VT,VJ6VM:=<Z3=Z?"MP89G1_-B=MJLC*=IRV%QG@GK0!J^*
MM /B;09M)-U]FCF=&>01[S\CAQCD=U'X5L('$:B1E9\?,5& 3[#)Q7.:1XQM
M=4\13:&T:)=K;"ZC>&=9HWCW;2-R]&!QE3ZY!-7/%/B"/PMX=NM8EM)KJ*W
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M@[G8*2%^F2,C(!O'ZUC:%H4VD^;->ZK<ZI>R (;FX5%(0$E5 0  98G/4_@
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M3GY%8 #S 1]WWSDCFJ5[X@74X]9T&]LFMKM-+-YM67>#&P8#)&"&!'(Q]":
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MRQS*6C<[]P20X!'!(.,]JVM-TS7IO'O_  D%_96=K;/I2V;1)=&1U<2,^?N
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M(]N\8X^:,=,\&O0J* ..N(/&VK^&M0AF-AI&I-:M%;_9IVD#2'&7+;04'!
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M]L[JUT^UO+AX/+MDN2Z($D5V9I-F23MP !QZG/'<(6:-2Z[6(Y7.<'ZTI(!
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M%#*0P(XR#ZUFVFN^)WM_!-XVKPN->B6.>)K1=L;& R"1<8.[*GC..>@KK?\
MA%XI6GFN]0O+F\EM#9BZD$8>.(\L% 0*"3@DD'H/2J\?@JTBMM @74+_ &:$
M0;3F/)PA0;_DY^4D=OSH Y;4O%'B+2_#7BX+J,4][HM]%%#=26Z@R1R"-L%1
MA<C>1G';I5W4O$6O>$?$OEZM>1:GIUWIUU>1+';B)H)(%#LH()RI!P,Y.>_K
M%X[\,?9/"'B>6Q;4KV\UB6&1X$B\P[E9!E0B9&%7OZ5UD'A^UN+H:A?3W&H2
MM:M;)]J15V1/C>-H5>6P,Y&>,<4 8NFW?BR[O-)NXR6TZ\MRUV;A8 D3,@9'
MA"-N(SQAB>,<YK#TCQ/XEDT'PCKEWJ<4JZGJ"V5Q:K;*JE7:0!MW4,"HZ8&.
MH/4]1H7@:VT JEOJ^K36L(86EK<3J\=KD$?(-N3@$@;BP ID/@&Q@T32-)CU
M'41;Z5=K=VY+1;MX)(W'9R,L?SH H0>*+H>,?['U.[GTRZ:]<6UO/ OV>]MQ
MG;Y4FW._&TD%NN1CTKR>)M8MM6T<M?)=1W>LR6$Z01*;9(SYFP)(5#&0!!NP
M2 =P..!71MX3MY9X6N;Z[N8(+XZA%!+L*QREF88(4-M!8D#/MTXK-B^'&G0V
M]I;)JFK+;V5\;ZTB$R8@8EB5'R9*G>W4DCL10!CZ-<:M9Z/X_P!1CU>>6YL]
M0NO*^T1HZ@QPQE3@ 'H N,XQVS6G8>([[5;_ ,.Z,+IK>>\T4:G=7*(N]C\B
MA4# J,LQ)X/ P.M:G_"&6:KKJ1WU_'#K)=KB)73:C.H5V3*GDA1USCMBD/@R
MS6/1F@O+R&\TB+R+:\4IYABVA2C@KM92 .W49&#0!RESXO\ $444E@MS;K>V
M/B*WTR6X:W!%Q#*5*L1D!6VMAL?ABND\-ZCJG_"6^(-$U&]%ZEDEM/!,85C8
M"4/E2%X(!3@]>><U+<^";"ZM(H#=WB.NH+J4DZ%-\TZD%6;*D8& ,  8 %7[
M+P]#9>(K_6TN[I[B^CCCEC<IL CSMP H(QN;OWH UZ\:TS4/$'A[X<MXBL-0
MA-G8ZA<M+IS6P/GQF[<-^\SD-R2,8''0U[+7,VW@BQMK9K'[7>2Z6;DW7V"0
MH8]Y?S,$[=Q7?\V"Q]\CB@#"\5>)M8TA=5O+:^1_L5W;)':P1!XUB=HPPG9E
MR'.]L!6R!M.,$FK&N^*+K2_%$EA?WD^DVTKPC3[IH%>UGSC>DC[24?.X#D#&
M#];FH?#O3M075XFU+4X;;5)UN9K>*5 BS J=ZY4G/R+P21[=,7;WPA;ZC%>6
MUUJ%]-97C1M<6LA1E8H%'!*[AG8N<'KG&* ,.XUOQ+K":M-X>23S[#4'M887
M\GR)/+(#B0L?,!/S8*XP-O7G+[S5K_Q%!XMAMKPV4.EQ-;*B(C^;)Y.]BY8'
MY?F"@+@\$YY&-"?P'8OKMUJ=OJ6IV:7K![VSMIPL%RP&,L,9!(X)4C-27?@B
MTFU:_P!0M-0O]/.HPB*]AMF3RYP%VAB&4E6QQE2#0!-X#_Y)[X;_ .P9;?\
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MLO+3R_+2-22NT%,Y!8]2>M '$6.KZIXDU#X<W\NHSVS7]K<RS10*FPR)%C<
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M<G@=2<]: /5J*\]TV*WU[Q=XFTSQ"@N/LUM:_9!<KM*P-%EI$'\+%]V6'((
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M+"!2"0(RX7(SCDCH2*V_#-M86'Q4\5V]DD,*-9V+>5%@ -^]SA1T['CUSWH
M[VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ.M:
MK!H>B7VJW.3!9P/,X'4A1G ]STH BF\.:'<7S7TVCZ?)=M@M.]LA<XZ9.,FK
M5[IUCJ42Q7]G;W4:L'5)XPX5AT(!'!]ZYWPY#J^N:!::QJ.JW-M=7T2W"06H
M01VZN,JH!4[B 1DMGG.,5?M=1ETC3[.UUJY-SJDAD $$19I@K'YPBYP,%?89
M ZT 7YM&TNXM8K6;3;.2WA.8H7@4HA_V01@?A2'1=*-Q)<'3+/SY4V22>0NY
MU]"<9(]JSI/&F@1:7!J3WV+6:Y%H',3Y68MMV.,90@\'=C%0GQWH6Z\C\R]-
MQ9X,MM]@F\[:02'";-Q7@_,!CWH J:OX.6ZUWP[+9:=I2:5IDDSS6S#8&,B;
M?E0(5X///_UZZ*31M+FTXZ=+IMF]B3DVSP*8R<Y^Z1CKS6;/XV\/V\6FRO?D
MIJ41ELS'#(_G*%W<84\X_AZY(&,U)IWB_1-5TJ74;6\)@AF^SRJ\3K(DN0-A
MC(W;B2 !C)SQ0!;?P_HLB2H^D6#+,$$H:V0APHPH;CG X&>E,N]'MTCDNM-T
M_34U2. I:S30#"''R@E1N"Y[#M5&?QQH-K9:C=7-S+ NFE1>1R6T@DAW#*DK
MMS@]CT]ZGMO%NBW5_=6273I-;0&Y?SH7C5H0<&168 .@/\0R* )-"T^^MDGO
M-6DMI=3NBIG-LI$:!1A43=SM')Y[L>G2M>L=?$^E^5<2RRRV\4%M]JD>X@>-
M1%_>RP&>G3KZBH3XPTKR[TC[49K2U%X]N;9UD:(YPRJ0,@D$>W?% &Q=6EM?
M6[V]W;Q7$#C#1RH'5OJ#P:K#1-)62WD&EV0>V&V!A;IF(>BG'R_A7.1^*;'5
M_#WAO4;J\O\ 2WU"XMC&D4+@2RN 1$24(*'=UX!QP:V]1\3:7I;W*W$LI^R*
M'N6B@>00*1D%RH.WCGZ<].: )UT+1TMKFV72K%8+K_CXB%N@6;_?&,-^--3P
M]HD<9C31[!4,0@VBV0#RP20F,?=R2<=.:JW?B_1+*\M[22Z>2>YMS<P)!!)+
MYT8QRFU3NZC@9-7M'UBQU[3(M1TZ8RVTA8 E"I!4E6!4@$$$$$&@!T.DZ;;6
MTUM!I]K'!,-LL20J%<8QAAC!&..>U3VUK;V5M';6L$4$$8VI%$@55'H .!4M
M% !6<?#^BF*>(Z18>7.V^9/LR8D;U88Y/UKD_&7BI1;Z4=)OKN/?K-M:M+#"
M?*F'FA9$\PK@]QP1T(YP172ZAXHTK3&N1<S2;;0 W4D<#R+;@C(WE00O!!]@
M03@<T 6ET;2UN(;A=-LQ/"NR*00+NC7T4XR!]*CA\.Z);",0:-I\7ER-*FRU
M1=KD8+# X)'!-)>Z_IUD$W2O,SPF=4MHVF8Q#J^%!^7GKW[9J&S\5Z+J%S9V
M]I>&9[VV:[MML3[98AC)#8QD9&1G//2@"8^'-#-L;8Z-IWD&3S#%]E3:7_O8
MQC/O3[C0M(O+JWNKG2K&:XM@!!+);HS18Z;21D?A6>WC;P^EC!>M>LMO/>&Q
M1VMY%_?!MI0Y7Y<'/)P.#4)\>Z"JWN9+WSK(CS[?[!/YR*1D.8]F[9CG=C'O
M0!TU!&1@]*RW\0Z:+2UN897N4NX?/MUMHFE:2/ .X*HSCYAR?4#J15'_ (3G
MPZ8=-E6_+QZEO^R%()&\PH"67A>&&TC:><\8S0!HV_A_1;0Q&VTC3X3#(TL1
MCMD78Y&"PP."1U(K1KD=3^(&F6OA6ZUNSCN;D07 M'B-O(CQ3%@NV12 5P6'
M7KD8Y(KJH)EN($F02!6&0)(V1OQ5@"/QH BO=/LM2M_L]_9V]U#G/ESQAUSZ
MX(Q3+O2=.U"P%C>6%K<68QB":%7C&.GRD8XJY64WB'3UN_L^^9CYXMC(D#M&
M)?[I8# /Z9XZ\4 33:'I%Q9064VEV4MK;D-# ]NC)&1T*J1@8]J1]!T>5'1]
M*L61YOM#J;="&EZ;SQ][D_-UJE)XRT.+2;W5)+N1;.QN#:W+FVES%(" 05VY
M_B'.,<]:GU3Q)IFC^?\ :Y9#]GA\^X\F%Y/)CY^=]H.T<'KUP?0T 6GTG3I-
M/.GR6%JUD>MNT*F/KG[N,=>:8VB:2]A]@?3+)K/=N^SM ICW>NW&,^]<G<^)
M?L?Q%A8ZA<W&DW&AFZAM[>(RAW\U &144LQ*Y/?C/05U^E:I9:WI=OJ6GS":
MTN%W1R $9'3H>0<@C!H :-&TL7(N1IMG]H$?E"7R%W!,8VYQG&.U-M=!T:Q:
M!K32;"W-N6,)BMD3R]WWMN!QG SCK6A6!JWC/0]$OY+&]N)ENHX/M)BCMI)"
M8\@;AM4YY/;I@YZ4 :-OHNE6EX]W;:;9PW+DEIHX%5R3U)(&>:?#I>GVUS/<
MP6%K%/<?ZZ5(55I/]X@9/XUGWWBS1]-8FZN)$A6589)_)<Q1.V-JNX&%/(ZG
MC(SC-%SXMT:TNI();EQY5REI+*L3M'%,^-J,X& 3N7Z9&<9H NZ=HVEZ.)1I
MFFV=D)6W2"V@6/>?4[0,U>K+N/$.GVMT]N[S,T<T<$C1P.ZQR2;=BLP& 3O4
M^P89QD5%J'BG2=,:Y^TSR;+3'VJ2.%W2WR 1O900O!!/H""<#F@"_?:98:I$
MD6H6-M=QHX=4N(ED"L.A (.#[U$^B:3);W%N^EV30W,GFSQM;H5E?^\PQACP
M.35*\\7Z-8ZBNGR7$LEVUM]JCB@MY)3)'D#*;5.[J.!GN>@HA\7:-<Z?IUY;
M7+3IJ)86B1Q,9)2H)8;<9&W:<YQC% &F=-L3>17ALK<W4*>7%/Y2[T3^ZK8R
M!["H(-"TBUO;B\M]*LHKJY!$\T=NBO*#UW,!D_C7)^)_%,3V'AC6-+U66/3Y
M]8CM[C:NT.F)-ZL"NX$,F,<>F#5V^\66.M>%/$4FB7\\%]IUK(SJT#130.$+
M*2DBY ..N* -W_A'=#^S+;?V-I_V=7\Q8OLJ;0W]X#&,^]5-<\.V]YI.J)I]
MA81ZE>6DEL+AT"'#*5Y<*6P,]*BTC7HH/"VB2WDD]Q>7&GQ3%(HFEE?Y%+-A
M03U(Y]2!U-:VEZI9:UID&HZ=<+<6DZ[HY%R,\X/!Y!!!!!Y!% &?X8\/P:)H
M]C$]C8Q7\-LD$LML@^<@ $[MH)!(SS6I;6%G923R6MI! ]P_F3-%&%,C?WF(
M')]S5BL;5/%.DZ/+<17<\FZU@%Q<^5"\GD1$D!WV@X'!_ $]!0!LU7N+"SN[
MBWGN;2"::W8M!))&&:(GJ5)&0?I6))XOM4\7V^A)!<2"6Q:\\^.!W4C>BKM*
M@Y'S$D]!P,YJ/0O&MEK&F7=_)%<6L4%V]NHE@<%BK[ !Q\S$C[HR1D#&: -H
MZ-I9U Z@=-M#>D@FX\A?,R. =V,\5=KG)_'.@6MG?W-S=2P#3W2.[CDMY!)"
M7^YE=N<-V;H?6G'QMH8O;BR\VZ-W#&)1 +*8O,A.-T2[<R#(/*Y'?IS0!O2Q
M1S1-%*BR1N,,CC((]"*@MM,T^SLFLK6QMH+5LAH(HE5#GKE0,<UD-XX\.IIF
MGZBVH8M=0<QVTGDO\SC.5/'RD;6X.#P:SM0^)&C0>&-7U>Q^T7,NF_)+:M;R
M1R(Y^[O5@"JG^\>,9[\4 =+I^CZ7I5L]MIVG6EG!(27BMX%C5B>I( P:-.T?
M3-'CDCTS3K2R21MSK;0K&&/J0H&361=Z_P#;-;TS1+$RQ27<,EU.[QM&\4"$
M+PK $%G8 $CIN([&K\OB'3H+IK8O,Q2=+9W2%W1)7V[59@, _,O7@9&: +%G
MHVEZ=*\MCIUI;2/G<\,"H3DY.2!Z\U9,$1G6<Q(9E4H)-HW!202,^F0/R%8E
MGJTEMXNG\/74ADWVHO;.1NI3=M=#ZE3M(/<-SR"3OT 4;K1-*OKZ"^N],L[B
M[@_U,\L"M)'W^5B,C\*>FEZ?'?O?QV-JMXXPUPL*B1AZ%L9-9_B[Q$GA7PS>
M:N\$L_D)\D<:$Y8\#..BYZG^N*GFU^QA\A3]H::=&DCMUMI/-*J<,Q3&X $C
MD@=1ZB@#4J&ZM+:^MGMKNWBN('^_%*@=6YSR#P>:ATO5;+6M/COM/N%GMY,@
M, 000<$$'D$$$$'D5<H I+H^F)9362Z=:"UGSYL(A79)QCYEQ@\ #FDM-%TK
M3WC>STVSMWCB\E&A@5"J9)VC X&23CW-4-8\7Z+H5Z+*_N)EN3 UPL4=M)(6
M1<;BNU3G&>@YQST%+>^+]&T^%I[BXE6W39YTPMY"D&\ KYC 83AE//0$$X!H
M N6F@Z/8"Y%GI-C;BZ_U_E6Z)YO^]@?-^--'A[1!##"-'T\10/OB06R;8V]5
M&.#[BH=3\4:3I G:ZG<K;QB:X:*%Y!"AZ,Y4' X)^@)Z4^Z\1:;:LJB62X=H
M!<[+6%IF\H]'P@/!YQZX.,XH U:CGMX;J!X+B&.:%QAHY%#*P]P>M9"^+M#>
M72HX[TR_VL";)XX7=)< DC<!@$ '()!&*M2:[I\37:R2NIM)$BES"_WV *JO
M'SL=R\+D\CUH @'A/PV%"CP_I04=!]CCQ_*KJZ5IR7SWRV%JMXXVO<"%1(P]
M"V,D5D3^.-!M;'4;NYNI8%TUE6\CDMY!)"6&5)7;G!['H?6M+2M:LM9%RUD\
MK"WE\IR\+Q@G .5W ;@0001D&@":RTRPTT2"QL;:U$C;G$$2IO/J<#DU'::+
MI>GR/)9:;9VSR AVA@5"V3DYP.YYJ]37=8T9W8*B@EF)P /6@#._X1W0_LS6
M_P#8VG^0S^8T7V5-I;^\1C&?>GW&A:1=WEO>7&E64UU; "":2W1GB Z;6(R/
MPJI8^+='U&X@@MYY2US;M=6Y>!U$\0QED)'S=1P.<$'I52V\?^'+LV?DWDS1
MWEP;:*4VLHC\W<5",Q7"L2#@$@GCU% &S>Z/IFI2QRWVG6EU)&"$:>%7*@]0
M"1Q2W^DZ;JL,<.H:?:W<4;!T2XA6158=" 1P:YKQUXEBL/"VOK8WEU%?65J[
M&:VA+B&39N16;:0">/< @\9!KI=(D>;1;&61BTCV\;,QZDE1DT 1OH.CR1O&
M^E6+))+Y[JUNA#2<_.>.6Y//7FEDT/29;>*WETNR>"%M\4;6Z%4;KD#& ?>K
M]<O?_$+PUILEY'<WDV^R<)=!+25_)R <MA>%P1\W3GK0!:CT[6+O7_/U.2P_
MLRTE,MA%;H_F$E2H,A)QP&; 'J#QBMZN<O\ QUX>TZ<0S7DCR-:B\006\DN^
M$D .NU3N'.>,\9/:K%WXMT:Q$SSW+B&!UCGG$+M%"QQ@.X&%^\,YZ9&<4 ;=
M5;/3;'3ED6QLK:U$C;G$$2IN/J<#DU637].DU]M#6:3^T%@^T^687 ,><;@^
M-I&>.#UK-U#7M*N7TD_VI?6GFZEY$(C@=!<2KN4Q-N3[N0?3.W@\4 ;%KH^E
MV-U)=6FFV=O<2_ZR6*!4=_J0,FIC9VIB:(VT)C:3S638,%]V[<1Z[N<^O-<Q
MXV\20V'AK7DL[RYBOK.S=S+;0E_(<H2@8[2%SQ[@'/ YJ[9^(;:S\/Z;)>27
M$]R]A'<2+#"\S[=HRY"@G&<_7G&: -:\TS3]1:%KZQMKIH'WQ&>%7,;>JY'!
M]Q4#>'M$=55M'T]E64S*#;(0)#R7''WCZ]:LZ??VFJZ?!?V,Z3VLZ"2*5#PR
MGO5F@"EJ&C:7JWE?VEIMI>>2VZ+[1 LFP^HR#BFMH6D-I\FGMI=D;*5BTEN;
M=/+<DY)*XP3GFL=?$Z:AXCUKP]#'>6\ME;Q,+E8&^^XD)()4J  @P6X))QG%
M97@/QI:WOASPY:ZE>SRZI?VV1-)"^R60 LR^9C86P"<9SQ0!U_\ 8^E_V5_9
M?]G6G]G;=OV3R%\K&<XV8QC/M26.BZ5IC;K#3+.T;8(\P0*AVCH.!T]JI1^+
M=&EO8;9+ESY]R]I%+Y3^5),N=R!\;<C:W?G! Y%1:#XIAUW5M8L8[:YB_L^Y
M^S[I('4/A%8G)&!RW )S@9Q0!T%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %9GB'1X_$'AS4=(E<QK>6[P[P,[21@'\#S6G10!QWA
M75K_ $O0;+1M:TC4(]1LH5MMT%NTL-P$&U7611M ( /S%<&H[^#5+'Q[IGB.
M:SEELI-.EL+B.W4RM;,9!(K;5R6!VA3M!Y'I78R7$,4L44DT:22DB-&8 N0,
MD =^ 34E 'E>H>']133[^[CL;ECJ/B:WU%+9(R6CA1X]SL!T)"%L=>0.N170
MP1SQ_$C6=0:SNOL<NE00I*(&(=T>1F4<=<,*[.B@#Q_2$N-%C^%]O?V5U'<6
MHNXIH?)8NA\EN=HY(YSQFK>K^&M6GFUOQ%8:<\HEU:TO(].?]V]S%#'L?@_=
M9MS$ \_*.,G%=_J&@6^I:SINJ2W%PD^G%V@6,J%!==K9!4YR./Y5K4 >8:_9
M?VUX$\0R:5X2O+"ZO;9(%6> +<W# YP0"<*H[L>Y_'2UF">X\:K?+I-U=V?_
M  C]S;LAA95DD9D81'(X+!2/:N]HH \MAT[7])T_6+;08KS4]*_LMC:6>LP$
MO!.6 \E2X!D3;G@Y&549YJ6UT_4;KQ;=74>EZN(+WP\;47%]M!\[>QPPW83J
M/E  ]!CFO3:* /+_ ++J4G@/P19MH]_'<:;?6'VF-H<LJP@"1\#/RCMW/85I
MV4%]H6K^++:[TZZO+?59S>6<L,1D$NZ)4,3$?<(*@ M@8/6N]J."XANHA+;S
M1S1DD!XV# D'!Y'H010!YSH'A^_T#6_!UM<0SS)INCSVUS<1QLR)(YC(4''(
M^5A^ JQX=U.X\*^'KA[W1M2<3ZW<DB.#F**65F65LX^7!'3GG&*]"J*:WBN-
MGG('",'4'IN'0X[X/(]#S0!+4<\;2V\L:.4=T*JX_A)'6I** /((K;6X_ 6B
M>')?#VHG4=)U*U\XQQ@Q21QS!O,1R0&!49]0>N.M;MG:ZAH[>+]-N],N[I=5
MN9;RRDBB+K*)8POE,PX0J5QEB!CO7H51S7$-L@>>:.)"0H:1@HR> .>] 'F>
ME:;K/@+5M-DETV\UBRDT6WT^9[%1(\$T18_=)'R'>>?;FM2_AO['Q9X:UC^Q
M+C[,EG=6TEO9(KFW9VC9 P!P.%()' /?'-=Y10!Y+#IFKKX>LX)M&OHY8_%O
MVYE\O=^X^T,Y?C/ !_'MFNBC@N8_&WBN\:RN_LUSIUO%!((&(D=!+N X_P!M
M?K7:RRQPQM)*ZQHHR68X _&B.6.90T<B.I&05.01ZT >1Z9IVJ:%:>%M0O/#
MU]J%K%HZZ=>6L$>9[:56#!PA(W \@X] :W9=->+6?!LUGH$EA:6]Y<W$T$,.
M?(62%U4OMR-Q9@2!G&?;->A44 >4ZGI&J77ASQQ#!IEVTMSK,-Y;1F(J9HD:
M DKG&3^[?CKQ[UZC:S&XMHYFADA+C/ER@!E^H!.#2SW$-K"TUQ-'#$OWGD8*
MH^I-24 %><RZ7?P>*AJ&A)J5G-/J8&H6,T9>SN8=V&G5B-J/M ;(()(QCN?0
MWECC.'D13Z,P%"31R'"2(Q]%8&@#R;6M.UA?#7C?0H=$OY[F^U)[NWDCC!BD
MC<QD8;/)^4@CJ/IDC<\_5-"\::S<3^'M0U'3M<C@>$VR(YA=(]C12@L H.,Y
MSCDUZ!10!Q45O=P_$JTOIK"6.VCT$VTCPPLT22^:K[%('/ ./RZ\59^&]I=6
M'@FUL[VVFMKB*:X+1RH5(#3.Z_\ CK"NHCN(99)(XYHW>(@2*K E">Q':I*
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MU2RME62SB:46\L(8&/:H+!3N)!QCUQ7<44 >:KX.U*U^&@C@BV:U9WLFKV4
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M':NNHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP74#.89%4)OBP0#D <-QD?A5BY\-ZI%XM76--O;<1S:>EC<"Z1G<!&9E=2"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ J.:"*XB:*>))8V^\CJ&!^H-244
M 1P6\-K$(K>&.&,=$C4*!^ J2BB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHIL@<QL(V57P=I9<@'W&1G\Z '45RG
M@OQ8FN>'M-EU.\L8]6NQ*WV:-PA8+(ZY5"2V,+[UU= !114<PE,+B!T27'RL
MZEE!]P",_G0!)17E\/Q$URW^'5CXWOK;3YK*60+<6D".DD:&4QY1BS!CG!Q@
M?6O2+N_L]/M_/O;N"UASCS)Y BY^IH L456DU"RBLUO)+RW2U8 K.TJA"#T(
M;..:!J-B;$7PO+<V9&X7'FKY9'3.[.* +-%4O[8TS["+W^T;/[(6VB?SU\LG
MTW9QFI?MUIO@3[5!OG&85\P9D'7*^OX4 6**J1:KIT]Y):0W]K)<Q F2%)E+
MH!P25!R*@;Q#HBXW:QIXRI<9N4Y4-M)Z]-P(^O% &E15<W]F# #=P9N/]2/,
M'[WO\OK^%+=WMK80^=>7,-O%G;OFD"+GTR: )Z*JKJ5@]W]D2]MFN=N[R1*I
M?&,YQG.,4UM6TU+/[8VH6@M=VWSC,H3/INSC- %RBJO]IZ>(K>7[=;>7<D"!
M_-7$I/0*<_-^%5]0U)5L-1^P75J][:0LY1COV$ D;U!!&<>HH TJ*PO#NNB]
M\%:1K6J3V]N]U:0S2NS!$#.H/&3QR?6JO@_Q!<Z]-KPGFM)HK+43;6\MJN%>
M/RT8'[QR?F/.: .GHJM)J%E%>)9R7ENEU(,I"TH#L/9<Y-4M5U$?8)Q8:KIU
MO<PRHCR7+!DC.X95@&&"1D#GK0!K455O-3L-."F^O;:U#_=,\JIGZ9-8NOZW
M?:=X@\-6MLUNUIJ5T\$VY"7P(G<%6S@?=]#0!TE%5&U73EOA8M?VHNR<"W,R
M^83C/W<YZ<U2T[Q/I&JZQ?:79WL,MS9,$E59 3NQD@#OCC/H>.U &Q152TU3
M3[^66*SO[6YDB_UB0S*Y3Z@'BL?QQK-_X?\ #;:EIY@\Q+B"-EFC+ K)*L9Q
M@C!^;/?ITH Z.BJUKJ-C?231VEY;W#P-LF6*57,;>C '@^QIMOJFGW=Q);VU
M_:S3QC+Q1S*S+SCD Y'- %NBJ']MZ3YL,7]J67F3.8XD^T)F1QP549Y(]!4U
MKJ5C?23QVE[;W$D#;)EAE5S&WHP!X/UH LT54M]4T^\N9;:VO[6>XBYDBBF5
MF3G'(!R.:M,RHA=V"JHR23@ 4 +156SU*QU!'>RO;>Y6,X=H95<*>N#@\4R#
M6-,NEF:WU&TF$(S*8YU;RQZM@\?C0!=HJH-3T]EMV%];$7)Q 1,O[T_[//S?
MA3)=;TF!MLVIV4;>;Y.'N$!\SKLY/WN1QUYH O45CR>*-(B\2+H#WL OS"9F
MC,@&T9 "GG[QSD#T'TJ9O$.B+C=K&GC*EQFY3E0VTGKTW CZ\4 :5%5S?V8,
M -W!FX_U(\P?O?\ =]?PK.\6:E=Z/X2U;4[$P_:;.UDN$$R%E.U2V" 0>WK0
M!LT5EPZW9P:18W6IWUK:O<0))F:58P25!.,GWJTVI6*7*6[WMLL[KO2(RJ&9
M?4#.2.#S0!:HJDNL:6]L]RFI6;6Z-M:43J54^A.< U:EFB@A:::1(XD&YG=@
M% ]230 ^BJ0UG2R("-2LSY_^I_?K^\YQ\O///I6'XN\23Z39V\FEW%G)*-1M
MK6ZC<;V199%7LPVG![@T =315:TU&QU#S?L5Y;W/DOLD\F57V-Z'!X/M3+?5
M],O#-]FU&TG\@9E\J=6\O_>P>/QH N452AUC3+CS/(U&TE\N,3/LG5MJ$9#'
M!X4COTJ2RU"RU&)I;&\M[J-6*L\$JN 1V)!ZT 6:*R-7\3Z3H=_I]E?WL,,]
M\[)$KR!< *S%CGHORXSZD"LK2_%1&O\ B&RUJ]L+>&PNX;>V<GRM^^)9 #N8
MY;YL<>G2@#K**J7FJ:?IVW[=?6MKO^[Y\RIN^F3[BJ5UXHTBSU^TT6:]@6]N
M8VE5#(!A00!GGJ2>!WP?2@#8HJEJ\]Q:Z->W-J8Q/# \B>:I9<@$\@$'''K6
M;H/B&*Y\&Z-K&KW5K:R7MG#,[.XC3>R!B!D_7B@#?HJH=5TX&W!O[4&Y ,&9
ME_>Y_N\_-^%(FKZ;(D[IJ%HRV_\ KF692(_][GC\: +E%,6:)H1,LB&(KO#A
MAM*]<Y]*I_VYI'D)/_:ECY+L463[0FUF'8'/)]J +]%5GU"RCDEC>\MU>%/,
MD5I5!1/[Q&>![FDM]3L+NWDN+:^MIH(B1))'*K*F!DY(.!Q0!:HJM::A97X<
MV=Y;W(0@,890^WZX/%+=WUII\0EO;J"VC)P'FD" GTR: +%%5S?V8LA>F[@%
MH5#"<R#R]IZ'=TQ7/>&_$DVL>(_$=H]Q9SV6GO +>:VZ,KQ[CN.X@D'C(QTZ
M4 =3152UU73KY96M+^UN!%_K#%,K[/K@\4V'6=+N+J.U@U*SEN)$\Q(DG5G9
M/[P .2/>@"[16/I'BC2-<NK^WT^^@F>RF,,FV0'.%4EAS]T%MN>F0:O6>IZ?
MJ/F?8;ZVNO*($GD2J^P^AP>* +5%<G=>*BWCG0](T^]L+FSO$N3<"(AY(VC4
M%>0V #GICMUKJ)[B&U@>>XFCAA09>21@JJ/4D]* )**J0:II]U<S6UO?VLL\
M S+%',K-&/\ : .1^-4[S6K*:PN4T_6=-2[^SO)$\DRNB8)7>P# E0W!/MB@
M#7HJD=0MK/3H+C4+^TC5D7,Y<)&[8SE23T/)'/2I&U&R6"&=KRW$,[*L4AE7
M;(6^Z%.>2>V.M %FBH;2\M;^W6XL[F&X@8D"2%PZG!P>1QUK-TWQ/I&K:M?Z
M;97L,MQ9.(Y560$EL9( [XR 3V/':@#8HJI:ZII]]-)#:7UK<2Q\ND4RNR_4
M \57\07-[8Z#>WFGM;BXMX7F N$9D;:I.."",XZ\_2@#3HKE_"?BS_A+-#E=
M(UL=8MCY5Y:3*6-O+[C()4]0<\CZ&K^C:R9O"VGZMJ]Q:6YNK>.9F!\N-2ZA
MMN68^N.O- &S15)]7TR.TBNWU&T6VFXCF,ZA'^C9P:G^UVWVA+?[1#Y[KO6+
M>-S+Z@=2/>@":BJ=OJVFW<DT=MJ%I,\ S*L<RL8Q_M 'C\:;'K6E33Q01:G9
M/-,ADCC6=2SJ.K 9R1P>?:@"]17+>*O$_P!C\#:MKGA^]L+J2RB9@V?.CRO5
M3M8<_C^%;ECJMC?.]O!>VTUU"H,\,<JL\9/]Y0<C\: +M%5(M5TZXO)+.&_M
M9+J,$O"DRET .#E0<CFD@U;3;J=8+?4+2:9E9ECCF5F(4[6( .< \'T/% %R
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \1L-,TZ^^&6G:?
M90VX\51ZD#$$4"Y@D%T26?\ B4"/))/&,>U>PVFK6-]?WUC;7 DN;%D2YCVD
M>667<O)&#D<\5<P,DX&3WI<#\Z "F3316\+S3R)'$@RSNP  ]R:?10!X+X9L
M/LWPZ\+^)4634[32GE;4=*>1I%5?-?$R1DX$B?>QCD9^M=AKWB?3[?Q?I.L7
M&K/!X?NM/DA@O[<*\<<Y=6*N2K;=R@=<?=QZUZ52$!A@@$>] 'E"W&E>$-1\
M+7BFZ3PFHO$CN;@$I#-(5*2$8&U6'F!3@<,>@-6[^33M.OO"VIZ;;M#X6&J7
M$US*=WEF62,B.8ANB>8S8)PHX(XP:],(!&" 1Z&EP",'I0!Y[9Z';^(/$/C6
M)"LF@ZI;P1,T9!C>XV,'=#TR!LR1W'J*7PV^MZQX;N9+F)XM7TNSFTN%FXWW
M*Y5I0>X.V+!_WJ]!  & ,"B@#RKPI=^&]=C\/B:\O7U?2(2DEC+&L?V/]WME
M$N$'R<$?,>>.]6OAWX?T'6_AFMO+9VDCW"W=M-(J+YBHTS\;NHX"$?13Z5Z4
M  20!D]35+6+6_O-,E@TS4?[.NV*E+GR%FVX()^5N#D9'XT <GX'.IZA*L>L
MQ,)_#ZOIWF,.)Y<C,H^L8CP?^FCBNF\1Z+#XB\.:AI$^ EU"T8;^XW\+?4'!
M_"K&EZ>NF6"V_FO-(6:269P TCL2S,<<#))X' & .E7* /(8M2\0--H?C+[
M_P!K*?V%=6Q3F20Y'F$]E%P OL,GO6]=*OAKQ[X=%]($T9-+FM8;B4@(EV60
MEG/0,ZJ<$]22.]>@8'I2$!A@@$>AH \<O[=K+0M5U%?ET)/%=M>V[ ?(D(DC
M\V1?1-^XY''4]ZV8-7T^Z\:>,;F"ZC>"71;<QS _(X FR5;H1R.1Q7I9 (P1
MQZ4  =!0!X_I&JPZ99_#6]U&98]$CTUH7G8_NH+HQ(J^8>BG&]03TR:Z7X>7
M-G-JWC$6;QM&^LM,I0?*RM%'\P]02#SWKNB 1@@$>AI<8Z4 <=X_@DLK?3O%
M5K$TESH=QYTBH,L]LXVS*/\ @)W?\!K'\>6\=O\ #2:>_2-+VYO;:Y</C<KM
M/&2H/^R@"Y]$KTGK10!P4&H6UC\1_$*Z[-!':7UE;'3I;A@(I(55O-0$\9W-
MDCN"#TKF]*CFTO3OAU;:A(8F34[AH4G;#I 4F$0.>1\K(.>F0*]@(!QD XYY
MI: /%]9UC3Y=QA=+'[)XMADN+3#-(I$P#3R,<[58<J!@8.,GI6C?RW#W'Q+L
M-.\S^U+E8IK>!5(DDC^S("5&.^&7/KQUKU? HH X#PO>^&O$6O66KZ7J%[>7
M]O:- Z,BQBVC."8Y J*,[@,#GH2. 35KXKR0KX!N4F= 'NK0 ,<;L7$9/Z G
MZ"NT  S@ 9Y-+0!Y3K\;?\)?XEM/#;0QWD_A91 EL0I>0228VX_BVD8^HJQ)
M-8ZY%X#DT)XOM5G<)Y\:8W6UJ(6$R2#^$9"K@]\5Z=2  $D  GK0!X?.FDCX
M5ZRZ"T$J^(F,;+MW!?MH(P>N-F2,=LUT&MH!XWURT\/M!%>3^$V6W2V*KNE#
MOLQC^+!&/;':O4:* /-O"5[X;\0ZEH=Y9WM]/JNG6[Q&U,:Q_8U*;724*B\
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MU<OHUAIFH>!O /\ 9"6QUV*\M92\&/.15_UQ<CG;L!!SQ]T=Q7LMW \UE-#
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MR B7;W!:3<!ZA$->CT=* /-M#OO"?B.^M=5MKZYNKFTLI(9HID6-+6(CYDF
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;2W6Y:.W@!W(Q(RI9@/X3UQ[9-31>+M,N;/1KBT\ZX;6$+V<,:@.ZA=S$[B
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MG3":TN%W1OC'L00>A!!!'8BN8M+'6=(\::GK2Z7)=6FLV\!EAAFC\RVEB!4
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MF^OKFPOX2K,4EA1R3&VX<$H.H/!H ] JEJ6K:?H\"3:C=Q6T;R+$A<_>9C@
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MM,?#*P!!&2/7C<* .RHKS^S\>75S?^$',MG]@UN BX(MW#PS[<JN=^%#,KJ
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MIM:TT36"RZ7=PLUQ*L0C^ROM#+@ER74\CIG.#TXH ZN21(HVDD=4C0%F9C@
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MUWJ3WFG:3*LMG$\0#Y0$1B1\_,$SQ@+T&<XKJJ1W6-&=V"JHR6)P * .-N/
M;7.@^(-)?52(M;NVNIG%O\T9;;D+\W3Y%ZY[_A+=>#+PZ_+K.F>(;K3+B[C1
M-02&!'2X*# 8!\[&QQGGM756\\5U;17$#AXI4#HP_B4C(/Y5)0!SC>%/LNNK
MK&D7IM+EK5;2=98_.2=$^X6&X'>O/S9[\@U6N/ T"Z=I,&FW\MG=:9=/=Q73
M1K(9)'#"0NO .[>W3&.,>E:7B#Q -!?2U:SDG6_OHK(.K@",N< G/)[]!^5:
M\TT5M!)/,ZQQ1J7=V. J@9)- '+V7@ZYTZ;4;BUUZY^T7MZEXS20H5#!0I!
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MXF(P1@@AE(X*GJ*VZ* ,NTT_42\;:GJ277EG*I!;^2K'U8;F)(^H'MTQB0>
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M]64Y&>3@]O0TX?#U4T:?3UUFZ+'51JD$S1(3#+YGF=,#=R3G/Z5VE% '._\
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M50221EB=N >#M7:H]E%=+6!K?B@:+K.E:8=.N+F;4W=+=HG0#<B[B&W$8XH
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ML[2Y9R9?*Z@;CDDJ6*[CSQ[4WQ;ISZ7#XUT6"[O;G2/[!%_Y=Q<R2_9YRSJ
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M]IMY>Q^5=3VL4LR8QM=D!88^I-<?I5C;I\3/&LP,@=;:S<?OGP2T<N<C.#[
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M:=-AU!;V&2TGQY,L;;Q*3T"XR6)]!S7)K=RV7Q&;6;J"Z_LG4=+2&WG:W?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0W+Q-,I?RFWJI)V[AT)'0XZC/0\]:FHH **** "BBB@ HHHH **** "BBB@
MK&E\/K+XM@\0_;)EFAM6M%@"KL*,P8YXSG*CG-;-% !1110 4444 %%%% !1
M110 4444 %%%% !1110!C+X?5?%[^(OMDQF:T%F8-J[/+#%QVSG)/.:V:**
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METUQRLJ2#&\H?F+>PSGBM&Q\/6GBS3_'^D7 0F769/*D(!,4@ABVN/H1_,4
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M5="SC;G8$P>,CZXKO_!MC9Z;X5L[/3[ZXO;*+<L%Q.P)=-QQ@@ %>RGT [4
M;U,CECE3?'(CK_>4Y%<Y\0+NQL_!5_)J*2O:MY<;K%+Y>=TBJ S8.U<D;C@_
M+G@UP<TME)=_$>U>YTZ5)=%BF6.U $9=8ILE1DY(PN6]ATH ]?66-VVJZLV
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M\N4));QWBS $;F&W;@2;3QP2!7>^";#3]-T VVDW\M]8"XD:&5BI0 G)6,J
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M;8^7#']BM]D#;XE\I<1MZJ,<'Z5C2>)T;QJWAE;:Z5A9?:&N%B)&6?:N#@C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %9^NVLM]X?U*T@4--/:RQ1J3C+,A Y^IK0HH \\
MM-)O=8TCP7ISZ?<VDFB2V\]Y)<1[0C0Q%-BG^/<Q'*Y& <G. :?AG2[FQCA\
M.:KX-%U=6ER3%JKQ1O;O&'++*6)W!P#]T#.<<CDCT^J=WJ^FV%Q%;WFH6MO-
M,0L<<LRJSD]  3SG% 'FVHZ3JEQX-\?V4>F79N=3U"26SC\HCS49(U##TY1N
MN/UJ[>VUUI_B^_O;KPK<:YIFKP0F,PQ(TEO(B;&C=9",*1@YS@<UZ#=WEK80
M&>\N8;>$'!DF<(H_$\4MO=VUW&)+:XBF0@$-&X88/0Y% '&7]A<P>)O!;P:2
MT5KIZW'VA;.+,5L'AVJHQU&>.![X%5;C2-1O+SXCQQV,Z_VK:+%9.Z[5F86Q
MC(!/3YN.<>O2O0Z* /-KK2Y-5TK1#<6&N:1J%G8!+?4+1<RPR *#&Z*3N5B
M<$8^7G&:[70/[4'AK3_[62)=4%LGVA4P%$F.1QQU]./2KMS>VMEY7VJYA@\Z
M588O,<+O=NBC/4GL*GH \HL+77YM1\(ZC?:!J*W5E=SB^4%%BBW1.H\I V @
M)'S 9(QRQK0L/#^IZCX \6:/]GEL[R^OKV6W\]=H=9)"R'Z'H>X[BO1Z* .+
M\+L=1O;>YN/!)T>^MHV6>YN(HQAB,%864EF!/)/ P.^:L^+K2[;6?#&IP6DU
MS;Z??/)<B!=SJC0N@8+U;EAD#)]JZ>>>&VB,L\L<48(!>1@HR3@<GU) IEU>
MVMC$);NYAMXR=H::0("?3)H \S\3>']1OK'Q7J=MIUPTNKRV"6UJ$_>.D#J6
MD8?PY&[ /.%&<$XKH]?M;Z+QAX?\26UM/<V5O#/;74,:$R1+(%(D"=3@J 0.
M<=C77EU"%RP"@9+$\8I(Y(YHDEB=7C=0RNIR&!Z$'N* /-KW3-;M+C7-=L-.
MF=-4U6T=K=8U,\=M$BJ\J*W D)!(!Y P>#TR[SP]K\I\1R6.CWBD:I8ZI;1W
M,ZL;I8ECW1EBQ);*D\\< 9KUR.6.4,8Y%<*Q4E3G!'4?6@RQB58C(HD8%E0G
MD@=2!^(_.@#B+.:^OOB/!K?]B:E;V']BO;L\\:JROYJO@KNST!' /Y<U5T'P
MS/?_  @70=2BET^]C65E:4;3!*)6DC<'V.TY'N*]!EECAC+RR*B# +,<#G@5
MDZYHFF:W-91:C-,#&[&.&.Z:(39'S*RJ1O7'4'/&>Q- %7P4M[/X?BU;541-
M2U-5N9U3H@V@(H]!M ./4FL7Q7!K-[K6I62Z5=SV,^E&.UEM&5 \QWY69]P;
M R,+T.6X)Z=G=:A8Z<(A>7EM;"0[8Q-*J;CZ#)YJ?S8_.$/F+YI7=LSSCIG'
MI0!Y_<:-JLWPX\.7-II\L6O:'';S06TI 9RB!)(R03@.NX?E6CKEKJNF:3HD
M%I:2WBB\WZE):JIF&X,7>/<?ER[<D<A2<8ZCLJ* /(KG1=9_X0CQ?IB:)?B>
M\U@7-JC,LAD0O$WWMQR0$;))Z]R:ZG4(;]_B-::E:6,TD*Z+/ LCQD)YS.CH
MK=QPISZ5VE07=Y:V$!GO+F&WA!P9)I B@_4\4 >9Z19ZW+KO@W4;K0]226UC
MN(;\R&-8XG>-0-B!L+&"#C &1CJ:5- U*\^'VH^#I=-N(KRZOIOWSH/)2)[@
MR"4/T.%/"CYLX&!UKTRWN[:[C$EM<13(0"&C<,,'IR*FH \YU3P_J.KZSXYM
M8H)H4U32X+:UN9%(1W19 P)],NHSWYQFM#PLSZA>6DUWX)_LF_M$83W4\46%
M8C!$#*2Q!/4X P._%=M4%S>VMGY/VJYA@\Z588O,<+O<]%&>I/84 <UXQM+U
M]4\,:A:6,]XECJ)DGC@V[PK1.@.&(&,L,\UEV5GJ>BS>+;"YTRYNX]6N)+RS
MDB7>LADC"F)ST3:5QEL#!ZUZ!10!B^&M%ET7P;INBS3[YK:S2!Y%/\07!(]L
M]*XWPAI]Q:6FFZ%JO@H?;]*= -3>*-K<K']V5&SN\PJ. !D$\XYKTRHYYX;:
M(RSRQQ1@@%Y&"C). ,GU) _&@#RRXTG59/AOKFG+I5X;RYUM[F&'RN6B-VLH
M;T^X">OM6YJ<%R_CR^U$6EP+%O#KVPG:,A?,WE]ISR/E_#MUKN)9HK>/S)I4
MC3(&YV &3P.345] EU8SP2RM%'(A5W4@$*1SR>G% 'F>AV,WB3P)X!LH;2>,
MV,MG>S3RQE41(ESE6Z,6X  SPQSC%%UX>UJ_T3Q7%:V<R73Z^FJ6D<PV+=1I
MY)"Y/ R8VZ^V:]#T+3K32=#L[&PE:6RAB5;=F</^[Q\N&'48[U>CECF!,<BN
M%8J2IS@CJ/K0!R7V.?7_ !OHFN):7-G;Z;:7"R_:8S&[O+L CP>H7:Q)Z9(P
M3SBIX?T.YL?&FHV 9&T.RF.H6B \QS3@AH_8+^\;'_35?2NRO([>\@ET^:4K
M]HB=2J2%'VD8)4CD8SU'3BH-&T:ST*P%G9B4IG<\DTK222-@#+,Q))P /H .
M@H X'3-+N;&XOO#^J>#1J9DOII[74GBC>W>.20R!I2QR&4MT ).!BBVTRYL=
M2UC1=2\&C5TO;^:ZL[YHXWMV25R^)BQRNPD]B2!P.F?3JIWVKZ;IAC%_J%K:
MF0@)Y\RIN.<<9/K0!PVHZ/?IXFDU/08M0L-2:^B6Y@*EK*^A!4-(V<JK!,\C
M#97@'(-=!X^T:^UWP==V>F;3>!XIXHV;"R&.17V$^^W'UQ72U7MK^SO))X[6
MZ@G>!MDRQR!C&W7#8Z'V- '*RVT^O^+_  _K@LKNS@TJ"Y:<7$11R\J*HC Z
MMC!)(R.!@G-2_#ZWNK/1KV"]L[BUE;4KJ=5F3&4DE9E.>G0].HKK:* .1N;:
M^M/BBFJ#3[B:QFT@6IGB (C=9F<[AG/W3Q@'/2N5@TG54^'^C6#:5>"[M_$"
MW<D7E<K$+MI=WI]PCW[5Z;>:II^GLBWM_:VS/]P33*A;Z9/-6(Y8Y@3'(C@<
M$J<XXS_(@_C0!YLFGW.GZWK>FZCX.;6K?4;Q[JSO!'&T6V3!*3;SE I]CQT'
MKVGB*"1_!^IVL$)DF>QDACBA3[S%"H '89(^E;%5_M]G]O%A]J@^V%#(+?S!
MYFP$ MMZXR1S[T <%J>E:K)X!\*2VVE-=76C-;RW.FS *TJK"T4BC/&X;B1V
M..*CUNUMK_P3K%Q#X4GTQ[MK98H@D4-W-*L@VL0"0=IP54G)P1P"*])K.UG1
M+'7K);6^20HDBRQO%*T;QR+T964@@B@#D=%U&.;Q)=:AJ.EZW;ZI=68M8FN;
M$11LD>Y]B;7?YB2S<GG''2LO3?#SR>!/"VFZK8:O97EE X%[8[A/8S# 'W<[
ME8$C@$<#/J._TS0;;3)/-%Q>W<X!59;RY>9E!ZA<G ]\#GO6I0!YQ;V7B6._
M\%:EJEE+>W-JM[#=O J*P\S B=UR ,JH+8Z$FKV@6^J6EMXU:+3G%U=7\]U8
MI<IM2<&%%3/L60@@X.*[FB@#S'1K;5AXI\-ZM<:+JJK'IL]O>23[/W<A\L\1
MAL*GRL % SV!JM::3JL7@#PS8OI5X+NTUU+J>+RLE(A<O(6]#\K#ISVKU>B@
M#A]*.I:#JWC&=M$O;E)KK[=;&'9B=?)C78N3G=E3QC^F>LTG4$U;2;34$BDB
M6YB641R##+D9P<<9^E698DFB:*0;D8889ZCTI418T5$4*BC"JHP /04 >51:
M!KZ^#K:TCTN<7FBZ^=1\IF0+>1BXD?;&<\_*X/..0!756MA-JGQ B\1K;SVU
MK;Z8UI^_C,;RN\@;&T\X4+U/4MQG%=;10!R/CBWNKJY\-?9;.XN!:ZQ#=3F)
M,B.)5<%C^+#@<US?C6RU[68/%FGKHU[*LUO'_9S6Q5(I1L&XR'<&9]V0%8'
M P.IKU*B@#BX(KV3XE6FJ2:==PVG]AM;L[ID)*95<(<$\[0>F1GC.:L?#ZTN
M['0KN"\M)K:5M1NI@DJX)1Y6=3^1%=910!P-[HFI7/BGQA:K:S);ZYI<,%O?
M*5\N)ECE0[N<YRZ\ &JZ:9J6N>'O">CW&FW%G>:3>6LUV\BXCC$ Y*/T;?@
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M-R4V[LC) P,$UW=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCEC>"ZMC(/GVY^7<I21=N.?4CZ@&3>:]/XA^$LWB>&);74+.*6[BVDD)+ S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$G\Y=C$G  ;.#S0!;HJK::E8:@\Z65[;7+0-LF6&57,;>C8/!]C6'X_U^_\
M"_@^\UK3UMI);783'<(S*X9U7J&&/O9[T =-15"35+2P01ZEJ5E%.D1EDW.(
MAL! +89B0N2!G/>IAJ-B; 7XO+<V14.+CS5\LJ>AW9QB@"S17*^'?$TNK>(_
M$MK)=64UAIS0?9Y[?A=KH6;<VX@D'C/'3I6W%KFDSVL]U%JEE);P'$TJ7"%(
MS_M'.!^- %^BJ']NZ1YEQ'_:MCOMD\R=?M"9B7^\PS\H]S3UU;37M(+M-0M&
MMIV"0S"92DC$X 5LX))XXH N45035;&]L[N33]2LI#!N1Y5E61(G _CP>,=Q
MD5S^K^+4T/1-$%SJ>G37VHRP0?:48"+#?>F W?<P#CG&2.: .OHKG-"N-9;5
MIH=2UG1[N#RC);Q6B%9G0L"LC?,1C!QP,=#GG%;$&JZ=<W<EI;W]K+<Q@EX8
MYE9U .#E0<CGB@"W15*+6=+GGD@AU*SDFB4M)&DZED ."2 > #UK%3Q98:YX
M<OKW0]9T^!X6>-;FZ8-'&5<KN8;A\IVG!R,\&@#IZ*JWFI6.FQ+)?WMM;(W1
MYI5C!]<9-+)J%E"L#2WENBS_ .I+2J!)QGY>>>.>* +-%5K'4++4[?[187EO
M=P[BOF02K(N1U&0<9HO=1L=-C62^O+>U1B0&GE5 <#/4F@"S155]2L(U@9[V
MV5;@9A+2J!(,9RO//'/':BUU.POK,WEG>VUQ:C.9X95=!CK\P..* +5%<I8^
M*'O_ (AR:/:WEC=::-,^U!K<[F63S N&8,0>#GH.M6O'&MWOAOP?J&LV"V[S
M6<?F>7.C,KC(&.&&.M '0T5FPZK;VUG;G4[^RBN7@\YP7$0V@9) 9B<#US4X
MU73FT]+\7]J;)\;+@3+Y;9..&S@\T 6Z*IQ:OILWD>5J-I)]H)$.V93YI!(.
MWGG!!Z>E(VKZ8L,TS:C:"*%MDKF==L;>C'/!]C0!=HJ@=<TA8'G;5+$1)*87
MD-PFU9!R4)SPP].M2G4]/$-O,;ZV\JY($#^:NV4GIM.?F_"@"U156SU.PU&W
M>XL;ZVNH$8JTD$JNJD=02#@$4EGJFGZ@)#97UK<B+ D,,ROL[\X/% %NBJEE
MJFGZD9!8W]K=&(@2""97V$],X/%8?CO7M1\-: FHZ>+5G^TPPLEQ&S B1PF1
MAATSGWH Z>BN2C\2ZE8>.K/PSJD=K<"^M7N+>ZM4:/:4^\KHS-@>A#>V*Z&?
M5=.MKR.SGU"UBNI2!'#),JNY/3"DY- %RBLR.[==;O4EU*Q-K%!&WV<<2PG+
M99SN^Z1C' Z&I(]=TB:=((M5L7F>+SDC6X0LT>,[P,Y*X[]* +]%<GXL\5-9
M>"[K7/#U]87?D2QH7!$R'=(J, 58 ,-V>_TK>BUK2I_M/DZG9R?93BXV3J?)
M/H^#\OXT 7J*JC4[!FMPM];$W(S !*O[T?[//S?A4:ZUI37"VZZG9F=G:-8A
M.NXLH!90,YR 02.P- %ZBJEIJFGWY<6=_:W)C +B&97V@]"<'CH:9!K6E723
MO;ZG93+;C,S1SJPC_P![!X_&@"]15!-=TB68PQZK8O*(1.46X0L(B,A\9^[@
M@YZ5+;:G87MB;ZUOK:>T ),\4JM'QU^8''% %JBJ$>MZ3-9S7D6J63VL)Q+,
MMPA2,^C-G _&C^V])+72C4[,M:+ON5$ZDPKZN,_*/K0!?HK+T#Q!IWB72TU#
M3;A)87)QA@2!DXR.V0,X/K5V^:Y2PN7LT22Z6)C"CG"L^#M!]LXH GHKB)M:
M\40^,[+PZUWHY:YL9+LSBQEPA1E7;CSN<[NN1TZ4]?$FKZ?XJT_3M<FTVWM9
M-/N;FXD12BJT<BJ&W,Q 4JP.#TSUH [2BJHU*Q-@M^+VW-DRAA<"5?+(/0[L
MXQ3[2]M=0MEN;*YAN8&SMEAD#J<>A'% $]%<YK7B.:W\06'AW2XHI-4O(VG9
MYLF.V@7@R,!@MD_*%!&3W%6!)K]KJEA#,;.[LYW99YHH6B>'",R\%F!!( SD
M8X&#G( -NBJB:KITE\;%+^U:\&<VZS*9!CK\N<\5%-KVCVQ(GU:QB(E\@A[A
M%_>8!V<G[V"..O- &A152+5-/GO)[.*_M9+JW&Z:!)E+QCU9<Y'XU''KFD37
M,-M%JMB]Q.I:*);A"T@!()49R0"#T]#0!?HJF^K:;%?+8R:A:)=L0JP-,HD)
M(R %SGIS3+G7-(LC*+O5;&#RF59/-N$786SM!R>"<''K@T 7Z*JG4K$7JV1O
M;873#<L!E7>1ZA<YQ4D%W;7+RI!<12M"VR01N&*-Z''0^U $U%9TT\PU^U@6
M_LTA:"1GM''[Z0Y7#+S]T<YX[BIH-5TZZNFM;>_M9KA02T4<RLX .#D YX/%
M %NBHKBZM[2,27,\4*%@H:1PH)/ &3W-5[?6-,NTN'MM1LYEMCMG,<ZL(CZ-
M@_+^- %VBJ4.LZ7<B4P:E9RB&-99"DZML1AE6.#P".0>A%9^L:ZB^%=6U/1+
MVRN9K*WEE#!A,@9%+;6VL/3U[T ;M%8WA_7K75=.L5>]M7U.2SBN)[>.1=Z;
MD!)*9R!DUB>(/$&JZ1X;N]2M=1TR\>/5(X!Y<18)$\J($.'_ -8H?D_I0!VE
M%48-6T^^CN?L6I6<S6^5E,<RN(F_V\'CZ'%8_P#PEEAH]AHL>LZQ837FH$1K
M- P2*0@$LXR3A1CKGJ0.] '3453FU?3;:YBMI]0M(KB;'E1/,JL^>FT$Y.?:
MJ?B/6H='TFZD%_96]XL#R0)=.,.P' V[@3SQP>] &Q165X8U"?5_"FD:E<[?
MM%W90SR;!@;F0,<#TR:P=3\5R77B2]\/Z/JFF6MY:VBS+)=$.LDQ9AY1 8$8
M"'=C)&X>G(!V=%9]CK-A>*D:ZC837/DB61+>=7 7."PYSMW9&:DM=6TV^65K
M34+2X6'F0Q3*X3OS@\?C0!<HJA%KND37$5O%JMC)--&98XUN$+.@ZL!G)'!Y
MJ6QU*QU2!IM/O;:[B5BA>WE610PZC()Y]J +5%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7B&_\)74
M\F@>()+)YI8-XMKE/FD0DCY,CYFR#POS5#X:N$\,^%M TS6;F1+J=OLML)06
M=C\S1HQ ."$ !SQD5U=% !1110!YO,EGJ/QNO()+N1 =!2+,%RT3;_.8E<J0
M<X(..O>IM<L+3PGJ_@S[-;):>&K.XN%N,9*0RO'B*1R?]HN-QZ%N3752Z)=R
M3.Z^(M5C#,2$0087V&8B<?4TS^P;O_H9=8_*W_\ C5 ' ZU&!IOQ-O[21#I%
M[9(L#(W[N6Y\EA(4[$G* D=2,=0:T[J>S;QG\.YDE@+M:W(WAAD@P*%&?<Y
M]ZZO^P;O_H9=8_*W_P#C5']@WG_0RZQ^5O\ _&J .(\'ZGH]YI-AX>URW>7Q
M-IVHM-):LCB07 D8^?D=5PV[<3C''/ J[J&G7>F>,KS1;.!CI?BD>=(R<"WD
M3 N"?3S(L8/]ZNJ_L&[SG_A)=7_*W_\ C59UCX0U..[>[U#Q?JEW<#>D#I!!
M'Y<3$$KC8<GY5R>,X' H ZL!40  *JC  X %>7^%M+TGQ)KGCBTO)I)H)M5)
M:"*Z=%FC\M1R%8;ER"#Z]*[;^P;S_H9=8_*W_P#C5']@WG_0RZQ^5O\ _&J
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MSN!H%EKM_P#;"O*0;GE%NS =$!;()X&0?2O4?[!O/^AEUC\K?_XU1_8-V?\
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M'4PW4]HWP1\2Z?*5-W;7ET'B=?F1VNF*CG^(@Y'?%>G_ -@WG_0RZQ^5O_\
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MNMV/-*H P; [#->LR,4C9E1G(&0JXR?;D@5PG@_3]<\/>&)]-O-!-Q*]S<3
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MU+>M '34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ8[P0_7"\BI-+\0^)M2DT/48--$NF:BJO<)L5/LT;KN1U??\^,@'Y>>H Z4
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MT^33I;<0X66.0@OD[L@G:/PKI** .4\/^$+W0EB@?Q'>WUE:*5L;:XC3$/!
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MJWFRNI1LH>,;3M'H .3WKR?#S?INI6']MW+17VI+J+F2%"5D#*_& .K(,^W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@$'I7!>(]6O-1\;
M1^'+:SN[JQL[/[=?16KHC3EF*QQ%F90%X+$9^;@=,UTOAC5],UO08+W2(O(M
M263R#$(VB=20R,HZ$$&@#8HHHH **\I\02^'M,^+.HW6NVD3:>F@)-(3:&95
M<SL"Y"J<'&!NX^M;'@VZO?"_P_N]0U]IQ:I<2S644LHDECMF8"&,MD@GGC)X
MR.1V .^HKD$\>6]OJ%[;ZG!%#!;6+7WVNUG-Q$44X92=J[7'4+SD=ZG;Q3?P
M:QHEC=:,D*ZP9!"_VK<T16-I,2+LP#@ <%AUYXY .HIN]#(8]R[P,E<\X]<5
MQ[^/"GAB?6FTSY;?4CI\T0N.01,(=RG;R-Q!P<<59_M6W3QSJELFBC^T8-,C
MF^U!U#3QEW"I[ ,&ZG\* .IHKA].^(,UWHEIK%SHIL["^CB^R2R7:'S)7;&P
MC&5 &6W>@/&>#,GQ MX8]7^WV91]/\K8UK+YT=UYAVHL;D+\VXA2"!@GKCF@
M#L"ZAPA8!B"0N>2!_P#KIU>?Q?:F^,]C)>:?;VLS:'/\\,WF>8/-BX)*J<CZ
M'J.:ZSQ+#%/X8U5)8U=?LDIPPR,[#0!J45XIHMG++H'P_F\,V=S#J^^W?4+F
M*W>.)[;;^]\Y\!7SQC))/:N^O/&Q@TK4=9MM--UI&G3O%<3+-B0B,XD=$VX9
M5.>K G:<=L@'5[U#A-PWD$A<\D>OZBA'21=R,K+DC*G(R.#7#QM;R_&""^M$
M207'AMY Z  RCSX]IS]/6I/#_B>PC\,V$FGZ.EG+?ZA/:VU@D@ ,JR2;V9@.
M!\CL3@XZ#/% ';45R&I^,-2TC1=3U"[\.R+_ &;.$F'GG8\1P?-C;9\RC/(P
M,8/7%;8U9GUF.QCBB>'[)]IFN!-Q&"<(,8YW8;!R/NGVR :E%<)\7/(G^%NM
MRJ8W>*-&1Q@E#YB\@]C699);WGQ(TO\ X1&!K.UTZ.1-<58C;QL&0&)#$0"S
MYR0V.G?M0!Z=3=Z[]FX;\9VYYQZUR6M>.H]-.HFTM8KP:;(([B,7(29VPK,(
MDVG>0&'4KDY Z52M9;=?BS>W\$#%9O#<-P52/#R?OI,<=2V !^ % '>45R>G
M^,9[K6K+2KG3$M;N^L&O88VN<O'C;^[F78#&WSC^]T/I6=X=\;7C^$K34M9C
MM%N+Z^FMK8+<$*S"67AB5&U56,\_,2!TR<4 =[3=Z[]FX;R,[<\X]:Y"#Q_#
M]GU 7-BR7=K=0VD4<$OF1W3S8$?ER$*#D\'CY<'-4M-%Q_PNB[:ZL;>UF;04
M),$OF"3]^>22JG/;D=A0!WU%<[X^BCE^'_B'S$5]FG7#KN&=K"-B"/0@]ZYS
MPG;:#?6'ANW70I(;Y+&*\^W?8C#EXQ'G]X5&[<6]3D9H ]"\Z+8[^8FU,ASN
M&%QUSZ4OF)O5-Z[F!(7/) ZG]17EOB.YT_5OA9XY,6C16+6]U<I,F5;S)UVY
ME.!]XY_3K752ZA:Q^-='L9-(62\?3II(+XLNY579N0#KSE>I% '545PD/Q$N
M9-/MM2DT!XM/?4CIT\INE+1-YIB#!0/F&[&>1C/&:T=5\9FR?7_LFG_:DT&%
M);PM-Y;'*>80@VG<0G/)')Q0!U5%<F?&ADGL[2WLH?M]U8?;HK>XNQ&9%)(5
M4(4AFXR1QC(_#J87:6".1D*,RABAZJ2.E #Z*I:II=IK-E]COHQ+;ET=XST?
M:P8 ^HR!QWKS[1/#&A7WQ%\;Z?/I%DUI%'8B&,0*!%OB;<4P/E)/.1CF@#TP
M.I<H&!8 $KGD ]/Y&G5YA;75QX:\9>-YM,TI;WR+2QFE4S+""%BD+$G!RYQZ
M<\Y(KII?&MK)%8"Q6W:>\L5OT2\N?(58VQM!;:QW$YX _A.2.,@'4T5E>&]<
M3Q'H-MJB6TUKYP(:"889&!*D>XR.#W&#7+W$Y\2?%6XT&\^?2=)L$N'M3]RX
MFD/!<?Q*J]%/&>?2@#O 01D$$&EK GT72-&O!K\:1V$5E;R^>(EV1M&0&+%1
MQD;!SC.,BJ?_  F;P#1;F_TPV^GZS(D5M.L^]T>0;HUD3: NX<<,V#P?6@#J
MZ*X.X^(MU!I&I:J?#[_8M,U![.\)NUW@*RJ71=OS<MG&1QW/;5@\57G_  D5
MQHUWHS03BQ:^MMMRKF5%8*5;@!&!9>,L.>M '3T5P-G\29YK/0M4NO#TUMHV
MK2) MY]I5C%(YPNY ,[2>-V1].F=&\\:R6%_;1W.EM#;7.J#3(FEFV3.Q.T2
MK&5YC+=PW0@XH ZVBN)U#QW?6LGB-;?P\TXT':]PS7:INC,?F$KP?FVGI^H[
MZ4'BLS>)]/TIK(1VVHV1O+2[:;_68"DIMV_> 8'KTY]J .DHK/T;49-5LGNG
MMUAC,TB1%9-_F(K%0_08#8R/8BL[5O$_V'7/[&M;>">_-I]K2&:Y\DS#)&V/
MY3N;Y3D<8R/7@ W]Z[]FX;\9VYYQZTZO.[B6ZM?BU/<:;I23WD_AZ-VB:40@
MMY[???!.< #H3T[=-JQ\9/JNBZ-J-AI;E=2CDD=IY-D5J$'S>9(%;'/ XYYZ
M4 =2SJ@!9@H) &3CD]!2;UWE-PW@9VYYQZUYKKFLVWBKPYX.UM+41.WB*V0!
MB',;+,R, PZ@E>O<8K8TJ&*+XO>(3'&J&33+1WVC&YM\HR??@4 =I40N8"Y0
M3QEU8*5WC(8]!]:RO%UW>6'A#5[NP"?:(;.:16:0ILPA.X$ Y(QD#OZBN*MK
M;2].L/!FJZCX9M)K^[>TLXKJ.?/EDIN61LJ,MD,>A(S][DT >FAU+E PW  E
M<\@?Y!IU>?V][9:!X_\ '&ISJ(K>'3[*>8HHRQQ-GZDX K9TWQ<UYXCCTB>S
MB7SK<SQ7%K<>?&"#RCG:-C<Y'4'GF@#IZ*HZQJ$FEZ5/>0V4][+'M"6\"Y9R
M6"C\.<D]@":YN;7XM>L_%>B75I;B;3K4>:(YA/$XDC<CDJ,$%""".,"@#KQ+
M&51A(A5_N'<,-WX]:?7E-E#$=.^$D_EKYH5$#XYV_8V.,^G%>JLRHI9B H&2
M3T H 1G5!EV"C(&2<<G@4!T+L@92RX+*#R,],UYEXLU=_$&D^&-4ATV+^SI=
M=LVMKEY?WNWS@ ^S;PK ?WB<$9'7&Z?$>GZ=K?C"Y?1S#/I5K!/<W"$,]TFR
M0J,#I@*<9/?MB@#LJ*YD^+A!I=QJ5S;0O9A(3:S65SYZ7+RN4"*2J_-NVCT^
M8>]1ZE?7E]8Z[I6JZ+Y4::>TJ3J_G02@JP*[BJX8$9QCI@YH ZE'5T#HP96&
M00<@BEKAO"FN"R\'^#-*MH5N-0O=)B>.-Y-BK&D2;F9L$@9*@8!R3]2)V^(-
MK!;W"7ENEI?VNH)I\\4\^(HW<;D<R;?N,O()4'/! H [*BN9O/%-WIPTLWFE
M*GV[4ET\%+G<!N!*R*=HW*0/8U6U+QPVFQ^*6;2FE;0$CD<).,3*Z%P<D#;@
M#GK0!U]%<F?&-S"84OM*CL9;Q_\ 0?M%ZH66,(&9W(!*8R%Q@G)';)%>'XA6
M[6,<ES:):7#ZDVF_O[C;;[PC.'$VWE&"X!V\D@8'6@#M**J:;<W-W9"6[M!:
MS;W4QB3>,*Q4,&P,A@ PX'!K-O/$$UGXLL]#:R3;>VTLMO<M/@.\>,QXVG!P
M0<YZ ^F* -VFJZ,S*K*2IPP!Z'KS7*Z-XSDUK1(+V#3XA<RZ@U@;7[5DHRL0
MQ+!,<*I?'=>^>*R-1\2MI^C>.K_2-&M[34=-D_?222?Z]O)5A(=H/(4C [XZ
MB@#T$NH95+ ,W0$\FG5YMJ,EZGCWPA>C3H)=2FTV]#+'-P^!%MW2%0<<D]#C
M)P#78>&-?_X2+27NWM#:7$-Q+:SP%P^R2-RK -@9''7 H V:*YOQ!XGN='UK
M2]*M=(>^GU)9O)(G6,!HTW8.0>O'/;WZ50OO'<EG;79&FPM>V$*27MF]Z%D5
MV0.8H\*?,8*1Z D@ ]< '9T5R:^-5O+R2UTRS2>>.UANS;SS^3.Z2#=\B;3N
MP.O(YXJ&]\::FFJ:YI^F^&9;Z;21$\F;M(Q(KJ6^7@\X' [\YQQD [*BN0A\
M?V.H66GS:8+=Y;VS^V*EY<>0J)G;@MM;YMP88 (^4\],R:9XV76K;3%L=.D7
M4;Z*68VMR_EB%8V"N68 \;BH& <YSQS@ ZNBN$OO%FO-=>&8X='6R>_OIK>X
M@NYBK9C20X4A#E#M#!L<C''.:[H[MF0!NQTSQGZT +17!Z)XTOET'4M3UJW@
MRFJR6-O%;3%B\GF^4D8!4<9Q\V?4D#I6[:^(Y!XG&@:G9):W<MN;FV>*8RQS
M*IPPR54AAD<8Z'.: -^FEU5E4L S?=!/)KG_ !UJ]]H/@G5M4TY(FN;:W9U,
MK$!>/O< Y(ZXXSZUSFM/=Q_$#P;>#3H9-2ELK]2D4W#86+;ND*@X&2>AQDX!
M[@'H;ND:[G95&0,L<<G@4ZN!OO%]KJ/A2.]U+P^)C%JZ6%Q:O,K+!.LX0,&Q
M\P#8(P/RK:G\5,==OM)L;6&XN;$Q>="]SY<K*X!WHFT[E ;DY'((^H!TE%!&
M1@]*\4-CIK'XAQ+IL\NHI?,NGM96KM+'(8E*!'0?)\YR>0.N>* /:Z:SJ@!9
M@H) &3CD]!7):+K6KPVFF:%<01WGB&+3([F_\V?RT0GY1E@K98L&Z#'RDYZ9
MPM?UJS\3Z;X6U&.V,-S;^)H+::*4 O;RJS*Z9'N!TZC% 'I0="Y0,I=0"5SR
M >G\C3JY+^W],L?%7B-[K35M)-.L(;BYO]P+30_O"!@<\;6[Y.:M1Z_K$ES!
M$?#S[+JU:X@D6XRJL,$1RG9B-B#Q@L,@^F: .CHKEM,\8/JOA[2]2M[!1<7U
MU]F^R//AHF!8.&.WJH1B1CMUZ5U#$A20I8@< =Z $1TD7<C*PR1E3GD<&G5Y
M_8^,;72_"-MJ-AX<,,-QJ[V3VL,JC9(TYC+YQ@DMDX_7O70:)XCN-1US5-'O
MM-^Q7=BD4H"SB59(Y-VTYP,'*D$?J: .@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=N="N[?Q@?$.
MF^1(\]H+2ZMYY#&&"L61U8*W(RP(QR"/3F/2-"U+P_86MM8/92&>_ENM3>8,
M,B1F=O* [@E0,]AZUTU% !1110!YU/-II^)%]JM]JNA&PETW^RY;:2[S)Q(6
M)92N.Y!7/XUF1V^GCPOJGA-_%>E-H[<Z9<_:\W%J 0Z(P(PP5@,'<#@8^GK%
M% 'F,FHOXC\.:AI'BCQ/X=B6>U>W5M.G+;W(XD;=C&,?='')YZ5F-XCD_P"$
MF\%'7-9T&1K2>X5Y;&X+!A]G=0[EL;<G''/)Z]J]AJK<Z9I]Y<PW-U8VT\\'
M,4LL2LT?^Z2,C\* /)KR 2:)J^B6WB/PV+2XU;^T;>:2[;>0;A9BC*!@8P>0
M3GC@=1O_ -J6(\:7^MC6]":&?2X[)$^W$-O5G;)^4X!+X[]*]$I&8(C,<X R
M< D_D.M 'E$4-B/AQI&AKXIT:WUC2'BFM;F.YWQ&2,_+N! .""01[]ZGU6\'
MBCPO<VFL^*/#]GJ&Z*6T%C.7BCDC<.&8M@G) &,<#UKT#0];L_$.EKJ-AYGV
M=I)(QYJ%&RCE#P>1RIZUHT >:6FK_:/&6G:]J>M>&X1;V$MI-%;7S2;BSHVY
M2RK_ '.AZ>IKHM9\3Z'>:+>VMIK>E&>>!XD\VZ"J"RD9) )[^E=310!Q/@_6
M]'T+PEIFDWVNZ0T]E L!>"[#*X48SR 1]*Y^-;&ST77?#EKXCT1M)U269HIY
M+O$MLDV?,79@A\98J=PZ\]*]6HH \Z@O-'L?&EGJ=IK6B_V=:Z0=-CC:]Q)]
M]6!^Z1CY0.O?/M6'%:6\'AC3HK?Q/H,.M:7J<VH6LGVHO#()'<M&_ (!60C(
M!Z5[#52?4$M]1M+(P7+M=!RLB1%HTV@'YVZ+G/&>M '+6GBS2'TV?_A)_$.@
M W*^4UO#=#R50@@KN?!8G)R<#C QQDY/@RX\,67A*2PU37+*]2YW1[;N5<_9
ME^2&-@?2, D'NS5UWBG4M$TW19+W6[9+JSMY4)7[/YVR3("G&"%.6')QC-;E
M 'E_B:R\)7'@G4] \,WOAW3FU#:)&\Y8D&&!R0H.3@8JQJ-YIQUO3O$6DZ_H
MEMJT:"WOH7O/W-W!_=+ 9W*>5;;Z@\5Z.[K&C.[!549+$X %9HUZR;Q*= 'G
M?;A:F[.8B$\O<%X8\$Y/;- ' QZE/I/B#4;C1?$WAHZ=JLHN9XKNX8O:S;0K
MM'MQO!V@X.W\*L7-Y9R>*[[4X/%&DQ1SZ*--BG^U@S)(&=A*5V@=7Z9[?A7I
M-% 'DVC-%9ZOX<OKC7O#,8TVUFMKE8+IF:4OLS)D@99BG.>F<Y:J\=K%;^&K
M6RM?%>@0W^DZE)?:;-YY99 SR$K*.P*RE2%STSFO8:* /+M8O!XCT!#?^*?#
M]KK%K=PWEFEO.7MXY(B2-Q;#-NR0>!CC .#FSIVKQ/XX7Q#J6M>'88VTP63P
M6]\9"&$A?()5<CGT_P :](HH X[Q1K^C:OX7U/3++7=)$][:R6X::["JN]2N
M> 2<9Z4_P[XBT33?#NFV%YK>D_:+2VC@+0W096VJ%R"0#SCIBNCU#4$TZ.%W
M@N9A+,D(%O$9"I8XW-CHH[GM5N@#R29+6?PAXLT@Z_H"SZU>SW$+B^)6-9,<
M-\F<C';KGM6O+JEC+XOT;63K6A"&RL9K:5/MWS%I-AROR]!L[XZUZ)10!Y#Y
M5O\ \(:=&_M[P]YYU?\ M#?]O.W;]H\[;]S.?X?U]JKZQKVGW_B76KBVU/PI
M):SK%;30WNIRVIE"+D[@@(D7+$!F'3(Z=?9JS[K0='O;Q;R[TFQN+I<;9I;=
M&<8Z88C- 'G6KZEI/B_25BU!O#@B:VV11RWVV2SN%9QYD3JF2I&PC[O ''-=
MQH9U';8*E]9W^D)IZ(;L,QGFN%(!;^[M(!/KFMVD#JS,H8$KPP!Z4 +7*Z)H
M.J6'CCQ#K5S]C^RZJ+<(L<K%X_*0KR"@!SG/7CWKJJ* ..D\-ZL=9\6WB_8C
M'K%I%;P S."A1'7+?)WWYXSTK.@\)>)M'_L*_P!&N-,.H66EQZ7>6]R\GD3Q
MIRKJP7<K Y/3OBN]N;B&TM9;FXD6*"%#))(QP%4#))]@*SM,\0VVIWTEFEO>
M0RK"EPIGA*K)&W1E;D?@<$=Q0!<T^.[BLHQ?S)-='+2-&NU 2<X4'G Z#//%
M<_J_AJ^3Q9#XHT*2W%_]G^R75M<EEBN8L[A\R@E6!Z'!XXKH[J\AL[>::4L5
MA0R.J*7;;ZA1R>AJ'2-5MM<T>TU2S+FVNHEEB+K@[3R,B@"A<Z=?Z]IEW8ZN
MD%K;7-O);O#:S&4L'4J2795Q@$X '7G/:L6V\*ZO=:5H.D:Q)9/;:/<0S"XA
MD8O<^2"(\H5 3G:6^9NF!UX[:B@#SRZ\%:Y<^#_$VC[M/6?5]1DNXG\]RL:N
MZM@_)G(VXXZY[5M7&C:F_C>'7W6T6UCTJ2R=!,Q?<SJ^1\@! V8ZCKGVJ\WB
MFP&I16B1W4B27+6@N8XBT2S*.4)'(/!&<8R",Y!K8FABN(7BFC22-QAD=00P
M]"#0!YCX+T6^\0_#3PG9W2VL>GP&&Z=TE9I)1&VY4V[0%RP&3N/ /KQ:N?!7
MB6?>#<:5+)'KD>IQW4K2>;-&LFY8W^7Y=HX&,C@=.M=;;7^CZ5K4'AFSM1:S
M20/<QQ0V_EQ;%(!(( &<L.E;5 '#S^%=9F/C7FP_XG\*QP'SG'ED0"'+#9[;
MN,^GO53Q#8176@Z'H*:I;6WBBPEMA;_990\D9QL=MIPVPQ^83D=!WQ7H=4KF
M'3[*2?5WM(_M"18DGC@W2E!SMR!N(]J +%K;0V5I#:VZ!(88UCC4?PJ!@#\A
M7+^,/#$_B836LUCIUU:&V MI)I6CFM;C+9D1E0G&"G0C[OO70:/JMMKFCVFJ
M69<VUU$)8BZX.T],CM5V@#D;'P[J]CXNBU5YK:ZBBT:/3B\DS+++(K%C(PVD
M#)/J?7VK'TKP7XBTO3?#-MYVF7":69Q<6TLDABD+ME)1\G+IDX!'<X(KT:B@
M#SFW\$Z_;^&]*TLS:;(]AK?]H[P\B!XQ,TN/NG#'?C'08ZFNCL]%U"#Q[J.M
MR?9?L=U9PVRJLC&13&7.2-N.=_KVKHZ* ,OQ)8W.J>&M3TZS\GS[NUDMU,S%
M57>I7)P">,YZ5S]]X:UBZT/PK9J+ 3:/=VT\Y,[[7$2%<+\G4YSSTQWKJ1J"
M'5VT[R+G>L G\[RCY1!8KMW]-W&<>G--OM2BL;>.8Q3W"O,L&+:(R$%FVY('
M0 ]3VQ0!RNH^"[S5]6\4M=2P166M64-K&\4C&6)H]^&*E0.KYQGM[UJ>'8/%
MJF-?$=SIC+ NT-8ARUP>FY]P 7CG SR>H P>CHH P_%VEZCK/ANYL=+NH[>Z
M=D(,A8(ZAP61BO(5@"IQV-85IX6UR#4_$%WC2HX]4T^&W2WA9P(7174+G;]W
MY\YQVQM'6NX)P"3GCT&:SM$URSU^TFN;'S?+BN)+=O-C*'>APW!Y'/K0!R\'
MA/68;'P5 38%M *^>?.?$@$)B^7Y/?//T]Z[:X@2YMI8) 2DJ%&QZ$8-244
M>:Q>#/%,7AK2O#QGTJ6VTF_@GMKMI) \L44FY59 F%; QD,<_K6XF@ZY!XA\
M2ZI;M8 ZE;P1VV]V.UXE8?.-O0[NQ.,=ZZZB@#S>Y^&;W,&LBS-MH@O4@DAM
M[.1I(8[J*3>)L%5 SA5P!T!/6NBM[3Q3>Z/>QZP^EK=26SP10V;R>4688+LS
M+D>P XYY.>-S4;U=-TZXO7AGF6%"YCMXS)(V.RJ.2:L(V]%8 @,,X88(^HH
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M;K;744C#8Z+G:   01N)!!SS3=+\&:;IUA/9RS7VHQ30FV(U"X:;;">#&N>
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M1$KY1A!)"[<>I)_'TXJKI_@[3=.2T@CENI+*RE\ZTLY9 T<#<X*\;CC)P&)
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M%HH]@(&Q>BYSSCK0!=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX9BP*\J) &/)R?4UV_@FPT[3="DM](OY;VP^TR/#*Q4H,G)6(J -@.0,=\T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[V/+#@<8 ^O&.GHH JQ:9806TMM%8VT<$N1)$D2A7R,'(Q@U95510JJ%4#
M& !2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH OT5E7GB?0=.:X6\UFP@:WVB827"J8RV=H89X)P?R-5]0\7:-IVK:7ITU[
M)M1#/$QD 4(%)W9Z8)P!ZYXZ4 ;M%%% !17'>/?%@T+0KA]-U*R348IH8S%)
MAV.YU!4#/#;6W<YX&<=ZZ,ZSI8:\4ZE:!K( W0\]<P YQOY^7.#U]* +U%4)
M];TNVL8;V;4;5;69-\4QE&V1<9RI[C'.1VJW;W$-W;QW%M-'-!(H9)(V#*P/
M0@C@B@"2BBL6_P#%6E:;XAL=$N+J)+R[1I%#N%"J,=2>Y)  [\T ;5%4)M;T
MJWO5LYM1M8[EG$8B:4!MQ&0N/4CH.IJ_0 445RUWXQLKEM?T_2KVW_M+3("W
M[SY@7VLQ 7(+8 &2#U/M0!U-%<UX3\4V>L:/I$5QJ5I)K-QIT-U/;)(HDRT:
ML3L'('/ZUK#6]*.HKIXU&U^V,2%@\T;R1U '<CN.M %^BBD)"J68@ #))[4
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M[<*\6\YY.3SU]NU '2T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M1SN8[>5UC:0JA(1>K<=!]:DHH \=T._AGUKP#<Q0SPP1"ZA:SBM)!'9,T6!%
MN*[BV1@DGMG"@UZKIFK6FKQ3RVC2,L$[V[[XV3YT.&QN R,]QQ5VB@ HHHH
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M[235/#?B3??'0?)GAN9+='#VDK^64:1 -PX5EZ<9]ZZ__A'?^HQJ_P#X%?\
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MFM)+FY651DJ2D05P SY)Z D=.XKN?^$=_P"HQJ__ (%?_6H_X1W_ *C&K_\
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M&2Y$>X)@K)&^".N>#V/Y '46WC"UO;32WM[.\^UZD)##9S((Y5$?#E\G"@'
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M^?)ZD C\?2H[?PIKVE1:3%%#;7UI)<W=UJEG]H,<9EF;<G)4[T3)&".>#CT
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M5SW8^Y.2?<T 6J\UBSXGU[Q3'J^EW[)I]S"+9H9T22V"Q*^U&#@@L22<'!!
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M@%6]=\'IJVL6VLV>JWNE:I#$8#<6FP^;$3G8ZL"" <D<<$UTBD,H8=",BEH
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MGC"A"GR]MB]<YQ7644 8$GACSM:TG59M4NY+G38I8TW+'B3S,;RV%'/RC&,
M8K/?P!;2>'[W1FU2]\B[OS?R/B/>)#*)2!\N,;P#TKI[N]MK%(FN95C$LJ0I
MG^)V.% _&K% 'F&KI-+XPOY9]2\0:5.ICBMS!I0O(IU5<^8A\IPIW,WR@CIG
MOQWVA#4!HUN-4D,MY\VYVC",R[CM+*O ;;MR!QG-:-5+.>]EN+Q;JS2"*.7;
M;NLV\S)M!W$8&WDD8YZ4 1:YI*:[H=[I4L\D,5Y"T$CQ8W!6&#C((Z'TK+U;
MP=;:OH%AILU[=QSZ>R26E]"P2:)T& W QTX(Q@UK:S?OI>BWNH1P"=K6!YO*
M+[-X49(S@XX%&BZ@=7T+3M2,7E&\MH[CR]V=F]0V,]\9H S8?#5Q#:0[M=OY
M;^.<3->R!"TF%90A4*%"88\ #GG.>:J3> [*6S"1WEQ;W7]J#5C<P*@/VC&W
M(4J5QMXQ@^IR<UT=S>VUF]ND\JHUQ*(8E/5WP3@?@"?PJQ0!QFH_#JUU"/6H
M#K&I16NKE)+B!&C(\U0H#@E2W\"Y&<<5ICPG!_;[ZLU]=R--9K:74+["ERJE
MB"WRY!^=N%(!],<5T%5YKVVM[JVMI956:Y9EA3NY52Q_(#^7K0!S>@^!QH!2
M&'7-3N-.M\FSL9W5H[<]N=NY@N> Q('ID TR/P!;1^&[+0UU2]^SV=Z+V-R(
M]Y<2F4 _+C&XD]*T_#NOR:[+K$<MF+9].OVLR!+OW[41MW08SOZ>U;E '.7/
M@VROM4U6]O;B:X35+-;*XMV"A/+7=C&!D'YFYS46D>#I=+M6MYO$.J7Z)$8;
M7[44/V=2,9&%&YL<;FSQTZG/444 <I!X&M[?3_#UFFI7GE:%()+8D1Y<A2@#
M_+R-K$<8K2T3P[%H5WJ4MO>7,D5]=271MY-NR)W.7*X /)]2<=JV:* "N9D\
M#Z=/)KR7$]S-8ZT=]S9L5\L.552ZD#=G"KWP#S7354U.>]M["273[-+RZ!79
M \WE!@6 /S8.,#)Z=L4 9ECX9$%UI]S?:A<:A+IT;1VC3*H*;AM+-M W/MXS
MZ$\<UO444 <UK7@]-3UV#6['5;W2M22'[/)-:;#YT6<[65U8'!S@XXS4EQX1
MMC?:=J%E=3VFH6,30K< AS-&QRRR!OO9;YL\'/.:Z&L/Q-K\GAZWL)ELQ<K=
M7T%FW[W9Y?F.%W=#G&>G% %*Z\#V=S816RWMU$ZZBNIRSJ$+S7"L&!;*XQP!
M@ < "K\_AY9_%-GKQO9UGM;=[=80J;&5R"V>,YRHZ'M6U10!R<_@:,Z_=ZG8
MZSJ6GQ7[!KZTMG41SL!C=RI*$@ $J03Z@\TL_@:'^WKC4].U?4-,6\5%O;:T
M9!'/M&T'E24.."5(./0\UT%[/>PR6@M+-+A))@EPS3;/*CP<N!@[CD 8XZU;
MH PQX9MX_%":Y;W5Q XM$M)+:/;Y<B(Q9,Y&1@L>A&>/QW*** .6U3P1;ZGJ
M>JW8U.^MH]6LQ:7L$)3;(H5E4Y*DJ0&/0C-/T_P<FG:I8ZBFJWDL]GIQTY/-
M6,AHR5;)PHYRJ]/2NFJGJUZ^FZ1>7T< G:WA:7RB^W=M&<9P<=* *GAO0(O#
M6DC3H+J:XB$LDH:8+N!=R[#Y0!C+&M66-)HGBD4/&ZE64C((/451T+4O[:\/
M:;JIB\DWMK%<>7NW;-Z!L9XSC/6F:YK,6B644TB&22>YBM8(\XWR2.%4$]AD
MY)] >#TH QM!\#KH#I##K>ISZ; 2;2PG=6C@/;G;N8+G@,2!QW -/A\$6\/A
M'4/#G]I7C6M\9C)(PC\Q1*2S@87')8]1QFKNDZCK]UJES;:GH,5E:Q [+J.]
M$HF;(QM7:"!@]3CD$8[UN4 8&H>%+?4M)TVTEN[A;G39$EM+U-HD1T& <8VD
M$<$8P0:AO?!MOJ5AJ\-W>SM<ZM MO<W2JH81 $!$&"%'S,>YRQYZ8Z6B@""R
MMC9V,%L97F\I GF. "V!C)Q@9J9@2I ."1P?2EJI<SWL=]9Q6]FDUM(SBYF,
MVTP@+E2%Q\V3QU&.M '-IX MDT*UTD:I>^3;:B-11\1[C)YAEP?EQMW$G&/Q
MK6L_#Z6?B:_UP7D\DU[#'#)$P78!'NVXP,Y^9N_>MFL/1]?DU37=<TN2S$#:
M7+%'O$N_S0Z!P<8&."..: -RBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "LCQ6I/A'6</)&RV4S*T<A1@0A(((((Y%:]9VOVMQ?^'M
M1LK54:>XMI(4\QMJY92,DX/'/I0!YM:Z6=/M_AYK.FW5VVHZ@;>WO UR[BX@
M:W+/E2< +MR, 8J.RM7L_!_BOQ#:R7DNK:9?:G':2-<R/Y2!ROW2<-@#/S G
M('H*[WPKX;M]%T/389[&UCO[>T2WDDB^89"@-M) P&(R>!GO6K8Z1IVEI*EA
M86UJLS%Y5AB"!V/4G'4^] '&Z1I.FWNJV.HVFN6DUI?6;Q/9VD3!;M",B1\R
M,=RG^,\Y."<D55\)(\K#P?>AI)]"OGDN)7R3+#]Z!B?5]ZY]?+<'K7:Z7X<T
M71)9Y=*TJSLI)SF5K>%4+_7 Z>U7DMH([B6X2%%FE"B20+AG"YQD]\9/YT >
M3WNIWFC^'_',MM<7(2/7XXI)O-9GA@98!(58DD85FY[9SVKHKRR33_B%HUII
M<:C3M2L;K[?;)S$5C"&.7;T#;GV[N^?:NM@T72[;[5Y&G6D?VLDW.V%1YV>#
MOX^;\:-/T?3=*!%A8P6V5"GRT ^4=%^@[#H* /+=*O6;P3\,IGNF-W+J44;N
M93O==LNX'G)&0N<]\5K137.E>+K5]3M([VQN]6E6RUBTD_>1R,746\Z'DJOS
M*".!M7@&NQ3PCX<C9F30].!:<7!_T9>9!G#=.OS'\S5F'0M*M[LW4.GVT<YD
M:7>L8'[QL[G_ -XY.3U.: .!T[06\1^&O&MA#*T-V=>NVMIE8J4E&PJ<CMG@
M^Q-;7A#4E\6W%OKC6QM_L-M]D:$J5V7)(\Y<=PFU5!_VFK7N],N-)LI&\*:;
MI,-W/.))Q.#$C@_>8E 26]S5_1]._LO34MV=9)BS2S2*NT22NQ9VQV!8GCL.
M* +K*'1E.<$8."0?S'2O*M&AU*\^']BFGW$$]W'K5V5M=0D8I>JLD^8F;DYP
M-P)R,H,UZJRAE*L,@C!![UEKX:T-+1+5-)LD@27STC2%5"R<_.,#AN3R.>:
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MUW;HLB,CC*L,$'N*R[#PQH.ESQSV&CV-O-&FQ)(X%#*OH#C-:I 8$$9!X(H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !45S<0VEK+<W$JQ00H9))'. J@9))],5+6
M;XABBG\.:E%/927L+VTBR6L6=\RE2"JXYR1TH HZEXQTS3M)U._9+MSIUN+B
M6'[)*C[3NVG#*.#L;GH,'.*DB\4Z<;&QFG:=)KN(R);K:RM(0H!8A N[:,CG
M&.1ZBN);2==;P]XJT>VGO]5TV71V6QEO[<QW*RE7'D;F"F0 8.2."V*T3?7L
MM_X<#:)J<5DVGO&]Q%:$7"R_(/*8_>A0X))^7)4<@#) -J]\<Z7!/H*VWG7<
M.L,WDS6\#R*$6-F)^4')RH&WKR2<8K0U#Q/H^ER,EY=F)4D6.27RG,<3-C:'
M<#:A.1]XCJ/45YQH-CJFGZ%X!EGT74E.E7ES'=1" F1-\<JJVWKMRP^;IWZ<
MU=2VDMM4UW0];\,ZKJ<=_?27-I)%O:UF20A@DA#;4*G@Y'0 \\9 .QO/&_AZ
MPEOXI]0_>6&W[4D<$DAB!!.2%4\8&2>@XSC-36WBS0[S5(-.M[]9+FX0R081
MMDP R=CXVL0.2 217*K;7$>L^/V-A>>7=6<$=NRVLA68K R$(<?-AB!5>TM;
MM(?AFIT^^!T^/;=_Z+)^X/V4Q_-QQ\QQ^O3F@#M9O$^CP7L-I+=E'FG^S1N8
MG\II?^>8DQLW9!&,YR".M4I_'OABV^T&75% MI_L\["*1A$_'WR%PH^8?,>/
M>N0\/V;Q1+X:UOPSJEW?6MXSQ73[VLI%\PNLV[=M4@'.,9R/4U'J-C?3>%/B
M/;)IE^T^H7DC6B?9),S Q1J"O'(W*U '<+XKM6\8S>'A#<B6&V6=Y3 ^SYF(
M'S8QCY3\QXSQG(-7;'7M.U&YC@M99&>6$SQEH'19(P0-RLR@,/F7H>XKE8UN
MH/'\UZVEWLUK>:%#"C"!@N]'D+(Y/W3AAP>3VR:J>%[?4-"U*(6 U:Y\/+82
MR&SO[5A/8N-I6&)V +AN1MYQL'/3(!Z/61?^)](TR29;N[*"W*B>01.T<!;&
M/,< JG!!^8C@@]ZGT/5XM=T>#48;>YMUEW PW4>R6-E8JRLO8@J17#V]M?:;
M8^-=$OM.O+F34KJYN;*2*!I([A)DPJ%P-JE3\IW$8&#TH ZK5/&?A[1;E[:_
MU%8IT@^TLBQNY\O(&X;0<]1T[9/0&K^K:M;Z/HEUJLZRR6]M"9F$,9=BH&>
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M+B'5+BQA2-MOF"-L# 8Y)[\5OSWMK;2Q13W,,4DIQ&DD@4N?0 ]:\6OUTL^
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M&0%.<@D D;@-W;- #O\ A'KP(R#Q)J6UAAAY%I@CW_<T)H%['$(D\2ZFL8&
M@@M  /3'DU0N/B)HMM;7]RT6HM;Z?<FVNY%M'Q 0%RS9Y"_,/?KQCFKUOXMT
MZXUA],\J]CG^SM<Q&2V8+<1J0&,?=L$CC&>01D4 +%X?O8(Q'%XEU.-!T5(+
M0 ?AY-)#X=N[=2L/B/4HP3DA(+09/KQ#5"#XC:'/;:==JE^MGJ$AB@N6M6\O
MS,D!">NX[3@ 'GCKQ5E/%>F:A8ZTCIJ%J^G1_P"E1M R3(C*2KJ!D\@$@CIC
MMB@"9?#ETC%E\1:B&+;R1;VF=V,9_P!3U]Z/^$=N^?\ BH]2YZ_N+3_XS61#
MXMCLY/".G6%K?WMKJEJ94N9B&D:-8MPW$G)?E22?>K>D^,X[VXU\WEG/9VNE
MW9M_-D4'=A$/0$G<2_  Y&._% %W^P+W(/\ PDNI\# _<6G ]/\ 4TG_  CM
MWC'_  D>I8]/L]I_\9I8O%NF_;KVRO!-87-I;?;)([I0N8,D>8""01D8/.0>
MHJ2T\36=SK0TB6&YM+UX/M$,=S&%\Z,'!92">F1E3AAGI0!0U/PE?7^G3VT?
MBC48GE7&\V]L1]"%B4D'H1D9'%9EAX'UQKE)]9\4).\+B2%K+2[>%E<=]Q5O
M7I^M=AJ6I6NDV+WEY)LB4JO )+,Q"JH Y))(  [FJ-OXEM9[^YTYK:ZAU&"$
M7!LY%7S'C)P&0@E6&>.#P>N* $.B:@1@^*-5_P"_-K_\9IB>'[V,Y3Q)J:GU
M$%H/_:-8'@62Y\36-CXCNKG5(+I9;@R)YV+>=#(ZJGEY(P@"X( .1U.36SKG
MB>32?$NB:1'I\\_]HF4M(@! 5$)P,D<YVGTQF@";_A'KPJZGQ)J6UQAAY%IA
MOK^YI/\ A'+KR!!_PD6H^4!@1_9[3:!]/)KEM+\6Q>'K[Q:VJ2ZE<VMKJNWS
M KS+;1&*,Y)_A4$G@>_'6NNU3Q+9Z6MPQAN;H6L(GN?LR!_)C.2&/(SP"<#)
MP,XH C'AZ\6)8AXDU(1KC"""TP,=./)H;P]>.S,WB34B67:Q,%IR/0_N>E:U
ME>6^H6,%[:2K+;7$:RQ2+T96&0?RKS[^T[>+XE>(=.U;Q#-96,%K;2VT<FH&
M%59@V\@DC/0<<@4 =;_85_O#_P#"3:IN P#Y-KD#_OS3%\.W:R/(OB/4@\GW
MV$%IEOJ?)YK#\&^*)G\/:QJ.L7K3Z59WTD5CJ,D>&NH 0%.% WG<=H('S>F:
MZ"'Q/8MJ,NGW23V-W';FZ\JZ4#?$.KJ02"!W&<CN* (_^$=N\8_X2/4L>GV>
MT_\ C-*- O5;<OB74PWJ(+3/_HFFZ?XPTW4;FU@2.ZC-Y:&]M&DBXN(1C++@
MDYPRG:0#R.*J6/Q!T2_MFNXUOH[)(I9'NY;1UB3RWV,I;'WL]%ZGZ\4 7$\.
M748<)XBU%1(<OBWM!N/J?W/-'_".W?'_ !4>I<=/W%I_\9K#_M>YN?BMI5N%
MU*U@DTNXE>VN&Q&^&CVL%!(SRPYY'<#-=U0!B#0K]69AXFU0%NI$-KS_ .0:
M&T*_<8?Q-JC#T,-J?_:-6+[6X+.]%C'#/=WGDF<V]NH++'G&XY( R> ,Y.#@
M'!K-E\>:%'8Z7>)+<30ZG*8;8Q6[L3( <H1CAOE(VGG(Z4 64T"]C^YXEU-<
M^D%H/_:-#:#?.RLWB;4V93E28;0D'V_<UHZ9J":IIL%ZD%S;K*,B*YB,<B\X
MPRGD=*X76/%=UK'A+QQY-O?:?)I(N(X+A'V,&CA5LDJV0=S$X],=^* .H_X1
M^]V!/^$DU/:#D#R+3 /7/^IH;P]>/*DK^)-2:1/NN8+0E?H?)XJMH'BJSNYK
M'2)%NTNY+%9XY)X65+A5"ARC'[V"P_/(R.:G3Q?IC7NGP,MQ'%J3%+*Z=!Y-
MPP&<*<Y&0"1D ,.F: -R%&CACC>5Y650#(X 9R!U. !D^P I]17-S#9VLUU<
MRK%!"ADDD<X"J!DD^V*R+?Q58S:A9V4L5U;2WT;2V9N(]HN !D[>>&P<[6P<
M=NM &R88BQ8QH6/4E1FD^SPXQY,>/3:*\]T_4+KQ'?:[=3_VW;OI>J;;9;24
M(HCC2,F)EW;6W%F)R#P>#P*SM+OX-1\->'O$NM:EXBM+BZEB5UM9W$-S))("
M@*@D*@.!_#D$CF@#U-H(6E25HD,B#"N5&5^A[4K0Q,6+1(2XPQ*CD>AK&U;Q
M5I^D"],J7$R6$8EO6@0,+=",@MR,\<X&3CG'(IU]XHL;."2:*.XO$BMUNI?L
MJ!O+A()#G)'4 D 9/!XH US#$228D)/4[1S3'M+:10LEO$R@Y 9 0#7-W'Q!
MT2*:**W6^OI)K(7\*V=H\AEA) RO'/7\,'//%=2&!0/R!C/S#&/K0 M-9%8J
M64$KR"1TK!3QCI;O8LPGCM-0E\FSO73$,[G. #G(W8.TD -V)R*9;^-=-O-8
MDTRVM]1EGANOLLS+9OLB?;N!<X^52.Y_ES0!O_9X<8\F/'^Z*'MX7,9>&-C&
M<H2H.WZ>E1:AJ%KI5A-?7LHBMX5W.Y!/L  .22<  <DFL^#Q+:RZE)IDMO=6
M^H" W,=M,@#31C@E""0>< C.1D9 H V:CE@BFV^;$DFT[EWJ#@^HKR^WUJ^O
M_#.I^*V;6(KW3I[V2-(Y<0.B&15C>,MM*J%4DXSD9!YJ[I[V:3^%]3U#4O$<
M-W?^5&ML9W-O<3^66WL,D $%OE! ./N\4 >BF-&=79%+KG:Q'(SUQ31!"-N(
MD&T87Y1Q]*Q-2\8:7I8N)9Q.UI:S);W5U&FZ."1B  QSD_>7.T'&><4NK>+=
M.T=+F:X2X>ULW6.[N8H]T=N3C[W.3PRD[0<9YQ0!MF&(L6,:9/4[1S2&"%HF
MB,2&-OO(5&#]17/W'C?2X=8GTN.#4+FZ@\DR+;VCN LA(5\@<J,<L./K5RS\
M1VM]<6Z007+07+R1P7.P>5(4SNY!R/NG&0,XXS0!J>1#L5/*3:HPJ[1@#VJ3
MH,"J]]?6VF6$]]>S+#;0(9))&Z*HZUFP^)K234TTV:WN[6\FA:>WBGC"F=%Z
M[""1D9&5.&&>10!LLBL5+*"5.02.AIA@A,XG,4?G ;1)M&['IFN%\,S7/BN_
MOKZYGU:SFL-8G2+RYMD311ML\ETR5.<9/&<]#6YXH\2R>'YM(ACL9KEM0O4M
MMR 83(+'J1DD*<?YR =%4<L$,^WSHHY-AW+O4'!]1FO/K?Q0-"\6>,I+XZI=
M6EL+65845IOLR&$LYQG"KDDG],XKK[CQ#:1I$;:*>^DEM_M*Q6JAF\KL_) P
M>PSD\X!P: -.6&.>,QS1I(AZJZ@@_@:'BCEB,4D:O&1@HPR"/I531]7LM>TF
MVU33IA-:7*;XW (SV((/0@@@CVKF8]4N?$WC[5M$BN9K;2]%BA^T>0Y22XFE
M!8#>.555'\)!)/7'% '8M#$\/DM&C1$;=A4%<>F*3R(<$>4F#C/RCG' K&^R
M/HE_+J,NJSC1HK1S+%=2EQ"P*G?O;+$;0V<DXQQU-+!XIL9-0M;*:&ZM9KR)
MIK3[1%@7"J,G;@D[@"#M.&QVH VU4*H50 !T %))&DL;)(BNC#!5AD&N4_X6
M-H?V2.\*7XLVNC:/<M:L(X9 ^S#D],MQ[9&<9JY#XRTR2?48)8;ZWFL(!<R1
MS6KJ[PG(#HN,D94CID=Q0!O"&)8A$(D$:\! HP/PH\F+"CRD^4[E^4<'U'O7
M+V'Q"T2_O=,MD6]B75(P]G<3VS)#,Q7=L#GC=CMZ\9S5JV\9:7=7=E%&+CR;
MZ>6VM;HH/*FDCW;E!SD?<;!( .W@F@#H:SWTJ,:R-4@;RIWC$-P,9$R DKGW
M4EL'T8CGC&%-\1=$@AO)VCU P6-W]DNY?LCA8&^7YFST7YA[^V.:V(?$%I-X
MDGT$1SK>PP"X.],(T9. RG/(SQQT[T 3ZCIB7]A+9!O)@G&R?RUPSH>"H/;(
MXSUQG&#R+<44<$*0Q(J1QJ%1%& H'  %5M,U*+5;(74,<J1EV0>8 "=I*DC!
M/&0<'OUZ5EZKXPTS2);])EN)5TZ))KYX4#"W1\[2W()X!.%!( H WV17QN4'
M!R,CH?6F>1#S^ZCYZ_**SEU^T;7'T=$F:\%I]L0!1MDBW;<J<XSDXP<5A3^/
MX)1X=ETVQNKFWUBYDA#[ I01A]PP2/FRGTQGVR =<]O!(J*\,;*AW*&4$*?4
M>E25YU;>*5\/^*/&C:@^IW5G:2V\@1%:86T9@#.WHJY)./K@'%=A<>(+2.:"
M"W2:]N9H/M*0VP!8Q<?.=Q  )( R<GMG!H TI88IU"S1I(H.0'4$9]>:0P1%
M-AB0KNW8VC&<YS]<USLGCW0DLM-NTEN98]1F:W@$=LY;S1G*,,<-E2-IYSVJ
M.VU_3-1\2:8<ZO:WDMC-,EI/$\,?EAE#%T/!<'&.N ?>@#IS%&5=3&I5^6&.
M&^M))!#*4,D2.4.Y-R@[3ZCTK _X3*Q6]TRSELM0BFU-L6JO",L,9+$ Y  Y
M)(XJ2;QAIEO<VBRB=;:[N?LD%X4'DO-D@)G.>2" <8)'!H WZ:R*Q4LH)7H2
M.E>?_$GQ*%\#:^=,DU!9;,>4U[9G:L4N1\NX$,>N"0" 3@D8./00?D!]J &?
M9X<8\F/'^Z*&MX7>-VAC9H_N$J"5^GI7+Z-XVAOK/6[Z_M9K"TTZ\DMR\H!^
MYM7'RDDL6)P .X')K5M/$5I<ZN=)EBN+._,/GI#<* 9(\X+*02#@XR,Y&>10
M!KU&T$3L6:)"3W*@UB^,O$+^%O"]WJT=H]R\0"JBXP&8A06R1P"1G'-%[XKM
M+&0PR6MX]REJU[+;HBEXH5."[9;'4' !)..E &ZJA0 H  ["F)!#'*\B11K(
M_P!]E4 M]3WKC-1U87'C;P9>6>H3?V;?VMW,RB0K%(@B5D8J>. Q/-;\/B.U
METV.^\BZ2.>01VZO& \['.-@SR#@G)P,<YQS0!J^3%DGRDR6#$[1R1W^M"Q1
MH2515)ZD#%9NC^(+/69[ZVA66&[L9!%=6TZA7B)&5S@D$$<@@D&I;[6(;*\A
MLQ#-<7<L;S+#"%+>6A4,WS$# +*/4YX'6@"V+:!9#(((P[-N+!!DGIG/K4-M
MIT%K>W5XO,]SM#M@#Y5SM7CTW-R>>3[8H6WB>QNM0LK%([@3WME]NMP\>-\8
MVY[\,-ZC!Q3+;Q;IEWIL=[#YQ\VZ>SB@*8DDF0L&0#VVL<YP "2<4 ;CHKH4
M=0RD8((R#2+&B'*HH. ,@=AT%>?>+/%$5[I%I<V%U>V<UCK]K:7D.2C+F5=R
M,%)# J0>"0<UU>C^([/6KV^LH8KJ"ZL2GG0W,)C;:X)1@#U!P?RYQ0!L4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C>+=&E\0^$=
M5TB&4137=L\2.W0,1QGVSUK9HH XRUD\0^)_#USI.J:+)H\LEE);7%Q)*CAG
M9"N8@C$[<G=DXZ <YR,Z/1=7UCPUX9T*_P!-DM+C2KJVDNK@NIC*V_1HR#D[
M\#' QDYQCGT2B@#S&\T+6Y_"7CVQ32+C[1JU[-)9J9(_WBO&B@YWX'*GKBMJ
MXM-2?QQX?U-=*N3:VNFW$,S;H\H[^60N-W/W#TXZ5U=_J%GI=HUW?W,5M;JR
MJ9)6VJ"Q"@9]R0/QJS0!Y99:!KL'@'PCIKZ/<?;-/U>&YN8A)%\D:2LQ;._!
MX8< YK8DTW5/^$D\9W0TNX:#4-/@@M7#Q_O71) 1C=D<N.N.]=W10!YS9Z-K
M5E%\/KC^R9I'TFTDM;R$2QAHF:%4#9+8*Y4YP2<=CTJ&_P##&NW=GXRTV"Q"
MO>ZC'J5E<2NAAFV"$B,C.[),1!R .>M>AS:A9V][:V4US%'=76_R(F;#2;1E
MMH[X')J"_P!<TK2I4CO]0M[9W*@"5P/O'"Y],D$#/4T <5/HU]XI\-:I;)X4
MM_#MW-9M"LDHB+/+D,%!CS^[RO).,Y''%:OA87EU<Q37G@RVT.X@C*S3D1,7
M8C!6(ISM[DG'88.<CL*J0ZI87.H3V$%Y!+=VZAIH4<%HP<XW =,X/6@##\=:
M-?ZQHELVEJLE[87T%_% S;1,8FSLR>!D9QGOBH$L+K4_&MKXD>PN;6&QT^2!
M8I=HEFDD921@,1A0O<\EN.!FNNHH Y7X=6%_I7@JST_4K*2TNH&EWH[(WWI7
M88*DCH12>)K'47\5^%]5LK![R&RDN%G6-T5D$D>U6^8C@$<XY]C6U<>(-%M+
MEK:YU>PAG49:*2Y16'U!.:N6UU;WD"SVL\4\+?=DB<,I^A'% 'F]_H>MW'A_
MX@6D>D7!FU>X9[)3)'^\!B1,YW<<J>N.*?+IFJ:9XGN;Z7PD-;L=4MX/E)A\
MVTE1 A5@YQM( .0>.:]*HH K:= UMIUO"T,$#)& 8K<8C0_W5]A7&V=OJMC\
M1_$.K/H5[-8WEM;0PR1O#\QC#;N#("!\U=W52;5+"WU"VT^:\@2\N=Q@@9QO
MD !)(7J0 #S0!YA_P@>NS:-XGFM[>/3WO=2@U#3]*,JE$,3!B&*Y53(1R 2
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M^O:38ZZ+;2-8>29[=[3S'@D?E]C[Q\I/.T@^Q%;EI:ZW;^)H0VIFXTI+'9+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MIKHDL;1R*&1@596&00>QIU!.!DT 8</@_0+>&SA@TZ.*.SD\VW5'9?+?&-PP
M>N.,^G'2EN/".@W4=]'<:='*M\ZR7(=F/F,N-K'GJ,#!'(Q5RSUS2]0NFMK3
M4+>><)YGEI("2F<;AZKGC(XI(==TJYO19PZC;/<-NVQK(,OM^]M_O8[XZ=Z
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M O)KO2M)MK2>;(=XU[$Y( Z*#QP,#@5SFM^!;.TN-)F\.:'#&\6KPWMR8V5
M$7)8*&/!)(X&!QS5FV\8QV/BOQ';ZYJUE!IMHMH;1GQ&!YJNQ&2?F/ _+H*Z
MB\U;3]/MTGNKR&*)QN1BWWAC)(]1CF@"A>^#O#VHWEW=W>E0RSWB!+AFS^\
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MH **** "BBB@ HHHH **** "BBB@ K"\:V5]J/@C6K/3-WVV:SD2(*<%B5/
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MR??\!0!/7DVR3_A _%OAC4X)'UR>YNS!$4):[:1BT,B?WADKS_#MYQBO6:*
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M,]E:SL<_:-P!1_8K"47_ (&U=[5+2M-32K%;=9I9W+%Y9YB-\KDY+-@ 9]@
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MGN:]:I#G!P0#V)&: /&1;V&J>!/&NC1P1S:K=:W>I;P!/WCR>>?+8=\*>K=
M <XYI_C.6:73/&6E_9;F*]6U@SY%JSMJ&V-<RL^T@*N"N!@@KR3G%>E>&] ;
MP_!?1&[^TB[O);PDQ[-KR,68#D\9/']:VJ .!MKBTG^+#7S+B$^'T42S1E,-
MYK,5^8#!VG)'7!K%TC2[BY^#&D7=FACUC1&:\MED!4AXW8F-@>0&0E<?[0->
ML5C:UH4NLW%ONU6[M[%59+FSA";+I3CY6)!('&.".": &^%UEFTLZI<Q-%<Z
MF_VMXV^]&I $:'W5 @/OGUK;HHH \;L?MMOX-T("TNRNB^('GU.#[.^5C,\Q
M# 8^?;N1\+GC!KL=+@^W?$Z]US3G#Z8VDQVTLJ?<GG\QF&#T8JG!/;<!79T4
M %>0*FF7?A_XCZ9+;QS:A=ZI=)! (\R3.8T\O;ZX?G_9ZG%>OUB>'M ;0I=4
M<WGVC^T+Q[UQY6W8[  @<GC"CW]Z .4T:Q6+XD0VNH*EQ-%X:MK625TW*\JR
M,77)X)Z-CKCFLO3_ .S9Q>^%_$EAJTVK+J4T\,*&<176Z9I(Y5=?E4#(R21C
M:?I7K5% 'E2MI+7_ ,2;.]ACDFN9PB0^7N>?-LF%08RS;NPY!(-59H[K3M/;
M0;VVN(=13PO%;FY@MFFDO7".#"&P5"J3SW.[.0!SZ)HN@/I&JZO?&\\XZG.)
MW3RMNQ@@08.3QA1U[UMT >5:"UM=^(_!!F@9EC\.O _GPD!9"(AM.X<$@/C/
M49QG--F.F1ZMXD\.>*+'59?[0O#-:1VZS&*\B94"*I3@,NT*<X P.>*]7HH
MCMT\NVB3;MVH!M+%L8'3)Z_6N4\8WR66M^'?,MG57FF']HI TS6I\O "J 1N
M?)4$@C@\&NOHH \5A"GPG86=Q!<%HO&'F2+<6[*?+^TLQ8@@#&TY)Z#/.*[;
M0'3_ (6?XL9?N2V]EL8#Y795D#8/0D94'TXKM** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ***I:QJD&BZ/=ZE<_ZFVC,C]N![]OK0!=HKG[?Q;I]YJEKIMM<VDE
MU=62WD(\_P"696W8\LX^8#8Q)QP,<<\9.F>-]4U/PU<Z]%H$)MK:29)(4O\
M,I$3$,5!C"GH< L,T =M15+2-5M=<T>TU6R8M:W42RQEA@X([CL:NT %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC1H$32;!5$/D "V0#R\YV=/NYYQTIPT/2%^S[=+L0;;_ %&+=/W7^[Q\OX4
M>?16 TK7=4\"K;?Z'K$ZWMK(%R%MR<SH3VVE<+Z>8OI7I$-S9_:'L()X/.MT
M4O;HPW1J?NY4<@'!Q]*R=$T[6/M;:CXAFL)+Y8S!"MBCK''&6R3\Y)+-A,]O
MD%:Z6=K'>2W<=M"MS,JK),J .X7H">I R<?6@">BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **Y+7_$NN:$YU!]'MY-#CN$@E;[01<X
M9PGF!-NW;N(XW9(YXKK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .)UGQ+97&L&RN].UF2UL9E<)%I5PZW,RG*X8)MV*V"#GE@#P!\
MW:@Y )&#Z>E+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex971clawbackpolicy003.jpg
<TEXT>
begin 644 ex971clawbackpolicy003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU1)6OLBW(C<+(1D[=Q& V 3M)R1SB@#H**QG\5Z+%IU]?O>%;:PF,-VYA?\
M<N "0PVY'##G&.:FU+Q!INDHS7<[J%C\Y_+A>4I'_?8(#M7@\G X/H: -.BH
M[>XAN[:*XMY4E@E0/'(ARK*1D$'N"*Y:XUR]U?QQ<>&M,N/LD.GVZ3W]VJ*T
MFY_N1H&!4<98D@\<#UH ZVBL:"WU:RUE&FU,W6D_9I#(9XXU=)0R;3N4*"NW
M?VX[D\8DM/$NDWMY!:07?[ZX0R6X>)T$ZCJ8V8 .,$'Y2>#GI0!JT5POC_Q6
MMAX>G;2=2FAO8;N& O% 7C+&5%>,N5*@[2> 00172:EXETC2&<7UV8EC*B60
M1.R0[NGF,H*IGC[Q'6@#6HI 00"""#T(K*O_ !+I&F23)=W>SR-OGN(G=(=W
M3S&4$)Z_,1QS0!K45R/BCQ-]BUS0=(ADN8X]1DD,T]O;O(PC6)F 0A2"2VW.
M,D#/3.:Z#2+2\L=-CM[[4'U"="W^DO$(V9<DJ"!QD# SQG&<4 7J*Y>YU34H
M?B5I^E?:(_[-N-.GG,(B ;>CQ@$MDD_>/3'XU5.K:GK>J^)K73M0-BVCE(84
M$:,)9#&)-TFX$[<D+A2. 3GD8 .RHKSM?'QOK+PG?7-P=(TW6('::["J52X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,PV]!D<^]3^(],U#4/\ A945KIUX[7MK:_9?]'<"<I&0P0D88@\8'7M7JU%
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MX6UNFMXM-N(7G6W<QJ[O&5!8#'(4]^U0>*M"BN[J\?1;2[37K^$6TES%++#
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MC90:9%YD<Z6^%EF?*G:SH5.U../^>A]*ZBB@#SWPW#=>%O'>NZ68-2N-)O\
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M:*]L]]J$NGRAY6&QT1GWIE!O1@O!XZ^U6_$F@:Q?ZAI6N:+=VMIJ]@LD;1W
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MWEEN(84 DQ%)!-YL<R;5(=6P.#DC'MU-9"V'BBYTXG4I](FNG=5DM$C<6S1
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M&U_*T2374OEQ*0N<%L'D] ._/I@QZ1HE[8^+]>U>=K<V^I" 1HC,63RE*\Y
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MZEM[33HG"HK*\A=BP7@ (S$A>IQWJ/P<DR?$7QMY]K!;RG[$6$#;E?,;_-G
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MPJ>F,Y'7)YH [&BO/M!N?$VM6/AWQ';ZC:);W122^BDNBT;QN,;$3R_E=6(
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M%:^-+JW9$ED\216PE<X6(2+;H7)P<8#$\@C..#TKK-%L]?LO$-T+Z]@DTJ:
M-#;O<M--'*#AB"47Y"".I.#C& : .EHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JO?6<>H6,]G,7$4Z&-]C8.TC! /;BK%(2%!)(
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MG20%5QZD=*YO0/$6I^)'M=1T\Z<VDR3SQ30L6$\:([HCA@2#N*9VE1@-U.*
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MS;>)F^SSJ%W1 7J8"'^$;2>!Q@FO<00P!!!!Y!%1?9;?&/(BQUQL%2@!0
M!P * /('>*\^''BRTU+ \20WUPVW.)S<;\VQ3OT\L*1V&!6G8:1INH_%&]MM
M9M+&ZN_[#LY)XW16#3AWW-C^\..>H'UKT@VT#7"SM#&9E&%D*C<!Z ]:<(8A
M)Y@B0/\ WMHS^= "3I#);R)<+&T)4AQ( 5*]\YXQ7BNDVEA9?!?2-;M+1#(C
MQ)J-S;1J\WV47&9%)(.5 494Y&!C&*]M90RE6 (/4$=::D4<:E4C55/4*, T
M >7WT'A^^T+Q;JNB>)9YGN]+*W=W"4,,>U3MR(U7Y\9!ZD#KCBK/AUM#\1>-
MM/U>.ZT-I[32OLJVEO<Q3R%]P.Y0O15 (!Z_,> .O9ZUHAU#09]-L+@:<TA4
MK)%$"HPP8@KP"K8P1QD$U1T_P[>&^M[O5WTEY+9S)%]AL#"2VTKEF9V.,$\#
M'U/2@#S2PU/38? /@FRDNK=;JR\01">(L-UOB>4'>/X/QQ6QK.H:=;:E\39+
MU&NK86]BLL,,NQF!C*GYAR!SR>PS7J8M;=7+K!$&9MY8(,ENF?K[TOV>'+'R
M8\L"&.T<YZYH \JAN[2[\7^)8$O+&\-WX=C9%M%'ER,IE'RC)W;1@9S^72J\
M<^D2>#OAE-;R69ECU&RC=T*Y5O(;>I/KG;D>N,UZ\D,49!2-%(7:-J@8'I]*
M:;: J%,$>U>@V# H \T26SN+;XA6'B,Q+>&XE=!-C<UJ8E$!3/8$'&.C9[FJ
M^C6$<_C;PS#XBAMY=2;PN3=K<*"SR!XL;P>I'/7N">U>IR6T$LJ2R0QO)']Q
MV4$K]#VI6@A=][1(6]2HS0!Q_P *GB;P+#%"ZM'#>7<:*IR$47$FT?3&,>V*
MJ^*]0TY/&2V,S06]X^CRXGNV+(\;. 8HH\@-(2HR>N,<'/'=QQ1Q B.-4!ZA
M1BAHHW='9%9TSM8C)7/IZ4 >,^'CI>I/\+?/-K<.=/N89=^&+;85PC>N#V/>
MJ^HV6D)\/?B'+%#:"2TU:<6K +F#_5LHC_N_,2>,<YKVP6T VX@C&W[OR#CZ
M4?9;?!'D18/4;!0!YGK&HZ2_C+6M/\3:O]@LK_3X192R>5Y4T.TB15=T8!MQ
MS@$$Y'H*++2M%7XBZ%9R1BXA7PY(H^WA3+(%EBV&0$#)V@D9&1CH"*],>UMY
M1&)((G$9R@9 =I]1Z4K00N^]HD+>I49H \7\/ZI;V%EX+%W-&F@1:IJ4<CLP
M\J*42/\ 9PQZ <MMSP#@]A4FI2:/-HWQ7CMY+.2([9XU1E(+&W7YQ[[\\CO7
ML36MNT+1-;Q&-OO(4&#]12BV@"E1#'M)!(VC!P,?R H \YEMM)O?B+X6%Q%:
M3B70YBP<*PDP8MN1_%CYB,^F>U85K=6EGX!L91?6T%II_BJ0K#)(%B>-9Y"(
MRW10 =XSQE1[5[']F@R#Y$>1T^0<5BZ_H-WJ'V*32[RWM)+64R&*>V\V"?*E
M<.H*GC)((/!]: .<\-77ARPO_%/BTZII'DW,J2.;:9)6MHPBK\[)G!=ANP,C
M..IKOK>XAN[:*YMY%EAE021R(<AE(R"#Z$5@V/AIT:6YOGL1>20F#=8V8B14
M)!/#%MQR!R>!C@=<[EI:PV-E!:6R;(((UBC7.=JJ, ?D* /-]9GGTSQ%?7UM
M)9ZOILFJVHO=.E&VZM;@>4J/$P^\.$;:??'>LK7+RPL](^*>G7$T,=W-(TL5
MNQ&]P;9,,J]2,@G(Z8)KUXVMN9Q.8(C,.!)L&X?CUH>VMY)&D>"-G9=A9D!)
M7TSZ>U 'F4-IX?U+XEV?VZ&PN(+CPS'(!,%9)2)2,X/#$#\@*P;+2[*WM/!\
M5_'&VF'Q!>161G[V;++Y:DGJC<8!X(([&O3)?#4MQXX.NSM:RVAL!9?9GCW'
MB3>'R>.IQC'XT[Q#X>N-9U71+F.6W2'3;AIWBE0MYN49-OH!ACZT ><Z_I]M
MI6A_$X::L<&BR00"*.+"Q"YV'S0@'&>4SCOQVK<UG5=.M_&YAU_5!8Z9>Z1&
MME<.(C YW/YR;I%8 D&,]L@#KQ7HXMH%A6%88Q$OW4"C:/H*)+6WEC6.2")T
M4Y560$ ^H% 'EMEI&A6WC+P;80YNK5=*O$C:_P!K22QAXS'NX&1C)7(Z8]*Q
M+FVTB#X9^);J&.T6:S\02+:RKMW0*+Q2H0_PC!) '')]:]N:")WWM$A;^\5&
M:3[+;XQY$6.N-@H \OU>[T:X\5>*=&\5:NVGPWL47V0N(@D]L8@"(V=&.X2;
MS@'.3D"K%EI>C2?$Z"UNH4N%7PS"66_56D<B4C=*",%]O4D5Z0]M!(8R\$;&
M(YC+(#L/MZ4K6\+.7:&,L>I*C)H \6\/SZ>FC?#.[O9+?[+%<7L#RS$%5 CE
M"(2?P %:.L)IWVGXL1%;;!TV"0H0O^L^SR?-C^]NQSUS7K MX0H40Q@!MP 4
M<'U^M(;: EB8(R6ZDH.: /-+"'3;'Q?\/Y+);:&6[TNY$SQX#3?NXB-QZMSD
M\]\UBZ?_ &)K-AI6@7NL:+)+8Z]+=2S75S'YERHED.TQ-\V]]P4@C&.<G@5[
M&]I"R$+&D;8PKJ@RON.*Y"U\&:D; :5JE]I5[8"/RFF.FD74J]]SERNX]VV\
MGG&: .GLM9TR^U"]TZSO(9;JQ*K<PH?FB)&1D5S?Q$N)+6UT*>4?\2I-7@.H
MG^%8N<%_]@/L)^@KI[?38+?4;F_ S<3JJ,V ,*N<#CZGD\_@ !;95=2K %2,
M$$<&@#ROQ-;0/K/C*>U\A])E\-,UYC!B-W\_EGTW[!]<;?:NP\#:9I=IX7TV
M\T^UMHY;NQMS//$HW3$)P68?>(R>OK70):V\< @C@B6(?\LU0!?RIZ(D:[44
M*H[*,"@#C?&,=V=;TZ?2=2L8=5AM;@I9:@N8+N$F/S!G.5887D>ISQFL"QU;
M3XO$/@;5;B&+1[.;1+B&-+B0*L>/*VIN.,\ D>HKTZ>VM[E0L\$4H'($B!L?
MG2R013;/-B1]C!EW*#M([CT- 'B$?]DW6B:*9_LYC3QK/%)OPI2-VG.UNX!^
M7@]:OZY8'1[OQG-X=MS'HXBL6NX;)!MWB7,X1<;<^3]X8_BYKT'Q+X=FUJ31
M_LTEM#%I^H+?.CQDB4A74KQTSO)SS]*Z"*&*"(10QI'&O1$4 #\!0!Y9?IX4
MU32/$NLZ9K#:H\N@RQSX\KR%"J3'O547$N2=N>0 ?:K*:-IT?@WPQ=:/=V.E
M:K<FUDANGB5H[J98'PDIZMD%^<Y!QCFO1TM+:.(Q1V\21L=Q14 !/KBE>VMY
M(?)>")HO[A0%?RH \D;7S = N=7A71=.BU"^M[V:UVR6RW>1ME!=2 C$R@$C
M@D\\5)='2-$31)K&_FNO"L^OR3WMS*4-N)&C)3:54*(A+@_W0PKU@V\#6_V=
MH8S#C;Y94;<>F.E!@A:#R#$AAV[?+*C;CTQZ4 >43SZ+<:I\4%AELI(9M,@E
MPK*5=A#+EAV)!QSZ^]/B@TN]U;X7BXCM9O,TN56#[3O MX\ ^HSG@]Z]36VM
MU0HL$80X!4(,''2C[- "I\B/*]/D'% 'CHFL[/PKJWE7MK;6EAXQWK SA(60
M2JWED]$7)+9/&177>#(M'OO%?B+Q#8WFE7$M\80L=I-'-)"BH Q9E)P789(!
MQ\HY)Z;>OZ#<ZC%:-I=W!936T_G%);82PS_*1MD4%20-V1@\$ ]J71]!EM+[
M^T;XZ>;T1-"OV&T\A C%2<Y9BQRJ]\#'2@#=HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ JMJ%_;:7IUS?WDGEVUM$TLKXSM51DG\A
M5FJ.M1R2Z)?1Q64=](\#J+60@+-D?<)/&#TY]: ,V[\60:?8ZA=WFG7\,=A;
MK<RY6-LQMN^92KD'&PY&<]..:L_\)%9C6;'2V299KZV>Y@<J-C(NW=DYR"-R
M]1WKBD\&ZHFB>)='TP7EOH][IC16=CJ$ZR&"X(8%48,VV/&T<GJ>.*L+INNZ
MOK_AZYN=#GL;6#3+FRN6DN(F>-G6,;L*QR/E.,'/J!W .CB\7Z=<76GPB*[%
MOJ;-'9W>P>5.0">"#N&0"02 #C@]*Y?PIXMBT?3;J+4_[3N(CKMS9_;'#2I#
MF<I&KNQSCH.,XXSBM+P9_P )3IFE6'A[4=%2)--18#J*W"-'/$@PNQ =VX@
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MK-L)SD,0K$<4_P /:V/$&E_;/L-W8N)&BDM[M LB,IP00"10!JT444 %%%%
M!1110 4456U&XN+33KBXM;-[R>-"T=NCJK2'T!;@?C0!9HIJ,6C5F4HQ )4G
MI[4Z@ HJ&2ZBCG%ON#7!C:58@1N900"1GW('/K6=X9U^/Q-H<>J1VTELKRRQ
M^5(064I(R'...JT :]%%% !1110 4444 %%12W,,,L,4DBJ\[E(E)Y=@I8@?
M@I/X5+0 445S^I>)GMKR]M=.TR?4Y[!(I+J*%PKJLF<! ?O-A2<9'&.<G% '
M044#D44 %%%% !161:>)-.O?$VH:!#+F^L(HY9E[8?.,?3C/^\*UZ "BBB@
MHHHH ***H7FHM'I][/I]N=0N+;*_9HG52S@ [<MP#R* +]%(I+("5*DC)![4
MM !116'XE\30^&(+.:>QN[I;JZCM(Q;;,B1SA0=S+P3WH W**PK#Q5:W?B"3
M0;BTN[#4T@%RL%R$_>Q9QN1D9E.#P1G/M6[0 445%#<PSO,L4BNT+^7( ?NM
M@'!]\$?G0!+13)98X(7FE=4CC4L[,<!0.232QR++&LB'*, RGU!H =1110 4
M444 %%13W,-LJM/(L8=UC4L>K,< ?4DU+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM[(!$5AC?H#\PR3\IR/;DUU]MX9OK.Z\^WL-&C(E,ZQB6?RUD/5UC^ZK<GD
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M1=&N]*T"73E.5@/FX4]=P(Y#9)YSGD^M1CPC<KI=OIJ:9HJ6EO*)XHUEG&)
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MQ)*KNJ^Y4'CO65I6I>%+F:_\36L=_<*+'R+NXN4EP5W9$.QP [9)Z XZ9YH
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MPCD]B*[3P?+Y'BKQ?9RQRI-+J?VE,Q-M:,PQ ,&QCD@CKV- ':4444 %%%%
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M6B1![75)/*M98IT=]Q!*[X\Y0-C@^XSMJ&'XBI+9V]^VAWT5@^H'3YIW>/\
M<R>;Y0)4,2PW8R1P,]3S0!V]%%<OJ'C">U\1W&AVF@7U[=PV\=R?+>-5:-G*
MY!9NV#P<$^F.: .HHKCK[XBZ98R+*566Q^V?8WF2=#(C[]A;R^I0,,9Z]P".
M:N7'B[8LUS::7=7MC;WGV.::W^9P^X*Q5 ,LJL<,>.AP#B@#I:*Y#6_B!I^C
M?;I/+6X@T^4176R=!*"<9V1GE]H89Z=\9(-2+JUC)XVO$M=)FEU1-)2=+CS
M%G@+MM1>>/FW<D#\J .KHKG-+\6QZOH.E:I:V;G^T9O)2!G ="-V[=VRNQB1
M[=ZHWGQ%TRSECDVK+8M>?8VF2=#(K[BF[R^NS<,9Z]\8YH [&BO/?'^M_P!I
M^!O%<5C9/<V]C#+!-<"4)ME"Y.T?Q!,C=R.^,D8KM]*_Y ]E_P!>\?\ Z"*
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M) Y/3:<#C)Y'%,LOB%IE[IB3JHBN6O9+#R)ID51*@W-^\SM*;>=PSG(P,G%
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M%N[*.Q@P?,7SA*[\?=&!@#WSGV'4<?;^"]6/@8>![L0/I\<JH+\2_,ULLHD
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M0RW4S+Y-S@AI@NT[R00,G!XZC)R^P\,>(+./P1-Y5@T^B6DEG<Q_:&V[6C1
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MGPQXCN#';R0V%Q:'1ELD2:X;;:7 4JTBKL(?(*X/!&,<<Y]#I"0H))  Y)-
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MM(Q@,3IL:(R;02<<[L=>V.:[4$$9!![<50O];L--O["RNI'2>_D,5N!$Q#,
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MZ;+86YM$%F5 : [?W9#*>/E&",$>M ')0>*O$5QX;\,W4=] MQ?:Y)I\[O;
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MVVIE3=7$C 2,5QLP5 "[<#  Z\\DG,V@^'!HBL9=5U+4Y]OEK-?RAV1/[HP
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MG:Y<'2U)RL+*$=4'HA)((Z88UTWA"_B\5S#Q/]D, 6W2TA1TPR..9OR8[/\
MMFWK0!UTDB11M)(ZHB LS,<  =2345E>0:C86][;/OM[B)98FQC<K#(/Y&L_
MQ5!%<^$M8AFB26-K.7*.H8$A"1P??%<%IC:+_8/@/3T2W:>XL_.\AF1;5W%N
MF]YA@[V 8$#J2<Y&,T >J45Y#I5C::_\)OL;W2OJ$%]<1Z;)"0SI()W\I5!)
M^3"\@G&P'/ R)Y-;,'PZU74-AMM9COXDU_:GSQ?O4$N ISL\LG;@_=.<YR:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@9+=!QSR*T+C7].@CMV$KSFYB,\*6\;2L\8 )<!03MY'/3D#J10!@:_X8O\
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M:ZBHO3SM8 F'Y/FX8'YMOIS5G2_"&KV4W@]YKJRE&@VDEL^P.OFAHUC!&<]
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MIY;=9BNLV>%*@D@R<@9]1Q7?US/C7P_?>)-/LK6REMX3;WL-V7FW'/EMN"X
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MLD0G&0&'?!P1T-9FN^![W6]/U]VFM8M2UA(("<LT<$41R #@%B26).!U'IR
M7QXON++7[_3M:L(K2&#37U..:*<R_N4;:X<;1AAP>"1SUJ*T\:W$FJ6$5SI;
MI8WL+R_:8A(PM2J[L2Y0  C/()Y&.>M2:CX5N=7\32W]XUN+*XT>72YX4=B^
M)&#,P.W';&/Q]J9H'A_Q+:V<>E:YJUE>:7;Q&&-H(62>X3:5 E).!@'^$9)
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MDX .1A>G)H [6BO+=)\0:WXEN/!,DFI7%BNK6%VUW% J %XM@#J2I(SDGG.
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MN-;O<2^;=0D!H7C8E?(5<@*0VT!NN1SG-<S]F:/X;_$B1KJYF*W>HQ8FE+<
M  \]\<4 >MP3+<6\4R A9$#@'K@C-25PNIWMWH&H^&=6DO9ET2=4L[R$L!'%
M(ZCRI3Z#=\IYQ\P-=%X;:>YTUK^>:5Q>RM/"DASY<)/[L#T^7!/N2.U $NJ:
MU#ILT-L()[N]G222*UM]N]U3&X_,0.-RCKU(JSIM^FIZ;;WT<4\*3H'$=Q&8
MY%SV93R#7':I9>;\8-';[5<INTJY?"28 Q)",#V/>LRSU'6+?3/%7B"XUJ_N
MO["OKY8;,B,1S(D8VJ^%SP2#QC&/<T >G45Y]=:CJ>E6OA#5H-2N+L:K<V]K
M>QN0R2"9"?,08PA4C("X&,YS6'=:GKT7@S7-;7Q!>F[TK7)8(%(38\:W"Q[9
M%"C<-I/3'M0!Z[39)$B0O(ZHH(&6.!R<"N/T^6_T_P")<ND2:I=7EI<:3]M*
MW.T[)1*$^7:!@$'I[4SXFQ-)H.F[9YXO^)O9*1$Y7<#,HY]<=1[X/:@#H+?7
M[6Y\27>A+%.MU:P)<.SH C(Y(&TYR>5/:M1E5T9'4,K#!!&017G=QILUU\2M
M8M8=3O+39H-M^^A9?-8B2;&6(/U..OY@P:'XGU77[/PK82RKY]_I#WD[^>;=
MIW4HN RJ2.K,0,=N< @@'I,44<$2Q0QK'&@PJ(, #T %5TOB^K2V'V2Z41PK
M+]I9/W+9)&T-GEAC)&.A%4/"\.KVND&UUR]M[R\AF=?-B;<=G5 YVK\X4C/
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M,;3XK )9$K&QB&%X8VJ_=]S(.W\0]:]AP/2C% 'F>@ZI%:^+K6XUBYB6RO-
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M2>#ARQ*_[6:Y?1;!+:Z^&EIK:1FY5+T!+H#>(BI,*L#SP-H /<>HKV4J&QD
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M+>S:YECVHH!4!"S!0S9(R 2.!S_,8.H:K<6?Q-TZ4VVIL)M&N&.GHX<EQ+&
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MY<3VDJW$8602[<<$@C&#G..V,YX .KL/%MC-J;:7/!=VDT=G]K66ZC")-$I
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M)S=0PF/<I;&U'#<,#UY QWKIKW7[>PF-I#;75[<QVWVEX+<*72+H&)9@.2"
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M3@'*YQZ&L&P\,>(]'TWPM??\(];ZG-8Z<=.O=-DGBW 9#+(C-\F00<C/0_D
M=6OQ$T62TTRXAAOIO[1FDMXHXX,LDR!MT;#/#?*1W]>G-='IM[_:.G07GV6Y
MM?.3=Y%U'LE3V9>QKC[_ $G5Y[SPM=1:'' MIJ#W5Q;VTD06!&B= ,DC<WS
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MO>2K?1BW=E\A+AHV9 '!!"C=R3G!K=UCQ1-ID&JZC'Y$^GV4,*H%4[I+B0C
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M@MT=/O#:K;/%_P ?!0@29DWC8>3C@] 3G.  =A++9Z78-)(T-K9VZ<DX1(U
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MN1[)4_AB.P*60=B=J$GN5'I6MI=_?7<MW#?Z6]D]O(%1Q*)(YE(SN1L ^Q!
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MY$9,<GF&0@L1EADG&>F><UT/AC7U\2Z*-16U>V!GFA,3L&(,<C(<D<?PUL4
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M$ U6C\.Z5#?"]BM!'<B#[,)(W92(NR#!X&><>O/6@#SC0==O]0TCP/IU]?\
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MZUZRB"-%1<X P-S$G\SS65<^%]#N[F]N)]-@>:^C$=T^"#*H&,-CKP /<<4
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MGPCX?\0W,%SJ^DVUW/ ,1R2+R!Z$CJ/8\4^\\+:%J%\MY=Z5;37"P^0'9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOB=&EC<F6]FD-LHM7S/F!%&SCYOF!Z4 >CZEKFFZ0I:^NEB 0R-\I;:@ZLV
M<+_M'BH+GQ5H-I*L4^K6BR-!]H5!(&+1\88 =0=PQZYXK@GN(]-\132:YI^L
MS:7JNG6T=O-9I<$*R*RO#(D?()+9&1W/O6A964.G^/O#JP:7/:65KHL\2(R/
M(MN6>,JA?D!MH;C)[CF@#H-1\<:+8Z?I5[%<BY@U2X2"VDA!93DX8D@<8 /'
M7(Q5^?Q+HUK-Y4]_&C QJQ(.V,O]P.V,(6R,!B,Y%>:6L-S!X1T25K&]"V7B
MM[F9!:R%TA,LQ#[ NXKAU/ [T>,)[K4=.\6VR:3J%M/]HMY8X+>Q<_:D'E'S
MGD"G<0 1M!&-O0GH >A#Q;II\4W.@EV6>VMUFED92$&XGC.,<!22>GZX=HVK
M6B^&XK^?78M2@:1U6^"*@D/F,H50O!(/R#'7'O6+;3M;_%*\NY;2\6WO=(MQ
M#+]F?;E'D+!CC"D!@<-@\^O%<KI-MJ-IX0\(WWV*\-OI>LW,U]:FW<2+&\DP
M6381DA1(&X!X.>U 'I7_  DVBBPNKY]2@BM[1MMPTK;#"W7#JV"I]B,TMCXD
MT;4]1?3[+48)[M(_-,2-SMSC(]<$X..AZUP/B:PFOY/&VL6$$[V=YH*V4:I"
MQ-U<8DP57&6P&5<X[D=C6FBG_A,_!,D5M.(8=+N(I7%NX6,LL6U6.,*?E;@^
ME '2^(/%%CX=FTZ&[WF2_N!!&%0D#@DDD#L >._YXL7OB'2=.)^UWJ1;4$DA
M()$2'HSD#Y >>6P.#6%X\65)_#%XMO<30VFLQRSF"%I61#'(N[:H)QE@.G>L
MVPE?2M8\86NM6=S(FIR"ZM6$#2"XB:%4\H8!^9=N-O7G/2@#OFFC6W,Y<&(+
MOW#D;<9SQUK@=5\=-J/@ZWUO0KIK8?VG#;N)(>6B:Y\K^(<94$^HS71^!]+O
M=%\#Z-INHMF[M[5$E&<[3C[N?;I^%>=K%./A1::1+IU_]KM=83SH39R'@7ID
M)'R_,-G)(R.: /4-.\0Z1JQNA8:A!.;0@3[6_P!7D9!/L0#@]#BG66O:7J-X
M]G:WB/<K&)?*(*LT9. Z@@;E_P!H9'O7G_B6PO\ 5?$7B^#3()C)=Z##%"YC
M94FD5Y"R!\ 9*L!U_BK8\,7.D:]J]KJ=OHNL0ZE;0M'+)J)G7[,&ZQ@R'#DG
M'3/ SD< @%WQEXE.@WNB6DEXNG6FHW#Q3:BZ B':N57YOE!8\9;( !X]'SZQ
M>>&K+5]2UN\%YI=K;I-;3108D<?/N5MO!/"\@ 8(Z<FK/B6YL2]MIFK:6U[I
M=['*)V^S-,D979MW@ [0<MSV('3K7 0^'KJST#QQI7A\WUSX<ETQA803!VVW
M!1]Z0[N67&W\3@9(- 'I4'B'3Y-+M+Z2;8+D#RXPK,[-C)55 W-CGH.@S4T6
MMZ9/I?\ :45] UEG;YP?C=G;M_WL\8ZYXZUQ$=U/#XF\,:_);7AT?^RY+%V>
MW=3;2DHV]D(W*&V;=Q&./0@UDWVFZI827OB.TL+J?31XECU$V4<9\R2 1>6\
MJIU)+G<!WV@T =1XR\4F+P1JNH^']16.\L9(TDS$"\9+J"K(XRIPV>174KJ=
MF^I2:<LP:[C0.\84DJIS@DXP <'\J\_\8W%KK?@'7[O2-'NE>^-N/-%BZ37;
MJZ_P%=Y"J."1CKCI6MX.O+O3]1O] U.*>:<2FY@U3[.P6]C?D;VQ@2*,*1QP
M!CCH 3^-]6U/2;GP\NGW8A74=4BL9@T2OA75SN&>_P OT]JU(3>V6IR&ZU87
M5K%;%YHF@4.C%AL8;1T(63C':N;^)D2W4OA:%[.:[ABUN&>X1+9IE6$*X9F
M!XY'6M33[G0=-U69M(TJ: W$.^Z>&PDBC5(PV#C8-SDO@ 9)'TH U;/Q+H^H
M1V<EG?Q3I>EUMFCR1*5^]@X[=Z=/XATFUO5M)[Z))6E$ SG:)",A"WW0Q'12
M<G(KAM CE\-^+TO#ITXTKQ"KS11QP2,=-D)#%6&"$$G!;H XQT -+X=NQ:0W
M?A77-"NKO4H]3FN(3):,\%P&F,B3>;@JH&X9R<C;@ GB@#2L/&4.FZ_XFMO$
M.L01V]I>Q16ID54VJT2.>@Z OU/MS73ZCK^EZ4Q6]O$C98C,P +;(P<;VP#M
M7_:.!7GNHPR2VGQ2"V5RTE['MML6SYG/V54&SCYOGR.*35+BXN([NQ_LV^A>
M;PXD<,]O9.TEX^U\Q.^T[ I/W3@DMU[$ ] N_$VAV$T<-SJMK'+)%YZ(9 2R
M<?, .QR,>N>*?!X@TFYT>/5H;^&2PD(5)E;(9BVT*.Y;=QCKGCK7!Z.6DU[P
M!,]E=HMKHDT4KRVKJ(G*1 !B1\I.U\9Z_B*S"AM_",MQ)!?0S6OBQ[RW46<C
M9!G9E8H!N9"A/W>^* /3;?Q)HMU)<Q1:G;>=:JSW$3N$DA4=2ZM@J!D=0.M2
M6&MZ=J=Q/;6ETKW$ !EA92CJ#T)5@#@]CT->9W<D.MZ9XINM&EN+G6[V6UO9
M-/\ L\UL6BMVC!1-ZJ6)"D%AW8# XKI-"O\ 0[J[N?$EEI&LK/;V#1SSWB3^
M:%!W^2J2$[SD$_+G!XSS0!W%%06=TE]8V]W&DB)/&LBK*A1U!&<,IY!YZ5/0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5D:[H*ZU]DD2_O+&ZLY3+!/
M:LN58J5.58%6!!(Y'>M>B@#,TW27LY//N]0N=0N]A037 1=JD@D*J*J@$@9X
MR<#G@5IT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HJHNHP-J[Z8%F^T) )R3$VS:6*_?QC.1TSFK3,$4L<X SP,G\A0
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MC6\\-TEPSR/>*J7#YP70#&SV7EN!_>/.3FM  *    . !0I+*"5*DC)![4M
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M^@BN?D\ :?+'KB/J&IL-:C6.\)F4[L($)&5X)  ]NV*Z2SMA9V4-L)7E$2!
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M?[7\(31OK(T:9+:*S<$XV;E\U1W#@ ;N<L: /0PZ,S*&4LO4 \B@.I. P)]
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M_9VM6(VFX@!C)$R_WON'=D@DGN37I) 92I&01@B@!-Z9 W+DG &>]#.J$!F
M+' R>IKQ%],TZW\!:GJD5O$M[9>)V%M<?QPC[<HPA_A&TG@<&NLMH['5_$?C
M>Q\2)$6AV>3YX'[NS,0PZ$]!N#DD=&^@H ]$I&=44L[!5'<G KG/ $FIS> =
M$DU@R&_:U4R&3[Q_NEO?;C/O5?QI:7EY/I(TRZL1J,,DDT-G?H6@NP$PRG'(
M8!L@C..>,9H ZP$'H:*\FM+VP?4_A_J9T^/2(UN]0MY(Y&7;"^R4% _ *[PV
MW\*SO[6M+'3-=D@DB_LG_A+T.H"'&T6C)'EB!_ 6"Y[$9'.: /2?&/B&?P[X
M4N]9L8(+IH"N5DD(7!8+G@'.,]./K70!E8D!@2O! /2O*_&D7AU? _BVZT*X
MBD%TMJ]S]FE#0*P=57;M^4,1@G'/W2>HK:L+&STGXPR6]A!';QW.A>=.D8QY
MKK. ';^\V&/S'GF@#NZ;O0N4#KO R5SSBG5XNNIZ4USX7U2RN+:WC?Q#-N:>
M4-=E6\X.97R-JDX 0@\;.>U 'LQ=0X0L-Q&0N>3075652P#-T!/)KR[0KGP_
MK%E<1>()T3Q)::U([H) ET95F/E*G\10H54 <8S[FBUN?#^K2>)K#Q/<)%JT
M&KL8P9 ESY:LIM_)/WL$  !>I)_O<@'J+.JE0S %C@ GJ:=7G%O'8ZOK/CJS
M\2)$9864Q&<#,5GY0*.A/0;@Y)'1O>LO0)IK?7/ U[XB>.&\N-!N4GFN2%:0
M@Q$!R>K;>3GWH ]:) &20.U5;_4K/3--N=0NYTCM;9&>60GA0.OX^U>-VZ:=
M=>%M*C0Q%8_&I11&VTHC7+X QRN1C\JL^(M-L;.T^*&G6EI!%:16%K<I;QQ@
M)'(8WRZJ. 3M'(]* /6)IKYKG3VM$MC:2,QN3*Y#JNTE=@ P3G&<]JN%T!P6
M7).,9[^E>=W\6ECQ7\/9-.2T$7G72*;<*%(^S.2!CCJ?S-<KJ&EZ;%X$\::B
MEO"+NP\0RFUG_BMR)HON'^#\,9H ]N9T0J&8 L<#)ZFG5Y=XFEM&\4^*;"]N
M+"Y>]TN&*U2XNHXC:.1(,?.00"2'W)DC XZ5WOAO3X]+\-:=91RQ3"*W16FB
M^[*V!N<?4Y/XT :A.!D]*C::-8&F+@QJI8L#D8%<AX]NGM[SPRES@:/-J:QW
MQ;[ARC>6'[;3)MSGC(%9Z:=%#XP\664$$)T-]-BGN("@,*77S]%Z E%5C_P$
MF@"R_C;4XM M?$AT^VDT>]@1X5$I6:*21U2)6ZA@V\9(QMYZ]]RQG\3_ -MM
M!?VNF?V:N[%S%*XDDX!7$9SC!W Y;T(KS>YTW2U^ >A3FRLQ(W]GLTGE+DL9
MH@Q)QU(R#[5UFI6=I9?%3PHEK;PP9L+Y=D:A1@>40,#ZM^9H [C>N_9N&_&=
MN><4;TW[-R[\9VYYQ7EW@^Y\/ZUHVCRZK.J^*+746:>-9 MT;H.RLK#[Q3!Y
M'3:/1>*>C'2==MH3JNM"T\1V6K.\D$:1K=^>)6 0$C<R,I QTV\< < 'KN]=
MVW<,YQC/XTZO.?".B:-+XF\57UQ:P&6PUII()&/^H_<1Y(],Y.?7 ]!CO=/U
M&RU6QBO=/NH;JUE!*30N&5L'!P1[@B@!FIZG::18M=WLRQ0AE0$]69B JCU)
M) K+_M^X7QX^@200I:C33?+/YA+$^8$P1@ #KZUD?%:"VE\$F2YBB=(KZT;=
M(H(0&XC#')Z<$@^QJG+INC:I\5(+1[6TN=/_ .$=)2 *&A(^T8'R_=(_K0!Z
M$SJJ%V8!0,DD\4 @@$'(/0BO%-"U2*WT+P1#JM[';Z-)'?0+-<*KPB9)<1*^
M[@80.%S7I'@FPT_3=%GM]*U![ZQ^UR/%)E3&FX@E(MO&P$D#'0Y':@#I*:KJ
MXRC!AG&0<UR?Q(O9=.\)?:1YGV-;RW^WF,'(M?-7S>G."O!]B:YOQ7+HUIX=
MU[5/"<ZR2316QOSITH:-(!( S )P',9;D<[1GCB@#U!75\[6#8.#@YP: Z%@
MH9<G.!GTZUP=U8VB?$+PZVB16XLKVPN1J,=NH\J6W"KY3,!Q]YL ^A(Z5Q^A
M6%C:^"?AYJT$,:7[ZS% ;H?ZPQLTJE-W7:1_#TH ]BM-4L[ZYO8+:99'LI1#
M/@\(^T-CZ@,,U:#J02&!QUYZ5XWJ%GI$>B_%*(V]DEXDDSQ+L42*OV:-@1WQ
MNY],UKZE8:?HG_"(R16L46E:E>1?VK+U69_)(A\PGJ"Y!)/4@9H [S7=2ETS
MPYJ&J6D<5P]K;23JCR%5?:I/4 ^E8L?BN\:_\'P&T@\K78&EE<.=T;"'S,*N
M.F>Y/X5SVH6S6&H_$&WL0(](.B^;)&G$<=T8Y-VT= 2@5FQZ@GK4D++_ &C\
M*OF'-K+CGK_H= 'I&] X0LN\C(7/.*;(YV,L;H)2"%#=,XSS7DFG'2==AFCU
MC6Q9>(;+5Y&:)$C6[\T3-Y:H2-S*4*J .,<=JV_!N@Z1<^)_%%W)9PO<66N,
MULQZPDP1Y*CMG)SZX'H, '::/JT6K6\S*ABN+>9K>YA)R8I%ZC/<$$$'N"#6
MA7 :/J-MI/CSQ]?7]U%:Z;&]ANFF<*BR&'#<GC/,8_$5WR.LB*Z,&5AD,#D$
M>M ".Z1KN=U4=,L<4I(&,D#/2N'\4W&ER^,K2PNC;BY&F3R!K]@;98V=5.$.
M-\AQCJ,+GKTKCM#2RU?2OA9]I:.Y;,]O+E\D@6[_ "-STZ9![''>@#VE65U#
M*P(/0@TM>5Z?X4L=>T/QOX=@BAAB@U=S8*$&VVD\J)U*C^$;\Y [$CO6_P"#
M;O\ X2F:/Q#=V MI[.W^P*CQX,<P/^D;?]G<%4?[K>M ':T4A 92K $$8(/>
MO,K'2HM-\1ZQX'%BG]GZE<)J<)$0V"W)_?(>,8#H% Z@2CTH ]"B>_.JW"2I
M;"P$:&!E<F4OSNW#& .F,'UJT'5F958$KU /2O,=3%S8>)_B ^B1[+Y="MY(
M5B'S>8!-@@#OTQ^%6M.F\-7VG6>K>%IHGUI=)E2"*UD!8Y3/[Y1R2' &6_B;
MWH ]$#H79 REEZ@'D4ZO*_"2Z!JY\-:K9:XAUB"(JUK"J+,[%/WBW  W$ @D
MEN^#DDC/=Z-)XF>>0:[;:3%#M_=FQGDD8MGN'1>,4 ;-%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %(Z+(C(ZAE88*D9!'I2U6O[ZW
MTRPGOKMV2W@0R2,J,^U1U.%!- !!IMC:F(V]E;PF)2D9CB5=BDY(&!P">U%O
MIUE:3S3VUG;PS3G,LD<2JTA]6('/XUAV/CWP]J.HVEC!=R^;>1>;:M);2(DX
MV[B$<KAF Z@'(Z=13K/QUH%_<M!!=3'8TRR2/;2)'&8N7#LR@*1@\''\J -J
M+3K*WNY;N&SMX[F;_6S)$H=_JP&3^-)_9MA]O^W?8K;[9C'VCRE\S'3[V,UG
M1>*])DOFLY)I;:86YNE%S"\6^$?>=2P&0.XZCN*23Q'IT]G=;GO;=5M#<&3[
M-(&$1XWK\IR>^,$CN* -*?3;&YN%N)[*VEG5#&))(E9@IZKDC.#D\4G]EZ?Y
MD<GV&UWQ*%C;R5R@'0 XX%9FGZWIUMX>T:1+VZO5O((_LCR*7GN1LW;B  <[
M>2< #OBL3P;XB,L/B:YU"_N9H+?6GMX/M$9$BC9%B,( #G<Q  &230!UHTG3
M5@> :?:"&0AGC$*[6(Z$C&#3GTS3Y9GFDL;9Y7&UG:)2S#I@G'(K&G\<Z#:6
M.I75U<3P#3"HO(GMI/,BW#*DJ!G![-T]ZEC\8:1-=WEI$UT]Q:VYNC%]ED4R
MQ9QNCR!O&>,CCF@#1&CZ8%C4:=:8C.4'D+\I]1QQ7)1^#-2:6>&_B\.ZC%+*
M[_;;O3]]P0S$X8$[21G .0, <=JZ#PIX@7Q-X=L]56"2'[1&)-CQLN,\C!(^
M;CN.*EU#Q#I^FS30RM-))!$)ITMX6E,49SAFV@XS@X'4X.!Q0!>LK6.QL;>S
MA+&*")8DW')PHP,GUXHN[*TOX/(O+6&YBR#Y<T8=<CO@URGBOQ9%;6.@MITT
MLMOJU]!%]HMHG?,+!F.QE!^8A<8'S8)(Z9&[I-J^E:;,9+Z^OHF=IXOM"EI8
MT(!$?3<V.<9RW.* +DFG6,ULEM+9V[P1XV1-$I5?H,8%,?2=.E\OS-/M7\H8
MCW0J=@]N.*\_U3QI-J_@K2]>LIKO35;5X(Y%*% T)N-F"Q'/RCG:<9R*[*Q\
M5:1?G40D\D#:< UTMU \!C0@D.0X!VD \^U &E'8V<-R]S%:0)._WI5C 9OJ
M>II+33K*P,IL[.WMS*VZ0PQ*F\^IP.35*R\1Z=?:JVEJTT5Z(?M"PW$#Q,\>
M<;EW 9&>#W'<"LWQIXBN=&BTNPTX1_VGJ]XEG;O(NY8@>7D([[1V]2* -V/2
MM.AEN)(K"U22Y_U[+"H,O^\<?-^-2VUG;649CM;>&!"<E8D"C/K@5BW>BZI#
M9HVG:Y>M=HZ,_P!H*,LRA@64C: I(R 5QC-37_BK2=--R;B:3RK1@MU-'"[Q
MVY(! =@,#@@GT!!.!0!M$9&#TK,TG1X])L7TV/:^GKD01,N?+0DDQ^ZC.![<
M=LFK=^+]'L]2DTYI+B6\2W%UY-O:R2L\9. R[5.[GTST.:KVWCSP]=_V<T%W
M*\.HNL=O.+:3RC(W2,OMVJYP?E)S0!M0:5IUM:O:P6%K%;/]^&.%51OJ ,&I
MK>VM[2(16T$4,8.0D:!1^0KF[_XA^'--DO4N+FYW6,@CNA'9S/Y&0#N;"\+@
MCYNG/&:O7OBS2+(#-P\_^B?;C]FC:7%O_P ]#M!^7T[G!QG% &Q+#%<1-%-&
MDD;##(Z@@CW!JJVCZ8T<<;:=:%(_N*8%POT&.*S[KQCHEK/8PO<R/)?P&XM1
M#;R2><@ .5VJ=QP1P.>>E0CQSH/]EVNHFXG%O<W/V-#]EE++/NV^6ZA<H=W'
MS8H Z)5"J%4  #  [5'-:V]P\;SP12O$=T;.@8H?49Z5"-2MCJITP&0W0A$Y
M7RVVA"2 2V,=0>,YX-9WB"^LK6[T:&ZU&\LY)[Y%@6W4[;A\']VYVD;2,G!(
M^[UXH O?V+I7E-%_9EGY;-N*>0N"?7&.M/FTO3[B6"6>QMI9+?\ U+O"K&+_
M '21Q^%8=W\0/#UF;[S;BY(L)1%=E+.5O(. <OA>%P1\QX],UTRLKJ&4@J1D
M$="* (!868NS=BT@%R>LPC&_T^]C-(=.L6OUOVLK<WBKM%P8E\P#TW8SBLV;
MQ;H]O=0PR7#A9KK[&D_E-Y1GY'E[\8SD$>F1C.>*Y?2/&,&BWOBA==U"\FAM
MM7,22F%I%MXC''C<47"+N8\G'?WH ]#JNUA9O=?:FM(&N,8\TQ@OCIC.,UFZ
MIXKTG2);F.YFD+6D N+GRH6D$$1)P[[0<#Y3[X!/2J^I>-]"TJ[-I<7$[3_9
MOM82&UDD+19 W+M4[ASVS@ YZ4 ;%KIMA8L[6=E;6[/]XPQ*A;ZX'-62 001
MD'J#6'?^+]&TU+N2YN)!#9E%NI4A=U@+ %0V!P<$<=LC.,U+=^)M.M+?SF^U
M28@^T,D=K(SI%S\S+C*C@\$9.#@'!H M?V-I7E&+^S+/RRVXIY"X)]<8ZT^?
M2].NGA>XL+69H/\ 5-)"K&/_ '<CC\*?8WMMJ5C!>V<R3VTZ"2*1#D,I&0:S
M+SQ;H]B96N+AU@@F$$]R(F,,4AP-K.!@<D GH"<$B@#;JO=V%G?JJWEI!<*I
MRHFC#@'VS7*>(-<,GC33?#F^_AMI[6>::2UCE#LP\L)M=1T&\DD<9 !]#OB>
M+PWX<$VKZF\T=G#F>\G4!G [D*.OT'- %J?3;"YM$M)[*VEMDP4ADB5D7'3"
MD8&*>+*T6.:-;6$).295$8Q(3UW#O^-5-.UVRU.^NK&$RQW=JJ/+!-$R,JOG
M:W/4'!Z>G-1ZQXDTK0);2/4KAH6NW,<.(G?>P!.,J#S@' ZGMF@"RND:8EDM
MDNG6@M5.Y8! NP'U"XQ3TTVQBN%N([*V295VK(L2A@,8P#C.,5A)\0?#C:-?
MZH;J>.#3Y/+NTDM95EA8] T97<,^I&*BN_%&C:A<:?&NI:E:,-32"/R[:2-;
MF3:2(R63!C8'.<C..#0!UE5!I>GJS,+"U#-*)F(A7)D'1SQ][WZUB7OCW0+"
M34(YI[HOIS 7@CLY7\D$;MS87A<<[NGO6E>^(-/L@@,DD[O";A4MXVE;RA_'
MA1P/Y]LT 6_[.LC?_;_L=O\ ; NW[1Y2^9CTW8SBA].LI;V.]DL[=[N,;4G:
M)3(H] V,BL(Z_H^HZOX>EMM8NO\ 3(Y9K2*!6\F[79D[SM_A R!D$$]*AF^)
M/A>#<TE[,L27)M99C:2A(9 =N)&VX3GCYL4 =%<Z;87LT4UU96T\L7^K>6)6
M9/H2.*==6-I>^7]KM8+CRG#Q^;&'V-ZC/0^]9>I>+M&TF6Z2ZN'Q9K&]V\<3
M.MNK_=+D#C/7V')P*SS>7B_%F&Q^V3-8R:))/]F)&P2":-=PP.N">N>M '0/
MI.FR($?3[5D#F0*T*D!B<ENG4]S3ETVP6665;*V$DH*R.(ERX/4$XYKG/B1?
M7>F>#9KZSOI;22&XM\O&0,JTR*P)(X&&/3%6K?QUH-S+?PK/<)-8P_:)HI;2
M5',7_/15*Y9?< T ;']E:<?)_P! M?W Q%^Y7]V/1>./PIG]C:7Y;1_V;9['
M;<R^0N&/J1CK5:/Q-I,L^D1)<.6UB,RV)\E\2J$\SKC"G;S@X-+!XCT^YGBB
MB,[+,7$4H@<QR;,[MK8P>AQZXXS0!@WGA/47UF[G6'0+^RG93$FHV99[50H7
MRTQP4X) XY8^M=+HNE0Z+I45A $$:%VQ&@1 68L0JC[JY8X'88%8.G^*]!TW
MP]#?2:Q>W-G<7SV\=S=1.6\PRE=A^4;5!R!N X%:=CXKTC4/[1"3R0MIP#72
MW4#P-&A!(<AP#M(!P?:@#6G@AN8'AGB26)QADD4,K#T(/6H8]-L8;(V<5E;)
M:GK L2A#_P !QBLY/%FD&[N+6::6UFM[8WCI=0O$3 .L@W 9 []QW IX\3:<
MJ7#3&X@%O$DS^=;NN5<D+C(^8DC&!SG QS0!;.CZ88! =.LS"IW",P+M!]<8
MI_\ 9MCYT<WV*V\V(8C?REW(/8XXIECJD&H2W$4:3QRVY42I-$R$9&1UZ\=Q
MD4R?6K&VUFVTB61UO;J-Y84\IL.J8W8;&.,CC.>: )TTZRCOGODL[=;MQM><
M1*)&'H6QDBC^SK'[?]O^Q6_VS;M^T>4OF8]-V,XK'D\<:!#8B]DO)$@^VG3R
MS6\@VSAMI5LK\N#W.![TT^*]'U#3]95;J]M381?Z43:R1S0JRDB159<XP"0<
M'I0!LQ:=9VYE:VM+:%Y00[)$!N^N.M1Z3I5MHVGK9VJ*D8=G(50HW,Q8X X
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MDN9)([>UB8\/-(P1 ?;)R?8&I'U&#2!#9W,US=W;1-,WEQ%W901N?:HX&2,
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MG,3AMKJ<,IQT([B@#E+"WO\ 3OB/J]W/83/:WUA:A;F%08U:+S-X/.<_,,
MDYKF-+T36K3PMX5O!IUR9]%U6XGNK%EP[12O*-R@\,0L@( ]QUXKUBB@#S3Q
M'HM[JK>+M8M+*ZVWVB#3;6 Q%9+B3YR6*'!4#<J@MCH>V"=$6UW)XQ\(70L;
MH06NG7$-Q(86 B=Q$%!_%&KNJ* .-^)-K))H>FWZ F/2]6M+^<#_ )Y)(-Y^
M@!)/L*;XQTI=2U*VFC_M6ROK>W9K35=-1G*,3S$ZC.Y3A3@C'!Y'?LW19$9'
M4,C##*PR"/0U35[#1X+>U>YBMXW<16Z32@9)Z(N3D^@% '$PQZ]8>)/#6LZG
MI,]S,VBO97:V**PBG+1OR,@!3M(SG /M6+IVF>(M(TG0-5&AW<LFDZI?/<V*
ME?,DAG=_GC&>2H8<'!.37K4TT5O!)//(D44:EWD=@%50,DDGH *(9HKB&.:&
M1)(I%#HZ-E64C(((Z@T <'XC^WZQIVD7,.A7=L!KEK=M"8AYPB1@7DD"D@'T
M&2< ?0:6B6]S'\1?$]Y):W$=K=06BP3/&0LAC#A\'VW#Z]JZVB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JOJ%Q-::=<W%O:O=
M3Q1,\=NC &5@,A03P"3Q5BLWQ!I;ZWX>U#2X[I[1[N!X1/'UC+#&: .>L/&5
MR^MW6F7$%O<RQ:6=0'V)B2&5MK0]2"P..0?P%7?"GB9O$L:74%Q87-F\ =FM
MF.^"7(S$ZDY! SSQG!X'?/MO!^MQ:M#J;:S9QSII+Z;MMK(HJ<AD9,N<8(&?
MR '6K^E>%FM?%+^(;C[)'>26?V686<91;@E@WF.">ORX YP">3Q@ Z>N2TKQ
M;)J^OS:?;M9J]M>2V]U92$K<PQIN"RX)^96(0C P _4XKK:Y&?PA<:AK6G:A
MJ$]H\VGWKW,-W%$4G,9+;86.?N@, 3W"]!G- $(\97T&M:39WMI;0_VA>RVA
MM1)NGM@ YC=R"0=P3..,!AR<&LW1]6@\.S^.+PP[\:Y'%%$@/SR21PHHX!/+
M,,X!/7@U+:> -8MK;2+<Z[;.NE:D][%(;,EY@V_=YAW\O^\/(QTYS5N?P%+?
M67B6UNM1"C5[M;V&6",J]K(@381DG=@QJ>W>@!9?&.J:?_;!O-&GG@L[+[9#
M=16LT4<G.&C(=<AAUXSE<G'&*VO#NLMK<4MQ%=6%[8E4,%U9L=KDYW*RDDJ1
M@<9[_@*=GI/BK^SY1J/B"UDOP@2WD@M"D8PP)9UW?,3MQP5 !..M43X8O-&7
M7M6TJ>TT[4=0CA4);6IDB5D)R_E\;G8,1V[=>20#M:RM=U&[TZVMWM8(W$DZ
MQS3S.%CMH\$F1LD9 P!@$<D5=L6NFT^V:]1$NS$IG5#\H? W >V<UD>)]!O-
M9?2I[&]BMYM/NQ<A)XC+%+\I7#*&!R-V0<\$4 8UGX^:XTMV-M"]^VL-H]N$
M<B.:3J).>579EB.>F,G(K,6\U#1_'GB^_DM[.:YM=$@G41LT23!6E;)X8J>"
M._0<C/%J7X=7\EM>$:W&M[_;']LV4ZVN!%-M *N-WS*1D8&.O4U;D\(:U=ZA
MK-_=:I8B;4]+73V2*T<+&1O^8$OD_?/'?VH CA\8ZZ]UX<5M+L3'KUL7MP+A
M@T4@B$IW_+C;C/3)X[U6U+QG>KX)\1W5_H]A<W6CWAM+BW:0F"4?(0P!4D\.
MORGT/-:D7A&^CF\)/]OMS_PC\;(P\EOW^83%G[WR\'/?FJ=]X#O[W1/%&G?V
MG;)_;MV+G?\ 9V/D\("N-WS<1CGCJ: -'4/$&LKXS;P[IUA9,3IQO([B>=@,
M^8$PRA?T&<^HK+'C*34?#?A759='M7_M'4X[65)7W?9Y-[(73Y>2"C8.01D5
MN?V#?_\ ":+XA-W;8&FFQ\CRFZEP^[=N]1C&.G>L6W\!ZA;^&]#TD:G;,=+U
M,:AYOV=AYN)&?9C=QRY&<GH.* +]OXMDO?$EWI-LUFES:7:PR64Y*3M%@$S)
MDX9>>@'09SGBL*/Q;X@TW0_&NL7$=G>#2]0ECCA+N@54CBP!P>,$GMDD]*W-
M2\(7&L:A:37\]H_V/4%O+:Z2(K<1('W>2&SR#T)].,9YJI?^!+^YTWQ3IL.J
MVZ6FNS/. ]L2\+.J*V3N 8?)P,#KR: -"36O$5ND3WEAI]M!//@77V@LEM#Y
M>[=*#MRQ;"@*<9/7UYZ\\9ZOJ>@Z+=6(M[:67Q NFW/WB'V2D97H0K;.<\X)
M'O72:QX>U/4+C0+RWU&VBNM+D9G26W:2&7<FPG:&!##D@YXR:R%\ :C'I+6J
MZS T\6N?VO;2/:G:&\PN5<!QG.X]"* -%_$ LO&E[::A8VD2VNC"^DOHR6<H
M'(*\@$*"K'&35=O&5[:Z=H6M7EG"NDZO+#&%1CYMKYP_=,QZ,#D!L8QGC=BK
MDOA6:[\4W&J7MU#-:W.D_P!F30"(JS+N+%MV[C.XC&/QJK9>"[M=(TK0]0U"
M*ZTS2YXY82(BLLJQ',2/S@;<+DC[VWH.: ,Z^\=ZY;:;XCU!-)L/(T*]:&=3
M<L6EC548[?E^]AR><#H.>M>@HP=%<=&&17$W7@:^NM$\5::=2MU_MZX:;S/(
M;]P&55(QN^;A!SQUK8LAKL7B?R9[F";219 %$MRACF!7!WD_-N!8X[8'KR =
M!7'W/BV^ETW7-5TJTMY[/1YY89(I&(DN#$ 9=I'"XY R#DCMFNPKCE\'7EHN
MO66G:A#'INM2R32))$6DMY)!B0H<X(/4 ]#Z]* ()/&6KZCK5O8>'].L9X[O
M2%U2VFNKAD!5F488!3@X/;/U%=N,X&0 >^*YBR\*/IOBNSU.TN(4L+72ETR.
MU,9+! P8-OSUX QBNHH XCQO+J(\3>$(;5H!#)J+';)N^9U@E(W8[#K]:9#J
M:Z-KOB>TL= TR":RL4OS)"VPW)<R$[R$R.5;UZ]>:VM?T&\U;6-#OK>[@A72
M[AK@I)$6,I*,F,@C'#'UJI=>%KZ?7-=U%+ZW5=4T]+)8S"Q,6W?AB=W/WSQQ
MT'- %/2O&.K7-[X6^W:?:16GB"U,D1BF9I(I!#YOS C&TC(&#D<4X>,KZ'6]
M)L[VTMH?[1O);4VHDW3VP <QNY!(.\)G'&-PY.#4EOX.OH!X0']H6Y'AZ,QG
M]PW[\>3Y6?O?+QSWYK/M/ &L6UOH\!UVV==*U%[R*0V9+S!]^[S#OY?]X>1C
MISF@!EWX]URVTG7]4_LFQ^S:)J#6UPOVEBTD:B,DI\H^;#YYP.@]ZW[S7]1N
M;_5['0K:">XTN%'D6=B/.D=2ZQ+@C;E<?,>!N'!YK*NO M_=>'?$^DG4[9?[
M<O'NO,^SM^YW! 5QN^;A!SQU-6;CPKK=MXEGUO1-8M;22_ACBU"&>U,J.R#:
MLB88$,!Q@DCUH 6]\6WYDGM+'3BFH6MG%<3P20R38D<$B',0(!^7ENG(P#SB
MIXEUR>V\+Z+XO-E/87,%Q!]IMIE*NL4KB.2)O7E@1[JIJS>>$M8M=?76/#VN
M1V\TUM';7L=];F=)PF=LG#*0XR>^#FG^)](DUC3M-\-B9[DO=0SWTS]1%&_F
M,3C@%F4*![G PIP =?16+IK:S_PD>JK=SQ3:7B,V@6 HT;8.Y=V?GZ Y[9QZ
M@;5 '%GQE?6^M:5:7MI;1?VA?269M1)F>W #F.1R"00P3.,# 8<G!JA>^/-<
MMM+\0ZDNDV/V?0KYH)U-RQ:2-0A.SY1\V'SS@=!SUIUMX UB"VTJW.NVSKIF
MJ-?12-9DR2AO,SYAW_,_[P\C'3G-6+KP+?76@>*=+.I6Z_V]=/<>8(&_<AE5
M2,;OFX0<\=: -5?$5S#XU?1+Z*WAM9+(W=I<;CF4*0'4YX!7()ZY!SQS6GH5
M[<ZCHUO>W<21/.OF*B9X0\KG/0D8)';..U<GXEATOQ3J.F^'A>A]:L+E'N1;
M9!AA:,^:&]%=#MZ]67TKO0   !@#M0!D^)-=B\.Z,]])'YKF2.&&(-M\R1V"
M*N>PR1D]AFLR7Q#J5EXDAT"]BM/M%]:R3V%S&&$;/'C?&ZDYX!!R#R,]*T/%
M/AZ'Q1H$^F2S/;LS+)#.@RT4B,&5@.^"!QW&:KV^@W=UK=EK&LSV\MS8V\D,
M"6T950TFW>YR2<D* !VR>3G@ X&34-2U?X>^"M6U 0W-Y/K=G*A&026D8D$G
MISQQT%=2/&]U8/K]MJ]E +K3)+98Q:.S+-]H.V,<KD'=P< ^H':J]MX"U.W\
M,Z'HO]KVKII%_#=1/]E8;TB8LJGY^ISR>G'2K&I^ Y=8O?$DMSJ*QQZO';",
MPQD/;20$F-P2?F^8YQ@=* "?Q?K5DNM>;HQFCLM/:^@NC#-;PR;<[HFWJ2'&
M,C&01Z5L^&=1UC5;);W4K.SMK:X@AFMA!,SN=RY8." !CC&">OMSGCP_XDOM
M U&QUG7;6XN+FTDLXW@M#&BAQ@R.NX[G^F .?6M[1;&;3-#L;">5)9+:!(3(
MBE0VT 9P2<=/6@"34]1M](TJ[U*[8K;VD+S2$#)VJ"3C\JYI_%E_8?V!=ZE:
M0+8:U+' ODL2]K+(NZ,-GAP<8)&,'UKIM3TZWU?2KO3;M2UO=0O#* <':P(.
M/SKF[/PC>M9Z)I^K7\-U::-,DT#)$5DG:-2L1?)(&W.3CJ0#QR" 9.EVU[J_
MC+QK9W\&G7=N'M8VBG5G3 A#H #VR<GW)Q6'IMY):?!Z#Q!J6D:9JTEK-++$
M+D$L&DN'5VY4Y.6Z<9]:[W2] O\ 3?$6O:J;NVD&JO$ZQ>4P\HQQA!D[OFR
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MY<WFM("4+'(^8C&>0: +%_XOU#1]1U/2[RSMIKR#37U*TD1VCCG1.'0@ABK
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MU>'4YX!>:!J5K+&99;O25?*R#:%$C%W#$KG'.0%]* .XHHHH **** "BBB@
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M,&'7J<G)-7O#,USXF\.:/XE.N7%I<O=E[F,.6B9=[)]G\O(5?X0&QNR,\DT
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MFI]BCA\*_%2427+,L]Y&!)<.XQ]EC/0D@GWZXXZ4 >JV=RMY96]TBE5FC60
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M@D^5MISUA*NQ]1C-=2^LW5MJR:1'H&L2P I&-1!B:( @?,2S[SC/)*DY!ZT
M;J1I$@2-%11T"C IU>//=ZO'X%FUP:]J9OK/76MXR9OD:/[9Y6UUQAAM/?I@
M8Q702W=QH/B[7K%M=NDLO[!&H>?>MYXMI=\BEU![8 .P<<<"@#OI7,<3NL;2
M%02$3&6]AD@?F:SO#FNP>)= M-8M8I8H+I2R)* & #$<X)';UKDO#M[J$7CJ
MQL7GO397.AFX9;N<NTDBR(OF[26\O(8_*#Z9 (K$^%VHC4-/T?1KN6ZL?LEH
MUQ:QI*4%^#(P9LJ>0AXV]><]#B@#U&UO);B[O(7LIX$MY B2R;=LX*@[DP2<
M#..<<BK=>7ZIJ.JPZ1\2C'JUZLFG,'M9 XW1#[.K[5XX&2>E:=C)?:=X[T*
MZI>W4.IZ7-+<17$NY!)&8BK*O13\Y''7OSS0!WM%>7:?)XBU:PT%ENM4BU=M
M3DCU8QEA L :3=M)!CP,(%*\GIS\U>HT 4M6U2VT739;^[8B*,JN%&2S,P55
M'N6( ^M1:7JDVH37D-QIEW8R6T@3]^H*2@C(9&!(8>OH>#7-?%.V2?PE$SM*
M"FH68&R5D!S<1@Y (S[9Z=JEMC+!\3+C1UN[QK Z&DWE27,CXD,S*6!))!P
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MR[BFEMM1M)HX.97CG5A'QGYB#QQZTD.M:5<+*T&IV<HAC660I.K;$895C@\
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M[*]CM[5F80[PT2OCYF.6^;M^5 &C)X/T.:/5(Y+65DU4@WH-U+^^P,<_-QP
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M,]D# YQDCKTZ4 =;7.Q>!?#L-K;6L5C(D%K<"Z@1;J4".0$D%?FX R<#H,G
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MKNQD2S-Y%+<A DT*D*S##$K@D<, <'I7,7_A;7W\*^,]$BLH7_M2\GN+287
M&X2E2,@CC&#G\,9K4U/P_?ZOXJ@N9+5X;%]%N-.F?S$+(\I0Y !Y "G\<4 7
M;7QWIMQJVFV+12QKJBL;.9F0K(0-V& 8LA*\C<!Z<'BMW5-3MM'TZ2^NWVQ(
M57CJS,0JJ/<L0!]:Y;PE:^*+.&STO5M)TZ&.Q01MJ4,P<W*J,+MCVY4GC))]
M<#GC6\9Z)=Z_X:FM-/FCBOHY8KFV:493S(W5U#>Q*X_&@"M;^-[6XO\ 4-.3
M3[M]0L[870M86BD:>(G&4(?:2#P02#GUJ?P_XPL?$JVTFG6UTT,MN)WE;RPL
M!)(\M\,2'RIX ..^*KZ=<^)FL+BZN/#ME97:0E(K6.Z63SI#CYBX "H,=.2<
MGT&:.C>'-2\/^(KN*UC>XT358_.O2SJK179X>1%ST88R!T(&/2@"XGC_ $EK
MW3(MD@M=3F\BTN@Z%7<@E<J&W*&QP2/KBK!\86Q>UEBL;V:PN;S[%'>1(&3S
M-Q7. =VS<I7=C&?;FL;PAIGBC1K:ST"]TO3C:6!$<>K),"TL*GY1Y6W(?  )
M)P.3SW7PIIOBKP[ OAQK.TDTRWG=H-4^T?-Y#.6VF+&=_)&<X[\XY -*?QW8
M6VA:WJTEAJ'E:-<M;7486/?N4*2R_/@KAQWS[4L7B:]E\>WFAC3)C;6]E'<"
M56C)8NS#)RP('R8 &3G.<#%<SK/A?Q'+I/C31;.PMY8M9N6NK>Z:Y"@;EC!0
MKC.04Z],'\#T-OIFL6WCU]8-G ]K=:9#;RE;CF*2-W8@ @;LAQ@\>^* *=AX
MNT?1_!Z:M:Z7J@TY]0E@D#,KO#(TQ0LY>3A=Y[$XSVKHM0\16FF3W2744R16
MMLMQ+/\ *44,Q55^]N+$J<#'XUA>'?"TS^!M1\/ZW;"-;R:Z+ .K_)+(S@@C
MN-P_$5#_ ,(AK%_\-[G2M0O8O[>N$C=[GJGF1%?+S[?NUS[ECCF@#9TSQ?9:
MCXADT-H9+>^%N+J-6>-UDCSM)#(Q&0>H/KQD5I:MJ]MH\$,DX=Y+B9;>"&,
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MPSC(!PQ!P#@=>E:7@S1K[0]*N;2ZGN'M_M3M917,OFR008&V-FR<X(8CDX!
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MVR:X8S<%HH\J555)7 ')"#V SQWK1O=*^PZXOBNZO7<V.GR6[PPVQ;>A(=B
M"3NRHP!]*Z6B@#DO"VGV=UKNK>*K:VG@34A&D0G1HRRJHW2;& *[B%!R.?+4
M]ZZ#3K.YM&O#<ZA+>">X:6(2(J^0A Q&,#D#!Y//-7:* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^N: /2K3Q7H=\M^T&H(18 -<[E9/+!!(;Y@,@X.",@]JN66JVFH33PV[2>;
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M0W^CRVU\;Y;&VC\S,=RS+N#)(5'RA0Q8[>-IX)XH N?\(MIW_/;5?_!M=?\
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MGTN=3=!)5#7)\I6#DXX^4@=ZO6WC"=_$UGHFJZ')91:G"[V,[3K()MB[F1U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)H HZKHEYXGT'4-,U=H;2*[MV@$=M(9=I/1RQ5<D$# P!UR3D8HQ^'M7U(Z
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MK'=89<;57:-OR_+A21^/KS4<?@^PC&AA;F[QH@Q9C>ORC9LY^7YOE^7G^?-
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M<9?,\S.=O3> V/Z<4:AX%TO4-;.K_:=1M;R2-8[IK.Z:$72KP!(%QGCC(P:
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M,$UUX%URTMH)9[BXLI88HHD+,SLA &![GK4>A^'[=K'2[J]>[N)K>T\F&.[
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MHTL\DBQ(%ED3R@)!\N1G<QQT]N*Q5\0^(IM&TF1=9D6>;Q/+IDDA@B.^$22
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MS2\_(&ZY.#@D8;'!-4F^(FA+'-,1??9X+S[%<3&T<)!)N"_.2/E&Y@.>?;%
M'1#3[);TWHL[<79&#.(AO(]-V,TZ.RM(9VGBMH4F?.Z18P&.?4U@0>+T?Q9K
M.DS6DT-MIEO%+)<NOR_,)&9CSPN$&/4Y]JT]/UN'4;A84M[J)G@%Q&TL8"O&
M3@$$$^HX/([@4 6GTZQD5U>SMV5W\QPT2D,W]X\<GWI/[-L-^_[%;;]NW=Y2
MYQC&.G3'%6JQ=0\46&G/>*R7,ZV*A[QK>+>+=2-V6[DXYPN2!@XY% %+7?#5
MU=3V4NDG3$AM_,\RPO+7?!*6P-_RD8< $ X/#&K>@>'TTF:YNWAL(;JY5$D2
MPM_)C 7<1QDEC\QY/MP.]:_\=Z+8W$-NIN[N6>S-["MI:O+YL0QRA PWW@>.
MW7%=''()8DD4, ZA@&!!&?4'I0 R>V@NH_+N(8YDSG;(@89^AIR0Q1JJI&BJ
MHVJ%4  >@K$\3WUA9KI27UU?VWGZC!'";3<-\A;Y4<@8V'N#C(JO?>.](L;K
M5+9HK^:;2U5[I(;-VV*P)W=.5 !.>GIF@#>@L+.UD,EO:01.1@M'&%)_$"DM
M]/LK,2BVM+> 2G=((HPN\^IP.:H3>);!8[=K;S;U[BV^UQQVR;F,/'S\D #D
M8R<GL#@USNHZZFJ:]X%U#2=1G;3M1N)@R(Q5)E$#L-R]R".AZ$4 =A'IMC$J
M+'96R*BLJ!8E 4-]X#C@'OZTZUL+.RW_ &2T@M]YR_E1A-Q]\=:Q9?&FDP:/
MJFJ2?:5M]+N&MKS]T=T;J%)X[CYEY&>M3ZOKEK"+JQC%W-<1VWG3"S7+P1G.
M&)[$X. ,L<' H T8=,T^WV^38VT>UF8;(E&"WWCP.I[^M/M[.UM PMK:&$-]
M[RT"Y^N*Y'P3K[_\(!X=DO'NK_4KNS\S8IWRRX^\Q)/09')(Z@=2!6O;>+](
MO=,M;VUEDF^U3-;PVZQD2M*N=R%3C!7:<YP !G.* -:UL+.Q\S[):06_F-N?
MRHPFX^IQU-3NBR(R.H96&"I&01Z5QG@C4;B_\0^+DFFO&B@OXTBBNF.Z']RI
M90.@&XGIP>HS7:4 4VTG37@\AM/M&ASN\LPJ5SZXQUJS%%'#$L42+'&@PJ(,
M #T KDHO%>AZ3IOB+5WO-4FMK.^9+H312.89-B92-2,JG(]!DGGFM:P\4:?J
M.MRZ1&MS'=I#]H03P-&)8MVTNA/4 D#\10!ISV=K=,K7%M#,4^Z9(PV/IFDC
ML;2*222.U@1Y 0[+& 6!ZY/>K%8.J^+M,TB:]CG$\GV"%)[UH8]PMXVSM9N<
MG[K'"Y.!G% &M:6-G81F.SM8+9&.XK#&$!/K@5)#;PVR%((8XD)+%44*,GJ>
M*<CK)&LB,&1@"I'<&LGQ5JTNA^%M4U.")I)K:UEE0*NX!E0D$^V1S0!HW%G:
MW>W[3;0S;?N^9&&Q],TEU8V=]$L5W:07$:D,J2QAP".X!K@M/>T2\\-:A>ZO
MXCAN;\1HMHTKF"XF\LL6;.0 06^4$ X''%6K346MO$?CU+^_OS86D=LR[&=V
M@5H69C&%!(YYX';VH [2YLK6\B6.YM8)T0AE26,, 1T(!'!K!\-^'9]-@UJ#
M4UM+B'4=0FO-BY=0LF/D8,.<8Z]_05';^+='TVP\/VOG:A<'4;026;/"\LDR
MK&&RS <N1C(ZY-6K;QEI%QHDVJF2:&*"X-I+%+$5E6?<%\O9UW$D8'N* -8:
M=8K&T:V=N$9 C*(EP5'0$8Z#L*:-+T\&,BQMLQ_</DK\O.>...:I6'B6QO\
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ME)2R%6);YU. X()[C %:$?B[2WOK"V;SXTU$E;*Y>/$5P0,X5O<9(R &'3-
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M<*J[@2<EB23R3TXK0_X1V];Q;IVN27T!%I8O:-"L!&_>58L&W<<H.,&@"O\
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M8VC'% &>WC74+A8+_3-+EO;![TV[0QVLQD\L.4,PDQL.",[?3OGBGZMXRO\
M2=0C6XM;6.)]4BL5MB^Z=XG8*)\@X4;CPI'('7-.TKP?K&BWL]K8^( GAZ:X
M>X%HUMF:+>Q9HTEW<*23S@D9.,'FJEUX U2:*]@CUV!89=775H3)9EI XD5]
MCMO&Y1MP, ' '.!B@#0'BZ2X\4W>BP2645W:W,<9L[G*S30L%+31G(! #-P
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M-];_ &6YD9>98O[I_(?D/2@"IJ'BV#3]6TO3#IM]/<ZG&[VPA,15MBAG&XR
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MS2-"Z YD1W)(SE1CIWK&TV\N-4TWPG;/J5[<7<^AK<2VD4[1-(2L8\^28,&
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M'P?;?:;BW#Q7X:2W?8^-D? ;M]1SZ8H [JD)"@DD #DDUY'<7VL:79ZII_\
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M5,Q#.%;#?,.3US4UWX4T2]N+*>6Q DLHO)@\J1XP(^/W9"D!DX'RMD>U;-%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB0<'<N0.1S@TWQ'<WB_$GP?-KMI%I]I'-+':W-K+Y_G7$B[1$Y*J4!'L<^U
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MP[K/;FW+/E22 %V@C  ''M45M?0_;_".JV%RQ@O=7N$-Y<3?Z1=QE9BWF
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M+.#[++N\R$H"LF[[VX'KGOGK4-OH.DVMK+:PZ=;)!,@21/+!#J.BGU R>.E
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MQ<VEE;P3W!W32QQA6D/JQ'7\:9=:)I=[>PWMUIUK/=0_ZJ>2)6>/_=)&1^%
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M.\7V6GW310V.OB&&-YR#Y),#-"C$\;M[*.>K8XKT=?#NBI]DV:39+]BS]EQ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444C9"G:
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M8I4,0K!L#(90&Z=ZJZGK36NK6.DVD*37]XDDJB1RJ1QIC<S$ GJR@#'.>V*
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M:RNS-+,,CS@<?>(X8_Q=3@UU]% '&>%_#?B3P_;P:/+JMG/HMD?]&98F6Y=
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M.=Y^F.]=#10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:VZW<!*PS#S@KJ<')4X89(VG'!/?H]2\9:5I::A+-]H>WTUE6]GACWK;E@"
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M6SU"+2KJ47<TT&I6+31$I&9I)(IHR7P,!\%0><],\UWG_"'>%_\ H6]'_P#
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M,GGM6]8Z#X)U-9VL-'T&Y6"4PRM#:1,$< $J2!U (_.K7_"'>%_^A;T?_P
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MG4?-NE$L1VQA)%W?>YR7' YP*ZG0K&_M_'OBF]N+&6*SO1:_9YF9")/+0JW
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MQR9RR')4L/E(R?6M?5]+U"_T33Y+'PN+!O[8M+M[2'R5D6.-PS/(0P7<0#@
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M@970HPP2,'!X/.#V- '$/JFKZ'?_ !#U72X[%DL;M+F9+D,3(JVT9*KM(VG
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M@[<5T.KZ7:ZWI%WI=ZA>VNXFBD .#@C'![&@#G;CQ'JVD:AH*ZI'9R6NL/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYGI.AS0:?\+;;4_M27.94=!<21E%^SRLHPK#:0" <8/&#Z4 =R/%]Y(&M8M
MN/[7BMWN9;"295(C5R@*MR&+$';T! Y(XSMZ-?W>I:<MS>:9-ILK,V+>=U9P
MN>"=I(&1SCM7)0Z9;GXS7GSW/&AP2<74O4SRC^]TXZ=/:L2PUR[L_#6G0W-_
M<BWN_%$]A<74D[%UA$DNU=Y.1DHJYSP">E 'K%%>?>))3X3LKO[-K,XM[O4;
M195GE8K812-M8J^=RJQ4]_ER2,=:S/&.GZEH7A7Q5=1>()E22R2XM[6WFE#6
M[@X+JY<D*V?N]"02.] 'JE%9FEZ9!HXF O+J9[N7S";JX,GS[1D)G[HXSM'
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M7D>EZK+IOA'3(%N%MK>^\37=M/.S%0JF6=@-P((W,JC((ZGUJ]K3ZEX2MKB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]M?"W)NK:(PPRM*Y*(>JC)Z' _(4^]UO2].D*7M_;P,JAG\QP-BDX!;^Z">
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M"""W4@=%)[D8K<KB-,\:P6>M:_:>(]9L+9;;45MK/S"L.5,2/CD\X+\G/Y4
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M '-:5HVKZ'9"STRUT.UMP<B.-9<9_.G76DZW>7UK>SQZ2UQ:DF!PTXV$C!P
M<<C@^HXK9U#6=-TH@7][!;DH9,2/@[!U;']T9&3T&:BN?$6BV;(MSJUE$SQ>
M>H>=03'_ 'QS]WD<].: ,;5M U37/L_]I6VC7'V>02PAC,-CCHPP?O#L>M:&
ME^'+?3]=OM9$4<=W>Q1QS^46(D*C[S$GD]AZ =\FKL.MZ7<:2NJPZA;/I[#(
MN5E'EGG'7IUX^O%8/AWQ%/J_C7Q'8"\@N+&RBM6@$<>TQE_,W!N<D_*.N/H*
M .MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \VAFT:+Q_P"/(M5CB99H+1-CQY:53"=R
M+Q\Q/'RCD\5G:+:W7A.Y\ MKB3((=)N;25Q&TGERL8V2,[0>< @>NWBN_P!,
MT!].\2:QK!O!*=3\K?%Y6T)Y:[5P<^G7/?TK;H \74K)X8LXKBUF7'C,SO'-
M P_=?:68MR.5 /)' [UTOC"'[+J[WFBZFFFZG%8;A!/"'M+^,N[>41_?W9/R
MG=\_0UZ'10!YU!?MI_Q TK4=3LI[(7OAV.!(DB>3;.)-S0_*#\P#?I6#X6O_
M +%HG@V"XL;JT?9>I]O-F[R0L9,^6@VD9<$'<01A<#D\>QT4 >+:8$_X0[P5
M9W%O,)+7Q)(TZ3P,NQ?,N#N.1C W)D]!D5=\0027=O\ %."TA>5IXK=XDC0G
MS=L"ARO][!&#CO7KE% %73;R'4-.@NK?>8I%!4O&R$CUPP!KE=4<V?Q8T>ZE
MBF\B;2[BV21(F<>898F"D@'' )YP.#7:44 >/+;W-U\)[[PE=1R?\).ES(@B
M((>29K@R+.I[KR&+]!@\UZ_&K+$BNVY@ "V.I]:=10!P7B+2KR/QF5L[=I+/
MQ)9&POF4?+$T?(D.>_E-(H]2JBG>!X-0MK&6/6E9/["233()I./.16SYOT*"
M$9]0WK7=]Z* /&](1+?P)\.(_*\N>WU:-IUV$-$-DH8N.JC++DGU%6-9AO;E
MOB%_9MO)<2?;K&X$"*<W,4:1>:J_WONLIQ].]>N44 >?ZGJ^B^(O#GB#5=+L
MIFG?1YK:2[DMGB;)4[(1N +')/ S@X]15.S\F/6OAKY2!1%83QR[5P(RT* *
MW]TE@1@]P>]>F44 %>,R,/\ A45QI$MO.+N#6<30/ W0W_F<9'S#9\QQG ZU
M[-10!Y5XKMKK4/$WB>#1T\R:X\-Q1Q"/A9G65R8P1P6*'&/1JV_#%WX?\0ZW
M:ZM86FJG4K>W:*9[SST^RJV,QMO^5FR.@ST)X[]UD?G10 R66.")I975(U&6
M9C@"O)/ 4'AN#X>Z>=9@\F_M[B2X8&!Q,&6X:1#C&3P%X[BO7J* /-_&MO)X
MB2WNM-MQ#JVE6WVR99F*;XG7YK5B,9WC.?[N!_>%,US7X);GPMXF-OJ*:$(9
MX;H0)(LEE(XCVET7Y@!M93QW]QGTNB@#RF=K#P_?:%XBT[3M0'AW^T+J:[D9
M)9'\R:-5%QY;?.%R''0<,2!\W-SQ&U@^@V&L:9ITL&GIXBMM0N)1;NK2KN'F
M3E,;L9[D<XSTP:]*HH \HOY'U:Z^)9L[6[D%[HT(MC]G<"8B&4$+D=?F&!U.
M>,U>GO8+S4_AU<1"3RXI)-[/$R[ ;9DR<@8!8@9/4UZ310!P-]I5[9^.[JQM
M;=VTGQ)"LMTZCY89(L++GT\R,JOUYJEK-U9Z9XXUJW\21:D--U:VA2TFMDF>
M.150J\)$8)SDD@8_B->ET4 4-#M(;#0K&TM[:2V@A@5(X)7+-&H'"DDGD# Z
MFN3O+.7P_P#%-O$<R.VDZEIXM)YU4D6TJ-E2^.B$<;N@/7%=W10!P>NP#QCX
MN\-KIK>=I^DW1O[J\3F/<!A(T;HS$G)QT YZBI/"UW!%XH\;2R2!(WO8Y$=N
M ZB!%)4]P"".*[BB@#QSK^SU8VA1_M2-;J8-A\Q2MTK$;>HPH)Z=.:WKG5K7
M1O'>O1Z];7$NFZU:VZV4T=L\\<J*C*\/R \DL2!WW'UKT6B@#RVZGLM!\42Q
M:Y8ZC9:-J&F6T%E]E65DBV!PUNXBSS\V1VZ\U8MM/TZT\<>%+2*P>"R@TFZA
MCAN 7,09H]B.6SABN[@GU%>E44 (JA5"J % P .U>.^*;W[19^(;=+.ZLY;?
M6[>5K6"T=O/598<W#OM.<A> I'W>]>QT4 >2^(M1T^UU_P 6V-Q=O;Q:Y901
MN]U9SMY1,13<FU"& 4@[25(8&M)/[*N?&_@XVDL=[81Z3<PI.5WJ2?+5=QQ@
M,P5Q@^XKI/\ A&;ZWU2\NM/\17MK!>S>?-;F&*7#X"DHS*2HPHX.0,<5NV=I
M%8VJ6\.[:I+$L<EF))9B?4DDGW- 'F%PVF0:UXD\/>*+/5734;KS;1+9)FBO
M(2B*J+Y? 9=NWG&,#FDE;3]/US7]#\4VFJBWU,QM9BW\^6.YB\E(S#F/^)2I
M'.,YS7J]% 'E>NQ3Z3/=7&A7#1WD5M;P7&@WJF:._0( JQM][> 2N03R!D=S
MZFI)4$C!QR/2EHH \PUBVU";7?B%IUC'.E_J6GV_V)A&P63;"ZMA\8'/R\GJ
M14\CQ^(_^$'.DQO%>Z?=)+=(4*M9PK"RR1R#^')VK@]>HX&:](HH *\;_LV*
M_P#AQK'AM;3&OSZI.T,#1%94=KDLDQXR%"X._ICC/:O9** /*)FTZ/5_$?A[
MQ7:ZM,VHWAFM5@69H[V)E0*H*<!EVX.<8P.:]2MT\JUBCVE=J!=I;=C Z9/7
MZU+10!Y\K:?8_$#Q<VLVX\F]M;58!) 6^TJJ.'1./G.<#:,GIQ6/X8L=1\(:
MIX5?7@\=BNB267F.<I:3M*) KMT7*!5STRF*]9HH \@O-/N+'1KO5?)F72_^
M$N@U*-5C8E+<.F^4*!G:6#-TZ<]ZFU2\CO;OXCS0PW+0WFA0I;.UNX$S"*88
M7(ZDLN!U.>,BO6:* /,\*->\ ?8]D;)I=U$65<+&S11A0WIE@>#W![U@QZ@A
M^'7A_1[BTO%UG3=6M/MMN;:1I%=9\O)P#D,"6R.N:]JHH 0'<H(S@C/(Q7F3
M1V,.H?$"SU.S+SZA*#;0-"2]VAMT4"/CYOF!''0\G%>G44 >:ZAI6J>%_#7A
M778H3=:MHMO#97D*,,W$,@5&0'N0^QA]#ZUU":A9>$=.TFRU.5_M%[/Y1ECB
M9E>XD)9F) ^4%V/7UJS<Z#+>:\E_<:K=/91A&73L((O,4Y5R<;C@X.,XR >P
MK2N;2*[\H399(W$@3/!93E2?7! /UH GKQN\OQ<C3G6RN[,VGBI99["&RD*Q
M#S'S*[;269\[OE.,-@#C->R44 >2Z@D,NG_%/$(,ETN(/W?S2_Z,J@+_ 'OG
M!''>M#2]4_LCQM%=ZJ)OL5_HUM#8W(B9T5T+&2(X!PQ)!P>N .HKTJB@#C/A
M7\G@&TA,$L)CGN1LDA:/ ,[L, @9&".E'CEC;ZOX2OGCE:VMM4)F>.)I-@:&
M102%!/)('XUV=% 'FUK,EC)XWTS7HI#+J,\EQ:AXR?M<#PJB1I_>9=NW:.1Z
M5UW@^QO=,\&:-8ZDQ:]@LXHYLG)#!1QGOCIGVK;HH \^U#58O#_Q$U1]>M[A
M],U6P@AM)TMGF0%"^^$A 2"V_.,<TV KH'CO3+RXLSIVA2Z+]CM-XPEI()-V
MQST0LFWKW7&3BO0Z* /'7TY[2VTYIH6%G<^-#?6L3QG]W;$,-Y4CY4+9;G P
MP]:V'6V_X23XCR,B?OK&!$8I_K"(&5@I_BYV@@=\"O2J* /)=,N+*WUCX;R:
M@8T$>@S(S3+@1R*D .XG[I!R.<<\=ZKZCIK67@KQ')! \=G?^(H;FQ@5#S&)
MH=SJO4*2CM]!GH:]'O- >[\6:?KOVP(;*&6%8/*R&63;NR<]?E&/ZUMT <)X
MMAO]*\0Z=XBT*-99K]/[+N%&"#OR8)3ZA'SG_98^E=EI]E%ING6UC!GRK>-8
MUR<D@#&3ZFL^/093XADU2ZU6ZN85;?:V3A!%;MMVEA@;B<%NIXW&MF@#D/'5
MO<VK:1XDT^UDN;S2KL!H8AEY8)?W<B#WY5O^ UD^'=&U73O%-YH=VAETYYDU
MLS@?N_-;.^(>@\X>8!V YKT6B@#S&ZA>ZO?BE#;Q/))<V2+ JJ?WI%J5(7^]
MAN#COQ1]JMK[4?AM($<Q0"3S#+"RA#]E*@G<./GP ?4<5Z=10!YUX?U_3_#<
M7B^_U RI:G7G=3'"SY5TB <!1RNX-STX->B*P90RG((R".]0WEI%?6SVT^XP
MR#$B XWKW4^Q[U/TH X**=;#Q_XQ6YCFC%W96KP.8F*.J1R!CNQ@8) Z]2!7
M/:2D=OX;^&""/RY;:Y'GJ$PT68)%;?\ W?F(!SW->O44 >2:0--N(Y/#'B*Q
MU:76H-2DGC@'GB*<F9I$G5U^4+\P))(Q@_2O6Z** /)=0BOS8>/M/L[.ZDOV
MU2.^2!(V'GP 0%@K8P2P1U !R>:NR7/AW6]+UO6M+@U*6[.BSVDMQ=B9=H(R
ML.U^&;<3]W./7D9]-HH \LU.WM/^%=>#%2VCW"[TSSE$7S!4*[]XQG"_-G/3
M)S6I$;1?B1XIN)%C\M])MT$I7AB/,W*#W."N1]*[^B@#R#2(7'A#PC);:S)H
MFMV>ELD<MQ%N@<93?#*K="2JD<@\$C.*](\+7%S=>%=+FO+ 6%PULF^U4$"(
MXZ 'D#V/(Z5KT4 >?^++P#Q5=67V6>WDFT9ECNX+9I9+HEF_<*<%5 ZGC/S#
MD 9.+X<>&74?ALTD3K]ET6:*4S1%?+D\N$ '<."2K >N#BO6J* /&899[*R@
MOQ!-)I=CXNNKF[CBC+%869_+EV@9* L&X'OVKJ_#%Y;WGQ+\3W5LDS6]U:61
MCG\AU20J) ?F(QW7Z]NE=W10 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <YJ/BMK8:F
M]AI=QJ,>ELJ7?D'Y]Q 8I&N/G8*RDCCKC).0)9_$;R7UY9:78/>W%E"DURAD
M$6W>"509'+D#.#@#(R1FL>'1O%&A>)M7DT9=.N=+U><71-U*R/:3;0KG:%/F
M*0H(&5],CK5BWT/5M#\6ZIJM@L5_;:K##YR32^4\<T2[ W"D%67&>X(X!H :
MOQ!L[K^P&TW3KN\36TE-NRE%VM&I+(P+<,",'L.>34UIXXMIM'GNKBQG@O(=
M1.F&RW*S-<Y "JV<$$,#GC R>U96G>";_1[KP@ML;>:'27NI;N1I"A=YU;.Q
M<'@,QZD<8JI<^"=>FM=0FA:SBOT\1#7+%6E9D?"A?+D.T%<C=R,]10!-9S3Q
M_%+7Y+G365UT2%FABF#B;]Y)RI;;U''..5^AI++Q1);V'@:W\.Z0L.F:H'VP
MO-\R(L+L$R<^@.<]L=ZT;;2?$,OB^]UVYL;&&.XTE+,0K>,[+(KNW7RP,?-U
M_G6?8^$->T_1/!21I8R7N@.RS1M.RQR*T31[E;83QN!QB@#4C\0Z+INN^+;N
MXL9+*73H+>2^NG8-YZE7*;0">@! Z$D]*O?\)0UMK%AINI:;+:2ZC&[V9$BN
M'91N,;=-KXYQR#@_-6'JG@B^UR\\8Q7;P0VFMVUM%;RQN6='A#89EP."Q!P"
M>!6A_8VKZS?Z#=ZS!;0OI#/.PAF+BXG*% 5^4;4Y+<\YP,=Z *UM\11<65C?
MMH=Y%87-^=/>=Y(_W4GFF)<J#DC<!DC@9[\UKQ^)_M.IW=K96@N%L[M+2Y*S
M 21LVWY]F/N#=USV/&!FN73P?KR^"K;1S%9?:HM9%^3]H;84^TF;&=F<X..E
M7=4\)7NJZ_!JBV=O9:G;WJ/'JEM.5=[8,"T<B@#>2N5P<CH<CD4 =7K6L6VA
M:8]]=;V4.D:1H 6D=V"JBY[DD"L^/Q+(NNMH=W8&#47MC=6JB8-'<*#A@'P,
M,"1D$=#D9H\9^'YO$GA\VMI.D%[!/%=6LD@)02QL&7=CG!QC\:KII&H:CXFL
M-?U"UAMI-.M)8H+=)MY>23;N); PH"X'<[B3C'(!B> +)/$%A;>(-4L!_:<-
MY=O'>K+\[YED0H<8RH4 !3D?*..*UCK5_>^/-2\/2V,9TZ&PCE+>;RV]G!8C
M'^SC&??O@6/ NCZCH/AI--U)(!-'/-(&@E+J1)*[]U!XW8J.71]6M_'MUK5I
M':S6=UIT=LXDF9'1XW=A@;2"#O SD8YZ]" <S\/O$[Z9X.\'V5UIMP+6_'V6
M.]+KCSCO8#;G=@[2,^H].:VX?$NCZ7<^+K]M-EM);">$7LCN,SL8UV-U(4;2
MO/'')K-LO!^NVOA7P=I;1V9GT6_2YN&%PVUT42#Y?EY)\SOCI6E%H.M0:CXL
MNA::?,FJSP/##-*2KHB)&Z2#8<;E5O7K0!TFFW]Q>/,D]HL(0(R2QR^9',K#
M.5; ST]/TP3Q'BE-/7XK:$E^P2TFTZY:8%RJNRE=I;'4C)P:W/!_AA_#EWJA
M@C-GIETT;6VG"8R+;L ?,9>RAB1\HX^7WP$U'1-5N/B-I.N0Q6QL+.UFMY-T
MQ$A,A!R%VXP-OK0!A>#M;OM)TZ]2^%]/:W6L/:Z#'=EA-+$1D9+_ #;  QRW
M. >O K8U378=4TOQ-H=[:M:ZC9V#RO%OW+)&R-MD1A@D9!'0$$5=\6Z#>:LV
MDW^FO$-0TJ\%U%',Q5)5P5="0#MRI.#@X-4KKPY?ZA?ZWK,L,,5]>:5_9EM;
M^;D*N78L[ =2S]@<!??  ,_1KVPATSX;VMWILD]Q/9Q_9+H, L#BURV1G))4
M$=,<UN2^+3M:YL]*N;W3X[W[%)/!\S[PVQF5 ,LBMD$Y'0D CFLJ#PSK,<?@
M53%:?\2%-MUB<_-^X,/R?+SUSSBET31/%/A^[O=)M#I\FBSW<ES!>/*PFMED
M8NR>7M(8@DX.0.<G/2@#7M?%2S:CKME<VGV231T660RRC$B,I97&!]W"GGL0
M1BMG3[F6\TZWN9K9K:2:,.T+G+1Y&<'W]:X_Q#I=KK?C72'L+Z/SPLEOJ<43
M!O,M5(<H_I^\"+CTD:NL=]2&M1(D-L=,,#&24N?-$N1@!<8VXSSF@"[1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 4[/2=.TZXNKBRL+:WFN
MW\RXDBB"M*WJQ'4\GKZFKE%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **P?%NOS^&]$&HP6L=R/M$,+J\I3:))%3(P#G!8<<?6MT]#CDT
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ML_.ZH,':<\L/2H;?Q7)%XK@\.:OIXL[VZ@:>UDAG\Z*8+]Y<E5(8#G!&,=Z
M.FHHKF]/\0W^HZAXEL(K"!;K276. &<E9F:(.NX[?E'(!X..>M '245%;-,U
MI"URB1SE%,J(VY5;'(!XR,]ZEH **** "BBB@ HHJIITE_+:EM1MX8)_,<!(
M92Z[ QVG) Y(P2* +=%0W5U!96DUU<RI%!"ADDD<X"J!DDTZ"=+FVBN(R?+D
M0.I/'!&10!)1110 45@QZ_._CF;P\]K&L2:>MZDZRDELR%-I7 QC![GM6]0
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MUO"TXC'4(&"DGTY8?7GTJU0 444$X&3TH **K:?J%KJEDEY9RB6WD+;)%Z,
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MY=&TM)XIUTVS6:%-D<@@4,B^@..![466D:9IK%K'3[2U8C:3!"J<9SC@=,T
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M<*>PKUR^TG3=3,9O]/M;HQY*&>%7VYZXR.*?=:=8WUB;&[L[>>T("F"6)63
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M-O L*I+=6QN! 0I9S9ONW%>=QXSWKUX@$8(R#6<OA_14CAC72+!4@8O$HMD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HKFM8UO6M+U2Q*Z7;RZ9<7D=H2LY^T#><>9MV[=H/)&<X&>.@Z6@ HHHH
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M8M=TZ\C^SR".:-$.\;V.0$9"A;)YR.!GI7<444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!QOC+3]4UB&ZTY-$2\C>,-I]XEPL9M)^?G?+!AM.U@4
M#'J,5J:CIE[<:OX:N!B5;&>1[F3(7K;R)G'NS#@>M;U% &%::9<MXQU/5;M!
MY8MXK6R.X'"<O(<=LL0#G^X*P=$T+5XF\-Z7=6/DVN@2._VLRHRW.(GBCV*#
MN&5DW'<!@C SUKNZ* ,+PUIMS8PZC=7T86^OKZ:>0;@WR!MD0R/2-4_6L6/P
MWJ<?@FQ!@1]:CO8]5N8C(/WLWF^9(F[IT)4'IPO:NWHH \[U'P[JNJW%SJEU
MI+O;W&H0RSZ.T\8DE@BB*J&8-LW>80^W=@A1D]J2T\$ZM)IVZ*Z.EQP37,EC
MIK(DZP+(H !.<!OOXP2%$A ->BT4 8'A6UU/2= T?2K^+S'@L%6:X!4"-U"@
M1[0>>,_,./E]ZET33KFRU?Q%<3H%CO;])H"&!W(+>%"?;YD8<^E;5% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex971clawbackpolicy004.jpg
<TEXT>
begin 644 ex971clawbackpolicy004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA5"L@20L&W#<I#)C''?(KJ-(UW3==AFETZY\T02F&56C9&C< '#*P!'!!Z4
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MPP97R!L*D;@V2 %QDY&.M &Q16?INMZ?J\ES%9SEIK5@D\,D;1R1DC(W(X#
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M!! (Z&O/_&MA<R:Q<7^D2:G9ZS#8*(Y(K5I[6^7<Y$$B[2N0<\Y! DS7H-%
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MF2:*$H)940R-L0,P&YO0>IX/%/H XC3[O3_LFI:S:>&-5#7$20.+V"4SW1Y
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M67;PP( X.,56A\&^(](&AWVC:GI_]I6.FQZ7=1W,3^1<1)RI&#N# YY[Y[4
M7[7QW]NL=-V:<]IJ%[#+,UM>ED\@1L$;)"DG+$8XY&3QTJ!/'UZ]IHTA\/RQ
MS:A?O8/%+,4\N159@RDJ-Z$+D-QP>G:I=5\,^(7O=+UO3-5M/[<M(Y(;@7,3
M"WN(Y&#%, EE"E1MY)XYS4VH^'M:U%]!N+B[LY;FPO\ [=/C<B'Y&3RXQ@D
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MKD?N;N!H6/ID8R/<=?PKF(? 3BY\/7MQ?F2]LE8:C+CF]W8?!]A*B$#^Z,4
M6HM5E?QQ'83Z'9Q:H=&:Y6Z\_<0/,4&'=LSMW'.?;.*XNZU34==\!>&M8U2U
MMY;H^(8&A:)\L?\ 2F!4;@-HP HY.0!DUW[Z)>GX@1Z^'M_LB:<UD8]QWY,@
M?=TQ_#C'XY[5SL/@;6K?PSINBB[L)(].U5+V)R'4NB3-+AN#\QW8XX&,\YX
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MU!@X50>,DDXY]: ,75O&VL2>#[VZMK*WM-1L]733+I3.74$R(I:-MH)R'')
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M7-N#[X^?D.X9XI?^$%T(G5#)%<R_VI;K;WGFW4C^:H! )R?O8/WNH[8KI**
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M!*-M(RN0#BMBB@#SK4/!\6EZUX1L]'M=033K"YN9I9HI&<V^^-@N"Q/&X_=
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M^)O$Z:6]SJ&HO"+?3A,B-Y42A%!?)4,<NW4\8'6NQ!)4$C!QT]* ,'QA/?\
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M@8!.>@R =;XDUAM \-ZCJZVKW1L[=YO*0@$A02>21P,9/?'0$\5C/KEK<_\
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MYSVF[S57!R5*\@@=^U<EX.TK6-.AL-&U'PG812:=MC_MA6B9)D3A651\^\@
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M  I8$Z>ZJFM9B*2Q*?E8+]\2$#'/0\Y[5U_BQ=8?PO?KH 5M4*#R Q49Y&X
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MB^TZVUZ'5;>UEU#3;V"T@^S;DCG:=4,>=Q)7E^>O )%-A34$^,MF+^6UE/\
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MU:XN)Y/+A\HIYQ)8#YFZ$\'^=+HOAG6+.V^RZSXDEU2WCB:&!1;+"P!&W,C
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M^TA@>5R,@XP1GH:Y+4?AX-1LO$"?;;>UN=<CBBN'M[0K& A)W;-_+G<<L3T
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M:&&R\E98Y""3R[$'Y1G''H!3_#OA+5-'CBL;WQ'+J.DVJE+:V>V5'VXPJR2
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MUCM;T&S$L5RJ9VML+?*PR><FNKL[<VEI% 9I)F08:60Y9SW8]LD\\<>E3T4
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M<:/'=%U*R,2<J%SD8P.3ZT 6ZXC1O"MLGA/4O VI(WV/=,+=AQOMY'+J5/\
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MFRY\]VE:5<8VLS$DC!(QG')JNGA31(X["-+$(NGMOM0LCCRFQC(YZXXR>W%
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MC/\ ":MQ6]_I&L^"=1M=6U&Y?5L6]];W%RTD<BF OO"GA2I7J .O/4YZC7M
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M4K2.X6"431;\_(X!&1CV)'OFJS>%M&8ZB3:'_B9+MO!YKXF&,8;GICCZ<=*
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MPYXDT[Q1I@O].F5XB[KMS\P =E!(ZC(7(!]:L7&NZ5:W@M+C4;:*X+*GEO(
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1,P:0] 2!@< GDCH: -"BJD.I6\^IW6GIYOGVR(\FZ)@N'SC#$8;H>AXJW0
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M(#+N;:<[<XPQYQGB@#=M/$VL+KWAV&6^2[CU*ZN;>Y\B(?9E*H[IY+E0S$;
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M26>C^*%T_P XSII9O;0VT<A.[*CS=V W(7.,]J *5WXF\46_ASQ!K7]JP?\
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M+D>;)]Y,GKNR1TQTKJGT>ZF_M]I='\1;M=C$=X%FL0% 3R_D^?CY>.<_GS0
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M.^]6;R56/<H9&AV$L1DXPQ/!]:U)/"=K-J]GJ-Q>7<TEK:/9B-_+V21OC<&
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MPW$8!?1"2&6<!0ZX+ ;PN,9Z9..M>A^#K.+3O#5O9V^J2:G!"SI'<OSN4,>
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M* "BBB@ HHHH **** "BBB@#D;+PDS>,=>U;5;'3+FVO_(\@-^\=/+3:00R
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MY<^GM0!V8\/Z,L-O"ND6 BMCN@06R;8CG.5&/E.?2GW&C:7=WBWESIMI-=*
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M\ETMF\HA<QI.V-L;.!@'YAWX) /- %VVT;2[*Z>ZM=-M(+B0DO+% JLQ/7)
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MPVIZ9>:GX^U%H8;B*WN_#C6,=VT3!%E9V;&<=0&!_3KQ2^$KS4[G2=-T6_\
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M)1 I/4Y'&,?CD=*Z;5],O=3M[:&:VTV[M6C=+RRNLF.0G;M*MM.""#U'?\:
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M!6W@L[:0917D4L\I4\%N  >PZ=:[:PAN+>RCCNKC[1<#)DE"[0S$Y.!DX'.
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M!B5 S.^U,@@D#:,\D<XYJ&S\;S3VJ17&DR0:I+J#6%O"Y98YR%+^:KLH/E[
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M4C/ZT >9R76H7DGPSU2YM8)]3F#%6$O,@:S8Y9BHV\DD@ X[9/%:VI>,9)?
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M#*;VW$<XS$_FKB3C/RG//'/% ' :IH=U<>*M1N+O1_$),S(MO=:-J8A22-4
M'F RIA\[NV,8Q[])IOA9%;2[[4KB[GU.P25(97N68HCMG:QX#G:%!8CG;FM>
M+5],GL3?1:C:26:G!N$G4Q@_[V<4^#4["YEN(K>^MI9+8XG2.56,1_V@#\OX
MT 8Q\$:(=,N-/,=P89[S[>Q^TN'6?=N\Q6SE3NYX-3S^$M,N/M"2?:6M[H(+
MBW,[-',$4*-P)/91G&-V.<UH0:MIMT[);ZA:S,L?FLL<RL0G]XX/3WIUKJ>G
MWT<DEI?6UPD7^L:*57"=^2#Q0!9(# @@$'@@UAV'A#2-.\A+>.;[-;2F:VM7
ME9HH'.>44].IP.@SQBM"'6-,N+I+:#4;26XDC\U(DG5G9/[P .2/>@:OIKS"
M!-1LS.Q=5C\Y2Q*C+#&<\#D^E %>R\/V.GZS?:K 9Q=WVS[0S3,ROM&%^4\#
M ],5+K6BV6OZ>;&_1VB\Q)5,<C(R.K!E964@@@@=*BT_41!H-M=:MJFG2.PP
M]U"P2!VR?NY)_GVJ+5/%FB:3;6-Q<ZC;>7?3)#;,LJD2%B 2#G&T#DGIQ0 L
M?AC3H=5?4XS<K=O:BT,GVAS^Z!) Y/7))SUR3S6=-\._#TVCZ?IOD7,<>G,6
MLIHKEUFM\]0L@.[!],_TK>N-7TVT\G[3J-I#Y^/)\R95\S/3;D\]>U6V8*I9
MB H&23T% %;3M.MM*L8[.T1EBCSC<Y=F).268DEB3DDDY-4M5\-:=J][;W\R
MS0W]NI2*[MI6BE53U7(ZK['(]JMC5=.,$<XU"U\J1]B2><NUFZ8!SR?:DN=9
MTNS\W[5J5G!Y142>;.J["V=H.3QG!QZX- $<>AV0M;BWG5[M;F,Q3M=.9#(A
M&-IST')X&!S5;3O"^G::UL8C<2?9(S%:^?.TGV=",$)GV &3DXXSBM*[OK2R
MM_.NKN"WC/"R32!5SVY)%<_X1\2RZMHE_?ZI<6:+;:A<6PFC^2(I&^U6R6/7
MKU[T 2'P/HIT9M(*77V)KG[48_M+Y,N_?NSG/WOFQG&:A\2>&H'L]9U.UBNK
MC5KG2Y+% )2=ZE6VKM)V_>;.??K6^FJZ=):1W:7]JUM(P1)EF4HS$X #9P3G
MC%2VMY:WT/G6ES#<1;BN^%PZY!P1D=P: .=\*>'8K71-#EO8[HWEC:)&D5S(
M6%N^P*^T=,]1GG . 0#20?#SP[;):)%!=".SN#<6R?;)=L+'.50;OE4[CD#@
M]Z-0\964EGX@BT>^LY=1TF!W*R'>I=4+%<!@3C !(/!/MBK_ (=UVWU;2M.,
MMW:MJ4UC#<SV\<@WKO123LSD#)H K2>"-%FTS4].D2Y:UU.<W%VAN7_>2'&3
MG.1G X&!Q4&HV=UKFJP:/=:*_P#95C<0W0O[B5'$Q0;E"KG<&WX!)'0-ZBM]
M=4T][\V"7ULUXH)-N)E,@'^[G-6R<#)Z4 %8_P#PC&DG5;_46MV:;4(Q'=(T
MK&*4!=F3'G;G;\N<=*MPZI8WL4YL=0M)FB'SM'*KB,XXW8/%5[#4XX=(LGU/
M5-.>XEBW&:%PD4I )8IDG@ $]>@)H BTWPMINEM:&$3R+9*4M$GF:1;=2,$)
MD^G&3D@< XK0U+3K75],N=.OHO-M;F-HI4R1N4C!Y'(J.76M*@MX;B;4[.."
M<9AD>=0L@]5).#U'3UJ;[?9^?)!]K@\Z-/,>/S!N5?[Q'8>] &(? ^B&ZM[D
MI=F:&W-J7-Y+F:+.=DAW?.,D\'Z=.*+/P1HM@=)-NETO]DAA9YN7;R]PVMU/
M.5XP>@Z8K8&J:>T4,JWUJ8YR1$XF7$A&<A3GG&#T]*A_X2#1?LB7?]KV'V9Y
M/*2;[2FQG_N@YP3[4 9)^'_ATZ)<Z,UK*VGSS&?R6G<B*0G=NCY^0YY^7 _.
MM71="L]!M6@M#<2%SF2:YG::5ST&78DX'8=!5B[U*PT_;]MO;:VWY*^=*J9Q
MUQDU13Q1I$GB-]"2^@:_2(2M&)!QD\+UY; )QZ8/>@!-1\+:5JFL1ZK<1S"[
M2 V[-%.\8DB)SL<*0&7/.#56R\#Z+I_]D_9DNE_LG=]CS<NWE[AM;J>?EXP>
M@Z8K8M]4T^[N7MK:_M9IXP2\4<RLR@'!R <CGBF+K.EM-#"NI69EG9DB03KN
MD9>"%&>2.^* ,B2R/A.&XN-#T>\U.;4+WS;F);H##L,&3,AP!\JC ]N.*O\
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M"SA+F*% B;V+':.@)/)I'U"RB2)Y+RW19E+1%I5 <!=Q(YY  )X[#-<]XO\
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MDEG#?6TEU&,O DREU&<<J#D<T 1Z1H]IHEE]EM/.8%M[R3S-+)(W3+.Q))P
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MU,:;<[U;SS;K-\H/*[6P.1W[5-IMA'IFGQ6D;O)LR6D?&Z1R2S,<=RQ)/UH
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M'X1N=&UBS\/Z;J5[J!\2:1<*TFGE%22*=<B1V(0$H068DM@Y[G%=G\1EO6\
MZK]@ADFF"HSQ1_>DB$BF11ZY0,,>]=1M 8M@9/4TM '$VNJ^$/$37FL:;Y-R
M_P#9I@N+G!$<<0.Y8G!^4-DDXQD8/3C/%Z1_95QIOPI6[-H^%D202%3C_1W
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MZ>U>F8'I6!'X>G7QM<>('O(GBFLTM/LWD'(".SAM^[KECVH \QTS3+33O^$
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MQK? *81+N*X/S;L;@5W;=N>^.:8WC:Q74K_36L;\7]F\2&V*IOF\PX4Q_/\
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M1@'K4/AWQH=3\/OJM_I\]H&O)+:%,HQE83-&J+AC\WRC).!U.<#-$VGZJOQ
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MG5%O&$KBUEB2.0QQE5+@,X!4EEQ@Y.>G!J6V\46EUJEIIRVUVD]W8?;X=Z*
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M6-2>I &*\U\4:'XIUFWUZVETG[9(;V&;3IOM<:QK CQML5">)/E;)(&<_>P
M* .GOO'5C97NKV:Z=JES/I4:2W*P6X/R,&.X%F ( 4^Y[9YQT%C>P:EI]M?6
MK[[>YB6:)\8W*P!!_(UQJZ7K)USQC>/I4@34[""&VVS1'<Z1R*P^\,#+C!('
M0]*Z#PA9W6G>#=&L+V P75I90P2H65L,B!3@J2".* )=2UV+3YVMH[6YO;I(
M?/>"VV;ECR0"=[*.2" ,Y.#@<&LQ/'NCR1:)<1K</9:RVRUN]JB(/S\CDL"K
M<$8QR1@9K,\0Z3JUIXU&N6.@V^O6=U9I:W%L\D:20LC,RNIDX((<@CKWJUJ_
MAZX\1:+#X=O].2UT^:-I;B2U*;87#92-.AR"02^W!V_[1P ;$?B2VDTFVU!K
M:YC6ZD$5M"X423DY(VC=C! )R2. 2<"LN;XAZ1:VM]+<6]]%-8W45K=6QB#2
M1-(1L)VL5VMN&"":Q+[2_%NK>%M'GO-*@EUO1;P2M;3R1^5?H$>,X()",5;/
M/ -2:UI6LZQX1GBM_"\.G7$UU:NMG%+#O"Q2J[,[ A>0"  3^O !N_\ ";VQ
MU&[TT:/JYU"WB6=;46Z[YHF) =#NP!E2/F*G/&,\4P_$#1S9:+=Q1WTT>L;A
M:B*W+'<JDE6'9OE(QSS[<TU;+4E^),^LG39OL+:.EJ'\R/)D$C/C&[/1@,^O
MMS7&VMCJ?A^R^'=C>Z=(+VVU*Y#0+)&2P:.9L@[MO1NY'2@#HM3^),*>&=3O
MM/TR]%_87$=K<6=TBQR6[2,%5F!;!4[AC:3GV&2-B74[&3QCI%M<P:E;ZE):
MSO#&7Q%M&W?OVL59A\N,9QFN:U[PCJVJV7BS4;>SV7NJ267V>S>1 Q2V=6RS
M E0S?-CG@!<D<XVKNRU6]\=>'M5;3)(K:WM+F.X;SHR8VEV;1][)QL.<9'/!
M/6@"W-XVTR"!+UXKD:6UQ]F_M$*OD!]VSGYMP7?\N[;MSWQS4%]X_P!/L9M8
MB_L[59VTC:UYY-N,(A7=OR6&0%Y]3V!P<<Y!X2UD_#F7P%<63%!)Y$>I"1/*
M:W\W?O*[MX<+D;=O4#G'(OSZ)J[7/CXIIDI35K9(K(^;%^\*V_E<_-QSSSV_
M*@#NK:XBN[6&Y@</#,BR(P[J1D'\JX_Q7JEV/%_A[1!8WDUE=BY>989$3S]D
M8PH)=3@%LG.,X&,UT7ARWGM/#.EVMU"T-Q!:1121E@=K*H!Y!(/2L?7+#4;C
MQWX:U"WL))K.P2Z$\JR1C:9$4+@%@3RO/% %;P]XGTVU4Z+:PZY<QV%U):3W
MEY'O$)5?,S)(3G;@[03SP,]B=*+QEI[R::98+N"UU1@EC=RHHBG8C*@88LI8
M#(W 9^O%96D^'M0N++QII]_;2V<>LW<[P3%T;Y)(5CSA6)!!4G!]JJ1:#K6J
M^'?#>A:EIQM7TFZMI+BZ$J-'(MOT,>&W9?"]57 )]!D TI_B/I4%E>WK6.J&
MTL;QK2[G%N L# J"S9;)7+#H"1U(QC.I8>*+6^U^31FM+VUNA ;F(W,019X@
MP4LO)/!(X8 \CBN,OO#>O7/@?QGIB:5(+O5=2FGM5,T6&1RF"3OP/NG(^E='
M)8ZC-\2-.U?^SI4L8]+EMI)&DCRDCNC 8#9/"$$C/.* .BU.\;3M+NKU;>2X
M,$32>5&5#/@9P"Q _,UYWJ'B*\U'1O >NS17MI)=ZC!YL,4A*SH\#OPB,=PR
M!C<,\=!7HNH6[7>F75LA >6%XU)Z9((KSZWT7Q ?#G@:RET61)M%NX&N0+B)
MODCA>,L/FYR6! '..N#Q0!U-EXQTZZM-0FEANK.73YUMKBVN8P)1(VW8 %)!
MW;UQ@\YJ?3/$MIJ.LW>D-!<6FH6T:S-!<!,M&QP'4HS C((ZY![5QNK>%-<U
M.X\6RP6:127-[9WM@;ET:.8P*@*. 20"4(Y'<5U'AA;Z5VN;SPQ;:"1'L,:R
M1R22-D$G='P%&._)ST&.0#I**** "BBB@ HHHH **** "BBB@ HHHH ****
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M*Q\&ZO);7=[I-E]OL7,$;3/"/-*Q/L4%B J;,@' ^M 'KUI>6U_:I<V=Q'/
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M'>AP0>A[Y[5Q>HW.JWGPJ\13ZA>173C6Q$O[HH<I?(HYW$8P   ./>@#V,D
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MC^%M:O!IOV75KX64UM%"X=2Q<!U<M@8*CY<'COZ 'I--=UCC9W(55!))["N
MTC4O$"7/CBX6YM+R6RO&2WAF7RE!$,;*"Y;"H,G/'/)R,U<TWQ1J-UKNJZ4L
MUK<^1IL=];77V9XU8LSJ1@M\ZY4$,IZ'J>M '6:??VNJ:?!?V,RSVLZ!XI%Z
M,IZ&K->>6WC#7;G1O!-S;QZ>LFNG9.KQOMC/E,^5PW0;>AZ],CK4T'C/4[2U
MU6UU!+:XU*TU>+3(9((F1)/-",K%"Q.0'/&[G &1G- '>U2;5M/35X]*-W%]
MODC,JV^<OL&,MCL.17)7GBS7= M-8N=5TT2VL*PC3[C:(?.DD8)Y;KN8C#$'
M<.V>,CEDD6HQ?%O0A?W-O/G2KLJ8H3'@[XMPY8\=,=^N<T =O=W<%A93WEU*
ML5O!&TLLC=%51DD_@*(Y+>_LDE0I-;7$893C*NC#^1!K/\47]UI7A75=1LQ"
M9[2TEG59U+(VQ2V" 0><8ZUSTOB/79-4\+6-H=/1=8T^2>1Y878Q.B(V0 PR
M/G^[QTZT =I#"EO"D48PB#"C).!Z<T^N=\&ZU>ZUI5W_ &B(?MEE?W%C*\"E
M4D,;E=P4DD9&.,FL_7;G55^)/ANSMKZ*.TFMKJ5H7A+ L@09)##)PY ].>M
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MX]JEL+^UU2P@OK&99[6=!)%(O1E/0UQ^G231>/O'4ML8Q,MK8LAD4E<B.3J
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M7H%URY@M-8F2XDA$*,4E4(,ACR5^1?EXZ=:I6<=XWQ4UE+35(TD_LNUB:2:
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MV:.[C,4D@CWL%/7'(Y_.M>JEM<W4U[>0S6+000LH@G,BL)P5!) '*X/'/7%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \I\9ZA,MGXFU+3;ZZDFT^\MH_/,YB6T<&+,4:C[
M^=V6S@'?CG'&E/HEOKWQ.\0VMS<WL,7]F69_T2Y:$YW38.Y2"<>G3U!XKJ+S
MP;X<U"YO+B[T>UFEO !<,R_ZS'0GWXZ]:FG\,:-<3I,]A&LB0B#=$6C+1#HC
M;2-R_P"R<B@#SW2M1U6XTCX?W%YJ%U)/)JDUM))YK*+J)5F",Z@X;(13D_7O
M6BN[^T?B>T<LL3KY3I)%(496%FI!# @CD5V]SH>F7CV33VB$V+!K4*2HA(&
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M=^,]<\Y]>: .6M77Q1'XI-YK%UIU[INIO%'+#,4-I#'M*,%S@A@&))!W9(Z
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MG>99 (P;?[I\O.TDDC^'@CDU0TO3K[_A3>BW4%C=)J^@2B[C@DA9'<QNWF(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<,EU&H?# X[' .,YZCBNE\<RS:/#X9OXYY)KF#68(&E<*&DCES&ZG: .0P/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:54C;.UB5!X."?IR<#FMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGRHF<!Y, D[1U. ">/2IZ //+T7::5#?Z/X3FL8KG486ND%O']L\H [I0N2
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MS$4*)(_F&#M &#D<<YHNO"6KVGB/^V?#^M16\MQ;1VU]'?0&=9O+R$DX93O
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M=1UB\M'!G*B)O-F; PO(^4C/Z&MF7QCXCCM_$D8TS33=Z ?,G;[0XCFC,0E
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M&,4 =;15/2HK^#2[>+5+J*ZOE7$TT4?EJYSU"Y..*N4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 QH8WD61HT+K]UBHR/
MH:?110 4444 %1R6\,K!I(8W8="R@D5)10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG5,)D#=R>F2!GU(H NT5GS:_HUOGS]6L(L2"([[E%PY&0O)ZGTI);B9?$%O
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MO)9Q94/%*K!W_N*0>6SQBI?[0%SJ]A]CU73VLY8I&: $-),1C#(0W08;/!H
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M\MP;^U$,+;)9#,NU&]"<X!]C35UC3'MH+E-1LVMYVV0RB=2LC9QA3G!.>PH
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M-'C\&W7B'Q+#''I^I,EQ-'<P^:%C8JL*L@!YP$)&.&)K5_L&[_Z&76/RM_\
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MOI(8LM ':41R,I4\ MSQQGUQ7;Z#J/AC1['4=;M+^X>PO[Q&DO)%)2:=\)E
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MB*PO+17@Z3V\L9Q.SKU (WDD\'<.N15VYGLY-1^*22R0LIMHL!B""1:[?T;
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M(.TD9 /:O,]-\.>*/[5\+:EJ&F6SW^GSS_;[I[P,\^^-DW@[>$&<A>W3 '-
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MF)"LGG\+@!\\$X/&>1@'(J-(O$^J>']1M]0\/V.GW#64L 6WN%D-Q*R[00<
M(G.>23^7,6HZ#J]S\/= TB.QS>V4EB9D,J  0,A;!SSG:<?7G% &M%XUM VM
M)?6%]8S:3 MS-%,BLSQ,&*LFQFSG:1CJ#UJ:WU^'5=0NM#N+.[LKL62W>UW
M+1.2N0R,2"""".,=LUA:OHWB677O$>HZ/&+6:\TJ*VLYY)$^65&=CD9.,A\
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MW DSAX_WF&4 $DY& #GH:Q_#6C^)=!/]@/I6GSZ?#.S0:N9AO$)<MM:/;DN
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MUMLG4\ BMG7]+\2^(="MKP6MG::I8WL5[:V$DWF(VP,K)(X&,L';IP,#GJ:
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M7DTL=K=Q/+=M$C,0@&$'R@X)<AO<1L*?\-M<EUKP=!'>,3J.G.UC>9!!,D?
M8YY^9=K?C0!->77@W5'T37[QK&X9YA#IES(N2TC,% 0=SN YQQUKJ:\=T_\
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M*9G2%VCC\QPI*IG&X^F>U<_HOB2\U_PKI6M6.E!C>R+YD#7 'DQEB&?<1\Q
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M,MQN:/:0TCEV'7IDG%;-% '/2^&7A\1W>MZ5?FSN+Z)(KQ&A$B2[,A' R,.
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M0#[4 <[)X"5O#NM:&NK3BRU2:63:8E)@$CEW"GC/)."<X%7I/"\B:W#K=CJ
MM]1%J+2X9H-\5Q&#E2R;@0P.<$'O@Y%.L_$LNM37)T.P6[M+:5H7NYI_*CD=
M>&$>%8M@\9P!GH352?QI)#)IROHUQ$;O5?[,=9Y%5HGVEMV!D," 2,'D$>M
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MECF\N2S@54:-X\_=W'<2<<Y(/&*DUR[/@_QA%K7ESW%AK-L;7RF).V\4%HP
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MIJ<:M-=2.H59I2N5)P2"H.3DYKTVU\(^';'[.;;1;&(V^[R2L(S&6P&(/8D
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M%...<<%JR;"UU?3_  5X6E;1=6E.A7DJW]G$CQS,KB1-\6""^W<#\O!#=>N
M#U72]8L-9AEEL+CS1#(895*LCQN.JLK %3[$4Z^U2STYHDN)&\R7/EQ1QM)(
M^.3A%!8@<9..,BLGPK%9.EYJ%CI-W8)=NK.]Z'6:=@,;F5R6 Q@#."<'C&"<
M_5H[S3/B5I^N26]Q/I<NFR6#M!$TIMY3('#%5!.U@,9 X(&<4 2^*/&EMIW@
M.]U_295NBL;+ RQLZB3.WYP!\N#U#8Y&.M:FB6UTDUS=-JUW>65P%\F"[MO+
M>%AD,<[5.&X.".,<<&N UG1+]/ 'C5H;&\=]9U%KBSLXX':3:3&-Q0#*EBK-
MSCC&>:]5AE6>%9$#A6&0'0H?Q! (H XL7FL7GQ,U+0UUNY@L8=/BNXUCAA+!
MF=E(RR'CCZ^]3:7XBU*Q\;S>%-=>&=I+4WEA?1IY?FQ@X9'7) <=<C@CL*I1
MSO9?%O5=1FL=2^Q/I<-ND\=A-(C2*[$@%5.>".>E4]2\.ZMXP\0:IK7V>33X
M(M'GT[3%N/DEEDD!S*R]47G !Y[X% '9V_B/2;^]33[>]*W,\320;HF3S4'5
MHV9=K@9!RN1T/2L/P;XD9O!-G?Z[?M+<S7EQ;+(8\O*PGD555$')VKT Z UG
M^%9;?49]+>\\,:Q;:KID;"66^$ICMSLVMY3,Q#[N  O;Z"LO26U'3?!>A0R:
M-?#9K%PUS)_9[23VB-),RR1H5)R0RC< <!CWH [QO%VAIIXOFOL6YN?LA8PO
ME9L[?+9=N5;/&"!U%6HM<T^?5+K3(YG:\M4$DT7DOE%/0],'.#C'7!Q7"Z'X
M>FU?PWXTT.[L[ZT-YJ4\UO+=*0?F5#&X8D[B&4'C.,5773/%%Y=Z+XADMI8+
M_5K<Z9J4 .#:P%<B3V*LLC?64+VH [B7Q;HD5M%<-=N8Y+<W2[()&80C_EH5
M"DJO^T0!27_C#P_I@MS=ZI"GVF W$.T%_,C SN&T'(P1]<\5S?B9;K^WKK3H
M=(NUM7T8Q6UQ8VN3.^6'DO*!^[5>"!E<Y//8YVBPW?VWX;-+I>HQBPTR:"X:
M2SD A<PQH-QQ\N2K#G'Y$4 =M/XOT*VM8[J6^ MG2.0SB)VCC5P"A=@,)D$'
MYL=:VP00"#D'H17F$T)L?$7B'2];\/ZSJ=KJES]HM9;/S'@F1D13'( P52"N
M,MQCV%>DVD0@LX(1&L8CC5=B$D+@8P">HH SY?$VCP7(@EO I,_V?S#&WE>;
MTV&3&P-GC&<YXZU!=>,_#UGJ,FGSZG$MW%)%$\05F*M(2$!P.Y&,]!QG&17!
M1Z5J4OPLO_!%U8W3:R)I(4E,#F*7=.9%G$F-N,'<<G(((QG KI]!MYH/B3XC
MEEMKKRI;2SCBN9+=PDAC$F_#D8/WE[\T =G6->WULGBC2[,ZPT%P\<S"P5 1
M<C Y)QD;<9&".O>I-#UZ#7HKMXK6]M6M;AK>2*\A,3Y !W =U(((/O6+KT4[
M_$CPG/':W,D%O'>":9('9(RZ(%W,!@9*F@"G8ZS?>*M>U:WLM3O--_LZ]CC@
M'V(E)$"(SB3>HY;<0!D$  @>O97M_;:>D;7+E?-?RXU1&=G;!.%5023@$\#H
M">U<OX-6:/7_ !8TUI=PI<ZGYT+S6[QK(GE1KD%@ >5-6O&MC;ZA::?%-_:4
M+K=;X;[3E9I+20(V'(4'Y3DJ<C'S<T :,?B729&LE%T0;V5X+</$Z[Y$+!DY
M'# JW!QT-21^(-*D2_87B*-/?9=^8"GE' .#N [$'WR*X"<:\ND^&M0U:TGN
MFTW7)'FEM;)A)+ 5E19S"HW DL"0!GG.*J:A9:U>MXMO+'2+XR#5K'48()HB
MGVN.)(BR#/!/R].N1@\\4 =;XF\3Q2>$O$<FC:A);ZGIMD]P5: I)&=A924D
M7[IQUQ^-7]!\4:9J9MM.2^674OLB3NA1AO& &921M;!.#M)P:P-=OAXC\&>(
M[BP\.ZA!/<:9);![BQ:.XF<JP6,+C<0"3R>,GC/.%2*=O%_@J=;&\$-OIEQ%
M.YM9 L3,L056)7Y>4;KZ4 =S<W,%G;27-S*D,$2EWD=L*H'4DUGV_B32;F2[
MB6\$4EI&)KA+B-H6CC()#D. =O!YZ<5F_$"PU'4/!]PFEP_:+N&:"Y6WSCSA
M'*KE/Q"FL#Q']I\<>#]7.C:#=VE]):HOF7]M]GEE*2*_D#=R5P&!/W<L,$\X
M .QMO$>EW=TUK%._V@0^>(9()$=X_P"\BLH+CW7-,C\4Z++8V%ZE\K6U_,+>
MVE$;;7D+%0O3@Y!'..E8$Z2>)O%OA75;2TO+9-.%Q+=-<V[PE \>P1?,!N)8
MY.,CY?<9Y.UBU"#PAX>T9M&U4W>E^(8Y;K%F^U8Q<.^]6QAQM(.5S[XXH ]"
MG\<>'+>]>S;4U:Y286[111/(WF$9"X53DD?X=:F\+>)+?Q5HD6IVT4T4<A;:
MLL;+\NX@')&#P 3C.#Q63X5BE3QIXPFDL[J&.ZN8'AEEMW1956!4.&(P<,#2
M_#*.YM/ ]CIUY975K<V>^*59XBF6WL?ES]X8P<CCGKUP =%J&JV>GM'#/,ZS
M3!C''#$TLC =2$4$D#(R<8Y'K7,^"/$K7GA-]0U34&N2VH7,$,IC^>55E8(%
M1%Y.T= .QJ/4I;O1?B?'J]S97ESI5WI8LTFM;=YS;RK(7(94!(# CG'4"N3M
M;35K+1]/U,Z+JLD%AKM]-<V<*/'.T,S2!9(P""V-PX!Y!/:@#T^W\2Z/=:?+
M?17JF"&7R)-R,KI+D#RRA 8/D@!<9.1QS7.^,_%(/@/7;[0-3D@OM. $G[K;
M)$V1\K)(N1D'(.!Z@UCZI:2"PLO$6@^'=06.WU:*^NK:97^U7:!'1GV.2Q(W
MC ."=O3I5KQ=(VO_  ]\13:;X?O8IKV.-$#63)<7+@CDH!NP   6]^V"0#JK
MG4;6/Q39VKZRT,PM99&T\*"LJ_+^\8XR-OU'6H;?QSX:NY+1(-5CD-Y*8(&"
M/M:0$KM+8P"2IP"1GMFLS4/-D^)7A^^2TO&M8M.NDDF%K)M1G,94$[>"=K<5
MRT%E?)\.M(M3I>HBYB\1+<O%]BEWK&+QI-Y&WIL(.?PH ]'U'Q+I&E2,E[=^
M4$=4DD\MS'$S8VAW *IG(^\1U'J*DN=?TVTN3;S3OO62.)RL+NJ.Y&Q68 JI
M.Y>"1]X>HKS\P?9M8U_1M<\.ZQJ4.HWCW-I);^:UM/&X7"288*A4C!W8X J?
M6+"_L]>NK[P\M_!J N+:.XT^2W>6RU!0L8WABN$*CC<#QY?- 'H]Q.EM;R3R
M!RD:EB$0NQ ]% ))]A6#H?C'3M8\-0:VWF6T$[ (LL3 L68A O'SL>.%SSQ7
M0L,J1[5Y%I%EJ]KX.\$S'2]0SX?O,7]JUNP<@JZ%T7J^W=GY0<@\9P: /4-.
MUBPU4W"V<^^2W?9-$Z,DD38R R, PR.1D<U->7UM81+)<R%0[;$55+L[=<*H
M!+' )P!T!KF='L9;KX@ZKXAABFAL);""T'FQ-&9Y%9V+;6 . "JY(YR<=*@\
M>17L%]H.L06-[?V=C/*+RWL683;)$VAU"D%MIZ@=B: ->3QGX?BTLZE)J 6T
M68V[R&)_W<H.-CC;E&R1PP'45H+K-@SWJ_: OV'_ (^6=658OE#<L0!]T@]>
MAKDA;:?=>'+^"U\.7D46N3>4RW<$K/(6&#-,#ED _P!H@G:.F0:QAI^N#P+K
MOA&.SNIM0T^59+2\:-T348Q(LO\ K",>80"AYZ\@^@!W:^*]$)O%DO?(>SA$
M\Z7$3Q,L9Z/M< E>V1D9J.S\9^'K^.:2UU..188XI'(1AQ+_ *O&1\Q)XP,G
M/&,\5RT<EGK.F:IJ5KX:UJWOAI<ULTNH13&8%AQ"@8DN-W)(X&!ZU'=VNJ0?
M#KP9=V>F74TNC26D]W8"(K,RI$4<*AP2P+9 [XH Z/5_$^CS>'M4D77FTS[*
M1%/<>21+;.<$9C=<Y(Z9'(Z5J7^O:;I0<7=PX,4(GE*0O)Y<?/SOM4[0=K<G
M'0^AKC?%LK>(/A]XCFTWP_>Q37L"1H'LF2XN7''* ;L 8 +>_;!+?%MI<3ZA
M/J6BOJMEK$>GH(\6;RVVH+ER()4*X# DC)P0'S] #M-3\0Z9HX<WUPR".,2R
ME(GD\I#GYGV@[%X/)P.#Z&M"*6.>%)H762*10R.IR&!Y!![BO-+K[5I_BO5#
MK^@ZO>6>LP0-&=-\V2-'$0CDAD5&  R,@G@@GFO0M)MDLM(L[6.U6T2*%46W
M5MPB 'W0>^.GX4 8T'B'2K(Z[?7&O/<VMK< 3@Q92R^0?+E5R1WR<XS6K)KF
MFQ:@MA)<A+EX&N51E8;HQC+ XP0,COWKSR^T^YU2P^*=E9Q-+<S2JL<:]7;[
M+'P/<UH6U]+?^._#^IQZ5JL=E%I-Q#)+-92)L<M$=I4C(^Z>W/;- &K=>.O#
M-_I5VEKXC2V)LY)A=1QDF) =A<97!()''7H<8.:V'US3["T@^T7<DI-N)BZP
M,[&,#_6,$7Y0?4@#KZ5PNF65XGP$O],.FWJ7[6=Y"+4VKB1G=I-N%QDYW#GW
MJ;6;&>:+3[S3Y-8TO6;728Q#<16<DL4_7,$L>TC((!YP?FR.E ';WFMZ?;QQ
MHUU()+B$RQB"%I9 F!\^T*2 ,CDC&2*Y#PKXC?4O"'ABZU/Q$\5[>7T@5EC4
MF]Q)(HC("X ( Y&/NTS3+C5=$\:'4-:TJZ\K5-)M(U:RMWG2UFC#;X2$!*@E
MR0>G'6L;2K._C\'^"+:32=1CFL]>:>>,VCDQ1[ISN.!P/WB_G[4 >D:AXFT?
M2Y72\O!$(W1)9/+8QQ,V-H=P-J$Y'WB.H]:J6OB^QN_$.KZ3LN(O[-2/S9I(
M'5=S!F/)&   ,$]<\9KF=/GNM)U+Q#H&J^'+S4EO]1DO+25;;S;:=),%5D<_
M*FTC!W=@,9XK3TH7&G?$/Q1)<6-WY-[%:RPSQP,T;!(BK?,!U!P-O4YZ8H U
M='UBPA\+V%X^M/J4,WR17CQX>Y8DXPBJ"3P> .@S[U)+XOT&#2[C49M12*VM
MI?)G,B,K1/\ W60C<#R.".]>?:%I^JZ;X>\ :C)IU]Y6D27$=_:?9W\V,2JR
M"0)C+!<]@3ACCO3O%FCWM_9^-M4L[&\DBU.*RM[>!+9_,G>-LL^S&X  @ D#
M.T]L9 /1M.\1Z1JNH7%A97JRW5NH=X]K+E"<!E) #+D=5R*NWEY;V%K)=7<R
M0P1CYG8\#G _$D@ =R:Y4++)\6H+U;2[%H=#:#SS;.J!S,K!2Q& =H)P:E^(
M%CJ%WHUA<Z=!)<OIVIVU]+;1\M/'&V651W/<#_9H UH_$ND2+>$WGE-9()+E
M)XWB>-3T8JX!P><'&#2:/XHT77Y6BTN^2Y=88YSM1@-C_=.2 #T/TQ@XKEM2
MM9-6\47.OV=M=K:0Z%-:,6M9$>>1V#*@0J&.W!/3JP]\;W@.*2W\!:#;36\U
MO/!8PQ2Q31-&RNJ ,"" >N: +.JWUM#KFC6CZPUI/-*Y2T5 WVL!&RIX) &-
MV<CI7.G6;WQ)XHUK1K#4[W2WT_R!;2I9%E+E2[F0.N,$84 E<]1G-7/%<4\G
MB[P?+%:W,L5O>RR3210.ZQJ870%B 0/F8"F^'%F3X@^+II+2[CAN6M?(FDMW
M5)-D6UL,1@X/% '4WE];Z? )KF3:I8(N%+,S$X "C))/H*H?\)/I $!:Z9!/
M="S3S(9%_?'HARO!^N*I^,[*VO\ 2(+>ZCU#8UTA6XT\,9K5P"5E&T$\$ 'C
M^*N/O(?$+>&K2?4H9]0.F>(X+@7,-F4GN;5-H\UH@,EADC@<A<XQS0!TGC+Q
M$(O"GB8Z/J+P:II-J99-L7S1DJ2N0ZX((!Y'YU>T?QAH>IW"Z=%JD4E_';B6
M1""NX <LI( 8 ]2I.*XO4K34=9D^(GV72=04:EIENMF9H#'YQ6)P0,]#\PX.
M#SR!6V+1M>\0>$KRUM+F%-(262XFN+9X2NZ+RQ$ X!)).3C@!?<9 -O1-8L!
MH!OO[;?4K<W,B+<O'AF;S"!&JJHW8/RC ).*M6_B71[JSNKJ.]41VDGE7 D1
MHWB?C"LC ,"<C QSD8S7F=G;W_\ PA.G:E965U?1Z=XBO+BXM;1F662(RSQD
MIM()8;\X!YK1U6R>[T@Z_P"'_#NH+)#J5I>W$5TKK<WRPDY&UR6^4$;<]2O
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MZ1?7CZ-))+97T5I*L,X:-Q(RJLD<A4;Q\W3 (((.* .ZIKNL:,[L%11DLQP
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M6TOFPW'FD*FR0JO.X@,"./>@#M:*Y@>*[J+Q'=Z+=:._GVUC]O+6TWFAXSN
M"@JI+;E*XQZ4W3/%C:AK\.AW^G1VT]SI_P!M""?S"BY4-'*I52K?...1U]*
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MGZE.ERF-WFJPC5"I&,8^7.<GZ5JZGK%CH\,<E[-L\UQ'%&JEWE<]%15!+'V
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MG:@FI6K3I;W, $CQ[+B(QME6*YP>QQD'N*M.ZQHSNP5%&69C@ >M '%-X?\
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MQA>&)Y)0Y*O@ONR#DD@?3 QBJ4OP^T6XT6;2YFNWBDO&ODE\[;+#.Q+&1&4
MJ<D^W- %OPU%KUN^H0:U<13QB8/9MO#2B(C[LF%4<$'!QR.O2L5O^2[1_P#8
MM-_Z4BNHT;1H-%M6ABGNKF1SNDN+N8RRR'H,L?0= , 52N?"EM<^(_[>%]?0
MW_V?[*'BD4 1;MVW!7'7G)Y]Z .8U]"/C=X7^P,4N9=/NUOVCQD0!?W9;V\S
MIGO46G>(?$4WP]TO52+O4I/M]PFH&T1!<- DLR QK@ D%8\@#. <>M=IIOAS
M3]*GNKJV20WUT )KR:0R3/CH-S9P!V4<>U4[+P=9Z;IUI965[?PI:7$EQ"ZR
MJ65GW%@<J0P)=C@@]?84 <=<7YUVZ\#W-EXBO+B&;4[I#*$2-AB.8@.A3&]1
MA>1ZG'.:V=-.NZIXU\061\17$-II=W;&*-+>(ET>$.R,=O3+=>ON:V)?!6DS
M6]K'FYCEM[Q[Y;B*8I(TS[M[$C'W@Q! QQTQBK>G^'K;3-5U+48+BY,^HE#/
MO92N57:I QQA1CW[YH XS2O%6JOH&CPW5^6N]1UVXTYKQHT!2-'EQ@ ;=Q$8
M4<=\\TOCRTU>R\$ZVD^NRS1?:K9K;8%65(GE1620@?,,EL<>Q)Z5T+^ =%E\
M/2:),;J2V:Y-VCF7$D,Q8MO1P 0=Q)_$]JG?P9ID_AZZT:ZFO;J.ZVF:XN+E
MGG8J05.\],$ @#CVY- &C?71T70+N\D>6Z-G;R3,7VAY-JEL?* ,\8X%<5+K
MVLV/AKPOXF_M![K^T9K5;RT*)Y96XP/W>!N!0L,<G(!SGK7?06D<%FMJ6>9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKG?$
MOBC^P[K3+6&W^T37E[;P2<X$,<D@3>?<G.!WP?0UT5 !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%<]KOBB30WN)&TFZFL;2)9;J[!5556)'R _?(
MQD@=..I.*FN_$]I:^)M/T$13R7-VS!G5#Y<6(V<;FZ9(4X Y[GW -NBN9N/%
M%_::_9:7-X?G O)VBAE6YB;*+RTA4'(4#!.?4#J13;'QD+Z>VV:7.MM?^:-.
MG:1,7+("V,9RFY59E)Z@<XZ4 =117*VWBO4KC5[G3#X:N$NH+;[0P%U$P&3A
M5)!P"V&QGLIJ%/',J2:A%=Z%<PRV;PP!5GCD\R>5@$B!!P&^92<] 030!V%%
M<L_C+RH7AETR9=42]CL?L?FK@R.N]6W]-A7)SUX(QFIT\7VB^&[O6+F":$VL
MLEO+;<.YF1MNQ,<,2V ,>O..< '1452TS4H]1T.SU3:8HKFV2XVL?N!E#8/T
MS5+P]XDMO$?]H-:PSQQV=S]GW3(4,G[M'#!3R 0XQGJ.>] &U1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!YGXJ\/^*U^S20:A8W*S:Y;7'RZ;(TD
M8$HVER)<%$4#. .!U!)->E1AQ$@D96D &XJ, GO@=J=10 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit2112024001.jpg
<TEXT>
begin 644 exhibit2112024001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H7*ZFNJ6DEL]
MN]B<I<PNI#CT=&]CP5(Y!SGC!OT4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM45E:+J%Y>2ZC;WT4$<UG<"',#%E8&)),\@'^/'X5JT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+=_\
M(ZZ3_P!>%Y_Z';UM5BW?_(ZZ3_UX7G_H=O0!M4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C_<;Z5C^$?^1+T+
M_L'6_P#Z+6MA_N-]*Q_"/_(EZ%_V#K?_ -%K0!LT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+X4_Y%
M^/\ Z[W'_HYZVJQ?"G_(OQ_]=[C_ -'/6U0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &+HO\ R&?$?_7_ !_^DT%;58NB
M_P#(9\1_]?\ '_Z305M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6+=_\CKI/_7A>?^AV];58MW_R.ND_
M]>%Y_P"AV] &U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% "/\ <;Z5C^$?^1+T+_L'6_\ Z+6MA_N-]*Q_"/\
MR)>A?]@ZW_\ 1:T ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX<U2>%RDL=I*Z.O56"$@BN(\)>(M4'A>YTO6;IY-532_[0M+MN&N('CW!O\
M>1CM/_ 3WH ZW[7XF_Z VE?^#23_ .,4?:_$W_0&TK_P:2?_ !BL73O$.LQ^
M%/#DEOIZ7\]SID4]Q=WEX+>(-L7@MM8EV))QCL>:5?'SW=MX<;3=(>XGUQ)O
M+CDG$8A>(?,&;!XSNY'IP#G% &S]K\3?] ;2O_!I)_\ &*/M?B;_ * VE?\
M@TD_^,5S,GQ$U2+2=4U!O#(\O1IWAU(?;A\I7!/E?)^\^4AN=G7'-:6L>-I;
M"[U 66FI>6NF0I/?2M=")P&7?B--IWL$PV"5Z@9S0!J?:_$W_0&TK_P:2?\
MQBC[7XF_Z VE?^#23_XQ4^LZ]:Z-X=N-:D#RV\40D58_O2;L!0/<D@?C61'X
MGUE-0.EWVAV]MJ4UH]U9HM]OBE"%0Z,_E@JPWJ>%8'UH T/M?B;_ * VE?\
M@TD_^,4?:_$W_0&TK_P:2?\ QBN7^#SZA>>#DU74O.EGOLR&YEOI)S,0[C_5
ML-L6.!A>O?I5&_U%6UW5;77?%.J:!J7VIETPEC':>5@>6PR-DF?X@QSG(XH
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M27?_  CJW9F%RQ1E\P#;Y7W2Y/._KVH VOM?B;_H#:5_X-)/_C%'VOQ-_P!
M;2O_  :2?_&*S--\87LVN:?INJ:/'8G44D:W"7@FD0HNXK*FT;#MR>"PR,53
MTCQWJ_B!+^72_# DAL+B>WE>6]";WCSA4&PDD_+GH!NZGF@#?^U^)O\ H#:5
M_P"#23_XQ1]K\3?] ;2O_!I)_P#&*I+XT@N=)\.7ME:FXDUR:..*'S-IC!4M
M(Q.#]P*V?<8XKJ* ,3[7XF_Z VE?^#23_P",4?:_$W_0&TK_ ,&DG_QBMNB@
M#$^U^)O^@-I7_@TD_P#C%'VOQ-_T!M*_\&DG_P 8K;HH Q/M?B;_ * VE?\
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MXTOH?&4_A?2]"^W7J6B78D>Z$4>TL0=QVG&..F2<].IH UOM?B;_ * VE?\
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M2O\ P:2?_&*7PI_R+\?_ %WN/_1SUM4 8GVOQ-_T!M*_\&DG_P 8H^U^)O\
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M:-IY.5[8ZFND@\-:3<01S1OJH210R[]2NT;!]5+@@^Q&:?\ \(IIG_/34_\
MP:7/_P <H P;KPAJ4WA?QKIJO;^?K5U/-:DN=H5XD4;CC@Y4],U6U/P5<'6[
MV]AT'0-5-_%"/-U-<FUD1 A.-A+H0%. 5.0?7(Z?_A%-,_YZ:G_X-+G_ ..4
M?\(IIG_/34__  :7/_QR@ \3:"=<\*76CV\D=O(\:^2VWY$=&#)P/X<J./2L
MZSTO6]3\3VVLZU;6=FMC9RV\$%O<&8N\A3>Y)5<#"  <GDYK1_X133/^>FI_
M^#2Y_P#CE'_"*:9_STU/_P &ES_\<H K> =!N_#/@?3-'OFB:YMD=7,3%EY=
MFX) [$50U6T\87-KJ6D-9:/J5G=F18;JYG,?E1OG"O$(R&*YP"",X&<&MC_A
M%-,_YZ:G_P"#2Y_^.4?\(IIG_/34_P#P:7/_ ,<H P+7PYKOAS7(KK28[348
M7TJVT^1KJX:%D>'=B3A6W AN1US6=IW@SQ)I-MX5D@?3[BZT>6_DN%>1D283
M,Q4*0IP<-Z<'UKH[W3/#VG7=C:W=WJ4<U]*8;9?[2NSYC@%B,A^. >N*N_\
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M7TN2-7634]K $?\ $TN?_CE &[16)_PBFF?\]-3_ /!I<_\ QRC_ (133/\
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M/#]Y!IUS8OK-Y;7[$13V]_=NB8!Y<^9\HX(Y[\4 +K?AF^U'Q%J=_"T(AN=
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MDRLC1NFX [3A\@X/(J;_ (133/\ GIJ?_@TN?_CE'_"*:9_STU/_ ,&ES_\
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M$JL20N3R2WW1@#%=C<:W'=6TMO-HNL&*5"C@6Y4D$8/(.1]10!YE>33^,/\
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M(O\ J#ZO_P" O_UZ -JBL7_A(O\ J#ZO_P" O_UZ/^$B_P"H/J__ ("__7H
MVJ*Q?^$B_P"H/J__ ("__7H_X2+_ *@^K_\ @+_]>@#:HK%_X2+_ *@^K_\
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M"_\ UZ/^$B_Z@^K_ /@+_P#7H VJ*Q?^$B_Z@^K_ /@+_P#7H_X2+_J#ZO\
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M.1]"Y:2M&_T#4M/CL] C@U>>PAT>.WLQI]PT,377S"1IW5E(&-AYXQNX)XH
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M^XWTK'\(_P#(EZ%_V#K?_P!%K0!LT444 %%%% !1110 4444 %%%% !1110
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MZ5>6TTD488M=S%"6(/W5;:1GHH4#IBO0=.AEMM,M()WWS10HDCYSN8* 3^=
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M9(T93TXY8]*PM$UOQ&+'P7K%_K N8];=(+BT%M&B+N@>174@;MV4&><<G %
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M2I=3AVWF;:*W$S$[$YVGCB@#>@TV]NH5FM_%U]-$WW7CBM64_B(JE_L74_\
MH:-2_P"_%M_\:KS77-.O;?PYKVH6%M<^'M.O-2L/(L_*C1FQ(B.Y3D)N)4XX
M)V<\$@ZNM>*-<MM4U>SLK[4Y;C1XXHX8H-(:=+Z7RED;S72,A-VX* I7'7I0
M!VG]BZG_ -#1J7_?BV_^-5'_ &;>_:/L_P#PEM]Y^S?Y7E6N[;G&<>5G&>,U
MN0R&6".0HR%U#;6&"N1T-<4W_)=8_P#L6F_]*5H W?[%U/\ Z&C4O^_%M_\
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M]9U*QTOQ;I$^H7EO:0FRNT$D\@12V^W.,GOP?RKI*Q;O_D==)_Z\+S_T.WH
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MK'\(_P#(EZ%_V#K?_P!%K0 W_A,?#/\ T,.E?^!D?^-'_"8^&?\ H8=*_P#
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M^!D?^-'_  F/AG_H8=*_\#(_\:VZ* ,3_A,?#/\ T,.E?^!D?^-'_"8^&?\
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M3H XWPSXK\.P:&D<VNZ9&XGG.U[I <&9R._H0:U_^$Q\,_\ 0PZ5_P"!D?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8MW_ ,CKI/\ UX7G_H=O6U7-ZS]N_P"$MTC^SQ;F;[%=Y^T%
M@NW?;YZ<YZ4 :FO?\B[J?_7I+_Z :\K\*Z-?^%O"VA>,].-SJ9?38H]2LY<-
M)]GP"#!Q\I3^Y_$/?FO2L^)_[FD?]]2?X49\3_W-(_[ZD_PH Y>3Q#HT7CRT
M\0W=_;QZ/>Z(([*]E;;%O$I:1-QX#$%.#R=I':LCPO9_\3GP:\ML4A+ZQ<VD
M<B8,<3RJ8^#T^5LCV-=^?^$F(P8]'/U:3_"C/B?^YI'_ 'U)_A0!YY;R0Z;J
M]OJ-]B+2+3Q1J!GD8?NX6>-A&[=@-Q(ST!:I]4O]/EUG1M;TB\BT;2//OE?4
M;BV#023N(\2#+ 88+( YQD@^M=X3XF(P4T@C_>D_PI#_ ,),1@QZ/CTW2?X4
M >>VTFD:+K?@N[NM06>P/]JSQWDT'D1QEWC.[!X1,L0IZ88>HJ.PFM[?4K'Q
M!.53PV?$E[/'.PQ$H>'9'*>P4R"3#=,L#WKM+O1_$5WX@TW5F;2@]C%/$L8,
MF'$NS.>.VP?G6G_Q4V,>7I&/3=)_A0!D>"Y(KW7?%.IV)#Z5=WL1MI4^Y,RP
MHLCKZ@L,9'!*FL?Q#<^$CX@U&:\U>_\ #.N1%4,\4YA:[4*-CA.4F'..A/&.
M.*Z_/B8# 32/^^I/\*0_\),2"8]'..GS2?X4 </I>N?8-:L]8\:M':&]\/Q1
MK)<1[%:02.9$QV=E:,[.IZ8XJO<0_:O&UI'HUG-9++X-G6SMY%V/%EQL4C)P
M1QQGBO03_P ),>L>D'_@4G^%&?$_]S2/^^I/\* /-=/%M?:-&T?B"*[N-/\
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MQ]/^NJ5/;P1O\5Y)7C5F3P_"JL1T!GDR/T%;&?$_]S2/^^I/\*,^)_[FD?\
M?4G^% 'FWA&^LM#N/"U_K$T=KIYT>ZMK>><XC27[0"5R> 2@X]0I%5+<1MH_
MA V\+10_\)I,4C*%2B^;-@$=L#'%>J'_ (28]4T@_P# I/\ "C/B?^YI'_?4
MG^% 'FM[K4<FHVTLU_:6@M_$N^YTZ&V53;*)BGG32'D%Q@[N =_'>O9*Q?\
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M%#,/]O:-WZYK.SXF_N:1_P!]2?X49\3_ -S2/^^I/\* #1?^0SXC_P"O^/\
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M:?93PPW N(9T>8$K^[</@XYYQ4FGKXN^W1_VF^B&SY\S[,LHDZ'&-QQUQ^%
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MPO\ A6W10!B?\(?X;_Z =A_WX7_"C_A#_#?_ $ [#_OPO^%;=% &&O@WPTH
M70M/ '86Z_X4O_"'^&_^@'8?]^%_PK;HH PQX-\-+G&A:>,G)Q;K_A2_\(?X
M;_Z =A_WX7_"MNB@#$_X0_PW_P! .P_[\+_A1_PA_AO_ * =A_WX7_"MNB@#
M$_X0_P -_P#0#L/^_"_X4?\ "'^&_P#H!V'_ 'X7_"MNB@#$_P"$/\-_] .P
M_P"_"_X4?\(?X;_Z =A_WX7_  K;HH Q/^$/\-_] .P_[\+_ (4?\(?X;_Z
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MPK;HH Q/^$/\-_\ 0#L/^_"_X4?\(?X;_P"@'8?]^%_PK;HH Q/^$/\ #?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit321001.jpg
<TEXT>
begin 644 exhibit321001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 _\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8=R[@#N=2S;2#A03@BK-GXHTZ_U6RT^V,KR7EA_:$+[,*8MRKSGD-EAQCUH
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M@AD) P26W$ L 2%('K4EQXQ6/5[[3K70M8OGLI%BFEM8HS&&9%?&6<'HX[4
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M(]CX*AU;&3\K*P(/>LZ/X@6\QNGM] UV>VM;B2WDN(;9'3=&Q5L /N(R.RT
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M'>J%_876J>(?BW8V0+74^G621JO5B;>3Y?QZ?C7J\,,5O$(H8TCC7HB* !^
MI$MX8YI)DAC667'F.J@,^.F3WQ0!RMMX]\,)X7MKY+Z%E,:1I91$-/YG \H1
M==^>,8_2L;5;K5M>^(T9TG3;>^M/#L>)$N+HP+]KF7U"/N*1\8[%Z[Q=*TY+
MXWRV%J+P];@0KYA_X%C-3Q00P&0PQ1QF1R[[% W,>I..I]Z .&^',UWI4NI^
M$M2MX[6>QD^TVD,<OF*+65B5"L0"P1MRYP.PJYX#_P"/SQA_V,$W_HJ*NM\B
M'[1]H\I//V;/,VC=MSG&>N,]J(X(H2YBB1#(V]]J@;F]3ZG@<T >.)!--X8\
M<RQ0O.EKXN-U-"BY,D4<D+N ._RJ3CVKJ/'?B'1M;\!W=AIFH6E_=ZK$+>Q@
MMY0[R2,1M( Y&W[Q)Z8YKNXK>& R&&&.,R.7?8H&YCU)QU/O5>WTG3;2Z>ZM
MM/M8;B3[\L<*J[?4@9- ' 3Z#-K'BCQ6+681:M9-87%C<G^"986Z_P"RPRK#
MT8U;^'FLKKWB/Q5J'D/;RL]JD\#_ 'H95BVNA^C CWZUWJPQ)*\JQHLDF-[A
M0"V.F3WIL=M!#)+)%#'&\IW2,J@%SZD]Z .,T_4+/0_B/XEAU6XBM'U(6US9
MR3N$6:-(@C*K'C*L"2.OS9KE?&%Q#K$/CK5M,D673TTJWLC<1\QS3K(S-M(X
M;:'4$^^*]:O+"SU&$0WMI!<Q YV3QAUSZX(I196HM/L@MH?LP&WR?+&S'IMZ
M4 9.F:?XEM[Y)-2U^SO+4 [H8M-\EB<<?-YC8_*L7Q#%JDWQ(T9=(N[2UN/[
M*NR7NK=IE*^;!D;5=3G..<_A7;TPQ1F99C&AE52H?:-P!QD9].!^5 'FOB;0
M+S2]+TW.IK+JVH>)+6XEO#;X19"-B[8]WW55%&"W..O-7+:VU%/B586_B;4Q
M=F&WDGT=H;<01R2%2DP89)+JI&!G&&)[5WTD,4VSS8T?8P==R@[6'0CT/O22
M00RO&\D2.T9W(S*"5.,9'H: /'(/^2?^-?\ L;V_]*X*M>-(W\*V]QHH4_V/
MJVH6MQIY X@G%U$\L/L& ,B_\#'I7JWV&T$4D0M8/+D?S'7RQAGSG<1W.0#G
MVIT]M!<JJW$,<JJP=1(H8!AT//>@#BM!U.QT+Q?XIT_5KJ&TNKN]6^MY+AP@
MG@,2*-I/7:48$=JR_B-KECK_ ,,M0N=-9I+:/4;>%9]N$F*SQY9#_$N>,]"0
M:]%O=.L=214OK*WND4Y59XE< ^HR*>]I;2VPMY+>)X!C$3("HQTXZ<4 <0\&
MN3_$K7QHVH6-GBPL?--U:-.6^:?&W$B8QSUSGBLOQ+IES::7HW@+2@-1NKR9
M[[4#-)Y(EA63S)=Q .P/(P48!XR*].6*-97E6-!(X 9PHRP&< GOC)_.D\B'
M[0;CRH_/*[/,VC=MSG&>N,]J //=(N=6T/XD/_:VG6UA:>(H\1K;W1G074*]
M22B[2T?;')2CX7:]H]EX"M+>[U:Q@F6XNMT<MPBL,W$A&03GI7H4L$,YC,L2
M2&-@Z;U!VL.A'H?>J1\/Z*S%FTC3R2<DFV3G]* ,'XG,K_##7F5@5-H2&!R,
M9'-)I%PJ:K 9/B&FI*6*_9"+0>:2" /D4-U(/![5UDEO#-;FWEAC>$C:8V4%
M2/3'3%4XM"TB"598M*L8Y$.5=+= 5/J#B@#S;Q9IUQXWUVZOM!M8YK;1U\B[
M+,RKJS*ZNUKD'!5=IY.1N..F:N>*-:LM=@\%:EI^J_V9!+J+XN65 ULPMY05
M8."H8'*D$?TKTF"WAM85AMX8X8ESA(U"J,\]!5>72=.GC:.73[61&D,I5X5(
M+GJV,=?>@#AM9MKC5?!7B/3;/Q</$%[/8/Y5NOV<,,=<")03NR!SZCUK:C\?
M>&!X>M[^*^AD2142*RA(:<N< 1"/KN!XQVQ706NE:=8RF6TL+6WD(VEX850D
M>F0.G H32M.COFODL+5;MNLZPJ)#_P "QF@#C])U&ST?XD>+8=2NH;-[W[)<
MVWVAP@EC6$(Q4GKAE(/I4W@B:/4?$/B_6+1A+87=_$EO.O*R^7 B,5/<;@1D
M<'!KJ[W3;'4D5+ZRMKI%.56>)7 /MD58CCCAC6.)%2-1A548 'H!0!R'P\_X
M]_$G_8PWW_H=87@W1;?Q%X+\8:1<\176MW\>[NAWC:P]P<$?2O2HH(H XBB2
M/>Q=MB@;F/4GU)]:(;>&W#""&.(.Q=@BA=S'J3CN?6@#R_0]2N_'&L:#I>H(
M0_AX&YUA3T-XC-%$OYJ\OTVTZW<KXV\7@>,AH?\ IT7[DBW/F?Z-%\W[U2?;
MCCBO38[>"&262*&-'E.Z1E4 N?4GO5:?1=*NIFFN-,LYI6^\\D"LQ^I(H 33
MG%QHT?DZFM^3&4^V*4_>-TW?)\O7TKC_  )XBT71_ =G8:EJ%KI]WI,1M[Z"
MXE5'CD0G<2#R=WW@1US7=6]M!:0K#;01PQ+G"1H%4=^@J"?2=-NKI+JXT^UF
MN$^Y+)"K.OT)&10!Y/IEAJID\%BRG73)[JZU2ZM_M%MYGE0R$NJE-R]5([\9
MK?\ &-EKT.@Z;%>ZS:W-V^N6(MYX['RUB/FC!*;SNYYZBO0FAB>6.5XT:2/.
MQRH)7/7![9HEABF"B6-) K!U#*#AAR"/<4 <M>66OVN@:TVK:U:W\)L)@L<-
MAY!5MIYSYC9XSQBN/TB>+2O#WPQUN^(CTRUM6AGG;[L#RPA4=CV&05ST&ZO6
MW171D=0RL,%2,@BHQ;6ZVOV801"WV[/*"#9M],=,4 <_J/B?1[QKG2K*ZCO+
MI[&:5C;$2+"@7J[ _+DGCUQ7)>"+A8O"WAYY/B(D4:6EN6L6%H H"KF,DKO]
MNN??->D6FFV%A"\-G96UM$_+)#$J*WU '-5QX>T0'(T?3_\ P&3_  H XB*T
M\13^-/'$F@ZK;6DB2VVV*>T\T2/]E3;\VX;1VZ&M[X=BV;PHMS%+-)=7-Q+-
M?F< 2+=%L2JP& N&& !V KJ$ABCDDD2-%>0@NP4 L0,#)[\<4D4$,)<Q1)&9
M&+OL4#<WJ?4^] 'GFEZ;K^IWOBZWT_6+*QLIM6ECDWV32S F&($JWF!1P1C*
MG'O4L"V'A3XEVEO<3I:6#^'H;*SEN'"J[0RME-QXW!64XKOXXHXBYCC1"[;W
MVJ!N;U/J>!4=W96M_ 8+RVAN82<F.:,.N?H: /--6NH-7U?QYJ.GRI<V4'AO
M[&UQ$=R&8"9RH8<$@,N<=,U!J%GK">&_#D.NZTDWAF[^SQ7H@M!$\0(4Q!G+
M-\A<*K$8/(]37J45E:P6GV2*VACMMI7R4C 3!ZC;TQ3I+:"6W-O)#&\!7:8F
M0%<>F.F* .%U4:;_ ,)#J]WI?BUM U:'8+Z*XV&&7"#:[1R=1MP-RD=,=JH:
M=KQD\6^%O$6MB*PCU+0I8!(YV1>>9(WVY;IN4$@'K[UZ%=:3IM]+'+>:?:W$
MD?W&FA5ROT)'%37-I;7ENUO=6\4\+=8Y4#*?P/% '!RZ[IQ^)&H:Y%=1SZ;I
M.@.EW<0L&1',H<)D<%MJ$X^E<RFC>,K_ ,'SZBNAV7]J7=ZNN17+7Y\V.08:
M-/+\OM&!'MW=SZUZ]'IEA%9&RCL;9+0]8%B4(?\ @.,5:Z4 >92?V;X_\2Z:
MYW?9-2\-3.I4_/$WGPD$'LR,/S6CPMJMY>_$U;'5AC5]-T:6VNR!A92)HBLJ
M^SJ0WL<CM7HT-E:6[*T%K#$54JI2,+@$Y(&.Q//UIPMH!<FY$,?V@IL,NT;B
MN<XSUQGM0!R>B_\ )5?%7_7E8?\ M:NQJ-8(DF>98D$K@!W"C<P'0$]\9-24
M <1X%C>;0?$<43[)'UK455O0F5L&H?!/B?0])\ 6%KJ%_:Z?<Z5;+;7MO/($
MDBEC&&RIYY()'KGBNYB@B@#"&)(PS%V"*!ECU)QW-5YM)TVYNTNY]/M9;E,;
M9GA5G7'HQ&10!@_#FUGM/ UBL\+P&62:X2%Q@QQR2NZ*1V^5AQVJCIFL:5)\
M4M6$6HV;>9IEG%&%G4[F$D^5'/)&1Q[BNXJA'HFDPSK-%I=DDJG<KK;H&!]0
M<4 >4:?(HTW0M0&IB3S->!7P[E=EN[3LI _Y:;H\F3YB5R#\H&,=I\23Y.BZ
M7?N#]FL-8L[JY<#/EQ+(-S'V&<GVKJ%TRP2^:^2QMEO&&#<")1(?^!8S5D@,
MI5@"#P0>] '!^+]6T[6K_P +:?I=];WMTVL6]UY=M*)"L,>YG<X/"@8Y]ZU?
M%5WX>OM(,.I:BT,*7T<'VJVDVM:7(PR$N.$(..6X^8 ]:W;/2M.TYG:RL+6V
M:3[Y@A5"WUP.:E-G;-%-&;>$QS$F52@Q(3P2P[]!UH XS0]=N-/\0WFF7OB.
MVUC3;>P-Z]\RHCVN& VRLGRG*Y8' /RFA=2LM&^)][<:E<106^K:;;BQNI6"
MQL8VDWQACQGYU;'>NNM]+T^TM9+6VL+6&WDSOBCA54;/!R ,&GW-C:7EM]FN
MK6">#C]U+&&7CIP>* ,NU\6Z)=R:@T-Y&;:Q:-)[S(\C>QP$#]"PXR!TW =:
ME\4G2QX7U#^VE<Z8T16XV DJA."W'(QG.>V,]JOK86:6@M$M(%MAC$(C 08.
M?N].O-3D!@00"#P0: //K#4KK3/$6FZ5:^*$\0Z??QS927RWGME2,L)#)'C<
MI("_,,Y8<UC^ 9Q%X,T)G^(:6J+;1EK)A: (/[A++N]N3FO3[/2M.T\R&RL+
M6V,GWS#"J;OK@<U!_P ([HG_ $!]/_\  5/\* .7T/4['0_&GBBRU6ZAM;B]
MNH[VVEG<()X#"B?*3UVLC CMFNGT77+#7X+BXTUFEMHIVA$X7"3$ 99#_$N3
MC/3(-6;S3;'4(EBO;*VN8U.56:)7 /L"*L1QI%&L<:*B*,*JC  ] * .-^&'
M_),=,^D__HZ2N(\*R)I_P^^'.M7?&F6%W/\ :G(RL7F>=&DC>@#,,GMFO9X8
M(;>$0PQ)'$,X1%  _ 4D5K;PVPMHH(HX "!$B +@]1CI0!Q7BO4[#7-1\-Z7
MI5Y;WE]_:L%X1;R"3RH8R6>1B/N@CY>>I;%8ECI]U#:ZGXETF)I-3TO7=0+0
MIUNK8RGS(?<X&Y?]I1ZFO2[+3-/TX.+&QMK4.<OY$2IN^N!S4\<,4(811H@9
MB[;5 RQZD^YH X[X8WL&H^'=0OK5]]O<ZO>S1-C&Y6F8@_D:CO=8TJ/XK:8&
MU*S4QZ7=Q.#.HVR&:#Y3SPW!XZ\&NS@MH+6/R[>&.&/).V-0HR>IP*JOHFDR
M3F=]+LFF9MYD:W0L6ZYSCK0!P7CW6[._TJ]DM]93&F7(BN=#F15-[(K@A.TG
MS<;<'!XR",U%XA;3-,7Q7JNG>+;VSUB&7SS9>8J+]H$2!$\LKF0.%0=P<\<Y
MKT>33+"6]2]DL;9[M.$G:)3(OT;&11+IMA<7D=Y-96TEU%_JYGB4NGT8C(H
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MY 3 QRBXXW)WZCTJQX)\1:)H^BZU_:.K65H8]9OV99IU5@/.;L3FO0)H(;A
MD\22J&# .H8 CD'GN*J_V+I7V@W']F6?GEM_F>0N[=ZYQG- 'E>F!M*.@^)]
M0A>UT637+^Y'FJ5^S17 987<?P@GN>GF"NH\3ZE8Z[KGAC3-*NX+R\BU..^D
M^SR!_)@C5MS,1]T'(49Z[J[AT21&215=&&&5AD$>AJO9:;8::KK8V5M:JYRP
M@B5 Q]\"@#SGP[X?UKQ#X/FT^75[2#0[F]O$E@CLF-PT?VJ3<OF&3:,\\[.
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M#). RMB@"WX"U"[U'PI$;^<W%S;3SVCSMUF\J5HPY]R%&??-<9#9V6DW*_\
M"56&KV.JB]WCQ#"[212$RY3+@D(I!"%'4* <>]>E:+H]IH.C6VEV0<6]NNU2
M[99B3DLQ[DDDD^IKFYO!>K75@='N_$\EQHC,-T4MJ&N7C#9V-.6Y';.W=COW
MH Y<0Z7=>,/%7]I^'M8U9X]058Y+0.R1KY$1V\.N#DD].];5]:PZCJ_AKPO%
M'=V&C2V<][/:&1HY)-A0+$Q!W8S(21GG K3_ .$6UNTUC5;W2O$<-K%J-P+A
MX9-/$I5@BIPV\=D':K&H>%KS4K739YM9,>NZ<[O!J,%L%!#<,K1$D%2N 1GJ
MH.10 EMX$TBSFN$MOM$6G74/ESZ<)F,+,&!#C)RK<8^4@'O7,:#X/T.;Q[XI
MM)+-VM[(V9MXS<28C+1EFQ\W<C-=?I.@ZC;ZHVIZQK;ZC="(PQ)%#]G@B4D$
MD1AFRQ('))Z<8J?3M"73_$>LZN+@N=3\C,6S'E^6A7KGG.<]J . N]<O=$U?
MXJZA;2,9K.&S:W#'*QL8.N.G4Y_"MK4O .FZ?X:N;VUN;Q-;MK9IUU8W4AE:
M55W;F)."I(Y4C&#C%;$/@ZT&K>)[N[E^TV_B!(HYK=DP$5(S&1G/.0<]L50;
MP7K,^F?V+=>+)IM%*>2\8M%6YDBZ;&FW=QP2$!([T <K<ZCK.H>)M,\3:?YK
M75OX<M;^:P1CMN(W=_-C _O8Y4^JBNJT?5(=6^(TUW97'G65QH%M-$0?E(::
M7G'8_P"%;EMX?AM/$IU>&0(@T^.P2V5,!51V8$'/^UC&.U9V@>";?P]XHU/5
MK6[<V][&$CLRF%M_G9V"G/0L['&.,F@##\4#29?&\T/BJ29=/;3H_P"S &D"
MF;>_F[-O67'EX[XZ5F^%B?'$VD6WB#S;F&VT*.<Q/(RB29Y9(S(V",L!%^!8
MUW6M:/K%]=B;2_$#:<CPF&6)K83+USO3YAM?DC)R.G'%49/!CV)TZ3P[J0TV
M>RLA8;I;<7"RP@@C<NY?F!!(;/\ $<@YH X>VOKS63H6@W5I=ZQ#;QZ@6@\_
M8+@P7'DQM*Y(R N?7+%>*]#\%W%I/X9A2S6\C2WDE@>&\DWRP.CL&C+9.0IX
M!R> *I#P2UC::2=&U-K2_P!.CEB%S/ )A.LI#2>8N5SEP&X(P:V/#VB+H.E_
M9/M#W,TDLEQ<7#J%,LLC%F; X')X'88H X_PMX<T[QEH"^(=>6:\OK^25U)N
M)%%L@=E5(PI&S: .1R3DDUSMYJ"S6F@V.ORWE_:6&OWNGRNBR22W$<<4GEEA
M'\S$?+G'=23WKN4\):MIDES%X?\ $?\ 9^GW$KS?99K)9_)=SEO*8L-H))."
M& )-3VW@JTL1H"VUS*%TFYENF:4;WN9)$=79VXY)D+9Q[4 )X.3PZOVQM L;
MVV^X)OM5O<1;OO;<><!GOT_'M7/>/?"^CI?:%=):NLU_KL$5RRSR#S$<.6!&
M[ !('2O2:Q]>T)=<;2BUP8?L&H17PPF[>4##;UXSNZ^U '(^)(K;PEK_ (.C
MTNQO'M_METS6MJ3(\A-NW9FYQUZ]J6Y\03:K\2/"47]EZKIR 7A87D8C63]T
M,8PQSCW]:ZW5-!74M=T34S<&,Z7++((PF?,WQE,9SQC=GO1J.@KJ'B/1=7-P
M4.F>?B+9GS/,0+USQC&>] 'E_A2UT2[T""74/"FO:A=/+-ONH5=DD_>N!@B0
M=!@=.U>I>(;.^N?"VHV6CS?9[Y[5X[9]VW:VW ^;M]>W6L'2O"/B/1-/33]/
M\56Z6L;NT:R:6&8;G+$$^9SRQKI;_3I-1T26PDOIX9I(@ANK8^6ZM_>7TY&<
M<CMS0!Q/AE="M/$EE"NE:OX=U9HW3[+<$F*]PN6^?++(5QN!R&[],BN>\1^(
MX[KQ!JOB:WUF",^&[F."TLOM2H;I4S]J^0GG(8JO'6/BNY;PMK=Y=6]SJGB2
M.XELED:S\FP$029HVC$C_.=Y 9N!M'-7=$\&Z-HVA6FF?8;:Y\B((\TT"EY6
MZLS9SR22?QH Y7QM>:3?^(_!\UY'=7NE75M=RA+2.60R K$4;;%\Q'/ZUGV3
MP/:^+KGPXE_;^'X]'FB=+DR*!>*'W;$D.Y2%X;@<X]*ZS1? PT:XT5AJ3S0Z
M.+J.VC:+!\J8J50G/\ 7 /<8Z8JU=>$EEN]=DM[UH+?6K0PW$ CW 3;2GG#G
MKM(!'?:.: /-(19V>@>'+ZRTK6=&N]]H]QK$[N+<(=OF%\.V5<9 W*!\PR17
M5_$&^L]6UO3O"%SJT>G6\L3WM].UP(B$4%8E!)')<[L>B5;;P)JUYH4.@:GX
MF\[1TBCAD@@L%B>6-,84N6; .!G S6OI_A"RM]6U;4[\0ZA=:A.'#30+B&)5
M"I&H.> ,\\9)- '&WFOOXA^"%[)+<AKZV9+&\D@DZRI,BLP8?WAA@1V:EUG5
M+VT\#ZOX=U&X<ZKI4MJ$G)PUU;-.@CE^N,JW^T#ZUT.H?#^WN9-:6SO!96NK
M);^;;QP JDL3 ^8N",94!2,=@<U9\9>";?Q<MF_VM[*ZMI ?.C3=YD>X,T;#
M(R"54^Q4&@#D;Z+3;KXB>)UU/0=6U;RVM1$;,,RQ P@D'#KC)YK7UG26D\/:
M)_9VA7\NCP3O)>:/YOESNA#8R&?YL,=VPMSQZ8K4G\+ZS%XBU35=)\016:ZB
M8C)#)8";!1 @PV\>GI5FXT+79[6SD'B4QZG:NY$Z6N()588VO#O^;&!@[@1V
MZF@#+\-:OX6T?3M3N(;RZTNTBG3[19:GNB^Q.P  "ORH;KP2I.<=ZBU&YM/&
MGBW2])COC-H)T^74'%K,56[82+&JEE()53N)&>3C-=!H>@3:=>7^H:C?B_U"
M^\M995@$4:I&#L54R< ;F/)).:;KWAMM4N[+4;"_?3=4LMZPW*1B12C8W(Z'
M&Y3@'J"" 010!A+IMOX4\=:-8Z5YD>F:Q%<17%BTC/$KQH'610Q.TXRIQP<B
MN?U#4-0\/ZVW@"QU+9::C*GV?4'<L^FQR;BT))_C.TB+)S\WL*[;3_#-['JK
M:QJNKC4-32!H+5A;"*&V5L%BL88DDD#)+9P,<4RU\#:<OAF]TC4'>^EU!C+>
MWCC;)-*>0XQ]TK@;0/N[10!E:S:QZ3XQ^'VG61>.UCDNHPF\G<!;G&[U/?)[
MU?\ B?(T?PYU=U+@A8_]62&/[U,@8IM_X/U2]7P]<?\ "0@:GHQD(NWLP_G[
MTV99=XP=O?/)YXI^H>%M:UG0-0TK5/$4,RW2H(Y(]/$?E%7#9QO.[IC'% %#
MP_IV@#6[=K7PEK5C.NXK<72.(U^4]<R$<].G>L^[O]9\#WTOAK3H'O%U9V;0
M9)#N6VD)S)'(3SL0$R#V!':NKLM+\3PWD4EWXEMKBW5LR0KI@C+CTW>8<?E5
MC5?#ZZIK^AZJ;DQG2I99!&$SYN^,IC.>,9SWH E\/:+'H&BP:>L\MQ(N6FN)
M6R\TA.6<_4_ETKS;QKJZZOXDU0VNMV]E+X9@1[.)[I8_M%YN$C*1D;@$0)@]
MY#7KC;BIVD!L<$C.#7.Z!X,TW1M)6UN88-0NFD>:XO)[==\TCL69CG..3TST
M% &)K&L)XLC\(6=G=30:;KS//<-#(4=HTB+F+<.1EL XP<*16O;>!-(L+QI+
M#[1:VLT#P75E',QAN%88!8$G##GYEP>>M4U^'L,6F/9VVI36Q@U%]0TR6*,!
MK%FR2@!R&3+/\I X;'O6CIOA_55U:'4=:U]K^2W1E@A@M_LT*EN"S*&8NV.!
MDX'.!0!R5MX-T%_B=J.F-9.;*/2H)TA^T2X#M+("WWNX4?E73^.KVZTOPBR:
M=,UM/<3V]E'.O6$2RK&6&>X#'!]<5H0Z$L7B^ZU_[02T]E':>3LX78[MNSGO
MOQC':K.MZ/::_HUSI=Z'-O<+M)1MK*000RGL00"#ZB@#B?%7A73O"GA:\U_0
MS<6FJ:;']I6X-S(YGV\LDNXG>&&0<^O%95W-X=N/'_B,^(++4;D@6A@6WM[F
M41@P@D'R@0.?6NIE\'ZOJ<,5CKOB4W^EHZL]NEDL+W&T@A97#'(R!D*JYK<T
M_1%L->UC5!.7.I-"3'MQY?EILZYYSUH 72X;1_#L,.E>?:6SPD0%T99(P<\[
M9!N!!.?F%<-#86FA^(P_AQIY3I5C<'6+EYF=9Y-@,:.2<-+N!8X^Z/3(%>CW
MD4L]E<0P3FWFDC98Y@N[RV(P&QWP><5S/ASPKJNA6UO82ZW;76F1HRR6XT_R
MVER#EF?S"2Q)R20<\^M '-65E'H.F^#-?MY)WU'49H4U"5I68W8FA=VW G!P
MP!'IC XJ'3+9;3PUX2\6I)*=8U&]M3>3F5CYZ7#;60@G&T;Q@8XV#%=3I7@J
MXLKC2X[O66O-,T@DZ?:FW",AVE%,CY._:C$#A?4YIMAX'FM)K"VEU<S:)IMP
M;FSL?LX5D89V!I-WS*FXX&T=!DG% &1J.A6EIXGTR#3+BZNO$CZ@M[=W33,6
MCM=Y+K)@[0A7]VJXYXQT)KT>N.TCPGKND7MQ-%XDMY%NKHW-SOTT&27)^Z7\
MSLN%''  XKL: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:UN0?E(4 KYG'[L.#E3S[@'BL;3?$YU71O!^H:I83K/J=RI@:WGVQHYB=AN
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MO!-?$W<J7%S*\8;DY#>5SG/1B., ?-U.M^+[719+J%(3=264*S3Q+*HDVG.
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MP+*P8D'< 1T&,^G%5&\:6JP6U^;:3^R;F\^Q)>!A@/O,88KV0N-H;W!P <T
M=-17&S^/7AM=8O%\/Z@]GI+SI=2B2$;3$H;@%\G(/;/]!*OCRUM[V:#5]/NM
M,C6Q?4(9IBK+-"F-^-I)##(.T\X/X4 =;17.CQ5Y5_;V5YIL\$UY:O<VBAU;
MS0@!:,\@*X!!QG'7GBJVF^,[C5-+L]1BT"]CMKU8FMI9'380ZLS,Y4DHJA>6
M(YW+CK0!U=%<4WCB>]C\/3:98AX]1U":SF#RC*-$LN0I&003&<-Z?7BQ;^)=
M.LKC7'^S7B7":G%9F*27>9IW2,)L&XA5(9?3H2: .MHKDM1\=0Z3%JBWNG3B
M\TT0O+!$ZL'CE;:LB,<97.0>,@CITK4TG7SJ6KZCI<]A-9W5DL4A61U;?')N
MVL"I(SE&!';% &S17.0:G+J7C'5+&//D:/##^[#8\V>0%N?95"X[9<GL,<J_
MB+4M6TWP=K$MO-%-<:P\9M[>X^65/+GPI&0#@HO+>F>* /3:*Y>W\;6LMB'F
MMS:WAOI+ V\TJ@"5 6;+]-NT9S[@8SQ6GX?UR/7["6X2WD@>&=[>1'Y&Y3U5
MAPRG@AAU!H U:*Y.W@\4V,.GSW]QI\L=J\[7VQY<RIC*.O\ M<-E#\HW<=!5
M?P6DOBCPO;:_JEU=FZU$-,J0W,D:6Z%B$1%4@< #)/).<^E ':45SL.I3:9Y
M>A0++JVHV=DLT[M(%9DR54DGJ[;6XZ<')'&:L'CJWU"73(]*TZZO#J5E)=V[
M;DC'R,JLC9/!!;!^G&: .LHKDM-\=1ZB=&D_LF[AM=69X89I&3Y9E5F*%0<X
M_=N-W3(]#FH(/B%'*MC<RZ+?0:==7S:>;MVC(BF$C1@,H8G!9<;AP"10!VE%
M<VGBZ/\ MNSTV:PGA-[-/#;^80LC&(,2Q0X(1@C;6YSQTS52P\=K?'3)#I%W
M!:ZA=S64<TCI\LR&0;2 2<'RFY]?SH Z^BN<LO%@O;&25;"1+J/4/[/>T:1=
MXD! )XXQM.__ '1GVJ&/PM>(T1&LZAB/4S>*'NV?$1QF)LCYU.&^4\+OX)P,
M@'4T5SVAZE)_PD.M:!,[2?8##- [G+&&520I/<JRN,^FW//)-1\51V1U5K>R
MENXM(4-?-&P!3*[R$!^\P0AB..HQD\4 =#17'WGCZ*$ZD;/2;J]AL;&+4&FC
MDC57@<.VY<MGHAXZFNDDDCOM'::-Y!%-!O1D8HV",@@CD&@"Y17FW@"[BU;P
M]X=>XN]=;4GMQ<RW$LMR(G*D;@2YV/G=T&>Y[5T47C2VD33+LVLJZ9JD_P!G
MM+O<#N<YV;EZJKX.T\]1G&: .GHKBI?B$T6D:EJO_"/:@;'3VGCFE\R+B2*3
M85QNSZG(R.*MW/C&XM[^_L!H%VUU:VJWBIYT8$D)+#=G=P<H1MZ\CWP =515
M73-0AU;2;/4K;=Y%W D\>X8.UU##/O@URVD:G<6#>.+B>XGNDTZ\9XEE?=M4
M6T4FT>@R3P/6@#LZ*\[TW4[^QA\#:A-=SSRZ[A+Y7D9E9I(3*&52<+M9<#&.
M#CTK;\2>(=,NO"WB2#3=7M);ZUTZY9H[:Y5I(BJ,,D*<J0<?0T =317E7AS6
MY_&RZ5H#7=UI]E;:=;W%P7WQ7&I': ?+8X/E!@=S Y;V!R?1-;-W!H%X=.:*
M.YC@8QM("57 ]CGIG'OB@#1HKR/P#=ZEI/A+PW96%OIQU'74:X^T2*^ B+EY
M)><N^64#!'7VK=N?&^LPVT-JEA9OJXUL:/,N]A"2T1D60=P,;"1R?O#GB@#O
MZ*AM/M(LX?MAB-UL'FF$$(6QSMSSC/K4U !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!F^(--EUGP]J.EPS)"UY;R6_F.A8('4J3
MC(SU]:R;;PQ>P7_AZZ-[;M_9%E):%1"1YV]4&[[WRX\L<<]36CXE\167A;0K
MC5K\MY,(X5>KL>BCZUCGX@:3;ZY>6]Y>VT.GQVEO<03DG,GF&4-QZ 1CG'&>
M: -7POHDN@>'HM+GN([DQO*WF)&4!#NSXP2>F['6LK0_"&H:9IAT*[U:.ZT&
M*.2&"$0%)S$P("2/N((4-@84$X'/&#LW_BC0]+%NU[JEK"MRGF1%GR&3CY\C
MHO(^8\<]:L:OJMMHVCW.IW3@001ER?7T'XG _&@#!T_PE=0V^AVM_?174&AM
MNM"(BKR$1M'&9.<?*K'IU.#QTJO9>"[VST_0+7^T;=SI-_+>[O(8>;O$HVXW
M?+CS3SST%5O#/CF[UW2=)OYKG1K=K^Z6/R TFX*4+>6"1S)^F,UU%MXET6\U
M.73;?4K>2\BW;HE?GY3A@.QP>N.G>@#!MO!=[!IVDVAU&W8V&K2:D6\@CS-[
M2-LQNX_UIYYZ#BK&B^%]5T>62P&L12Z!YKRQ6YMR)T#,6\HR;L% 2?X<XXS6
ME8^+?#^I?:3::O:2BVC,LQ$@ 6,=7R>J\?>''O6;K'C>PB\':SK>B7-O?2:=
M"9#&20 <9&X<$ CH>] #_#'AO5M!MH=,GUB.YTFS4I:(MN4F*8(59'W$,%!P
M,*,X![8JG8^"K^STCPSI[ZG;R+H5R)486Q4RHL;QJI^<X.'))]0.*Z/^U[:V
MT&+5=0FCMH#"DDKL<*FX#],FK%QJ-G:7-M;W%Q''-=%EA1CS(54LV/H 30!R
M\7@AX]+ET%KR-]#:^%XL1C/FJOFB;RMV<;=XZXS@X]Z;=>"[VXTW6;0:C;K_
M &CJT>I!_()\O8T3;,;N?]4.>.IXK<L?%.A:FER]GJMK*ELGF3,'P$3GY\G^
M'@_-TXZTVV\6:!=Z?<WT&J6[VUKM\^3./+S]TD'D ]CWH T;RSAU#3Y[*Z0/
M#<1-%*O9E88(_(UR^F^ X[&ZT.[EOY9[FPA:*ZD9>;S[I4O_ +C(I7TP*Z33
M=5L=8M3<Z==1W, =H_,C.5W#K@]ZJ6OBG0KVXN8+;5+:66V1GE57Z*IPQ'J
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M=79W<%_907EK();>>-98G7HRL,@_D:FH **** "BBB@ HHHH **** "BBB@
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MNVMFV3""4/Y;<\''0\'\JKW6K: MW&+O4]/6XM9"562Y0-&^"IX)X.&(_$T
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M%\RXD"*6/09/?VH \E?2Y];\,W4-G?ZO>:E;:!/;+:RZ>L"0;E0& D(I+$H
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M9\K4+)I+B>334ACM)<*RF%BF"I!9<-NSP<UT]EX)TJQN=(G0W#G2[ Z? LC
MJT1 !W#')^4>GTJ71O"L&BRQF+4M2N((83!;6UQ,#'!&<?*H"@MC  +EB .#
M0!SOP9M98/AII<KWDTR3(S)$ZH%A_>/G:54$YZG<365H<%Q)J/B5HO!ECJZ_
MVW<_Z3/-$K=1\N&4GC^M>A>'M"M/#.@VFCV+2M;6JE4,K M@L3R0!W/I6/\
M\(-'%>7MQ9^(-<LA>7#W,D5O/&$WMU(!C)_6@#+\5>)-0\%+I]TD5N+.]@^R
M1Z<61%M;G&5;< ,Q=0Y[  CO4&KZMKMGJMMH+:KJC3V^F+<S7>GZ<DS3S.[*
M-R["%C&P\  G(YXKJ(O"5@;DW%_-<ZG(;,V6;UE<"-CE^ H&6XR>X4"JQ\$V
MRP626VKZM:SVMN;07,4R>;)#G(1RR$''8X##UY- &+8ZCXF\4W<MLE_)H5U9
M:;:S20BW1M]S*KDB0.I(1=@&!@\GFKCZYJT0\:++<)YNEV<<EOL0;8W-N78C
M(R1NYYS5_4/!-C?2*\5_J5BQM%LIS:S@&XA7.U7+!B2,M\P(;YCS3+WP%IMW
M-<F.\U"TM[NV2UN;6VE58YD12JYRI8$*<<$9 P<T <YILNHW'CN2^DU:Y./#
M5M=&'9'L9F,@(^YG&X;N#G)QG&!3O"?BC5Y+/P=?:I=K)9:Q9RPS'RD14N5R
MZ-D 8W(KC'3@5U(\'V2:I;:A#=WL3PV"Z>\:.NR:%<[0X*DY!8G((J";P%I$
MW@JV\*F2[6RM@ODS+(!,A4Y!#8QGDCIT)H Y1?%FMWT>EEKK48;?6)+R]A;3
M[))IXK6-D6% "C##;PY8@GG'&:[7PY?ZI=^$X[K4;>5-042J5EA,32;&8*Q3
M^'< K8_VJ??^&+2\@T]+:XN=.ETY2EK/9LH>-"H4IAE92I '!!Z#TK1TZQ33
M=/ALXY9Y5C&/,GD+NY)R2S'J22: .,\"^'-$U?P!8W>H6%K?W.J0?:+Z>>)7
M>65^6RQYX.0/3'%<6T-]J.E> E.L7BQQZW-:02!8W)6-IECERZG+;5 YR.,X
MSS7HS^ K-7N$L=7UC3K*X=I);*SN0D)+'+;<J63)))"L.M7YO"6E2QZ)%'$]
MO#HTPFM(H2 H(4J <@Y&"??/>@#AM,LKZS^)/C:Y_MJ[EDM+&V<^9%#^]S'*
M55L1C 4@8VXSWS5KP[K>N>)K'PUIXU:2QEN=';4;J[MX(B\C!U15 92JC+$G
M"]@.*[)?#5BFK:QJ0>;S]6@C@N!N&T*BLHVC'!PQ]:SU\":?;Z=I5K8WVHV,
MNF0-;6]W;R()3$V-R-E2K E0>G!&1B@#GM5UOQ)%JC:.U]?+>6.G13/-I6G"
M=;B=VD +AE;:F(QP,$EC@\5>TK4_$.M^,EMIKV33;6#3+*^GLU@3?YKE]\9+
M D+\N#WX&".<ZC>!;".*W2PO]2TYHK;[(\EK,-\\62V'+*W.68[AA@6.#S6I
M9Z#9V.L7&IPM-Y\]M#:L'?< D98KUYS\YR23F@#+\17FH3>)-&T"QOI+!;R*
MXN)[F)$:3;%L 5=X91DR DD'@>]<%XKGU/5]!M;6\U68RZ=XJAT]I4BB'GC>
MC)(P*D;E##@84G.0>E>GZUH$&LRVEQ]JNK.\LV9K>ZM642)N&&'S*RD$8R"#
MT'I5!O ^E/I-MI[R73+#?KJ+3-(#)-.K;MSG'.3U  XX&* *GQ"BN;?X6:VB
M:A<>=%8.&N-J!Y1MY#87 W#(.T#KQBLB/2M3G\>?9(-?NX)%\/P%[Q883,Y\
MZ7:,%-@'/.%R<#GK7=:OI=MK>CWFEW@8VUW"T,FPX;:PP<'UJGI?AN#3+Y;X
MWMY=W0M%LS+<LI+(KLXSM4#.7(SZ ?6@#@+?QEK>LVND0BZU&VF?1X[V:73-
M/6X,DSNR#<"K!4_=DX&"=W48KJM9UC5H_A/>ZPT#VFKC26F>/:0T,OEY;CJ,
M')_"I4\"6-M9V$%AJ.I6#V=L;19[:5!))"3G:VY2.O(( (R<$9KH8K."/3TL
M=ADMUB$.V4E]RXQAB>3QUSUH YFW\$^%7\)VUHUA;"V6%)1=J DNX -YOFCY
M@V>=V:R]0U/7;R'Q7JECK#V46A.\5M:K#&Z3&.%9&,I92Q#%L?*5P!GDUI)\
M.M-6!;%M3U>31T(*Z4]T#;[0<A/N[R@_NEL=L5:U+P18:C=7LGVV_M;?4 HO
MK2VD58KG"A?FRI894!3M*Y YH YB^UW7]27Q->66L2:?!IFF07]M#'!$^7:%
MI"KEE)*_+VP>>HQ4TFM:_IUQ#)-JS7 U'0;J_$1@C5;::-8R/+PN2O[PC#%N
M@YKK9/"VGR?VSS*HU>V6VG56 "HJ,@V<<'#'UJIK7AB";33+;"9[NTTJXL;5
M-PPPD11SQUS&O/'>@# L-7US3I_"]YJ6M_:H-:MG-S%+#&D=NXMS,&0JH; V
MD'<3G.>*RAXMUNUM+]TU2_NO,\/W>HPW%W8) BS1!"K0KM!*'?T?)X7GDUTV
MA>!;:+3M,;4[B^N6M]/^S)9W$JF.VWQA9 NT DXRN2S8' Q3F^'.GR0K'/JN
MK3D64VG[Y)D)-O(H4Q\)C P"#C=D<D]* ,YY_$\.I65C'K[RW&L:3<SQ[[>(
M):W""(J4PN2G[P@AMW3K5G2O%=[XCN_"\-D_D--;R7FJKL!*"/\ =F+D<9F)
MZ<XC-=%=:1;07-EJJQW,]QI=K+#!#$5S(KA,C!P"W[M<<@<UC^"?#TFG7.M:
MU=61LKK5[HS"V9PQ@B&=JD@D EF=R <9?VH Z^O)_"<^KZ1X:\'7BZM(]K>W
MGV.2P,,?E"-O,(8-MW[@5!SNQVQ7H^A6-SINBVUI>74EU<1@[I9)#(S98D98
M\G (&?:J4'A+3K?2M(TY'N/(TJX6X@)<;BPW8W<<CYSZ4 <CX;\4:]JM]I=^
M/[5FM[^:07%N^GA+:WB(<HT<H7)((0'+$'<>F!533_$?B,>!-!U:\U>ZGN]=
MGA@_T6RC=K9 DCLT:!?F=@G.[(!/ P*[?3_"5MIM\DT&H:C]EBDDDAL#,/(B
M9\[B %#$?,V S$#/ '%(G@[3HO"]AH,,UU'#IY1K6X20>=$Z]&!QC/)'(P02
M"* .*N;G7-3NO#MO//>V\T6O216M]>6BQ320FTD.\H5"[AEU!VX)4'':KDWB
M+7=$GOUN=2>\M-$U:".\FDAC#2VD\:G+;5 #1LX.5 R!S723^"K2ZMK1+C4]
M4EN+6[:]2[:<>:92A0'[NT  \* %XY!YS4U+0CH_AC5+*RL+W7;S6&=;AYY(
MP9'=-@:1OE"H  /E' ' H OZ#J5[JWB'7I3-_P 2JTF6RMHPH^:1!F5\XR?F
M8)UQ\AK-MYO$&O:MK%QI^L?8X]-U 6<-FT"-%,%5&<R$J7R=Y VD8P.M;OA?
M0T\.>&K#25D\UK>+$LIZR2'YG?\ %B3^-4;_ ,$V%_J-Q=->7\,%W(DMW9PR
MA8;ETP 6&W<.%4':1G SF@#F;+Q/KM]K8NK?^U98?[7>S:T73P;5;=93$7\W
M;NWC&\G=C@C%9&KW6OZM\+->U>\UZ<*)I[>.WAAB5=BW)3YCMR3@8X(X [Y)
M]"B\)VT&K->0ZAJ,<#7)NVL4F @,QY+8V[N3R5W;2><4C>#=,?PG=^'&:X-E
M=/*[MO'F!I)#(2#C'#'CCMWH Q_M>JCXD#PU_:\_D'P^;C[1Y,/F^=Y^W?G9
MC..V-OM7)> KG4O#OP^\+ZP-2FETF6]>"^M9(H]D222R(L@8*&XD*$Y)ZFO2
MK+PO;6FOPZV]Y>76H1V'V RSLOSQ^9OR0JCYL]Q@8[5B:KX<&C?#QO"6BZ9<
MZBEQ%+;Q&61 L1<EM\C$C@%B?E!/% &KX:U*]UC4=<O'FSID=V;2QCVC_ED-
MLCYQDYDW#K_!7*ZCJ_B0:=XOUJ#6VBCT*\D%O:""(I*B1H[+(2N[!#$#!!'7
M)XQWFA:3%H6A66EPL76VB6,N>KM_$Q]R<D^YKD;/P.VHW?B+^T[C4+>SOM4:
M5K6*51%=PA(\;N"0"0P.TJ2!@Y&* &WOB?5$\*>.]0BN=DVF2N+)C&O[H"VB
M<#&,'YG8\YZU8BO/$&H^-M?M;;4_+M-,BMY(+41)B:22)CM9B,A<C/'//4 <
MW=6\ :=J\FJB6_U*"UU0#[7:02JL4CA @?[I8'"KT.#@9!K6B\/645_JMX&F
M,FJ1QQW WX "*5&W&"#@GG/Y4 <"/$VL6?A^^>76KX:M$MJ9K/4+".*2%GG1
M':,JH5XR"0/O8X^:N@\0>(+S3M?U6V&H1VEK#HJ7,;O!Y@CF:5T#;1\S'A0%
M[G'%66\!6-S:W4.H:EJ=^T]N+99;B9=\,88.-A51SN53ELG*C)I'\ V%Q]LD
MO-1U.[N;NV2WDN9I5W@(^]"NU0JE6P1@8]0<G(!RTOBC7K33=?MX+Z^:>TDT
MYK:?5+2..4">?RW5E55!7"G' /S'G@&F^,;C6;+2?&.C3:[=74<>B)?1S/%$
MLB[FE1X_E0#:0@[9&3SWKJV\ V$LMU+<:CJ=Q+=K +EY)4S,T,HDC8X0 $'Y
M<+@8/3/-7]5\*:=K$^I2W9F)U"P&GS!7  C!=@1QPV7//TXH ;=P75MX&N8Q
MJ=RUS'9.PNRL8DR%)!P%V^WW?UYKC_#$FK3Z;X2\/6^MW5M'+H:ZA-<K%"9=
MH$2)$F4*A1O)R06X'/>N_M-+6#11ID]U<7L?EM$TMPR^8ZG/4J .AQP!6'!X
M#M;2QTZ"VUC58I].1H;6\62/S4A(4&(Y3:R?*O52<C.: +7@[5+S4M)N4U"5
M9KJROKBR>=5"^;Y;E0^!P"1C('&<UE:!IEII7Q-UZ*TC*^;IMI-*S,6:1VEN
M,LQ/)/0?0 = *Z?1M'M="TU+&T\PQJS.SRMN>1V8LSL>Y)))K&L_!*6>OG61
MK^MRW+!$D66:,I(BEBJ, @^4%F[]Z ."L$86.B3MIT::2/$'G1:X&7SYMT[;
M"R=0'9@A;<>.< 'CV6N6@\!Z?!- HOM0;3K>Y^U0Z:TJ_9XY VX$?+O(#'(4
ML0#VKJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)F5V &3EL,^WCTKJO%\^MPZ"RZ!:2W%[+(L9:)HP\,9/SNHD8*6 Z GJ1V%
M'-/XIUVQ?4M'>XM+W4(]0M;&UOO(*)NF7<V] W+(H)P",Y7I4E[XIUO07U+1
M[N6UOM47[)_9]QY)B63[1*8AO4$_<923@C(QTIG]E7LOAVWATWPS>V$^E7T-
M_%%>W$+/>L&/F9=7;YR"WS-CDCMTCU'0=:\17&I:_P#V:]E=Q_8O[/L[F1-[
M_9YC,=Y4LJ[RQ4<\8R: -)=3\3V.HZAH1ELM3U+["MW8SM%Y"G+['5U#'A3A
MN",@XZ\U:T/4-9A\67F@ZG>V^HK'91W8N(;?R3$S,R[& 8CG;D=\ ]:R[H^)
MKF]U3Q+8Z#-!>QZ<MCI]E<RQ&1W:3<\C8?:%'RX!;)VGID58\/SW.AZ/J,DG
MAK4X9XX)+R>[OKBW+WLJCHS)(V"<<9 50,<8Q0!U&M:C_9&BWNH^1)/]FA:7
MRXP-S8&>Y%<7:>.[^?4_#\LFGWWE:AI$MPUA#"K/)*&APRDGA=K/C+ 8Z\XK
MKK])=8\*7*11[)KRQ<)&Y^ZSH< GZFN7\+:9JPU/PW=7FE3V26&AR6$XF>,D
M2[H,8VL<@['(/MSB@#87QK93Z787ME8:E>->^8([>" >:GEG;)O#$!=K<=>3
MTS51?'4=UXCT.PL+"YN+/5+-[H7*H!M 9 ."00!N.[C(XQGFN?@T'7+2WT^W
MNM,U"YL1/J+O:V5\(#YLER7A>1@ZDIL+="<9Y7-.\.Z+KFCWWA*6XT:X=;*S
MN=.N3'+&?*+R1E9>7Y0A2>,M[9H ZGQ'XHET+6M"T^+3;B[_ +2G>-FB4':J
MQNW&6'S9 /IC/?%-?QSIB7CH;:^-DEW]B?41"/LZS;MFTMG=]X[=VW;GC-1>
M+;/4&UGPUJEEI\U\FGWDCSPP,@?:\+H"-[*#@L,\US\FAZW_ ,([<>#ETF4Q
MRZDTRZGYL?DBW:Y\\L1NW[P"5V[>N#G% '<:[KMGX>L$O+X2F)YXX!Y2;VW.
MP5>!R>3VK!E^(VGP)?\ FZ3K*RZ<-][#]F4M;Q[=PD;#8VD9/!)X/'!K0\7Z
M;=ZG8Z;'9P^:T.JVEQ(-P&(TE5F/)[ $^M96HZ#J4\WCQH[4L-4T](;,[U_>
MN('4CKQRP'..M &_9^)=-O9=3C21D.F[6G,@P-C('5QZJ5SS['TJIJ.O-<?#
MR^\0:;YL#-IDMW;&9 &7]V60E3D>AP:X[Q1HMXNH:!86A$<VN6*Z1J48;YA"
MFUVD&.NU/-3/_305W?B2PDN_!VKZ=8PAI9=/F@@B4A06,955&>!V% &?;>,+
M2*Q@2X,US=Q:6M_>M#&"(5\O=E^0 6P<*.3CL.:DT_QMINH7L%N;>]M4N;9K
MJVN+J()'/&H!8J<YX# \@<<C(KEM/\)ZUX>T6_TFRMY;VSU?3',IDF0RVUYY
M.P@L2-R/@ 8SM([ \:FH^&=0U!/#=MY1CC@TNYM+F3<O[EI($0<9YY!Z9Z4
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M#-@')X!'7M0!I455DU&TAU&#3Y)U2ZG1I(HV!&\+C=@]"1D<=>]6J "BBB@
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MY5A97P"<J-S<9[5S&J^"=;O]+FTZ73(KQI-&@M+2:6[Q%92+$5D^3/+%L$,
M>V2 * .KU/QU%87>JP0:/J%\-*C2:\D@\L*D;)OW#<PW<9X'/!]LR7OC>UM[
MJ6.UTZ^OXK:U2[NY[8)M@C<$J2&8%B0I.%!./RJA#H.JS6GBUY;589=6LHXX
M(C*K$.+;802..&XS6/)'J'AN;68HEL9FN=&MC<&2[5#9M'$T99UZLAQD$=P1
MQUH Z)_'EN]G;7-EI.H7JOI\6I3K"(\VT$@)7=N898[6^5<GY3[9ZFWN(KNV
MBN8'#PRH)$<=&4C(/Y5Y1I_A&Y?2M(U Z FK"YT&RM_+>[,!MY8T/WN1E"'&
M<9(V].:[W6;34[;P7-8>'X(DU!;5;>V4/M2(X"Y!/91R._ H Y>T\9:K+XMB
MOI)(_P#A%+R_DTFV^09$R@;9=W4JTBR(.W2NCU?Q:FFZA<6=MI5_J3VD"W%X
M;0(?(1LXX9@68A6.U<G ]QG NOA1I_\ PB9TBSU/5E>*$?9]VH2F))EY5_+S
MM^_AL8J2WM_%^FWMUJD.D6US>ZK96ZS*URJ):W4:LI+?WHSD'Y>>",<T :FC
M>*;S5?&6KZ2=,E2RLXH'CN24'WPS98;LX8 8&W(P<XXJSJGBG[#JDVG66DWV
MIW%M MQ<BU,8$*,3MR79<L=K849/'TJKI.G:O8>.M6O+BUCEM-2M[;-U%(%"
M21(RL-A.[DGCKQWIEW9ZWH_BG5-4TO3$U*+4[:%-OVA8C#+'O +;NJ$,.F2,
M'CF@# \0^+-2U3Q+X3M-$&I#2]3@ENO-LV@1[E0BLH!D/RA=WS @$YXS7=:^
M^III$QTE[>.YP?WLX++&N"2P4?>/H"0.>:Y/3?!FH:5JO@7:8YK?1;&Y@NY0
MV/G=$ V@\D$AJZS7I;^/2I%T[3OMT\F8S'YRQ;00?FRW'IQ[T <NWB'5KCP5
MX/DBNT@U#7&MHIKPQ*?*+PM(S!3\NX[< $8RW2GVFH>(9VUW0(=6MI+_ $VX
M@!U*>)5*V\BARQ11M,B@,!T!X)JO9:3K3?#JPT74/#-K<26$=M"]M-=J?/5%
M +QLOW'! (R?QI=(\/:UHECJ6I:9IEE;7=Y=1/\ V8\NX&W0;2ADY'F-EVW<
MC) R>M %OPUXAE4Z^]_K4>IZ/IPCDBU;8BALJQD0F,!&V8'*C^+'45-X+UO6
M-8O]<&K((1%/$UM;; &@B>,.JL>[8(SZ'(K*MO!EWK-UJT]Y!)X=M+MK5H[.
MRDB=F>$LQD<;6CY)08P<A!FM;PQX:U/1_$NNWUYJUY>07;1>49_)_>8C4%F"
M(N"""HZ#'8GF@"Q/J-WJ'CV+1[69H;/3K5;R]*=97D++%&?085V/KA?>H= U
M+6YO&6MZ=JTUL8H;:VN((;=.(0[3 @L>6.(U)/ SG J.U_XEGQ4U%9N$UC3X
M9+=ST9X"X=![[9%;Z9]*KZ6OB1?'-]JESX=$-I>V]O;%OML;&(1M*2Q ZY\P
M<#TH R_"/B>76;ZU:[\:+]IFN)@-,^RQ*K!78! ^W).T X!S73^,-6O-)CT,
MV<HC-UK%M:S94-NC=B&'/3ZUD76G^)=:_LW2[[1[*TBL]1BNY+^WF'ELL4F\
M>7'RRLV #G@9;DUM>,=$N];TFW_L]XA?6-Y#?6ZS$A'>-L[6(Y (R,]J &>+
M]6O-)_L'['($^UZQ;VLV5!W1ONW#GIT'-)XWU>ZT71(+BVN/LD<EU'%<WIB\
MS[+$<[I-O3J ,G@;LGI6==6GB'Q3JNCC4-'CTFPTZ\6^D9[I9GF= 0B*%X"Y
M;))P>.E;%_<^)/LK366FVC20WC*;:2?FYML$ JV,(Y)!P<CC&><T 1^%Y;R?
M[1+_ ,)%:Z]ICJIM[E!&)%?G<K>6 A'W2#@'KFJ5[?:SKGBV\T32=1&EVNFP
M1275TL*RRR229*HH<%0 JY)()Y JII>E:M9ZQJ_B"U\.VVG22V2PQ:<MP@-U
M*K%M\C(-JG!V@\GKGM5N^T_6]&\57.NZ/8QZC!J,$4=Y9F<12))'D+(C-\I&
M&P0<= : -C08-=M5NK?6;RWO520?9KJ-/+DD0CD2(!M!!XRO!'85<U.VN[NR
M:&ROWL)R01.D2R$#/(PP(YK(LKCQ3]ENKV\L+7SI9XQ;Z<DX_<Q9 =GEQAFP
M2V ,<  \YK?F,BP2&%0TH4E%)P"<<"@#SL:KXGLM,\4WT&JOJL&G@6]L\MI&
MI,RG]\X$8&Y4!QCN485)I_C%K";6;C^V_P#A(]&L--%[)=PI%NCD!.8@8PJ$
ME1G!Y'<\U<;PIJ+?"B#0%,8U+R(WG61_DEEWB25&8=G.]2?]JLW5O#>M:\FN
M7$>C1:4;C0Y=.BMC.A:>5CE68I\H5<$#)S\QZ4 ;0\=.^H_V?'X<U5KR6#[5
M:Q9B'GPYP7R7PF..&P?F'&:WM%UJUUS0K75[8/';W$?F 2C:R=B&]"""#]*S
MDTB[7QO8ZH47[+#I$EH[;AD2&2-@,>F%/-)X4T2XT[P1;Z/J"B.8)*D@1@<!
MG8\'Z$4 0:=XXM[^?3F;2[ZVL-3<QV%],$\N=MI8<!BR[@I*[@,^U6O#?BI/
M$_FRVNFWD-I&SQ_:9]@5I$<JRJ Q)Z9SC';.017/:;H.ORV?AC1+ZPBM[;0I
MHI)+U9U9;@0HR1A$'S MD$[L8P1S70>"-)N]#\+0V%\BI.MQ<R$*P88>=W7D
M>S"@#+\8+X@L(WN=-\2S13W<R6]C8BTA93*W !8J3M&&8GL :S/$GB/4M,U/
M4K6Y\21Z4]E8QRV*-!&?[2D*MNX8$M\P"[$P1GW%=5?Z9=WGC/1[THIT^QM[
MA\[AGSWV*O'LGF<^]8.L:)JL>M>(98M#M]8AU>"..%Y)D7[/MCV%'#<[,_-\
MN>6/% &D_B^XB,5HNAWU[J4=E%=WT%J8P+;>#\I+L,L2K849/%0MXB/B'7M!
ML=&NF2RN+3^UKF91AFAR%CCYZ;F//?"$=ZI:?HWB'PI=M-9V:ZRUSIEI;2N;
MA8RL\",NYMW5&W Y&2,'@YJKX?T9_!OBOP]9W<BNEQH?]G"8?=-Q$YE*C_>#
MN1_N4 3ZOXWGO$TQ]-LKZ"RN-:M[1+\[/+N%$P20 !BP4X8 D ''N,W(I]7G
MN_$7AE=1DCU"U5+S3;Q@"QCD+%5<8PP5T9#ZKCOS61!X=\2PZ3H_AX:;#]ET
MS5XKDWIN5Q- L^\;4ZAL'D'^Z<9S6G!?6Z^.?$_B*:0)IVEZ?%8R3?PET+RR
M ?[H=1]3B@#7T+Q.VM:)H=^FGW#?VBI$QC *6SJ#NWDG.-RE1C/.*T-8U232
MX83!IMWJ$\\GEQPVP7K@DEF8A54 'DGK@#DUS'@^2_T#PMX5T^>P+2ZC)*T^
M9-K6V\23\KCG'W3TP?RK0\8Z7?:B^EM!9-J%E#,[75BMP(?-!0A"22 0K<D$
M^_.* &'QW;/#IGV?2[^>[U![B&.U4('26$[9$<E@HP0><XXZ],HGCJWEL;5H
M=+OI-1N+R6R73AY8D66/)DRQ;9M 7.<]QZUC^&?"NKZ;J&B_:;*""'3[O478
MPRADV3G<FT=<#)7GGBE'AO6].U2+6;:R2[EM]9O;C[*)E1I()UVAE8\!@0#@
MXXS0!M>"]8NM9?Q!)="=/(U5X(X9P T*B*(E.,CABW()!SP2*ZFN9\'Z=JEB
M=<N-5MXH);_4FNHXXY X5#'&H!/J-I!^E=-0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45B^+=:?P]X4U+58D$DT$/[E#T:1B%0'VW$5E3^'KRWTJRCO?$]Y:V%G;O+
M?W"3;)9YC@EVD.=J#YSM&!R!T&* .OJ&WM+:U:9K>"*(S2&64QJ%WN< L<=3
MP.?:O.XM3U>Q\)>'O%%Y=7+M#=""Z$OR_:+.6;RXY'3@!P#$^< _>'<UTGC[
M6=2T#PC<ZAI<<3W*21)F1\! SA<CY3DY(&/?/;! .@-I;&]%X8(C=+&8A-M&
M\(3DKGKC(!Q4U>>'7_$%EXI\1M%I:W9M["TN);=K\K%!\LI8(Q0[F./[J@[>
M2.*NW?Q Q&)M-TZ.ZABT^+4+CSKL0NL<BEE1%P=[[5)QE1TYYH [:BL/Q!JE
MM'X'U+5@LLUJ-/DN (I3$[IY9;Y7'*DCN.16+;>+;^0VFFZ-H?VN7^Q[;40;
MF^*@(^X;"Y1B7^3KCG)SC'(!VU%>3^(-?U7Q-K'@==.@E33-7AFNO)34Y+5Y
MB(@VUVC7*A<YX)W'TKI7\<W"Q2:H-(4^'X[W[$U[]I_>Y$OE&01;<% _&=V<
M#.* .M6TMEO'O%@B%RZ"-I@HWLH)(!/4@$GCW-%S:6U[&L=U!%/&KK(%D4,
MRG*G![@@$5Q]QX\NXD\1W$6A[[+03,L\[704R,D8<!5VGKGGTR.O9Z^,-<DU
MA-*C\-1?:[FT^VVN^_PAB! ;S3L.Q@67@!A\W7@F@#LZ*XY?&E[>>'],U33M
M&C87<+R2_:[U8(X2AP8]^T[F)SC@#@DD57T_Q?J>L>,-'@L;.'^R+[1O[0/F
M3;9 &:,;B-IY7)&W.#N)SP* .YHKSWPYXQ\[PMH2Z1IDTUYJDMRL%O>7[/L6
M)VWN\S*S8Z8&T_> Z"KQ\=SB*VA716;4Y-4?2Y;47(VQRB)I0P?;RA4*<X!
M;ID8(!VE%8GAS79]9&H0WEDMG>Z?=&VGB2;S4)V*X96VKD%7'4 ]:HIXJO[G
M4K@6.AM=:7;7OV&:Y2?]Z'! 9EBV\HI."=P/!(!Q0!U-%<9_PG-QY7]J?V0O
M_"/_ &[[%]M^T_O<^;Y/F>5MQLW\9W9QSBHY/'EXBW5X-"']EV>IG3KBX-WA
M\^<(@Z)M^9<LI.2#UQG&: .WHKA].\4:_+J/BL2Z5%<0Z;=+#;117(#$E(R
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M%P@42'L3G&[VZT <QXK.HZIHNF>';Z*U75-3O8O,CM)&D2."*19'DRRJ<!5
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M@_6CIDOAI9+#^P9+\W7VDR/]H6(S^<8MFW;G=E=V[H>F:[1=2L&N#;K>VQG
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MW.[Y=V[IVS5J?PA?2^%]6TL3VPFO-7:_C8LVT(;E9<'C.[:I'IGOWKL&GB2
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MN1;0:A:2W#)Y@B2968K_ 'L YQ[T^/4;&:\ELXKVW>ZA&9(5E4N@]2N<C\:
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M DAD#J3]1Q0!R=[X*FU+7/%4]S<1+9ZWIL5DFS)DC*JX+$8Q_$".>U)'X?\
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M/:HO#C6%M?\ PTFO3;1>;H#Q123;1NEQ!L4$]6ZX'7TKUE((HUVI$BK@C"J
M,'K2F&-@@,:$(<KE1\I]O2@#Q;PZUO%I6@W&IF,:/%XDOS<M-CRD<^:(F?/
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M/++EAW4<$^P-3>*6T[4)O%,VBO;RZ6]CI\5S):,/*>?[2> 5X+!",XZ K7L
M11NPH&[KQUI$ABCC\M(D6/\ NA0!^5 'FGB73=)@\3:O:2O'I=A+H,'FRPP
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M %=O+$6Q%RZLI\LD[ 0P8 ],BO8#!"8A$8D,8QA-HP,=.*<(T#%@BACSG'-
M'DZ6XTK2+GQ!:QA!X?\ $=Y(R(.!:/)MF4 =@K;\?[%=1X0N+>RT;^W-2D$%
MSXBOO/02 YQ)\L$?X1JGXYK8\0Z ^OV:V!OY;6PE)%Y#"BYN4.,H6/*@\@XY
M()K86*-41%10B8VJ!P,=,4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-<7*%E7>K*VU<EN%()..<9JOK7C#6;-O$5Y:1Z<MCH,BI+;7 ?S[G*(Y*L&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MQ8HUE>58U$C@!G Y8#ID]\9/YT^BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR3D#YC@CGGVK2T%M1F^)OB;S=2=[2&"TV6YC& &60@ ]L<_7//2@#MJ*\_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit322001.jpg
<TEXT>
begin 644 exhibit322001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 _\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]9G&0>U;6OZ[!X?L([N>WN;CS)X[>.*V4,[N[;5 !('4^M &I17-0^-K(IJ
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M.,]<9[4 >>Z7<ZMH7Q(+:MIMMI]GXBC"*MO=&=1=1+P22B[=T?&,')05J_\
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M_BC6KN/2RV5)CED8^;ZA1&&;./0U<*:MX2\1^']5NM&L]-TE(4T6Y-O?&?\
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MFYM[2W:>[GBAA3&Z25@JCG R3P.<5Y7#JEC)\&M3BCFM;EA=7 D42Y\E'O6
ME(4@@*&WYX^[UKU:XMX+N!H+F&.:)OO1R*&4\YY!J"VTK3K/?]EL+6#S%VOY
M4*KN'H<#D4 <9X<'V?XASP'6&UUY-)5VO9"A> +)@1_NP%P^XMTS\IR3QB;4
M+NWTCXN6MWJ$\=K:W>BM;0S3,%1I5FWE-QXSM.<=^:Z^STZQTY&2QL[>U1CN
M98(E0$^IP*?=6=M?0&"[MH;B$]8YD#J?P/% '%6&HV>H?%'5=5M;J*73K#1H
M[:XND<&))/->0KNZ9"\GTSS4NO-HNH>(+26W\22Z-K'V(26]W$R>7<0,V<8<
M%) ",X'(W ]ZZ^&RM+:T^RP6L,5M@CR4C"I@]1@<5'=:7I][;QP7=A:W$,?W
M(Y85=5^@(P* ,#PCXD;4-+ U.^M)IS?365M=1#8E]LR=Z+D]@V0"1\IQQ65X
M&US2M"\/W6D:M?VUCJ&FW=S]K2YE6-B&E=UD&>JLK @UW(M+95A46\06#_5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^ZV9\SS$"]<\8QGH<T >8>%HM#O=!AFU/1/$][>/+,)+FW^UM&^)7 P5<+@
M <>E>I>(;74)O"VHVNBR&*_:U=+5]^"K[<+\QZ'W_&N?TCPKXJT+34TZP\3:
M<+6-W:,2Z2S,-SEB"1,,\L>U=/?V%QJ&B2V+7\UM<R1!?M=K\C(_]Y1DXY[9
M/'% '%>&#H4'B.TAAM]<T+5#$ZO8W[2%+SCD[F+)(5QG*G/7MFL/Q%XADN=?
MU7Q-::JJ0^&KB."&R%P%^UJN?M64SSPVU3CK'Q79/X9\07]W:W.J:_:226 D
M>S^S:>8P)FC:,229D;=@.?E&T58T7P)H.DZ'::=+IME>R0QA9;F>V1GF<\LY
M)!.223U[T <[XXOM)NO$7A&2_FNY-(NK>[EQ9^>3)\L10XA^8CG]:S[.XB>V
M\63^&IM2'AZ+1YD)NGFPMXH?/E^;\XPOWN@SCO74:)X'?1[C0V.J&>'1ENXK
M=&APQBE*[$+;C]P+C..1C@8JU<^$C)=:^UK?>1:ZU:-%/;^5N"SE2GG*<CJN
M 1CG:#F@#S>WEM;31/#E[I]KX@TN^:2T:XU2[EG%IM.WS/,W.5*L,@<8R1R*
MZ[Q]=QZOK.G>$/[5_LZ.:)[V]N%G\IDC4%8U!R.6D(./1#4C^!M<OO#T/AW4
M_$MM)HZQ1P2QVVF^5++&F/EWF5@,X&2%_*M:R\%V"ZQJVJ:K';:G<W\ZLAGM
ME(@B50J1J#GIR2>,D]* .4OO$$VO?!.\FDN674;=DLKR2"3!$R3(CD,/[P^8
M8[,*-7UB_MO VKZ%J%S(-9TF6U3[0&*M<P-.@CF!]QE6_P!H-ZUMWWP\AE.M
MQ:?>1V-CJR6Y>UCMAMCEB8'>N& ^95 (QU&<]JM>-/!$7BT6<L=ZUC=V[@-,
ML>_S8MP8QL,C(W*I'H10!RM^-,N?B'XFCU;3==U 1-:B$:>;@I$#""01&P )
M//-:VLZ<W_"/:(=-TG5YM$BG>2]TU9I$NG0AL9WN&8!R"4W<C'7&*TYO#.O0
M>)-5U71]>L[5-1,320W&G&8J8T"##"5>N,]*LW&C>(YK6SE7Q%#'J=L[DNEF
M1;3HP^Z\7F9.,##!LCGUH S_  QJWAG3-.U*X@U6XLK**=!-::M(T1L7( VX
MEPRANH!)&<XJ'4[J#Q?XMTS1K?4C)H;:?)J$K6-P0+LB18U3>ASM!+$@'DXS
M6WHOAZ>TN]0U#5KN&_O[_P M93';^5$B1@[%5"6/\3')))S2:YX9>^N['4M*
MO1IFIV(=(I1")(WC?&Z-TR-RD@'@@@C(H Q4L(_"GCC1]/TZ6?\ LO6(KB.:
MREF>5(Y(U#ATW$E<C<I .#D5@W^J:IX?UH^ +/4ODU&1?L>I2R[I+"*3<6B8
MGDO\K"/)YS_LUV5AX;U'^USK6L:K#>ZE% \%FL5J8H+8-C<0F\LQ.%R2W08&
M*BMO EB?#=]I>I3/?76HN9KR_(V223?PNO79MP-H'W<#WH S]8@_LCQA\/\
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M#EFD,K98L<DD'//2@#GK*V.A:=X.U^.YNY;_ %.6)-1>2X=Q<B:%G.5)P,,
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M\D5U;K<0HV%8AER >P/:N#B\3:AJR>!M:-M=Q/?7$Q>T@F&V93;R,HQN"G!
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MC! 8.[/T/INQ^%9.A>$]4T[23X?O=3@N-"BBD@@5(66=HF!4([;L84'&0,G
MZ<@]!?:_H^F?9_M^JV5K]I_U'G3JGF?[N3SU'YU-J>I6FCZ9<:A?3QPVT";G
M>1PH]AD\9)P![F@#G-/\*7L=OH-IJ-U!<0Z$VZV=%*M.RQM'&7'1<*QSC.3@
M\=#7L?!VHVFG>'K4W5J[:3J$MXS ,!*'$HVCTQYQYY^[[\,\,^.YO$6DZ=J
M_L.!;RZ6+R/[2W2(I4G;C8,R\?<].]=3!KND76IS:9;ZI9RW\.?-MHYU:1,=
M<J#D8H YFV\':C!IND6ANK5C8:Q)J3, WSAVE;8!V_UIY_V>G/%G1/#6LZ.\
MFFG5+:70!+))%&8&%PJLQ;RB^[;M!)YQG'''6MNR\0Z+J+W*66K6-RUKDSB&
MX5O* ZEL'@<'K69JOC/38/".K:[I%W9ZHNGPM(RP7"LI8#.TE<XH C\+^']:
MT*T@TJYU6WN-*LE,=KL@*S.F"%61MVWY0<< 9P#QR#2L/!NIV>C^%]/>^M)1
MH5TLH<1LOF(L;Q@=3SAR2>G&,=ZZ>+5;<:'!JE[+%:0/"DKO+(%1-P'5C[G%
M69KNVMYH(9KB*.6X8I"CN 9& )(4=S@$\=A0!R,7@F9-(E\//=1/HC7XO$R#
MYJIYPF\GT(WC[V<X.,9YIMUX.U"XTS6K075JIU'5XM25B&_=A&B;81WSY(Y_
MVCQQSTMCK^CZG]I^PZK97/V;_7^3.K^5_O8/'0]?2F6OB70KVQGOK76+":TM
MSB:>.X1DC/\ M$' _&@"W?64.I:;<6-V@>"YB:*5/56&"/UKEM-\"&SO-$O9
M]0>>ZLX#%>R%?^/T_*4+?[C(I'TKJ;+4++4HGEL;N"YC21HV>&0. XZKD=Q5
M>WU_1KNZNK6VU6RFN+4$W$4<ZLT0'4L >,=\T 86I^$+G4[CQ5ONHHXM<L([
M-,*2T)19 &/KGS.G'3WJ6'0-5&OPZM/<6<DB:6UBR(K*"Q<-N&<\# &/Q]JU
M[/Q#HNHWS65EJ]C<W:H)###<*[A3@YP#G'(_,5F7?C33%U;3M/TZ\LKZ:XO_
M +'<)#<*S0?NY'R0,]X\8/K[4 7O"VDRZ#X7TW2)Y4E>RMT@\Q 0'VC .#TK
MG]*\&:GIMKX7MGOK2:/0I7*D1LAE0QM& >3@X?)/3C'O746VN:3>ZC/IUKJ=
MG/>P9\VWCF5I$QP<J#D<UDMXTTR?7]+TS3+RSOS=SRPSM!<*Y@*1.XR!GJ4Q
M^?I0!D_\(5J]NBWECJ5K#JD&J7-_ SQL\3).27B<9!QR/F'H.*Z^Q@ODL-M_
M=)+=ODN\,>Q%)[*"2<#W)SU]JDO[VWTW3[F^NI!';VT32RN?X549)_(5B^$/
M%B>*[">9K&6PNK=U6:UF8%T#(KHW'8JP/YCM0!@VGP_U FQ34=1M)HX["ZL+
MIXX&$ERLVS,A8L?G.SDG/7O5Z#PGK%[X7N/#VO:O;SVAM#:0RVL!CD88PLCY
M8C< !P,#.3Z8WK;Q+H5Y?I86NLZ?/=NF](([E&=EQG( .3QS4%]XGTU+6\%C
MJFE2WEO"\WES7BHBA6V$N1DJH;*DXX/% &5<^%];UWPS<Z5K^KVS2LB+!-9V
MY3#HRNLKAF.6W*O P.OKP_4/"]]K'VZ[O9K5-0FTJ33(O*W&-!)R[G/)R0N%
M[8QDYR+,7B>1_&UIX>-O$5GTHZ@;B.7<,APFT<<CG.?TJQK&M:C9W\-AI>B2
MZC</$TSLTHABC4$#!<@Y8D\*!VR<4 4[3P[?VVMZ3J!EMF%AI;V!3+#>6,9W
M9QP/W8X]_:N8T_3;OPYXJ\(Z.MS93W5KIE\AW,4#AI(2/4J>O8YVG\.AC\<'
M4+/23H^DRW=_J,<LHM99EB$*Q,$D+OSC#D*, Y-;>@ZS'KVEK>)"\$BR/#-!
M)@M%*C%74XX."#SW&#0!SB>"+VUDL3;:C;NBM=2W<=Q 61IIWWF5%###*<JN
M<X!/.<Y=H/A'4]'GT"62[M)_[)TI]/PJ,GF9,9#=\8\H?7)Z=*WM<U>ZTP6L
M-CI<VH7=U(4CC5MB( "Q9W((48'N22 !6,GCDR:<NS2)CK#:@VFC3_.7_7*N
M]OWG38$^;=CIVS0!D7>D1:=X/TSP;+?C^WD99M/EMXF)5UER)>00 N?FR?NY
M]:Z34_#DDZ^'H;&2.*#2+I)]LF2758VC"Y'?#YS[>]5T\8SMI]S_ ,22Y;5[
M:\2RDT^-PV)' 96\SH(RK!MQ QR,9XJ]H&ORZM<:A97NGM8:A8.BSP^:)5(=
M=RLK@#((SV!&#0!BOX.U%K"XM_M5KNEUU=7#8;  E63R_K\N-WOTKG!>.^OZ
ME-:2Z+//_:+W":5=+/%<M(GR*1&&*ECM!#[#U#'IQW/AOQ9;>)KO58[2"18;
M&98DF8\3@C.]1_=ZX/<8/>MV62.&)Y976.-%+,[' 4#J2>PH H:[97>I:3+9
M6LD49G(24R9YC)^=1CH2N1GMG/:L76_!T=Q<Z1>Z'#I^FWVGW8G\U8,;TVE7
MC.T#(8-^&*V+?Q+H5WIL^HV^LV$MC <37"7"&.,_[39P.HZU;L-1L=4LUO-/
MO(+JV?.V:"0.AQUY'% '):IX.U#4K;Q5$+JUC_MQHBIPQ\G8BIS_ 'L[<]NM
M2ZEX3U#4&\4G[1:Q_P!N6,=HOWCY)5'4M_M??)[=/>J5C\2(M8U/78-.FT3[
M-IJ,(YKC4PIG*J"7P%($0S@OD].E;4?BB1O&6GZ ;>%ENM+:_-Q'+N4$,J[5
MXY'.<T 9]_X2U6>ZNYK6]LXA?Z.NFW(DC9BI3S,,A!'7S"#GI@'GI5+4? 6K
MWVFSV+:M9O%+HZ:>IEMF/D.H8%HQN^7?D;NI^4?0=C8Z]H^IO<)8:I9736W^
MO$,ZOY?^]@\=#^59=OXRT[4/$>GZ9I5U9W\-S#<223V]PK^6T1C^7C/7S/TH
M DL]$OH?%K:S<3V[JVG1V3)&K*=RNS[ADG@EB,>W6FZMH-UJ/BW1=762W%OI
MR7"/"X),HE55//08V^^<]JV_MMK]HFM_M,/G0H))8]XW(ISAF'8'!Y]C42:M
MITMM;7,=_:O!=,$MY%F4K,Q!("G.&/!Z>AH Y4^!KM-#U#0+;4UATQIEN-,.
MPF6Q=7615'.'0.N0."!QFJ'C)=9MO!@?6]1T]KQ]0L1$+>)HXEVW,9+$,Q)/
M<\@ #ZD[47CO2K:WT5=6U#38[K5'=(S:7:RP#;N.[>=N5^7;G'WB!4NB^--+
MU*0VMU>65IJ#7EQ;16C7"^9((I7C#!3@G.S- %+5O!4FO3W>ISW45OJ<GV4V
M;Q R)!Y#F1"<XWY9FSTXP!TR36_!UYK]MK$UQ/;0ZAJ&GKIR%-S1PQAF8GL6
M)+>V, >I.YXA\2Z7X7L([S5;E(8I)HX4RR@EF8+W(X&=Q] ">U9L'CK1QJ^H
M6E]J%A:0P2PI:S2W2J+D21))E<]?OCIGMZT 6M2T2]O=8T+4X;FWBFT_S5E1
MD+JZR* =O(P1@8S3M?T*;4K_ $G5+*=(K_2YFDB$H)21'4HZ-CD9!X/."!P:
MO7FN:3I]];V5YJ=G;W=Q_J899U5Y.<#:"<GGBFZ[K$.@Z+<ZG/')*D(&(X\;
MG9F"JHSQRQ Y]: .>U+P;<WVC:U#'<0)?ZQ=Q7,\A4E(Q'Y>U5'4\1@9XR23
M[5T]_!<7>DW%NGEK/-"T8W$E5)&,],GK69IFM:M-J8LM5T"2Q#Q-+'<13B>+
M@@%68 ;&YR >#@X/%7K#7M(U43G3]4LKL6YQ,8)U?R_][!XZ'\J .03P#?V>
MDZ ^F7UM::[I$*6IO@C%+B!1@QR)QN!P#C/!Y!K2FT'Q##X@DU?2]2L(&OH8
MXK^">!Y4#)D+)'AE(.#C!XX%;-IXET*_M9KFTUG3YX(76.66.Y1E1F.%!(/!
M)( ]:LW.J:?9M*MU?6T#0Q":022JNQ"2 QR>!D$9]J ,G4O"L6HZ[INHR3L5
MMX&M[F-@#]J3*L@;_===WXD=#6=%X+NK+P/+H-CJA6X,JE+B520T:.NR)@"#
MM\I%C.#SR>]:[^(K6:]L8["_TN>":>6"5FO '#(N2L8 .]AW&1@<UGP^.M+U
M73;BZT6_TV4V]X+:3[5=K&O+E=P*[OO8)3^]0!GS^!M1FM=<07]C&]_=6EY
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M::T=JJB::2] DDD(8E(HP#N*[?FR1BNRH PO">A2^'_">GZ+=213M9P^3YJ
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M:,DGH?6NSHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2P7YB?[2 W?]\\9]*]/GO[.U<)<7<$+D9"R2!21Z\FF?VKIP>W3[?:[KERD
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MI'5++[ A*M=>>OE*0=I!?..#QUZT <SXMN;>P\<^#KR[=8K99+N)I7'RAWB
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M>:$(1M8M&T9W<=,,>F.:B\3>'K7Q5X?N=&O9)H[>X*%V@(#C:ZN,$@CJH[4
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M\MKR34!J4=S$R;H9?*$1"@J05*C!# YR?; !2\$1W4.O^,([RX%S.NHQ S!
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MW;P,$$$#@9!Y-6!XHU!?%EHL6IS7=G<:H]BT*:>5MD4!\;9BN6D#(,_,1]X
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MKH"IB<.JJJH$497G"Y.>O3 !AK::S#\3]%M;GQ#<7(CTJYE<_9XD$G[Z+*X
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MV[<=>^.:YY] UR7PI9:/_9%RMQ8>)5NV=BFR2$W,DF]#NY 5AG(!YH [6_\
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MEBS'YMI)YR#4=YX8U$7DFH2V6H/#%KEU.T5A<F&=X98E42(592<,!D9!()H
MZQ_&VF?9K62W@O[J6X\TBV@MF::/RF"R;U_AVL0#[D8S6]:W,5[9PW4#%H9H
MUD0D$$J1D<'D=:\[FT-(-,LY%\-Z_#*TEQ,ES::EOO8'=A]\L_(<*"02P! !
M'>NFL=!OKVUT>^UC4]1BU."VA%S#:W12&21>6W(ORMDD@]B/:@#/M=3\3>)Y
M[ZYT6[T[3M,MKF2V@:YM6G>Y:-MKL<.H5-P(&,GC-3Z1XU22S5-:@%I?1ZBV
MEW!BRT*SX!4[CR%<%<$]V -4M+DU?P8;[2SH%]J=B]W-<V-Q8F,X65RYCD#N
MI4AF//((QTJF_AS6KCPY?V%Q9QK>^)=0>:]8,KII\)51U_B<(B@$?QG/04 7
M/&'C.2V\-WMWH4S"6SU*"RDF:(%&8R*LBKGKC)!/8Y]*V[SQAIEEJDEE(ETR
MPRQPW%RD),,$CXVJ[]B=R^PW#.,UQFJ^'-;/P\?PO%IS32Z=J%N+>:,J!=0"
M57\P\\.!G=GJ03SFI[SPQ+_;^KV]UI6LWT.HWZ7$3VVI-#:^650-YJAQ@J58
M_=.X;<>P!U__  ENE#0-0UEY)$M=/DEBN0R8='C;:R[?7.,>N1ZUM(^^)9"K
M)N4'##!'UKS;5M'GE^)@T6#:VE:HT.KWR _<:W.W!'I(P@^NQJZKQM'JUSX8
MN+#18F:\OF6U\T$ 0(YP\AR?X5R>.<XH P_#?CB_U7Q.L5W!!'HNJ>?_ &-,
M@(>3R6PVXYQ\PRZ\#@=ZV]2\::5I>H36DZW;+;,BW5S% 6AMB^-HD;MP0>^
M03BN9UKX>7ECX>M6T36]5NKO16CN--L[AH/++1\!/EC4\KN7KWYJY:2Z]HFH
MZR+7P]<73ZO=QWMM(9$6.(M%&CI,=V5V;"> <\8H V?#OBHZ]K&MV/\ 9]S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^EPQ&:5HI_)0G<-H& 2<#DD=J[?3K[57\""\U*-[?5$LW,@9 K!U! ;;T&<
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M,QVOS= 4V?-Z_+0!YKX<&M6WP\\.7$-[K<UA,)I+UM/2*2XB.?DVJ5R4SN)
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MN-:CN;JVC=T,<):.9XP2!DX 7.,Y/KWKI;^>XMK&6:ULWO)U V0(ZH7Y[%B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW\5S8FRO;"Y-M<0^:)%!V*X*L ,@JX[#O5$>++J;4YTLM#N+K3;:\%C/=Q2
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MI=2UG4_C%#8J)_[+M].CNHXX+\QHX:4CS74#Y^!C8>/SH ](HKE=?U[5M/\
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M S);B57 QMR-PX/+  ]^<4 5(_#*R>--4UB]M[2XMKFTMH85D0.RM&9"W!&
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M(Y'!JYX>U:36]&AU"6V2V,HR(DG6; ZC++QGV[5=BO;2>>2"&ZADFB_UD:2
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M:-=0K<L,K"9 '(]0O6N?3QE#<^-Y?#=I;K,UO&KW-P;A%"%MV%5>KGY><=*
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M9\9(4$@8 !))( '4T <-]AU[5;GQ[I6F1V1MM0OC;233S,C6^ZUA5F"A3O\
ME/ RO(]^+=QX ,.M7;P:#X?U*"\>%Q=:E'OEMMJ)&R[=AW@A,@;EY8UT6C>(
MXKK5Y=,N]%O-'U&1#<".X6,B=1A2RO&S*Q'R@@G(X[5M0W]G<F407<$IB.)
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M9ZEL#!(YX%>Q?9+8O$_V>+?$-L;;!E!Z#T%(MG:H\3K;0JT0*QL(P"@/8>E
M'C6J6UM_PBWB2YL]4T*6/_A'F1K;1[9HUVYS&[G>PR!O !P>3Z5T?B+3;/2M
M:^'UM8VT4$7]I,Q$:@;F\@Y8^K'N3R:]"2RM(HY(X[6%$E),BK& '/J1WJ1H
MHW9&:-6*'*DC.T^WI0!X_I^H6DGBCPY?Q-H]IY^L76^WAC8W2;DG4^?,7/+-
MCY2HYP!]VNI^$_\ R*E[_P!A:\_]&FNS^Q6H9V%M#N=P[GRQEF'0GU/O4D<4
M<2E8T5%))(48Y/>@#R*33(O^$-\>:A;V\7VYM7NHWN&CW,L E7S%R.=FW>2
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MJ*9X8@LM4U;PW:7 M;N""^U<B)(ML0&]63$9)VKR&523CCTKUXV-HULMLUK
M8%QMB,8VC'3 Z4Y;>!93*L,8D)R7"C).,=?H!0!Y3%;KH^E2Z_:1B./P_P"(
MKPM&@P%LWDVS* .@ ;?C_8KJ?!\\%MI+Z]J,BP7'B*^\^/S."5?Y;>/Z^6J\
M>I-:WB'0)-=L?[/2^-G83EA>QQ1 O<(<94-GY<\@G!)![5L""$1QQB)-D>-B
M[1A<=,>F* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117
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M>^2]FDN)X3*(XXICD!0RY)+J.O S77?#PW!L=<^U^7]H&M70D,0(4MD9(!Y
M/7':@#L**\PU_P %>'(O'_A6U328%@O#>&X09Q(5C!7//8G->C6%A:Z78Q65
ME"L%M$,)&O11G/\ 6@"S1UKBM?MD\0^/K#P]?L[:5%ITE_+;*Y5;F3S%10^.
MJKDG'3)&:KZ))X6T7Q+>6FB&\L+AK>7=8S02P6;F(_-(I=-H(R 64XP<X/%
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M1[(5@CACE #E5&26.!R2>E0W?B3Q+H,,6H^(-)TY-*:1$G:RNG>2T#$ ,P9
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M(R!78'+$*V >..QSFNTHH YG2?"MWI7E6J:W.^DVZNEM9^2JE5;("N_5PH/
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MQH P)+')"#CV&?>JM]I=X?!/C&%+"<SW&M/+&@A.Z5?,BPP&,D8'4>E>F44
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>forvisconsentupdated001.jpg
<TEXT>
begin 644 forvisconsentupdated001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*;DMMNY?8@!A]: /I&BO%]0\>^,_&/CG4/#G@-K*TM]-++/>W*AMQ4[2>0P
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+'2]/TM'33["UM%<Y86\*QAC[X S26^E:=:7DMY;:?:PW4V?-FCA57?)R=S
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MW;"J!U))Z"H-/U.PU:T6[TZ]M[RV8D"6WD#H2.HR.* +5%%% !1110 4444
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M8+2;!^\;'3/ ZXS6KK>CVGB#1;K2KX.;>Y3:Q1L,ISD,#V((!'N* .7U&_\
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M,MPP9IY)496+=@/FX P!@4E_X2N6UJ\U71M<N-*GOD1;Q4A25)"HVJX##Y7
MXR.#@<<4 <];^+/$FOR^%;:S,.E3:K:7;WAFMF<Q-"R+N16(/))P&[,"<XI%
M\7^((+&XTEYK2?6!KRZ/#>F$JFUHQ+YK1@]0N[@$ D"NHLO"%M8W^BW4=Y=2
MMI5M-;H9W\QI?-*EF=CSG*?3FJUUX$M+J/4C]MN(KB[U)-3AGC"AK:=$55*Y
M!!&%Y!'(8B@#,U[6_$W@K0]0NK^ZM-31C!%8W!@,;K+(^PB2-,[E&0PV\GI[
MU'X;\67\WBFTTJ34)=8M;N&1FN#I,MF;:1 " =P *L,X[@CJ<UI2^ H]2@U
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M<ZKG:61QC<,X!&.* //M=>QF^'GBV+2;6[T.\2\@FU'3+F-2(V8H!L"G:%;
M;(/.T^M=5XAUS4=,U.#39_%5G8E;57S#8-<W5Q(206,*YV)P,8SDYY&*O-\/
M[:?0=9L;W4[RZOM8V-=:@X4.2F-FU0-H5<<#'<TY?!FH0ZK-J=MXFN8;R\MX
MH+Z46L1,QCR%=01A&PQZ CVH XX:MK'BJ'X?:F][':W,FHW,3[;7@O&DR[]K
M'(RJGY3T+>U2W?Q#U.ZEUB[LM2%M]AN98+33O[(FG6Y\HD?/*HPI8@@;?N\9
MS731?#N.ST/2M/L-8NX)M*O9;NUNF1)'_>%]RL&&&XD89J2X\#3B74(M,\17
MVFZ=J,S37-K#&A(=_OF-R,Q[NIZX))&* *"ZWXD\1>)O[.TN]ATFV;1[;4"9
MK3S94>0N-F"0.PSGIM]^,W2_%?BJ?1/#/B.[O;+[-J5_#93:?%;8 #N8_,$A
M;.[(W8QC!QVR>YLO#MO8>(9M6BFE+264-D(V.0%C+$')Y).[OZ5G0>![6#PU
MHNB"\F,6EWD5VDA4;G,<A< ^Q)Q0!QUW\0]3NIM8N[+4A;?8;F6"TT[^R)IU
MN?*)'SRJ,*6((&T_+QG-;B:WXC\1>)_[.TR]BTFU;2+;4&,UIYLT;R%QLP2!
MV&<]-OOQ>N/ TXEU&+3/$5]IVG:C*TUS:PQHQ#O]\QN1F/=U/7!)(Q6Q9>';
M>P\0S:M%-*6DL8;(1L=P"QLQ!R>23N[^E 'G<VI:UXD7P'>RWT-M=_VK<V\I
MCM]R&2-9DW@$]PAX_P!KVJY=>,M9MO$ES;7^KVNCRI?F*UL=0L72WN;?< &%
MSS\S+D^QXQ70-X!2/2-.M++5KBUN=/OY;Z"Y$:.0TC2%E*D8(Q(1^ INH^ I
M=2BO=/F\0WIT2]G,TUB\:.>6W%%E(W*A/;MV(H Z^>5;>"29\[(U+MCT S7F
MI\3>*8/!<7CN:]LS8LJ7+Z2+;[MNS 8$N<F0*0<XQGC%>FE5*E2 5(P0?2N)
M7X= 6,>C/KEZ_AR.42+IAC3[H;<(S)C<8P>W7'&: *-QJWBS4;SQ8VGZK9V5
MMHLQ$"-9^8TV(5DVN2PPO/4<_-[<]IX?U)M9\-Z7JCQB-[VSBN&1>BET#8'Y
MU4M_#,%M_;^VXD/]LRF23('[LF)8\#\%S5[1M-31M"T_2HY&DCLK:.W5V&"P
M10H)_*@#S6%KL?$;QG]G\(1:Z/M-MF1YH4\K_1TX_><\^U=%>:EJ@O\ 0_#F
MD6MMH=S>P2W=R3&LOV9$*@JBJ0K,6<<] ,\&M_3-!BTS6]9U-)G=]4EBD=&
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M=/2^T]VM;M-JG<]P/NY)88&-N!UKI9? ]K+X7U/0C>3"*_O9+QY-HW*S3"7
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M2X6-1*X_B8#D_G4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5@<%2/0@&O)4T&\T-?"FH-)K^FZ=#9W,+R1P1W%Q:/+()!YBB-@%(X^5?EP
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MF"N_8H5"<G P,9QVJ'Q%IU\;'Q^T5C<N'U2PN(UCA8F1$$!=D 'S8VMG'H:
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M5&!UX(QUR,=>*X[Q-:W6F_$:;5[G4M8T^PNM.C@BN].M%N KH[%HW!CD*YW
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M<9,@("* !@ $DGFF)K&M6/B06NIW>F"XA\.2W4LP7;!YRRA0Y?&X)CDCH.:
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M\Q89.<=J /4**\IO?&6NZ)I>IZ;+>O>WT6N1:7!?"S#R".2)9-QB0 .ZC<
M!DXXJ1?%/B"QMM>1)M7N[:'1KB\M[_4=)-LT%Q&I(0_(J,#U'&?E(YH ]2ID
M4T4P8Q2)(%8HVQ@<,.H/N*\\M[_Q-I]YX4NKW7?M<6N-Y-Q:_98T2%FA:16C
M(&[@KCYB<^U8FB-XDTGP5?S:9>7UX6U^XCN3;VL4DT,0FD$DD:8 9F.W(.0,
MG H ]AHKD/ NMMJT>HQ-KC:I]GE4*+BT^SW4 *_=E3:HZ@X( SS4=W=ZSKWC
M34=%T_5WTFTTNVADEDA@CDEFDEW$#YP0% 3L,DGK0!TNK:SIN@V)O=5O8;2V
MW!/,E; +'H!ZGVIT^JV%KI1U2XNXHK$1B4SNV$"'H<^G(KRG4;O6/$1\-1W6
MJM!>6/B273I9;>"/9))''+B8*P.#MXV],D\=,=?\5@1\*_$ )R?LO7U^84 =
M1J&J6&DVHNM0NX;: LJ!Y7"@L> !ZD^E6P<C->7Z)/=:C\1+=_&=D;6[>V\_
M0;4R!X8P/]8#V,X&">N >.E,U#Q;K&HZ]KD5I?:M8PZ;<&TMH['1FNTED506
M:5]C<$MC:I4@<]Z /4Z*\R?QUK6GVTEYJMN]JUWH!O+:SEAV-'>1ML>,9&3N
M+QD YJ70/%6MW\F@Z1=748U2">\_MF0(H!2W)3TPH9GB.0!QF@#TBBO'_P#A
M,M6ADTF^A\0W6I_:-0AM[F.+2MFG[)) A$<S1AB1G@[CG'2NJM?$&I2:)XYN
M7N 9=*N[J.T;8O[M4@1U'3G#,3SF@#MJ*\XM=3\2:]K^EZ9!KC6$$WAZWU">
M6*VC>1I68@[=RD 'OP>G &<UF2>.=<72=)TR2YF_M"XU*]LKB_L['SY#';,0
M62%01N;Y>Q Y.* /6J*\IF\<Z]HVA:Z[PZC>"#[.NG7NH:8]N[M*^PJR!5#E
M"01M SG%:7AW7=<'BFQL7FUO4["[CD%Q-J&C-:?9I%7<I#!%&UL%<')!QS0!
MW=_J%GI=E)>7]U#:VT0R\LSA57ZDU0T7Q5H/B)Y$T?5K2\>,9=(I 64>I'7'
MO6;XYTEM9M-,M[:^L8-1@ODN[."]YCN7C5B491R1@D\9(P#6/!J<P\::.?%?
MAH:?JA6:&PU"SNO-AF)3+(W 8<*2 P/(XYH ]"K'\-6FEZ?I366D3^=;07,Z
MN=^\K*9&9U)]0S'CM7+^';CQ7XAT73_%$.NPQ+=RB7^S)8$%NMN7QMWA3)OV
M\[LXSQC%8UQXTU6WM18P221W%[X@OK7[1:V(FDB@A9B=L:K\SX &2#W)SB@#
MUFBO)[OQAXCTWPYXF='U*9+*TCN+'4=0TPVS[BVUXV4HJL1P00!P?:MTR^(]
M(\7:3I=YX@:]BUBWN0W^BQI]EEC0,&CP.1R1A]W3O0!V#ZI81_9MUY /M,I@
MA^<'S)!G*CU(VMQ[&J!\7>'AJTFEG5[3[=&ZQO#YG*NQ "_4D@8Z\UYQX1GU
M'3?"/@R-=0:5+[69H2)((SY28N"0IV\$LN[/7DCIQ3-%?4M%L+B4:FUSY_C/
M[+(LUO%@YN-KOPO#,/3ICC% 'LE%>?V=QXI\3)J^J:;KL>GK:7TUK9V3VZ-"
MXB;:3,Q!?YB#]TC QUK>\<7=[9?#[7+NT)2[BL)75HS]P[3D@^W)_"@!TWCG
MPK;ZF=-F\0:>EV'V&,SKPW]TGH#['FN@KF])T#0_^$!M=)^S0-I4MDH<$#:Z
ME 2Y/J>N>N>:Q8[NYU37+3PUX<ULV6DV>E17/VV )<2SAF*(JM(&& $)+8)-
M '?45Y9<>)_$\EM;:1%J4,6IQ^(CI$U\+=2)8C"T@DV'@-@J<#C*^AQ6E GB
MB\\77F@?\)3-%;6.GV\SW*6D/G22NT@S@J5 PO(QV&,9.0#T&BO,K#Q5K^O2
MZ1H$=['97[S7L5]?PPJQ(MG"9C5LJ"Y8'D''/%0ZQXG\2Z+;:[I"ZE'<ZA87
M.G_9KZ6! 7CN)0I610 N1AAD 9!'0T >ITR6:*!0TTJ1J6" NP +$X Y[DD"
MN UJ\U31)-/TN]\97!DD265Y+335FO9CD;0L21LJH.<L1DG KF+S4]8\1^%;
M,76IW,<]EXKALEF>T2.5P)$*.Z%<*Z[N@ !QR* /88;ZUN+JYM8;B.2>U*K/
M&K9,98;@".V00:KZAHUKJ5]IMW<;_-T^8SP;6P-Q1D.?488UP>H^)]7T[5/$
M%A:S0M=-J6G:=:3R0+^[::)-TCA0-V/F(!]ATXJ[>ZEKWA;6H].NM9?5(;_3
M[J:"6:"-)()H4#?P*%*D-T(R".M '?T5YA8:OXHM=,\':]>ZZ+M-9GMH+FQ^
MRQI&JS(2&5@-VX<$\X// '%>GT 5UOK5K][!;B,W<<:RO"&^94)(#$>A((_"
MK%>=>+?$6IZ3JOBHV4T<9LO#\=W WDH660O*,DD9(^4<'CVJ>*]\0Z-XF\.I
MJ&M?VA;:PLPGMS;(BP.D1D!C*C=C@C#$T =]5>TOK6_21[2XCF6.5H7*-D*Z
MG#*?<$8KA_#D_BOQ!HVG>)XM=AC6\E64Z9) @@6W+XV[PI??MYW9QGC&*R_#
MVJWFGS6-M;2A(K[Q;J,%PNT'>@,S8YZ<J.E 'JE5Y;ZUAO8+.2XC2YN%=H8B
MWS.%QN('?&1GZUP?B'QAJVE:IXIM[:2-C;)IT5BLB#;%)<.Z%FQR0.#@GM[U
M6U"WU30/B!H%UJFL2:M!%I^H2J9((XY%94C+@;  5.!CC(YY- 'IM1SSQ6MO
M+<3R+'#$A>1V. J@9)/MBO(]-\9^)KBPTW6DDUF\FNI(I)M,70W%J(7(R(Y0
MF<JIR&+$''3FM'5;CQ!XFT'QA?6^L_8[2Q>[LH;$6Z,DJQ*5<R,1NRQW8VD8
MXZT >EP3Q7-O'/!(LD,JAT=3D,I&01^%25D>%/\ D3M$_P"P?!_Z+6M>@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S/$&A6OB
M/2)-.NWFC1F61)86VR1.K!E=3V((!K3K(\4:@=*\.75Z+]+#R]G^DO 9@F74
M?<')SG'XYH S;#P-906^KKJ-]>ZK<:M +>[N+IE#&(*5"*$ "@;CT'4YJ*P\
M!16NI:3?7>NZMJ$FDEOL:W#Q[44H4*D*@W<'[QYX'/7-C4_'N@Z5J%Y832W4
MMU98-S';6<LQA4J&#-M4@+@CGZ^AK=MK^VO-.BU"UE$]K+$)HY(P6WH1D$#J
M>* ,,^"=./@R3POY]U]B>1I#)N7S,M,9CSC'WCCIT_.F:AX,6XU2\O\ 3M:U
M+29+\*+Q+-H]LQ VAOG5MK8P-RX/ KE_^%G2S>'[+565K1/[>%E<F2TD5?L^
M^0?+N'+809QR#Q@'BNEE\:Z9?:)K<EG>S:?=:=;--*;RQD5X%*DK(8F ++P3
MQUQ0!T&F:=;:1I=MIUFK);V\8CC#,6.!ZD]3[UR&G_#5M*29;'Q?XA@$\S3R
M[7@R\C')8DQ9)^M:M[XWT?2BL%S+=7$T=ND]PUI92RB%&&0[[%.P'!.#S@5T
M%K<P7MI#=6TJRP3(LD<BG(92,@CZB@#G;_P:)]5NM1T[6]2TJ:]55O!:&,B?
M:-H;#HVU\<;EQT%2V_AQM*F\/6NCS2VVEZ:)5F@\WY9E9"!N&,LV\ALY_O=<
MBL#5_&NH67CD0PB(^'K*>WL=0D*_,)YPQ4ANP4^4#_OUTVL^+-)T*^AL;R6<
MWD\;2PV\%O)-)* 0#M" Y//3TR>@H ;XL\+P>+M'73+J]N[6#SDE8VQ4%]O(
M5@RL"N<'&.H%0Z;X4DLVG2]U_5=5M9H&@>UO3$8RK8SPB*<XR.O0FD/CSPXN
MAPZP]\R6<MR;3+0N'689S&R8W!OE/!'IZBBW\=:%<66IW+37-N-,B\Z[BN;6
M2*6.,@D-L90Q! /04 0:7X%M]/O;":?5M1OX-,!&GVUTZ%+?*[<Y507(4D L
M3@&J-E\-CIKW36/B[Q!;FZG:XF*/!EY&ZDDQ9-=5-K-A;W>FVLLQ$VI%EM5V
M$[RJ%SSCCY03S6,WQ"\/+<B,SW7V<S_9OMHLY?LWF[MNWSMNS[W&<XSWH U=
M7T.UUK0KS2;IG$=W T$DJX\S##!(.,9_"H;G2[M;_0OL-U)#:63O]IC#X69/
M+*J"N.3NVGL!@^U5M#UB[O\ Q3XGL)V4P:?<01VX"X(#P(YR>_+&L>_O_$.H
M>/[_ $73M<M],M;6Q@N!OLUF+L[.#R6&/NB@#K=7TNWUO1KS2[L-]GNX6ADV
M]0&&,CW'45SX^'FC;?#89[ECH!+6Y+C,I."3)QS\RAN,<BJWA[Q'J$/B36M$
MUK4;&^ATZUCNSJ$$?DB-6W924;B 0%SUZ5J:7XWT35[Z"TMY;E)+E2]JUQ:2
MPI<J!DF-G4!^.>.W/2@!NH^"M-U1?$"SS7(&N)$EQL8#R_+7"E..#WYS5G2_
M#<>G:LVJ27UW>7LEG'9R23E/G5&9@Q"J/FRY]N!Q6?'\1O#4K_)=7!@$WV>2
MZ^R2B"*7=MV/)MVJ<^I[CU%6]6\::-HU_)93O=37$,8EG2TM)9_(0]&DV*=H
M[\]J +N@Z);^']--C:R2O&9I9LRD$[I'9R. .,L<>U0VGAC3[:UUFU</<0:O
M<27%S'*003(BHRC 'RX7Z\]:J:CX\\.Z8EDTMZ\WVZ W%JMM \QF0$9*A <_
M>!QZ9/8U!X5\8CQ)K6N67V:>);"X$<+/:RQ[DV(3N+  -N8_+P<8.,<T )I_
M@9+2YL&N-<U6^M-.8/9VEPZ;(R!A22JAGV@\;B<5$?A[;./LDFL:F^C?:1<_
MV6S1F+<'\P#=LW[-W.W=6MK'BO2]$O(K*X-S->21F5;:SMI+B3RP<%RJ D+G
MN:@G\=>'8--L-0;4-]MJ#M';-%"[F1U!)3:!D-P1M(SGCK0!S6F>"+V^O?%)
MN]3U73K74-5E+V\#($N8"B $$J67/S E2"0/85T-[X,MI+RVO=)O[O1KNWM5
MLQ)9["'A7[J,KJRG;S@XR,UH:'XDTWQ"ES]A>82VKB.X@N('AEB8C(#(X!&1
MR#7.>(-4UR7Q_#H.FZW;:5;_ -EF\:2:U6;<_F[,<LN.#^E %]O >GC2[*VM
M[V_AO+*=[F'41*&N/-?.]F+ JV[)!!&,=N*BE^'UE<:;=0SZGJ$FH7-U%>2:
MD603>;$1Y9 "[ %Q@+MQR:M6U_+X<T:YU#Q+XCM[Z .H2:*T$6TGC:%5F+L2
M1@#FGVWC?1+FWU"5I;FV?3[<W-S!=6LD,J1 $[]C*"1P>1GTH V)K!+K29-.
MNI))HY8#!*[$!G!7:2<#&3["N:C\ Q6]GIBV^N:I%?Z;&T%M?@Q&40G'[I@4
MVNHVCJN<C.:>OQ(\,FV2Y-W<+!),((9#9RXF<J6'E_+\^0IQC.3@=QEC?$SP
MVL$TADO]]N2+J#^SYC+;  $M*FW*+@@Y/![=#0!L:!X>MO#]O<+%-/<W-U,9
M[JZN6#232$ 9.         !5+4_!MKJ6LWNH_;[V WUB;&Z@B9/+E3#A2<J2
M&7>2,'TR*Z"WGBNK:*X@D62&5 \;J<AE(R"/PKCK3Q5K%Y\1H-(DTQ['2GL[
MB2-KC'FSM&Z+OP#\J_,<9Y/7TH VIO"]G/::%;-+.$T::.:W((RY2-HQNXY&
M&/3'-9,WP]MG%U:P:SJEKI%W,TT^FPR((F9CN8*VW>BL<DJK <GI5*YUSQ-J
MC>(=0T6ZL[>ST6>2WCMIK<R&[>)0TFY]PV#)VC [9-=CHVIQ:UHEAJD*E8KR
MWCG53U 90V/UH GGM+>YLI+.:)7MI(S$\9'!0C!'TQ7,6/@*VM9[#[5JVHZA
M9:<<V-E=,ACA.TJ"2%#/A20-Q.,UD6OQ!GBL]1@DB6_UI]9N[#3+"+"M*L;8
M!;T51RS'M7::)#JD&E0KK-W%<WY^:5X8]D:D_P *CK@=,GD]?:@#G8?AU9Q1
MV]B^K:G-HEM,LT.E2.AA4JVY5+;=[(#@A2Q' K8@\,V<$&NQ++.5UF5Y9R2,
MH6C6,[>.!A1USS7)Z)XZ:]USQ%J&I:E+9:+I<IA6WFTYXUP%3YFD89WEG($?
M7IQS72V'C31M0DN(E>ZMI[> W+P7=I)!(8AU=5=067Z9H JGP.D'V)]*UO4]
M-FMK*.P:2$QOYT48PNY71EW#GY@ >::/A_I]M9Z9'I=[?:==Z<LB0WD+JTC+
M(VYQ('4JX9OFP1P>F*TO#_BO2?% F?29)YHHE5O-:W>-'#9QM9@ W0@XZ$5R
MVL?$&YAE\:V=I!)%-HMEYMK*]I)M+A&+%F(VXSC;_>&2,B@#:B\!Z=':1QR7
M5Y/<?VE%J<UW*ZF6>:,@KN^7 7  P , <8IT_@73IK2[B%S>133ZDVJ1W,;J
M)+><@#*'&,8&,$'()S2Z)XYT?6+JSL$FN%N[F'S(6EM9(H[C:,L8V90KXZ\'
MISTI3X]\/B^-M]IG\L3_ &8W?V63[,)<XV>=MV9SQUQGB@"DWPXL+I=6.IZG
MJ6H3:K;);7,LSHI 1BRE J@*02. ,<=.3FS!X)!UK3-7U#7M4U"]TUG-NTQB
M5 K(48%40 Y!Z]>!SVK=U?5K/0]+GU+4)#%:0 &1PA;:"0,X )QS^%-NM9L+
M*_L[*>X"SWBR/",$@JB[F8GH  1R?44 <\/AY8+83V0U'41$;TW]H5D0-8S%
MF8F([>A+MPV[@XJQ#X(LY(]2_MB^O-8FU&W^RS2795<1#.%14557DYR!G/.:
MDT_QWH.IWMO;6\]P!=,5M9Y;62.&Y(Y(CD90K=#T//;-1WWQ!\/Z?<7$<TUT
M8;67R;FZBLY7MX'Z%7E"E01D9YX[T 1V7@98-9TS5+S7M6U&;3-XM%N7CVHK
M(4(.U!N.#]X\\#GKG:US1+?7K.&UN9)42*YAN5,9 ):-PZCD'C(YJC>>--$L
MM=71))YY-08Q_NH;:23:'^ZQ*@@+TYZ#(K1UC6K#0; WNHS^5#O6-0%+L[G@
M*JJ"68^@% &3J'@G3M2DUAY9[I3JLUK--L9?E,!4H%XZ'8,YSWZ5;U7PO8:S
MJ:WMX96(L9[%HE8!6CEV[L\9S\HQ@]ZKP^-]#DTW4;UYI[==-3S+R&YMI(IH
M5(R"8V ;! ."!S2Z;XVT35M5CTZVFN!/,C26YFM9(DN57JT;,H#@=>#TYZ4
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MU)X)9)MX5XY8454D0J!M;Y0WU]N*+;P5$+J:\U/5M0U2\>U>SCFN3&OD1/\
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M2*W1E (R1TR*TO&FD:C>:SXJDMK&XF2X\*_9HFCC)$DOF2G8/5L$<>]>DT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !110: "BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDH
MH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDI: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M91^%OB3K>C(@VQ:5 [%>K,BIN/XEB:XS2]2F\1)J45BQF\2>);MHI&P?]$M
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M/;-,LKNUMOCOKTUQ/'$B:6@+R,% YC[G\* -SXK@?\*SUDD=$3_T8M<AH_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0:** $HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2EH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKC]'^).AZWXWO_  I:
MB<7MGOS(X7RY"A 95.<DC)[#H:VY/$6FQ>)H?#IF8ZG+;FZ$04X$8.-Q/3KD
M8]J -6BL+PMXKL_%EM?SV4,\2V5[)92"8 %G0#)&">/F%;M !1165IWB+3=5
MUG5-*LYC)=:88UNAM(",^X@9/4X4YQ0!JT444 %%<GXJ^(&F^%[^VTS[+?:E
MJURN^*PL(O,E*_WB,\#@_E2>%/B#IWBG4KK2OL5_IFK6J[Y;*_B\N3;Q\PY.
M1R/S% '6T444 %%%% !165KVM'0K.&X&FW]_YLZ0^78P^8Z;L_.PSPHQR?>M
M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%=.DBDL_#^G0212B:-T@4,KCH0>O%3^'O#L'A_\ M)H65GU"]>\EV1A%#,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
>%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892516432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-5286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KEWAUNEE SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-0715562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2700 West Front Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Statesville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28677-2927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">873-7202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common&#160;Stock&#160;$2.50&#160;par&#160;value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KEQU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,982,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,840,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;28, 2024, indicated in this report are incorporated by reference into Part&#160;III hereof.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000055529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892017024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Forvis Mazars, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Atlanta, GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">686<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370982128112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 203,755<span></span>
</td>
<td class="nump">$ 219,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">151,704<span></span>
</td>
<td class="nump">183,906<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">52,051<span></span>
</td>
<td class="nump">35,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">33,770<span></span>
</td>
<td class="nump">30,224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings</a></td>
<td class="nump">18,281<span></span>
</td>
<td class="nump">5,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionExpense', window );">Pension expense</a></td>
<td class="num">(4,177)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income, net</a></td>
<td class="nump">814<span></span>
</td>
<td class="nump">939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,799)<span></span>
</td>
<td class="num">(1,734)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">13,119<span></span>
</td>
<td class="nump">4,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">(5,938)<span></span>
</td>
<td class="nump">3,139<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">19,057<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net earnings attributable to the non-controlling interest</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">$ 18,753<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per share attributable to Kewaunee Scientific Corporation stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 6.51<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 6.38<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896453392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 19,057<span></span>
</td>
<td class="nump">$ 1,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(598)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAbstract', window );"><strong>Postretirement benefit plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement loss included in net income</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Income taxes on postretirement benefit plans</a></td>
<td class="num">(3,870)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Total postretirement benefit plans</a></td>
<td class="nump">658<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income, net of tax</a></td>
<td class="nump">19,117<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to the non-controlling interest</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">$ 18,813<span></span>
</td>
<td class="nump">$ 1,038<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896988800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 30, 2022</a></td>
<td class="nump">$ 35,694<span></span>
</td>
<td class="nump">$ 6,983<span></span>
</td>
<td class="nump">$ 4,483<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 28,023<span></span>
</td>
<td class="num">$ (3,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 30, 2023</a></td>
<td class="nump">37,409<span></span>
</td>
<td class="nump">7,084<span></span>
</td>
<td class="nump">5,059<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">28,761<span></span>
</td>
<td class="num">(3,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">18,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of Treasury Stock</a></td>
<td class="num">(1,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 30, 2024</a></td>
<td class="nump">$ 54,760<span></span>
</td>
<td class="nump">$ 7,273<span></span>
</td>
<td class="nump">$ 5,406<span></span>
</td>
<td class="num">$ (2,051)<span></span>
</td>
<td class="nump">$ 47,514<span></span>
</td>
<td class="num">$ (3,382)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370897030368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Stockholders' Equity (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock (in shares)</a></td>
<td class="nump">17,045<span></span>
</td>
<td class="nump">12,758<span></span>
</td>
<td class="nump">6,932<span></span>
</td>
<td class="nump">36,735<span></span>
</td>
<td class="nump">66,191<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885877760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,267<span></span>
</td>
<td class="nump">$ 8,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">2,671<span></span>
</td>
<td class="nump">5,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, less allowance: $588 (2024); $476 (2023)</a></td>
<td class="nump">45,064<span></span>
</td>
<td class="nump">46,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">20,679<span></span>
</td>
<td class="nump">21,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,136<span></span>
</td>
<td class="nump">6,135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">96,817<span></span>
</td>
<td class="nump">87,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">17,649<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">7,454<span></span>
</td>
<td class="nump">9,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">7,401<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">5,445<span></span>
</td>
<td class="nump">5,406<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">134,766<span></span>
</td>
<td class="nump">118,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">3,099<span></span>
</td>
<td class="nump">3,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityCurrent', window );">Current portion of financing liability</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of financing lease liabilities</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">2,123<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">23,262<span></span>
</td>
<td class="nump">23,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and amounts withheld</a></td>
<td class="nump">6,041<span></span>
</td>
<td class="nump">4,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,374<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">1,772<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">40,780<span></span>
</td>
<td class="nump">40,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNoncurrent', window );">Long-term portion of financing liability</a></td>
<td class="nump">27,420<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion of financing lease liabilities</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">5,434<span></span>
</td>
<td class="nump">7,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_AccruedEmployeeBenefitPlanCosts', window );">Accrued pension and deferred compensation costs</a></td>
<td class="nump">3,008<span></span>
</td>
<td class="nump">3,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">1,218<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">78,557<span></span>
</td>
<td class="nump">80,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">7,273<span></span>
</td>
<td class="nump">7,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,406<span></span>
</td>
<td class="nump">5,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">47,514<span></span>
</td>
<td class="nump">28,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(3,382)<span></span>
</td>
<td class="num">(3,442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common stock in treasury, at cost: 70000 shares (2024); 3 shares (2023)</a></td>
<td class="num">(2,051)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Kewaunee Scientific Corporation Stockholders' Equity</a></td>
<td class="nump">54,760<span></span>
</td>
<td class="nump">37,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">1,449<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders' Equity</a></td>
<td class="nump">56,209<span></span>
</td>
<td class="nump">38,485<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 134,766<span></span>
</td>
<td class="nump">$ 118,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_AccruedEmployeeBenefitPlanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_AccruedEmployeeBenefitPlanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370987803424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for receivables</a></td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,909,000<span></span>
</td>
<td class="nump">2,833,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">2,839,000<span></span>
</td>
<td class="nump">2,830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370888552128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 19,057<span></span>
</td>
<td class="nump">$ 1,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash used by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3,125<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment', window );">Provision for deferred income taxes</a></td>
<td class="num">(7,127)<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivables</a></td>
<td class="nump">741<span></span>
</td>
<td class="num">(4,947)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other accrued expenses</a></td>
<td class="nump">691<span></span>
</td>
<td class="num">(5,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="nump">286<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">19,564<span></span>
</td>
<td class="num">(3,790)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(4,373)<span></span>
</td>
<td class="num">(4,148)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,373)<span></span>
</td>
<td class="num">(4,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">148,061<span></span>
</td>
<td class="nump">60,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments on short-term borrowings</a></td>
<td class="num">(148,549)<span></span>
</td>
<td class="num">(58,601)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ProceedsFromFinancingLiability', window );">Proceeds from sale-leaseback transaction</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_PaymentsOnFinancingLiability', window );">Repayments on financing liability</a></td>
<td class="num">(642)<span></span>
</td>
<td class="num">(575)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments on long-term debt</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of Treasury Stock</a></td>
<td class="num">(1,998)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(3,014)<span></span>
</td>
<td class="nump">14,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, net</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="nump">12,123<span></span>
</td>
<td class="nump">6,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</a></td>
<td class="nump">13,815<span></span>
</td>
<td class="nump">6,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at End of Year</a></td>
<td class="nump">25,938<span></span>
</td>
<td class="nump">13,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,799<span></span>
</td>
<td class="nump">1,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">6,240<span></span>
</td>
<td class="nump">3,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Assets obtained under new operating leases</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">3,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Assets obtained under new finance leases</a></td>
<td class="nump">$ 204<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred income tax expense benefit net of rate adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_PaymentsOnFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments On Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_PaymentsOnFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ProceedsFromFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ProceedsFromFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896568608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2024 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 94% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated. Included in the consolidated financial statements are net assets of $18,547,000 and $16,786,000 at April&#160;30, 2024 and 2023, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $66,517,000 and $72,778,000 were included in the consolidated statements of operations for fiscal years 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2024 and 2023, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span></div><div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows. The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:59.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Receivables are stated at the amount owed by the customer, net of allowances for estimated credit losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for credit losses is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential credit losses, a reserve for credit losses is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for credit losses for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unbilled Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets. The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2024 and 2023 was $11,840,000 and $13,459,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter. Property, plant and equipment consisted of the following at April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value. There were no impairments in fiscal years 2024 or 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2024 and 2023 included $312,000 and $1,191,000, respectively, of unbilled retainage, $2,611,000 and $2,352,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $31,000 and $111,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for credit losses, self-insurance reserves, and income taxes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#8217;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of the Buyer, entering into a lease agreement. The lease arrangement is for a 20-year term. At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). The Company concluded that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For additional information on the accounting for the Sale-Leaseback Arrangement, refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7c2284e7bf3e47828f4617b389f29ad2_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2024 and 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $294,000 and $235,000 at April&#160;30, 2024 and 2023, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Concentration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs credit evaluations of its customers. Revenues from three of the Company's domestic dealers represented in the aggregate approximately 45% and 36% of the Company's sales in fiscal years 2024 and 2023, respectively. Accounts receivable for two domestic customers represented approximately 21% and 23% of the Company's total accounts receivable as of April&#160;30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under AC 740, the Company evaluates the realization of all deferred income tax assets and determines if a valuation allowance is required on an annual basis. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2024 or 2023. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Experimentation Expenditures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and experimentation expenditures are charged to cost of products sold in the periods incurred. Expenditures for research and experimentation expenditures were $920,000 and $1,012,000 for the fiscal years ended April&#160;30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses. Advertising costs for the years ended April&#160;30, 2024 and 2023 were $336,000 and $226,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect. There were no antidilutive RSUs and stock options outstanding at April&#160;30, 2024. There were 33,900 antidilutive RSUs and stock options outstanding at April&#160;30, 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:65.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Stock Options and Other Equity Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited. The Company granted 117,747 RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2024 and 87,969 RSUs in fiscal year 2023. There were no stock options granted during fiscal years 2024 and 2023. (See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7c2284e7bf3e47828f4617b389f29ad2_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note&#160;7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company adopted this standard effective May 1, 2023. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures," which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2025. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements for Income Tax Disclosures," which requires public business entities to, on an annual basis, (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. This ASU also provides for additional disclosure requirements to provide clarity for investors related to income tax disclosures. This guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2026. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890071632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary performance obligations identified by the Company:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laboratory Furniture</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the marketplace such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installation Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Terms and Transaction Prices</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allocation of Transaction Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients Used</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the following practical expedients:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment terms with the Company's customers which are one year or less are not considered a significant financing component.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing balances of contract assets included $11,840,000 in accounts receivable and $312,000 in other current assets at April&#160;30, 2024. The opening balance of contract assets arising from contracts with customers included $13,459,000 in accounts receivable and $1,191,000 in other assets at April&#160;30, 2023. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $4,374,000 at April&#160;30, 2024 and $4,097,000 at April&#160;30, 2023. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended April&#160;30, 2024, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately 100% of the contract liability balance at April&#160;30, 2024 is expected to be recognized as revenue during fiscal year 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896899504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:74.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,931</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>At April&#160;30, 2024 and 2023, the Company's international subsidiaries' inventories were $3,239,000 and $2,740,000, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890284960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt and Other Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-term Debt and Other Credit Arrangements</a></td>
<td class="text">Long-term Debt and Other Credit Arrangements <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $15.0&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $1,000,000, up to a maximum borrowing availability of $30.0&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus 4.10%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, there was $3,000,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $11,587,000. At April&#160;30, 2023, there was $3,548,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $10,286,000. The borrowing rate under the Revolving Credit Facility was 9.54% and 9.02% as of April&#160;30, 2024 and 2023, respectively. The Company was in compliance with all financial covenants under its revolving credit facility at April&#160;30, 2024 and 2023. In addition, the Company's International subsidiaries had a balance outstanding of $99,000 and $39,000 in short-term borrowings related to overdraft protection and short-term loan arrangements at April&#160;30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, there were foreign bank guarantees outstanding to customers in the amounts of $7.1 million, $435,000, and $226,000 with expiration dates in fiscal years 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April&#160;30, 2023, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $5.2 million, $142,000, $3,000, and $233,000 with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140371008842784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionDisclosureTextBlock', window );">Sale-Leaseback Financing Transaction</a></td>
<td class="text">Sale-Leaseback Financing Transaction<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#8217;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a 20-year term, with four renewal options of five years each. Under the terms of the Lease Agreement, the Company&#8217;s initial basic rent is approximately $158,000 per month, with annual increases of approximately 2% each year of the initial term.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of 4.75% to reflect the Company&#8217;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#8220;lease payments&#8221; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. No gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;30, 2024, the carrying value of the financing liability was $28,133,000, net of $648,000 in debt issuance costs, of which $713,000 was classified as current on the Consolidated Balance Sheet with $27,420,000 classified as long-term. As of April&#160;30, 2023, the carrying value of the financing liability was $28,774,000, net of $708,000 in debt issuance costs, of which $642,000 was classified as current on the Consolidated Balance Sheet with $28,132,000 classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expense associated with the financing arrangement was $1,287,000 and $1,316,000 for the years ended April 30, 2024 and 2023, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will depreciate the building down to zero over the 20-year assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $41,000.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for sale leaseback transaction. Includes, but is not limited to, terms and conditions of transaction and gain (loss) from transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//840-40/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890255936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $371,000 and $406,000 for the years ended April 30, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax (benefit) expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:64.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax (benefit) expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:66.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of pension settlement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in valuation allowance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on unremitted earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,303</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,562)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,453)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(926)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, non-current</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,401</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, non-current</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both positive and negative, to determine the amount of any required valuation allowance. As of April&#160;30, 2024, our deferred tax assets primarily related to proceeds on a prior sale leaseback and Section 174 research and expenditures addbacks. A valuation allowance of $926,000 and $8,568,000 was recorded against our net deferred tax asset balance as of April 30, 2024 and 2023, respectively. For the year ended April 30, 2024, we recorded a net decrease in valuation allowance of $6,579,000, as compared to a net increase of $1,667,000 for the year ended April 30, 2023, based on management's reassessment of the amount of its deferred tax assets that are more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state and local tax returns with statutes of limitation generally ranging from 3 to 4 years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2020 or state and local tax examinations for years prior to fiscal year 2019. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of 3 to 7 years and are generally no longer subject to examination for years prior to fiscal year 2018. The Company has no unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890239744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stock Options and Share-Based Compensation</a></td>
<td class="text">Stock Options and Share-Based Compensation <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stockholders approved the 2023 Omnibus Incentive Plan ("2023 Plan") in August, 2023, which enables the Company to grant a broad range of equity based awards, with potential recipients including directors, consultants and employees. The 2023 Plan replaced the 2017 Omnibus Incentive Plan (the "2017 Plan"). All outstanding equity granted under the 2017 Plan remain subject to, and will be settled under, the 2017 Plan. At the date of approval of the 2023 Plan, there were&#8239;64,633&#8239;shares available for new awards under the 2017 Plan, and 168,791 shares available for issuance under equity awards outstanding under the 2017 Plan.&#8239;These shares that were available for new awards and any shares subject to outstanding awards under the 2017 Plan that subsequently cease to be subject to such awards are available under the 2023 Plan. The 2023 Plan also increased the total number of shares reserved for issuance under the Company's equity compensation plans by 310,000, for a total of 374,633 shares initially reserved for issuance under the 2023 Plan. At April&#160;30, 2024, there were 383,572 shares available for future issuance under the 2023 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2023 Plan and the 2017 Plan, in the aggregate, the Company recorded stock-based compensation expense for employees of $1,018,000 and $845,000 and deferred income tax benefit of $223,000 and $199,000 in fiscal years 2024 and 2023, respectively. The RSUs granted under the 2023 Plan and the 2017 Plan include grants with both a service and performance component vesting over a 3 year period and grants with only service components vesting over a 3 year period. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $1,656,000 will be recorded over the remaining vesting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2024. The following table summarizes the RSU activity and weighted averages.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"></td><td style="width:48.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(103,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168,791</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders approved the 2008 Key Employee Stock Option Plan in fiscal year 2009 which allowed the Company to grant options on an aggregate of 300,000 shares of the Company's common stock and an amendment to the plan in August&#160;2015, authorizing an additional 300,000 shares. Under the plan, options were granted at not less than the fair market value at the date of grant with options exercisable in such installments, for such terms (up to 10 years). This plan was replaced by the 2017 Omnibus Plan with all outstanding options granted under the prior plan to remain subject to the prior plan. The last grant of options, issued on August 31, 2016, under the prior plan will expire August 31, 2026. The Company did not record any compensation expense related to outstanding stock options in fiscal years 2024 or 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued new shares of common stock to satisfy options exercised during fiscal years 2024 and 2023. Stock option activity and weighted average exercise price are summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:40.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2024:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$15.85-$23.62</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.68 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370897071552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholder's Equity</a></td>
<td class="text">Stockholder's Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue 5,000,000 shares of Common Stock, par value of $2.50 per share. Holders of the Company's Common Stock are entitled to 1 vote per share. At April&#160;30, 2024, and April&#160;30, 2023, there were approximately 2,839,000 and 2,830,000 shares, respectively, of Common Stock issued and outstanding. The Company has not declared or paid any dividends with respect to its Common Stock during the fiscal year ended April 30, 2024. The declaration and payment of any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2023, the Board of Directors of the Company adopted a share repurchase program with authorization to repurchase up to 100,000 shares. There is no expiration date and currently, management has no plans to terminate this program. During the fiscal year ended April 30, 2024, the Company repurchased 66,191 shares of the Company's common stock for approximately $1,992,000, excluding other costs such as broker commissions and fees.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share repurchase activity for the three months ended April 30, 2024:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.554%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares that May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 - 29</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 - 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,758&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,758&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - 30</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,735&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,735&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">        On August 31, 2023, the Board of Directors of Kewaunee Scientific Corporation (the "Company") adopted a share repurchase program with authorization to repurchase up to 100,000 shares of our Company's common stock, which commenced on September 1, 2023 and has no expiration date. The share repurchase program is designed to help offset the impact of future share dilution from employee stock issuances. The timing and amount of any repurchases under this program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions or any combination thereof. The program does not obligate the Company to acquire any particular amount of its common stock, and the share repurchase program may be suspended or discontinued at any time at the Company's discretion.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Excludes other costs such as broker commissions and fees.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions that occurred under the share repurchase program prior to the fourth quarter of fiscal year 2024 are presented in Item 2, Unregistered Sales of Equity Securities and Use of Proceeds, in the corresponding interim report on Form 10-Q for the periods ended </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">October</a><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> 31, 2023</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552924000009/kequ-20240131.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">January 31, 2024</a></span>, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890293600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss)<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. The before tax income (loss), related income tax effect, and accumulated balances are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,833)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(598)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss included in net income</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on postretirement benefit plans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//220/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896855872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Leases, Commitments and Contingencies</a></td>
<td class="text">Leases, Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $7,454,000 and $9,170,000 at April&#160;30, 2024 and 2023, respectively. Operating cash paid to settle lease liabilities was $2,594,000 and $2,278,640 for the fiscal year ended April 30, 2024 and 2023, respectively. The Company's leases have remaining lease terms of up to 8 years. In addition, some of the leases may include options to extend the leases for up to 5 years or options to terminate the leases within 1 year. Operating lease expense was $3,458,000 for the twelve months ended April 30, 2024, inclusive of period cost for short-term leases, not included in lease liabilities, of $864,000. Operating lease expense was $3,344,000 for the fiscal year ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,065,000.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2024, the weighted average remaining lease term for the capitalized operating leases was 4.2 years and the weighted average discount rate was 5.1%. At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was 5.1 years and the weighted average discount rate was 5.0%. For the financing leases, the weighted average remaining lease term was 4.5 years and the weighted average discount rate was 8.3% at April&#160;30, 2024 as compared to 3.1 years and 6.8% at April&#160;30, 2023. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into a new lease that has not yet commenced as of April&#160;30, 2024 with future minimum lease payments in aggregate of $681,000 that are not yet reflected on the Condensed Consolidated Balance Sheet. This lease is expected to commence in the second quarter of fiscal year 2025 with a lease term of 3 years.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892095568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Benefits</a></td>
<td class="text">Retirement Benefits<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended April 30 ,2024, the Company settled its non-contributory defined benefit plans by transferring approximately $17.8 million of pension obligations through the purchase of group annuity contracts for all remaining liabilities under the pension plan. In connection with the transfer, the Company contributed $287,000 in cash to the pension plan, which was intended to fully fund the Company&#8217;s remaining defined benefit pension liabilities.&#8239;These non-contributory defined benefit pension plans, which covered some domestic employees, were amended as of April 30, 2005. Following this amendment, no further benefits have been earned under the plans, and no additional participants have been added. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2021</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-796">Recognition of net loss</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-801">Effect of settlement</span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-804"><span style="-sec-ix-hidden:f-805"><span style="-sec-ix-hidden:f-806">Total net periodic pension expense plus special events</span></span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.431%"><tr><td style="width:1.0%"></td><td style="width:66.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.138%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age 21, completed three months of service, and who elect to participate. The plan provides that the Company make matching contributions equal to 100% of the employee's qualifying contribution up to 3% of the employee's compensation, and make matching contributions equal to 50% of the employee's contributions between 3% and 5% of the employee's compensation, resulting in a maximum employer contribution equal to 4% of the employee's compensation. The Company's matching contributions were $957,000 and $932,000 for years ending April&#160;30, 2024 and 2023. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2024 and 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892327120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7c2284e7bf3e47828f4617b389f29ad2_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">203,755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">636</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,062</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,125</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,048</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91,656</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134,766</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896574144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">$ 18,753<span></span>
</td>
<td class="nump">$ 738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370893411840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370893043840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370991918400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span> The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2024 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 94% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2024 and 2023, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span></div>The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span> Receivables are stated at the amount owed by the customer, net of allowances for estimated credit losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for credit losses is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential credit losses, a reserve for credit losses is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy', window );">Unbilled Receivables</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unbilled Receivables</span> Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span> The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span> Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentImpairment', window );">Property, Plant and Equipment, Impairment</a></td>
<td class="text">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_OtherAssetsPolicyTextBlock', window );">Other Assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2024 and 2023 included $312,000 and $1,191,000, respectively, of unbilled retainage, $2,611,000 and $2,352,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $31,000 and $111,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for credit losses, self-insurance reserves, and income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#8217;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of the Buyer, entering into a lease agreement. The lease arrangement is for a 20-year term. At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). The Company concluded that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For additional information on the accounting for the Sale-Leaseback Arrangement, refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i7c2284e7bf3e47828f4617b389f29ad2_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $294,000 and $235,000 at April&#160;30, 2024 and 2023, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Credit Concentration</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Concentration </span>The Company performs credit evaluations of its customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Insurance</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span> In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under AC 740, the Company evaluates the realization of all deferred income tax assets and determines if a valuation allowance is required on an annual basis. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2024 or 2023.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Experimentation Expenditures</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Experimentation Expenditures</span> Research and experimentation expenditures are charged to cost of products sold in the periods incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span> Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span> Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Stock Options and Other Equity Awards</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Stock Options and Other Equity Awards</span> Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company adopted this standard effective May 1, 2023. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures," which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2025. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements for Income Tax Disclosures," which requires public business entities to, on an annual basis, (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. This ASU also provides for additional disclosure requirements to provide clarity for investors related to income tax disclosures. This guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2026. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_OtherAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_OtherAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482105/912-330-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//310/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370893046112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:59.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock', window );">Schedule Of Allowance For Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for credit losses for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(164)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">588</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment consisted of the following at April&#160;30:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,913</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-10&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,234</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(46,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Hierarchy for Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2024 and 2023 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,077</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic to Diluted Weighted Average Shares Outstanding</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:65.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,938</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140371075432128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,517&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890206000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:74.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,931</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,706</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,679</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890306496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock', window );">Schedule of Remaining Future Cash Payments for Financing Liability</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Remaining Future Cash Payments for Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896848640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income Tax Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax (benefit) expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:64.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax (benefit) expense:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,378)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,996)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Income Tax Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax (benefit) expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:66.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">575</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of pension settlement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in valuation allowance</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes on unremitted earnings</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax (benefit) expense</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">950</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,303</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,316</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,211</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,671</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,078&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,562)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,453)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(926)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, non-current</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,401</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities, non-current</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,183</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140371008840720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of RSU Activity and Weighted Average Exercise Price</a></td>
<td class="text">The following table summarizes the RSU activity and weighted averages.<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"></td><td style="width:48.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.94</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(103,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,077)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168,791</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity and Weighted Average Exercise Price</a></td>
<td class="text">Stock option activity and weighted average exercise price are summarized as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:40.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2024:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$15.85-$23.62</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.68 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,584</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896571456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Summary of Share Repurchase Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share repurchase activity for the three months ended April 30, 2024:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.554%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares that May Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 - 29</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29.18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,612&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 - 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,758&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.63</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,758&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,854&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 - 30</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,735&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,735&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">        On August 31, 2023, the Board of Directors of Kewaunee Scientific Corporation (the "Company") adopted a share repurchase program with authorization to repurchase up to 100,000 shares of our Company's common stock, which commenced on September 1, 2023 and has no expiration date. The share repurchase program is designed to help offset the impact of future share dilution from employee stock issuances. The timing and amount of any repurchases under this program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions or any combination thereof. The program does not obligate the Company to acquire any particular amount of its common stock, and the share repurchase program may be suspended or discontinued at any time at the Company's discretion.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Excludes other costs such as broker commissions and fees.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-5<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481142/505-10-45-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-10<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896897712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances</a></td>
<td class="text">The before tax income (loss), related income tax effect, and accumulated balances are as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,833)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(609)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(549)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(598)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement loss included in net income</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on postretirement benefit plans</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,870)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,382)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 45<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896908784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Finance Lease Maturity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,557&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140371008843568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to insurer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2021</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Summary of Components of Net Periodic Pension Cost</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-796">Recognition of net loss</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic pension expense</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-801">Effect of settlement</span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-804"><span style="-sec-ix-hidden:f-805"><span style="-sec-ix-hidden:f-806">Total net periodic pension expense plus special events</span></span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock', window );">Summary of Plan Assets by Asset Categories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30, 2023 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.431%"><tr><td style="width:1.0%"></td><td style="width:66.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.138%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock', window );">Summary of Fair Value Assets in Defined Benefit Pension Plans</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,732&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (b)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896843728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137,238</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">203,755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">636</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,062</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,524</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,125</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,048</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,240</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,938)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">304</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,055</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,890</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,753</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91,656</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">134,766</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">614</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,175</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,517</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,692</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,898&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885821104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203,755,000<span></span>
</td>
<td class="nump">$ 219,494,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,840,000<span></span>
</td>
<td class="nump">13,459,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Property plant and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sale agreement for property</a></td>
<td class="nump">$ 30,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityTermOfContract', window );">Term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionContractorReceivableRetainage', window );">Retainage included in accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 294,000<span></span>
</td>
<td class="nump">235,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">920,000<span></span>
</td>
<td class="nump">1,012,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000<span></span>
</td>
<td class="nump">$ 226,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive options exclude from computation of earning per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,517,000<span></span>
</td>
<td class="nump">$ 72,778,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,238,000<span></span>
</td>
<td class="nump">146,716,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,547,000<span></span>
</td>
<td class="nump">$ 16,786,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,747<span></span>
</td>
<td class="nump">87,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Segment | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_UnbilledRetainageCurrent', window );">Unbilled retainage included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312,000<span></span>
</td>
<td class="nump">$ 1,191,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Assets held in trust account for non-qualified benefit plans included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,611,000<span></span>
</td>
<td class="nump">2,352,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance policies included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="nump">$ 111,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Labway Asia Pte. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Scientific Corporation Singapore Pte. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Labway India Pvt. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Koncepo Scientech International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember', window );">Kewaunee Scientific Corporation Singapore Pte. Ltd. | Kequip Global Lab Solutions Pvt. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_UnbilledRetainageCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Retainage, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_UnbilledRetainageCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479910/205-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionContractorReceivableRetainage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer withheld under retainage provision in long-term contract or program when right to consideration is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionContractorReceivableRetainage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeLabwayAsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeLabwayAsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeScientificCorporationSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeScientificCorporationSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeLabwayIndiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeLabwayIndiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KoncepoScientechInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KoncepoScientechInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KequipGlobalLabSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KequipGlobalLabSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889093584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash Equivalents Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 23,267<span></span>
</td>
<td class="nump">$ 8,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">2,671<span></span>
</td>
<td class="nump">5,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 25,938<span></span>
</td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 6,894<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370891958320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance at beginning of year</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs, net</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance at end of year</a></td>
<td class="nump">$ 588<span></span>
</td>
<td class="nump">$ 476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370894961280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 64,234<span></span>
</td>
<td class="nump">$ 61,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(46,585)<span></span>
</td>
<td class="num">(44,966)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property, plant and equipment</a></td>
<td class="nump">17,649<span></span>
</td>
<td class="nump">16,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 17,280<span></span>
</td>
<td class="nump">17,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 46,913<span></span>
</td>
<td class="nump">$ 44,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896644480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($) </div>
<div>compensation_plan</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>compensation_plan</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">$ 2,642<span></span>
</td>
<td class="nump">$ 2,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">$ 3,009<span></span>
</td>
<td class="nump">$ 2,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_NumberOfNonqualifiedCompensationPlans', window );">Number of non-qualified compensation plans maintained | compensation_plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember', window );">Trading Securities Held in Non-Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">$ 1,565<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember', window );">Cash Surrender Value of Life Insurance Policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember', window );">Non Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">3,009<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,565<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Trading Securities Held in Non-Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,565<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">3,009<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Cash Surrender Value of Life Insurance Policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Non Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">$ 3,009<span></span>
</td>
<td class="nump">$ 2,910<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_NumberOfNonqualifiedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of nonqualified compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_NumberOfNonqualifiedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370888577248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">2,879<span></span>
</td>
<td class="nump">2,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of stock options and RSUs (in shares)</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding-diluted (in shares)</a></td>
<td class="nump">2,938<span></span>
</td>
<td class="nump">2,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889117008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">$ 203,755<span></span>
</td>
<td class="nump">$ 219,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">198,315<span></span>
</td>
<td class="nump">214,772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">5,440<span></span>
</td>
<td class="nump">4,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">137,238<span></span>
</td>
<td class="nump">146,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic | Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">131,798<span></span>
</td>
<td class="nump">141,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic | Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">5,440<span></span>
</td>
<td class="nump">4,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">66,517<span></span>
</td>
<td class="nump">72,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International | Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">66,517<span></span>
</td>
<td class="nump">72,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International | Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370982175312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets in accounts receivable</a></td>
<td class="nump">$ 11,840<span></span>
</td>
<td class="nump">$ 13,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">4,374<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_UnbilledRetainageCurrent', window );">Contract assets in other assets</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 1,191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember', window );">Fiscal Year 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage', window );">Contract liability recognized as revenue percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer, liability, revenue recognized percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_RevenueRecognitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_RevenueRecognitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_UnbilledRetainageCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Retainage, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_UnbilledRetainageCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885592848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Summary of Inventories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 3,042<span></span>
</td>
<td class="nump">$ 3,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">1,931<span></span>
</td>
<td class="nump">2,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Materials and components</a></td>
<td class="nump">15,706<span></span>
</td>
<td class="nump">16,097<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 20,679<span></span>
</td>
<td class="nump">$ 21,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370992239728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember', window );">International Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories measured using FIFO method</a></td>
<td class="nump">$ 3,239<span></span>
</td>
<td class="nump">$ 2,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885881264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-term Debt and Other Credit Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 19, 2022</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,099,000<span></span>
</td>
<td class="nump">$ 3,587,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember', window );">International Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement, Mid Cap Funding IV Trust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Loan agreement</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,548,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Unused and available credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,587,000<span></span>
</td>
<td class="nump">$ 10,286,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at period end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.54%<span></span>
</td>
<td class="nump">9.02%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Additional tranche available, minimum amount</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption', window );">Maximum borrowing availability</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Credit Agreement, Mid Cap Funding IV Trust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt, variable interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=kequ_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kequ_CreditAgreementMidCapFundingIVTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kequ_CreditAgreementMidCapFundingIVTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=kequ_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=kequ_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370888543936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($) </div>
<div>renewalOption</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityTermOfContract', window );">Term of agreement</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNumberOfRenewalOptions', window );">Number of renewal options | renewalOption</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityBasicMonthlyPayment', window );">Initial basic monthly rent</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAnnualIncreasePercent', window );">Annual rental increase, as a percent</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain (loss) on sale leaseback agreement</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiability', window );">Financing liability</a></td>
<td class="nump">28,133<span></span>
</td>
<td class="nump">$ 28,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs on financing liability</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityCurrent', window );">Current portion of financing liability</a></td>
<td class="nump">713<span></span>
</td>
<td class="nump">642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNoncurrent', window );">Long-term portion of financing liability</a></td>
<td class="nump">27,420<span></span>
</td>
<td class="nump">28,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_InterestExpenseFinancingLiability', window );">Interest expense on financing liability</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 64,234<span></span>
</td>
<td class="nump">61,368<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAnnualIncreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Annual Increase, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAnnualIncreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityBasicMonthlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Basic Monthly Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityBasicMonthlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Number of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_InterestExpenseFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_InterestExpenseFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of finance lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479741/842-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370981429280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearOne', window );">2025</a></td>
<td class="nump">$ 1,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearTwo', window );">2026</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearThree', window );">2027</a></td>
<td class="nump">2,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearFour', window );">2028</a></td>
<td class="nump">2,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearFive', window );">2029</a></td>
<td class="nump">2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidAfterYearFive', window );">Thereafter</a></td>
<td class="nump">31,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaid', window );">Total Minimum Liability Payments</a></td>
<td class="nump">41,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(13,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiability', window );">Total</a></td>
<td class="nump">$ 28,133<span></span>
</td>
<td class="nump">$ 28,774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885862080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsSection174REAddback', window );">Deferred tax asset, Section 174 addback</a></td>
<td class="nump">$ 2,303<span></span>
</td>
<td class="nump">$ 1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax asset valuation allowance</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">8,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign tax credit carryforwards</a></td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FederalStateAndLocalTaxReturnsPeriod', window );">Federal, state and local tax returns period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ForeignSubsidiariesTaxReturnsPeriod', window );">Foreign subsidiaries tax returns period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FederalStateAndLocalTaxReturnsPeriod', window );">Federal, state and local tax returns period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ForeignSubsidiariesTaxReturnsPeriod', window );">Foreign subsidiaries tax returns period (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember', window );">India Income Tax Department</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_TaxWithholdingExpense', window );">Tax withholding expense</a></td>
<td class="nump">$ 371<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsSection174REAddback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Section 174 R&amp;E Addback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsSection174REAddback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FederalStateAndLocalTaxReturnsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal, state and local tax returns period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FederalStateAndLocalTaxReturnsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ForeignSubsidiariesTaxReturnsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign subsidiaries tax returns period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ForeignSubsidiariesTaxReturnsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_TaxWithholdingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Withholding Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_TaxWithholdingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370888577696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax (benefit) expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2,332<span></span>
</td>
<td class="nump">$ 691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">1,736<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax expense</a></td>
<td class="nump">5,058<span></span>
</td>
<td class="nump">2,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax (benefit) expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(10,378)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(893)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax (benefit) expense</a></td>
<td class="num">(10,996)<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net income tax (benefit) expense</a></td>
<td class="num">$ (5,938)<span></span>
</td>
<td class="nump">$ 3,139<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889068496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Reconciliation (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax expense at statutory rate</a></td>
<td class="nump">$ 2,755,000<span></span>
</td>
<td class="nump">$ 945,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal income tax benefit</a></td>
<td class="nump">575,000<span></span>
</td>
<td class="num">(119,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="num">(355,000)<span></span>
</td>
<td class="num">(433,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effects of differing US and foreign tax rates</a></td>
<td class="nump">243,000<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount', window );">Effect of pension settlement</a></td>
<td class="num">(3,870,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount', window );">Return to provision adjustment</a></td>
<td class="nump">743,000<span></span>
</td>
<td class="nump">413,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Impact of foreign subsidiary income to parent</a></td>
<td class="nump">96,000<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase (decrease) in valuation allowance</a></td>
<td class="num">(6,579,000)<span></span>
</td>
<td class="nump">1,667,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings', window );">Deferred taxes on unremitted earnings</a></td>
<td class="nump">371,000<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other items, net</a></td>
<td class="nump">83,000<span></span>
</td>
<td class="num">(99,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net income tax (benefit) expense</a></td>
<td class="num">$ (5,938,000)<span></span>
</td>
<td class="nump">$ 3,139,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in Deferred Taxes On Unremitted Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892473200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits', window );">Accrued employee benefit expenses</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Deferred compensation</a></td>
<td class="nump">950<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits (state, net of federal benefits)</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign tax credit carryforwards</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsSection174REAddback', window );">Section 174 R&amp;E Addback</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Unrecognized actuarial loss, defined benefit plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory reserves and capitalized costs</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback', window );">Proceeds on Sale Leaseback</a></td>
<td class="nump">6,316<span></span>
</td>
<td class="nump">6,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">1,211<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">12,671<span></span>
</td>
<td class="nump">14,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Book basis in excess of tax basis of property, plant and equipment</a></td>
<td class="num">(1,678)<span></span>
</td>
<td class="num">(1,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty', window );">Book basis in excess of tax basis of Sale Leaseback property</a></td>
<td class="num">(1,028)<span></span>
</td>
<td class="num">(1,106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesPrepaidPensionCost', window );">Prepaid pension</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(919)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesAPB23Assertion', window );">APB 23 Assertion</a></td>
<td class="num">(1,572)<span></span>
</td>
<td class="num">(1,318)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use assets</a></td>
<td class="num">(1,142)<span></span>
</td>
<td class="num">(1,526)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts', window );">Debt Issuance Cost on Sale Leaseback</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(5,562)<span></span>
</td>
<td class="num">(6,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(926)<span></span>
</td>
<td class="num">(8,568)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">6,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets (liabilities) classified in the balance sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, non-current</a></td>
<td class="nump">7,401<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities, non-current</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(943)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 6,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (943)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Proceeds on Sale Leaseback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsProceedsOnSaleLeaseback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsSection174REAddback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Section 174 R&amp;E Addback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsSection174REAddback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesAPB23Assertion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, APB 23 Assertion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesAPB23Assertion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesPrepaidPensionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Prepaid Pension Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesPrepaidPensionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Sale Leaseback Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesSaleLeasebackProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889018656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 26, 2015</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Aug. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,996<span></span>
</td>
<td class="num">$ (515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,791<span></span>
</td>
<td class="nump">159,640<span></span>
</td>
<td class="nump">144,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan | Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember', window );">2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under stock option plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in number of shares available under stock option plan (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember', window );">2008 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember', window );">Two Thousand Twenty Three Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember', window );">Two Thousand Twenty Three Omnibus Incentive Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,018<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Remaining estimated compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember', window );">Two Thousand Twenty Three Omnibus Incentive Plan | Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease', window );">Increase in number of shares reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember', window );">Two Thousand Twenty Three Omnibus Incentive Plan | Service Components | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kequ_RestrictedStockUnitsRSUsServiceComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kequ_RestrictedStockUnitsRSUsServiceComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892674864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">159,640<span></span>
</td>
<td class="nump">144,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">117,747<span></span>
</td>
<td class="nump">87,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(103,519)<span></span>
</td>
<td class="num">(50,315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(5,077)<span></span>
</td>
<td class="num">(22,841)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">168,791<span></span>
</td>
<td class="nump">159,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of year (in dollar per shares)</a></td>
<td class="nump">$ 11.94<span></span>
</td>
<td class="nump">$ 12.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollar per shares)</a></td>
<td class="nump">15.97<span></span>
</td>
<td class="nump">13.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollar per shares)</a></td>
<td class="nump">11.03<span></span>
</td>
<td class="nump">13.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollar per shares)</a></td>
<td class="nump">10.54<span></span>
</td>
<td class="nump">15.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of year (in dollar per shares)</a></td>
<td class="nump">$ 15.35<span></span>
</td>
<td class="nump">$ 11.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885744896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of&#160;Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">47,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(3,700)<span></span>
</td>
<td class="num">(7,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(5,500)<span></span>
</td>
<td class="num">(5,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">24,700<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year (in shares)</a></td>
<td class="nump">24,700<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of year (in dollar per shares)</a></td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="nump">$ 19.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (in dollar per shares)</a></td>
<td class="nump">16.09<span></span>
</td>
<td class="nump">20.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollar per shares)</a></td>
<td class="nump">22.21<span></span>
</td>
<td class="nump">14.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of year (in dollar per shares)</a></td>
<td class="nump">20.05<span></span>
</td>
<td class="nump">19.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of year (in dollar per shares)</a></td>
<td class="nump">$ 20.05<span></span>
</td>
<td class="nump">$ 19.97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889067920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price range lower limit (in dollar per shares)</a></td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price range upper limit (in dollar per shares)</a></td>
<td class="nump">$ 23.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">24,700<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">47,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price (in dollar per shares)</a></td>
<td class="nump">$ 20.05<span></span>
</td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="nump">$ 19.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (in years)</a></td>
<td class="text">1 year 8 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 386,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (in shares)</a></td>
<td class="nump">24,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (in dollar per shares)</a></td>
<td class="nump">$ 20.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 386,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892903552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">2,839,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,000<span></span>
</td>
<td class="nump">2,839,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of Shares authorized to be repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock (in shares)</a></td>
<td class="nump">17,045<span></span>
</td>
<td class="nump">12,758<span></span>
</td>
<td class="nump">6,932<span></span>
</td>
<td class="nump">36,735<span></span>
</td>
<td class="nump">66,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod', window );">Treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,992,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized to be repurchased</a></td>
<td class="nump">33,809<span></span>
</td>
<td class="nump">50,854<span></span>
</td>
<td class="nump">63,612<span></span>
</td>
<td class="nump">33,809<span></span>
</td>
<td class="nump">33,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value Excluding Broker Commissions and Fees, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370893241952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder's Equity - Share Repurchase Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Purchased (in shares)</a></td>
<td class="nump">17,045<span></span>
</td>
<td class="nump">12,758<span></span>
</td>
<td class="nump">6,932<span></span>
</td>
<td class="nump">36,735<span></span>
</td>
<td class="nump">66,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average Price Paid Per Share (in dollars per share)</a></td>
<td class="nump">$ 35.11<span></span>
</td>
<td class="nump">$ 31.63<span></span>
</td>
<td class="nump">$ 29.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Number of Shares that May Yet Be Purchased Under the Plans or Programs</a></td>
<td class="nump">33,809<span></span>
</td>
<td class="nump">50,854<span></span>
</td>
<td class="nump">63,612<span></span>
</td>
<td class="nump">33,809<span></span>
</td>
<td class="nump">33,809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=kequ_PubliclyAnnouncedProgramsMember', window );">Publicly Announced Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares Purchased (in shares)</a></td>
<td class="nump">17,045<span></span>
</td>
<td class="nump">12,758<span></span>
</td>
<td class="nump">6,932<span></span>
</td>
<td class="nump">36,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=kequ_PubliclyAnnouncedProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=kequ_PubliclyAnnouncedProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885428592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (3,442)<span></span>
</td>
<td class="num">$ (3,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(598)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement loss included in net income</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Income taxes on postretirement benefit plans</a></td>
<td class="nump">3,870<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(3,382)<span></span>
</td>
<td class="num">(3,442)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(2,833)<span></span>
</td>
<td class="num">(2,543)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(549)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(3,382)<span></span>
</td>
<td class="num">(2,833)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Minimum Pension Liability Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(609)<span></span>
</td>
<td class="num">(1,199)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Settlement loss included in net income</a></td>
<td class="nump">4,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Income taxes on postretirement benefit plans</a></td>
<td class="num">(3,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (609)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370885812144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 7,454,000<span></span>
</td>
<td class="nump">$ 9,170,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 2,594,000<span></span>
</td>
<td class="nump">2,278,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeRemainingLeaseTerm', window );">Remaining lease term (in years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeOptiontoExtendTerm', window );">Option to extend, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeOptiontoTerminateTerm', window );">Option to terminate, term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 3,458,000<span></span>
</td>
<td class="nump">3,344,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_OperatingLeaseShortTermExpense', window );">Operating lease, short term, expense</a></td>
<td class="nump">$ 864,000<span></span>
</td>
<td class="nump">$ 1,065,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate (as a percent)</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease, weighted average remaining lease term (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate (as a percent)</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Lease not yet commenced amount</a></td>
<td class="nump">$ 681,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Term of contract</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeOptiontoExtendTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Option to Extend, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeOptiontoExtendTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeOptiontoTerminateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Option to Terminate, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeOptiontoTerminateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_OperatingLeaseShortTermExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Short Term, Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_OperatingLeaseShortTermExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892674160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 2,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">1,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">1,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">1,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,894<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Minimum Lease Payments</a></td>
<td class="nump">9,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(2,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">7,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total Minimum Lease Payments</a></td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370889083024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation, April 30</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18,368,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Projected Benefit Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, beginning of year</a></td>
<td class="nump">18,368,000<span></span>
</td>
<td class="nump">20,022,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">890,000<span></span>
</td>
<td class="nump">845,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial gain (loss)</a></td>
<td class="nump">53,000<span></span>
</td>
<td class="num">(1,113,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Actual benefits paid</a></td>
<td class="num">(1,558,000)<span></span>
</td>
<td class="num">(1,386,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation', window );">Transfer to insurer</a></td>
<td class="num">(17,753,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,368,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">17,732,000<span></span>
</td>
<td class="nump">18,867,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">1,292,000<span></span>
</td>
<td class="nump">251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan', window );">Transfer to insurer</a></td>
<td class="num">(17,753,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Actual benefits paid</a></td>
<td class="num">(1,558,000)<span></span>
</td>
<td class="num">(1,386,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,732,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status&#8212;under</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(636,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts Recognized in the Consolidated Balance Sheets consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(636,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract', window );"><strong>Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Net actual loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,526,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Deferred tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,064,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">After-tax actuarial loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted-average Assumptions Used to Determine Benefit Obligations at April 30</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term return on plan assets (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370982104512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 890<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">$ (1,312)<span></span>
</td>
<td class="num">(1,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognition of net loss</a></td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent', window );">Net periodic pension expense</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Settlement loss included in net income<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Effect of settlement</a></td>
<td class="nump">$ 4,019<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total net periodic pension expense plus special events</a></td>
<td class="nump">$ 4,177<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Excluding Settlement Cost Component</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes amortization of gain (loss) component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes settlement and curtailment gain (loss) component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes settlement gain (loss) component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480535/715-20-45-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896912048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities', window );">Defined benefit plan remaining pension plan liabilities</a></td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">$ 287,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions', window );">Age limit of employees to be eligible for contribution (in years)</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod', window );">Minimum service period of employees to be eligible for contribution (in months)</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Employee's compensation (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount', window );">Employer matching contributions</a></td>
<td class="nump">$ 957,000<span></span>
</td>
<td class="nump">$ 932,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution', window );">Matching contributions by company (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Contributions by employer per employee's compensation (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employee's compensation (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution', window );">Matching contributions by company (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Contributions by employer per employee's compensation (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Benefit Obligation, Remaining Pension Plan Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan age limit of employees to be eligible for catch up contributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan eligibility minimum service period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEligibilityMinimumServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Employer Matching Contributions, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEmployerMatchingContributionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan employer matching percent of employee contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370892895984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 18,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370884810464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 18,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanLiquidAlternativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanLiquidAlternativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370890278272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2024 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140370896520576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 203,755<span></span>
</td>
<td class="nump">$ 219,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3,125<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">13,119<span></span>
</td>
<td class="nump">4,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(5,938)<span></span>
</td>
<td class="nump">3,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to non-controlling interest</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">18,753<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">134,766<span></span>
</td>
<td class="nump">118,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">4,373<span></span>
</td>
<td class="nump">4,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">67,692<span></span>
</td>
<td class="nump">75,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="num">(8,224)<span></span>
</td>
<td class="num">(6,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(12,113)<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">3,890<span></span>
</td>
<td class="num">(7,181)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="num">(4,698)<span></span>
</td>
<td class="num">(11,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">137,238<span></span>
</td>
<td class="nump">146,716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,524<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">15,048<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">11,808<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">91,656<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">3,759<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Operating Segments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">1,175<span></span>
</td>
<td class="nump">2,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">66,517<span></span>
</td>
<td class="nump">72,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">408<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">6,295<span></span>
</td>
<td class="nump">7,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2,935<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to non-controlling interest</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">4,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">43,110<span></span>
</td>
<td class="nump">38,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">1,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Operating Segments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">66,517<span></span>
</td>
<td class="nump">72,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">$ 4,062<span></span>
</td>
<td class="nump">$ 9,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_RevenuesIncludingIntersegmentMarkup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues including intersegment markup.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_RevenuesIncludingIntersegmentMarkup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M(A7O&>6_8HYC\P7)"Y+B!#*4@'O&OWB>,4#6_(;$CUN2)H@6/X'P6XG9,[@
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M;]TDM%S%;K#.V393+*]G*:!_)RU!#T$Y]FE$^WUE,L.^;<2U2,5NIG[M5)
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M_%S6[49=X3&H&6%B!K[-P%>[K-W@/:W[$:R T3<X$WU -\]/_5V[1C8@LT>
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M.VA+@9)5+NSJ;48R@S@,8LTFC E<:_+,.,@ _" G2/N3&#5"73#1%'Z</K>
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M*RAM=C>ITF@DC<9C.[:KQG%<<>W=BBMQ[C[<N@\0"4F(*8(AR-%H?_V>[@9
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M"BM2;+)4GB3B^E*9C R+-=G.(NS!%2(A-V1Q9J)_-BD3Z(>2Y*D9X8=E20'
M,8,_P$:U#TD1P >=0SZN LK4)=)%035.4^_$N"ID]VC1Z$/]_(Y0,R68RR38
M:VJ,:%^ECYS'\=. _0Q["Q,J0@XM]VQUEC2]+L17>YJ[9,)1#.;HR*Y V7_K
M4$L=@L"S &NS;>&HK2>78D )FO[*;:Z"[;A0MTW5PO],LW/!>-J'[+NMB53C
M#KK.?90ONH;P1A&EX270+H"&TGO74C1M.)D1(HL,D;8..PN7_0JF(YX@2W-U
MK W'%.2 QJW+A_&X-H4U#XPL"&T/)-H[WXQ !O\$9EB;3)./(,<*&J>D)%J1
M;0^Z:$V,"$$.)XW $#F\)UQ!U0%Z9#.FV/&N."W,G;,,33_H8N)Q2#FB5 *Z
MQXKJ#)A%6F)GA6K7#F>J;R?O?WX[^:Y#* Q]9^I?NJX)(D*N>VHFD!!K <^:
M.Z'(M#K(PJ/ R_ M@,V HT@@8@.'!S_/4:XE\;$W0+ET/L=:=!@?NH&2=%]P
M9(;<EUM)H1N&OH7=6XHLL3ZK'D$P4^_:%,H([H@C_@""?#)G4?8^=D)9[ZFS
M8%@,#T($!D6N#72>&VH)N']CI7")0![![WX'KXQ,Z4T36@@*[JF08PJ$:Z10
M$ 5A=-HA<5FS3T$TS$U@&QD.CDD_5<Y+RTN;X8YM(:G2583.2&&GZ.?4A#:T
M4!2X_W5M.&WP4B6'@@'@C30K#P'69PF^K,W142L ?==:$EAPH(PR6Q<9R9$@
MFZ4NGZL&NQ-UUEZDEM-"=H/KB#G(6KTC3N3NZ1F"P@I9!K<'C0*11PO,(S !
M 1O-B+&ED :<>6P(*>0##$1]RYEB.R0ED4F0K0"J56W%EH6MCT93\4HT3RCT
MS/*%KL '0QQ%M-0^=<RY2M9UJDJ:.0]?.3[J/>G[0Q_A_1K[HWX"]C O!:3O
M6OU16,C1G-Q!7-5G<%ZQ\]@.:7 L9^Y"VD="40T7@[8*@, +;@JR4"N_:4LN
M</0XY(&Q^DK2J<S4G/ $\R([]'U[KX\]MU[73E/"@@:W3W!MRP=7/$26>GAG
ML/R,+\3K'KV1EN:H ],?1@^19D 2B=N08W&'%4P0.SZ+V(<3B7<QS&D]"[4V
M79@G7'*>*R^>3CTOCS),N6._A&>9?E%(\Z%0M:*W7M"9%M!!BLXO0:<+VA['
M2-.O."_IJD-)&2$&6W88(M(1Q*/CB$[J@).BMC;-@=+X4(=,Q2=T&:MVZ@M0
MR=>,+:178/?M!_HE]SI#&-PAYI344GQ^: 3^[_?4 ):G$<#5)_7E?<!9YB#&
MDZ9!M,KH!54,VLD!N*#E(^&TA/$WK71U%*2LLD%6$0<%C76RAQ34=6L+2DP>
M:;$)"U+O0Y[P/C59TQXW!PO $OD9&4-(14@L((U F!.]P4)Q\NIJ:85+0;QQ
MI#D -[F C0>D(]?Z "I]ZHXI;K=B'%"#BO311\4/FKE@Z2AXS]<E# G>$Z?T
M[S_,0;>E,6"UDSTT2O!9[D="<LJ2#PS2+8ZRXZUSWVT&4=%K:V- CN>2W(WT
M[]QJL832M9^/UF*Q#\!W.":,"AT6PC_;NUZ0S-L](),N#0S()86MG*>&N]WW
MV(KIJ\_6(!N-:/Q2NR;IA1!UK0F;7]&]!O]TM>8Q2FR[!-9<ZKRFJ3D9)IK1
M)*J(5Y[]UJ[=[M 7G668V$U]##WM)QY^D\"?>@/:C_5IQ?^[[PTV>%;2>2>Q
M(.-"[D7LH\FO9,3;<YG88U P,5B*M@Z5D4!_(!(Z;RBF-G#;4F(5]3T_Q;H7
M68JGR6P_-$H<';WX"HD/648&A60PHK-SA0"GT\N)\QDV>E];]!J!<]?O /\3
M':-</*D)Y 77>GLZU.SP=O(U:7UYUMR+QM@Y\.![7[F2;-SWH#0^;FNT%B8H
M60[EGK)++P,&6;\C,#XRR-DY.)I,'WN855J^?N2CRFO.%2!4]@_M^#\K>?=R
MGQ#L<>:N7^L:A(0X'RG*#!9Q-G(A,TU)/K<;V(P9.E9/31M/L5X'YMY+4J96
MMV88R0.O,,\[O2F"#0R-&W2<*\5FE.8!K#)+7L"WM=21ZZ\;ZS6NT<6( UL&
M.F6ZK$FN^06J7DD6<V6H-[%)#OTG#\6]*?A&)"2#D2LCO@OME +HN>GZJ2$L
M;Q%I?,OKUJ0KSB%5G:K>>>3QJ*77O5$;8?>6)ON=-] =:WQHZZS=$_L!<76J
M)X?^HH S]3/9YV ]."^@OLB>YLI-X&?3]6Z](8- H&13.07*N7209S65QK([
M).@CV/6T)]5-5VZ3ZCOWYB'3:&=/1P[04,]).ZU.U>]MON52$EJ,@%7RLQ%K
MDE@P^D4_D<J)YU.I"DAD:UO&P!>GT/GO,"%54>[@N!/Q?A\&^]31\TT=(?NK
MJN#^I][2,*>"-)IN:E "22=<%W[$^MQR./U&=KIX\3>XD:O2?I/VOU1_^\OS
MY?+9]TR#R@?66Y?.1>?OZ4MA!0N'4(^=",TFJ*3@:T!RTIS0P(=?")"RU%U3
MQ]-B.9=ZQQEOB!=Z.)J'%(S0H7J:3)#*"H(?XV.BIZO+;"!QU)IYY)NW\%)"
MNLIO]"-!)CJAD*%L!ZNDY8B7V6)0P6;T^@;R=2F7J2V\G"XH**]9QE^#B0$T
M6G)7D8,B4E@6)N]K@"%=>!<O!2,SE*FQ4BZ#Q,OXZH[V=*KBG4&HO&N>S_+I
MJ#88:F1RSP':;%'J&=9AZ-K%IT]S3TI6S /U<];[LTE?\"(?0O3,%8E"F&SU
M:?2'7-+NI3H)I"+NE;=U*K.G/C)3OYZRI>(5&DW^AE5W2&O+ X10\Q/ADQG=
MV2R4G!$QE/,1?V8P*C"^,][8E.^=]7H+OK9,/;YJ=!_?]2.")=*+F.($P/4
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M^I;I2>['K3\'#_V)@0Y9:&R8%'^$O;(]"K1[:/$HHP]RB/,NT2WV7)72Q^.
M"&OKL%P_9-\6J.D@[05J-$E#H)H&U@1L//ZV@$WB_S1L3]U AKU[(_J^\+=C
M"_[L%JZ0W=/N CX+]\[M]'![_\C,0BB+9^X"39/! =YW3;@1AX'3E;^%SK7#
M0/N?2\ZP&] $?%]H+*)F0 MT_Y8X_1-02P,$%     @ YEW<6"!HW9%P!P
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MK2K=UXW@P @MP.\KI>S^@11TE_"7_P502P,$%     @ YEW<6% %-"=I"
MYA8  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULI5A9<^,V$OXK*,65
MM:LX$B]=CNTJ>^(<E<J.:[PS\Y#* T1"$M8DP0"@9>77;W<#I"A9UB2;%UL
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M+[#[8(B0TPAAW3KOD69OHZ>TD7Y^L+FW]KP>N@!K8 ')![VOUO<#&@<&!8?
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M!JL*^B"LX@BLJ8L3P$N<<\0AG9;4'7:@K_[7:9$3"0LT6R3\+AR1JF(G?2H
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MI!4*5OZHS[+RLV':Q(%L N61@!S&L#52V%%8$-%\./GZ,<#I/P(0LOX.P#$
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M[I-3C>=;D+=&YSRIWTE#P2#NZ?[=#(11*!ZH+;0#9PN^G5P\!C7D*.9#1UX
MF'Z78$_'.T6_?.#4M.WA_4#G*7!GT1>Y&V3*T?6"YE1=M)>P#7@CI3.E<KYP
M-#A*2D8#>+7S;),577AH5(]S?2%+&2-;K)31:L<-O)E?>>C U0BF<#2KRQP%
MS'<WG\YT;8')^J9KZB@++^,P(GAV]+6)]Y:F@H-H^-1E>=3[Z%$HM^%/.R0$
ME3-^_^AVNZ]'M_&CR:?C\=/3&^DVNB37K4$Z'I[/!W$D;Q?!5OP)!<-KL 4_
M;E%!E*,#>+^V-K0+$M!]4[OY U!+ P04    " #F7=Q8AS+')$H)  #.&
M&0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6RM66UOVS@2_BN$-[N7 JIM
MR:])DP!IVN(*M+M!T][B<+@/M$3;O%*B2E)Q?+_^GB$E68Z=; K<A\:2.)SW
M>6;(7FRT^6[70CCVD*O"7O;6SI7G@X%-UR+GMJ]+46!EJ4W.'5[-:F!+(WCF
M-^5JD R'TT'.9=&[NO#?;LW5A:Z<DH6X-<Q6><[-]JU0>G/9BWO-AR]RM7;T
M87!U4?*5N!/N6WEK\#9HN60R%X65NF!&+"][U_'YVS'1>X)_2+&QG6=&EBRT
M_DXO'[/+WI 4$DJDCCAP_-R+&Z$4,8(:/VJ>O58D;>P^-]P_>-MARX);<:/5
MGS)SZ\O>O,<RL>25<E_TYN^BMF="_%*MK/_+-H%V!(EI99W.Z\UXSV41?OE#
M[8?.AOGPB0U)O2'Q>@=!7LMWW/&K"Z,WS! UN-&#-]7OAG*RH*#<.8-5B7WN
MZHMPT@AXV;&WHA!+Z>S%P($Q+0_2FLG;P"1Y@DF<L,^Z<&O+WA>9R/89#*!1
MJU;2J/4V>9;C=6GZ;#2,6#),QL_P&[5FCCR_T<O-9/^Z7EAGD!;_/F9QX#<^
MSH]*Y=R6/!67/=2"%>9>]*Y^^R6>#M\\H^VXU7;\'/>7!N6GF;!W^"E$UGQ@
MMXH7^%H96:R86PNV%=PP04%D"(%4B &+* :17[[1><F++;/".04:XEGHXG6*
MZ!NYJ)PV6ZH)+V11"RF]D,66P=F%70KCI?&R-/I!HJZ$VK*3>-:?([^5HE+5
M2U;6=:\72JXX%;"%!D97J[77I*Q,ND8U$NT*GTO&BZ*2;LN\+HBJ98 LQI4"
M=A ZD5 E^4(JZ:2PK(*5)O"J99&B??:Q(!9%C1H;Z8+ 1OE]1[2&P]Z39#Z+
MAL,AD^# +;;I _81VZQENF8;;D'F@J=!MZP4O+"$3EWVO_TR3^+9&]NQX,"Y
M-?..97W:-CI[\W6-Q'Q!>#KJV4:_5-\+ R*K<\$R_+%.IDSDI=);(8@,RXSG
MP0 8@S T"4-%.YSTV0>M /DALZ0-Q)2.$72"J0:&FD8+R];\7N!-% PI2/IU
MXA,TXW .=O(LDQ0:KEC)#=22<-4> U"(K,]@_]%<]'EAN>)&8J6UB2$?[V5&
M#[5'6MW<FCO&83#A?\8TZ0@G-5O_9GW=>"<0%,A4>&6AD$%C\YD);5,$%9Q]
M,K-L5W.*6\>0"I1,5J05M2DDD(*[4(PMYR#-U_-Q?Y.]!W:N=66064>L;*V#
M;=9QRF">ZXI<V9IY:-:3DE&-!6Q%[D/"?U ]':]WBYC7*;ZC7W)IV#U7E2]F
MKSFW0)A0P$3[<SGLM_D @5T#:O8QJE$XPR0B_QM2>.GSU9ZS$]+*P7,6REK?
M@NC/B%VG:957RONJ@= _6MNB'?,3YDLW>8.G>!Z-IG-VT]I[V_KGD(?MK![Q
M7H2/*UEX)(!Q'JU;"2=0,AHF"1#,H3J15*G&G_G9D,W'$RCO*AB+1%P!2]BI
MTM:^8I,1.XVC.!Z]"@1JEQ<EEQDM3B;S5_0[FD]?L:\U#!)HR<)6!H^G\2R:
M3<"A,?HO;$ D.MH_YRG*A>N0"Q^>RI(G? *51DE@.I_.&N.,<)4I6)TJ39[%
M47*6L&02L_>A3LP.V'U0@.RMGO\_-SUCTI,N"F9]J'PR4]E6MEX->-DE/IV.
MH,IU7=1?1*I7A4]VG][490JKE<Q"/@,0"U3X'8V2UF.11/;HY3G[G<JO,H:@
MI]M!7RJK6S9_>-2G_F;$FJH66/>Q2*G-G'[R&7G3E8Q3"0_^IG3=DSB.)LF4
M)AH,%-1$^4.;;0T1HC&<CJ'6$@7QFBAX6P0'_$;1>)JP/_T8+[+7US5X(_VJ
MO QI\,V&;OU.@!^&<7&T@H&G+1"\DS8EES #Z]GO@VLVZ<=#]BO[0N^(\%Y3
MD$6*@Y4-A/3OLS:.*YIJ'%^H\/W6R-?)$"-W766TT5*["#MNL9C$[)^4.>_W
M("_Z6>/(^[?"2)VA]S>6WA"F["#Q20/?/Y0! I0N5J^)Y1/%1WMF_=GDQ4[Q
MW084NA"4:S7(%X+:0*ULTP].I4^M5TP\T"=QT!J6DESW=(=X45O8Q]L3C[@G
M'G-;)QPWG= B3CQJC(?XK<O&U3,PF>33=#(?LFDR]P$YL+$Q#> PH28P XHM
MEQ ;^C8-ZGYH&$?#^*S-]Z\:B77<:0W#4E6661A Y2+NO;.I[.+9+(BY[9B"
M\=X_87!Q8J4-X</AL !GA<'Q6;>. N:SF\!J6\,*)=4//^+?84HR#0;%231#
M)&9 1?D 5]=HTJ$91Q2+9 :&F,II /$/Q.R>QBSJ -,1BX-3[ YF8PSSE&W+
MW21+94A#%$9K:.13: _%Z4OMDA9E_2R/(?'YJ:4#&\%5YT=]\0F14- U_";U
M[XA]X@8%?<-+BDTT C1VP:UYNLMQ(!I\EIFG3#Q=L];\^G0N>#UCQ]%L/#J@
M>9\+LR*'?.;F.QD[&R8'1'OQ"$%X3/))(@BH.56+O(=SI\GL@.[YR#VF?AS'
M8YYH_&AVQ^1N:0(X5)4)]@WE""/N:$!&5_1=,-VRM5"9SWD$U<I5X7N;,Y5U
M(LS^(F0JG>AL#6DY74)A"<E3]RR[RU$))!:>97O:(EK@%3";C@:FU"8T&#]O
MHS[W1!!8X8CJ3V/^H@M#OZ_E,&?;6C+-\#\J3;;4PS48V35V!Q9TKR>QE=]S
MJ2C7^^V=P4UG(@JE_[5S$,99W#LCT':GI^!6?Z"DA+'5 F-+X0 J) ?'\];@
M]DQ&NCX^N(13AN=U>(1!VR).NU/.9JW#@9 [Q[U*U.Z2./*=0PD?KK5!L/)P
M<;4[XX2#)C'P5X?$NSUG.G%,#7\\[-X*Y/P[&'.7KLGB_5$244-5@2G Y=<&
M,3HG25J6R^WCC:PJ:=/HV)9NNPS:OTB!R5'Y^\0+X39TI(9<XCOY:_'(I$HY
M$@O\XW15*?,J;^CW!^N=+N._8MSO9AO6GC#.=Y>3LTFXB"&53\Y&B7^A?&_[
M/.W<0]NQ)R; [;/K]H9!;:/V!N+9>&]WR>)]S_V9]:B27I&]FXO:9%_]7;:@
M?2=2D2_@ME'L[P!H="$C]MS!,DDW(^XG=*!C=W?TV?? L2O,0>>.F<#?WZ13
MC-"9PW5S^[6]K+\.=]0[\G#3CYZ!WF&9$DML'6+VZS$3;L_#B].EO[%>:.=T
M[A_7 "9AB #K2PT$JU](0/M?&%?_ U!+ P04    " #F7=Q8?_??>R@&  !X
M#@  &0   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6RM5VUOVS80_BL';^AL
M@(OU9DE.DP!IVF+%T")HN@W#L ^T3%M<9=(CJ3C^]WM(67:<)FF!]4O,MWMX
M]]QSI_!LH\UG6POAZ&[5*'L^J)U;GX['MJK%BML3O18*.PMM5MQA:I9CNS:"
MSX/1JADG492/5URJP<596+LV%V>Z=8U4XMJ0;5<K;K:O1*,WYX-XT"]\E,O:
M^87QQ=F:+\6-<+^MKPUFXSW*7*Z$LE(K,F)Q/KB,3U]E_GPX\+L4&WMO3#Z2
MF=:?_>3=_'P0>8=$(RKG$3A^;L65:!H/!#?^W6$.]E=ZP_OC'OUMB!VQS+@5
M5[KY0\Y=?3XH!S07"]XV[J/>_")V\4P\7J4;&_[2ICN;3 =4M=;IU<X8'JRD
MZG[YW8Z'>P9E](1!LC-(@M_=1<'+U]SQBS.C-V3\::#Y00@U6,,YJ7Q2;IS!
MKH2=N[@12U#LZ)WJ$@RFSL8.P'Y[7.U 7G4@R1,@<4+OM7*UI3=J+N;' &-X
MM'<KZ=UZE3R+>+DV)Y1&C)(HR9[!2_=AI@$O_4J8'\5:&R?5DOZZG%EG((J_
M'XNW0\L>1_.%<FK7O!+G U2"%>96#"Y>_!#GT<MG?,WVOF;/H7]K2IX%>=S%
M1Y#I4RWH2J_67&U_LH1B-V'=$C>"JH9;*Q=2S$DJI\EM-,U:B[NL)=NAV5-Z
MK5?".ED15W. .V%4 .'-2<#?[S^TI;61JI)KWC1;U)*52V49Y*W:!3+3PG$6
M,*6R#F=@5TF8P:/N+B>J6LF*-[1HC9+>@N%PU;1SGV/KA&C"P8W6<VKX3",Z
M;;94\1D<<6;+8+D25&,?=U6H;]]%L-J(.SEK!-DM4%;8"WVR-7!,]#/74=7-
M9D*A8^X<KL!H"QX(BXVV/I*.BB-VON #2+6L:IBCZUF'?"S(P0KI0GM1:)TS
M*^>2&RDLR7E'14@.?=!.4$R,;KKVZDUO8..YXF#ZLJITJX+TKW4C*X_ P+^^
M!8X-MQQD@.5Y6^%^'XL7CPQ!'Y@%"[*1KD\:PZ_CLH$K0BT1DD!>ERS$X4P;
M&G!'#)#_04/V.4;/#QI8&+T*]Z\;KE27-^QAR>AV62/)-KB]XW4EK?\B^!6$
MN,^I] P'=GMMH;J5Y=5!S494VJ _$7>D? $TWIV%]-X8> V RZ;Q2A>FZKA
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MK4&J\D.X4F1'VA\+NW11NP![OU:*=H9+T*_Q]!=02P,$%     @ YEW<6)M
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MNZ"H#B-M7CN7A;R@:>%T%\6)S&FY7-:]1JC< %+]CN!75&8\>QLHS&9D2>\
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M>NRNI#Q*;D/Q69.K'^)K5/1AOK8ZZD$']#I<E E#/MK1T\8/&7@GMD:X^6B
MG.Q6%,!N238:*F@?[Z;7[*819>ZDX9"H:B3(Q;%AP=P+4Y_^@GC.9L]COW.-
MM^@LN#&L,OM0X\0["R(6QUZ ZZ+G0;^@C<0D]L(H9DG@14G*;L%@%&994S6E
MRR YH$FR+A4]0UFS=(:TH[2S)#EA[] 3ZE%+/2&H27Q&+XD7^^&8,\P'9YB/
M.L,;+C3[Q,L&V&\"--?9ZM'Y[C7Z;)=';@5?8!*U6&0.N<2X@H<]2JTKR=V1
M2OP-CO&7JJJY?/P50Y70K!V:U1X:@5 *(3$Z!%J:;[&56VRL FX:##ERG!U)
M=):B4M!HW?N!5'+;@8>D-G.C _;^UA9J-]<YV;-=YSLY;T=O80TE"[K_L/N/
M.G=X,\#M3/F@N7-$0YI;Q"LH<_)KQ//\:\-+/,Y0LD9[X#&R]13R!..R ]+N
MS9(9_C_])0V#\,7>6SOF2@L:05-Z&PQ0H)DP.H3$$9=@ZN&,A')[&0%6G/DW
MK78K6\UM[ZY>K$AQN+/9'6=A[WZXK?!D3UCD^?[9@9X>QH]G.K;^!V("_S@Q
M-/;OB(EFZ3>M+3&MYK9WGY@XB?XK8D+,?/Z!GN^).3:3-O2P#79&%S"+/\/L
M1OW8SIN5P HN9%8V.1ELC6<;EQ6[7"!<D//%0C"K\1IR2LH,],-=E2&+8^+Y
M BX/[1#N=0JXAI:;G#6&?.)KHRAYMXLP08N,$@U>H41=$M3%HTMALJD62"N*
M-RN4@;ED(R'WNA1UD.(#*C%OH3!,7-D!;SEUI%"9WDMZM!S(=,PJ!T7('(]&
M.?747%O4A?:VYE<J1G0,ZT^[;?Y4N(2.1QKA8I*T0K>GW 5(*##KGH[4F'2H
M,>EH"?BP?PQ'(]U@RLT(\"M1-F3?S^XV2@>R-:;]);#[UHSO&XLG;TGA>:CT
MC.H]?GK<UB-*_-]>$Q#?HL>7=_@V/3[>X4,7K7!NS_86YGD/_<AQY?-/2^JL
M%'KI_(R>*,&92ZR1\:* S+DSWKBS+TS5!+V[3]U_-&QVQO#Z\//*NG#M]QNZ
M>P(^CYPRICLW^ KTTGVGH#!#!VLO\T/O\"GDNOT"L)W>?D=YR_62TD )!2[U
M3^=X)=#MMXFV857MO@<LE+6J<J\KX!@7- ''"X4AVC5(P?"!Z.H?4$L#!!0
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M0N.+?!* [M=>KUC5^56S498FQ(LU_2E0.P?ZOE7*'A678/SWK'X!4$L#!!0
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M!M>C@0>Z'4*M8U75-/Y:61HCC5G0W$;M F@_5\H>'%>@^Q,D_P!02P,$%
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M<!1T/^]Q]B9E#?!\*Z79_[$.QM/\Q?\ 4$L#!!0    ( .9=W%C8.,"$, 0
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MB:)V!O2_5,KN)\[!<"VO_@)02P,$%     @ YEW<6#57J$<. P  /P@  !D
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MA#E' !N+D\U4=I@@>;28%E8A:*PM=&%E(*]: 6TNMW&6+$D=;7_B3!O@1#M
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M761?8*RA85_KT_R*L0'/YVB65* 9*\OC6,_S@W=-J=XIK(GVH-4*<UD8, B
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ML=(44_V)P44!'L=@8E$M#Q::>PRLY8DO:WEB5,N#BI9BH;G4'BWCART/4E%
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MH']_JBKU\L'LX/!&C.7_ %!+ P04    " #F7=Q8[9F<,ZP"   C"   &0
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MY'Z6HM.3,W2""$-W.:\D9@L9NTKG:M[H9DU>UW5>_BMYC4MQ@0+O'/F>'W;
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M\:*^DNJ)XJ5MTG.N=,NWPUS?XB!,@-Y?<JZ>)Z;OM_\+DK]02P,$%     @
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MM"KT\G^>O0H5]=W+]XZ/GY>W1BKHGFPI[PJ_?#-_R68-=FW69I4[9\B2MF8
M*KKS>WNN9TM<5D3K+2C/KS#/-W->:USW7R*9AM<U4MN!W:_@S3<3TPU>X2CW
MVM<:9XF<"B?>@L/\"L3\TST7L%4XLZ6M^;M'16?0R#.M&G*AHF?F#9W45MZ
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M6R6XJM"2F2KK 0L\FS"Z!ZR(EFC%A>J-RI;5)'DQQH5@\MM$YHG9,]F1?$O
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M+$S+!FD3S/I:"+T+;%?H?@+I'U!+ P04    " #F7=Q8<#X\3J$%  #O)0
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MA?&B_@V@OE"\K%ZCK[A2/*\^;AA-F- &\/V:<_5TH=_,M[_$+/\'4$L#!!0
M   ( .9=W%@?BF^5Y0<  -M1   9    >&PO=V]R:W-H965T<R]S:&5E=#4T
M+GAM;,6<[V_B-AS&_Q6+G::>='>0! )T+5*O2;Q*NUW5'[<7TUX$,! =29AC
M2COMCY\=4H(A->3V2/1%FQ_^?FSS?6H[#TDN5BG_GLT8$^0YGB?996,FQ.*\
MV<Q&,Q:'V:=TP1)Y9I+R.!1RET^;V8*S<)P'Q?.FW6JYS3B,DL;@(C]VRP<7
MZ5+,HX3=<I(MXSCD+Y_9/%U=-JS&ZX&[:#H3ZD!S<+$(I^R>B<?%+9=[S0UE
M',4LR:(T(9Q-+AM7UCEU7!60E_@6L56VM4U45X9I^EWMW(PO&RW5(C9G(Z$0
MH?SSQ*[9?*Y(LAU_%]#&IDX5N+W]2@_RSLO.#,.,7:?S/Z*QF%TV>@TR9I-P
M.1=WZ>I75G2HHWBC=)[EO\FJ*-MJD-$R$VE<!,L6Q%&R_AL^%Q_$5H#5?B/
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MD"7X-CBFQ3<XE+86-][DE.&D O,(DB@M?^'W:B&. )RG'6!4 .,<,+H ,"N
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M%S JBD]T*&V'EH:"7$B65& X01*GY3?^5NEP @">=H!5 :PFP+D"L"N _5*
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MFT/]N)+].S!E(+\O*!7[@9J@_8_ ]#]02P,$%     @ YEW<6,Q.Y%1( P
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MU[&H"N-V1 7HNHB[,/JTPDZ/+8U5&V"%2<]9"<]E;=_KBL!])TF.LP9HLVV
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MT_=;_VJ:7Z=49O+;G8],XAY6D0@6:-*['& 9EOF%2?ZBQ3J[<Y@)K46</:Z
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M< 4T FD$<'\AA-Y-S ?*?TD,_@502P,$%     @ YEW<6)9ZX=(0!   [1(
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M@=?S4 )SLF+JD:__A))0V^#%G$G[&ZW+N8&'XI54/"V-M0<IS8J_Y*448L<
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MK"CN5HH7Q7-[/3'C2O'4/BZ!)"#,!/U]SKG:OI@%JANNX?]02P,$%     @
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M_7?:P#TJ8-267 ^=X-OJ,_P/\D$F>YX]:$2Y7-L(DB90-*Z.$H7MF2U::-R
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M.LN%IA0H3:!H7"VE%!<XHJ5F:7OL#VG-CDO61,[P*&=XZIS1+=E3G6(U2GL
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M*2_7+%RRO#"0OS]FF3C<%"^H3X//_P-02P,$%     @ YEW<6$V=!BDC P
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M4LQ"*;&%\-;LA! Z.XW\NP^&V0DAS$(IM85ZBIOO/'3,0BFUA7HQCV;"<5G
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MJ'?\I-YU^-J7>NWY7N-/03])]7"^MUP??UE^GT2<%Q><TVU%??H+4$L#!!0
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MC?\17+P 4$L! A0#%     @ YEW<6 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #F7=Q8>M:R8^\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ YEW<6,>4KK3A!
MD1(  !@              ("!P!(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( .9=W%BY%$(@" 0  +P-   8              " @=<7
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #F7=Q8\N?!
M8^$$  #>&@  &               @($5'   >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ YEW<6!)_AK[! @  \P@  !@
M ("!+"$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( .9=
MW%AE8)4I40<  )P@   8              " @2,D  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " #F7=Q8Q/B*4^L"  "X"   &
M        @(&J*P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
M  @ YEW<6' Y"G3J!@  3QX  !@              ("!RRX  'AL+W=O<FMS
M:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( .9=W%@!]_!R'AT  "I7   9
M              " @>LU  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L!
M A0#%     @ YEW<6#K],C+V$   (S$  !D              ("!0%,  'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " #F7=Q8D7!'<7\"
M  !X!0  &0              @(%M9   >&PO=V]R:W-H965T<R]S:&5E=#$R
M+GAM;%!+ 0(4 Q0    ( .9=W%C@%\"30 8  *(0   9              "
M@2-G  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ YEW<
M6"!HW9%P!P  M1(  !D              ("!FFT  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " #F7=Q8IG(,NXD)  "0%P  &0
M        @(%!=0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( .9=W%A0!30G:0@  .86   9              " @0%_  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ YEW<6+%GA"<S!P  8A$
M !D              ("!H8<  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " #F7=Q8'CNNU9<#  "7"   &0              @($+CP
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( .9=W%BP;N4G
MLP<  %\3   9              " @=F2  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ YEW<6(<RQR1*"0  SA@  !D
M ("!PYH  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #F
M7=Q8?_??>R@&  !X#@  &0              @(%$I   >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( .9=W%C:'ERN: (  -(%   9
M          " @:.J  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#
M%     @ YEW<6)M ^F%# @  B@8  !D              ("!0JT  'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #F7=Q88?FT8A$"  #=
M!   &0              @(&\KP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM
M;%!+ 0(4 Q0    ( .9=W%AT:F+I_!(  #@[   9              " @02R
M  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ YEW<6*W4
M?5BA!@  +!(  !D              ("!-\4  'AL+W=O<FMS:&5E=',O<VAE
M970R-BYX;6Q02P$"% ,4    " #F7=Q8G\:]?O,"  "'!@  &0
M    @($/S   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M .9=W%B%E<DBC (  ( %   9              " @3G/  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ YEW<6%G&>2/2 @  %08  !D
M             ("!_-$  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " #F7=Q83)ME#&D&  #9#P  &0              @($%U0  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( .9=W%C8.,"$, 0
M *X+   9              " @:7;  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ YEW<6)C!U#S_!   S0H  !D              ("!
M#.   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #F7=Q8
M@GF<250#  "B!P  &0              @(%"Y0  >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( .9=W%@U5ZA'#@,  #\(   9
M      " @<WH  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ YEW<6%)A98=A!@  S1$  !D              ("!$NP  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #F7=Q87=4S0'H$  "P"@
M&0              @(&J\@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( .9=W%C+L0?4]0@  !U#   9              " @5OW  !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ YEW<6.V9G#.L
M @  (P@  !D              ("!AP ! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " #F7=Q8U;I0X?P"  #Z!P  &0
M@(%J P$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( .9=
MW%@P9A@>8 0  ((:   9              " @9T& 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ YEW<6+6VB*R$!0  IB$  !D
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M=#0U+GAM;%!+ 0(4 Q0    ( .9=W%B"-?L#3@(  ! &   9
M  " @>0> 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
MYEW<6' ^/$ZA!0  [R4  !D              ("!:2$! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    " #F7=Q8M.@XMM($  "H%0  &0
M            @(%!)P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( .9=W%CGB)K/#0,  "<+   9              " @4HL 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ YEW<6,L<<4CB P
M>1$  !D              ("!CB\! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    " #F7=Q8]*=#,4D#  "A"P  &0              @(&G
M,P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( .9=W%A*
M Q8!!@0  .0,   9              " @2<W 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ YEW<6 O_"%O@!0  E1D  !D
M     ("!9#L! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .9=W%A%+)8L, 0  #D7   9              "
M@8U5 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ YEW<
M6#MC-)C6 P  T!   !D              ("!]%D! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    " #F7=Q8X)4"*K0$  "3%   &0
M        @($!7@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   ( .9=W%AD/GLU$P0  !T0   9              " @>QB 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ YEW<6,Q.Y%1( P  ;@P
M !D              ("!-F<! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    " #F7=Q8UKT.3_ %  #"&@  &0              @(&U:@$
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( .9=W%AG; E=
M, 0  )X0   9              " @=QP 0!X;"]W;W)K<VAE971S+W-H965T
M-C0N>&UL4$L! A0#%     @ YEW<6)9ZX=(0!   [1(  !D
M ("!0W4! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " #F
M7=Q8C4&@%+@#   B%@  &0              @(&*>0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( .9=W%@9+$47Z @  *=K   9
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M 0!X;"]S='EL97,N>&UL4$L! A0#%     @ YEW<6)>*NQS     $P(   L
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64$L%!@    !- $T $A4  (2> 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>195</ContextCount>
  <ElementCount>405</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statement of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity</Role>
      <ShortName>Consolidated Statement of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statement of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statement of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Long-term Debt and Other Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements</Role>
      <ShortName>Long-term Debt and Other Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Sale-Leaseback Financing Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction</Role>
      <ShortName>Sale-Leaseback Financing Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Stock Options and Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation</Role>
      <ShortName>Stock Options and Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Stockholder's Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockholdersEquity</Role>
      <ShortName>Stockholder's Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Leases, Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingencies</Role>
      <ShortName>Leases, Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Retirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefits</Role>
      <ShortName>Retirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/RevenueRecognition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/Inventories</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Sale-Leaseback Financing Transaction (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables</Role>
      <ShortName>Sale-Leaseback Financing Transaction (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Stock Options and Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables</Role>
      <ShortName>Stock Options and Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Stockholder's Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholder's Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/StockholdersEquity</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Leases, Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables</Role>
      <ShortName>Leases, Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/LeasesCommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Retirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsTables</Role>
      <ShortName>Retirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/RetirementBenefits</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SegmentInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail</Role>
      <ShortName>Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Revenue Recognition - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail</Role>
      <ShortName>Revenue Recognition - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Inventories - Summary of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail</Role>
      <ShortName>Inventories - Summary of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Inventories - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail</Role>
      <ShortName>Inventories - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails</Role>
      <ShortName>Sale-Leaseback Financing Transaction - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails</Role>
      <ShortName>Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Income Taxes - Income Tax Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail</Role>
      <ShortName>Income Taxes - Income Tax Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Reconciliation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Stockholder's Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholder's Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Stockholder's Equity - Share Repurchase Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails</Role>
      <ShortName>Stockholder's Equity - Share Repurchase Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Leases, Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail</Role>
      <ShortName>Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail</Role>
      <ShortName>Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Retirement Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail</Role>
      <ShortName>Retirement Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail</Role>
      <ShortName>Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail</Role>
      <ShortName>Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Segment Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail</Role>
      <ShortName>Segment Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="kequ-20240430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Segment Information - (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationDetail</Role>
      <ShortName>Segment Information - (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SegmentInformationTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy in us-gaap/2023 used in 1 facts was deprecated in us-gaap/2024 as of 2024 and should not be used. kequ-20240430.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="kequ-20240430.htm">kequ-20240430.htm</File>
    <File>kequ-20240430.xsd</File>
    <File>kequ-20240430_cal.xml</File>
    <File>kequ-20240430_def.xml</File>
    <File>kequ-20240430_lab.xml</File>
    <File>kequ-20240430_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="785">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>103
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "kequ-20240430.htm": {
   "nsprefix": "kequ",
   "nsuri": "http://www.kewaunee.com/20240430",
   "dts": {
    "inline": {
     "local": [
      "kequ-20240430.htm"
     ]
    },
    "schema": {
     "local": [
      "kequ-20240430.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "kequ-20240430_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "kequ-20240430_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "kequ-20240430_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kequ-20240430_pre.xml"
     ]
    }
   },
   "keyStandard": 346,
   "keyCustom": 59,
   "axisStandard": 28,
   "axisCustom": 0,
   "memberStandard": 45,
   "memberCustom": 24,
   "hidden": {
    "total": 9,
    "http://fasb.org/us-gaap/2023": 5,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 195,
   "entityCount": 1,
   "segmentCount": 70,
   "elementCount": 702,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 785,
    "http://xbrl.sec.gov/dei/2023": 38,
    "http://xbrl.sec.gov/ecd/2023": 5
   },
   "report": {
    "R1": {
     "role": "http://www.kewaunee.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.kewaunee.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
     "longName": "0000003 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
     "longName": "0000005 - Statement - Consolidated Statement of Stockholders' Equity",
     "shortName": "Consolidated Statement of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical",
     "longName": "0000006 - Statement - Consolidated Statement of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statement of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R7": {
     "role": "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
     "longName": "0000007 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "0000008 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "0000009 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000010 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.kewaunee.com/role/RevenueRecognition",
     "longName": "0000011 - Disclosure - Revenue Recognition",
     "shortName": "Revenue Recognition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.kewaunee.com/role/Inventories",
     "longName": "0000012 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements",
     "longName": "0000013 - Disclosure - Long-term Debt and Other Credit Arrangements",
     "shortName": "Long-term Debt and Other Credit Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction",
     "longName": "0000014 - Disclosure - Sale-Leaseback Financing Transaction",
     "shortName": "Sale-Leaseback Financing Transaction",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SaleLeasebackTransactionDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SaleLeasebackTransactionDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.kewaunee.com/role/IncomeTaxes",
     "longName": "0000015 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation",
     "longName": "0000016 - Disclosure - Stock Options and Share-Based Compensation",
     "shortName": "Stock Options and Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.kewaunee.com/role/StockholdersEquity",
     "longName": "0000017 - Disclosure - Stockholder's Equity",
     "shortName": "Stockholder's Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "longName": "0000018 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingencies",
     "longName": "0000019 - Disclosure - Leases, Commitments and Contingencies",
     "shortName": "Leases, Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.kewaunee.com/role/RetirementBenefits",
     "longName": "0000020 - Disclosure - Retirement Benefits",
     "shortName": "Retirement Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.kewaunee.com/role/SegmentInformation",
     "longName": "0000021 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-139",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.kewaunee.com/role/RevenueRecognitionTables",
     "longName": "9954473 - Disclosure - Revenue Recognition (Tables)",
     "shortName": "Revenue Recognition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.kewaunee.com/role/InventoriesTables",
     "longName": "9954474 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables",
     "longName": "9954475 - Disclosure - Sale-Leaseback Financing Transaction (Tables)",
     "shortName": "Sale-Leaseback Financing Transaction (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.kewaunee.com/role/IncomeTaxesTables",
     "longName": "9954476 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables",
     "longName": "9954477 - Disclosure - Stock Options and Share-Based Compensation (Tables)",
     "shortName": "Stock Options and Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.kewaunee.com/role/StockholdersEquityTables",
     "longName": "9954478 - Disclosure - Stockholder's Equity (Tables)",
     "shortName": "Stockholder's Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "longName": "9954479 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables",
     "longName": "9954480 - Disclosure - Leases, Commitments and Contingencies (Tables)",
     "shortName": "Leases, Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsTables",
     "longName": "9954481 - Disclosure - Retirement Benefits (Tables)",
     "shortName": "Retirement Benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.kewaunee.com/role/SegmentInformationTables",
     "longName": "9954482 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:AssetImpairmentCharges",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails",
     "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)",
     "shortName": "Summary of Significant Accounting Policies - Cash Equivalents Table (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail",
     "longName": "9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail",
     "longName": "9954486 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail",
     "longName": "9954487 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DerivativeAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail",
     "longName": "9954488 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
     "longName": "9954489 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)",
     "shortName": "Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-80",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
     "longName": "9954490 - Disclosure - Revenue Recognition - Additional Information (Detail)",
     "shortName": "Revenue Recognition - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:ContractWithCustomerLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail",
     "longName": "9954491 - Disclosure - Inventories - Summary of Inventories (Detail)",
     "shortName": "Inventories - Summary of Inventories (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
     "longName": "9954492 - Disclosure - Inventories - Additional Information (Detail)",
     "shortName": "Inventories - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-95",
      "name": "us-gaap:FIFOInventoryAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-95",
      "name": "us-gaap:FIFOInventoryAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
     "longName": "9954493 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)",
     "shortName": "Long-term Debt and Other Credit Arrangements - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-101",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
     "longName": "9954494 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)",
     "shortName": "Sale-Leaseback Financing Transaction - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "kequ:FinancingLiabilityTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "kequ:FinancingLiabilityNumberOfRenewalOptions",
      "unitRef": "renewaloption",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails",
     "longName": "9954495 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)",
     "shortName": "Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "kequ:FinancingLiabilityToBePaidYearOne",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "kequ:FinancingLiabilityToBePaidYearOne",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
     "longName": "9954496 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "kequ:DeferredTaxAssetsSection174REAddback",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "kequ:FederalStateAndLocalTaxReturnsPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
     "longName": "9954497 - Disclosure - Income Taxes - Income Tax Expense (Detail)",
     "shortName": "Income Taxes - Income Tax Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail",
     "longName": "9954498 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)",
     "shortName": "Income Taxes - Schedule of Income Tax Reconciliation (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
     "longName": "9954499 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)",
     "shortName": "Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
     "longName": "9954500 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)",
     "shortName": "Stock Options and Share-Based Compensation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-116",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
     "longName": "9954501 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)",
     "shortName": "Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-124",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail",
     "longName": "9954502 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)",
     "shortName": "Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
     "longName": "9954503 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)",
     "shortName": "Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails",
     "longName": "9954504 - Disclosure - Stockholder's Equity - Narrative (Details)",
     "shortName": "Stockholder's Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-130",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails",
     "longName": "9954505 - Disclosure - Stockholder's Equity - Share Repurchase Activity (Details)",
     "shortName": "Stockholder's Equity - Share Repurchase Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
     "longName": "9954506 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail",
     "longName": "9954507 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Leases, Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-1",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails",
     "longName": "9954508 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)",
     "shortName": "Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
     "longName": "9954509 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)",
     "shortName": "Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail",
     "longName": "9954510 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)",
     "shortName": "Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
     "longName": "9954511 - Disclosure - Retirement Benefits - Additional Information (Detail)",
     "shortName": "Retirement Benefits - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "kequ:DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "kequ:DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail",
     "longName": "9954512 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)",
     "shortName": "Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-20",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
     "longName": "9954513 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)",
     "shortName": "Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-68",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail",
     "longName": "9954514 - Disclosure - Segment Information - Additional Information (Detail)",
     "shortName": "Segment Information - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.kewaunee.com/role/SegmentInformationDetail",
     "longName": "9954515 - Disclosure - Segment Information - (Detail)",
     "shortName": "Segment Information - (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "kequ:RevenuesIncludingIntersegmentMarkup",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kequ-20240430.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r804"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables, less allowance: $588 (2024); $476 (2023)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322"
     ]
    },
    "kequ_AccruedEmployeeBenefitPlanCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "AccruedEmployeeBenefitPlanCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued pension and deferred compensation costs",
        "label": "Accrued Employee Benefit Plan Costs",
        "documentation": "Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum Pension Liability Adjustment",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r19",
      "r44",
      "r904",
      "r905",
      "r906"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r224",
      "r618"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After-tax actuarial loss",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r44",
      "r931"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r141",
      "r228",
      "r613",
      "r647",
      "r648"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r19",
      "r44",
      "r557",
      "r560",
      "r591",
      "r643",
      "r644",
      "r904",
      "r905",
      "r906",
      "r911",
      "r912",
      "r913"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation Adjustment",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r19",
      "r44",
      "r242",
      "r243",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r904"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r512",
      "r513",
      "r514",
      "r658",
      "r911",
      "r912",
      "r913",
      "r972",
      "r997"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r480"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net earnings to net cash used by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r839",
      "r849",
      "r875"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r830",
      "r842",
      "r852",
      "r878"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r843",
      "r853",
      "r870",
      "r879",
      "r883",
      "r891"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r519"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for receivables",
        "periodStartLabel": "Balance at beginning of year",
        "periodEndLabel": "Balance at end of year",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r323",
      "r327"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Write-offs, net",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive options exclude from computation of earning per share",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property plant and equipment impairment charges",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r65"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "verboseLabel": "Segment assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r226",
      "r260",
      "r290",
      "r305",
      "r311",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r550",
      "r554",
      "r568",
      "r609",
      "r691",
      "r804",
      "r816",
      "r921",
      "r922",
      "r982"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r232",
      "r260",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r550",
      "r554",
      "r568",
      "r804",
      "r921",
      "r922",
      "r982"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsHeldInTrust": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsHeldInTrust",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held in trust account for non-qualified benefit plans included in other assets",
        "label": "Asset, Held-in-Trust",
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations."
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "us-gaap_AssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net assets",
        "label": "Net Assets",
        "documentation": "Amount of net assets (liabilities)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "kequ_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108"
     ]
    },
    "us-gaap_BuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingImprovementsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building and improvements",
        "label": "Building Improvements [Member]",
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r222",
      "r763"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r172"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Year",
        "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Year",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r147",
      "r256"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase in Cash, Cash Equivalents and Restricted Cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r147"
     ]
    },
    "us-gaap_CashSurrenderValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashSurrenderValueMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Surrender Value of Life Insurance Policies",
        "label": "Cash Surrender Value [Member]",
        "documentation": "Cash that could be realized under a life insurance contract or contracts owned by the Company (for example, but not limited to corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI))."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashSurrenderValueOfLifeInsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash surrender value of life insurance policies included in other assets",
        "label": "Cash Surrender Value of Life Insurance",
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Treasury Stock [Table]",
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r80"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies (Note 10)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r119",
      "r611",
      "r678"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases, Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r345",
      "r346",
      "r747",
      "r919"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r807",
      "r808",
      "r810",
      "r811",
      "r812",
      "r813",
      "r911",
      "r912",
      "r972",
      "r994",
      "r997"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in USD per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r679"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r130",
      "r679",
      "r697",
      "r997",
      "r998"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r612",
      "r804"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets (liabilities) classified in the balance sheet:",
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income attributable to Kewaunee Scientific Corporation",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r237",
      "r239",
      "r248",
      "r604",
      "r627"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less comprehensive income attributable to the non-controlling interest",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r99",
      "r106",
      "r237",
      "r239",
      "r247",
      "r603",
      "r626"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income, net of tax",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r169",
      "r237",
      "r239",
      "r246",
      "r602",
      "r625"
     ]
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r245",
      "r601",
      "r624"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r113",
      "r114",
      "r319",
      "r746"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r113",
      "r114",
      "r319",
      "r649",
      "r746"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r113",
      "r114",
      "r319",
      "r746",
      "r899"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Concentration",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r189"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r113",
      "r114",
      "r319"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r56",
      "r113",
      "r114",
      "r319",
      "r746"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r550",
      "r551",
      "r554",
      "r555",
      "r592",
      "r757",
      "r920",
      "r923",
      "r924"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r550",
      "r551",
      "r554",
      "r555",
      "r592",
      "r757",
      "r920",
      "r923",
      "r924"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r292",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r313",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r360",
      "r362",
      "r363",
      "r921",
      "r922"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r292",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r313",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r358",
      "r360",
      "r362",
      "r363",
      "r921",
      "r922"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r770"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r103"
     ]
    },
    "us-gaap_ConstructionContractorReceivableRetainage": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionContractorReceivableRetainage",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retainage included in accounts receivable",
        "label": "Construction Contractor, Receivable, Retainage",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer withheld under retainage provision in long-term contract or program when right to consideration is unconditional."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r598"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unbilled receivables",
        "terseLabel": "Contract assets in accounts receivable",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r407",
      "r426"
     ]
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerDurationAxis",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Duration [Axis]",
        "label": "Contract with Customer, Duration [Axis]",
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts."
       }
      }
     },
     "auth_ref": [
      "r790",
      "r927"
     ]
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerDurationDomain",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Duration [Domain]",
        "label": "Contract with Customer, Duration [Domain]",
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts."
       }
      }
     },
     "auth_ref": [
      "r790",
      "r927"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r426"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r426"
     ]
    },
    "kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedPercentage",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liability recognized as revenue percentage",
        "label": "Contract with Customer, Liability, Revenue Recognized Percentage",
        "documentation": "Contract with customer, liability, revenue recognized percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r304",
      "r305",
      "r306",
      "r307",
      "r313",
      "r916"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of products sold",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r600"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_CreditAgreementMidCapFundingIVTrustMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "CreditAgreementMidCapFundingIVTrustMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Agreement, Mid Cap Funding IV Trust",
        "label": "Credit Agreement, Mid Cap Funding IV Trust [Member]",
        "documentation": "Credit Agreement, Mid Cap Funding IV Trust"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r910",
      "r968"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r910"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r539",
      "r545",
      "r910"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax (benefit) expense:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r910",
      "r968"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r319"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt and Other Credit Arrangements",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r258",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r381",
      "r388",
      "r389",
      "r391"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r124",
      "r125",
      "r174",
      "r176",
      "r262",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r579",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r908"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, variable interest rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r390",
      "r579",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r908"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r262",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r579",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r908"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date, Period Four",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date, Period One",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date, Period Three",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date, Period Two",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r73",
      "r76",
      "r115",
      "r116",
      "r118",
      "r120",
      "r157",
      "r158",
      "r262",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r390",
      "r579",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r908"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r910",
      "r967",
      "r968"
     ]
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs on financing liability",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r926"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r910",
      "r967"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "verboseLabel": "Deferred tax assets, non-current",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax (benefit) expense",
        "negatedTerseLabel": "Deferred income tax benefit",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r168",
      "r194",
      "r544",
      "r545",
      "r910"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax (benefit) expense:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for deferred income taxes",
        "label": "Deferred Income Tax Expense Benefit Net Of Rate Adjustment",
        "documentation": "Deferred income tax expense benefit net of rate adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r175",
      "r533"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "negatedLabel": "Deferred tax liabilities, non-current",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527",
      "r610"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r910",
      "r967",
      "r968"
     ]
    },
    "kequ_DeferredTaxAssetLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxAssetLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Asset, Lease Liability",
        "documentation": "Deferred Tax Asset, Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory reserves and capitalized costs",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "kequ_DeferredTaxAssetsProceedsOnSaleLeaseback": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxAssetsProceedsOnSaleLeaseback",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds on Sale Leaseback",
        "label": "Deferred Tax Assets, Proceeds on Sale Leaseback",
        "documentation": "Deferred Tax Assets, Proceeds on Sale Leaseback"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DeferredTaxAssetsSection174REAddback": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxAssetsSection174REAddback",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax asset, Section 174 addback",
        "terseLabel": "Section 174 R&amp;E Addback",
        "label": "Deferred Tax Assets, Section 174 R&amp;E Addback",
        "documentation": "Deferred Tax Assets, Section 174 R&amp;E Addback"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits (state, net of federal benefits)",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign tax credit carryforwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued employee benefit expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized actuarial loss, defined benefit plans",
        "negatedLabel": "Deferred tax benefit",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset valuation allowance",
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r965"
     ]
    },
    "kequ_DeferredTaxLiabilitiesAPB23Assertion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxLiabilitiesAPB23Assertion",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "APB 23 Assertion",
        "label": "Deferred Tax Liabilities, APB 23 Assertion",
        "documentation": "Deferred Tax Liabilities, APB 23 Assertion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt Issuance Cost on Sale Leaseback",
        "label": "Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right of use assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "kequ_DeferredTaxLiabilitiesPrepaidPensionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxLiabilitiesPrepaidPensionCost",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid pension",
        "label": "Deferred Tax Liabilities Prepaid Pension Cost",
        "documentation": "Deferred Tax Liabilities Prepaid Pension Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Book basis in excess of tax basis of property, plant and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r966"
     ]
    },
    "kequ_DeferredTaxLiabilitiesSaleLeasebackProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DeferredTaxLiabilitiesSaleLeasebackProperty",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Book basis in excess of tax basis of Sale Leaseback property",
        "label": "Deferred Tax Liabilities, Sale Leaseback Property",
        "documentation": "Deferred Tax Liabilities, Sale Leaseback Property"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-current liabilities",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r126",
      "r160"
     ]
    },
    "us-gaap_DefinedBenefitPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Postretirement benefit plans",
        "label": "Defined Benefit Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Benefit Obligation, April 30",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net actual loss",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r44",
      "r931"
     ]
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual return on plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r795"
     ]
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Actuarial gain (loss)",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": "kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognition of net loss",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r455",
      "r469",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts Recognized in the Consolidated Balance Sheets consist of:",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAssetsTransferredToFromPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssetsTransferredToFromPlan",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transfer to insurer",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan",
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from assets transferred into (from) plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected long-term return on plan assets (as a percent)",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r472"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Projected benefit obligations, beginning of year",
        "periodEndLabel": "Projected benefit obligations, end of year",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Actual benefits paid",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r475"
     ]
    },
    "kequ_DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan remaining pension plan liabilities",
        "label": "Defined Benefit Plan, Benefit Obligation, Remaining Pension Plan Liabilities",
        "documentation": "Defined Benefit Plan, Benefit Obligation, Remaining Pension Plan Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "documentation": "Information by defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r460",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested."
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Projected Benefit Obligations",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Plan Assets",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r445",
      "r471",
      "r793",
      "r794",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DefinedBenefitPlanEmergingMarketsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedBenefitPlanEmergingMarketsMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Markets",
        "label": "Defined Benefit Plan, Emerging Markets [Member]",
        "documentation": "Defined Benefit Plan, Emerging Markets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Securities",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r795"
     ]
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r794",
      "r795"
     ]
    },
    "kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Small/Mid Cap",
        "label": "Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]",
        "documentation": "Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanEquitySecuritiesUsLargeCapMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Large Cap",
        "label": "Defined Benefit Plan, Equity Securities, US, Large Cap [Member]",
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r930"
     ]
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": "kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expected return on plan assets",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r454",
      "r468",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value of plan assets, beginning of year",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "terseLabel": "Defined benefit plan, Plan asset",
        "verboseLabel": "Fair value of plan assets",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r443",
      "r445",
      "r446",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Funded status\u2014under",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r441",
      "r795"
     ]
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanInterestCost",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": "kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest cost",
        "label": "Defined Benefit Plan, Interest Cost",
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r434",
      "r453",
      "r467",
      "r795",
      "r796"
     ]
    },
    "kequ_DefinedBenefitPlanLiquidAlternativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedBenefitPlanLiquidAlternativesMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquid Alternatives",
        "label": "Defined Benefit Plan, Liquid Alternatives [Member]",
        "documentation": "Defined Benefit Plan, Liquid Alternatives [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net periodic pension expense plus special events",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r466",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes amortization of gain (loss) component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r466"
     ]
    },
    "kequ_DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net periodic pension expense",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Excluding Settlement Cost Component",
        "documentation": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Excluding Settlement Cost Component"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r466"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r466"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes settlement and curtailment gain (loss) component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r935"
     ]
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes settlement gain (loss) component of net periodic benefit (cost) credit for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r466"
     ]
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Actual benefits paid",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r936"
     ]
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Effect of settlement",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r456",
      "r470"
     ]
    },
    "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanSettlementsBenefitObligation",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transfer to insurer",
        "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement",
        "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plan, Plan asset percentage",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan."
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average Assumptions Used to Determine Benefit Obligations at April 30",
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30",
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Age limit of employees to be eligible for contribution (in years)",
        "label": "Defined Contribution Plan Age Limit Of Employees To Be Eligible For Catch Up Contributions",
        "documentation": "Defined contribution plan age limit of employees to be eligible for catch up contributions."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DefinedContributionPlanEligibilityMinimumServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedContributionPlanEligibilityMinimumServicePeriod",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum service period of employees to be eligible for contribution (in months)",
        "label": "Defined Contribution Plan Eligibility Minimum Service Period",
        "documentation": "Defined contribution plan eligibility minimum service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions by employer per employee's compensation (as a percent)",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee's compensation (as a percent)",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DefinedContributionPlanEmployerMatchingContributionsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedContributionPlanEmployerMatchingContributionsAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contributions",
        "label": "Defined Contribution Plan, Employer Matching Contributions, Amount",
        "documentation": "Defined Contribution Plan, Employer Matching Contributions, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Matching contributions by company (as a percent)",
        "label": "Defined Contribution Plan Employer Matching Percent Of Employee Contribution",
        "documentation": "Defined contribution plan employer matching percent of employee contribution."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee's compensation (as a percent)",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r66"
     ]
    },
    "kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "documentation": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r567",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r685",
      "r686",
      "r730",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r769",
      "r808",
      "r995"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Liabilities",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r567",
      "r660",
      "r661",
      "r662",
      "r663",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r692",
      "r694",
      "r695",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r769",
      "r995"
     ]
    },
    "kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "documentation": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of RSU Activity and Weighted Average Exercise Price",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r87"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835",
      "r871"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference [Text Block]",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "kequ_DomesticOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "DomesticOperationsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic",
        "label": "Domestic Operations [Member]",
        "documentation": "Domestic operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net earnings per share attributable to Kewaunee Scientific Corporation stockholders",
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r276",
      "r278",
      "r280",
      "r281",
      "r282",
      "r284",
      "r564",
      "r565",
      "r605",
      "r628",
      "r772"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r278",
      "r280",
      "r281",
      "r282",
      "r284",
      "r564",
      "r565",
      "r605",
      "r628",
      "r772"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, net",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "kequ_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes on unremitted earnings",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Taxes On Unremitted Earnings",
        "documentation": "Effective Income Tax Rate Reconciliation, Change in Deferred Taxes On Unremitted Earnings"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Effect of pension settlement",
        "label": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Return to provision adjustment",
        "label": "Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation and amounts withheld",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining estimated compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityClassOfTreasuryStockLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r215",
      "r241",
      "r242",
      "r243",
      "r263",
      "r264",
      "r265",
      "r267",
      "r273",
      "r275",
      "r285",
      "r325",
      "r326",
      "r404",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r563",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r591",
      "r643",
      "r644",
      "r645",
      "r658",
      "r718"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r839",
      "r849",
      "r875"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r836",
      "r846",
      "r872"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "us-gaap_FIFOInventoryAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FIFOInventoryAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories measured using FIFO method",
        "label": "FIFO Inventory Amount",
        "documentation": "The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods."
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy for Assets and Liabilities",
        "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r171"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r111",
      "r112"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r566",
      "r593",
      "r594",
      "r595",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a01",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r445",
      "r450",
      "r566",
      "r593",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r445",
      "r450",
      "r566",
      "r594",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r566",
      "r595",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r593",
      "r594",
      "r595",
      "r781",
      "r782",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r28"
     ]
    },
    "kequ_FederalStateAndLocalTaxReturnsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FederalStateAndLocalTaxReturnsPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal, state and local tax returns period (in years)",
        "label": "Federal, state and local tax returns period",
        "documentation": "Federal, state and local tax returns period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of financing lease liabilities",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finance Lease Maturity",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term portion of financing lease liabilities",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Minimum Lease Payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Imputed Interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, weighted average discount rate (as a percent)",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r803"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, weighted average remaining lease term (in years)",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r803"
     ]
    },
    "kequ_FinancingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Financing liability",
        "terseLabel": "Total",
        "label": "Financing Liability",
        "documentation": "Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Liability [Abstract]",
        "documentation": "Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityAnnualIncreasePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityAnnualIncreasePercent",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual rental increase, as a percent",
        "label": "Financing Liability, Annual Increase, Percent",
        "documentation": "Financing Liability, Annual Increase, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityBasicMonthlyPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityBasicMonthlyPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial basic monthly rent",
        "label": "Financing Liability, Basic Monthly Payment",
        "documentation": "Financing Liability, Basic Monthly Payment"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of financing liability",
        "label": "Financing Liability, Current",
        "documentation": "Financing Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Liability [Line Items]",
        "label": "Financing Liability [Line Items]",
        "documentation": "Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term portion of financing liability",
        "label": "Financing Liability, Noncurrent",
        "documentation": "Financing Liability, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityNumberOfRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityNumberOfRenewalOptions",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of renewal options",
        "label": "Financing Liability, Number of Renewal Options",
        "documentation": "Financing Liability, Number of Renewal Options"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityRenewalTerm",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal term",
        "label": "Financing Liability, Renewal Term",
        "documentation": "Financing Liability, Renewal Term"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityTable",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Liability [Table]",
        "label": "Financing Liability [Table]",
        "documentation": "Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityTermOfContract",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of agreement",
        "label": "Financing Liability, Term of Contract",
        "documentation": "Financing Liability, Term of Contract"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaid",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Minimum Liability Payments",
        "label": "Financing Liability, to be Paid",
        "documentation": "Financing Liability, to be Paid"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Financing Liability, to be Paid, After Year Five",
        "documentation": "Financing Liability, to be Paid, After Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Financing Liability, to be Paid, Year Five",
        "documentation": "Financing Liability, to be Paid, Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Financing Liability, to be Paid, Year Four",
        "documentation": "Financing Liability, to be Paid, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidYearOne",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Financing Liability, to be Paid, Year One",
        "documentation": "Financing Liability, to be Paid, Year One"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Financing Liability, to be Paid, Year Three",
        "documentation": "Financing Liability, to be Paid, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityToBePaidYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityToBePaidYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Financing Liability, to be Paid, Year Two",
        "documentation": "Financing Liability, to be Paid, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FinancingLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FinancingLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Imputed Interest",
        "label": "Financing Liability, Undiscounted Excess Amount",
        "documentation": "Financing Liability, Undiscounted Excess Amount"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_FiscalYearTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "FiscalYearTwoThousandTwentyFourMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiscal Year 2024",
        "label": "Fiscal Year Two Thousand Twenty Four [Member]",
        "documentation": "Fiscal Year Two Thousand Twenty Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FixedIncomeSecuritiesMember",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fixed Income Securities",
        "terseLabel": "Fixed Income",
        "label": "Fixed Income Securities [Member]",
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r806",
      "r807",
      "r930"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "kequ_ForeignSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ForeignSubsidiariesMember",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International Subsidiaries",
        "label": "Foreign Subsidiaries [Member]",
        "documentation": "Foreign Subsidiaries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_ForeignSubsidiariesTaxReturnsPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ForeignSubsidiariesTaxReturnsPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign subsidiaries tax returns period (in years)",
        "label": "Foreign subsidiaries tax returns period",
        "documentation": "Foreign subsidiaries tax returns period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r879"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r879"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r879"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r879"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r879"
     ]
    },
    "us-gaap_GeographicDistributionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionAxis",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Axis]",
        "label": "Geographic Distribution [Axis]",
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r606",
      "r607",
      "r776"
     ]
    },
    "us-gaap_GeographicDistributionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionDomain",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Distribution [Domain]",
        "label": "Geographic Distribution [Domain]",
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r606",
      "r607"
     ]
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionDomesticMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic",
        "label": "Geographic Distribution, Domestic [Member]",
        "documentation": "Allocation of business activity identified as domestic."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r777"
     ]
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicDistributionForeignMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Geographic Distribution, Foreign [Member]",
        "documentation": "Allocation of business activity identified as foreign."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r606",
      "r607",
      "r778"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r260",
      "r290",
      "r304",
      "r310",
      "r313",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r568",
      "r774",
      "r921"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank Guarantees outstanding to customers",
        "label": "Guarantor Obligations, Current Carrying Value",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r822",
      "r835"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings before income taxes",
        "terseLabel": "Earnings (loss) before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r142",
      "r179",
      "r290",
      "r304",
      "r310",
      "r313",
      "r607",
      "r620",
      "r774"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r523",
      "r530",
      "r531",
      "r537",
      "r542",
      "r546",
      "r547",
      "r548",
      "r655"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax (benefit) expense",
        "totalLabel": "Net income tax (benefit) expense",
        "terseLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r195",
      "r274",
      "r275",
      "r298",
      "r528",
      "r543",
      "r630"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r524",
      "r525",
      "r531",
      "r532",
      "r536",
      "r538",
      "r651"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Impact of foreign subsidiary income to parent",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of differing US and foreign tax rates",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense at statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other items, net",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local taxes, net of federal income tax benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxCredits",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "kequ_IncomeTaxesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "IncomeTaxesLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "documentation": "Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "kequ_IncomeTaxesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "IncomeTaxesTable",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "documentation": "Income Taxes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receivables",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r834",
      "r843",
      "r853",
      "r870",
      "r879",
      "r883",
      "r891"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r895"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r895"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r895"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r181",
      "r244",
      "r294",
      "r578",
      "r703",
      "r814",
      "r996"
     ]
    },
    "kequ_InterestExpenseFinancingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "InterestExpenseFinancingLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense on financing liability",
        "label": "Interest Expense, Financing Liability",
        "documentation": "Interest Expense, Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r254",
      "r255"
     ]
    },
    "kequ_InternationalOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "InternationalOperationsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "International Operations [Member]",
        "documentation": "International operations."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_InternationalSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "InternationalSubsidiariesMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International Subsidiaries",
        "label": "International Subsidiaries [Member]",
        "documentation": "International Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment revenues",
        "label": "Intersegment Eliminations [Member]",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r309",
      "r313"
     ]
    },
    "us-gaap_InventoryCurrentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryCurrentTable",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Current [Table]",
        "label": "Inventory, Current [Table]",
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Disclosure [Abstract]",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r766"
     ]
    },
    "us-gaap_InventoryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory [Line Items]",
        "label": "Inventory [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r764",
      "r804"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r221",
      "r230",
      "r330",
      "r331",
      "r332",
      "r599",
      "r771"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Materials and components",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r768"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r767"
     ]
    },
    "kequ_KequipGlobalLabSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KequipGlobalLabSolutionsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kequip Global Lab Solutions Pvt. Ltd.",
        "label": "Kequip Global Lab Solutions [Member]",
        "documentation": "Kequip Global Lab Solutions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_KewauneeLabwayAsiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KewauneeLabwayAsiaMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kewaunee Labway Asia Pte. Ltd.",
        "label": "Kewaunee Labway Asia [Member]",
        "documentation": "Kewaunee Labway Asia [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_KewauneeLabwayIndiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KewauneeLabwayIndiaMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kewaunee Labway India Pvt. Ltd.",
        "label": "Kewaunee Labway India [Member]",
        "documentation": "Kewaunee Labway India [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_KewauneeScientificCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KewauneeScientificCorporationMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kewaunee Scientific Corporation",
        "label": "Kewaunee Scientific Corporation [Member]",
        "documentation": "Kewaunee Scientific Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_KewauneeScientificCorporationSingaporeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KewauneeScientificCorporationSingaporeMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Kewaunee Scientific Corporation Singapore Pte. Ltd.",
        "label": "Kewaunee Scientific Corporation Singapore [Member]",
        "documentation": "Kewaunee Scientific Corporation Singapore [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_KoncepoScientechInternationalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "KoncepoScientechInternationalMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Koncepo Scientech International",
        "label": "Koncepo Scientech International [Member]",
        "documentation": "Koncepo Scientech International."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseDiscountRate",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Lessee, Finance Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of finance lease payments."
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of contract",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "kequ_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease not yet commenced amount",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount",
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Lease Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Minimum Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Imputed Interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "kequ_LesseeOptiontoExtendTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LesseeOptiontoExtendTerm",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to extend, term (in years)",
        "label": "Lessee, Option to Extend, Term",
        "documentation": "Lessee, Option to Extend, Term"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_LesseeOptiontoTerminateTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LesseeOptiontoTerminateTerm",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to terminate, term (in years)",
        "label": "Lessee, Option to Terminate, Term",
        "documentation": "Lessee, Option to Terminate, Term"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_LesseeRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LesseeRemainingLeaseTerm",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease term (in years)",
        "label": "Lessee, Remaining Lease Term",
        "documentation": "Lessee, Remaining Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r260",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r551",
      "r554",
      "r555",
      "r568",
      "r677",
      "r773",
      "r816",
      "r921",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r178",
      "r616",
      "r804",
      "r909",
      "r917",
      "r974"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r220",
      "r260",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r551",
      "r554",
      "r555",
      "r568",
      "r804",
      "r921",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r176",
      "r992"
     ]
    },
    "kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowing availability",
        "label": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option",
        "documentation": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional tranche available, minimum amount",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate at period end",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan agreement",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused and available credit facility",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r69"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r477",
      "r597",
      "r642",
      "r669",
      "r670",
      "r723",
      "r725",
      "r727",
      "r728",
      "r738",
      "r758",
      "r759",
      "r775",
      "r785",
      "r797",
      "r805",
      "r925",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r477",
      "r597",
      "r642",
      "r669",
      "r670",
      "r723",
      "r725",
      "r727",
      "r728",
      "r738",
      "r758",
      "r759",
      "r775",
      "r785",
      "r797",
      "r805",
      "r925",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_MinistryOfFinanceIndiaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinistryOfFinanceIndiaMember",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "India Income Tax Department",
        "label": "Ministry of Finance, India [Member]",
        "documentation": "Designated tax department of the government of India."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r177",
      "r260",
      "r324",
      "r352",
      "r355",
      "r356",
      "r357",
      "r363",
      "r364",
      "r568",
      "r615",
      "r681"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Percentage of controlling interest in subsidiaries",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Financing Activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Investing Activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Operating Activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net earnings attributable to Kewaunee Scientific Corporation",
        "verboseLabel": "Net earnings (loss) attributable to Kewaunee Scientific Corporation",
        "terseLabel": "Net earnings (loss) attributable to Kewaunee Scientific Corporation",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r149",
      "r180",
      "r218",
      "r235",
      "r238",
      "r243",
      "r260",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r274",
      "r275",
      "r279",
      "r290",
      "r304",
      "r310",
      "r313",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r565",
      "r568",
      "r623",
      "r699",
      "r716",
      "r717",
      "r774",
      "r814",
      "r921"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: net earnings attributable to the non-controlling interest",
        "verboseLabel": "Net earnings attributable to non-controlling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r170",
      "r235",
      "r238",
      "r274",
      "r275",
      "r622",
      "r906"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r831",
      "r843",
      "r853",
      "r870",
      "r879"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "kequ_NonQualifiedCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "NonQualifiedCompensationPlanMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non Qualified Compensation Plans",
        "label": "Non Qualified Compensation Plan [Member]",
        "documentation": "Non Qualified Compensation Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-US",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1000",
      "r1001",
      "r1002"
     ]
    },
    "kequ_NumberOfNonqualifiedCompensationPlans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "NumberOfNonqualifiedCompensationPlans",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of non-qualified compensation plans maintained",
        "label": "Number Of Nonqualified Compensation Plans",
        "documentation": "Number of nonqualified compensation plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of business segment",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating earnings",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r304",
      "r310",
      "r313",
      "r774"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term portion of operating lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease payments",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r584"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets",
        "verboseLabel": "ROU assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "kequ_OperatingLeaseShortTermExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "OperatingLeaseShortTermExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, short term, expense",
        "label": "Operating Lease, Short Term, Expense",
        "documentation": "Operating Lease, Short Term, Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, weighted average discount rate (as a percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r803"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, weighted average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r803"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r313"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "kequ_OtherAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "OtherAssetsPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Assets",
        "label": "Other Assets [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income taxes on postretirement benefit plans",
        "terseLabel": "Income taxes on postretirement benefit plans",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement loss included in net income",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r141",
      "r161"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r141"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustments",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r27",
      "r236",
      "r239",
      "r245",
      "r571",
      "r572",
      "r577",
      "r601",
      "r624",
      "r904",
      "r905"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total postretirement benefit plans",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r141"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrecognized actuarial loss on pension obligations",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r141",
      "r161"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income, net",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r700",
      "r739",
      "r740",
      "r741"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentAssetsMember",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other Noncurrent Assets",
        "terseLabel": "Deferred tax assets, non-current",
        "label": "Other Noncurrent Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, net",
        "label": "Other Operating Activities, Cash Flow Statement",
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r841",
      "r851",
      "r877"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r844",
      "r854",
      "r880"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r832",
      "r844",
      "r854",
      "r880"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of Treasury Stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "kequ_PaymentsOnFinancingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "PaymentsOnFinancingLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments on financing liability",
        "label": "Payments On Financing Liability",
        "documentation": "Payments On Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Expenditures for segment assets",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r969",
      "r970",
      "r971"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r442",
      "r444",
      "r450",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r473",
      "r474",
      "r476",
      "r795"
     ]
    },
    "us-gaap_PensionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Pension expense",
        "label": "Pension Cost (Reversal of Cost)",
        "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanAssetCategoriesDomain",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "documentation": "Defined benefit plan asset investment."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r460",
      "r793",
      "r794",
      "r795"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Postemployment Benefits [Abstract]",
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid Expenses and Other Current Assets",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_ProceedsFromFinancingLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ProceedsFromFinancingLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale-leaseback transaction",
        "label": "Proceeds from Financing Liability",
        "documentation": "Proceeds from Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r652"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale agreement for property",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromShortTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from short-term borrowings",
        "label": "Proceeds from Short-Term Debt",
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net earnings",
        "terseLabel": "Net earnings",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r235",
      "r238",
      "r252",
      "r260",
      "r266",
      "r274",
      "r275",
      "r290",
      "r304",
      "r310",
      "r313",
      "r324",
      "r352",
      "r353",
      "r355",
      "r356",
      "r357",
      "r359",
      "r361",
      "r363",
      "r364",
      "r549",
      "r552",
      "r553",
      "r565",
      "r568",
      "r607",
      "r621",
      "r657",
      "r699",
      "r716",
      "r717",
      "r774",
      "r801",
      "r802",
      "r815",
      "r906",
      "r921"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property plant and equipment gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r223",
      "r619"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentImpairment": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentImpairment",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Impairment",
        "label": "Property, Plant and Equipment, Impairment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Net property, plant and equipment",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r608",
      "r619",
      "r804"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r190",
      "r193",
      "r617"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for credit losses",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r328"
     ]
    },
    "kequ_PubliclyAnnouncedProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "PubliclyAnnouncedProgramsMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Publicly Announced Programs",
        "label": "Publicly Announced Programs [Member]",
        "documentation": "Publicly Announced Programs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r442",
      "r477",
      "r507",
      "r508",
      "r509",
      "r596",
      "r597",
      "r642",
      "r669",
      "r670",
      "r723",
      "r725",
      "r727",
      "r728",
      "r738",
      "r758",
      "r759",
      "r775",
      "r785",
      "r797",
      "r805",
      "r808",
      "r918",
      "r925",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r442",
      "r477",
      "r507",
      "r508",
      "r509",
      "r596",
      "r597",
      "r642",
      "r669",
      "r670",
      "r723",
      "r725",
      "r727",
      "r728",
      "r738",
      "r758",
      "r759",
      "r775",
      "r785",
      "r797",
      "r805",
      "r808",
      "r918",
      "r925",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r836",
      "r846",
      "r872"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments on long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r653"
     ]
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfShortTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayments on short-term borrowings",
        "label": "Repayments of Short-Term Debt",
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development costs",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r522",
      "r990"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Experimentation Expenditures",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r837",
      "r847",
      "r873"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r838",
      "r848",
      "r874"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r833",
      "r845",
      "r855",
      "r881"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r222",
      "r256"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_RestrictedStockUnitsRSUsServiceComponentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "RestrictedStockUnitsRSUsServiceComponentMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service Components",
        "label": "Restricted Stock Units (RSUs), Service Component [Member]",
        "documentation": "Restricted Stock Units (RSUs), Service Component"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r159",
      "r614",
      "r646",
      "r648",
      "r654",
      "r680",
      "r804"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r263",
      "r264",
      "r265",
      "r267",
      "r273",
      "r275",
      "r325",
      "r326",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r556",
      "r558",
      "r559",
      "r561",
      "r563",
      "r643",
      "r645",
      "r658",
      "r997"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales",
        "verboseLabel": "Net sales transferred to customers",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r292",
      "r303",
      "r308",
      "r309",
      "r315",
      "r317",
      "r319",
      "r424",
      "r425",
      "r600"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r761"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r427"
     ]
    },
    "kequ_RevenueRecognitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "RevenueRecognitionLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition [Line Items]",
        "label": "Revenue Recognition [Line Items]",
        "documentation": "Revenue Recognition [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_RevenueRecognitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "RevenueRecognitionTable",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition [Table]",
        "label": "Revenue Recognition [Table]",
        "documentation": "Revenue Recognition [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_RevenuesIncludingIntersegmentMarkup": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "RevenuesIncludingIntersegmentMarkup",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment revenues",
        "label": "Revenues Including Intersegment Markup",
        "documentation": "Revenues including intersegment markup."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets obtained under new finance leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r803"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets obtained under new operating leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r803"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "crdr": "credit",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on sale leaseback agreement",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r590",
      "r803"
     ]
    },
    "us-gaap_SaleLeasebackTransactionDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleLeasebackTransactionDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale-Leaseback Financing Transaction",
        "label": "Sale Leaseback Transactions [Text Block]",
        "documentation": "The entire disclosure for sale leaseback transaction. Includes, but is not limited to, terms and conditions of transaction and gain (loss) from transaction."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r589"
     ]
    },
    "us-gaap_SalesRevenueSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueSegmentMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales Revenue, Segment",
        "label": "Revenue, Segment Benchmark [Member]",
        "documentation": "Revenue from specified business segment, when it serves as benchmark in concentration of risk calculation. Includes, but is not limited to, revenue from contract with customer and other sources."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r933",
      "r934"
     ]
    },
    "kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Fair Value Assets in Defined Benefit Pension Plans",
        "label": "Schedule Of Allocation Of Plan Assets Fair Value Hierarchy Table [Text Block]",
        "documentation": "Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Allowance For Doubtful Accounts",
        "label": "Schedule Of Allowance For Doubtful Accounts [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Components of Net Periodic Pension Cost",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Expense",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r83",
      "r84",
      "r85",
      "r86"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Basic to Diluted Weighted Average Shares Outstanding",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Inventories",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r136",
      "r137",
      "r138"
     ]
    },
    "kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Plan Assets by Asset Categories",
        "label": "Schedule Of Plan Assets By Asset Category Table [Text Block]",
        "documentation": "Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Remaining Future Cash Payments for Financing Liability",
        "label": "Schedule of Remaining Future Cash Payments for Financing Liability [Table Text Block]",
        "documentation": "Schedule of Remaining Future Cash Payments for Financing Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock Option Activity and Weighted Average Exercise Price",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r88"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Share Repurchase Activity",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r76",
      "r129",
      "r130",
      "r157",
      "r158",
      "r159"
     ]
    },
    "kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash",
        "label": "Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]",
        "documentation": "Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_SecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r344",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r779",
      "r900",
      "r993"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r662",
      "r665",
      "r667",
      "r724",
      "r726",
      "r729",
      "r742",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r762",
      "r787",
      "r808",
      "r927",
      "r993"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r302",
      "r307",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for issuance (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r495"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of RSUs",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of year (in dollar per shares)",
        "periodEndLabel": "Outstanding at end of year (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r495"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in number of shares reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Period Increase (Decrease)",
        "documentation": "The net total number of shares (or other type of equity) under an equity-based award plan, other than a stock option plan, that were granted, vested and forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in number of shares available under stock option plan (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized under stock option plan (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of year (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of year (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Canceled (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of year (in shares)",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "terseLabel": "Options outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r487"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of\u00a0Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of year (in dollar per shares)",
        "periodEndLabel": "Outstanding at end of year (in dollar per shares)",
        "terseLabel": "Weighted average exercise price (in dollar per shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r487"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollar per shares)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Canceled (in dollar per shares)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Tranche One",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting for Stock Options and Other Equity Awards",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r485",
      "r504",
      "r505",
      "r506",
      "r507",
      "r510",
      "r515",
      "r516",
      "r517",
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price range lower limit (in dollar per shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price range upper limit (in dollar per shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Terms of award (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price (in dollar per shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options and Share-Based Compensation",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r163"
     ]
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term borrowings",
        "label": "Short-Term Debt",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r174",
      "r804",
      "r991"
     ]
    },
    "kequ_SignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "SignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "documentation": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_SignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "SignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "documentation": "Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r257"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r287",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r319",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r779",
      "r900",
      "r993"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r41",
      "r215",
      "r241",
      "r242",
      "r243",
      "r263",
      "r264",
      "r265",
      "r267",
      "r273",
      "r275",
      "r285",
      "r325",
      "r326",
      "r404",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r563",
      "r571",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r591",
      "r643",
      "r644",
      "r645",
      "r658",
      "r718"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r662",
      "r665",
      "r667",
      "r724",
      "r726",
      "r729",
      "r742",
      "r745",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r762",
      "r787",
      "r808",
      "r927",
      "r993"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r285",
      "r600",
      "r650",
      "r659",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r718",
      "r809"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r285",
      "r600",
      "r650",
      "r659",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r698",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r718",
      "r809"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r840",
      "r850",
      "r876"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r129",
      "r130",
      "r159",
      "r491"
     ]
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares authorized to be repurchased (in shares)",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails",
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized to be repurchased",
        "verboseLabel": "Number of Shares that May Yet Be Purchased Under the Plans or Programs",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "totalLabel": "Total Kewaunee Scientific Corporation Stockholders' Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r133",
      "r134",
      "r151",
      "r681",
      "r697",
      "r719",
      "r720",
      "r804",
      "r816",
      "r909",
      "r917",
      "r974",
      "r997"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98",
      "r104",
      "r215",
      "r216",
      "r242",
      "r263",
      "r264",
      "r265",
      "r267",
      "r273",
      "r325",
      "r326",
      "r404",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r563",
      "r571",
      "r573",
      "r577",
      "r591",
      "r644",
      "r645",
      "r656",
      "r681",
      "r697",
      "r719",
      "r720",
      "r743",
      "r815",
      "r909",
      "r917",
      "r974",
      "r997"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholder's Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r259",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r562",
      "r721",
      "r722",
      "r744"
     ]
    },
    "srt_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries",
        "label": "Subsidiaries [Member]"
       }
      }
     },
     "auth_ref": [
      "r932",
      "r979",
      "r980",
      "r981"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Disclosure of Cash Flow Information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "kequ_TaxWithholdingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TaxWithholdingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax withholding expense",
        "label": "Tax Withholding Expense",
        "documentation": "Tax Withholding Expense"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_TermLoanBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TermLoanBMember",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Term Loan B",
        "label": "Term Loan B [Member]",
        "documentation": "Term Loan B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Timing of Transfer of Good or Service [Axis]",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "documentation": "Information by timing of transfer of good or service to customer."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r927"
     ]
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Timing of Transfer of Good or Service [Domain]",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r927"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled Receivables",
        "label": "Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "kequ_TradingSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TradingSecuritiesMember",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Securities Held in Non-Qualified Compensation Plans",
        "label": "Trading Securities [Member]",
        "documentation": "Trading Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferredAtPointInTimeMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Point in Time",
        "label": "Transferred at Point in Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred at point in time."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "us-gaap_TransferredOverTimeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferredOverTimeMember",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over Time",
        "label": "Transferred over Time [Member]",
        "documentation": "Contract with customer in which good or service is transferred over time."
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average Price Paid Per Share (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquityParenthetical",
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails",
      "http://www.kewaunee.com/role/StockholdersEquityShareRepurchaseActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "verboseLabel": "Shares Purchased (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r130",
      "r159"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock in treasury, at cost: 70000 shares (2024); 3 shares (2023)",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r77",
      "r80"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of Treasury Stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r77",
      "r159"
     ]
    },
    "kequ_TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/StockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, value",
        "label": "Treasury Stock, Value Excluding Broker Commissions and Fees, Acquired, Cost Method",
        "documentation": "Treasury Stock, Value Excluding Broker Commissions and Fees, Acquired, Cost Method"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_TwoThousandAndEightPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TwoThousandAndEightPlanMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2008 Plan",
        "label": "Two Thousand And Eight Plan [Member]",
        "documentation": "Two Thousand And Eight Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_TwoThousandSeventeenOmnibusIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TwoThousandSeventeenOmnibusIncentivePlanMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017 Plan",
        "label": "Two Thousand Seventeen Omnibus Incentive Plan [Member]",
        "documentation": "Two thousand seventeen omnibus incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "kequ_TwoThousandTwentyThreeOmnibusIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "TwoThousandTwentyThreeOmnibusIncentivePlanMember",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Thousand Twenty Three Omnibus Incentive Plan",
        "label": "Two Thousand Twenty Three Omnibus Incentive Plan [Member]",
        "documentation": "Two Thousand Tweny Three Omnibus Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "kequ_UnbilledRetainageCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.kewaunee.com/20240430",
     "localname": "UnbilledRetainageCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled retainage included in other assets",
        "verboseLabel": "Contract assets in other assets",
        "label": "Unbilled Retainage, Current",
        "documentation": "Unbilled Retainage, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r187",
      "r188",
      "r191",
      "r192"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of stock options and RSUs (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares outstanding-diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r282"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average number of common shares outstanding",
        "terseLabel": "Weighted average common shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r282"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a),(b),(c)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i),(j),(k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2AA",
   "Subparagraph": "a",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//220/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "45",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//840-40/tableOfContent"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(i)",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(1)(ii)",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(4)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(a)",
   "Subparagraph": "(5)",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1406",
   "Paragraph": "(c)",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//310/tableOfContent"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//330/tableOfContent"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-40/tableOfContent"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-7"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-4"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>104
<FILENAME>0000055529-24-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000055529-24-000021-xbrl.zip
M4$L#!!0    ( .==W%A2HWWR&08  $</   4    8V5R=&EF:6-A=&EO;C,Q
M,2YH=&VM5VU3&S<0_LZOV+HS&9BQ@8/09HQAA@ I;E[(I$P[_:B[V_.IZ$Z.
M=&?'_?5]5CIC8TR&=OHAQ-*M]N799U>KT<W=QP_G.Z.;ZXNK\]$/@P%=V:RM
MN&YHPC4[U7!.Z8+^L.Y>SQ2-ZXP& QRX&]]]N#[/V#6ZT)EJM*V/DV1T$/=W
M1@=!X\[H[>W5GY1.,FNL.^O-2]UP#]M7X]])&3VISWH9C+%;;OIF8?BL5RDW
MT?7 <-$,$ZY.YSIORF%R>'1\VHM^;IH^/$SV_YI.HG=KFJ8JSW4]&31V.CR"
M)C$T_O@+>9>)[:U*>M3H1@Y[HW-.>A3,G_7$?H]*UI.RP>KXIY/.[?/1N]M/
M=^3UWS@$^<YV8>MF()O#9-J<!@R&'01$=/VMU*ENZ#C93["\O/YR-WXWOKRX
M&]]^PIK&?;HK;:4\7>W336L,C<?8BSXOJ"E5,Q2Y9)_&5*H9D^.9YCDRUI3:
M8S6UKB%;TSOK*DH.!^_)%O2>YZJMF>FW3 -Z"9\NK8-L0.$4&H_VZ:WRT(.S
MU8+N:SLWG$^X_TAQ;ME3;1O*$*;2-:EZ06W=N)8! )@3: 2+BBJLG%:&"I5A
MRY&M$'ACHQP$-B1JSMA[Y18B4ZE[AN$UI1Y[.;R!32.Y$",BD&D'\D*LQG&X
MDK,CX)V5Y%OYLSH_9\>=DA!"I;UA)41!KIL2(?HI9\%%43R%;S9'H#.<"P6Q
M!H0@=OP=Q)@*7<,EB6[E0A]P01R?W=IW71?(54@$?F>FS:$38:Z9ZP,B[<R"
M: HO!6*!'NQX@+!SWF_81IIR+9K[(M$:"  W.^68>!\<RI0OJ3!V[I>@.IYH
MWS@%0THVH^-P,\;68>.7WCSQ5^"AU_O@\KJN5S^^.4I^/O4= AVI!7];@)'8
M$BMC4HY#//!/IX;%+C%03(WVI8B+6 7V"0-EG6N?&>M;G!->.FMB8/#/9IQC
MW],N LD9R$1GK[]EI:HG3!?(^)?60"(Y5H/D9)?WPMGD)(^KN-32L.J(J!@@
MH<4:T#%N<48,O<Q2\<A2 4L2Z2;^D)!"#V5/I/;HBCV:*)0'@C\7^RKTOA1?
MIEK_\B-2 RDCBLY25U>V==" Y,^T#YR"&-=!D72F%1O7*>W8J !,5U>KV/H=
MW>6C!C/AC+?HON$"@J'4ZUPKIR4$'>L_5%DMJEHO)1F8Y$/]!@9:SR0-K@F'
MI@HIR5JCI'006/!B5=HX$3M%8.ZRQ>%GRB()<D,!YT+F=!/V%_/A"?HO9U),
MPBH+SR<!F9OAUL)9Y6VMI&B41UZD*0K@RN7+V)$.K5)M=+.0:M]F-Y AX!00
MB&E\)+O654-Q?NM"FK:X4SSX(^TIRZS+@P>AO<;9PB 3^,+3D&.1P>T1T089
M]!3E$9I'MD?7,V7:P 7QA8L"_4W/H,5OZ5,/O>4%Y([+[9TKP"LG04P?.V1J
MV^9Y%UY2?^I!FJ7_%]ONEXT+AM+EU1)(PQ&+<%>'SD8Y&!E-/XU!+N6NZ80O
M6X'Z%SR4VK99UKK@Z%HA;5%;6=]@7R8\*/,9-'UM48?0O?O,D0*8@R ;TIWG
MN)PX#!0R:]0M!#K/]J)?I?(/?4>X%7+$>2B[@$A7$0N,#?=LNNEB0[[_8I">
M16F9EY/_>NN%:2Y?IK2_(H P<AW5%1<$E^UIW-Z)GG3@!]\4NG!CG7\H_; !
MG16&MH;Y.P676G07^9YK.!B4[ )[T-M+^<@/N0R6E.&O+1X5)M"CK;,PA>P-
MX\UV@8E&>ET8SR$@MZ@,K/CGNTN_NV#FK.ZE"F.K"748NF28,Y?3S?/PK-!9
MHWF\"^+PL84T*L=)SP^<>1;*KKGB"/! "^S'7N#1"'Q;X96#QT'LL5VY;AT%
MEWS"S7.!<BX<,M*'CQQ8A###"-OAT8^UH.N9-3.6@JC5I)O%74<\KJ;&+AA?
MYZ6-;%./T"; \[\TC'VX?> /MKQD:-O>9_1(7%[=K'-9:BXP-''62JNEVZY(
MB*X0[)!^Q3N&CM[TZ>CPZ#5V1P?R##L?'<B3;&?T^7QT\P78^!+3PCF6&P_#
M"0]2I/=^D#*@YJ$R<[7P>"&^JE,_/5VJV?Z?/&S#.U<>T/\ 4$L#!!0    (
M .==W%BV.9Z4'@8  %P/   4    8V5R=&EF:6-A=&EO;C,Q,BYH=&VM5]MN
M&S<0??=73%4@L ')MN2X#639@.-+K.;B(!52])&[.ZME32T5<E>*^O4]0ZXL
M698"MVB )")W.)<S9V;(P=WHXX>+O<'=S>7UQ>"G3H>N;5I/N*QHS"4[57%&
MR8+^L.Y!SQ0-RY0Z'1P8#4<?;BY2=I7.=:HJ;<N3;F]P%/?W!D=!X][@[?WU
MGY2,4VNL.V_-"UUQ"]O7PZ^DC!Z7YZT4QM@M-WVU,'S>FB@WUF7'<%[UNSPY
MF^NL*OK=X][)62OZN6GZ^+A[^-=T'+U;TS156:;+<:>RTWX/FL30\.,[\BX5
MVUN5M*C2E1SV1F?<;5$P?]X2^RTJ6(^+"JN37TX;MR\&M_>?1N3UWS@$^<9V
M;LNJ(YO][K0Z"QCT&PB(Z.9[H1-=T4GWL(?EU<V7T?!V>'4Y&MY_PIJ&;22C
M5":CT2&]4RY#/F@XQ'9T>T%5H:H^)+N'-*1"S9@<SS3/D;.JT!ZKJ745V9)N
MK9M0][CSGFQ.[WFNZI*9?D\UP!< Z,HZR 8<SJ"Q=TAOE8<>G)TLZ*&T<\/9
MF-M/%&>6/96VHA2!*EV2*A=4EY6K&1" .X%(L*AH@I73RE"N4FPYLA.$7MDH
M!X$-B9)3]EZYA<A,U /#\)I2C[T,WL"FD6R($1%(M0-](5;B.%S) !D03POR
MM?RS.C]GQXV2$,)$>\-*J()L5P5"]%-.@XNB> K?;(9 9S@72F(-"$'LY >(
M,>6ZA$L2W<J%-N"".#Z[M>^ZS)&KD C\3DV=02?"7#/7!D3:F071%%X*Q *]
M,2L(&^?]AFVD*=.BN2T2M8$ <+-3CHGWP:%4^8)R8^=^":KCL?:54S"D9#,Z
M#C=C; TV?NG-,W\%'GI]2*,GNE[]_*;7_?7,-P@TG!;\;0Y&8DNL#$DY#O'
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M537TZ6G-_X\_^'A__YW?4$L#!!0    ( .==W%C)P"=A:Q,  &D]   7
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M1I^P?Z.^6VWK)N1.(R*"AM-"%D*&#4N: GX^3:F&,BH.2O6"[JJ[,#G?B.I
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M2\) JJ(@Q]YB86$?*,'+.+TDC&)1MM&?#O_9ZD+R!3+/$@ZJ9:$!AMA:R3O
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M"?>"^9?-*>2%<^1>#K9S$5)=P@2D?:^.ZD.%4&=D'HZB*.X_3]8C+\KIO+.
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M4=Y:AM."DK*BU+B:O+HY25WX=^N'!!3["Y/P_(DU%US;)CAS&SWOZIZ=R@:
MJ*>%B3=R<1E&VR2^B\,@B=</L+Z#S39^".--< _1QRA\3.(/$8;Q1+2%S>-V
M]Q@@9;(&=PJ/H]TH',$N"KMD=W+C#"'80;!<;Y)H"=^=/Y]ZX[PR-,DJ@EVP
M?1L\1#M[_?$^^@1!F)@=SW$\%!9S2 7G--5,<+1"EZ!+"B1-1=T0?D1?(>"\
M)15L:2.D!I'#.WH@+:<4=BG#IK*<I1 *B=ND@[DV$"]^G7J>,P][G&[ES@>
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M'HXF[C18J!J>YI43GIHX*LE8I\FHQ5-MU=LB&MI?!_6#HA%T?TM$GL'O>(_
MF_8Z ,9J_&PZS\,)/XO]MWD%\,?F^5KX8_.47?F;A;_: A>J)!E=X/*'I[2@
M]EY2\F3O*3I'9Z0ZD*/"-_4%WZMF?H;Y^3_S$>B^">8S\S=02P,$%     @
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MN>>/;',4NG(<,7&E.Z2.P%"P_U%)\&-4+IUO_T7;O39U_9@H@^DY_C6(>B(
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M:I :C=*%J;[EE/A2R$KIPD7?<@QN*2A0VK#-'UBM&@YFD!N'(I9O15)$H&7
MHAC4U5 ^[3VOO(*UXB"M;L> _9+K939>\Q+#+J)6IE*&-Z/0[V5)AR#/_'OY
M+5!X3_</#8-^G353VH!127>_<4*[OR9;LK1!F\=WG\MKR57^@OW_7A7/&@ZF
MT]6-,UM%?-W!5-KX4L6DI6#2ESJ:2AO;>DF^*T^@HUG> %,9Y'[34E<&GZ59
MVEA8Q2(E">TT2QN$VRB+?'%TXTN9C]YO"><EJL_8#)O946U5NBAC*5BQ+-KJ
MI<R8TD4V2[CAZTQ,-DL;R"S1AC?7N>&EC>&5:,/7JE*V-&R'N7CLF=LN-W1+
MPT\ON]FV/=4XPJA+\W@%>VKVTJ^SI[8T0/,,RKR<';^E-O3ABP>%-A=P/'SQ
M:,9SB0R4:ZY.Y.9^_M2O(W)I?7:*J]_*<1:[0Y'(CS'"]8PL,?^8]> 6P;0=
MAE$&7I*G+GF!EJU24.K%7=IG'_SVNWV=.+ZXX_8%1#Y<G<B'ZTK '9;6H2JS
M.&Z$4B_NB3U;' _7=CJ^N-/S!41N;<($*JU#4F9QW BE7MQ!>5DS86T;T2IM
M*K?,++L12I4VH]I-X:7P-]C.D4Y-KBB9&^B:C;( $14(J#;@RA?OWUF2CEXD
MM?1"4=56>9V@9U/BG>S[H?3>RA#^H+A'LHT4*6W^KK2R488*@%9I$W"E%Z12
MD*^\WF=9I>Z%$JNMTN;Y2B](+T61TB8"2RL;94ABM,KKP9==D$I!OM+F'4LK
M=2^4FS\J;URA[(+T4A0I;?Q@?G_?$D)$.TED>@$4&$2Q@5]<_B.F)Z% $USC
MUM@*1Z6-)WP19:[\!^DQCL$V$J.TH80UB<F%2(;MT,/_H,3<BP"5W_;0I[0Q
M@ROAQW^(()-OI^;/W^".(G:'T_?R7@8S<J(OZH3C+$WHBL:Z2K9?2*=^2MZ+
M>" OQ'A[&*:T48IU,$RS8IBU,TQI@RGK8)C#BF'6SC"EC?5L[Y%$&=X5N*7;
M'8D@ &X!DX;G'6P/VY0VUK2]!]/WP#:EC7%M[_'T';#-<6D#<MM[2*UNU5Q'
MX:?M\;&/2QLJW-Z3:6=YI;3!R^T]CG:65TH;6]W>,VB9Z3*2\0#!LT7\66Y1
M>/=XI\.[Y7**MI5%=CJ@6RX':%M9I+0AW&^642W5T5<BSBAMK'8W.>.I$Z]$
MG%':<.QN<L93!UV).&.G(ZZE<EO>^^#@>NU 3=>]WZ+"H9.=#K"6RG/99B[9
MZ=!JJ9R7;>:2T@95-UF$6*ICL43,4MJHZG?#+-OCY9R4-K[ZW3#+]C@^)]]U
MI+5$="AM.-,T4[W-$A#$).GR+0J6633"03CN#;PSM;-]M30BEN8%W"<*?(_N
MV(%%S&@&];1PH%>T?FJ7H>/QI+3QS/*R1@=V,%8O=!GX(S^D*W>404H;UER%
M08A43!X15%SR<EQ2NA!G1:(9$IV6+KZX"HDNHG@<@=3*ZRA4\KVCY"EM8*^\
M!_$WL-%>J)G^M+0!NI*?JEM,\M*&V38GX.;)OTJ$WAP/?5?,>-ZK5*AN"V>5
MXIPI;0!OPYJGXL5OSXNEBP^ND1&VE295K+#TXKHAO,[3*E:X)2&&33%(%2NL
MN.1I+JEBA64GT5D5*RPU>:I881EMM!?*WI]5L<+OCN15K+"*SY3@G*EBA14O
MEH47JUCA)FGRRG]X'<LDRF)7)OS/H10>+=[S[\]_AO\A4ODG;K-YVI(GO?ZA
M;)V<-D_[K>/&2>_P]*S?/!->\W_1>,U_DZ33 $@&_M3^4.+L[->'Q^/TS<3W
MTN'KQL'!W_?HNO.?D[$(]=5N%$3QZ[\A.?O]-WU8Y'Y?C/Q@^OJ'.R!0XES+
MB7,;C43X0RT18;*?P&NI"Q/_/Q)N#,^@?T[XH2<'!V\"T"1Z$8WFP=_?X*OO
M>]*-6'6\SD)X8;P*UB1*LQ9G&,O^+WM_>WKG3_;.[T0OD$[4=RZ0LJ M?GXE
M@!RXN9HJ\[01V,2_GT;CUT>P5%J)"/Q!^-J5J&-A-U*ZK;J^%\6PMGW8F$",
M$_E:__'&\Y-Q(*9@&]'KT8_>J+OWHC2-1O2 >QFG*$?J(?0\_CIGB_H!LT8*
M#)AZ^LGJZSI\]6K^\[/3^MG!XJ\.Z@WZ_!7=+]9?:HX<IWOT&W@3W*E?]@[W
M9EY6+;\Q3AW2U@XQ!!!2?8^;-__E6'@>:.[7!PY\9Y[_BC;F<4*TEA!BB93
ML[Z$,T]7X,R]\T_7G;O+=T[WKGUWV2WRDK7XLJRV>WGQZ;9SU[GL.NWK=\[E
M/R]^:U__>NE<W'SXT.EV.S?7&WR%YDJO\&>[^UOG^M>[F^N:\ZY^47>:!T>M
MLPTN>U:#M18N^W^7_M_2I5L<?U@BCK^ZN?W@_ QG8!B%U]D(;N(ZZJB\15T,
M]LJ>$PJT13SI@T/D9GBPWTW'H*[QE.S#!>>-@_W?Z23-[W*^XT0\8DVZ#:?%
M8?VXU7CTL%CYW&G5&T=GJYP[RPX9?4XTQP]X4MAR$,C^_!Y$X[U'Q&AUSFG'
MO@B<3Z'O1IYT/G1755MSK,/;_VR!:8=A)H);.8[B=,_I1_%(I&!B/J2O^PA/
ML9_&F1&HYM[Y__SM[*1U_.9QF7J5>FO=YF]\ -!.MJ^O/[7?.[>7'V]N[YR/
MGVZ[G]K7=\[=C0.GVQT<84[CT+FY=1I'/WH_.3=7SMUOEXYU\)E#KWUQAU\W
MS@Y;9I=P?U:V0[Z-5E[%0@:M',5..I1.WT^ 2,Y4BM@!_T9Z7Z"J/Y(?=,G>
M49'UP!.7^R.XQ1!_MN^)Z3X^:E^&FA4/G\/K%UD<PP.O:-'_@ANM^M#\>2W@
MB''L!__SM\;QP1MT[HH"4'.P2&3V4Z<\I^YJ](WBZHBICI@U'S$T)L]'EWKY
M,=,706+.F2-USK2^@W/F[K9]W>W0@5*=-0O/FM2PC\.A,Z<?1R,GMXJ=-'*>
M9R.7Z34OHM'(3S#>":<J*-0PHRCHZF)V22',*_CM-?U42]'QWOG!_E'S]/BK
M':#SGWOQJ^4_^]8;VVRMM+'/W<%;.? 39+;T&K[1NWBR=_[[Y9_M3]>7('(7
MG<OKN\Y5Y\*YN+D%86W?42RCM/[EXHWY\?)!N"F]/X8I8_/>CDB<9"Q=C-9[
MCA\Z?IHX[E#$L-:?2O1:N^(VGYW53X^.GVO2M$[K1ZW'8ZRK?W[4>-RD>=:B
M'G_XEUM'S%;?XLQ^4H">:0*Q9D&,1ZZ; BU/^:R+* O3>'H!!EG!&H(5N9A;
M2N4XCN[Q/KD+<KIW_DX&8B)BN53E/&T0F3CX=T>%._'04;E(ERA1/"[/]LX/
M3_</3AI'1\?-1S=XW8S,.F'=N_ADF)4V\4=B1P=,K0ALK=CY=Q;[B>>[9&Y%
M?3KX?9M]Z=)X($+_/_3OGS;(>QO=N,XM&-ZC<1!-94S;5&0NYSJJ_[2(;9Z1
M^'KFOCWWLO6ZJX88Y;)XODA5M#TOEDFB_O,>[M<P286#O?,F/,7Y4R:I<Q7#
MK9QN&DN9;I,=^#6[<@%_WL1WT<2<3(W&WCGID>3>#X*YTZGV;&=&/8GN>1-_
MA*,0=-#J)V6CN7=^'<7IT+D0<00O+IX(S+VH[OI.A.5C!-0(_I\_9J-&4>(0
MI.7T^.1DOWG6/%DAFK,%1N**YX/:%O2PQC&PKS\6@2,?I)LAT"E\#">%3#9Y
M?&YN;X!+'&23!0?DMD6I\JC!#XF3RD".AU&HHS@U<*+=($.R.&"V"P<CL*^=
M'Y^1ND !@U\6A*JU=WYR,)=L^(ES$ZO?^WT$O/ 1EUNTA!M'>^>G)X?[)\V#
MY89P"0\UKCTQ2/HJL"%CZ3GC+$XRC'"DD0-7H('&N]5H_MC["644(XUM-WU=
MXEC!2:/Y[/1'HWY\<+H6#W^=MSJLMTY;WS18L#E7X;$2QSL_Y5+!2^&"L1*(
M)'G&>;#M+Q\+4HS=Z:@7!3\^ZRC<\E?' #/KGZC/_[U\<(<B'.A/E7::#'W@
MBUR/O6@88ALB.4J[3QO-'LF..;*..9&B-ZZ;1NYG_O._F_6C _YS+&+^XQYQ
M9K\BB+93>ZKDD,70;"CE/?[QJ=JD(N-I.>44T:P_*N';&5?T%*2]W7W7_H?S
M:Q#UP 7@06U/!QBWS1!^ON$U*!A>SC48HB4R+U^HP';=ZSY;:=F=T,.XI'1Z
M4\<=2O>S ZOZ[/B\_58&T$\<X4QD$.Q_#J,)+%.*!.CBP1=)A@Z-2!R/$=TQ
M07B;@?W2.CC2A+28 &A:9U+/_^^_9&+_4V_=>NM95ML94VCRK"6LDS;+-NFY
M<9@_@6J_(]&ZBF8=(IG11&<8%)O5.Z4BP_&;G1&B,$KAD[\R'Y4@Z#XJ[8BI
M_"EY1"D>8GJE^!'5_.1ZLI*I;RE3?T1!%J8BIO*:.#&%T >5++V(+$V&DM*0
M,P+U8T,%MX9P_* H>8X( B-/MJ#UI+H ;KQ M@KB9)U6VJY#$<.OL83.\>!;
M<%#QTG$L74GN:J/I4)%PXOP(]P,+T$DR<-*2881E,KI$+1V*=/8M)B*9UPGT
M8_4B/\'Q&GK.CTWK;7M@3,)%O7_#N^"/Z'KX)2Y%W8Q:DFDEM%*1I,[9@>.)
M:;)463Q7#E0%-==OHK.0BC3+Q:&Q=P[J9TODH43JZ#HJU1ZU=DEGH/" W(S\
M- 5QDP'(3QR%Z'8&4T>""SIU"+Y N)2/>2=2X5SQ*5W0)OD][&/;-GQOY2 +
M..G?W;]S?D1JGKQQFH?-NC&-?2JD&V,AW4NK%5ZP410R^6EM:L#:,-POI16,
M&FA6:J!2 R53 ^30!K!LZ0C7!36 Z&4>"09ZL^'"3\%\#_<7?I&,0'_ 4V)]
M$H+0C& /IC6T+N!V<!KC%@V<01Q-TJ'^N@[&AJ2UD?=,Y>R4&]Y;MK8]9V_A
MATM7L$?&P]Z2!>P9=[W1[.TWM0EDVSVES7U]8>]/XZS>.%I/QNJH53\Y>U[-
M[;);->%=FNLIWVW6CPZ;W[ CZ662*4]*/5'^/8H)*TA++/@#DHVOBTRO6J3S
MPCU8J^W%0BW] N^] 3*W9U5>1=:O2O65C;Y?TM84J]&BTP4)%[J(&,55%^6Y
ME^8A1FD6'.3K36J]-(^M<_N5#5PT-'=)?W39.N(7-"82_U-90N6F]EHURG.E
MC79/X_T]B0;1>@X<Q(HJ;+VE[EO L)?*7&<699N]8M?5V%7OW:^T:Q?:T7FB
MN[SYK/;RY^3B-^0/]Q_Q.[$"=<6L%0;,*$P&QR2FK]+(R1+V68$*C/*QH!<;
MW%Y\5C#%AT]\>#0\U@GAU2)T4N_]A([=4(0NL@H<QMC[AA<C>J\G8B]QL(3?
M]QXM%SC\4?RTR&FMESUT\JUY@HI$GQ\J55D5%59P@, 831!I*K') @D.),%^
M8%B:&%#.X44B:4_78= +_K"9,!X].W%$DL !B7N@65+V^Y+BHJ&J^<>M\AD>
M-R!-%D>!$X$FMF0A#^%0;:#F>*=UT+*JDKLB[@FX[?[-0R"GE*#ZL7'D?*IW
M$9?NI'F,)<P_(:5SLJK:FUX :M22N+X?CSB&/(9G"[P(A)1*.SQ:L<@\/U7K
M*H-D<<7SRL="Q^W';7R%*&[GG'L5B,'3I\+QBJ="^;1_DJ<Q@:1/5%\YLQ7O
M2T\(6UGD/)MH.-Y$W\,.ME*W Y<&\<]4GK(?4/H2/G*C.):ZO90.KCC&S&6$
M+'GO1UD23#5'+GIJW=FDDG\^^,V5'W;347J);WEAWGTUECQYDB4WEL0HMTP\
MSM!HGQ#O1F#>,/OE7*EER.)S4I@FPX9'I!M1_A!.PF":^*SO0ZQ+A -@OR?0
MXD&;2(8)'YV8Y8.OJ"C!/-V6G!^2N=:P.+$3A3%89O<H8N;AROZR15PG'EL'
M]<;!N_T&"/IFQ65'TTG)4 :!MK"='ZV22+C'?(X%E.SR%&R)RK:>'2W ;5C9
MZSHMKS(K?49V03'71K;K#KA9# 8@#R@P(ZID=ZB9 GD]&8+J)&5X'RD'+P)Q
M BXAP:"<:A]- NP47V ]8"&#&(,O^. #)TFP _Y;L>05%1V (LU"GQDR2[R]
M&0YM[H$8NO#3(/EE[V">73^2.7P51&(&@2[,1OM>1+TZ^.L]!V$B)=U#\>[9
MWGGSN'9VVJRU<I!'O:ASAS5^Q#9/@/57;$'#APG<"?M_7;E0Z7//BD/M*GB#
M&S>->CI\>=@@5,G#6G[?GHK-8777PAN.(GHZGD6P?^282UH''!NAIW$[_\H(
MTZGNW(1PE:);#WP7.'A\*I"))DJ=>3X>C!&<1N@/+CBDYNGXHWS03:_JUE;]
M6C2F4_8GOAVVO<%!EJ U. GQ%Z,HQI@#L/;1W_6]HRRE6 %^7]RQ>1X"N]?A
MYVLS5*A:&'X..K!3K.OQ)!SONL@GY\NZ<X?%.A[L6JPGT)&EJJ\@6S1+=)%O
M"'N=)"(&67.POQ<MX 0WJ'B'OD%8@0-[#(8'/*A-F_=_LU#E-9LM1A&MS?OG
M7F$/EDH%;_>L8!S:@M&YOEI0WD>;2GO:I5O<Y$][IJP<(CY&[;1U4&NT#N=%
M)=<1-B'K1?7V;",[R1&6I/=V"I<"&X!!=@>_>QO  \SJX.<2ECS&EA*,99?.
M''EW<_'IP^7U7=?I7&N0N<MWSMM_.;>75Y>WE]<7EZ^!1=%TI>"!*B-!CE%'
M\0\43WN8YDX3<1_&\D >8#=#Y7]1L.YW.1' @=+INK["KW$N<KB?'U#N$2':
M&4E)2AT5/=)L& 4>RC\+$"EYN&<[&V1)JOCY5/.S]C"51/J)#C.AK>U;M$.-
M$VOJ8?PD<CZ"JN+[=3H=>$XLH_X,O\S:$XM)>EH-UIC)&VQ@L(9^U@GLE44;
M_/=J8)/V!!O0HQ2+?@W>D<!3:6ZF3?ZF]-B#_">B!Z^3I?,_6;Z*V=DMJ\WB
M.3&S>(:&-F,Q #\QEN(S6$3 A:]%,!'3!'=Q\<">%O)6-;"GK -[MD6+-!KU
MX].3M92QG1S7#UN/%Y^M>JO3^O')MX6.W! J /M02/-B\W_.=RNG>G<$2H]V
MY*,PN >,I&?LM^?@':QT6'U!AOREM>PB,W!36O:9:UE=RR)JWL?V[9W36:!;
MOYK;O\!.>3F4?O7[?;R8AATM%ZJ*@Y[!08=[YSB:TVG4OXB%GDO.BFAK(IHN
M)WM)JCT!IQCC6U5BN"Z*'BXA9:58MY*BQUJQMBO-NE54N_63S\Z5H.A\I5UW
MA:I'E7;=)8J>:>WZMM*N6T6U3R$.8P^P:J>;BCXGK)9$!RM56Y*U/(_$C8-*
MU^X224\0^)^U[46E;;>,;A=$L.U=_[0G8ZK$WO+W\--I=<+MCE@U&M49MT-$
M;>H3KED=<%M%M(]Q-,8]EI7_L#,T;30KW;I+)#U2NO6PTJU;1;3W<B "!S2L
M*PE,L5*Q.T/:2L7N%DE/E8IM52IVJXCV 7[B=$5?IE/GG9^X091D<67+[@Z!
MO[6BK0BW!L(=-G19Y8O455:ED[O!)2UUZ!Y5A^Y6$8U'A5'WWNV"KN'+OS(_
MG=;@NX!ZY[IY6Y[S 9&;5-,NSP%R/F:Q.Q0)=U_R;ZT)&-5)OBM<TZCJ,W>*
MI"=*>Q]7VGNKB'8KX?GWTGM1LE6J]5N2M%*M.T72ENXI.JE4ZU81[8/!( 5K
M&,-169+X"K*T;8&R71D P8LH]!BW%J\!U9P%C&!X,Y:\F,H"WAGV:+0J-;U#
M)#W6\8N3JD-ITVMY'M7^@<B4?DK8+*1XX8- _]M*(SCM7I2E:C2Z@WU-E3+>
M%1YHG%3*>)=(JL,1IY4NWBJBY;9P-X<V1IW<S<;C@/XMXBG-0:V4[ZX0O7%:
M*=\=(FGC4+>3GE7:=[NH=D$3:W F""E=,'[%()9*#1,29YOG= @:K1#J?R+D
M)OX@5]^YW5SIZ9UACU856=XIFK9TG\Y9%;/8]%J>239$8XR!,*1VJ:C<JTH=
M=XK"E;+=,9JJQAT&$3VKD%8VO99GTNZ&!B-T0AXT +>J=.W.T+95Y>)VBZ:G
M!5U;X:QL>BW/I%T>/<":8A'30)FK*(9GA<[_S6(_\7PU"(]&YWR,Y3V.$.F$
MR5A-R*NT\\YPP[?6SA7EUD&YH[SMI^K[J?AD.9_HPIG&075,;Q?9WNFQ>S7G
MTLS<N]$S]S RI8=T2>=7' B+V8$J(; [#-"J<(!WBZ:Z;J91#;#8]%J>2;9<
M 5]80[TK7;LS!&X=5[IVEVAZ?*!U;862N.FU/)-LJB%]ZMQ,0K!TA_Z8!C/"
MO@L_=-Z:$=7J>[*$\VX@U=RSM!V^TMD[PRB5SMXQFIKY;A7ZXJ;7\DRR:>U,
MBA<3!*"UDX(JOHMAF3P"/JFI^D>.;S@=>"K8U)ZLPA>[Q!.MJNMGMVAJIL15
MR(V;7LLSR?8Q]D/7'X/-G%>8.U=2JNX?&=_[;E7>N$,$_]:ZMZ+<6BAWII.Z
M?U0YW8I-E@YU,2.N*C3'3:_EF62[?!CZ/5]UW2YHQW6Z[E!Z65 =QCM$]%;5
M@;M;--5#0AH5'N.FU_),LEU%,99"[?_N=+/12,35G+O=H>WSU.QQ)97EH-PI
M6$7__*WSMG/'_02=ZW>7_ZS$<F>(VSJKQ+(D:WD&Y4X;>^?=SJ_7[;M/MY?=
M2AQWAJA'CPYY>96*7B#UYT::SG_NQ:]F?F212RVT=01O,HX2 EE]'5,J\%Z^
MF?A>.H37//A[D<A,^-<'^4]$+XF"+%W^$XLO7/"69;R<,6 37XH8>^?-F?VS
M_A=7ZWN_[*U CH,]_:-AG O/0.[W8BD^[XL^O.!K$4S$-,%HG;4/(S_4"SH\
MAA7/[M=+B\M)B<3EF6M975Q.]L[O4!JH^@@>B# ]"V1G5AC JQ@ >> \XK66
MA6<YL#POPRLRZ^'>$^_:W,B[+J(^G%P?+R\Z[??.]<W=I7-[^6O[]EWG^E?G
MZN;V3_AS__W-S>_X[^Y=^^[RP^7U77>I:K/>\+CX@O_.DM3O3S=$35UPD>1
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M-!KX+*HRS8NRJ+!)%UC:'OA,335B?O)X JNHU522V>6MQ6!;'H8@P=:5#PQ
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M 6$&,3A_A#T6NQTD4:U0IZ\:*.6]"#(CM8:XH0H>Z:2EFH@T4Q9!7AH>!VJ
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M(RN2?ZC3Y%:LGY4GM;K A=AE4^,.8(R$J-INF0ZQ(U -WGFR#+MKY2J _8)
MDM-!16^$)H.B95QT'E0$[X!)B"SDV@TN(I!%F!>3W1C(*"\73R75,F.H,J($
MF.O*,8&!SWI -:O(G*HX>JI)1DFK*6_"/<ICJ:HN@)U_^K.XF_F5J0":]3G/
M$1-5G-C4@]MQ5_NEI1XY2I?NA'#BR6%*!OM%<A4V/J\5F1G.=)N!VA<_T)@H
MD2CE^>DS1H$0_7^1):#&4/%",*-I]RHL'C(U%_:JY6VG&*G#\T0K8E8MJK)/
M%PLQ<H8*,+(;AX>#&N=@GJ6>K$X*/#AV0]G<A(,(B;>,P$O;\7&#%8(I;LVG
M>K>N#T.9%(T2FTD0.%=D%.PO)-,*X*- :YI#4:COL5*F?FAZ_4SVEJT"UD%:
M%Q3ETMR7S@X$ %<?VSR'KG\!;T=E^4@>N"P4SB+F$XH;+MVX6>Y.9MAT01I5
M0VTMG-8G,%Z$!3E\HP"4N^_IL(7>#K)TL-[(3U9A88Q!/.,%$(U(]:E2+0(C
MI@SMKD^]C[Y1^2RXRX"Y=D*(.I@-P6JM1.JXW CW$''B$3LE0.-2U^^Q7F2A
M86W(OE$/1(SJ)*]D+\[PI\V#9K/V:&O2-1QE0Z>=!A16<^[0'9LZ-_;XCY$<
M]=#F3DU5I.:B, KW9[]5+::> NZ25B$*;)#&(M OP6*1MQ!KI(ZP6#3 #$TM
M2&QW2$O<R:2F\CRE,]B%L+"+U6@-WD4*/.4@^OFB\(M>-'6CE&N9+;9/N3.6
M8,14M04IIP $B(/^INDI4NIPGGQ*,HG(:J:Y :3A]S8F3U&SV;,$DJ*>RU5
M\0ZX@J*ZF[,T-#R3K<=T8I/0#=FXP5? =C1JI4-\O&+))]I#I&3MIF<2V,+!
M'CI4"(0;KN&$BDK21F%+"UN#Q[-N/#/$*J>%]*@]]!ZDDT^ZVSQ/<Y%C75#K
M<2E?ZYF&WT5N"].9SK+)\YZ*,S;)KE*!69(?,IUS)LC%'KT5*KZFTE/C B_P
M]I=HD*7'XB.MA-MT@.1=KW8H8M;>H), :9+#I!MOBV+T1 ]5'8[IOXQS HHP
M^,>#3.;C,'9=-!<M:>+&*6=F^:_Y9%11G<P8?2%A,!%$E'XK973;/*4[F_
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M32I=LR=_4A\9#OTTLA:!;3X09MADAN* R1HXF*FY1+6[D C0&-HLU$"-6G^
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ME*N_2 6$3J1CWH2.X=E.P5SX!?_.$V1&P N*HY/]U"F[<*RPOPP_X;IR389
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M-BELQP,X.J[-+?_V67J-^!)$M9I^B%74"#I%Z5XP9]Y$\<G%A\9% //]%Z)
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M'NJY0/Y)(*[3X%'4X](Q9QOG>'%W"=%EKJ5%'7]FNO4\,P=QJJ*^0*JNB<Y
M,UU]1+<5'RNTJ5(W;I^-7;!G6OOTM06=@6+\Y*A?'W4MXEUNZLI=W@J%?GIU
MFFJWWUBP.,V9Q7&]V5?/+T9+[;>2[CHS*[+^3-MJN]U;W,:(ACVW32M7O]_H
M%EF]=J=7T:9'L^R1JNA?O/D-T>]%@-;F]>$R1!^A"+V'PW8GZ'S^V/4"CC^4
M E(CBNB)K?28 "'PL=L"];E-<,ZL5#O=7SHM/=DKCBD_#;WA6/1^3&-R$>@@
M(10@I41=Q0W' 5(;1J"$Z?M!-#QYQH0H&<FBOX30<))P_9 QT^<$9\<H2]2X
MBTB++QX'+%RQ\#ER"1BFJ2U9_29_<3P,N@F4C"X:-D4M%>:.E-,8-J*]5VH:
MT0ZF\147[^"*58KWE;#Z<A:( ]S6WX45<7A>FAC_!3G"*1/7+0\_)!9MB3A,
MM??Q>+>M81!W,X#QV_SO&9QHSP^4/T)88H29&V6 ]E2.1D1=D5Z';!HA0WL,
M04IIIR=\& BY;[TR\PP;)#+JH8@Q>%^@5>.(DB%0(R%Z*#R$OG'\P!,]'$0K
M4^Q!@%"@-B/L)(=WVTI>S.$'\;E3PXI1CQ$"N8JM/:YR\ \%=&I+;7:;"7AS
M2]5:O>*]5')?D-L6"U^*B\O,>1,E3\#4E6]S-).+Y4@;9<#.(=1F0I7&%';[
MU<(FF?"27UH)Q"$7;O/TF'WF')EG!@YTL6-8SNH1V[]<[V<:=),WD>FD\"47
MM<@-IYP2?EFC-6Y*EZ+!E :4%PTW$.U;?))J!$_#T>LM6+@S#<:T:BQ&\GR]
MKL_?I52X4^^MJ\ P07L3T"K'QA_:A(T,I@2)/='P+3$"0&1.L"LV=A=-BWK;
M $D?O,RT-/7CKGGP4"-1W+%NY4N.(%>B?6$R'(N0K:@I-3P0Q'*J_<X7U_!,
M_.,K-?I&=&1\+D'%FFQ*+;^G+B+7XI,Y?G(:#'9V1DFCHHA>YT%DGYD?<,A;
M>#+XN2^@LJC%(GLB5A_%"(^@:#CN'6]1@U:#G^VO8SEH23 3$6NC=@NB*; P
MJ'SRTP@7%]2P;2K8,I O1\HR2:V6$\/U#BUO&$[0FAPRT5>8MRJ,@*0CM-V\
M99P8V%*5382T\YC-GD&J+C%T3@_]OK,8_;X "G<O1N&6D/G'"9E_.!CU']=7
MU[>/RN75U=WOMX\WMW]3'AXO;[]>_OCZL);'4BH,=8D9NE7"[K<$9*@F(4/G
M"(TP)LDI?@"RQ_YPH/J4RZ1W]+UK(P3]@<&F!63O.AC3'('XF^M-%*UQ]@^.
M/AQUDA &E0/C2O7'!O.#!YJ$]<.M$XL0JR-(8%/!'DOP> J5C.!WN/[=#2DZ
M6GD;4MS]_OC][NX?%1.:RX160BEW86"[[L_JN2VS4<DHRDK@T^ Y#X/8F6 3
M0H#% '] AC4V_O+)U+:<D$.U@Y5+MC40]1-8K Y=ZKD8R_>Q 504:$)@68\[
M]188TW"GR0R;>1QS=N9"<'N^)J^>-?WC0:!_8_NN\%?0H">7A<*8X63 PV6V
M,< M=$7OC3&\,1@/C041+9_Z=#H\FO4)7ATYOQ0@QNX85NI:PP9#TWP3(8CT
M\^;CODD'+HRQX*#3K>M&=HBIL/QDB5X +H-E<UEB430'ER%^;]1W*YG:S%R
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ML]VE^0MQQ5C,$ +F>LA, H@D6]/'=2!5:/D__864'6U"'E^LH'HUS9/S0^
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M6NVBIU7Z)#B?.\IN99>:)G=O2"^E2;UVT6_VMV0A5\T(/L3.WF!*. (4S!O
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M;4P-TYH55F$R#Z Z0K\X>39K%YW6MC*$)8C!^ZK_J^<[+M=/F(T8:RD)S'-
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MI78[1X"Q+4O+2D#TNP^+;8'H$7:HJ[9R<@=+2'DG<'YRBZ@4<)7GVC8"G5I
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M_ITR,- QQ'0BYO@<-X*]XN],.@*'DO2$L_0%-^8JM2^%K:L>54#JV=S("JD
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M4:NC=0?-7G^D]PU3_T]?JT4WC;W$2']B9P./&3_/C!',\-RP7XPW'UDN38M
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MH>)%O_KQY_!@K-%EL&R,V?28%]<U$5B'O;C>3Q6>-6'*&#[SX2VF,24#29G
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M!UG2_1,4=P";)L2XIU ^ LID4(O6,P\<\D8'C \*G^OPC@FY\Z"8273%%)S
MM_H<]'K>;7X$DYRR7*)@;70H'B_%)*2!CT ^PE]Y =TE\5PPE,B9XJ8>28)1
M+ GLR/I6R<X$=Q1VF@9 ^--G].' ]3S";Q8&3.[Q-CH%XH0-[HZ>2V'C*7AQ
MKQ0UP@N!6&>.L*OFUWV+!S]'P@01'GGCL*M#D8#PDH3%B:PX-#GZ8;A>2%]3
MPZ)#_@#E,IH(1K(QR@>D\5<KX(_\& 4 8_1R?, $H=(-\QG<<C!VW1"#CMY/
M%L162?RJY+F<>RB7!ZWF1"7 4(,7;$<BGH$T;>&KD&J%X;-<<LL^4C-]I#JR
MCU0)QK+O/E+9AB;X:6MQBP0R0*HA R>@2D*/AW_03ZTKUZ\P#/1E,6?*=O%;
MD/P#[ N25GKB1CH^3+1 =%8R$W:@LQ)0&S L^CSDQTWN $\ A,,[#86^ ;[(
M7!DZV6LQC4P,@D=F8T6T86^20T484XLXMIB'\<0WU$L#"NN0M/88QHV>F4U1
M)+X0=#+,HT%Q.Q<E>'$IJ$*6B4D1]M0*XC)3",J 2]-KJW(UASEU UI\TF5B
MI],#Q.@GM8+PS]=>[)G.]IUNO9V[ ?PC"PC0"<[/6OTZ[P)QB$WYCBO-DXLT
M_D_VY_^%;L!C5D-^D&C0@;U0N#R<BL8OI<@FW41FK:I4\Y"HM0FQXDDLK;YH
M:6\XGW-K'.C24=(;(HY7@2S3Y,LLNIK''7FZ*::0\K]4GD *R_W'S*[A'OD@
M<VS#R]^ASW,W6$Z\O_$H,-S']_XSWLU'+415SE IJ<%  PUX%&SR 6HY3(YX
M2U\DS#8@!H./,AQ@CJS(/"5V#VV;V_N"A"2)94FLN8C$?L_1*_%F^>%4'-3#
MIL Z!GS7'#?:%MIN2P2AD]M21^PB_)X2G,MV*2>(,FMZOR^,PK/.?A/J^L[Y
MP8;@<<)>7CKFK>MXT9]?#'!BR5K*YJTVNR6/IRQ1JW'+HH W=/3#"7KI?\[8
M*.C;Y^G?D8C7)X[_ M=X@3GD8M)=O,1TEY-:<U3N5L2>2Y-9/Z2[MGQ<2^M6
MIW]2NU'O]'M'WF!(#FK=0;6WT8HI'W! *WOGFC7[%6VR"*EBJG?BRI=O@=*F
MX3J5ZH4P9TYH\72Y>.]?O'7Z:LG%6PX#N"=\)UB[@Z 9+(NP)N=]LY56[T%Z
MV@J9';2=B1S<QH/;-V[-LE.+W:*)>@:EE/GH5W%_+"IYFBUOPLQVYO@\6(\U
M3OYN$CTZ%!]9-?"<0S/<V;-F/<?7PC PEQ,?M(]SD8)W-&,H&XC%ED!Q2@E#
ML3FL3;NS/,'[*PSAF2B(JXZBT!--;&"CMCM9?+GJ(=F4 +=",F*5&)&*/_3/
MDM(EI4M*EY0N*?T(*+V0<;6B1<_&QE5?&E<1(^X;OOM@+NE5L=3>8W)#A\<"
M[WPL2K2$,,S'21J%M,Z*?EJ;:IT6HM.JC6ZVDZ>D7$FY4JA)TMB%4.OO6*AI
M4JB]VY2N8%>" NB;<Z3U$"$4I:I([X6=>_T:,,>W!C:[=O#)=!QTZP9?><$#
M,[_9QE-"<WI\3CU?'%7,=ZHLP/AV&Q94"#]\<X'868$?OK% ;!Y/;*'L:.22
MOR5_9_A[1;^1C?F[=00&C^1OR=\EFGCU?%W)0)*!2C3Q;3;DVEA!M@G#O97M
MF2/Y^Q G;^5.K/Z>5.QM*;LZIZM2B9*$Y>AV.[J3R;"^/<(T:EVF41]!ID]E
MK?D*&.R2TLLTMT)QJ04MH;)F=\HD*FQ[8Q<KM=$XAOZWDALE-TJ](RE=4OIF
M>F=% [CMZ)VNU#MKAG4B7!]8)+:8>4_QJGUGHE<F?29NX[+%%)K>IBDTL^&9
M=W0T/VJ=LN75*;<ZJI[AM=WM.5"6JV1-R9J'R9S9Q%+L'X&E*,6'%!\G(3ZD
M9I>L>6@:E*RYQY2?#31[NR$U^[:R@CX1W',*3/I"HD:O?-0I S27<E"GC!J=
M+XT0.%ZB1B]9((D:O9W%DZC1&RR>1(TNNG@2-5JB1LO!2=3HPZ%&5R_;63E*
MU.C\C3V.9)RE1_KK';&T=EM[U28T%JV1!1^0F6FE(9AC9@9Q8""IK30[(JE-
M4INDMKTK^O:.%;U>+D6_5W>_*A#"Q^23)*'WBD,J;E.32,3+,HK>'7?F:1/
M6[/=VU3T2NJ1S"VWIR!S[[@S1+M5+N;>4^AW'\<HZYX<'3-LU9:<INK!5FV!
M\W>,SM]N;]>CDM!PI2(UR6/K\-B.P>+;G2UI5\ECDL=*-/&-XM"2B$NUER=+
MQ$44A;YC$/UV%S%$6YUF%12%3'63.)YR=%L>W<GDO$D<3WG>74Z#0&972&HK
MI_G97=O\W*2>M8<V:%]KE"3%0G+$B7&$E+^2VDHJ?_>")] OE_R5N([EQG6L
MRAGV<6.X;"HXCQ3#90>)21+B2++'<;/';HZN-S!).HTMF222A24+GP0+2PTG
MV4.RQY[/W#?1<-K1:+A%0'I\ @/OT\7L(17\B*8C7GV&;'2N=V=YZ[^A'UBC
M-_Z1Y9C,"<[/\*)MTU!_%0GI2$*IBJV]O_WSS$)IG7I;QV5X'#/ERIW :-Z4
MB6$Y ?SG*PMI/7WF^1\\\UP.7WES^VVF3\)M.!DP[VYTZSKQ.>I5ZI'W>(HZ
MPP<PUR'RP@O0GL^<F T:"1OH2WASY7AG.74OXVW6+H(7-P=Y<^Z#E3@JRLO8
M&HX5RQG:H8E%C<_,#[#EA&)0)@]BL1B*9PP&EA)XP IU!;;;9]'7L!*^Y0=8
M%3DQO)],P%;&@"ZJ>('A,5X_:2JACY@O?X1N '_PFY2I9PV!2">A'5A3&X<Z
M>%,"H"N'5@\?[X_A&;[BOCC,5!7#,1>58>:\T@CP89:G#',J.NO'(1?TTLD%
MI&S8I%@YT8XPI$8E<&EW8=FL9\O$3Z8&RG4+AA[XORK&< C:)5 &AHU[Z]-^
MNW"+IS## PI0/!98'C5'40;,82,K\.<V<K[3R5JM6"+M^H,],R=DWSQW<@57
M(C_]RPK&5[#I+CS@'FGM[1$>\,5VAS\3QFQQX6#!O>9E(#[#QS-@XBF\ )B(
MU6:H3,"UDDILY-+8_O/ B*3$&B@_V-!]<B@QY$#0OC0<)1J/!8*"&<#%R-D^
M$9(Q(7(!,4$"R13]<.B[2#6QURD;@L@"VO/8D('AA,*-O0['AO/$4 "#A(/Q
MC9CGH82:>JX9P@TD\>*G>'PQ_H1Y>6(\+V/FT*Y[KHU#,)0GUP5R]4 .>L\6
MBB8@(\MG)I>F0T%0R@>KSNJJ,F4>27\48NX -I[&_A'G&0\([H5QP[V" .O*
ME7@A7.4.4.7")322Y")E'"T/[R>$CS"!:X8D#D$04S4[L18] 23CP ^  RW#
MMM\4^('?XZ7 :? ]KDK$;,H(Y@3?@6B=FRU?KXGQ7]?#=XHGB/7[-5XV+@[B
MY80G@&FG!$ QT:;&TQ#;Y<>++"Z(]D0L("@SU_NI4+YB:IGKRM_=%WBG!UH#
ME(1'A+'VJ&!^>!=8-6?(I&)XPV3QTUM$%YN@#T&?!OPNW'*Z:XJS@U<&#$=*
M9)*,\ $4/#S*>,6?N*8X"F L&_8*GDMK'2T'%X:P(U80<+)XPJ5S4!:"(#7"
M8.QZB< 5HA2? GOD(GTX#"4KZ&UZ$DI5!M\Q+I]?R1(0[\0K?1P;T!L8WD@C
M\3!^Y=H4IDLOX ][=FT0L#"Z@1&( ;@C6!W.JO0H-#9@J+BAG%16/@&WPS/Y
M(\ 88<B6N(E(L?1$KM_Y.GN)E$AM(S*>$XD),'' 6,,EP20V$Q=E#)L&JP:&
M%LD)SV+(C3B>:)-0227<.:]LRB7/\P7H5R;(-%HB8;P1-<;,9C+* N2;89C/
M))9 ?L#SGOPLWT12$F4/;!7?C[$!PM5Q ^4-*8V!4$JVHJY<#L5V<[XFBU$8
MH/@94IGQ1,(Y$>WTYE^V"8(/\M,'94P/BE2\Z_V(A_0C&LAZ/G7*.&^#3]UO
MJ;"967L<%[70-%:% 78WC0Y,H]E>,(U N02;/0+0;:B*WM!;-#O$O%9A&WW4
MML#D]AN(M[$UG:+VP M W9I(3#!1I#UD<+'[Q*;X*6ZV(*Q(_'QA0T,H+/(+
MC"#T.(.2>Y,HFN5&(/XM##2#NTPISA7<TNP .V5382.D<PKDI.X2P8Y&<HLQ
M\$&(!8MOR8#['D@BZ-VYU4K]''N)&_3$S@8>,WZ>&2,8[+EAOQAO/@9=TF(/
M9%YZ >?GOG"&H]'.;-AEM0Q_-4HS%F7L(;/_Q>H.=;W78MW!J,E:W9[>&[4Z
M6G?0[/5'>M\P]?]T:Q>/)"^!V)';@7C\OWXR+O*V<8[2!5_KW<99UDG!3]NU
M1?=P%Z8:2BZKF3!8\*:\&!X8:B F+-^/S#R3H3%&EC,/<PA6!]O7!QLJ0)O-
M MN6J)Z$"PHCKAA):HT\<&<9-_*X1.*1"31UPN%83=Z:DG43-#T\*_&"DR&C
M0L:(*-DFH[C8)A(LPO#S0YOK0W<J_!P_'A,:+X[/3260JACI,'/\XO^?O7=O
M4EM)]D6_BH(]<\:.H%D(\?3:EQOMUSI]MI>[K]N>B?W7#8&*1ML@L?3H=L^G
M/YE9I1<J 0(!$FA'[#4V!JDJ*]^5^<M,%;C3N>:*I(%-4<?QA7XSW9\?8$E@
M[^!/D:T92,+F@21L/D<8S->K)/8169DU^W(.EL^46J1@(CL;!DI3OB>&"3#!
M0<!/Z/6%[GTKS2A!!!X&?PYC:8_0@)\#ITQ!O$!:''3I5L"TC&*0P*E[>G(8
M>-+PIQ7(Z2]RQT'L,CTCG@=,%29VXLY19ROK/3 '/P![IH8>STTG8L-A8]Q-
M T+\G:0K[]*T8I>&<Q3[DJ6ER!_$6* _\#'@@NMP!AO=,YE#3NF0%SLZS2C\
MC)_G8<?7+91& RS74 LZOEZQ2\-[MG1WJ^3X/)N">,F)Z"2C.=SNI-K/I;0?
MV6)V%V36OS',[+"LG"<*806SF^'VSIK3E-^=@6L*!W!#=QL@9'-0I-[\9HH&
M'L3MR=&7R:0DL(N#:CE*;"QLUT4]#5(\7>CF,O(&E(GO46P.8@P^3G@AHX-?
MM%QQ6R!+B^ 38[F1Y (PT0B28BLKWYG.Z=?(B.8,6 V>L+JA7T=W->#Y+,PE
M6""Q.'UB/S/,B(DD$P_ZUS9I(,/$G^)PQD0/SU4LQ@R\&1(6!BV5QW-I,Y]B
MQ;4-*(:)B2EAR]8WNM(]<-)2:9YU<W]4S^G.FH+"_:[_RI0\+>TV#;22N$U\
M]<IWS&E6P5LBPHV5.XN4KV,0A[V8WERY??R@#+J@;!OQ/364-PWQ+XVWS40^
MVG<93U 'EU\@V\R;V^3^\*L+E#C\!HCSL^GB,E!43?Y\G@?FSCY/F^'7C2!]
M%WTKN(7EMZ'119NX^4B$$^(J#2(;QO!2 ];.S0AL ,70P2MBONPH\G ]^"U=
MLCG1)1 Y?A @+0QZL;B+X9?&GN>8H&#XQ0(M,0Q>//TGL_">@%_$\-3UA(G/
M*0##[SL,I-5J*3\HC7\K2)^XR.%>JUBL \K1_+<>9/7QTF(+I<*P#W0)KC)T
M@O'']@M1B;+'?_FFP_4@YHXM"U/ E#</5_<H61ZX1 M*OBM+VV$W"_,G&.,;
MT$36#5>[,D+BZ>/2<:F^)=0@GN7:0=D6OYBQ7X+=1T\C7\)V^7[#>QI2@920
MU15PNG4>RL*&>NV_*[0X<TX7.#/X#4UC 6W%KY/\E8T79""%%J>/N)2'YY/%
MB&X:DIK:, VR,/RM\($+6A!M 83"T>X2W.%FI12!+NC:R**1PS+P.:^#77"C
MI_-;R_B(@\/L%;+[)QYL<_4<:67)'?! =@=\GCM=OA$2A$]D#.G>B(Z7]@-Q
M(4AS-50VI:64Q)[8VIY8;$_\5FT.W,&5SUJJV<5RM#!$Y;F?1!8EQ8%Q@I$(
M.SLOY05O2W+=!&RYS]C(HGF3_Q#^C$>==D%W&%NFX!2[<L*<:ZL=^=HIK"43
M%PN.L1C(V#^R.JKFN36HXA%=] ^80\ST!24IM$%94FBQ32BTBTIH%TJ?*?&U
M1UE<69Z5YWZ#4CK/T0WTML!2-_$OO'PBR/W"9Y2HP?]9KN@/48D3Y:&9$;S$
MC66<HWLRD?R%9P9?DVFH].H#"=B5]8O75+$U[2ODP\98T_JG44\%+!=;FSOR
MY1:7L_D,WB8HF@]4W0@J NM2^$M<T*STUP7/]6;ID&&[DID<L7$EV+D2V^O9
MDSN26(KR>%AJ91HFA%WP0C@%763'[\!#T$G8PQHWGI^A>-)&HS4-]BG*H&;@
M4N->8__44C[-9IRIE#_U5T4EH>XTE?]B+[IO,:8\3DTLPL$$S0?;68E+2>41
M7J6OL!CHP6,MY8MGM'B%$WGIW&V*UO.C]=A2#!Q&[Y B1/4B6TR2$(GKK$B-
MQ2ZVPE5^T2<OL/Q;%V@2+8C*FC#;)"'1KDNZS8B<U_.Q,\%<B?/BKTN<1E!N
MY0G>H],$8OT Q<,,KEL?/8I:^>HHXHFY(3>,7$91C>C@-T5=6#/4\-Q(4-G5
MC$+ M3?"$SE'XI]!:V$93?*1I/Z9#AXJ]V];P.Q>^ @\E"?*0,*W1 HQ97?(
M1&$EN</FL"I>1XEQ=I/REBL=7T1? (;A19FN!VH&XUPJ&\.XVH,C^(/G.JTH
M6XF9N(#@(9=[,44FS@=BW,1Y[&0;=\SC9:JU+4TDA[MZGW0'?03W@3F/6.R>
MJ:;5M*LW5$OBZ@6;4& 7"FVC"KX>D6^LO-==."86; %+-JGM --!84X<]4-*
MRJ(^!6#\)7PK:%?P/:RHI3&W1I3V0X%O*1]-K!(R9"]TV&S!JY7GC*?FR1]D
MSM3D15#Q!Y-X =-'I0 B^P>+<T5F"!;C =GQ=?SKZ!&YRIO&M\<?;N.MJ)I-
MZKYGD"[;=\4/TLTCJ)BF;.7QNF-\$+T\N1R1!%*PK-C #:/"8&2=9 [K=RHC
M))\STX?CM-WH=<:Z<$(_+K: Q[!!Y9.H=^65_LN5SX/U^]FZ--[2E432]9N9
MOYAQ\V_FV!*O;]AIC*UTCTZ2$!E$BY^N/#'6.H!2W=-3:KN3/-30IV^.Y"Y]
M 2336MD9PUQ*/]]-ZG3.#'_!TF0B98,Y#ZX%J*Y+HNR[FWSRTI1=D8=G8UX:
MZ6_R.FT@S10<JS W/R'U2DT(7/&EU&BF\GRW2\JE1\U7H@4M*,ZD?E,LI==7
M+GL7_.'W +7(M&@S]*/?Q;-$1:<$])3HS?]9%#B.AJW1J(NF14 >B1>+\L<6
M$.>W].?]7JO?UZ3_U&ZI.3_O=7JY?I&U*+7;ZG9&E[VHS4_: EVU+]APH0(Y
MW '#NS%^Y!)$N6PPX2!$N^!T[PCZO($.O)RY3)1 8WGQ6Y?##:#1VV?K^R*X
MY8'=+R^\V[]V-DJ'(-\7B*^>3>L2@+^?8'$%8<=S8)51R9%5R&O<B_$V0+>&
MO]\T<7)7&-=SPJ[(3< A@63Z/B#0#[=</03X#MSBWD?:@4XJ+R#+$)O'FL/!
M2(+M<)9,MH!UJB@F\<4P=DX\H1WB_E,S=I\8&WVQ4L#['LI<!:'<5L/H?$SF
M[<*4?B+GB'F9HWE$51^%?#;#)+)+*2&^I6IJO(Z4">N@,>Y5V@35T[POQP3M
MQ\+#QGA0EK'>)8EP2FUC=@^[!<BH2"*?,Q;:'^YP/2-2.FD_8R25)>^Y74X^
M44)+:X$*&;+".:T"D=@%B]49X[BBQ&K$4=';G6*'M5:4M26PLR=M$@RNDI.@
MHO<4E]U:QEV M44PHVN=*B-)(=&H+(5$HBD=KY.Q9NV1XLW[6+QY3X5HGZB8
M3+E]T1VC$F7E(UYJ%#\M49D=E'U[MB2ZYF5W_'.=-JL\(;1(!)4:]I_%FEQT
MJN;S) 5QL6HDTU$0]94P#ZDHL"FJ@:B]31TVE49\M<+]X@<2_X=60_EL.S,6
M:[9)@L\E.FOP;QRHE4J<^);P-S/^#'G'3;S-+-A_3NTYZ&\I?Y&+U"TBN3Q1
M >_[U^@K#_HK?D3\]S40/,Z4=X3,116_?_"EYJV)&74:8U4=- ?=0;HHANI@
MHK*M3EL=*/=+RYSXKA**O4(@K$DTB*B^/R_E!M6AG-88#P?-43^=Q>"$2Y-$
M.V9)U=Z4$1J/R.#>60\D.W\XMNOF*$4;=0]SW<NWH9ZTMBY]UDE%&F@,H?NR
M$5):RIM'QK;-8BX(+4P*J7PFY+*<:]D=N4Q5.SC\VF.BESF.6G8.\]P\SJ#M
MZ.WTQ'>F!][==(?UI/T;$I\;DI^$F3TGU=8'?==HBG$TQ6&-IEB"M1P-37'W
MH RV&(4O#XYMV8AZ0/X,#\&R6CM&_53LE0WCV*M(?QX^)A;-/6+>(1ZMG:4W
M[\Y2_H]OD=O<Y_@=GV\?WW-T2 ,BGQ_T+S>J!M'/GS&$$V05#I[WA3<MP9%\
M#EO;8HYKLR'"&X>M%OJ4!9CFV-7D16A,A#8DT&%\5P1* 4()=>WRMRW"MT6-
M=!S3I"E:GRB:HZ;C"#0,AV$@A(UN1:@KL0>*%Z/C:X)WY)M& '["PO9!7$_<
M40JZG+&/>1FB).!;>+&IRX+O31CP(^V! VA^A&51EXS:X^V(Z_A.X*9A^(MK
M<063Q!82]3%R3YW_( 0^B?\H"4"2@!\QX65X@VVM];IL@][DX YIY,T-304E
M$$@Y\P/O?[6?^5EP= ,Y_W>TF_8 ^/^1/1'O?R/$,#S0-]_M%:C!SK#]5KE1
M[I8(8R1Z6SU;?(\T:_#3C\!!P'&8& @%P^0_<P42F9@<P[]OA-\/<'BX4.&D
M&* KT 3!<VS_::XP:XY<:\1^0X!BOI<X^.#)84=@'J;?RLO:1K'(]:AN4BQ>
MS,6"L_H:DZ<CV-X:#(\-A$ QX*+/\RR9,@/G=@IQJ:2TA$>T35I&:R!A@: ,
MNFE!01Z+OBN5$,'ZKK+R)^ P*!-L/&8(8P>FE/J5/;LIP:=J*F_4MX$\L B*
M#[O,GVQJF16Y..K57>O4049^TWG+L<D,Y!G#%/W3IL5#] "P+/PE-OUX;"G@
MII:,X22,OWQLW/+(X8^PKH3@(=$X9"!_#2=([%T9*@ 9-5@9P99YKR*YB$E,
MVTGD46, 8#'ML%7T!2T#*3Z>Q/8K)['ID$]VW8%.ZG;_>P0.^%9%<"ZGU0;!
MZ(#,%CHW2N+Q2W![1A+<'NDPIO7A!FM=BM+K!WJVY(V=TD43V9V&]3"F>AC3
MT88QE=E#D>NJAQC/WD<CBLJ\$;ELWV:('V\H#L]R7:+ACQ-@-)[(P7\4_>'\
MGX5/ H\('X F'O]9(+XD'NS&GAP;QI641CX+8LG$0!MR;\0G CF8F%IP8]+(
MFP8'WF%NQF[#>58X*"NT_3%517!@"PX:Q(4OAI'"9VERYR>:KICQ(IJ%I[O@
M;TT6KP'HQ/J$I]AO47[B,_)BBE:@V7+5*B&DG5 C:?AHM@A!83V$*55<Z= @
M&@$V\Q<S<+(XY"RZ;:C;\**;Z0:G58A#(]]YJ85\EPY[ OXABF,X_)IYP"&S
MK9<)[-10?W(*Y+PT^0)A/IRR#03X[#L6%1Z4<E\[>S1PGA9.044E\P36G8,V
M!<Z-,/-HT"U_AD/I:+Z>D"IE$9*C*3#C$3*>9R8\-IU;A&\^"R@E,A8S1^<3
MQ'P.+\^A4-_@5;B)@]MB'H^K-*)W1 ]JO$V(<WPJ7("&"*+)%O3"%U3>4]UE
MZ!\TX2&@,Q& &!.+AK[B:: E_!P1O-Q7%Z/*)GSPS.A?\%<N1QY!\$2,A> 0
M;8NA,S2=8\9S8L+!/=%>77W&</H.^%P6\T3NDJWL7ZCL7*Q 02<%@L*9'DR9
MA4]_XKC#<-P%1%6!H\4/@,-GF6Q*M)<1!*,O=,OL%XJK* 4+[[-]9TJGJ1N8
MP-*?=7,AIM^)4\5AR)0MIOE!-$=(*#+X?H2MCZH.6(3;QD#%MI1/VQ<61IBQ
MD!$>#?0&_L>U<E8"[A451[*G-$.,(7J9F_DVU%*4AP5N7[SR[)C!$ 674ND.
M_R2(UXE,1%QZ==)$P$+Y:X.92PL>+L-QXUU:X$NZ8@8L&4J70["%MJ#A^#AJ
MV[-Y@B(2HL#*3&/#]!17(+<@!'<PSVF'HS?=< 8M.J'1VPEZ/'1'Y69IB[<>
MBA75> 4G980[(B<D2/8@I*X)8@^KPFP*PQ.G1<3?G<BL)+>$$$]6,&X4P>D@
M1''<$,S/=.=X?2$C 9IS"]3% ATAGOW!\"8Y[BKDH<0,"0O>!(N;<F&GVDU*
M^/ "$DK.Q)>/F%0+)MP&3&W$SBJE-/EDG%!=$N6RCE :"MDTNF(>D5Y@83GV
M%)-RN($)>_*!42,\0H+9NK%G-^+LR)OSO97O!;<^7HACR(=[X*,\F]?#B?T%
MK,'7AA*EATBRL=G'J,PP, H6A-2*2NRV+#IP.O&DR85RPFQ_ !48E\<)6YCL
MF=Q/TUW;T1)QM=-^I;O!L9R(\8ZF)X)B5$J<*OQG-*H]D CN7J[%XTGW\C,Z
MGR)31L>8!/E..D,1LR2//I%,"%X7#IC'>/-UA78&%CMSR*2CYI_8F)U[T_A\
M_[[Q-G)C*0+-,XOM^@HH1G4!10G6<LIQE#SS*,M':N7)1^:,2O[%ASZ:K(H9
M&$PS8KL%3ZO1+*;HQB$<9TEI$?$WD201\3_-[#4Q(\F$Z<5I+-P7(P,%2T25
MR$?'!&CH(D]HH3E8D+,@W#%#3 >A6QD^,XH9004Y6@/8?$OYZ(?>1?9@X%TG
M@U(Z)YH'M7CE$ZSW&Q;:Y(^C)V3/"XU]9\-TT#P#0=<#LO4C#%!ST9?8VUU=
M3_V&P45X<QBFZ'#:1AA13=BK35-2PW%@ 0--T=F*C'7(2#B<$B\]]$7 3BT^
M2$",[X"W"8?+9>(X\+1BKUC;=XS.L-&FF/D$SUB ,Y Y2%7Y],OCB/GQL SS
M;2G"1L$==Q8PBEQ H*WX*SI9.&LJ!X@]<^T)L6/9DLURQ4&\"B#D(.T7+2XH
M@(Y(%5(F+;ZB#4/0/:!W*7593LU\%X^;'T7<7,J-[9PP<D&D/'IX>/$BS0[P
M48#A<%=2#^X4% :7+=DOHE(;'J%3$M=E'L4$_DK$A<EA9GBQ$N"MX\="]\K"
MK!;6X 6SH'CJPTU.TEKJKS%5,G%L'8T$=1ADK]JTGNW%<["D6-B;^'IJ7?_
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MT7[#88]/JGYC36^D<>TWS6TIWX#=C\)UWF$0RR:Z:)=&E[MXC+#+E)JMVSZ
MZRZ.NM_Q)BR/Z.XZW*G40Y+NT0'")^XG;-M(<=A<E=)1ZV]YYWSMOO^*SI/Q
M72,%ZC_</$UF"Z+5IU^BM.56Y&"^Z[]R3Y09-<:JIC;!R2UH8%LI1L;D&Z9=
MBVLMKKN(Z^C<X@I[:(S[_69/30\EJ:6UEM9:6B-I';;/+ZTJ&-?1L*FIO2J(
MZS6,.GT($IO[>_)YQBE>TD!$F8QMF3)Z"AGK-,:]9K?;OI#A]C4;[L&&G2.S
MH60@5HP#-7X/JW9^KWGP>GE0.[\J[)9+%5Y#5I!RH:FKZ&-D!H\UDKET)-TW
MNBF"0!>DC[9,JCZ%/NIA;G'0[$C&P!\4_I1\7O6ITAFU1J@U0AZ-T#N_1N@?
M)WU9*X1:(=0*(:]"*$'R9H!U0%IST"LX07HFA4 1SV]4;+BEKE:KJQMSU-EU
M6YW^U5<WEG#I=77CANI&[<35C3O4F4ET7+G)F*/ <:=-U^0]3IUD3>.Z6K*N
MEJP+.HZ:O^B?/UX9-L9J5VV.1MTJ%'24+3]1B^LUB>O@_.(Z:HP'G>9@4-<V
MU]):2^M&:3U[*T)7;4/8K'9!7#M5$->Z6K(N$<HI8^?O'U#5QA@DK'.PA-65
M:I5EP]&Q"^,W5DNJG;I:LN;!T?GO'E6M7*KP&K*"=;5D::*;NA0BH8^.W4&P
M@S[J8FZQWQRH_8NHA2A;.J/6"+5&R*,1SM_/H?:.D[ZL%4*M$&J%D%<AG+^?
M0NUC@G34[!9]^UB>:LG?$OB=NU9/GA>5-#ANY;V^H,DG9096S1XF,5W8-#9D
M(G81CNND>7E\R*F 9#:4O^61'&U+L"^3%Q03[ROS=I.1=B0C _"BU>:PVVX"
MR5)B0O/#^; %5\SDXS->K)Q[ZF7LZ2?[RW_WPYJ8.'3R6S!^ZP,B[EKY-S-L
MC#6UD[D3/O5PRA\>G)'N<116KA&T=E-!I$4.GVROF!4[8]D1ZXY);,#QONV,
M(6S[,4)G2^:Q4$8@8*MFMS<Z,B-D1(Z%,@(0;JPVU9&ZA14VL8#&62 0<\+T
M3;)#4N07)I]8:K+8<<.;<"@YH08' RIWXY@7'"1\=+7Q12SZ-3>%Z6)$&W3E
M%)8+57YNV4<"]M]3!_?4'@UR[$EPB6<N33Y"/#AE,9U0C 8U:=P41QF?ZNX\
MF!,@(-$Y(+E<Q)I ("X5L0]=/L\[Q5L<V-_$(7(N<FXX+RV)C![H,W?.F)@\
M+<;A6K87FQPM1U-W/?B )LK17'0QJC(Y.TW,;W65%9\.DQJ($ YSTP/JP(',
MF>&#4F$N.CDFK([6A;/00CEI*3\DY(AFF2GZDE.0Z0Z..N,4H=&3.%X&)QG3
M"$KQ#$%SQR!Z<!D4K_)IAB=MU@C72$-N6LJM3!4Z_-0=@UXKIISQ 9X<[3XV
MY',"7T2'Q+?@<\,4TQG6!YC-::AE^ B<%V].D^,H6\K'=2;@$/M\@&5 _7">
M+F[8> ZL67S47GHTI>39R2FZNAMI-3>Q<O%@V<#+4@/IR_V]C[X3C)Z:F:@W
M^#2"&(9[4M$UPY'30.Z4QP"''#<6I.F1-X.Q!L!U)E"1QI/AE! @)S=7.$3;
M=I#]<$S6+W/)QPQF*E10>1/FI#(UB<CL[NOGA G>J%%%T/8MY( 'YF %.8YI
M#?3I32=2J!J888DJ_7LPB#%E/%]#U91A07!893!K+YAB*&-'@Y]8_+3@][V=
M)D;AZK>/ZU$16W S#W=.,.=$'F-]!36N:,&]<:XA#W<64!!'C7[D)L1WTK,=
MNITNYRH@'#-N/?$9/BPY\2%XF(E1WEJLNO\<BD=A*.YGX6*%HR@?1='M]%*C
M*.03E,0F)%OK9(ZOZ)]MFDV,NMR\T(!*(5O14,-U40H'&IZV>7(T;(U&W;S-
MDX-N2QOD;?S+^KS7Z>4=D"#_'!ZEEG!16G]81/]AWB3M&>2"GOC.]& ETQT2
ME\F!*FM&(/L^?<><>J7ZJU)S)"YQZW(NR-MD6DBA;*FO.CZ;%@^S:)CU+AV-
M>:Z?+K9P7BY95U X+]]XD5FJT*,+6/,/Y,ROS,-Q8S@-G+EY[X$Z_<98:[:[
MZ<JU,\T!;/-1A*4KT:]%ONZ5.<)-\+8D[C%$?H BWU7KSIB2\,N_;.?G#00&
M*\>>,G<_3V.7@O*JEXJ?T,#BD=Q9#_Q #I,V;/-NCC2UR@:VA-T156?F$YJ.
M IEY!(%B4QO6J-"G8XD_Q<V'N""UERO;PFNKH@/2G21+0K_22=8)S<0W_24\
MGH,$2\.BC%YST$[7ZU?(3,BEZZS%O55GYA.:B>*8&4<5];%8I* (HPXB=FV'
M,^-WBL6&$=M^<[F5\(=F-(LG4%FTTPE-[<YEFS$]U,%KC69_,*JR42V<>\X4
MN5VO_C@T/7JY^N.$WLT^^D/#'IGF<)C6'U64X8P6F62-UXY-,Z6J0-Q0KP06
MX#:[W!KOO!.EN?_ HL08C*WB^A/7-$P=':I_Q+VK/6K01UMF9GR^^WP?LNLM
M5>KFK=+6NIC:[V@9?0JY2\Q'6V RBUAR#U-*@XP>FR86@&-)H_G,%J]-9<ET
M++HS%-\-BDX7-AP%[S9P/<5V%(MY\"M@S']3"=>SOO#C!;RX9GB.-[<-(@B6
M)L=[$O [^L1^9@J)BMM*2XF26:4K^%+K ^.N;)=JE]]1S3%LX/>@%HF8-O8K
MH1#:T4_T"<B^[V7_1(;W?P[9P[QVHF H]M\\]:):6"\Z=Z+ZF2=V,X&C_'FC
MSV"+[_3%B_[JHBZ+JR7027&RKU,LDRZSV=&*3+EN-+#@G3CF';$??@O6I)=F
M+<K<03G_C^T'-(  DZ0)Y RKH'D"4A_+#K^<!;_=O0I^/[*)MZG65^NG"V*U
M?KK6]XMM/=U@?X2"3R2]<T]EZQ] F9E@H1P':^)Y/\+6:F"9L:.W;B@W+(^Y
MOK> "%.&Y?>*.B)SW$DVR)!"(VWLV8H>T B)]LBFOH.E\+=/#B-R*6_PEXV
MCL''C;>\8>5/<* ^Z"OE,W ]6HR[?RK?'=A^$POB0;^$#[A]HE\UPSZ3!78P
M.*(WQP,"4.</_N]*=V %>'P,/GH3M"MQ"T4/^\)_VWC+.Z#6%Z>L'/O9-("D
M8"MA@R[NBC>2V(MG7"92C6P:_Z6)S5+4_."O<!GYC'@2/+>WSN-?X%WW,[[&
MS_J46@W^U'^92W_YWG8<JI,&$L*_[-HVUH_D UMH>ZVL^Z(E=@[!\OD1? NW
M+P@6K ;I>/NLFXN@$2*RYIF_P6X(\-[^!TY&(2Z:!'NA]BH%5CKU%]2_).ES
MPD=3.U-0,9XZ0NIYY-X"/,^D+S*0+I/:G8(6*-X])APD?H$#[KD>-EDZ(L7*
M/1$#!5,TCSWXCNOKEA?TFZTO("DQ3Z ^1-L'?DS,W"3N,CV7+68A5PO.!#97
M9J;C(BN:-DF4&X@6><#,):Q.X#F%_3)!78@VSYGO :O"!O_R38?:2JAOQWZQ
M>$-.;%$MY3&B_U:"-B6"%M_A4L?&N;]\7)@WUSWZ1R$7<<&Q0:'Q-C=%YRRS
M8#OQRX3<0/ VL/>.F #C+1$'>$#?Z9SW+('#@;(1-M/!A@Z1QWZBQ4@FC+?$
MG/#8STQ'ZM^)97XQEV9^?YOJ$4##9_C;7,'H0&_2 #&QT>,2>."F>[DW_;_!
M@C GI9#N5_CJW&II!)YK>YM:XLJ;9(EX7\B.L@0II9X2QL43V=/UL;=4'(P(
M(TP'(WA&_:9@*L(G9O/@DK;JHF)9-Y'K[5E5",P__9JR%?;V@7+Q\(B\>1!A
MI<4_9#1W1W'5G4A5@3[0%?!OF0+\A/)J*]_1VWJ\__Q->?,H["L.$K&H8?0S
M;]B%YWZ#'[U55@O?S=TKF("Y[LI<QSO+!?\/]_<>;<3C"MC#N+?^J3LFZB5\
MMRIK#NRV&^-N2Y5T!PJ'0BA%ZC@5FABVO-1_,F4)BYPO8FH\[',5YBJ3ILW(
M]L'WX:%H'(!**R"H>(AB^-1^2(P*/ZD@4\KS04WNSRDOP*SY%%L"B+F]R;G*
MJZJ[*M5F9ZAJQ?8]U].Y6[N#Q(C3==@2W ]R@T+-/A7*="?!RZWY=R=0\(YO
MP1KW]#]C).P0A$MO*,<M +=2"ERP-S=@X^O1V$%#=NAUAY5FASP4.@(_(#!F
MN]D9]C/X ;5K1 FR*+M0 1DEK_D89;2:;Z+$G5#J:#ENO0?0@+;QR3*D-J37
M&(]:O32\U]_)F<FYVK5C.\)R^[C<=KHH_>_H/P"7;4[BQ]/$21N)1T-( \O5
MPHPB/(QL(MB.J0TQFHY&DI^V2; 0P6F+*'P6G/8&!!<.>W)GA<'#^OW"7>;]
M@C+7#8Q3 SREF#SG%[(MU^J/<W#&T$,*)6K'*I^8*$%H/RKJHD%M;P'-+6+!
MB("5C>#DXAMXCB[FBG*\$/*N@$4<P]%GE+[Q.$ -[33V2QY^QI-Y6WAEC7,O
MSIW"_\ QP2\LX&SKI_+DZY2KP"@GQN$( A-#!..W,'L&V'B;L#'C]4>PAOL)
M4)!DT14@"1_@\%YA0?_$6R-)Y-C%,5"M=#&_(F+&9MZE=C=:P]U7FD\6>AA@
M:+V,', >XML[SS; 0^YTY+:<JWGV:V4*6"&#@'^ MV+ )RZ%UL2S_68@E(/U
M6T>">_ 0R(F@5":O818O2'_-UK1\0J_#]^Z R_6MWB;^9UU(3-?U^3OC8G1,
MX>D?37AZX(WW6FD3O[?P#,[#=0C=TY5#*>;>PO \6^B*T+(8Z=\<XAUM$U@Z
MH,FWL;OT=YLGU0%%@BSU2PZRU-OKSO41COD+IE&QCNH[<([+SW33/6Q/<@_;
MD]S#XK-OPH?'TH"Q]^QU_<I?)EE"-C82GDYY_+CXK2S>QX(,J!MN9?$?D)BQ
M&[$P>?C>?T5 -MN)_YQ88? [1#E,-_X"C>"AL4)I@Z7[B-XF4,EXD(4R R=,
MOC>XT!W@,N5?F,W\[,!6E$</WDHW5(^(0>@^(V)A4_E**690*C9L<%W6JG *
MWR5DA?@5 U6N=X#C_M2=Z5P1>JLCNL(P3VL$%U?Q4PLN_OBAT!DBF<-#)&&(
M7L=CYS4QB54G\)3S2G_EU2 XF5M7-LJWIB;N>D*1"X'S,*J[GP78>@DC &2<
MOC-\Y\5V#)=9D;@/L++[!G7XNK32+:-(;F4:,3 ][$5?V.+R**60),8L8_%?
M*5N"O3+T1'X=Y:8W =8LW$3:D$%D.K-])VW%Q$(5OE(R,H<16ZP3:;X;I2'>
MF8$)Y/8R16RF3^>(.AIDR!)7O&NLU92J@^ *%R_1IXHC6$Q/@#CF\T8V8"BG
MZ8'W,M,_^97) [_CR.N&]*EW+R,KNP+"T(V,8$G=LGSJT^$WA40K_1#$2G43
M8&5ZO[?T_N &64!4RO)Q?0RM),DX/'&.&2E..3A //J*:MQ05_*R#03T%<9K
M@R(D^-E9Z$!XD0.Q;@DE]26WCQ^4(800RI$;47:'@B-BT$[=,S7'T J: 5CN
MFO(@,V@P9#+3"O%-@P/ :BWX>C+Q"W(BJGIESULR7D*"U\7FS)SRL$0\=[H
MIQX^Y;BI:V^A.U!A/5U@8/JUP S&SP*P95YX+#[DOPRN8INB?EFGV@ J5J&K
MADB][RK^6I;\AVEYG!#"N"+@;O5'\4I,RDLE'Z&^6X.>1/AAUPZ;+:BF1ZK+
M0:W@!E&?)RY1FI1_UYVH1&FFFXZ$1 8F5T%I8I;=31(/G@#/GO+CPW".\NR\
M(CPL!D^0.13CY)'HX$R]NJ:[YMXN!'(N?1^WC&$B NH:IBCT@!5,L# OL2;>
MCL]+V,06(A_V;:0+@)(WJ1^%FP7!T9\2Q8%A.14ID=_P'&WG;5 3B>RS2*VB
ME5V97FH%S,^'B]"ZM)D0-D\Y9C>6?1$LLKT(6.,A("#"@2-0-.EA <PM6"U.
M0/2'2<=@P0YG@(3F)BT#YX W,<"B"(/NH@U8A#: *O42AF+-$L32_RWEED#*
M"<2>+]F,U)B>NA]"U^?99"]<[\QUNGT*X<E)X>B(Z$Y(0<P(BE/7]RA2@.C&
M<(K.7U=8;\A9FNXHTND,O/)*\2_7J.F?FP1>SZ'=W5B9"*]WC.H'X\M -=$!
M#DB(*'VH_BX[*B)>=$SA?1Z$>G32X',&\-9)5B"BX'8FMOU3U-CR T-RKGQG
M9;L$+^^9BY@L,\N _1;@:L83&;>6(<ME_*&;UA>;T%BVSCN.>9H:)E;23N83
M%90Z<#2N2RP<P_V.76!M<6CXS>>/UF-+^>/V]J&"OMQMUD4QYZ"I2#8FS4XD
MN!'0>NZZCZPVY@PO/'>(T05G?-A4,Y*=3>IYRIOIW]9Z'<PW$+[#!]OUTORZ
MP]I[C7$_JVB%9L!,/+KE()V/35Q@F&$O?#C%,4]ASP$Z_7YC/%"STL[ .4GO
M,1BI)*KO/L3GAH@I7\HCSAKAKL(Q-_P5/.(]]XP)ET&SV\FH14MN>1%TNY *
MEXJD=G21S.H,+DHDAR22@XPI/_N)Y+9NYJ)$$B^QVR<1R9RGL*=(#MJH8S*&
MFYU6)'-N>'^1'*C")F1L.U,DT:,+BH37XB7LA757L"X(@KT7' 6$SJOA\VWC
M3!RYIX=1D@4/BKIRV6S&[\ZB+U&$RQMO6TI0&:;L<A]VM<VUG>SFVKI-MN)M
MLMD7B1WI1:)6D8O$0!> ]K&G)NG4, <B#9+WJ++>H&(#Q?*)+^-P0S_ $O)F
M)Z."/'^U1,;LWR,M'DM5FIJ:42(5Y,=X,41L9)=22*%BJ?CR^WH.P<"Q>,2A
MO(O3-Q=43678+Q:&RQB$\QM._.?--0QJJN@ER$8\@#OAW5K&I[]\<X7L_L-E
M,W_QQ9RQG2[@!MWLJTX0,1]35:"T+'L)JUK 4U.9,=?FF3/1,\DL(YE7Y1>F
M^/>H&2#TRT4KY2;''&DINJ[B'GWREPN=OS:?J&R)4#-I_(=CN[GK@P<0J';E
M4U%;J1J0[>4L)-#1-*ZPA^$S==!^T-VYN&]T/]N.Y%9</JUK("ET&4@*72HA
MDB%-@K9B&O\9F\N82%W)F"]08(FB+L:K(@-%1EXM%E'0T"_W7=KC3!3[;/)
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M^LVNFAXW7-5!81>D[9.5#J'RK].5I]?SZWG_F"PF[H<#P<PKA_TV]15T"AB
M5><7*Z'@C\Y1*N%R26;_GIRCKLJ/?W#82H>H!GN0:L#',A0:)/PF.IP'?C8?
M;-?+T??8[]1]CW4<4!XS(6/F---JC?%(O9PYP-4P K</[Y6.IF"JU]D;]O<:
M'*SSN.QP/!TM/)S<GE67"G8&Z6*$VE>_.B5\("M1.[FFEB#LNRHG_1O^&5,L
MOLM*4#10:KDZ6_8<0V"@RJWCZ-83H3;DOC#M]RD([AZBJFM_N4JJ^O@L17CG
MO<XA>97:I=[GLGWB*7>NZ].L)HQVZF; \NOP-6R>X*^?30N.$<B%YRCKM>WC
MA>=!:KOVL"]';>_-17B[V3_D;O,TSG4P;![6R+*9[OS?NM*JXI+T#6863Y5;
M:YS0]MQ94WO)DKHCKW\W:#?&O6:O7T#(L-N!52"8J"CGG=!>%<)YU"O>E0R'
M+1'GG7IB[#DXY)_ZPB?X2$4/IBW6D<7YM7M8.Q^>3S@,4R9-G<9X=%"47D<0
M5=;(&[DEIV+6&N,AN 27DZ4OM?I%V+]3^=_'[6DZ(VGE>OEO1VL0VIF)JUM7
ME*EA8CX?\&YN[=)%MT\=5GI\1UYV.5/0<['B+C_$*Q#WL^4D99+< Y>S>\SP
MK8[@]NC,Y/?[RIN8&_%6F2[@8W-FPG=,2_'F3)GH"[I:<N>,>65IX=3@@ W;
MGRQ8&7LX=UE=G?K>2VH,\SEXMGC$#7[_G3H$LI9&J)H*T.=FZL/'L?Y36/OI
M//0R6^6"G/!2&M[3^=EA;I5[V_NXV/W&>-#L2E#\J^=B5\"++K-(%N0HEU(D
M3P=CLDTD-_;1# ;9?325ACR\&.,>\Y2+LO#7D-T^\TWW/H9QR %T2Y#9KAFI
M-!?7Q$AI7AD=FMVHZ!T(*;M27(3(,AGGB;I$$H#32)8'.*!DI/H!6U'4*8L^
MJMR=RK!]<7<JAS)326/%"U4DQ=['7(PB*=-MS5 M]K;F' )*KM!OG@YO"ST
MOIVO_A(.8YJ(-9>Z\V1:?!WMI*C\C^]ZYNSU] S0H9KK.7;T+.'-KXKI*@Y"
M&I+/8ROLF<IW&%W1. Q6^V]>FH=@6?!1VC\B4$1\DG@,=GFA^5!TY3E=V(>W
M/_IT"B=$?WLQO;ER^_A!&73;-VK[1FO?=-Y,WK:4[W-8V)-O\J^M'/O9-(
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ML;C;VB7ZQKUL#WU4%1RMS9JT<X*;?5EHUQA_M4&"!LK-%A98-Z:/$&VPN;T
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MRT?3@07:(",TB-Y<+. ]*VQ\]5?P]24]6:=O-"'$G"Y\(UAU)$VP;KSSA&^
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M/\6>L1JX] 3JLP8%/3?@G-212NG/W=6F*/4"'4G?>K!=#]ND'<8UI,5FIO>
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MB5#+/M@XD0)AS.!/)-4TC"48KOLX9\P3LQ0X[> /")(;S&H(#B) S'<9$,G
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M]BO;L1DC<GYZ.%YD.) [/VC*<-R+F.45)TM3F"D$&L;I0,33\+V9C_.!9KZ
M*19DH7'*@]_=&.53;"P>'CN1%OY,&_T.%M=E.PA";'ENL+XI^,KH$--X$ /^
M YI@JC!.+<2&?F&(2KCD&XBYP@+LO]U#8&D$+.0R#!:?OHR:&&']8:L.:OY@
M%6)VRH0QBZ;TP4-C?,57AGX!_#*878+^@8YQG0FD2CQ Q_EL'+A6)O5\V #X
MF0X.& SW%,#SNB%%PK6%WFR(N\MT(%+P4_ 4Q!22&>@@Y]F<\NE0 <8T2A2Y
M#4M\,K<K1J3=%KKK@3M*X@*>H4]S!I'A<&I@]&3^-C)E&:$'$ATWG=KL'+PE
M8"_)5L,MP@9IK!6LFJ(!-]IK>F_9KZ_Q?C?@_8[6J%/C_9YC+2?%^R4/4>8W
M:GDQ=Q^G<V;X"W8_BXW83GD1[IW%;RWO9Y]UT_DG@GK?S]#PT30T-P.<MU=)
M&%[4=>"\6$^4! "=]C\\.Q#HO[C/$PP B+X_ _I$J.>D*\6(O0":-Y_IY(/\
MT"X(&/@0TC=P6Q.(OJZ_!+K2-(P8N&]V)BUV"#2V\L3PNZ-1:]CKYX7?'71;
M76U4"/)LN]53\STI$U.VW>JJ\G\Z\Z(V8_16"NAV(P9I$M6V.+C62@&Q8OQZ
M\5O/;%W5"H&?S7,Y5)(K3CDSQ&QZF+:)K'HSC*V*+H$Y;N%QZ<A\!5"4\HT7
M>5&<3JIL\DB3F969^8L9-_]FC@QOK-?A0\+5SN^II,J9IH:W^>#RTI6%UZ)_
MJB*2"HG^X34BVT9M'R+ZVXO5>C@R=]C4^NF4=@E%\$2=&;#X,]F,#V&H_!"&
MUFG?9+^&PH(*Y8]3P'>6Q5U#%??#IA1-$SY\,BVZY;!GE#TYM;=;9JM6D$-;
M2L-UN,^:WW =;JVZF=:J>LYJ!?S1,@MG02YG*87S<*]2/8-P]C#+U&QWBFIH
MKXBW>-X^7M&_"QL\8A-OU3L;#S=VN?,SP<%\@'.1"0LBS(W2A2P5,F,E[/.M
M.I\>KO>[1?/I /A4T@Y^'4!"FZHZCGKDMU//UZE>^@FKM-\L;#<VB9+70!3=
MD5MUT,8S*/GPF/Z 4_H"9R23H&%CW$NWK%=(T9<G7KD87BT :B&EZ5U8/_QI
M+Z[-Z>EC%71350\!8JA]_'S&8!'5C:YTTZA=_5Q6()=DY38#J= YZ'MY@)/*
M*UQ]FD_6ZZ537)6&X*DZ7QU#8Y^6KW"R6%,;IKO(+QX]YVQN_'?1>(/M)J:%
M;75.[<273GT_4@\;-8D?G 3MXQRQ07,@\?A/[AO5?'76S,KN;+6Q0JNO95=H
MU7GU,UV;,\LXZ,)\@\=42(E#&2_L#KU-S[W_LNB><Y2''J1QNA=1$YJ77\X4
M(5VLO!]Z05]9>3]'3>CACFNOJ$+04\C=B2+(4A2"8I<D[R0] 1AK_KK>4X$V
M%K&R:_!</V?UV!95['F +2NSN2K(/2VE13I'L:>T%SZW5>KS=(J6KBFKGB=:
M 6>SS ):D#]92@$]1\%G,0(Z(+=QV#\8[;JB=PMGO!!VF.<[EB+ ,(25/YJ/
M6/4,\+G*@Q;?Z)CNK0.$C 9.=D:5-H+UI48)K4;N2XULEDYS[:@Q[O34^M+B
M9"<?("M&T(Y';1:M>DG'&2Q")A1F2GH&'.VRRAJ_/&'/Q;#L&33^3NBM&^^3
M!FIA-]AUD'#ZJM%K\*3.4784.4^'E/4-.H>7B]:N^464BQ;$4-KA=:(5]=DO
MI$[T&ARA<RAL ><;S"Y@QG?[LV,O\9]R"UFW@#+1VK^^!/]Z9Z[:[&/W:A^[
M5'?MAU:(7B.*8 T@>L(*T1VN_S9KG/Y%5(G6R*%E5*Q7(//GJ!(MY,I_,,BL
MR2FA[%W#O<]GGP9>X# AWQ4ZF8:OU+TI=6]*"3T/8M='XE:NB/*X'<.+<#OJ
MYI0R*M(K$/@"$M-IOV-GZ!F9Z*=%?-08][4"< K*Y5B4.K^1,2)%S"7\QJ;V
MDT6#L\QPE'C& '$^PMET/<6>O2M)QXH&YVO8/@[O.ABI_#RKNP8W]BO.?O,=
M!\=MQF:KUDYL[<26S(F5CHL&]A7<F\.=';9K=[9V9VMWME3N[&&RGY9QM?9G
M2]!2+7=FXU, [VD\.@Z"=]@<S_F9*7?_M[UO[TX;R?;]*K5\YMQ.SL(8"?&0
M,\=W$<?I=B=.?&SW]#U_S2JDPF@B)%H/.\RGOWM7E80 8< 62$#UZN78H$<]
M]O[M1^V'9V$_]G=8)_,]5WN5:JM4VXU56Q81*@(RL92SRKM6>=<[: S)\6P&
MS@2:?62@G[('^G,31?4P&D56)V9JGWE6I6)OK:/CACR[^KBVVSRY,&HM?5'_
M5'%AVZ(6V&$>RD<B^C/)P%"Y%V4*21%927_*:$OZ,_GLZN<8V(PAQ\&_O'16
MS[/3 'H_C (6.0&OXYE\NHG8/(Q:>BI#9$\]%UND^S5$#]:4JS7:QO&EDI22
M\3>(T.P&D4/3]D%E6)M[ZT55!RA;$\%K:+CH8<OUM0(N\7MF00GUYO ;B[X/
M-C1D#R-N69VX5!&"CP KMF\?[Q0KUM!B.B<7S9K1?G.XLSK%*4 H_<G_ 'CO
MP9#H(\/2N/%HS*M3D#]"M+E]\HF!)C2">XFD#C(MC!P2&I'>.'!<TFRH0QQU
MB+.^5\<)+3Q") % T]:J*KUMT:JG17X[ZZD*5,7(4I!5?:R\\Y(X-=;*.$X0
M$P'SDKH62EM8I84J\@G)WP'%IZ+Q5)_*1FQN6M<6^UB7X%LN9[/^<V:.Q^#<
M1EK U&8KXSHBCF<%C(:O@\6"1-91P.)AK]62Z(FYM3H&9>/&#R(81C0A$07-
M2ZD;%5 W]G>MEC4Y<T![T/2C$V&RNQL*+J[3*"164JMX!+\%YM*U1>8ZXXB>
ME/;B/_@GZ?2%Z0WC=.DX9.?)+Q]L)QR[='+N>/QM_*8/(QH\.MZIF.IY:[SH
MJ\%%$E]_>';L:'ANFG6MV4%+0_*Y?+'X5JO#Z,\6/^\TZ[K1R?VJ4=<V_+RE
M&QO=L6Q0FE9O-;I5&U2C;I@OK]0*E%V345Z\S%RX+(=M+ :F9+ ;ONFN!3'_
MRVA KGA!@\1+5]M$0!VJ)Q-#B&_A3;[M6*E;\](/UPDL6A=W5W;2V@L* M0U
MUI%2;^YHMF_+E2^G8+F:A6B KUJ/RNF&;_?R;KNOW8H5/2ZM<8TPL+>=,5=/
ML=S0/VP4YAX&$91(('D]RI^5/F*S&!_QUJM%[:4#>0]=6QAZR%NKN[[W>(KZ
M38&MK [;CZ..V X20A..^ H,\0#\D/17FNNME %5LW%RT:EW6NK@[7B\ENK@
MK>K*Z/ZNU08';[/N2XD_W^(1O,)*@%7^N5AQ?Q8Y[ZTALV.7?1^(?N?A=7Z)
MT@=\XP,\Z*/K6S^F( @/9("-8WAD%,1,M'!(%DDZ1KFBV)A=Z7_%8>0,)KM?
M59UW>Q@RSL.^Q[ > 7 T5M3R6$3&B7]G+*(9R3N'ASN^)TRD:V#H(F'4&B9W
M#1R4#;S,>(@UQQ.OF1 #S0:A 0-U"NYS7?\YG%8M2'S/.:O5 L)6+FGEDGZ3
M7[5,!^#?1)4Z/X9GV.N8$1NZVROFUGN3%W2_IUZ61W/?G)K7N$4LC&#V:QT8
MJ-KT1>2#[6UM^A(ZHR84BN9P3A*&J9]<=,U%'^(>96RI3A-51,8CX.82FEJM
MXN8F<+/Q9N>5ZA]1L$-^MV[X?7<ME]&#,-FJQ$/\^C8NIL'[?&J+:8VJ V'E
MP'J[C6,+)"I>\<-H5("HCN%$8.:E\!#KU/EY.G1LFWGGN!OMDPM9[903C3_@
M7L:9FB#EA654F@VW8 &MW22C-_)ARO_FYSO?![]2QPLQWYV%>0S7.;EH=0_!
M+JJ Z7,PU+L%C7\[U-L]N6CKBZWKRZ&@HVDW_BWOJ$F>,&VG[_BJ>_;6J:!*
M1A7M(OS!_HIS8"4_<.8R8+837?VTW!B7Z)Y%D<LKOO ODS/6/.0Q05%M+2+/
M'LG-79234:R_/7_BWK+^UOR).V'];@-#YS15S*E""LG+=FRWH9U<7 T&S,+&
M&R1,=WK>B-U<9=EVAD&US80RC=QI%Q9@;[02>$FWF#WX4TX.M0W]3]V&CL7.
M&YJYSX)]TW2JJIO*>\H=)1R;O88I7BIVVFTTEQ<[K1I5'HWYO4K:&:LO::V^
MI'UR\>!'U,T/+$WB2<=N'))P#%0*5[(GI*]YJ?I6&?MVVT &DN;4(=Q;XZ%8
MOT$1"U05V"TA]BC?P-A8]^B@[J%U.ONL>Q1.5]7V.AP@LA3KEC@D9"E!H5N&
M+(O@T2W>*5$2]ZZ1)(1_X\HZ7DP%0F8R4>3N--NP?6,_Y$?7YP'#_,DG]B%)
M9^!;E[E+3K8QO87V85YQM/R6A1CVDO*!C,:<=I7Y.0RF$?B/[+0?,/KCE&*C
MCW/J/M-)B"N>3>-QO-/L L[/?>D,!X/M2&^8H: =8!P_X+M]#A3+ KP*QD0K
M,Q8R#)#+_\/I6+K>-5BG/V@RH]/5NP.CK77ZS:XYT$UJZ_\$0<\STM ;=8D
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M18H?3FPM";6H%7WMP]7@]F-PQU#@Y4Y:3,+U!@-%L>02"PP\D-#!SA/'JAQ
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M&TW1MWF1)I6'LG+D6*"N6R42-##GVS"K(I\/WK^YV")6>3G+UI17](Y[Z8C
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M6CM8K'RE[IOOL?JKR<#0]YP,>G6NXP1@2/)-O0U\B]EXPKWF5I:GYX#@"5$
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MEFH&ZX%]H^IP^)%9- [YSJ!H=+PA.N$BXCJP96)G:ALLUP@VSO,C1),G? P
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M:F$B&XT?*F.&V/H!*_O&"?TJ<4+32#@!30Q!NO21I3N5YR1*7?!SA"7#.IV
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MJ6-^('-Y&0.REO]=A%",QSX6,.!95Y2,Q#BS@4"S.4HPFQL:6$.9.I:^G=&
MU[0#)<8:,I>'^POJMM*Z,,Y,@5:>'OJ5WOD67RS798\B3Q.V[>9C;YH^^H<'
M@PY"6:;KUHFBL!\'C\,:^=T/V7A(;NKD"XW^#:\;^EC\9$ ^RK .&!P3M<(L
M1 .>K#9;O 03?M_!<HO\5"QY$H<B2WE^,:1C!NMV %M$<22"(-/GSE8MYQ5I
MD_)AM\SSPHG[1#V'KG][';;1P?(Z/B>KM#:DH*O:=.UY$%7(GGBN3Z;F4Q)%
M+&OE7@7P9O)_Z&C\@?POO.21UVG&7<FNZ<Q8^1YHIMG%Q ]05/FV:W6"+2KX
MKP0WT\T;'SX7R;U&>'Q:\"1(#*]8U$A2^I_2ARAAN,1B$+5_'Z[)_9@AGP!I
MW,A$'$ZBET,:N #X\,1O/%3GD@8^L"O=G^I"&^+@BV=+%8)"D2V$X+&(@QE*
M>+'R)WZ': >;[:>0)\NIY4"63$"=<@,B4P*@_&$IN-9G<M.''!(W S1\T[5G
M.\"%\\"592P!,#<4"RIE 8OT[!&P4EK9OQ@0?!E'!I*9.WB%R%.?8=E\884;
M@CFL_'D"5'I @I/0X0L,-\$<:KQ*H_,$O.E.!$[ALCNNF/4S[)&+LQZ+?H8"
M,?'-\$H8MTP\P['EP,@R\N"AZ:.Q[R%)W:-W#Q\RHRKEC$LF(_+;'UV_CVF3
MR;UAS,NC6D,L7<P3,I".) Q^9OT@1DJ"8;9Q"45V-1]SEIKDX.$)3Q3V(PZ)
MRRB&PF(!54 GV;'Y$T;*!2"MQP&NS#V0,.,5]2]K<]&HB_PS1\MSC^(LX\F2
MLX*>L>(M+ZD@=@4C=-.44[P<YBK*PQ).D>P1)%0_GK! HGMGEF'X&\@/-ID3
MG9F)1HR.DLIS23#M?'(K3H.GBS\#V!+;?TXK6J:50A,!Q'/#9W: $PK6>T1"
MB98)B9K($I5FL!PIRA>T&'!M[2>$(2#&]-Y1*F!P?&+T/_F_G-+@D9QP15!V
MLL73(E#SFUV<)-+K51)$N8>H%1) O\<N)Y1NOOS).9@CIXGN)_3)E6)A"6@_
M@ # NN!L%2 C ?-W8),7;MF)424B#>GZ3QJ'-"9_ A'XSWR\?P+ADOL)2)11
M+GF/@,5=?B7Z&\,ICG'8 3J&.7)*[<>.:_/T@$0R&%(R=%/&:W3E1P8?[HP&
M&O+!YNJAR)"_7I)?^0#2^5(Y(AS;$'80ZP!RM0_7U/*IR%68F<^ UVFSA@Z6
MSXP#1/1D%QW\@]=D<]!$QH?"(@'C\#1MF2(O /Q 6?#%P]0*L:)(^D!J:B,S
MSAW(26DFRTN+NI4@:^XE=X"\'OF1J/Z0,@:0^?Q3G*3<2:/1237'1&E<Y/\7
M;D=S-YPNZ%KJX6TX 7TL/>4 E<_Q_$!8T2E_<#;[DZ$NZ*662A8\.&. *(8U
MNDLL64G#./VDGNC]+7S-W0._W=V<WE_>K@*:,&'=^5EGA-4,\PIORQ,L ".?
MX\!S>*$$?.5OCO7#!Q$,EI<C-'1@:=!2L'[MW! 2YU>-;\5+>X=<_@_J/<:H
MTT_?=^G7T?5EU?-@;@ABE^%B@0HA;Y J;F)Z- QIM6;H3V7R3C-Y6[-KD?VI
M<G(/,R<W7\:51( B66OQ9[4JS^>&3U1(N'X",S'Q.2_QM>0[UWCY\8Q)I3>$
M'2MF^DNF+02V3L":.\]8V9?]A#?++CV)0,H<Z@NY%/%%LT6%W! G(60;(QYH
ML4+$97TUTI/PJC""C*Z^TL^2\< O4=Z_,F:C&2[^D2T9OL!K;']4D[(]JPID
M!E+#\D\3T*Y#^?0Y7P[(PIK\R3U'?.#<MX6CGQ/W?#ZWHB1\5H> CP:B*A&J
MOU.W\KT5Q".Y /#\A^NOY-UG/$WCSWN?7&G1U/+.+M?W@%H ++VLTKR&5UJ0
MRIR[@BL:\YO[R7ER>"FEZP=86U0ZN-"_\F ^N!I<;6?AZ6?0*OK4^Q&2&S_
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MJER(4^2!<ZU;VFC_2P0D+?Y\ ,I.,S)M(D\PB1,22N"MP".\HB>O!DHQ:"F
MW^7)KA],R-B%R<"'O,>&N+B^=#4R&X?C+FDMWO5<E_C TD$R79ALP AS^&>.
M1\=C%\B2]P8+B.='L$)_Q4[ [/K[=>=6F4YVGWT_@BFP<.V1S] L[UB7F<N_
MXC!R!K)1G\.3@,]/\:*R-G.*0;M__>Q2Z4:]:>!"H P1HD-DT::YL\EG#,,$
MX\")L/P,;\^>)']<^J.1$Z*FN)R+]FM_]*KN#P9P>BG@13[?EU7%R?XGI@'P
MLCM)4J/E?:OW,YM$_3_D7>8+KG)\\^L"D!NG+;W;?D\& #WXY+_2-XYA"7R
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MA4#!(_ ^&U)W@#(#'\2I35S GQRPV(.[^ -I' W] *9NKY6<*9:<I]].X32
MQY_"TKMT'++SY)</MA..73HY=WAZ]"F_Z8-\EL1@>-Q"UCMNLOAZBB/UAL 2
MF:DOWRR_KL-79XN?M_2ZWC!ROVK4M=S/ESU*KYNZ7LB3#*W>ZKP\J+>4)&CO
M9=;]EZL_>W]\N[HB]Y?75]\>KC]?7Y++[W>WW^]Z#]??O\UDDLO5F=, -$F7
M.RSBD%Y6; F)?=BOCY/S#:H;5+[:Q5EX1AZ&\)R0?*J3WV+7)=?7UWE4MQL*
MDX#*Q=XX(J":.C9)EF&?Z*1*B[I/ZX:5@!S>1!N-P<NAPP:+7;<6EW*=JA@E
M%E?X!-;L.3^LEJ%S76'RD@/4_];4\:9*'"IX?<:\1(^3FML ="G_&:,8QZ#!
M^1Z/7I3*G7Q-1DL4K@/^J47'U!(OAP7##D?36('9Y3\TM<]HU$VS4XBRI@&-
M%:1!\E&91>A]E1>G[YSEM8_V4S]]H??A >NF[7F%1#+O?NLD6U;V%A9-:7$'
M9ZZ^4CW;1V#8 V%SP-)FVH,2":UG67[L\926@Z*Q(Q,^GWR/NC9YJ)-?:6![
M+%#RY^5%V]6"[=.:_ /8GZ1RJ":1@AWYJ@A1O-"YMW;DR_(0,!K& 3 .BI%[
M9@4LHMBM\!"DQSYH* >GHO3(B/[+#YQHDGBA/OJ S?C')R=@5N0'X?E^T%?U
M1K3W%(]:SA<LF4MN0&:SH7N<M<1A&82G]7=_Z*'Y?!>'(7/=3:11D4I<>02Q
M)6(X& T7"420RB<9E/P"J50/L*HWHH. T!L:/%)0U<C'.KF%MQ\MBB8F\^<Z
MN1_2Y^/#S^U1PL% Z&H2J1Y*56]$!X&;L^<5M05OT4Y7[C  J)0EK1Y[5&]$
M!\&PG^@3,,4]&$A#Q[,5K[Y1$N)J"BOB/K$F=K.NU6./JHUH(4*O6EE.54D-
M:>G+$YK.^KX]@7^&T<B]^/]02P,$%     @ YUW<6,GK"JBL%   7^@  !$
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M3X?WEYTPA!5\T9SM0%Q3@REWS[L!5<_A$N$+QL<L[?$NY!2J/XB;B^_&HQ:
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M>C2QX)(&RPP719-_0JM0P7%R>XJ@B)["^6)LC(B-H7.=@DV0H_ZG(V</H=T
MSI^?W^3S+_1SZ_* %XO33QU^K%1_/F=6RSJ!NSY^R(*!1Y?3J'*@-RQW/*P"
M\AP"%%_T[WI#(4>'JVG7TWB>5GXS"_/E2?XOBD[KJ_] BDIJ1%J3/UXS#>2_
MU&1=/1!,2H"5K/CL$\N^=8Y_H*4T<;3N(>L5;>'9]-\];EZ7[T32?C[_X3JE
ME<3_&V;K_@_.]$)EMF&QJ& T:?5,FQ.C :>5!I\--\DJP6SK@H_A5[5E-#%P
MCG,$V^1.GW \P&H;F=RQKI^(D7/,5SE*?/QU'DX7W6KZ;\Q_"]-Y7Z?039=D
M!G]:=_3U#7;319\D2_5430@#7(=,B[$6O%8)M#92<R=RT(=227LN94P1TU/:
M&8=$T.#;82L&;[S,[WN?.Z]39L1Q@X["S$QAIN:1HLY"CJ O1><T1@N^_5)'
M%4D^I?TT)@@V/-:XM<X+)M)/9V<O;^HJ:-&;%,1IQFQF"4%2S%UMJ ?/! ?!
MT1I64M&^=4%:XR4TK,Z+T2(3%J$8$T!9F<$C"R"=2JFP8IQL;8/'6<][3)0]
M4!&\C7S&9>'N4'G&2,FYJ$NP#)1,"GQ K&5/7*,+3)KFA4:'B$&/?(0Y)NB.
M 3H'V0>OR"1./\Q?K+L.Y^G;^X[H#FEUMK[^IW- W%X+16Q9:^\ANTA6-!<)
MSAD)F))RI5@3=>OJM&%6LJ6?]O\WP>%P<PCO:T+;+AC--41?R\ P:_ R"/!%
MU_]0,=&Z\NX!<L;F9R8O2ZCEPL)'2\ZR*?58T-*7%$5BR%R,3\G/'*U_MA4.
M;]?M'$_JA]BDF]T1LCI[83*(XB+4PR@(641PBCN;K/="'# D>G+7NXZ S>9B
M/=@9X8]A5N\^O_N(N-K[YO#U#VM]_O< J8U.^]ZM%NFWCXL9X77Y\E_KZ>K;
M)(K(E$\.4@QDY84BK&@9@(6 T?+,E&M]=G2;B@8*Z70Q[S^WGF+@1!4LR=H(
M F7-U&8/0:@()25CM+5)1-]>PURC84S6;$^YWZ$H=F=W,RMTDO.TKCW,WH1I
M_GG^(GR:KL+L"G$3D:(V$0T8I)4J*34$9!ZXT3(289[9UE5*CU,UIM.;QL!H
M+))F4'F+JU!/?EZ&;DX6:WF2TOJT<AUS/1-*4PK -%>))0/)U;OPG@L(E3@R
M7,H7X5'HUL'%XU2-*>)M#)7&(FFG5;[3\5!<?>EP%<^E1,]!9T$.EW0,/'<&
MF K:%9VL\:WMYY8D;EGN]I1 -*2PFB'J?8=AN>Z^7;&7!.48)&=0C"-[F031
MH6,"66KUM]4JB]9VZ385F^!"'RJF:0R,/7G>3/:_3$.<SL@F8G]-Y_8B?<[%
M<<;)_@D!RA4%SJ@"Q9DB$>, =UL>HZGAFB=9<,=*S!"=#A02&@I,K2!KGQ*C
M93.9I!UN>6-RP9LBX2;<=V5Y,YS?7L].V2S$H@+W#&AC]BGG E%2'*$R\20'
MGIAJ71K>AO(Q^?2#(NT(@FZ9MCR=]F<<E3%GI?8?<)[JKF&LJ)0#@K?H09E$
M/ DJTX\BEJR<1-7Z!MT#Y(S)[Q\43JU$,H3!GDB3'=>^@!"U:8XF=>I5SI#0
MZQ20"QY:GZC<:[RV7PE%4=AUF"\OCESY;'*()U(K8J FB=E<V2L1(LF+W".=
MM&5*,=_ZTM\C)(W47&^%@YL ;RF%MH4&5PDA)=T?$%/,'9PU*2?@H>;P&29P
M+@5P2M#N#L4(-TBQP)W4C-2J[@6(1KQOW^#F%XJ8\(*P;U?(*L9*IW4B6QTT
MX905\,XJR-G87#4]"ZV;.3Q*U$@-Y'[(:"J)O0%23\)J@J5;8WYY^FFV^(9X
MI6JJ-J!8UKO(Q;)0P'JTH# D" (+:&<,DPJEYC<2&;</V#9YT)AR6/O*NSEC
MVXBZ7ADBQXO@=P?R<I9H:]?K8"*2:I(.0B8?SR=-+$A&AYL)JWOD_-!3MDQ(
MC5_(S5C:3-N?483W:IB436!%:A!9$%'D:$-DAASOE*TM3$K4K2]]/$+2)J P
M3P040TAAB,CGQ3D=WC%C'(]0<NVX5QR1H"D6<UQ:*X1D1;0^V[A-Q28 L$\,
M 'OR>G1INR1=D8(<$4=!NA(UFR,H<"^A6.5ES#ZW3F(/D;9K4D^C8V8V!@[(
M:E,O;B09;A^!ZRR\UCZ2<W_@>IJQU9X,CK''DY9;B:G9=OO[=+[H>@:<+TJX
MVFA?D0]0T_3*FMK2U"6(G',KC+*!M\XZWJ1A3#'V"*"REXC:%2$LETA! ')4
M3J4,]"@)2D4+404#4@2/II"+Z%O7I)P]N4F"Z>RCKK@UZ!G9-?)XT8L,2L9(
MSFZ6P+POT6@10QSD/M9-0L:D'7>0])T9I;V8W1BW%RY-K3U7]6"@.%[[VB4'
M+CH$6JICP="^S*WSY]<(&)-J:R#GW9G;3+ZWLMGGL,/5)$0OT5D.L8C:S+0@
M.!<#656N0N*D1)NWH+R?FC&E!QM(OA';6XY;^83=ZEM-5ZU.YKG:ZD_G=\<F
MQ:,MB:4Z6( ,IA$:@@T9G T,N2O6F-9&ZR%ZQI0Y; "%9JP?Z #A;67CZ_+K
M$OO%3KSPGEN5@'&L[I-%6JM/D"/+.:/EJ7DX]"!!8\HQMK#]S9@_D \@N<_1
M)08A>$N^."H(QM5#3JV*9I'IYF?H#_@ NU2.+RGB2"O,+\+R8ZU1H&]UTWT.
ML[YJ8?4B=-TWDL!9E6&P217I%'"53-V"9):9HMC#"^.MDT:;UGC?DL3Q>;^[
M8.5V.?EP<FI7@+01:3P;+6G)(%*N%5&V@!?DZ,F4G>29Z]+\TDHSX!S6G6X!
MG/8R:=AS^3/1LNB^5=ON)7<A"0$FYGH9PFCPG+P]5BRMW0:>76M%>O7YX_.H
M6PA_9PZWO&ZR6!/@WF)" E^<U2NW%TL+N9@L98;D6)TZK#*$.MB!)3+JJ(LD
M#[^U\7R GO&YTBTPT$P"#<,K_!2F^;SU\D7_FNLK+L%@D";44DL.*J %G\F'
M+"%[Q4-D]+UYE/4H6>/SKEL@I+4\ACRRI3C"&U-#"+))!%AI*?IC"%S7LD+M
MN)2MH^_'CFQW.%;[N.A6[[$[_7'1=8LO]7K@)"567$P(==81,9C7@38Z@)7D
ML>D<HHBM*Q/N(&-,SO.>TK]U2+8GTX>M4;E,>XJ@93]H7MH BK8UQ)0*<,>0
M2R<2^M9Z[R%ZQN03-\9#,S&T+5L^+YR[8['6VR*8J>-M;2*P6E]'HD2B*24C
MK'?6-4\U/4C1F'SFQN!H*(IF\+BHI7R+_87@.\ARY-VCIM@M.%TG64@-]8HI
M.$)K]#$+;EM7,C]*U)B<ZL8@:2N0H2O>+VBB@#XF'@/H%%.]SB3)DV,%F#+%
M*,U*E*TMS,,4C<FI;JU&VHFBX2W!VT,W;U&F7434Z, %[T 9R\"7) $+<N98
M=%A:7Y/9A*Z1%LNV@$ISL0Q5-7]!"QJ51"CD+!=2<,KV:HTB3M)O%H6T5M]L
M#+)QR?RX*V/WD79#GC9/T;T)WVIVZ!)K+&GFR+-!"H9JM[L"KA:=157KQ;*U
M%#P-E)R[3LDF,'!/"P8-67^<861A^?'5;/%E[X:#=W_HH(/'[B:]40/"FEJE
M![SI%I^G]&D_?OMU6<M::AY^6?V D[2:?CZOK^>9T9Z68&T-,8T4$*-T8!$#
M*R48X5M7"VY.W=XIWO"MY_?[Q4GZUWK:(3TSK^O'XWE50)3*98(V>!-J0VC:
M,>03:] :HT2I#.VIU@G>QX@:U4BN@:!T*_G;5%)-CY)OG%G>.@*__L*5=Y[-
M6?EYGFJ7)/P)S[Y?UEJ__)H^AOD'?$M:X64IF%83%E&AHPA>%=&?@U@(C'2O
MU44@-TX7UKHQRV%7N*\\[D'C98!S!8U1F\24)?_4U=XGQ1(OK4\0C XR\NBU
M;1T[;$[=F!+<(\;X32TQD/B;J8LME*7-,@G##45.K+:E\.2YV: @HY-:&,=M
M\PX0N]K=X^;;GSX\]Q7_T/"\# 2OT)>4#"KS",'5;D/19/"TGX!+LN.>QZA]
MZQSNYM2-*>/_].&YK_C;G2ST2WQ=KB[[]7PO!D\DN:)>2 3-@J>%U+!8\@+%
M&@Q621%D:S4[P#+&='KQA !_;$ -K;CO\GLLUR77^"N;VM'$% 71]&Z0Y2FB
MQY1;C_[;U>W=Z4;,]Q%ZAG013X"LU'9X*, +FZ#(K&6.BI?0OC)KC",.!\+&
M@],+-V=]PSMQGSI,TYXC$W2^"&G(>]*.R&<%Z[\4,,V))&7K)9S&PK_Z_#&Y
MQP<2_\[L;WD;[O.T3AI\M>A^6JSCJJQG%XGK"4L.%3T5 J]-_H)AX+U)=?H!
MTRA5I$BPO3:XEYXQ.:B'TP]MQ-.NZ\K'T.&/Y%[DVJ\>Y\LS\&HEN:S#F7GF
MG,";B1:F.'C.O W!<M7\ZM#=E(S)J3L02!J(I,UY\JVKON=5Q^<-XOI)!M5;
M_#ZO<1*ED9X+"<EH<OR<4$#$<7!99'J%G-2;5^SN.6C>_MEC*DT9&"F'D$[#
MFT,WXYC;MQPF.<GHM90@BZ$HQNK:8(SXD6)DZ&7B(K2NJ-Z$KBUK6(YRR-1:
M_327UX!(NK@S5=>L0V'&)T_FLV9CDK-0\0XQH6'D<C&66L=T#Q*T947,[Q0[
MNTKH .KGO)#C9)YO%P]/F,E*YX3 DND[8DIPS!H02GN.W+/0_.1A-TK'5'%S
M= W53*0#PN_";K]%VAEKG&@FC%6\0+8U@<<R18P9R>U/D>5HM/.\]<7*1XG:
M!%3^]PZJ?035]I[)'6N]*(VZ+)>:6)<+*SP #Y86+P6"CTR L*'H'#0O89".
M9IL0MU$JD/V^ #6,Y(YQS,D"+TE$!=G'.JVLFFST%DIVW$KGO?,'.H5_])AS
M]^JW5XON+7Y:=^DC;?[7Y>J84*M3QDA2X3Z0W^*SHXB)W-[@3='T/[.^=7#R
M.%5/H?YM7S#=5__62%8MLZX),2]?$6-^7B[7]:[BZ_++8OZAWF']">-JHD6R
M*+P#*7C-!FM9!P@5\D!\8A0M25E:CYE_G*HGD*)O#J&VHFJ3:+M*U.T+!Y/
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M,Y*!,79W?=]ZZC$J?A?!-GS1,PY.WN%I&/Y$"&<7B[TKLF09YQY,261:.%1
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M9MOI^LXC7K)B=Y-70W-HB6H\2OAEO&0;IK.W].MD%):!_'42N? \E)) ELA
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MK(S14;6.F'3%UG"[#,/AW4VR)X[<V2/[4,5]B67?U>7GV=_3<$R[[3^^)\,
MK[XY)N/@S]E/P\6V3+O.,J6VP670_4NZ-A:B6,MTR1R*\77(D*]A(5JA*!&5
MR%&C;S^KZU%8^ZY.Z9<.=^^!FJJEASS&S:N_FAS1!6)/%2P=X!VFKJ6Y:KM2
M9T>]'(A"*5GMB^7 C+'UOJM:MS:"CSGE[$COL759Y,&H\TA]S'-@SC;JZ($Q
M[\CL7)5[<"ZRE"C!FEC(S2#?)VK)(4K/=1;286I]OWCU]/V7T#17SKB)9'NH
M@'@]'PQK4O7;\R^3\5>\7KZKG5:2B]I\OC8.19TA6N]!%LXUMW38\M;QV\UH
MCH\#C23?PWO_2TAG9,Q/+JZO>EWW%:*U!1EHM+5./$F(F8PM\KZ]P*BTT*UC
M2P_ .3Y6M))]PV*'VC?@8PU1+<Z\)+STQFL@3T[7Q97:(2)"X2&8(KF,O%-+
MK4<:95P^\"@]CZ>+M ^]KNC5!4;#_C?7'KW_EC=/%/YM]>T@N<:-;:[#T;I(
M1.<@Y)KR:K2%D(0!8471A7NG6:<94X=6X /M:]KJ;QN!-=;;+R2I\_GY>H?/
M6D0A(NTE-7*FO()H@H.((B2E47'=J0KU$<W=>.A^&] \6>SC%C)KW$#NE_#G
M-2 Q)(<F)D!;:U&L#^!ST"!C8"S)9 OOY#P_IKSK#WV!RGNRS/89$UE>KO&B
ME"A.@[:EU*3O#$&9 ,$R9U4T1OC6'M##B)Z1O=LFW-]0 ?U,')F?SX>U]?:/
M^&6":;"XL:6OA[@0^RB_.A]/9H/_7GQ_<_6 8Z((KS(D)K!F&= >)44BKF>4
MC@NI3.M[HU;8CXYR!U'J/O>N6OVL18[.2 <672V/J]W_C>> D?/,R5M!WKK.
M^"$\1T>B9L+OH2G!1FR_3;',A[4\[@1+9JBC >/J\/FB:M==QZ%HG05GKM#'
M[HL?5["^'9H\414;&Q4<(H%G_5,_A\&R]/(_!CBI&>T793Q9E5:%X;)T-XSR
MNL9J,70B3.>36LZ=YI,)?2;]]:_CT63]Q]=A.ICVGOVS'_S[2QTZ@#X:Y1U=
M(GX=AK5H]],98K4 YU_HX9?(+SO6O0G+?+BK=Q0+%A$B!^]+ N430A0I@U&6
M*=IPDS>MH]*[8MYUE[]Z_L5]"):QR11('E+7\<0U.S"8V@:#CB//B@M"V6)]
MZVV^"ZY]Y2KME5>W]_[F"GHN64S7%G9WJWE72YF6PR6\(1E%";&8.G:*5A5T
M82!31,M]R$JUGLK8#=FA;A3:$V(SXUHII@>_Y1+:ZM197'S>Q;N>,M,!;$])
M35L!/4QZ4Q\:WT2JWM1U<(YYSCQ*I%W>FAIE0GK=D"5(,A/X6()UK4>,/0-N
M/9+_].RHM8V6^J34V]&7^6RZD !?1[&YS)(K!I$S!BHS HG9D!"X$Z8PF4WK
MRM@'X.S?B^Y1D9LHLZ,6>@@6WP=-7%Z6!!MYR8"^#MH*@D&PF0'** H*RW5J
M737Q )QOC2!/T4(?3>?7?L:R&+'6@(U'EQW7HPA*^)BAB-JG6VH)WJ4".D66
M7?;!^-89E@\".EHKN9T:>HC=WL*T>B&Z@.K)"+X7T(%G5.RNN'%?4N]AV[@?
M7.::\<)U[7GI:8\T#KPJ$IREO:PHCR&TCNSLD0I=9U?LB0G;"+OU#(M?QZ/_
M;QZ&@S*X639<KQ16YUJ0O"@1R?(6M%;E90 ?G0$=,YGAR9D2;B6>;&C_]OBS
M]F\Z--#(N#]Q]FE'OKY8Q.K?#,-T26SALHPI1W B.U!1*7!H&? 8C#*&5LY:
MSRC8".9HS8,VXN^AH_@EL.4-SOK.YOWHXXUKFM]&XSC%R:(/W<(&IK\>C])@
MN$QSN+ZJU;O495U]A]@:K^G@T;A=J+.)D,]![WT&5EJOKY9.A5P0.&>T"SC)
MR*%T"DQ*265'N[CJ;;M\$7SN'@%\"73>1MVMC;3/DY 7\R_7O;56IH2IH2CO
M$5 L)F"2%>J4]I"T\:B+(!NFFV6VX0$'C.0<5'WCQK+OP8R[VYE\C8O;XKQ$
MT$8(4"E8<,%KR#HSA4A6+.]4G;'%MK0)RS=.GZ:JZN%D_!$G@Z^A-NU;2NN$
M&9]1"PZ)&$QXC(&0L@=C7*+E,ZV;MZF[C>& E#E$$L=.*NAA5[G"<RU]ZR0;
MGGQR&6S1"HB61/Y<.Y-%)E*RA@75.AAT+Y!OEAQ/549K.^0NHHO+M;\OE_+X
M,)XN]/)33=^;#FB3_6DT/U]-^/QU//MQ,%TF%/T\#*<G/*D23(C O..@2&(0
ME!,@C)$\1I'E[3X &XR8/M!](Y1['MIM>.&Q#,;-JZC?EU_'H__:%)2;GLB<
M R<W%"RGW59E*\#'P"$P(RR6PIBRG?C7Z7'?$J':R[]AW.L6Y1?G;P.Z9UE=
M5?(*:">N38P5>,,+:.NS-DE:6=*6FUD;9-\2[PZJU8U#_IK64*R&F5:_Y73Y
M:9?Y^;_2BL,0I^2XCJ8%R>_(L_%Z?B6]>.'#>% S^S\/SC&,\ONO.*E?/KT>
MHC<L#6H;]B.G1G4*1+IP>CK!TU6C]!7XJS?"H0I1<PTE*.*A\1Z<,P%<G<)N
M2G"^>?^TQS#M[''<__G+BY9@#7G=BM9KE*/WSB6(F;Y"&ZPMB@DA6R>M/(1G
M7W4%37EPQZMH)?#G4B_P3QR?3L*7LT&BI<TF@SA?Z*0&DEGT/AHD]SE*.D$*
MV9V.-BZP:+DKL1C9?!SN9C2'NM)LI_!Q+X+O(;)U/[)5**\+MI[N(Q_"=9@[
MQ58Z[$2-'12P;Y*D8,CQB!J$)\]$I:0@:I\@".%5S?8-V#JC=O_D>.2"[A#<
MV$;N^^0$3F>#M$X$C^26YEA[0)7:?R\*B)@M9)-0B,02_;8O;ES#M7\/KYTF
MNU+DJ6KH(51^/\:?QQ,<G*Y3O3"ZDFQ-'B,WD3Q8GBM$#D9(+E*)B<M.S0QW
M9LH-6$=/E*<KH8<MA7S&P>CT?5F[F>_+/\?C_'[R"2=?!VG5Z%EH^I]""#RQ
MVM$#P3M9P"<T!%#Q4%K7EW> =70&:VM5])"@_PC$=<OW#B![,F$[ 3R,+=M<
MO=O19P?=['_;N<QS%CPB:LAUB+"*GNRXI"W$B$7JD'AVK<W< Q+H$7OW>?!G
M&Y7TP9NK:.@ZXKDZ1Z52M,%:!U98.D=CDN <G=/<YN09*QANEP'LSI5-8/9O
MPO2@O-OT:"+Y'BS=:\!>S19!\;>C:^BLYL7IS( \0E'K8<C2<KX T]+7**62
ML760]F%$1TZ.7770PZ:QLM"6DUZ7\^K_<S [6U^F+"?!DH3J=1S]ES^'/\GL
MCRAE'3V<<P05JEGN6(:BR9-3LD1,K7M6/@'F_KG4:_"_;T5MW'UZOOQ\E?/B
M]S!\.RKCR?FJY6:[&\V''M#+-67G%>UX][BX,+_[^"NZR2P,^>,!HHD2E-"%
M-BS/P0GOK>$"-<^/R?.QA^R4PW'W<Y>>HK"LN"@9:(EUU(DC!H=<"_Z#8%KG
MF!E_(O"]W 8VU<R-_(@6$GLNMW_W;6,_SI=Y' N+W>=2K)%DL?LHZO8E(8J:
MRA&L]](%P4/K)MN/8=IW8*6=TF]GMK<4?@]VR4/XULU .B#L*93R.+K#Q%':
M:G4+RNR@DL.0AY/Q9;FL6Z[QH+QRX%34D!"M5%I9%EKG%QR*-(_$3@[-F6TT
MT3HK_N?!-(7A_\8P^?S'^//9>%[;WW[^@PZWBY_'\\FZ[#_31JL2;=1&D1-O
M$IG1S";P3#O$I!B7I9,YTNEQ^_=;6BMIW*N$^QAU>"W-]5W]Z37UD^9HN5$@
MC>:@K#,0K5:@BY0I>FUC\R#K)BQ'8WDT$78/]S?WX5K?<W9 UI.EL1G582R,
M-MKK0(D=1-^#1?$ PJBM\\$5D +I>"R(X"PO8.F%$(9CIF/@A9/B$0MBWYS8
M1N*]C%?!+V&0?_JS5L/@]-4HOY^=X>3-HDYXMBY?7IQKOMB41(J UD6@;3+5
M>9\,BDA9&^V#MJT;371'MW]#HY5.[\S2Z$4A?93^WV-I+?#5X3!*)9UD*9!S
ML,LNI;&6F%O+,"1G<M"M>\4^A&=_].@E7-9<Y WIL%CP;Z,X& [K:(T9"2><
MXHJO)R+6W!CO@(=$NV8F"RORF.E]L,IEJ[17LI.[L>D)+URS[:2WI]##94WN
MB=8V2,XM;6OD12O'!00>'*!C1B>;Z2];VPH/ GKA3&@O]-9US \BNRF._\;\
M@=PRXC"Q^<0(K9D7D=QL5"2.FJTBM "9?$"#B4>O.FT"3T7PPJFQ/^GO9_+6
MVQ&A):(-R+YI>V/:\9,;7)4^90V-ZC/7C[ZX8A7S)ELM$P@9-3DG@5CEN0?.
M$(O!Z )K/87F+HI=CYO+3UP=?\OPC Q&THL1:"TU8EM'U,7L#>1$Y/4"N<JM
M@]OW ME7U>6.VKU]G.PNU$-?L=9QRK3Y3<?#0:[C3'\:S18M:)9=D,FTI=5K
MR$4[4+I.)RT%@1E&[KJTWN5.UZJ/3*/>]/Q#Y:8WT.JXL70;3XR_#]/:O>Z
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MD!!D%F P2R-=8/;VE<FWTDFE:37#CI+?1_+M->+^BK,3K11SR5F(TM)+P;D
MQVIIJ)5D?27A>/.2IT<@'1TI=I!XORFNU_>PXI)-DDPIS9VJC6<3A,"1/'+I
MD QQP6./]_$'.3;V&53=2KX]N#DUK6@\JD;S^[L-(U[=:!AQ>5[J$&SRDH$0
MC#PSFPL$D0U$&XBYCJ&[/=AB9TH\ >9+YTO?FNG1[[EJD;T 6S<WE*SVOU:
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MNEC%1_PRGZ0S6LNZ_&G7JK!MGM&JS.O)ZVI4M[5\\)MAF$[?E\^U#]=\<K%
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M([ 1R/X]@4:*&O<EY<;>P&9PT6BI,630VM4A&'1Z>>456(E)IH">_O?R5/^
M/[!/S6\CW!ZL@NL)NW4,L',F@I:"3-1B-2W..,#"A"I.Z!A;9U4?)&>ZH4+&
M;:39@\'_$;_B:(X_TZH7@VU"FOWG8';V9CZ=C<]Q\M.?:3C/=,#5G!?Z+W\.
M?YYH@=G6^'*ILPM5##5KB@7(G*<4C4'TK5L./P'FP>+!_>4*]*VLUM<"*[S3
MMZ,5L.NV;LWZGG\Y\5983"E!=BD0_XO\_[N[EJ:V82!\[W]1D2R_=.E,:'.C
MT"EPSNBQ!D])3.V$DO[ZKFP'XP873"3*^))#QN-]?5[M2KM:(@(,DIB([!6X
M&.&JE]51OX#8A"#A1;]>"F5O2]!Y+?%",,:YI@DF,X!83#-,DZ04A%/&0XC0
MG,I]UVE'?T+F/UB]'JI9FTKMDZ*J=@XJ7VU0Z.Y(ZQA0?&B>0]\$U?P>G1C2
MQYRWW-;:P*71%B"ADF]V>(9JO3 J"FF04,1NPMO:?\FL*TL88X')TM3]OH,W
M<28(Q/=B?(<);U\T9'E^?XM9 ;2%P8M8"1/P+",ZJ"]6PS!0@0J)3J.$2AX*
MHUQ7I0RP,ED\':9T#Q.T3V'=(7VV;@9!VGV>BV( O*'DP",6$Y918QMF#4DQ
M04 LQY*RB$)(75<VCF9R@OCQ:R@/[64]AA=<AID*0DEB2.U<;LG0Y:41@4#3
MC,M4&>YZ(F*/@:DC8I2"/8R@;EM(HI QRG5"1)1B<&YOHA&A5"1"\6*1:<B<
M]PW^K[X=[_9]A4H=#G1^:&N3V_HX]Z*8Z9^;O(1O96$VVO:QM@SB0A6G)DZ(
M$=)6;F*4+C3FYP'5)A"1DD:ZWCUYEJD)PL&M(5P/;=ZS8JT[ +,\FMNVIRK'
MI6J^VBS;Z/DDK]!*/6:>:N,:@11+L.J@8DF/:^UR((*C#J^V17BW&S]35;TU
MYB7VWJ=RJ,-H#AK:,-?UA]]_^9M_Y<]89N^;?5(7/DJ<UM=0?BZ6MR5<6YIW
M\"A_Q7ST)O]=8_8L:UF:K0R&C;OY*06*\3"$Q7:$VN;0YO"W3G+M[K/C0BC_
M#+]W<+R=S0;WQE[I[&M%5: _7A5W1Z#-T>R7+,T%4CE;W6Q'>O7'[VF HTV'
ME_Z;1_GS,5RZ:LV]EB4<RPJ,M2L:2C:(*^7JJKE@^'C;/=.NZ#5;#[RAD:TQ
M3^42OO2.:EWU ?E@\> S.\1RKM=@SM>%_G&)=JV^GU]^[7UOS@[>_D7K[<-&
MCXC9/VU[@9I=WT T0+0ZA_(NUV"E+E9=L2"-4T4%!:(@U"0,3$R43@Q1<:)
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MZID%+;<.J[1< ^BJ&,L97_/67+F&\ZBTRCD!,XO[A_B_Z\4;(2\D2Y5:%S+
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M7$N/1T5(C;_S]OZ!Y*7Z:1$Q@C(:2U^$)@BB."20\C2$<<PQCQ!+6: U<\B
MYL2ZWG-PU>P1M>4,&RZNP)8/,]W7 5// CB&R,P.:*,S;11C@($C0Z%#<59S
M80#!H=$PN=7.=+S.,L'J#]GK;ZQIQ*O*J3ZL7I+J3OU?T7LD2]%4;%=UF:NM
M)?4/DI?]7^Q<N4C]B.,@C%4AM0>1)S*(&<\@#3W?QW$0"F24:IV QXE-4\NQ
M2CB*CN>V7+/]N2G19I*A*S7NU<PZ3?&^]*S9,[\%,^NW?0$]NVW9IP3^90.\
M^A/LL'(%MEQVERB+>?#+_3M>2C\]7ZV5K]6U02]6#H;#S0"X(U,[!8>SFN8)
M(3XTY5.2LC/]3>GGB5* XX*#ZKVH?U^1^Z*LU;#P7TG>5!9<EWDE/_Y7ZU+^
MV58DW)!O"^3[*?*D:YD$:0P127U(2,A@(J/,,.99QH*T/U9SH[\*3,2NE@W:
M/YES8U.UWY07U>1;:_T?"OE.19UWH_!H5]'TH+@W6Q"F>HM^$D0!QACR9DY3
MRA*8<D1A0",<I8$0OF>TB#_GZ[ODM,6?[;WI+>;?P=LP6]"[.O53-7M]G=_I
MRD'%\&8.><LT:+GN"@JO@&3<W:H],;*.5NZIN)QU]9X8ZL,5?&IR=JOX-6/K
M^_52K4OG&%2T#YA4_URL^E.Y'_>L6B_!ATS9$XI1PF7 !A,19A"AE$""/ \*
M(CS,Y?^"+#!9!R;F=^+UX#J3-T'5')RP>DW*G"S!4K)K9ONG?F=Z:\!W]";,
MUH(=QL&I=>''EOF?@&+_W+I U)MT:_IG M31$C UM[,N!3-!?[@DS$76^CR4
M*$O!6T;D\]YMIQ-*$@M&./=$PJ ZP011B")(?1I#@FF*DXQRX1EM_(W0F]@T
M]]1!ON.S&Q_R&00LSE*&,?&@E_B9FET;0QJ@ ,8^)2RA410A8=8PP@5DE[2-
MV("FEK2=X9578%6L(%O+?S/=/QD#46]Q<O@MF2TN&T2ZZ$*2!N]V@7D_D+*U
M.0VD(Z:[@SN#U.8^8Z,C^HGC,%JWF3=M_FWUD*M#J3?YO>!OBL:8_XTLWRS)
MK6[CYH%'3&S]?GO_\>WNB>:&@Z9UTU['P.'NQD:0#.NQ0S3,]-<$"/!%\>)@
MMU-36JN.ST//G:WKLX9PNYV?=2ZW/.PA;I6;]$D\J.!Z=;LYB\"Q2()$^#"E
M!$MGAF00QUBNTI1G?ABF:K2\T?F.,X0FUN..+-C0M3_"<0XIO078A?QFFFLE
MNOG!C!&Y7)W%.$=FWN,7(\(>G;@8N]XZ1]7V<R-/ZKS7R]:M7" >D$#X*4S5
M]A *!8&$,P)#S+,@XZE($]\PM72"S-09H;YYXD-+U3@3= H9[03.A?(:YUU:
M43N"5^#E2(!@DT(9$,E=YN,4D;D3%@."GL@S#%UMIY4OUOE2M?Y^>_]0%H]M
MUY^NPE4J8$0S06'DR1@7I01!["48^IB)F. LQI%1TO<\J8FULR?<%'/D.]3-
MU'0 *CU5=0. F;IN9-\E.D$5\+ALCO1V@-"LNCLN\*'^:MQA6_DK'DC.NW--
M59]3[ S$=56)S8?*_"C!2>I)):9JA%L00TP8AJ&(0I8RR@-J=(I1G_3D=< -
M(_WIO&JWKUG+#&BY,:T#UH96SP9, YB93=#&:@([82Z_LXI@;<(S%P:; G)<
M'VS\!/.\F*H_ZPYBJSE.U]_R2C<?=N+6B8W!#D7P2O0G%U7&1S'PBW[JZY34
MXRFO"P4V4^9A667T+*D[2FX-R&65U#KUO-F260/"[":QABZS.#)\/./UIG@A
M/DKU;8H*_B%(^29_% N.XU2H&1&1QV54["4$TB#S8.+[(O5]YL4,:1\?UB0Z
ML5+>2)LDF@UWDX'SFG@-*^54*)AIZHF!RE?J^"P50'%Q!1H^@&($*$XF@,G@
MC/$$<-F=-W8&F]GQ8T/Y!X\BZSYKOF/)AM+M'5$VO=>IF6R>+C^5A4\2/R09
MAAP'&40\$Q +',',#Z@TG0$26.LHHR:]B8VC_&92)_J^P><BBV@CM6-CV.JS
MO-TM+$XLH T\$QF_<9A<F;U#H2TMWN8QWX.Q.Y1)T\X=W69AXGY?R6<NFQZ=
M1!*ZW:3]19:(,,4^9$DJ73\_C"!5+:>2**"8H<#'2:QMV,Y1F=B<]61!V=-5
M!5G+-6\JLT#1Y!J(03YF&++82R*Y&J30X[$/498ED%"2R%5!"A&G7I)0O'@4
M)2UF VV7FC9LZBRAVFGKH)D"*HUEP87X9HO!YG/9D!S?53*0V<#FNY#=SM+;
M8&!FVL=D&S3H9V^>SXR/\;]GO$<OMDNUORSN[_.Z2=U?KWA[]O=6R%5"5(LH
MQ5[BQP&D:4@APBR%.(TY#!$3$:(!\3.C2MH!6A.;[QW*36YXCS;X\7U1"^![
MAC.!AZ#3RYT[ L3,-@UBX2XOKB&;HT3X$*59,]\:(A^FNG5NL3P'W9[=E\Z>
M(%)=MN6DW=39ZM5:;(JG$$IQPD4(4Q+'4*HWAI3X1*J[YZ4DBGD6&4UP-2$^
ML>IO6#$\R&H"GYZV3P6*F?ION]UUW("&G:MS\=B;O&)DV89EOY%Z74[56]@&
M'E?G1DU(SWL8U *4HQ.>-L\PWU![NZIR>:4:C*H.@JKN2XI&6;!W^4J\K<6]
MSE:3QE.FTXV...BH@YY\LTXJ'@17[8/!%\4+:)AQM!-E(+;5SI3.\V?;J3(0
M=G?GRN0VRS)LV^GMW8SVU]]$R?)*%;.U4]H7A/@)B], "DX)1$15<F=<U9U%
MF"<H)H2;]>=WS>'$J^\./36<4D@]*K*FS6[3;[=2O.HVW)WN+>FMW\^*O9DA
M:_B #2/[!T1VN 7T">Q>UW$,&I;[;KB5&D"U8?L*M(P[K%N?"E-7!>_.^9NW
M4GXJ>(]*["<C9)&)[@_3W9!O;;'09\$4%3]!GUY?<VF)V1\+X>$T"VD @Y3&
MJ@-$!(DO@Q],L]0+/4*9'QND6'5H3IYNW3OWVJ18KT#'!Y", -+R89""U(+2
M1U1@0E+(:>S)Z)$'D$81@PE)DY1R+TC\1#O![QI(J]-*6\@^_0NY?_BWU^!Z
M&N@TLM>N 3%;23:?E#HQW-+?_Z8F!L@@U>T:*+NTMS/ S'+A)L(/YL6U'C1?
MCMQ$KKU\N=&-%N6CZZ7J%1?Y<HV[*>]7-3<Y47WZ[HG-FB(*%%7H[_F!FY[\
MYR?&ZXH_'M]?+KF9_1H7VNEQZ6'Q[(I*3S]ROKK209'V2DN'K[3QY(I[4=4Y
MVS:B[<XFI$@0-<=!-6YD$ 5I @E!'HQBE"&/9SABD;[+<8;*Q/K8DS59,L_A
MH>-'.)#2T'?H*.[T$1X_@&$@M(EOX$!X2W^@!Z'8D/Z+JS5_1*CA=?[<S3.N
M[2/\[Z_G8Q=;=I.20>?M;:FZ#,EG?LBZ89[;E'6BYOAB%D.*B#K.[44RN&$8
M$HRRC(DL#KG1H=$Q@E,;G3WR*AG7CX+52FK;8:B77W.)C*&AN@P4\_Y(FI*Z
M:I T1F[>#DF:PA^U2-*]S\X0]'.J3NV5/>WLE&V.'F#N"0^'/O03GT"4T 1B
MP0,8Q%F$_"PF*&0FAL&4@8D-A?R*L)D9,$90SRQ,B8N9F3#=.G=X@N-2,!Q9
M$F/RLUH66W .+8WU<RX[A5J(ZGU1?Y+.3EXVT\0?1?FDQA<UTXML#J<./W'J
M=,/..4XN.0&KH@9ERPOHF;$[N3J"E$868A*0##,3N^=<%3Z2"_#I !_PQ>G\
M*CO9+SX+.T+F68[(ZHE^[N2LYMV690A'8\%5@>JV^]_V2\=^',6J6H]S3\WP
MCD-(J8<AY23FL2]?B# K+]"E//4.S):/?ZVZ@?:&10+:&.IY(9,@8V8P6K*.
M+8*U?*XVV+7ISKMQ;@K'T8:X\0/,;$55UI)&9XY^%<5M21[N<D:634L'GZGI
MMU$"DX3(V(0' :08"QBG 8E\A&GJ"1V[,$AE8ANP2VZLZX,!-,/J[DQ@,]4V
MD55;M;5D&5)C^8 =%9;_M57?X6?/HJI:XO5JJ7>QW7*]Z=E\:G6)$,Z"**60
MI53UO8@IE#]$4/@L3AB)&:)&Z<,A8A,KY+9UN&D'^D&$]-9?5W*;Z>5.M_2=
MYLO3K, Z$CI:= =)S;K.Z@A]N+1JW6.^FG[XNI(Z<9<_-,M$QN,(QX'45I:E
MTK/F!.(H(S!#)/,S'/HH2W57T+TG3ZRD&UK&2^:^_./+I+549BJH+9#1NGB2
M^0O6POWGS;;^G11C=\T[?8'=.K==-J7BU65.URH1_ZJX)_EJ06/,TB 3D 8>
M5]GPI@80P13[68KC*/2$T0FR(6*S.9Y@ES;XTE(WW!P;1$UO[7.%A:U/:@B#
M\<JG(Y^CE6^0U*PKGX[0ARN?UCV6VU_;8V%]G\7^=",1.")^D$&>AC*81(*K
MPZ$IC ,AY/\C'J=:_3O&24VLV'TOT!T&#'>XSH.DN9?E1'3#7:O=,3\]!%,<
MX!P7SM4NU'E"\^XWC0I\M+,T?L=E0]'>"'D/66Y<Y*Z':C>C;1$0%B2A3V&$
M8M6*)_%@FOD"$A1@Z=%&$0^URN;,R$ZLUAUQNWE>(X#IJ;5[&,Q4?%-SWC&P
M.^6KXP'\V'%Q_K"=]9@O/;$=3_L:(?HL0[_T@#@W^TOS[@N35&JS:L6D$6K*
M:%[>J8KHMZNC:GDU2:H]P[5<%E^)A&'!?$Z)R'P89ZHI%9+1<.HS 4.<II[T
M\CV,C&817<[2] FO4NW]@Q^Y:'_Z276P>NSY *1GQ#(=9O\N#)-FLR!LN)N5
M9>I QG;@N3)6GU2'YWUFI<_2L*N0/W&V!FQX!ANFK\#UO1HL,D%N[F(@76?P
M[!EZGCS?Q0">S09>_N1+"@?;WHJBJ152>4GU_:FO>8$I#:.44<@20B%28]RH
MP E$V(MB'OD>)T:)D6%R$UO$GA0H)2V;ZL"S,&G&3\Z$-XRANLJ_CG)?][>!
MX],0')9%?F-2.BWI.TOL&0KXQ@0_7:XW>I>MW]2H23- [O4R[V<1="=0(L0%
M1QZ'B9_%$!'I$I% A-"C/N$4^2QD1O4W@]0F]W:VM$'9%E<;[_,-@:7KLSB"
MP'2G;T?Z';I3C(S1$M&9HS!$:V8?0$/LX^5=YZ:9V_VT!3UO5U5=-B?"JF8^
MS8UT.;IV%N^+U:.H:L'_+O+;._GW]:,,[6[%K_+1S=B--R0OFV&]GXKE\DU1
MJJ<N>!"G"><(9CY3+2D2#%,UB!V3)/"CQ$\8-G(5OC/Y)K9?/2N@XP4TS+1#
M8Q0[)E.BOU,$IVY4]/SOW<QH.VASU!55[LC<#0ZKI=3;)D@;P:^ WG<VS93?
M[_/%/G>OI8FD^W-T:IKVU3KK\S0QFW8.P&M2KO+5;?51E W7K_+E6E)>I#ZC
ML: 8BBR2,3OB$20)#F"4^<+W@HP3KE7\,T)G\F"]H=(TVEM7'#Q(J]8TW#/L
MMW<.);W%R('LAHG%CB"0%%O+KP+UAJ@[2SPBE2.+>([*K)9I1-1#"S%VN?D9
MN8^BN"EJLE06Y_J^UCT(=W#;Q,KV\?4'T) [<$2&$]&CL@[KV(5BFNF5G81&
M1]/.R&)U_NSP6;,=,CLCQ.Y)LG.76(:Q[$[P]5)\R#Z6JLE(_?11OKCZ>M4L
MN@]JM;U1C147W O]E/DA]%(D((H8@CA)?1C'L<^]@/DH,IKGH$MX:M7KB%^!
MAGS3K'G# /C2L&!8M*<-J69 -@%0ALI[$4;F@8JAP*XB"%VR\[KVAF <^=RF
M]]N9D1NUP[TNGYJ3:XVCO4BX0%%,/!@AI/S@T(=$'2_%+(T]Y(LD"OABI3IR
M"*YG,HZ):'WSN/WF=TGI5_T5]_=RG:H41;6)7'<L7*F&U*RHZE] XLG_=<VH
MP8^J5])/_P;"W5^$AC[S"3#U3(4E0%9&H:<%&F)7(PDR8R-P7A1'ZGZ"P*R*
M?5[ 0Q4>N-).6:]9L\%5?1),Y(]-VV11]^/!0A;$P@\3Z,=>#!%."4Q)@"'U
M<4Q3+R%RM3=9YX>(3;RV;TE65T#^46UK;GX!_RM*TXVZ_B^4Q%:J.@BEGM*Z
M LA,?7NJ8$M6VK1F=O"FM@%D10E>EH+G-7A75)7#$6PFPCM2^$%2LZJ^CM"'
M1D#K'O/PN)N'<5V6+Y[>KGCKEVK&R*?NG5BC^]DJ.SE#^552E8+G^6/.U[J5
MO&=E'X^9+Q7;=)D=E=B=!SXFGE4L??*!LP740^+L1M6#U]DMLYN<\]O5P[JN
MWHE'L0R[<H8XH$&(0P832C%$G :0D #)/Q*?)$B&TT2KZ[T&K8E5LB'U+_\L
MO85_"\W6SB%\])9.1U*;:>1VF^X*M'2O0$-9.OWNRSTT1'2T/@Y1FG5YU!#Y
M<'74N<5!8-M&@TUFNEI@&GA^$ODP23.IPB(@D&9,_A'%OL HHIYO5+YUEM+D
M:VH7R%5M(-<'KK83ELXC9A'$VN)P62S;4KUJ-X <CC4=%6V*V':/SO.%N*?$
M'8QT3]Y@>SYU)3YD;233+3!^0"A->0Q9%A&(XC2&-$A3F"8Q#5C"L!<;M58Y
M)C'UNJMZ"Q=9%Y^9'D4]PD-/-R^3TDPI]P6<8&D]+XRSHZ9'!&8^8GI.P..C
MI6>O?)YAB!_D*EZ3E7+)NS%[">-!$*H96R$)(:)(0"IB#W*6JG'B?B:\;/$@
MRKS@GVM2UIJ[4*[Y--&'0VZU56.'JLI#4W&;K]2^^?./1SQ^;RD38<H]!DGL
M)1!YD0<I]1D4TDWR2!K[#)'NO;U>:6X$? =OK>?5]IU]%\,LC]\6#1.&.(JD
M*ZN*E[*,0X)H##W*2!QE043-.K$\ZYNR&OC=UNT7.V_K.WH]>JOTLX)NMLB[
MG#6ZP_;W-VOT+*;/7?]ZEK\_1P7K&+RN9XV>)V3G*+TLFJK69KJ<_+DI^B[*
M;9;_DZA)OB*W8L&1"$6613 *F72 ,B^&:91ET).K*,4>QWYF5("C37GR7;J.
M#LA7;+GF4L.EP27]_E2Y8<C,^.H#JV=4)X'+S%CNL@"V/%SM[>%M^'!G^XQ%
M=V33].G.:JN,X3BT0>8/L)MC+(,ZWC4 444_[T7]L?%=<];]]F51U6W0]_J;
M4CUIU#Z+NEXVAK#Y1VDCBY7:RQ8XBV*:IC (J'3CHYA ' @,$\S])$$\BY5C
MJ.H2AZW/!+P9V:<-A]I:)UD##QUO0*T82OM$VU[%;&"MR_<Q;+2>&64SL];Q
M"3J6FB)#Z<!)V'MF-_^D. (_M@S_I*;+=SR#+=/M-1NVG^\-F0T??J8W93VF
M^!G>F/%,XPDP'9M^[)+DK'.2)\#J<*+R%"3,%D8N\GZC__/3/2V6"X]'04CD
M.D8911"EJ?PI( C&(DQ2$GE)(+2V 8Z>/%,A3$M,S\@=2S^\B%PDD^D&G)8X
MVA;@+.L#%2SRGM8IE3]L?='C)\VBEF<%Z)7J_ 66"7NR%-<KWG1 4=/-Y;-E
M;-RXJ+]*9U25_TF%77@^C5.",0PY]F00&B-($$Y@%K#$R[ ?4*95/V9&=F)E
M4I3 CTM)ZR>@BKTE3V#9<P3(;2D:"V28_-,#5#.CYQPFPS2=@D0=^]AP '98
MN (M@HJ-GQH_P&'>S4AR5\DT/:+S9LB,@#A*>YG=;1%OMBV4U,3#?MCAN\T(
MWP@A)&C (?68D*LL22#-@@SZ7N1'&4^P%X;: ]<'"$UL)S:4MS,[+08?CZ*E
M$=HYPL#,",PDOD'<Y @&NR#H!!R.0A<-L0;CD*'[YPLJ-*38BQ!TKC<O<']?
MK#Z*XKTHKA]OFQ.SK%Z3Y?))#=DU. \^\IB)#8^D#M4)ZO?R_WWCF/W=LHZ=
M9G:P\;GQ,8R&#9)C>,QLDEMDC KE-66VJID?>_9LY?.:0NY6TNO>8A>G2"^E
M;=JJ7):%2!(18L)@DJKB$BJ:\%U U?$L1DF$(A[I9*5//GV&O++HVXV0NIW(
MH=+_:@SX?XFO9+T2 GQFN5R9\BQG\KLN'XJR^:S-0I%]S&(:"48$E]Z7],@D
M0C*$PS21?P0\8"3F.!4+J4JTT WBK%';I6*'6Q>US0A?$N(4B9C C) ,(NX'
MD)+$AUY">.CS#(5Z&:/+/SF+=>1YH=.+=:T!,5PY)!9=\_ V< 77!TA\)&[/
M.IX4S%'$NO_L60/3DV(=QI^G+W(U;4@&F$D:2.8ACE)ITZ@O0\THD#8-\4PD
M+$U8*$S6@6,2$R\&76\<]S.&K&<+3:=YIV8*33E(R+&JG2#PS(.#SBG=P)47
MGFC<#L^L-D.L$$_](,2!],52"I&7!C#U:0JIZB@09=QGS*COW1"QJ1,]VTZ<
M.\1UNG*:PZ:GGZ[ ,,SX6.-@?\YQ0$#7!QU/D7J>DXX#0I\]ZCATCZ5Z[W3!
MWR1ANAK(ZM5:_$/ZCC=?BX7/8Q_Y/H8I(C+J$E$$"1$9Q#SE,?*PGX5FAY?U
MZ$ZL]/([B0WU6A,O315WCX)-?G<SGV+#PY5RAJEH,BA70+$!)!\.5=],<%=6
M0)/JO ;!#(HCVV!XNZ69*$J1WZY:EX(][6PE5=<KWOSGLAU_\+%8YO*"[3S[
MA H2^SZD%*40A9FGL@XQ#-4<&_E3YGF^D>&PY61J_Z'E"_2,@1U6#$V,-=::
M1F<.! W-T$GP.J::3>A=MD#+%_C2_:T8! V'+IV32U%R9;.L^9C7BET*UY%=
MN_B!YAM'[0PP_E&(\M>R6#^\66UU2W/3:. 1$QN@CC)0I$%#^PJ\*8IZ5>A.
MWAJ#8'Q/R)'T9L9C2'#PQ:EQT)31:O]GZ+FS[?UH"+>[[Z-SN84:%I_%4K!:
M\-^:WA#B/;G7[E!V\N:I5:^X?R"K)]!3!AUIH&@;Z-Y)N36T[E*1#?7-2EHS
M'1N2R$Z[3CYQ/KT:$FA/HP8OM'/>?R/L+E^)\FFW W#7 P1'09)1XL$P$3*N
M3R(&2<9BF'DDB#U&LB0UBNL':$VLA!O*C;\H>MIFOO<05'K>M2, S%1R7_:=
M/MW.&ZAHB.?(\1VB-*MKJR'RH?.J<XN=+A^?J5#_;R?5=K^L5-)F@2B-* D8
M3 .5FH]2!+&($YAZ<>1Q'F5>F)FUXM8EK?697]*@NZTN ;2C"1XD43,UUT91
M3^>=(N/P/)WZLQM[?=7_4]7D]-P9!%/9'5D';;*SF@I3, [MAO']3HJVKU<K
MJ4_]\/J/0GYBJWK!B._YA/F08,XA\@-?&I HA1A3'B=!YM,@OJ" ^R31B5V$
MEB90NZ+RK[RC?05(!8@Z[\O,#H_J(CEL1*;"QV8C8*^R^0IT>+W= /5Q,HPN
MJ@"_&"MGU> 6F%U:)SXHO&'-^.EG/6?]^*!T([7DP_=>7(@D?;NF:>5=L93W
M5^W PLT>?Q3[D2^"$"*>8!E8L122((MABL/84_66<9:9-9O4(SRQ"7WW]OK%
MVW=O;]Z^_@RNW[\"GV\^O/RO__SP[M7K3Y__%;S^?W]_>_,/Z_JE843U?+$I
M<#(SI3L<;,(Q=6QF@@H*4V'=ET,-DWVN(BDM, 9*I_3NMXW@:+T=:_I)<''?
MM)EJ#\9??\NK!4(R>HN]".+4C]08)0Z)EW)(,8Y"D=(XB(PZ\HV3G-AJ* 9V
M1B:KCD4]#U==_PBI'Y(/PRHK#2QU(SB7")G&;A>#8Q&UZ<KK+%X;)3ASI*8+
MP'&,IGVG=7LXY:BTM?>?\NH/&?FQNWM2_O&JN"?Y:N%Y."$J9\N(RMGR!,&4
M( Q%FH19AA*4,M.N<(,$)]\]V2$/%'VP80!\:5DPM NC$.I9!9? F.ZQ7(*)
M3;<W+4'=-7D;)C=W;S<MX4^T=-.[S[([AW) WE;56O!7ZU+&-:V!:9OC-__8
MM:=\_4U&-GDE^(*FR,_\,(91A *(/%5U%7DI3(2$!6=9&(O0+.=KSL3DV=\-
MI0N:])I#JV<P)H+KV=OL]NQ6JDUG*Y/#=A_6H+EJ_6'.P+QM0*P!.FH)8O\D
M:U^FB9G^GM=W+]=57=R+<I.?67AI$*<<"\@04^<JD0=QD&!IKWR6QFE&:6@T
M3F>0VO1>3$,;+&T/<@UCI>VQN$' V%UIA?\JZ8*>\)7++AE&$KKS4P9HS>VD
MC(M]PD/1N,EB#^G=SNR0-X2UV5;&Y/W2>+P1I%Z7XC_SVSM1OBC*LO@J+<U+
M\B OK)]: [,088(BPI!J)BM=E4BJ/@F\&/(H1H1&J4B#2'MWZ6)V)B]-^9;?
MK^\![:D#\DCRY9AN3(&[QE[4K&B:IE;WY@/UW%V!#7^@8_ *M"R"#8^@9[)S
M:V:%W6![:U;X[3:^9GD-9OMBSE ;W#&[G,I\>VG.$-G;97/W5,NHF-T)OEY*
M'EYW32VD"]M/;\C9]8J_RI=K&50VTURWM>M!F/D)1P0RJIJ^"N%#S#,$4XQ(
MR"CF26JT'6?)Q\0+S2>AO@SY4MI(3ZIHPXTZS->Q _XNY-M1/_2MDUKG?W>2
MBF$P;?E&-"/JZ7$V#*L[AA2X/4LJ)&YQO.H 5_M^/>+MJ.9I3BE="(^K -J2
MBWFCZ,N@.@JE+WR<;3Q=U1^R7XN"-WN4HGS,F8S<BR5?!+$,G7GHJ4U#!A%+
MF9I-RZ$?>&F8)#@TM'#G24T>25>UTJZ'LN!K5E>@DC1-0^FS,.G&T2Z$-PVB
M6[D;JHT%Z>F"ST,(6(308\(YBY_/$IHY>!X3^#AR'KUCYB&9S1]_$U6]R=KY
MBR )(I;1""8))S*(QCY,PPC#V/>2Q!<<,VKFU#AD;F(CT1'KIK0T6P%JKN)L
MX_I.O0Y-C^:90)Y]]Z#Y"_0OROFNP00P/O=<OE.L_3E&\@V ZFP:WQ -\T.F
MK[\)MJ[S1_&2U.*V*)^::B'-0Z8G;Y[8XFUH@I[H+_I'2T]+.VRPG AJ9G6.
M9716^30JC=6QTM-/G.U8Z:! N\=*AR^T+&3<-*/ZD(TJ=75.J[<) 93X1"2"
M0B82#E', Y@RYD%.O(RG2&0T\8RJ'MWR-[%Z?U[?WQ/YO<L X-/GWU4/Z_Q1
M94E5''"4L^FW9\''4OJEAC63CE^;GM?SC"_#S 1M&56O0L<-J@;]H$G3/Q.A
MZJKFTS%W\Q:(3@/M437I1&1FCD[;"OEM66SUH;X3Y<T=674%)>^+U:-TW03_
M5"R7;XI2W;3P&>4\"!FDU$<0T22&V(]BF%*Y9HDD23*D-2/F>=B?>$%H1TUW
MZX%A*<G,[W'BP'?RMS-[:-P="=H1"30R@5H*M2V[V\C5S[;?+$D5^*)D!9VP
M+G<4GN4M/7?D;<?\GR,VO^C%.(O>+^/"<CG+;U=JF &1/+2SY57J0+6+RT6U
M]6 I09C+4$-^3U2==,<4IMP7T*<R&F$4\30V"CSTR,X73^SP [8,@9XCPZ5%
M#U/-)<$Y4H:F?!@9Q]WC[*1V91KUB,YKTHR .#)%9G=/Y!&?]<D/*JFKM]T)
ML3Z8[V+Y_M^;2'[!0NRAC&"8!%$$4202F/H1A7[(:1P@D26AT:29>=F?/@.Z
M<_*#RV6"E&H#R/(0R+QOUI&/_&SOR[V//)PW&3Y]<F6=$W/O$$_R2N9RB-TR
M_WTYQ).\&&.'>!HN+ASF\G;UL*ZK=^)1+/VNO:$GA/ 1DFN-(#Y$J9>IENT(
MRA6)\) &OH>,O. !6A.O$PVI?_EG/_;^S;><VG("'ST#[DAJ,VN[G=ER!5JZ
M5Z"A#/P)6D!JB.AZ:LL)2L\SM.6\R&=GM@S<8KYK;=$0>;XVR&;=CLUZ',_2
MV=A](V-7[8N?I6GQ2*OBRQL4JZ>\D9P5*Z$JU^5Z]_1VQ4T^[M-W?U??^1D!
MQS_YRV4S7$5:>J GJ-82GC_F7/6S<Z<2PV)9:<>91\ZF*,,B[>K,R)5V7MW'
MLI!1</VD>H76NQV'M^DX+CP4QP&&/O8)1#Y/(6&A#P.:Q-P7(J2Q5C-/?9)3
MIS=WCF'TS+0-;^O]'MAF#J &E'I^H%N S!1Y$(])ZQ'TI7;D(6H0G-51U ?@
MT%\TN-.VGPRIFX"TW8E1T:JT1#(^;4H!8\S#-&(8)AYGJI1<0!)1#"-*_"SA
M-*"$&R4>AZA-G2=L=U>W-*UZRPWCI9G.<X6"F0$P!L"B9XN&8,[:LPS1FKD3
MBX;8QTU7=&XR]YRO.<]5!HDLD1<\;@N)C&=6C3YH8GW=T@>2@1\??]J9/*OO
M9X_#,>YR.T7"3&>'0)A@BI6VI%8.^?C39_/-M07===/U;YJYSJXM ^I*!:OK
MMHO(4LBPXE=Y;[T@Q/<)3A D*0LA"BB'-,Q"&,5!BD.<QH1HQ=93,SIU=-#6
M2)&>+,B*$F1KU9P W"KZU07-XZ9Z=YHNQ7?P1LPLFX-ZN:/JM^N]-]L(\!V4
MP&E"_-S%;F-L?E^[>!>"[:R 39?>S"M"MXO8\+#90ORU+*IJ0?TH14%"H"=4
M1X"8,)C&B0>])$X93K$?$Z/1RQ/P.+5GJ:A7K<F_J&'H!&]G8G/O!O/9+?VF
MZ*-E?+?BHV'^.[#RX\@^MX$?X/#/8=O'(79FUC5(683FZLF_KWBY?+K]+-BZ
M;*=*W-?:(?FY!TQL,"5)(6FJ(M@M68,8_*S<&K&W"Y$-8^[F@-Y)F<'UO:HH
M=11LCXEF%V2??>I\P?688'M!]>C%EMM?4MNE"K_^IM1>+&3XBV.<<D@BYD.4
M12&DD0A@)&7C/N69#)#[)N@W!CM>>U2TOLG]+N<WYMK8T02B)6JXE;4/B^:V
ME;F4=EM4G61-SZ,?/XE'"0Y9-CTEY6_.>V?F.U(G!7*U^[3_\'EWFDX*=K2K
M=/HJ,T7C(E^\7M5Y_?3YGBR7+]95OA+2@TU2GGI$Q% $ 8<HI!E,"1$PC6CH
M93$+$=7:5#[S_*EWB1J*H"$)>IIZ*G8.D&$=<R"FX3:0D83:JC4BQ\!:)N]L
MU4K^L-6F<\^;19U&A.GU:>PRVVY^]P^EN%,Z^BC>KEAQ+]X7]<Z.190E-.8L
M@RQ%1&I8@B#V6 0Y267LGF8XI<BLI]\PP:G#<<;6]^NE6@V[\ZY[#(&6(_#C
M.^E]&T;HHU#JK7\N 3)3U@$D@&)AHK-HN@([ZP@X0F[FOH!ZPA]W!]2\SWR=
M?2??V/+C7;$2;;YQ@1A- HZDSOLD@BBA#-)8+;*A2+#4?RZ$UHFP4P^?6-T;
M<J"AUV7P]9?7(QS&U]9+I#/350/!C%;5<Q)8+:E'#YMM/3TGQNYB>O8:NY6T
M'_+[2K1_OUUU1T*K3X*)_%%EZA=RL8R1%\<PB 2#*" 9Q"@-( DIP2%&7HB9
MV7@L';(6H:*9FFU)&1[EU@)-;]UT!H25/O;4P8\]_9]4XKAG 6QY<+=PFDCL
M:/'4(CGK FH"PN$B:G2O>0JV+['^D+TN2[5@;ZLXWDG?_6TM[G4:(.H\9KH/
MNZ?>-)LO2VDMBW6U?&HW2PXW67;KA11OH&'.4;V0"0Y6V4PM K,E-DW$W<UQ
M&MUG>8:SF7,OWBF=V0QSZG8TJE=K\0]!RC?2+UT$L>_1( QAYJD#G111B!.4
MP$30+!)"+H:14<V_+N&)O4KYU6##4YVZB.FM=5/@8&86.@Y P\+.E+4K->B#
M"O"1Y/P**#Z 8L3AT4]#T5V= ]4E.^^A4$,PCDZ(FMYO9B^JLEY\7M,JYSDI
M<U%UQYBC#$=>%%.8T"R%R&<QQ#%+H" ^C]/$)XBF.E;A]..GKNO;(:AG \Z@
M,*SIE\MFIL^[M!P>V!X68T@WY9T[>BG_:ZN39QXZB^8-"]3KU\A5=JONL6_:
MZQ/W41Q''@QPK(:Q2\TB'A,P3&)5BDLH28TJ;L\1FCXUJQTKF0&DMZBZ$-M,
MZ4Y(/$&SA#&Y'*V09\G,NB*."7NX HY>;Z>K-R5959DH2\&OZX]%OJK?KF[R
M^_Z#I!0E$0L\&&:"2[\XC&":Q2K!FI"$^"CR J--E6%R$^MM0T\E.Q1%,XT=
M@4E/;]T);Z:].W0!J<$>#!.HL9Z8CI1YA-BL*JTG^*%B:]YEI]X?'D1)5*^_
M?<_YO11H+2FNZ@5%?D!"GD O\0.(,,L@\1F!TNW%*0Y"[IF-0ANE./E&RNH6
MROONP4-1]I,=BYXIL&QRG]9SQ\?QU#,%3E$RLP8;TB="XBU]=^9 6U1'%F&<
MWJQ&05O\0[N@?Z/%4/*/:[K,V?+I>K627@43_&-9W);DOH_Y,H]@QKD'*?,S
MZ:E[@3H;AR&F82RX%V:4:%D%'6)3K_H==; A#WKZ!F.MQP ;5GO7,)AI_  "
MX\N_.10&\[L=0F(WG=OFXS ;MJTIXN H[;%GS#<H6U.:O3'8NO?8>3B?1%67
M.:L%?TFJN^M5\Y?J'O!(EDWC@/HE*4M5L=YTF%L@+\/$5SF]3*00>0Q!&LL
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M95%5'\M"+GF+6&11[(L(TCA0$ZX"^1/*,NA1#WL^1_)GSZ1R>.?9$]<!-Y3
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MD) &/H(()RH23C*8LDAM4A"?I5DD1.199AH&R$ZLXV^*4N2WJVX+3B7MMJR
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MD7":R0A4=GU.8G(%;0A>41%] 1=3M;Q&6JA&@@2UGUUS)HOKJ36?7J=$N%_
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MMBV,?!0FG*69D$1RHYJ@44H3FZV:=G5R.:;NU>3-J_"&\1JV0TY1 ![\; $
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MGAH6/-;E 9"V> 74P[9F1@#!QJ<:M-8EVDQ/W</:,G;TH1+6R/-:> %YH_/
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MU/,3FI_J#[R74K!M%?'N3EAX6P?>K0N@S%Z)V1EB0J#!<8+S/FH-M/,4-X$
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M]&,_3'(?":E+T8)0(,+]% 4XI('("<THJ ,JA/C/Y 8W_3^!!U40U,X\8BL
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M308AS+"Y10\^&]$&!5>#$4&TYYV*: /+V4A$JT5<5=Q>KK]:Y#(D(64<17E
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M:>;"78N4]QEQS@R]TKRX:P&\/#ONZI7A[;/J-NWO?Y2\&<Y@V3[K\*FI ED
M2W1&M'Z+<IU4,,M0T_$^MN&R!$Y-M(Z6FJR)UGD1]IMH7?B$]Z*$#]J%F=$P
M5&$4"$QS&6$2"8D9282I9*0BE4&09%85R);T1E8E_88+;RGX-3X6-X1^I8:I
MFEW2O>'!+RS>2A.@\(Q9F] +D\_BA'VAKZA.J)?Y6<H3]F4"U"<</.:_3_*V
M<6XJ59$6:88)#10F>:'M7)11')BVY8QKX\<Y:&*F!=&1C5W3-)<?!''F31#G
MS<($?ORU+/;8?_AUF@FWP:TN(&:":_JX.%E3X%?H\/OSM>N]IO?NE8UT=[73
MVXC.6UH]?EBL_JJV&<P13TG&H@CG-.28% ''-,L33#)2I*',29' 1O/U$!L[
M)+(?\#7$44W=)GL9CIME*,,3&L @A3L0#OT3AB7TUA6AA]3$O0Z&A3[M8&#Q
MC,>\S";WL/R=KOFCZ9*@SZ4U\?8/<O^!69!R29)08$EHC$D<9[A00F 2DBR-
MDR*2A56&C3>.QL[9;'DXR'>KS.1&XUG0Y0MZ0RM$30J-X=%'4B;H?5@<P*9&
MV>UZ[TS"9LL@VKZ#ED5TI[H_RH/GI@;?0SKG6"_!>W)G]S*>NI?1?N/WTY</
MGAL[V=,%.:?43Q"AUT\$=<'%*BW4:6%?"4#MCW=L,7]HU(VG*L[C),%1:,ZM
MI,BU/YH(+&20BI#G81XF\/'O%I0A:N@\NOU+N?JWY.9&KANSL]HR4-V<CG*_
M-K'E%%\1A07+),%A096IPBTP$S+!02JEY"%-THA YZV/@BYX5OH MGNST_VC
M:G<:\(R3VXY\F'#3_6O'P9@I+Q?%'2TGY93B*R>-7(1@.*OC\J-NYKCIH_;6
M#)&Z4_>EI-6F?*GO)3]IRA_U::6:!2'79X!"85-/KLVQE/I@$ NL[48A6!0H
M$0A(>,""YM@7CVWOP9J'.A[6<M&-"C2,H)H38+S !D\[0^$9)9BA\ (0V%@
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M41C@(LISG)) BB K5$@RZWC[,+VQ'8<= ^ALEP:(YMI":!'D\PL,T#EX#4P
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MYS_HV#*$5H^W2V'^QR09?*<+XU/L6HB=_WO;BXKG+$AY+G!!PP@37A28TCS
M@L=9D9. 2FH5Y/3!S,A;V5[K.T,>V%CD&I#MMK"IH(.9A?K^R*09U3_L$;Y!
M1X!>^-0D0PH\0.>K[\DUK$S;&,4#:">=4WRLZ=1$]KM<;J2YBGI8UJ&MW4X;
M\#C.)0MQDD3&Q!&"*3&%4R11.9%QQK(4T#'V(J'1S5=-&>V1MMN:86A9W(MX
MP@!FAR82']3:U0L,KGU<'>& ]FT=E'&@2>OEYZ?LR#HHQ5'[U>'/P\\!=YMU
MM:9U=KA9^;LL7TR XO9I;1N1N[S"R+;G(#@U,&4$(O?P(<B/R#!3LT<3=401
M! +086A80J<34<^RDQV+AD7;/QM9?-JYK8DL2RGNZ8_;JI+K2O_0_>[]#_-6
MY?[;U?Y)-Q?R_=/S8O4B9??OF5)1RD-"<1R;G!#3@KZ@B9G=R&06D[!0*6C8
MO3_6QH[-<UYNM*,O6[+=:%DD&R[A@QU]O1*[P]7K  VS.QT_]4RGALMFOM/V
M#RVG-X?6R)R[.NYN4,?O]E=>6V]X!M%?0PU?C$W=)L,SH&>:7_BFX-S8]KAE
MQF>YOE.&L7737<], K]?F;&8J^5:P[@P=70F>5P?'V>,IYP%48#C)"_,X&Z"
MBX 2S"4KLE0?Y1@'6=XK^1G9W'Z2587X08.=>9/92_>8,_>&ZT>)EF;6[HY'
M_=&&27#OW*O>D&64:SK<@8&N<^V,NA9()K7:7.[0'S?H]N@-'#**/@Z![]*T
MUP=D_AK[7L7-U,U_?4!WID&PEV6=ZX&_S\U X0^K\MUJP]9JL]#^F3F25#-)
MA>22FSH_EF%"A;:3))(X)"&G81I2$F? 4N"+Q$8V@EO22*W*=A0H6FB%A'J;
MO8#9F2U?, #OY%H*YA@JY]_-=^JF;=>&C&7J'$+TQH0LRHHN+O=+=ZG\'139
M7]'O95)3U_L."GVFU'?X&8>@]C?^*,5F(>^4*2)NW+=?7^K_?4O7\F%5OMS7
M9F8[NUH54<Y"FN%(D! 35H3Z9,HS''.5!H$^H8K8OF0!3'YD<_!M\_1$RQ>S
M#QN&VA.2*6FJ?T(M4W-;Z^"(L46 ?%3D8!:D8\4DD.^C]NL1:B^HY@C]:7,_
MYP-&0*!]5#@=L_6W^1'FZTB%F+>%U[0&E6^_BO7AG#XU5ORO^?IQKL_KW=]?
MM/=.UVA>F3I*;32TXXXV2VT=MN%'X]V7\^I_5V;A%9^;*=KU,DA2_GA([<57
M.;,SWKU7 ?!5I[L@<);XX-K ?177N&:7[-_0FL5!*D2241R3-, DE2FFG"4X
MXSP+0J7=/P)J W-,8&0#ORMP:<A!0XI':-@&!MUEA(;WMA4^-2F?<;GS,GB+
MKATM/W&,[+QPIY&N"Y]S\+S:1/QODF_*NDBUS2)/\R M:* =*A9Q3)00.$]2
M@5E&$Y(DVO<*0FO_Z@*1D96L*^S8D47_4RY,0;@)9.#_9T,7<S4W*3W[(69C
MT"!NU24 +9PG#[# ]/(,(@[M4RY)#/!S/$CNYLVX( !S*09$ZW4<+CT[G7LP
MP/V!$S#T6=>&T+24O])*BH-H_:Y0Z->7W4>^T)>ZT93)-3595NN7O5F/=]JE
M+.\?Z?+NV2Q1Z3.KDO.UR?3]EYP_/&H'\_:[+.F#_$TOOC8C[;;3(V=!RAB+
M4X9IF"MLKCOU3R3 <1I(,X*N2#BHPN'G$&MLMZ9AI1UK)U:+!2W1LRS=)MS]
M')!9-]W^&9@=\71MF,<U]T<)(GMC-]D+VO]<*R:JY;Q!C:3[8W51+:LY&BY1
M*^T-VI/W!G42HU9D5,M<S_1$N[F]/KN._TROT5NC\Y]"J(E[J_\4,E_PX'\R
M[JY.-NI*\+43\$G2ZJBR=\:24*54A9C$J<0DDA)389JVLC3+PD@?-*)@MI0/
M)N9S[Y12U,^ E5DL&K-XPH9]HJJ!VP3)-I5LXE7NJ4(#@-H>^'WB<WVBSQX3
M-ZAEPZ[;P#7Y.W:B^T_/&:#[6MDW=G#T)-=8+G"=36ENFC6U]MJO3<V9Y23.
M1"("G ;&DE">X#QA%*=I0(. 1 '/H]EZM:8+F FY0 _D+V^IVI]&S2-(=#JR
MUCKRILTV_*5+-W0S(9?P"_.4I41R7,@LPX1$"2XX#W$1R2(069CD[!I+? V,
M5]O?K:UI\X<,G"V:?D&$65\/7RU'F]MF]AC3N[T];ZE[O#RWE-.S@;U$[57,
MZH#HEXSIT&.. 93C(5ZF"NTTBV?;.#0*2*:B*,8TY R3(.>8)69(2<(*Q9-(
MT014%PND/_95^OY$O_-S_!Q[[$-QMHPCC(<>\,#O SCX^=M-?%\'92#U:4^T
M;M"<'#T=EW$S1LU%IS2.XJY/VRR(DY0GV@LA0FJ3$R;&VBB&!<]CE14T#D)0
M</4LE;%OEXSO!K,8Y\&PLPM7BPC3_I9<?4J3-[L^C?XTO5<@3_I\GL:D6MLK
MYK%N]G_830-_DZN'DCX_SOF[>=4D[#;Y>W+^L&QO[O(XUL>"B&!.S&6OT#^Q
M),YQ*K.$J(#I4Q?(!;"@.;)V.DS,@ !FI[.>88!I\(XXVJ=>Q]<-?8_WG@[R
M>E)P&XJ3JCL @F/EASPZTM5J=2GL?!I<_KALY@H?!9G?_Y EGU?R2SGG<I:D
M0JBPT-8D2 ),6)+AO) "AP6G62*C+&34ZR6J9P%&-E)OC;%?3'5;ZOOE>KH7
M?<57YO\&M!JX CUWR6GRD1JYSEQW=K*A6K@)[SE'>BU3W6CZ9O_GNKL<Z>6
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M#83>TA/@DM-5H+C)>E"(XKB$@[W]3_D7W2RE,4Y_T9>/2S&G[5<\S'D8ABK
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M9IG$1'"%\XPE^I]%KM4D#7/]H*52'*T]]IYDJ*'NU 38B\[!,*P=5P@'W'D
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MV[6F:VD/E.Z@:3WT61]!H%]I-:^^/6O#+.Z6_Z3EW%QXF!!I.!-%' :A#'#
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MF,6A6Y%>RPN4I//K\GFAPNY660^75QC9JM2$ TU9E>K>+YZT&OSZ^>YF+WO
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MOAZ#I(3SQ8C%K(Q6)(945/5]-;B(%DHNCCN3R!TZ+FJ\;_7]L-%]#K*!:+N
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M'R]&OC9?Q<A EDQR,:Z \YC "LS!V^)UNF\JUE'@N8N@3K!T@*9W@>9HL7>
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M=O\2PQY;C0'14)H=6)$U([A*(]S!2[#<&P3+6+U$X4CX5@4<+[;>KAC7?"C
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M_^2^B7U_^ZQ2HBE&64@VT]E9G",VJOO&'#+I62C-;P&>(64K^-C>CZ"6\NX
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M1)",\YA\1&WD 8AZO&(WY19'@-.!\N[5-KWY\).0U8E<K M#F"03:T4"%V4
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MX)A9_9UDW<\!5TL6Y[,:KIP];HSTYEYCI!L?08=@DY<,A& 45MM<((AL(-I
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MCE\Q^HPI6Y \>E!2*8@*,Q1K)1I-ECXT'R'[@W3\8G6L;#(9M$HD.NWQ:MA
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M3*<47?-V07N2NAUB3_A*X9BJ[+6M^JOU#[?=:FX$1#]R]YCY+:PN%X<U7A^
MBN-4AQPHG48U(U=DWNP%)8(N)@HP7$10TD:()2.$9'VPF5D66X\FOD]!VX#]
M_33$Z?ET1>*^OA/^Y?+.SO?<B, D9!9C?16?P%GI0%F&M"<5\Z(UM[O0-VY-
MR '(>#D2;ZB47@_S#8??[_#W.VW8SW_A^3?\C:S U^7$".,X-W3.K%.U11EP
M.B @+TJXHF)N'H_O2^NX0!P./=L<YJU5>4*0_3>&Q>>_YN1>)ZE=UJ#06W)6
MF(/@@P%C$-&8H%7S"OH=21RWS*D[@.ZCN%/#)0$-)]&@-R(EL.M6$5X)<!(=
MH,Y:H*'@C[=NAK8SD>-65_6)S9V5=V+H?#N_7$S(13*L/C-ATB=0QC#PF7N@
M>),E[[2)>JP#_IK&<:NZNL3FSJH[-6A.O]4* <$Y(U_%ZSH@$SD'SR*#Y+(5
MUD:?W5$R22_0.&X969_0W%5U)P3--X76O&&2%22W15BPV1&3!@.X4A)D3"F(
MK%)J/F9^+T+'K4[K#J3[*_&$D#I!JXI Y&"RS>15!P9!T5X47' =K%)JM'-]
MW.JW[O"XDZKVA^!\%<Z'A^#=>Z]?_T[THYO;+R,$SX7V63&6Y!=" J^JQ\)#
MI-."MEIH70ZW%Z'CUL3U <XF2MP=J?X*J3/\LFX4.U!YW V7)+_",\D0DBB2
MN'$!0D$%4>MDO/(N^^8M?YXF9=QBMZ.!KH4B.CB#[]Y^O2(M&8,S214P*=8!
M+Z* D\: "9B=3&@$MKZ[V9ZZ<?.1#6]N!E)(IU![,<GOE!12DG'6):P[@&H(
MZU?*G&MBVSN+K2M[=Z5QW'N:H;"R!22;*>X$@'F=W+>1<5%"@6C)OJOB%#A,
M''R1Y.V6R(UJ?<9N2=JXUJ\3&.ZCIE-!WU7ZGH*K:+" 5*R^=10!O' (Q287
M2BQ%"3X&_L:_<^D)@3NKZD0PN$[3LT2.39U9("0C/YG%#%Z7 AR+M5DJ"IW&
M@.#X-RL=(7!G19T* &N*DV3#+2\"LM?$%U?D6JL20%#<%8ME(>5C^X1]W)_T
M!,!=%74" +R?:,=$$9X*"K@6N@X:3>"S49!%=L65S,GV'QF%'=V2= +%_55V
M GB<"/)B1>$*&%Y%5AF"XP70&*N+CE$,^KBPO[N03E"WDV(ZN %YDI]GD^;%
M<>>27X]4%B0Y<FD#9PC&&>YEM#'&UN5?.Q$X[HW'F!!LHK)^[CF>Y''B.:<M
M9"FLTBF#4K3!@G$<A,HV*AU4:C[VZTE"QKWC&!-F.ZF@UW=4'Q\.2%A^NKRX
M"(OO\_+SUS#[@M/9A\7\?S"M;KI?G\7SZ9?UPNMG19N?>ANFB]H''N>EML=>
MM]0\8)[Z4>AJ\M;J^!)LU[&WMNP)FWDSMWP\\4Q1>\RY< ;%ECH6SQOPB5D0
M5A3M5,B,MXXU=R#O4 O[N+O[W:GU#W4VX=:4(!U9$JPMC@JG8T06!2FS$D,V
M5N;6(<]N%([>SW<07#TTR@-JK8.HYS%W5W;BW>P1:W>[QW.'B22JP:-GH"0G
M@18GH B-(L1D61@>F]M0.GISX)$PVER+76+U\?9+0C,OR47*MCX'BLY!*"'5
M(7XZ,A3T_]8WAEN0-:ZE/ 8Z7@7D8:KJ9M[B8\;>4?Q'"EW]/%^NR%</PI!3
M#EHDDID@=B*C3<Q*TH(EF71N/:'D98K&M7]=(&]O!75I\MZDU6583,/Y]2B@
M"06'&K.U(".GB-.%3!X'19Q*U%%RQ>G4_(9P"[+&O9[N GB'J:J+V0];V/'K
M</1#F.:)S)*9K MPES,H4\>%9IV!8^;*ANB];CVM;T<2Q[VT[@*7[51X:/9R
M((Q^PM7J?.UG+Q^['44G@P(%F*#7UU)U$@NG[Y(50EH3F6[=C&\W"L>]U>X"
MH<T4V$]Z?1N/V+B@@RD&#)8("J6#:#4#H<@7]LEE7WH-7@:[VNX"CX>IJNE(
MNR%2/3<IX;,[*>&[TD2.12;.@-E,?DL)EK:<D,"$"]X$%F5IW1UE?VI''_4S
M<LJGJ3:[C(&>Y'!"D9V-PBB0,I,T+9(T8STF"M=.6Q\4BX.#]$G2>DW_M$7*
MJP ]7&T=IX'6P=XY;??+Q>QL=H<_;6+*JC8S,+5QJQ3T7:+O&.<B:"99\7YP
M6#Y'7:_IH2,CLXGRNC25ZW:L=1YPO07^Z?NO%W^>S[_C8L*%+98;"];7*4Y.
MUL<;UH!6+NF<34$U/"J?(:[7U-&10=E"=5UB\DIPGQ=AMKRBZ//\+:FA_M6D
ME&"$8P:*RP&4(3F&%!)HAL8G'\D_&CX$>H' 7M-'QS:8C538<WQ^R^>]_)AS
M*+E(!=;AI4*L@].+@L@C)J^$M67X*YZG:>LU<W1D<#907*>)S:<]:.F"B*7R
M5%(B)T5'< 83G0HI&N(*L^LY\!DA==1%X+.+VKI-(;V]K"6"%%BM+I=7W$U<
ME(XQ)P$-$Z!2EA#I*^B8.$5S/ ?9NF)]&[I&G^X[4EKH0 UU\&#B"?=C76B_
M_(AI_F4V_0_F=[.?PGFMG?[T%7%U(TD;F?!>(7AE:8MY0]8^BPS&>)>SY#HU
M;_6_-[&CSQ0>JYIR %WV%_:0;$FRE=\[[P=^G\_2Y:*J9V(LB][ZVEY=I]K&
M6D-0J"#1,>0+'0M.#UQ0^0J%O>4P!X'-RV!MJ<-.'<P[I<UGJZ^XJ&9A@5\K
MY]_(;TKS"ZR%+.N'GI_#W[=21N8C9EO/$3I1M"G@.:O-&%!&AM99-GQ0M"?Q
MHX_?'K^,?3!=]V>(MV/\)RSS!1+7$[16%R,T..FQ7O36R>0)0;.D;(D%=1[>
MF]V%XNX,]3%@U@+L^^F\#__X*@='TKO*RX6_K_]L,R_]@96YR8O,2=B/'I9-
M%,LBE9C)L"2R,\(@.$7BL"6$C"K0J38 YIORT-O%UDB[8#Q<=.'@;"GU)_T\
M$L?ZW]R71=7E\G=<G96UH0A.J<PHD!:"#$6P&9SE"3C+K%B5G,+6I=<#L]3;
MW=L8^Z8GU'3I0#V8G$S&Y?+BS_4UY1_+&HC]',Y3E=]T]N51Y=R-AK#.LS69
MD0EA#)05Y,Q:4SL'*AY,D5KSUO,YAN%DW"8LX\4/1T=!EWOA =LO,7UWPOA$
M>,%C4@F$"(&,0"U0=3Y##"B"#CP9<X2X8C_B>PLQCH_$;2[(!X=%E_MA!UW0
M@?AA?3TU39L/J$_T;A3BK/>A]O0.LLZ/3A2 T:DM(=2YYR6DH%CK?EL#LC-N
MGZ23."4:XJ'+K?&\37B:\WN& 1T*69(%:5.I#U<51,\]U/F7W);HBAK^V=(A
M')SPH=$2F ><'(U1\D/LD9K'J"V/WL]G7S[CXN*ZAG=38U%,\,D9!D$H75NQ
M&0A,"1)/D8KK0O%6?[OF99YZRVS]*/NH(9).L0L;.0CS67UP.2]WY+/):JSM
MS"!-UK9==O >:GOQ/T*+-,69BL$'2)G,O,JUJZ[V'&)RB2<K$XNM7]B/VB+M
M7O<.KJ31+ A@&&D36BO!218A,IL3YX6A&_[5PL[M5;IH@;8+;G;LJ;*+5KIT
M.JY-_Q,/@)AU(26)9.>U!*43!V<"I]\J1&92R6+X]PC/TW<Z[<W:XJ^1QKJX
MI'K,W=,.RL]$W'3UYF*^6$W_LY;Y6;GN+%/+.]>2/RM7%Q1G3]U:_%J/J^4T
MGN/[*>U;'6I622K0MMZ1)$%Q0L0$QHN8N-("^?"-@X[#Z^F\"6^[3SI$4I<G
MP&-9+*LP<#EQQ=A"_CUX;^ID04;F1 9=#8M5I1@IL'4#[!W(.YVB]K:X;J.O
M4<U_C9-VW+&__IW.+S-%L+?]<=9_>1V[3+0OM M];:D8,JAUV2NW!;C0,A3R
MQ&)QKT5K ]!U.J7M^Z!T;$7V48&V _>W3!]TZ* HTEM&DG$\T:%C-,E(T7>U
M 50RM3'4\#7'P_-Y.N7)QW-=1D!0EV[+[>L'DM:U*'ZYQ,_S.QW4^"2E0F>@
M,Q0(U8*CG R=CC%#B26'H()CS<?Z[DOKZ133M$7[ )KL^6W]2YO[;FYIKVWM
MA3,R2 /(JPM8"RF\30FBP,1M8L&$X>$^)(>G4TMPO"/AJ*CI\C!XV>&\FR_;
M^\!DUF%A1D&BTQ&4"AXB4P&"I>^=I7.3#3_V87@^QQTVU>?^&@%!)[?+;H]J
MTMO/EXMZ8=C 27561!TH]A.J#K9F$!U'T)$Y)X6M#4@["7/:<;W=O1K[[]J"
MH\/KA#;D)(MB"U,*A-$U#VC(9\[:@A:*64X,*S-\)_JG:=L.W#_@K7$#535+
M=@U>6O,FTY:E3PWG[V9EOKBXJO5N6$3ST@(#E<MLS=,(A3$);8Y.>R@<2^WX
M[<#+:$#*Z#(/WLF'N>]3*HSYE+YBOCS'L_)X6RUOEUM^#F38)U98&1)+()QW
MY&71C@I:,1"<?H\L2VY;U\GL1.#IE,WL@JJ'!G XG75Y$/_T_:8*XV=R1+[,
M%U-<OOE[NIPD(641TD%"50<BETP&/FM(444K'"?9#M^&Z5GRQ@7C@"!Y?:Q!
M$XUU ,8GV/AE?D%N\42G&-$("Y()VK]*D\!29&"SR(F)A*:T?D3T+#&]O8!H
MI/[Y$+KH %1/5)W]W^5T]?T3ILO%NO?3;W@1<3&10C)GN0=F)0?EO0)GBX>(
M0B>/094X?(3^-&WC0JX1%%ZO!CQ<+R/B;;E833[6OJ3KK4<Q=Q+>"T!37_"D
M^OINW;16U=;)3/@BMCHKZ5/O (E^=PNB>PN.6T$Z_.FWOW1[@,0&R8KKX$U"
M2#P&4)HY"+6OMHPQ9W),37"V%2C&-!P'*.NANO>0W,@*_RW\/;VXO-@0CLRI
MPBV'Y(,"%3!"$$Z2\5),V9#1^:WZ [RB\GN+CJST?50V;R&_L14_G=TAG)62
M!+<(9-0DJ"@#$,,1D@XFJ>R<V*Y8XS7%WUUTG$.@F>+WEE^77N;ML?>>_N;=
M"B^6$Q^+UY8QR)%\<16"!?H_L><YVH3D+_GA+UZ?(&S<NOHQ8^=#M30B])XI
M6'W4F.0C5E]].OOR=.?;23#6<JDE.([$)$\<2) 6?+1&.L4T[>4]JXUWI:6W
MT/I@=+Q<6SRHJKHTBL\-0TK92)THD.28(BB;(W@N(J!VSGI=>]L?83+E 7.L
MCOA2OQ4HA]52)X;Q+BOK/,87DMH%[;FRX8J.E?E/^"OMP'J7_G:^^#FLTM<_
M_KPG@XF*AB5C/?!H:S,=DR"F@D#2]D5'(451N]C(-F3UUN5Q"',Y@@([A>X5
MB_4H^+YQE3_AXMLTX=5E_$3PPK,. 42,Q&*,"@+/&;1,-C,NK%'B$(R^LGYO
M(]6. <:6*ND5=1OC_UO=56O/9)'6M4G7V^_N/YB8H+F-@L(^1H>#RD74!WP&
MG)5%9A<M"_H@#.Y"36]SU(Z"R,'4U8\_^9#G3<;HS6QV&<[OF7WB_IKOC2 F
MQF'B@B-D61CQS>@,^/_;N[;>N'$E_;[_A;ND2$KBRP&<VTR 3&S$GEGL4\"K
MK9UVRR-U>^)_?TBYW79WJ]6Z4"8])T'@&<!!J?A]Q2)9K"HB;6>HRK02C L\
M5P.V*6K']@+;3'O05V,V7F/>G\ [O]^,% JCM: :,.J>,^:2 I&I''!F$HZ9
M(8F>*8PT0MNPI6#!3-<WCV_:8L]-\\OODBH[0[$"*;9C)=QNBCC*$4B2'%*"
M.4Z2F;HECU<Z;)56S/8[AM4WLLO=66L>WRC[GE&.,Y-(P TCKG4@ 0S;8<(T
M89AEA*O]&YUI>]L6'<)6-,6QHYU*S1OLZOC<%DL\["?BS-'.\?3WYN[C.'#$
MGO+4W6L?NC&WG6SY;15%EAN[4$M C2MZ@TGJ[J(3@$V:*HPI3*COU:M;H]?-
M1M=(<MVT!G0A#$(4 SF7.:""8D9RF?+,=RG.&\I&]V@[TQ+0A] 4SZ:R5SXK
M02G$*47 </><M^!VHT%R R2A F+)F!;SOS7SCTA 'V0D$Q+0AS 6@3$>SW3-
MC$P2R#60++6HI3BQ [%'-2-41I0=99;U2MW[STI 'T1_[P3T(5Q$8%2]$YWM
MT9\D5".[/-A-,]$X![ENGH\1QMBQID*_0I/:-Y6 /L@4QB:@#^$E GO[5/QP
M#?M=D?C!4%*J.,R%/8TEC+NWK07(J1* :V489!IBXKO&H4.=L)D5\UB5+_1'
M&]*]KD0Y7P(/KV]<VP+['S=;[OG"=;1ZFB@P,\H]FIXW%>#6Q8.<8 %,#F6J
MB)(6U/FS>#HT#)LP\5INS!M'$3BS?C$GFF)I"*' >F)I_3)4P&XX5'/$0C*G
M*8?S5Z:.S:N-I"K'[Y%@*DM1FMXG7E1_\,7:(OJB4[U!&KO\(9 2Z.I;,+5>
M/:= (FUH+G.ADOD?N&M5+;:#PF2C.&EVTQF*TO .'V?2J[-%(ZG);C-$$:84
M!DA*%VE7&6#,'KN8@AAF4'$JYW\?ZX22;R&-UJ\Q^F3M#=Y:;.?BXRPLEGL(
M/:>XSW.+,?S[<]]J3$0D0#>>#.894X2[3!J[*<@Q X(0#%0*F6&9$ SZ#GM%
MVXW':$X15AJDPK58X]2N(EEB 5%I:G*29+GW)R3>T/W'7%8U[3)D"&<1K/Q;
M!_'N8?N_OQ9V]:CDS<,7?:\735B5D@0S(S* <NS:G%,"6*(0P":3"4E-JO:S
M;*='<7II]I:N0 :9QGZ0QS]/,5G?;YH[H)IFY8?CV\0L=)IHXIXX%YHF@$"[
MJ>8"(9 CJG6B(,^@[_;<@Q0,:XMS6,@Q(_1.5TRV^'EYMU[5#6)H$\)"2D))
MB0&(Y.Z9*I*X2>OB9BE$B)&$Y+.YOT-U(K$S_T9PS-PF,A*I<25/?0>($AJG
M[LK2N,=$7':NL1#9!0%QD0AH$M\Y!AWJA#TTAS6N,8Q$:EQX,Q0N(86"&I!H
ME=H!N/B"A BD5E5[JI59FOK.(.M0)^QM2%CC&L-(!,8U)/E"91 RS@00U$X9
MNYG( '/%VU+@+%6)>^K7]]G==[94)%<C4XX*<S$6@3$>O\^$,B<,*E=M+9AK
M%" !@PP#R2%.I32&\Y_M.J?1WSM;:@@7$1A5[ZR<1 JB\PP!A(D"!!D(.#3,
MSDP[6U/&:,KG?S?P;65+#3*%L=E20WAY$_;V>_V%5]?Z/;_;C% HSC6D B0L
MLQM2A37@!D- #)>8$PLE>OT\O7TM8W-[/JQEL$E.HBZ24K6NX5U>WO+%P@[O
M;*E^*]2+<4)[YL89 3AS2PGD&(B<6FQ1"@FTJXE)]RZ$>_?TZJU$;!>^'BWP
M5?EY$T[R:[G\_0E19#C6$N8@35U7"6T08-R>U=Q1#;E&93F9OYE7AX*QM4T*
MXAK'$A:A5[S5U76QO/Z-5W_J;9ZC0-(0*%.00]?[WKB42LP2BQ[B"<),(<K&
M>L"V#\;6_N@5O-UDW..SI2^%A4V=+>P'EI:\^RUN+"6"N)?<$6KB1,S5 %CP
M[,89IW8/C3A!(\WIV#=C:U\TOT5Y03^"Y;*K!D G"%+7PA/;I1X0B@Q@2*?V
M!^)9IAFBV/>;3F^P F/*2=47^A$8TL#<?BTE9EA#H#&ROM<ENW)!E1NB4$F"
MTE3/GP;Z%NLO_ 9&O'$4I06VY<T:F$G"[1J0)M9)$V@')82F0) <9EA (?H]
M;!&D_B*2ON9^+QFFLA2EZ;5G]V.<JYQ1 G325#2)Q.704  A<VVRL\0(WXE(
M_Z#ZBT%&,;+^8@A#'NL>/:>Z7^IK=T?]XLE4SV_##ON EV3U"6/RE(V^T>";
MOBNKE3U-;I.$.299[K*"4^3>+"8I!3RU1TH-=>ZBN$F2^I[6QW29ZLF^KMW2
M?V[.[W3%G>#-AUQ;:HI4(A.@<A>/UMAN125&()&4J)Q(E4'?]=A'E0F<O.O#
M#O8=E!_@8ZV].9R\/GW/O&XFA$<Q"D&E,0%&.DN".+.;*^H>+\PTS)5"N?#=
M-G4NC_*\M=S_P@N,WSUL?OFXP82&0Y@A#+(D18 8>^@0+-7VA\Q(S@G)L'>'
M.ES-2+W0$-LY7K(R#UD1[-4O+46/-6_KVFX)Z_K)T3Z^ "BL94#. *29/?-J
M) &GB0"Y'5:F3$88\?Z.>9="L92IS&0.^^;GC9L8#.U1]TW<)A>2&)/8PPO*
M7&<>F@+!4P648A@3:4\SF>^ UXX"@0W)'['[)C,:Y>!7.N6MKE>%W.SXRN7V
M%6$DE)&( 8JAA4/E]IRK$ 72I"+%.:6(J%.;I,XO1+%PC6&L] U?:!OXO-Q<
M(+E3[,%(J#8()MQA8S?]A"L&&!;,'@1$JCF!N12XER%T?B9P>K,?:_ '9."G
M6=];K<M%H1K]F[A7XR*U)!AE- &&(>%6509RE;H* *12@BBSI\0^R\>)-UK;
MOQY+ OR\FQ!/Z$=G/T^-NTC&-,LSD)/43BWWE([ 20J8@#JG2-'4R_/.Q[X?
M[J5G'YQVFL@(@"/8GAX$FC:^4J%46:?HGNL4RCT_1X!URA0(I+!&.A<L]QUZ
M.*)*3"8SAN/2/^ 1V,W[LK+NUV[GOY;+S4B>5EDNN$9,@U1F=I6EB00B3RQ,
M.1))F@JC]U_U\]"!Y8@RX=X7G\5V_( >@?4T^[3Z<00?%\5M\;AG>WJ/'9L<
M8BV X2('A#$[*:"=%)F+<F>NUY3R7:[0J5"82_G9K,@?^($W.=MPPB^ZO*[X
MW4TA^6.7BBS/DUP+!!26=CI@! '/# 3V_*!SNZ(+FO7R02=V.4<5B"6-8_ZM
MLA\.0AO2(Q(OA["99R*EF&JN *6Y>Z?'.E=&& $9UA)+KIG]X\.0CBD0;O/C
MB=C2-\H1K%XO*Q'<$_9YG@I <6*W;2:C%HPT!]K A)@\H4+X+AT96A@RCWGX
M(7/_^GLDLA$818>K_;+-74):9 JQ!*2I3 #)7(A;Y"F0W"@)29IB-5/XOU.O
ML*4@KWZ]Y)NI"*SOF[[7R[7^9,%MGIOC<O6_Q>KF_;I>E;>Z^OA#+M;*70_7
MM;9_U17_\9TF6F4N+F[<"\I$<)?8"SE0"$DITE1KYCN59X2:4=Q2>+25\G6)
M"WVUL1E?_7FY&<C+TX<KQ%K??6=9DFDI)5"YY'8R&PQ88F<T8M0U][=G#M&O
M5*G'QZ*XYO!O3K-@'8%?^Z#MEV71(/2=(82QA)D]FFIK][FQAU[.&< 08:*I
M-07AOX'&\_<#'^KF]D2CH8[ 3!Z+I[Z4=?WD2(OEVH+T? 7X3ENX].._LSY4
MUQ]_6&=K22N6O'IHT+.;3^E<<+E8/,T=7:^^*T$)3#)HYTF&-Z5\'#F7FR&$
M$F7RW'\T:K;A!-[JS6W$L1A"-'/"#O'C#]?G6F^*'KZG@JD$&P-DTG1PM8<T
MH04!,J<9Y)@P)7R?08ZH$K9>^)5L<1H!$=C15[UZGE5GJ\>GK-TA[*H\,E$(
MQQI3E )DH'*]0A3([='?SIN40T2A)M!W]N1@)7O97OIF;6]>TJ)XZFUGB-\Q
M)T8DA(-4Y]"ICZQSSBG0B80&\UPH[/NMYQT%>ME3]L^PIT%@1^#!-D5]E" $
ML<P H[D]^KB6A8QP :B%(V5&:N.]D<& JLK\S=K&"'BC<" 7O'GYO+XJS^1?
MZZ+2%U6IUM*U\=@,R2[(::[2#"C&74:R/04QF1O+LU0)HX(K[CM"=E*I7L;$
MWJPQ^24E?"%<([O6\K^OR_O_T5(]BC_[FU?JREV]7S^7..\JW58%MV-=+X4^
M&I94S_;4_H6!M7&CE?=5&'=CC?(=K[7:>:RGJOCR^K']]KN'YW^S,9U&O4<=
M[6?.ELK5=7_EMWISH^KY>F4.%2=?!M1VPR=76EVN2OGG[\MB57^[_'US9>@[
MHM_UK;#!AAFMYS",WP/RT=YHX2$,WZI??:FK^T)J!U"Y?$Z;ZQ=L'R0R[%G_
M%4QA LYA#,,Z].^/P[MM'/EV 1^]Z!R7Z$'%WY9WA1-Z91>7=_:7?WI1\U!J
MD/O&DUP\65DO1 *>N7;TTZN;4GGF:T]FD.N\<6RUHQ$)5Q?VLZOJ=JD^+?BU
M%Z9V)0:Y.QO%4RL2D;#D9OS[9:TJ?S3MB0RR8QOM_0ZQB(2H7\N_G_7SZP&/
MB ZROQI%7#<V@0G<KJG%K5:?RLKMV/[@B\G3K4MND*N(0=3U0"6&B5>_7Y2U
MOBJWZC8W'OYFWPGY0:X AD_!?BA%R^=,-(8)TGMB+Q+2/B]5<5^H]:8(9@I1
M>Z+"'LJZ,2]/ 1!Z*BT6SWK5)Z. /291F\!@#!W!O.P'0 S7D]L04_>D&74!
MN2,[[&&YURSJ!,4[6:^=3MX^JOWZA#F#E>'-_>/MW:)\T+H)D)[?O2BS]6OZ
MQ[\3-@7\%6\E3D(=@3DTNIW=/><>?RNN;U;UY=FWRUG,XO3WPJ9YOZ)Y](8^
M] :F;?6P*[H;H?_3P)/@('D6T\\#>[C$0-WO2U4M'JZ?WS8YNUU-YZU5:J_5
M'89GK0N2&"C[^*.2%U4A/<RO9U&]R(G@:NU@\#$P\HM= 58?^$IO7RR83DV+
MS%X<17"A=AR.P&3MSNR'W_Y<-:;T_F9Y?2&GN;T3HGM1%_:.K1\XL6;M?:R:
MP/=,&7N'TKUDZYU0>F*FGB/UFY;EO:X>SLW!MPZ,893=]_K A"F[D?KTF>E1
MYE:!P0)D0_AY.5F[8 GL9%V:U:8]C5L#)D>;V^0%XZL3][(7"/_1]P"S[$[Z
MDO+S!N#G#< @;KZ6RZ^Z]$'*KJ1P-V9=6)<G!A[1NJ*MR*?>B,Z_>EM@#@0'
M<VIC=P9]8 KM\JZO5YM!38XV[8H*ELDXEJUV* +S\Z30DB\>ZJ+VDZ1S5&BP
MK,:)>^^C\ 1F[W+UYT4ESZNKNOI8KXK;30-9?^G>O3X0+.5Q+*M#8 O,\/EZ
M97W\LFD]YL^5'I<:+ =R+)<G 8IG ?Q:KOY/;U=J[2L?N<\'@J5$>E@L3\(6
MF.%/5FBYU$\C]7$A>D1DL-3(L2QV0Q,7;Q_6^JK<M BRXW0%];+96D]UMD.^
M$^RRVQ/#?4",D/8_BG+1P'QN?BUO]?MRO5Q5#U_XWW-PW_FQ<!?G/BV@#YX1
MFH$=\5]KOBA,(3?:7_$?FW9ADY,E1GTPW%6]3W/HBVM<)F'=V((O-PI_OKUS
M/8'M $2Q*%8/?O9NX[X8+C? DU$,0S:>$YC/+5Z'V' )!!X.87'N]5H4]'R.
MWA?;B\2H8EVG,8KH5J#4M3T7?M--;ZKM;: 7ISS@,[U(CBKT-1S#6+. +N[G
MR@#:E>PE^Z=#60^9/Q?\X8_Z0E=-#[BEU+X3?_K(GS"O+3C3<WVV0H)=N Y@
MX>6,W!]]Z NA'UJN79N_]]9-7)?5P^34D7:)X6C:Q[OL.?C0@>3%8E^]0GM*
M(CDN.%SV52<5Y3!< E-WH4L//#U+"9E3<AKKLF/@X9-\K$I?O="Q+RM<4>]
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M,2YH=&U02P$"% ,4    " #G7=Q8MCF>E!X&  !<#P  %
M@ %+!@  8V5R=&EF:6-A=&EO;C,Q,BYH=&U02P$"% ,4    " #G7=Q8[5Y=
M@"\!  #5 0  "@              @ &;#   97@Q,#(R+FAT;5!+ 0(4 Q0
M   ( .==W%C)P"=A:Q,  &D]   7              "  ?(-  !E>#DW,6-L
M87=B86-K<&]L:6-Y+FAT;5!+ 0(4 Q0    ( .==W%A,NFXIZ0$  &@#   2
M              "  9(A  !E>&AI8FET,C$Q,C R-"YH=&U02P$"% ,4
M" #G7=Q8KV6-:'\#  !M!@  #@              @ &K(P  97AH:6)I=#,R
M,2YH=&U02P$"% ,4    " #G7=Q8%8ZNDX8#  "2!@  #@
M@ %6)P  97AH:6)I=#,R,BYH=&U02P$"% ,4    " #G7=Q8#\!8ITD"  #\
M P  &               @ $(*P  9F]R=FES8V]N<V5N='5P9&%T960N:'1M
M4$L! A0#%     @ YUW<6$$%=IP7G $ U144 !$              ( !ART
M &ME<74M,C R-# T,S N:'1M4$L! A0#%     @ YUW<6,GK"JBL%   7^@
M !$              ( !S<D! &ME<74M,C R-# T,S N>'-D4$L! A0#%
M  @ YUW<6,BQ<4Y4*P  O+\! !4              ( !J-X! &ME<74M,C R
M-# T,S!?8V%L+GAM;%!+ 0(4 Q0    ( .==W%CZ87-2]5(  &.* P 5
M          "  2\* @!K97%U+3(P,C0P-#,P7V1E9BYX;6Q02P$"% ,4
M" #G7=Q8#HT-WF([ 0 O0@P %0              @ %770( :V5Q=2TR,#(T
M,#0S,%]L86(N>&UL4$L! A0#%     @ YUW<6&NDW-+;L@  7E(( !4
M         ( ![)@# &ME<74M,C R-# T,S!?<')E+GAM;%!+!08     #@ .
+ (D#  #Z2P0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>kequ-20240430_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kequ="http://www.kewaunee.com/20240430"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kequ-20240430.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayAsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KoncepoScientechInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KequipGlobalLabSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">kequ:FiscalYearTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-19</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">kequ:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-30</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTwentyThreeOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-08-26</startDate>
            <endDate>2015-08-26</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">kequ:PubliclyAnnouncedProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="compensation_plan">
        <measure>kequ:compensation_plan</measure>
    </unit>
    <unit id="renewaloption">
        <measure>kequ:renewalOption</measure>
    </unit>
    <unit id="segment">
        <measure>kequ:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-32">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-35">0000055529</dei:EntityCentralIndexKey>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-796">http://fasb.org/us-gaap/2023#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-801">http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-804">http://fasb.org/us-gaap/2023#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-805">http://fasb.org/us-gaap/2023#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList contextRef="c-1" id="f-806">http://fasb.org/us-gaap/2023#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-04-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--04-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">0-5286</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">KEWAUNEE SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">38-0715562</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">2700 West Front Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Statesville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">28677-2927</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">704</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">873-7202</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common&#160;Stock&#160;$2.50&#160;par&#160;value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">KEQU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="0" id="f-29" unitRef="usd">26982424</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">2840143</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;28, 2024, indicated in this report are incorporated by reference into Part&#160;III hereof.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-36">Forvis Mazars, LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-37">Atlanta, GA</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c-1" id="f-38">686</dei:AuditorFirmId>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-39" unitRef="usd">203755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-41" unitRef="usd">151704000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">183906000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-3" id="f-43" unitRef="usd">52051000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">35588000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-45" unitRef="usd">33770000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">30224000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-47" unitRef="usd">18281000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">5364000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PensionExpense contextRef="c-1" decimals="-3" id="f-49" unitRef="usd">4177000</us-gaap:PensionExpense>
    <us-gaap:PensionExpense contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">71000</us-gaap:PensionExpense>
    <us-gaap:OtherIncome contextRef="c-1" decimals="-3" id="f-51" unitRef="usd">814000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">939000</us-gaap:OtherIncome>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-53" unitRef="usd">1799000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">1734000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-55" unitRef="usd">13119000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">4498000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-57" unitRef="usd">-5938000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-59" unitRef="usd">19057000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-61" unitRef="usd">304000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-63" unitRef="usd">18753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-65"
      unitRef="usdPerShare">6.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-4"
      decimals="2"
      id="f-66"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-67"
      unitRef="usdPerShare">6.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-4"
      decimals="2"
      id="f-68"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-69" unitRef="shares">2879000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-4" decimals="-3" id="f-70" unitRef="shares">2824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-71" unitRef="shares">2938000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-4" decimals="-3" id="f-72" unitRef="shares">2902000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-73" unitRef="usd">19057000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-75" unitRef="usd">-598000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax contextRef="c-1" decimals="-3" id="f-77" unitRef="usd">4019000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax contextRef="c-1" decimals="-3" id="f-79" unitRef="usd">3870000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-1" decimals="-3" id="f-81" unitRef="usd">509000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-83" unitRef="usd">-658000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">-590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-85" unitRef="usd">19117000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">1659000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-87" unitRef="usd">304000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">621000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-89" unitRef="usd">18813000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">1038000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">6983000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-92" unitRef="usd">4483000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-93" unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-94" unitRef="usd">28023000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-95" unitRef="usd">-3742000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-96" unitRef="usd">35694000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-97" unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-3" id="f-98" unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-12" decimals="-3" id="f-99" unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-100" unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-101" unitRef="usd">101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-102" unitRef="usd">576000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-3" id="f-104" unitRef="usd">7084000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-105" unitRef="usd">5059000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-106" unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-107" unitRef="usd">28761000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-108" unitRef="usd">-3442000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-109" unitRef="usd">37409000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-110" unitRef="usd">18753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-111" unitRef="usd">18753000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-22" decimals="-3" id="f-112" unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-113" unitRef="usd">60000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-23" decimals="-3" id="f-114" unitRef="usd">189000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-24" decimals="-3" id="f-115" unitRef="usd">347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">536000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="INF" id="f-117" unitRef="shares">66191</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-25" decimals="-3" id="f-118" unitRef="usd">1998000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">1998000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-120" unitRef="usd">7273000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-121" unitRef="usd">5406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-122" unitRef="usd">-2051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-123" unitRef="usd">47514000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-124" unitRef="usd">-3382000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-125" unitRef="usd">54760000</us-gaap:StockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-3" id="f-126" unitRef="usd">23267000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-20" decimals="-3" id="f-127" unitRef="usd">8078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-3" id="f-128" unitRef="usd">2671000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-20" decimals="-3" id="f-129" unitRef="usd">5737000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-31" decimals="-3" id="f-130" unitRef="usd">588000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-20" decimals="-3" id="f-131" unitRef="usd">476000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-31" decimals="-3" id="f-132" unitRef="usd">45064000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-20" decimals="-3" id="f-133" unitRef="usd">46081000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-31" decimals="-3" id="f-134" unitRef="usd">20679000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-20" decimals="-3" id="f-135" unitRef="usd">21889000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-31" decimals="-3" id="f-136" unitRef="usd">5136000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-20" decimals="-3" id="f-137" unitRef="usd">6135000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-31" decimals="-3" id="f-138" unitRef="usd">96817000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-20" decimals="-3" id="f-139" unitRef="usd">87920000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-31" decimals="-3" id="f-140" unitRef="usd">17649000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-20" decimals="-3" id="f-141" unitRef="usd">16402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-31" decimals="-3" id="f-142" unitRef="usd">7454000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-20" decimals="-3" id="f-143" unitRef="usd">9170000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-31" decimals="-3" id="f-144" unitRef="usd">7401000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-20" decimals="-3" id="f-145" unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-31" decimals="-3" id="f-146" unitRef="usd">5445000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-20" decimals="-3" id="f-147" unitRef="usd">5406000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-31" decimals="-3" id="f-148" unitRef="usd">134766000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-20" decimals="-3" id="f-149" unitRef="usd">118898000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings contextRef="c-31" decimals="-3" id="f-150" unitRef="usd">3099000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-20" decimals="-3" id="f-151" unitRef="usd">3587000</us-gaap:ShortTermBorrowings>
    <kequ:FinancingLiabilityCurrent contextRef="c-31" decimals="-3" id="f-152" unitRef="usd">713000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityCurrent contextRef="c-20" decimals="-3" id="f-153" unitRef="usd">642000</kequ:FinancingLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-31" decimals="-3" id="f-154" unitRef="usd">111000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-20" decimals="-3" id="f-155" unitRef="usd">85000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-31" decimals="-3" id="f-156" unitRef="usd">2123000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-20" decimals="-3" id="f-157" unitRef="usd">1967000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-31" decimals="-3" id="f-158" unitRef="usd">23262000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-20" decimals="-3" id="f-159" unitRef="usd">23599000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-31" decimals="-3" id="f-160" unitRef="usd">6041000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-20" decimals="-3" id="f-161" unitRef="usd">4304000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-31" decimals="-3" id="f-162" unitRef="usd">4374000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-20" decimals="-3" id="f-163" unitRef="usd">4097000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-31" decimals="-3" id="f-164" unitRef="usd">1057000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-20" decimals="-3" id="f-165" unitRef="usd">1772000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-31" decimals="-3" id="f-166" unitRef="usd">40780000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-20" decimals="-3" id="f-167" unitRef="usd">40053000</us-gaap:LiabilitiesCurrent>
    <kequ:FinancingLiabilityNoncurrent contextRef="c-31" decimals="-3" id="f-168" unitRef="usd">27420000</kequ:FinancingLiabilityNoncurrent>
    <kequ:FinancingLiabilityNoncurrent contextRef="c-20" decimals="-3" id="f-169" unitRef="usd">28132000</kequ:FinancingLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-31" decimals="-3" id="f-170" unitRef="usd">235000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-20" decimals="-3" id="f-171" unitRef="usd">148000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-31" decimals="-3" id="f-172" unitRef="usd">5434000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-20" decimals="-3" id="f-173" unitRef="usd">7136000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <kequ:AccruedEmployeeBenefitPlanCosts contextRef="c-31" decimals="-3" id="f-174" unitRef="usd">3008000</kequ:AccruedEmployeeBenefitPlanCosts>
    <kequ:AccruedEmployeeBenefitPlanCosts contextRef="c-20" decimals="-3" id="f-175" unitRef="usd">3546000</kequ:AccruedEmployeeBenefitPlanCosts>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-31" decimals="-3" id="f-176" unitRef="usd">1218000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-20" decimals="-3" id="f-177" unitRef="usd">943000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-31" decimals="-3" id="f-178" unitRef="usd">462000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-20" decimals="-3" id="f-179" unitRef="usd">455000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-31" decimals="-3" id="f-180" unitRef="usd">78557000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-20" decimals="-3" id="f-181" unitRef="usd">80413000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-31" id="f-182" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-20" id="f-183" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="2"
      id="f-184"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-20"
      decimals="2"
      id="f-185"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-31" decimals="-3" id="f-186" unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-20" decimals="-3" id="f-187" unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-31" decimals="-3" id="f-188" unitRef="shares">2909000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-20" decimals="-3" id="f-189" unitRef="shares">2833000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-31" decimals="-3" id="f-190" unitRef="shares">2839000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="-3" id="f-191" unitRef="shares">2830000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-31" decimals="-3" id="f-192" unitRef="usd">7273000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-20" decimals="-3" id="f-193" unitRef="usd">7084000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-31" decimals="-3" id="f-194" unitRef="usd">5406000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-20" decimals="-3" id="f-195" unitRef="usd">5059000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-31" decimals="-3" id="f-196" unitRef="usd">47514000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-20" decimals="-3" id="f-197" unitRef="usd">28761000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-31" decimals="-3" id="f-198" unitRef="usd">-3382000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-20" decimals="-3" id="f-199" unitRef="usd">-3442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares contextRef="c-31" decimals="-3" id="f-200" unitRef="shares">70000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-20" decimals="-3" id="f-201" unitRef="shares">3000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="c-31" decimals="-3" id="f-202" unitRef="usd">2051000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="c-20" decimals="-3" id="f-203" unitRef="usd">53000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-204" unitRef="usd">54760000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-205" unitRef="usd">37409000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-31" decimals="-3" id="f-206" unitRef="usd">1449000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-20" decimals="-3" id="f-207" unitRef="usd">1076000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-208" unitRef="usd">56209000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-20" decimals="-3" id="f-209" unitRef="usd">38485000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-31" decimals="-3" id="f-210" unitRef="usd">134766000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-20" decimals="-3" id="f-211" unitRef="usd">118898000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-212" unitRef="usd">19057000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-4" decimals="-3" id="f-213" unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">3125000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-4" decimals="-3" id="f-215" unitRef="usd">2867000</us-gaap:Depreciation>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-216" unitRef="usd">276000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-217" unitRef="usd">120000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-218" unitRef="usd">1028000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-4" decimals="-3" id="f-219" unitRef="usd">886000</us-gaap:ShareBasedCompensation>
    <kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">-7127000</kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment>
    <kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment contextRef="c-4" decimals="-3" id="f-221" unitRef="usd">516000</kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-222" unitRef="usd">-741000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-4" decimals="-3" id="f-223" unitRef="usd">4947000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-224" unitRef="usd">-1210000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-4" decimals="-3" id="f-225" unitRef="usd">-1907000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-226" unitRef="usd">691000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-4" decimals="-3" id="f-227" unitRef="usd">-5558000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-228" unitRef="usd">277000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-4" decimals="-3" id="f-229" unitRef="usd">568000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-1" decimals="-3" id="f-230" unitRef="usd">286000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-4" decimals="-3" id="f-231" unitRef="usd">-1508000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">19564000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-4" decimals="-3" id="f-233" unitRef="usd">-3790000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-1" decimals="-3" id="f-234" unitRef="usd">4373000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-4" decimals="-3" id="f-235" unitRef="usd">4148000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-236" unitRef="usd">-4373000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-4" decimals="-3" id="f-237" unitRef="usd">-4148000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">148061000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt contextRef="c-4" decimals="-3" id="f-239" unitRef="usd">60599000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="c-1" decimals="-3" id="f-240" unitRef="usd">148549000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="c-4" decimals="-3" id="f-241" unitRef="usd">58601000</us-gaap:RepaymentsOfShortTermDebt>
    <kequ:ProceedsFromFinancingLiability contextRef="c-1" decimals="-3" id="f-242" unitRef="usd">0</kequ:ProceedsFromFinancingLiability>
    <kequ:ProceedsFromFinancingLiability contextRef="c-4" decimals="-3" id="f-243" unitRef="usd">13629000</kequ:ProceedsFromFinancingLiability>
    <kequ:PaymentsOnFinancingLiability contextRef="c-1" decimals="-3" id="f-244" unitRef="usd">642000</kequ:PaymentsOnFinancingLiability>
    <kequ:PaymentsOnFinancingLiability contextRef="c-4" decimals="-3" id="f-245" unitRef="usd">575000</kequ:PaymentsOnFinancingLiability>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-3" id="f-246" unitRef="usd">202000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-4" decimals="-3" id="f-247" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-3" id="f-248" unitRef="usd">88000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-4" decimals="-3" id="f-249" unitRef="usd">121000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-250" unitRef="usd">1998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-4" decimals="-3" id="f-251" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-252" unitRef="usd">-3014000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-4" decimals="-3" id="f-253" unitRef="usd">14931000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-254" unitRef="usd">-54000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-255" unitRef="usd">-72000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-256" unitRef="usd">12123000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-4" decimals="-3" id="f-257" unitRef="usd">6921000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-20" decimals="-3" id="f-258" unitRef="usd">13815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-3" id="f-259" unitRef="usd">6894000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-31" decimals="-3" id="f-260" unitRef="usd">25938000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-20" decimals="-3" id="f-261" unitRef="usd">13815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-262" unitRef="usd">1799000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-4" decimals="-3" id="f-263" unitRef="usd">1862000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-264" unitRef="usd">6240000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-4" decimals="-3" id="f-265" unitRef="usd">3158000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-266" unitRef="usd">200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-267" unitRef="usd">3902000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-268" unitRef="usd">204000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-269" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-270">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2024 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 94% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated. Included in the consolidated financial statements are net assets of $18,547,000 and $16,786,000 at April&#160;30, 2024 and 2023, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $66,517,000 and $72,778,000 were included in the consolidated statements of operations for fiscal years 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2024 and 2023, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows. The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.918%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.851%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,671&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Receivables are stated at the amount owed by the customer, net of allowances for estimated credit losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for credit losses is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential credit losses, a reserve for credit losses is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for credit losses for each of the years ended April&#160;30 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.005%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unbilled Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets. The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2024 and 2023 was $11,840,000 and $13,459,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter. Property, plant and equipment consisted of the following at April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value. There were no impairments in fiscal years 2024 or 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other assets at April&#160;30, 2024 and 2023 included $312,000 and $1,191,000, respectively, of unbilled retainage, $2,611,000 and $2,352,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $31,000 and $111,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for credit losses, self-insurance reserves, and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#x2019;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of the Buyer, entering into a lease agreement. The lease arrangement is for a 20-year term. At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). The Company concluded that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. For additional information on the accounting for the Sale-Leaseback Arrangement, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i7c2284e7bf3e47828f4617b389f29ad2_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Financing Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $294,000 and $235,000 at April&#160;30, 2024 and 2023, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Concentration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs credit evaluations of its customers. Revenues from three of the Company's domestic dealers represented in the aggregate approximately 45% and 36% of the Company's sales in fiscal years 2024 and 2023, respectively. Accounts receivable for two domestic customers represented approximately 21% and 23% of the Company's total accounts receivable as of April&#160;30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under AC 740, the Company evaluates the realization of all deferred income tax assets and determines if a valuation allowance is required on an annual basis. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2024 or 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Experimentation Expenditures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Research and experimentation expenditures are charged to cost of products sold in the periods incurred. Expenditures for research and experimentation expenditures were $920,000 and $1,012,000 for the fiscal years ended April&#160;30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses. Advertising costs for the years ended April&#160;30, 2024 and 2023 were $336,000 and $226,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements of subsidiaries located in India are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect. There were no antidilutive RSUs and stock options outstanding at April&#160;30, 2024. There were 33,900 antidilutive RSUs and stock options outstanding at April&#160;30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic to diluted weighted average common shares outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting for Stock Options and Other Equity Awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#x2014;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited. The Company granted 117,747 RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2024 and 87,969 RSUs in fiscal year 2023. There were no stock options granted during fiscal years 2024 and 2023. (See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i7c2284e7bf3e47828f4617b389f29ad2_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note&#160;7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options and Share-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company adopted this standard effective May 1, 2023. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures," which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2025. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements for Income Tax Disclosures," which requires public business entities to, on an annual basis, (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. This ASU also provides for additional disclosure requirements to provide clarity for investors related to income tax disclosures. This guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2026. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-271">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt; The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2024 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 94% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-32"
      decimals="INF"
      id="f-272"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-33"
      decimals="INF"
      id="f-273"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-34"
      decimals="INF"
      id="f-274"
      unitRef="number">0.94</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-35"
      decimals="INF"
      id="f-275"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c-36"
      decimals="INF"
      id="f-276"
      unitRef="number">0.70</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:AssetsNet contextRef="c-37" decimals="-3" id="f-277" unitRef="usd">18547000</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c-38" decimals="-3" id="f-278" unitRef="usd">16786000</us-gaap:AssetsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-39" decimals="-3" id="f-279" unitRef="usd">66517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-40" decimals="-3" id="f-280" unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-281">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2024 and 2023, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.&lt;/span&gt;&lt;/div&gt;The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock contextRef="c-1" id="f-282">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.918%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.851%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,671&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-3" id="f-283" unitRef="usd">23267000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-20" decimals="-3" id="f-284" unitRef="usd">8078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-3" id="f-285" unitRef="usd">2671000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="c-20" decimals="-3" id="f-286" unitRef="usd">5737000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-31" decimals="-3" id="f-287" unitRef="usd">25938000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-20" decimals="-3" id="f-288" unitRef="usd">13815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-289">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="c-1" id="f-290">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt; Receivables are stated at the amount owed by the customer, net of allowances for estimated credit losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for credit losses is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential credit losses, a reserve for credit losses is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock contextRef="c-1" id="f-291">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for credit losses for each of the years ended April&#160;30 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.005%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-20" decimals="-3" id="f-292" unitRef="usd">476000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-10" decimals="-3" id="f-293" unitRef="usd">357000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-294" unitRef="usd">276000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-295" unitRef="usd">120000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="-3" id="f-296" unitRef="usd">164000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-4" decimals="-3" id="f-297" unitRef="usd">1000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-31" decimals="-3" id="f-298" unitRef="usd">588000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-20" decimals="-3" id="f-299" unitRef="usd">476000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy contextRef="c-1" id="f-300">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unbilled Receivables&lt;/span&gt; Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.</us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-31" decimals="-3" id="f-301" unitRef="usd">11840000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-20" decimals="-3" id="f-302" unitRef="usd">13459000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-303">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt; The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-304">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt; Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-305">Property, plant and equipment consisted of the following at April&#160;30:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,913&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64,234&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(46,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-41" decimals="-3" id="f-306" unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-42" decimals="-3" id="f-307" unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-43" decimals="-3" id="f-308" unitRef="usd">17280000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-44" decimals="-3" id="f-309" unitRef="usd">17147000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-45" id="f-310">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-46" id="f-311">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-47" decimals="-3" id="f-312" unitRef="usd">46913000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-48" decimals="-3" id="f-313" unitRef="usd">44180000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-49" id="f-314">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-50" id="f-315">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-31" decimals="-3" id="f-316" unitRef="usd">64234000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-20" decimals="-3" id="f-317" unitRef="usd">61368000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-31" decimals="-3" id="f-318" unitRef="usd">46585000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-20" decimals="-3" id="f-319" unitRef="usd">44966000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-31" decimals="-3" id="f-320" unitRef="usd">17649000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-20" decimals="-3" id="f-321" unitRef="usd">16402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentImpairment contextRef="c-1" id="f-322">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.</us-gaap:PropertyPlantAndEquipmentImpairment>
    <us-gaap:AssetImpairmentCharges contextRef="c-4" decimals="INF" id="f-323" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="INF" id="f-324" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <kequ:OtherAssetsPolicyTextBlock contextRef="c-1" id="f-325">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other assets at April&#160;30, 2024 and 2023 included $312,000 and $1,191,000, respectively, of unbilled retainage, $2,611,000 and $2,352,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $31,000 and $111,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.&lt;/span&gt;&lt;/div&gt;</kequ:OtherAssetsPolicyTextBlock>
    <kequ:UnbilledRetainageCurrent contextRef="c-51" decimals="-3" id="f-326" unitRef="usd">312000</kequ:UnbilledRetainageCurrent>
    <kequ:UnbilledRetainageCurrent contextRef="c-52" decimals="-3" id="f-327" unitRef="usd">1191000</kequ:UnbilledRetainageCurrent>
    <us-gaap:AssetsHeldInTrust contextRef="c-53" decimals="-3" id="f-328" unitRef="usd">2611000</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrust contextRef="c-54" decimals="-3" id="f-329" unitRef="usd">2352000</us-gaap:AssetsHeldInTrust>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-53" decimals="-3" id="f-330" unitRef="usd">31000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance contextRef="c-54" decimals="-3" id="f-331" unitRef="usd">111000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-332">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for credit losses, self-insurance reserves, and income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-333">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#x2019;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of the Buyer, entering into a lease agreement. The lease arrangement is for a 20-year term. At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). The Company concluded that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. For additional information on the accounting for the Sale-Leaseback Arrangement, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i7c2284e7bf3e47828f4617b389f29ad2_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Financing Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-55" decimals="-3" id="f-334" unitRef="usd">30275000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <kequ:FinancingLiabilityTermOfContract contextRef="c-31" id="f-335">P20Y</kequ:FinancingLiabilityTermOfContract>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-336">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c-1" id="f-337">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,077&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,642&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,009&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DerivativeAssets contextRef="c-56" decimals="-3" id="f-338" unitRef="usd">1565000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-57" decimals="-3" id="f-339" unitRef="usd">1565000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-58" decimals="-3" id="f-340" unitRef="usd">1077000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-59" decimals="-3" id="f-341" unitRef="usd">1077000</us-gaap:DerivativeAssets>
    <kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag contextRef="c-1" id="f-342">Total</kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:DerivativeAssets contextRef="c-60" decimals="-3" id="f-343" unitRef="usd">1565000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-61" decimals="-3" id="f-344" unitRef="usd">1077000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-31" decimals="-3" id="f-345" unitRef="usd">2642000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-62" decimals="-3" id="f-346" unitRef="usd">3009000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-63" decimals="-3" id="f-347" unitRef="usd">3009000</us-gaap:DerivativeLiabilities>
    <kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag contextRef="c-1" id="f-348">Total</kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:DerivativeLiabilities contextRef="c-61" decimals="-3" id="f-349" unitRef="usd">3009000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-31" decimals="-3" id="f-350" unitRef="usd">3009000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets contextRef="c-64" decimals="-3" id="f-351" unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-65" decimals="-3" id="f-352" unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-66" decimals="-3" id="f-353" unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-67" decimals="-3" id="f-354" unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-68" decimals="-3" id="f-355" unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-69" decimals="-3" id="f-356" unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-20" decimals="-3" id="f-357" unitRef="usd">2463000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities contextRef="c-70" decimals="-3" id="f-358" unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-71" decimals="-3" id="f-359" unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-69" decimals="-3" id="f-360" unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-20" decimals="-3" id="f-361" unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <kequ:NumberOfNonqualifiedCompensationPlans
      contextRef="c-31"
      decimals="INF"
      id="f-362"
      unitRef="compensation_plan">2</kequ:NumberOfNonqualifiedCompensationPlans>
    <kequ:NumberOfNonqualifiedCompensationPlans
      contextRef="c-20"
      decimals="INF"
      id="f-363"
      unitRef="compensation_plan">2</kequ:NumberOfNonqualifiedCompensationPlans>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-364">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $294,000 and $235,000 at April&#160;30, 2024 and 2023, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConstructionContractorReceivableRetainage contextRef="c-31" decimals="-3" id="f-365" unitRef="usd">294000</us-gaap:ConstructionContractorReceivableRetainage>
    <us-gaap:ConstructionContractorReceivableRetainage contextRef="c-20" decimals="-3" id="f-366" unitRef="usd">235000</us-gaap:ConstructionContractorReceivableRetainage>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-367">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Concentration &lt;/span&gt;The Company performs credit evaluations of its customers.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-72" decimals="2" id="f-368" unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-73" decimals="2" id="f-369" unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-74" decimals="2" id="f-370" unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-75" decimals="2" id="f-371" unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SelfInsuranceReservePolicyTextBlock contextRef="c-1" id="f-372">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-373">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt; In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under AC 740, the Company evaluates the realization of all deferred income tax assets and determines if a valuation allowance is required on an annual basis. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2024 or 2023.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-374">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Experimentation Expenditures&lt;/span&gt; Research and experimentation expenditures are charged to cost of products sold in the periods incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">920000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-4" decimals="-3" id="f-376" unitRef="usd">1012000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-377">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt; Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">336000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-4" decimals="-3" id="f-379" unitRef="usd">226000</us-gaap:AdvertisingExpense>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-380">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements of subsidiaries located in India are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-381">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt; Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="INF" id="f-382" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-4" decimals="INF" id="f-383" unitRef="shares">33900</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-384">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic to diluted weighted average common shares outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-385" unitRef="shares">2879000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-4" decimals="-3" id="f-386" unitRef="shares">2824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-1" decimals="-3" id="f-387" unitRef="shares">59000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="c-4" decimals="-3" id="f-388" unitRef="shares">78000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-389" unitRef="shares">2938000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-4" decimals="-3" id="f-390" unitRef="shares">2902000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-391">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting for Stock Options and Other Equity Awards&lt;/span&gt; Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#x2014;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-76"
      decimals="INF"
      id="f-392"
      unitRef="shares">117747</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-77"
      decimals="INF"
      id="f-393"
      unitRef="shares">87969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-4" decimals="INF" id="f-394" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-395" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-396">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2022. The Company adopted this standard effective May 1, 2023. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures," which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2025. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements for Income Tax Disclosures," which requires public business entities to, on an annual basis, (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. This ASU also provides for additional disclosure requirements to provide clarity for investors related to income tax disclosures. This guidance is effective for annual periods beginning after December 15, 2024. The Company will adopt this standard in fiscal year 2026. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-397">Revenue Recognition&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the primary performance obligations identified by the Company:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory Furniture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the marketplace such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Installation Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Custodial Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Payment Terms and Transaction Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allocation of Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients Used&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected the following practical expedients:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Payment terms with the Company's customers which are one year or less are not considered a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.260%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing balances of contract assets included $11,840,000 in accounts receivable and $312,000 in other current assets at April&#160;30, 2024. The opening balance of contract assets arising from contracts with customers included $13,459,000 in accounts receivable and $1,191,000 in other assets at April&#160;30, 2023. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $4,374,000 at April&#160;30, 2024 and $4,097,000 at April&#160;30, 2023. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended April&#160;30, 2024, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately 100% of the contract liability balance at April&#160;30, 2024 is expected to be recognized as revenue during fiscal year 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-398">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.260%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-78" decimals="-3" id="f-399" unitRef="usd">131798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-79" decimals="-3" id="f-400" unitRef="usd">66517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-80" decimals="-3" id="f-401" unitRef="usd">198315000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-81" decimals="-3" id="f-402" unitRef="usd">5440000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-82" decimals="-3" id="f-403" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-83" decimals="-3" id="f-404" unitRef="usd">5440000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-84" decimals="-3" id="f-405" unitRef="usd">137238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-85" decimals="-3" id="f-406" unitRef="usd">66517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">203755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-86" decimals="-3" id="f-408" unitRef="usd">141994000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-87" decimals="-3" id="f-409" unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-88" decimals="-3" id="f-410" unitRef="usd">214772000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-89" decimals="-3" id="f-411" unitRef="usd">4722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-90" decimals="-3" id="f-412" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-91" decimals="-3" id="f-413" unitRef="usd">4722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-92" decimals="-3" id="f-414" unitRef="usd">146716000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-93" decimals="-3" id="f-415" unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-3" id="f-416" unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-31" decimals="-3" id="f-417" unitRef="usd">11840000</us-gaap:ContractWithCustomerAssetNet>
    <kequ:UnbilledRetainageCurrent contextRef="c-51" decimals="-3" id="f-418" unitRef="usd">312000</kequ:UnbilledRetainageCurrent>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-20" decimals="-3" id="f-419" unitRef="usd">13459000</us-gaap:ContractWithCustomerAssetNet>
    <kequ:UnbilledRetainageCurrent contextRef="c-52" decimals="-3" id="f-420" unitRef="usd">1191000</kequ:UnbilledRetainageCurrent>
    <us-gaap:ContractWithCustomerLiability contextRef="c-31" decimals="-3" id="f-421" unitRef="usd">4374000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-20" decimals="-3" id="f-422" unitRef="usd">4097000</us-gaap:ContractWithCustomerLiability>
    <kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage
      contextRef="c-94"
      decimals="INF"
      id="f-423"
      unitRef="number">1</kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-424">Inventories&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following at April&#160;30:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;At April&#160;30, 2024 and 2023, the Company's international subsidiaries' inventories were $3,239,000 and $2,740,000, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-425">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following at April&#160;30:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.511%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.368%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,931&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,706&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,679&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-31" decimals="-3" id="f-426" unitRef="usd">3042000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-20" decimals="-3" id="f-427" unitRef="usd">3412000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-31" decimals="-3" id="f-428" unitRef="usd">1931000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-20" decimals="-3" id="f-429" unitRef="usd">2380000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-31" decimals="-3" id="f-430" unitRef="usd">15706000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-20" decimals="-3" id="f-431" unitRef="usd">16097000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-31" decimals="-3" id="f-432" unitRef="usd">20679000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-20" decimals="-3" id="f-433" unitRef="usd">21889000</us-gaap:InventoryNet>
    <us-gaap:FIFOInventoryAmount contextRef="c-95" decimals="-3" id="f-434" unitRef="usd">3239000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount contextRef="c-96" decimals="-3" id="f-435" unitRef="usd">2740000</us-gaap:FIFOInventoryAmount>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-436">Long-term Debt and Other Credit Arrangements &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $15.0&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $1,000,000, up to a maximum borrowing availability of $30.0&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus 4.10%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2024, there was $3,000,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $11,587,000. At April&#160;30, 2023, there was $3,548,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $10,286,000. The borrowing rate under the Revolving Credit Facility was 9.54% and 9.02% as of April&#160;30, 2024 and 2023, respectively. The Company was in compliance with all financial covenants under its revolving credit facility at April&#160;30, 2024 and 2023. In addition, the Company's International subsidiaries had a balance outstanding of $99,000 and $39,000 in short-term borrowings related to overdraft protection and short-term loan arrangements at April&#160;30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2024, there were foreign bank guarantees outstanding to customers in the amounts of $7.1 million, $435,000, and $226,000 with expiration dates in fiscal years 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April&#160;30, 2023, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $5.2 million, $142,000, $3,000, and $233,000 with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-97" decimals="-5" id="f-437" unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit contextRef="c-97" decimals="-6" id="f-438" unitRef="usd">1000000</kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption contextRef="c-97" decimals="-5" id="f-439" unitRef="usd">30000000</kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-98" decimals="4" id="f-440" unitRef="number">0.0410</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCredit contextRef="c-99" decimals="0" id="f-441" unitRef="usd">3000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-99" decimals="0" id="f-442" unitRef="usd">11587000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-100" decimals="0" id="f-443" unitRef="usd">3548000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-100" decimals="0" id="f-444" unitRef="usd">10286000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="c-99"
      decimals="INF"
      id="f-445"
      unitRef="number">0.0954</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="c-100"
      decimals="INF"
      id="f-446"
      unitRef="number">0.0902</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:ShortTermBorrowings contextRef="c-101" decimals="-3" id="f-447" unitRef="usd">99000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c-102" decimals="-3" id="f-448" unitRef="usd">39000</us-gaap:ShortTermBorrowings>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-103" decimals="-5" id="f-449" unitRef="usd">7100000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-104" decimals="0" id="f-450" unitRef="usd">435000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-105" decimals="0" id="f-451" unitRef="usd">226000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-106" decimals="-5" id="f-452" unitRef="usd">5200000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-107" decimals="0" id="f-453" unitRef="usd">142000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-108" decimals="0" id="f-454" unitRef="usd">3000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-109" decimals="0" id="f-455" unitRef="usd">233000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:SaleLeasebackTransactionDisclosureTextBlock contextRef="c-1" id="f-456">Sale-Leaseback Financing Transaction&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#x2019;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a 20-year term, with four renewal options of five years each. Under the terms of the Lease Agreement, the Company&#x2019;s initial basic rent is approximately $158,000 per month, with annual increases of approximately 2% each year of the initial term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of 4.75% to reflect the Company&#x2019;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#x201c;lease payments&#x201d; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. No gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April&#160;30, 2024, the carrying value of the financing liability was $28,133,000, net of $648,000 in debt issuance costs, of which $713,000 was classified as current on the Consolidated Balance Sheet with $27,420,000 classified as long-term. As of April&#160;30, 2023, the carrying value of the financing liability was $28,774,000, net of $708,000 in debt issuance costs, of which $642,000 was classified as current on the Consolidated Balance Sheet with $28,132,000 classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expense associated with the financing arrangement was $1,287,000 and $1,316,000 for the years ended April 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will depreciate the building down to zero over the 20-year assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $41,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Liability Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SaleLeasebackTransactionDisclosureTextBlock>
    <kequ:FinancingLiabilityTermOfContract contextRef="c-31" id="f-457">P20Y</kequ:FinancingLiabilityTermOfContract>
    <kequ:FinancingLiabilityNumberOfRenewalOptions
      contextRef="c-1"
      decimals="0"
      id="f-458"
      unitRef="renewaloption">4</kequ:FinancingLiabilityNumberOfRenewalOptions>
    <kequ:FinancingLiabilityRenewalTerm contextRef="c-31" id="f-459">P5Y</kequ:FinancingLiabilityRenewalTerm>
    <kequ:FinancingLiabilityBasicMonthlyPayment contextRef="c-1" decimals="-3" id="f-460" unitRef="usd">158000</kequ:FinancingLiabilityBasicMonthlyPayment>
    <kequ:FinancingLiabilityAnnualIncreasePercent contextRef="c-1" decimals="INF" id="f-461" unitRef="number">0.02</kequ:FinancingLiabilityAnnualIncreasePercent>
    <us-gaap:LesseeFinanceLeaseDiscountRate
      contextRef="c-31"
      decimals="INF"
      id="f-462"
      unitRef="number">0.0475</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet contextRef="c-1" decimals="-3" id="f-463" unitRef="usd">0</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <kequ:FinancingLiability contextRef="c-31" decimals="-3" id="f-464" unitRef="usd">28133000</kequ:FinancingLiability>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-31" decimals="-3" id="f-465" unitRef="usd">648000</us-gaap:DeferredFinanceCostsNet>
    <kequ:FinancingLiabilityCurrent contextRef="c-31" decimals="-3" id="f-466" unitRef="usd">713000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityNoncurrent contextRef="c-31" decimals="-3" id="f-467" unitRef="usd">27420000</kequ:FinancingLiabilityNoncurrent>
    <kequ:FinancingLiability contextRef="c-20" decimals="-3" id="f-468" unitRef="usd">28774000</kequ:FinancingLiability>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-20" decimals="-3" id="f-469" unitRef="usd">708000</us-gaap:DeferredFinanceCostsNet>
    <kequ:FinancingLiabilityCurrent contextRef="c-20" decimals="-3" id="f-470" unitRef="usd">642000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityNoncurrent contextRef="c-20" decimals="-3" id="f-471" unitRef="usd">28132000</kequ:FinancingLiabilityNoncurrent>
    <kequ:InterestExpenseFinancingLiability contextRef="c-1" decimals="-3" id="f-472" unitRef="usd">1287000</kequ:InterestExpenseFinancingLiability>
    <kequ:InterestExpenseFinancingLiability contextRef="c-4" decimals="-3" id="f-473" unitRef="usd">1316000</kequ:InterestExpenseFinancingLiability>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-110" id="f-474">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-41" decimals="-3" id="f-475" unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock contextRef="c-1" id="f-476">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Liability Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock>
    <kequ:FinancingLiabilityToBePaidYearOne contextRef="c-31" decimals="-3" id="f-477" unitRef="usd">1970000</kequ:FinancingLiabilityToBePaidYearOne>
    <kequ:FinancingLiabilityToBePaidYearTwo contextRef="c-31" decimals="-3" id="f-478" unitRef="usd">2009000</kequ:FinancingLiabilityToBePaidYearTwo>
    <kequ:FinancingLiabilityToBePaidYearThree contextRef="c-31" decimals="-3" id="f-479" unitRef="usd">2049000</kequ:FinancingLiabilityToBePaidYearThree>
    <kequ:FinancingLiabilityToBePaidYearFour contextRef="c-31" decimals="-3" id="f-480" unitRef="usd">2090000</kequ:FinancingLiabilityToBePaidYearFour>
    <kequ:FinancingLiabilityToBePaidYearFive contextRef="c-31" decimals="-3" id="f-481" unitRef="usd">2132000</kequ:FinancingLiabilityToBePaidYearFive>
    <kequ:FinancingLiabilityToBePaidAfterYearFive contextRef="c-31" decimals="-3" id="f-482" unitRef="usd">31736000</kequ:FinancingLiabilityToBePaidAfterYearFive>
    <kequ:FinancingLiabilityToBePaid contextRef="c-31" decimals="-3" id="f-483" unitRef="usd">41986000</kequ:FinancingLiabilityToBePaid>
    <kequ:FinancingLiabilityUndiscountedExcessAmount contextRef="c-31" decimals="-3" id="f-484" unitRef="usd">13853000</kequ:FinancingLiabilityUndiscountedExcessAmount>
    <kequ:FinancingLiability contextRef="c-31" decimals="-3" id="f-485" unitRef="usd">28133000</kequ:FinancingLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-486">Income Taxes &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $371,000 and $406,000 for the years ended April 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax (benefit) expense consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax (benefit) expense:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit) expense:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reasons for the differences between the above net income tax (benefit) expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes, net of federal income tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of differing US and foreign tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of pension settlement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign subsidiary income to parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on unremitted earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee benefit expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;E Addback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,303&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss, defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves and capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,671&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of Sale Leaseback property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APB 23 Assertion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt Issuance Cost on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities) classified in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,401&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both positive and negative, to determine the amount of any required valuation allowance. As of April&#160;30, 2024, our deferred tax assets primarily related to proceeds on a prior sale leaseback and Section 174 research and expenditures addbacks. A valuation allowance of $926,000 and $8,568,000 was recorded against our net deferred tax asset balance as of April 30, 2024 and 2023, respectively. For the year ended April 30, 2024, we recorded a net decrease in valuation allowance of $6,579,000, as compared to a net increase of $1,667,000 for the year ended April 30, 2023, based on management's reassessment of the amount of its deferred tax assets that are more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal, state and local tax returns with statutes of limitation generally ranging from 3 to 4 years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2020 or state and local tax examinations for years prior to fiscal year 2019. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of 3 to 7 years and are generally no longer subject to examination for years prior to fiscal year 2018. The Company has no unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <kequ:TaxWithholdingExpense contextRef="c-111" decimals="-3" id="f-487" unitRef="usd">371000</kequ:TaxWithholdingExpense>
    <kequ:TaxWithholdingExpense contextRef="c-112" decimals="-3" id="f-488" unitRef="usd">406000</kequ:TaxWithholdingExpense>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-489">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax (benefit) expense consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax (benefit) expense:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax (benefit) expense:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,378)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-490" unitRef="usd">2332000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-491" unitRef="usd">691000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-492" unitRef="usd">65000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-493" unitRef="usd">197000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-494" unitRef="usd">2661000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-495" unitRef="usd">1736000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-496" unitRef="usd">5058000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-497" unitRef="usd">2624000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-498" unitRef="usd">-10378000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-499" unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-500" unitRef="usd">-893000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-501" unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-502" unitRef="usd">275000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-503" unitRef="usd">515000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-504" unitRef="usd">-10996000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-505" unitRef="usd">515000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-506" unitRef="usd">-5938000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-507" unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-508">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reasons for the differences between the above net income tax (benefit) expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes, net of federal income tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;575&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of differing US and foreign tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of pension settlement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign subsidiary income to parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred taxes on unremitted earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax (benefit) expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-509" unitRef="usd">2755000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-4" decimals="-3" id="f-510" unitRef="usd">945000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-3" id="f-511" unitRef="usd">575000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-4" decimals="-3" id="f-512" unitRef="usd">-119000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCredits contextRef="c-1" decimals="-3" id="f-513" unitRef="usd">355000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits contextRef="c-4" decimals="-3" id="f-514" unitRef="usd">433000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-515" unitRef="usd">243000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-4" decimals="-3" id="f-516" unitRef="usd">260000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount contextRef="c-1" decimals="-3" id="f-517" unitRef="usd">3870000</kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount contextRef="c-4" decimals="-3" id="f-518" unitRef="usd">0</kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount contextRef="c-1" decimals="-3" id="f-519" unitRef="usd">743000</kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount contextRef="c-4" decimals="-3" id="f-520" unitRef="usd">413000</kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary contextRef="c-1" decimals="-3" id="f-521" unitRef="usd">-96000</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary contextRef="c-4" decimals="-3" id="f-522" unitRef="usd">-99000</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">-6579000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-524" unitRef="usd">1667000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings contextRef="c-1" decimals="-3" id="f-525" unitRef="usd">371000</kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings>
    <kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings contextRef="c-4" decimals="-3" id="f-526" unitRef="usd">406000</kequ:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxesOnUnremittedEarnings>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-1" decimals="-3" id="f-527" unitRef="usd">83000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c-4" decimals="-3" id="f-528" unitRef="usd">-99000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-529" unitRef="usd">-5938000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-530" unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-531">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee benefit expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;950&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;E Addback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,303&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss, defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves and capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;296&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,211&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,671&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of Sale Leaseback property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APB 23 Assertion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt Issuance Cost on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(926)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities) classified in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,401&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities, non-current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits contextRef="c-31" decimals="-3" id="f-532" unitRef="usd">152000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits contextRef="c-20" decimals="-3" id="f-533" unitRef="usd">153000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-31" decimals="-3" id="f-534" unitRef="usd">151000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-20" decimals="-3" id="f-535" unitRef="usd">114000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-31" decimals="-3" id="f-536" unitRef="usd">950000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-20" decimals="-3" id="f-537" unitRef="usd">1156000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-31" decimals="-3" id="f-538" unitRef="usd">170000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-20" decimals="-3" id="f-539" unitRef="usd">170000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c-31" decimals="-3" id="f-540" unitRef="usd">638000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign contextRef="c-20" decimals="-3" id="f-541" unitRef="usd">638000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <kequ:DeferredTaxAssetsSection174REAddback contextRef="c-31" decimals="-3" id="f-542" unitRef="usd">2303000</kequ:DeferredTaxAssetsSection174REAddback>
    <kequ:DeferredTaxAssetsSection174REAddback contextRef="c-20" decimals="-3" id="f-543" unitRef="usd">1558000</kequ:DeferredTaxAssetsSection174REAddback>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-31" decimals="-3" id="f-544" unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-20" decimals="-3" id="f-545" unitRef="usd">1064000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-31" decimals="-3" id="f-546" unitRef="usd">296000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory contextRef="c-20" decimals="-3" id="f-547" unitRef="usd">201000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-31" decimals="-3" id="f-548" unitRef="usd">152000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-20" decimals="-3" id="f-549" unitRef="usd">249000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <kequ:DeferredTaxAssetsProceedsOnSaleLeaseback contextRef="c-31" decimals="-3" id="f-550" unitRef="usd">6316000</kequ:DeferredTaxAssetsProceedsOnSaleLeaseback>
    <kequ:DeferredTaxAssetsProceedsOnSaleLeaseback contextRef="c-20" decimals="-3" id="f-551" unitRef="usd">6963000</kequ:DeferredTaxAssetsProceedsOnSaleLeaseback>
    <kequ:DeferredTaxAssetLeaseLiability contextRef="c-31" decimals="-3" id="f-552" unitRef="usd">1211000</kequ:DeferredTaxAssetLeaseLiability>
    <kequ:DeferredTaxAssetLeaseLiability contextRef="c-20" decimals="-3" id="f-553" unitRef="usd">1558000</kequ:DeferredTaxAssetLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-31" decimals="-3" id="f-554" unitRef="usd">332000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-20" decimals="-3" id="f-555" unitRef="usd">254000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-31" decimals="-3" id="f-556" unitRef="usd">12671000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-20" decimals="-3" id="f-557" unitRef="usd">14078000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-31" decimals="-3" id="f-558" unitRef="usd">1678000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-20" decimals="-3" id="f-559" unitRef="usd">1417000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <kequ:DeferredTaxLiabilitiesSaleLeasebackProperty contextRef="c-31" decimals="-3" id="f-560" unitRef="usd">1028000</kequ:DeferredTaxLiabilitiesSaleLeasebackProperty>
    <kequ:DeferredTaxLiabilitiesSaleLeasebackProperty contextRef="c-20" decimals="-3" id="f-561" unitRef="usd">1106000</kequ:DeferredTaxLiabilitiesSaleLeasebackProperty>
    <kequ:DeferredTaxLiabilitiesPrepaidPensionCost contextRef="c-31" decimals="-3" id="f-562" unitRef="usd">0</kequ:DeferredTaxLiabilitiesPrepaidPensionCost>
    <kequ:DeferredTaxLiabilitiesPrepaidPensionCost contextRef="c-20" decimals="-3" id="f-563" unitRef="usd">919000</kequ:DeferredTaxLiabilitiesPrepaidPensionCost>
    <kequ:DeferredTaxLiabilitiesAPB23Assertion contextRef="c-31" decimals="-3" id="f-564" unitRef="usd">1572000</kequ:DeferredTaxLiabilitiesAPB23Assertion>
    <kequ:DeferredTaxLiabilitiesAPB23Assertion contextRef="c-20" decimals="-3" id="f-565" unitRef="usd">1318000</kequ:DeferredTaxLiabilitiesAPB23Assertion>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-31" decimals="-3" id="f-566" unitRef="usd">1142000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-20" decimals="-3" id="f-567" unitRef="usd">1526000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="c-31" decimals="-3" id="f-568" unitRef="usd">142000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="c-20" decimals="-3" id="f-569" unitRef="usd">167000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-31" decimals="-3" id="f-570" unitRef="usd">5562000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-20" decimals="-3" id="f-571" unitRef="usd">6453000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-31" decimals="-3" id="f-572" unitRef="usd">926000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-20" decimals="-3" id="f-573" unitRef="usd">8568000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-31" decimals="-3" id="f-574" unitRef="usd">6183000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-20" decimals="-3" id="f-575" unitRef="usd">943000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-31" decimals="-3" id="f-576" unitRef="usd">7401000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-20" decimals="-3" id="f-577" unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-31" decimals="-3" id="f-578" unitRef="usd">1218000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-20" decimals="-3" id="f-579" unitRef="usd">943000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-31" decimals="-3" id="f-580" unitRef="usd">6183000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-20" decimals="-3" id="f-581" unitRef="usd">943000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-31" decimals="-3" id="f-582" unitRef="usd">926000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-20" decimals="-3" id="f-583" unitRef="usd">8568000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="0" id="f-584" unitRef="usd">-6579000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="0" id="f-585" unitRef="usd">1667000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <kequ:FederalStateAndLocalTaxReturnsPeriod contextRef="c-113" id="f-586">P3Y</kequ:FederalStateAndLocalTaxReturnsPeriod>
    <kequ:FederalStateAndLocalTaxReturnsPeriod contextRef="c-114" id="f-587">P4Y</kequ:FederalStateAndLocalTaxReturnsPeriod>
    <kequ:ForeignSubsidiariesTaxReturnsPeriod contextRef="c-113" id="f-588">P3Y</kequ:ForeignSubsidiariesTaxReturnsPeriod>
    <kequ:ForeignSubsidiariesTaxReturnsPeriod contextRef="c-114" id="f-589">P7Y</kequ:ForeignSubsidiariesTaxReturnsPeriod>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-590">Stock Options and Share-Based Compensation &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's stockholders approved the 2023 Omnibus Incentive Plan ("2023 Plan") in August, 2023, which enables the Company to grant a broad range of equity based awards, with potential recipients including directors, consultants and employees. The 2023 Plan replaced the 2017 Omnibus Incentive Plan (the "2017 Plan"). All outstanding equity granted under the 2017 Plan remain subject to, and will be settled under, the 2017 Plan. At the date of approval of the 2023 Plan, there were&#x202f;64,633&#x202f;shares available for new awards under the 2017 Plan, and 168,791 shares available for issuance under equity awards outstanding under the 2017 Plan.&#x202f;These shares that were available for new awards and any shares subject to outstanding awards under the 2017 Plan that subsequently cease to be subject to such awards are available under the 2023 Plan. The 2023 Plan also increased the total number of shares reserved for issuance under the Company's equity compensation plans by 310,000, for a total of 374,633 shares initially reserved for issuance under the 2023 Plan. At April&#160;30, 2024, there were 383,572 shares available for future issuance under the 2023 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2023 Plan and the 2017 Plan, in the aggregate, the Company recorded stock-based compensation expense for employees of $1,018,000 and $845,000 and deferred income tax benefit of $223,000 and $199,000 in fiscal years 2024 and 2023, respectively. The RSUs granted under the 2023 Plan and the 2017 Plan include grants with both a service and performance component vesting over a 3 year period and grants with only service components vesting over a 3 year period. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $1,656,000 will be recorded over the remaining vesting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2024. The following table summarizes the RSU activity and weighted averages.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159,640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(103,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168,791&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stockholders approved the 2008 Key Employee Stock Option Plan in fiscal year 2009 which allowed the Company to grant options on an aggregate of 300,000 shares of the Company's common stock and an amendment to the plan in August&#160;2015, authorizing an additional 300,000 shares. Under the plan, options were granted at not less than the fair market value at the date of grant with options exercisable in such installments, for such terms (up to 10 years). This plan was replaced by the 2017 Omnibus Plan with all outstanding options granted under the prior plan to remain subject to the prior plan. The last grant of options, issued on August 31, 2016, under the prior plan will expire August 31, 2026. The Company did not record any compensation expense related to outstanding stock options in fiscal years 2024 or 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued new shares of common stock to satisfy options exercised during fiscal years 2024 and 2023. Stock option activity and weighted average exercise price are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.717%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$15.85-$23.62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.68 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-115"
      decimals="INF"
      id="f-591"
      unitRef="shares">64633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-116"
      decimals="INF"
      id="f-592"
      unitRef="shares">168791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease
      contextRef="c-117"
      decimals="INF"
      id="f-593"
      unitRef="shares">310000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-118"
      decimals="INF"
      id="f-594"
      unitRef="shares">374633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-119"
      decimals="INF"
      id="f-595"
      unitRef="shares">383572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-120" decimals="-3" id="f-596" unitRef="usd">1018000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-121" decimals="-3" id="f-597" unitRef="usd">845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-120" decimals="-3" id="f-598" unitRef="usd">-223000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-121" decimals="-3" id="f-599" unitRef="usd">-199000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-120" id="f-600">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-122" id="f-601">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-123" decimals="-3" id="f-602" unitRef="usd">1656000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-603">The following table summarizes the RSU activity and weighted averages.&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;159,640&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11.94&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;117,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(103,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,077)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168,791&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15.35&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-124"
      decimals="INF"
      id="f-604"
      unitRef="shares">159640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-124"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">11.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-125"
      decimals="INF"
      id="f-606"
      unitRef="shares">144827</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-125"
      decimals="2"
      id="f-607"
      unitRef="usdPerShare">12.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-76"
      decimals="INF"
      id="f-608"
      unitRef="shares">117747</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-76"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">15.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-77"
      decimals="INF"
      id="f-610"
      unitRef="shares">87969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-77"
      decimals="2"
      id="f-611"
      unitRef="usdPerShare">13.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-76"
      decimals="INF"
      id="f-612"
      unitRef="shares">103519</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-76"
      decimals="2"
      id="f-613"
      unitRef="usdPerShare">11.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-77"
      decimals="INF"
      id="f-614"
      unitRef="shares">50315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-77"
      decimals="2"
      id="f-615"
      unitRef="usdPerShare">13.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-76"
      decimals="INF"
      id="f-616"
      unitRef="shares">5077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-76"
      decimals="2"
      id="f-617"
      unitRef="usdPerShare">10.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-77"
      decimals="INF"
      id="f-618"
      unitRef="shares">22841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-77"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">15.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-126"
      decimals="INF"
      id="f-620"
      unitRef="shares">168791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-126"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">15.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-124"
      decimals="INF"
      id="f-622"
      unitRef="shares">159640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-124"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">11.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-127"
      decimals="INF"
      id="f-624"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-128"
      decimals="INF"
      id="f-625"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-129" id="f-626">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-627">Stock option activity and weighted average exercise price are summarized as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.21&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-20"
      decimals="INF"
      id="f-628"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-20"
      decimals="2"
      id="f-629"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-10"
      decimals="INF"
      id="f-630"
      unitRef="shares">47400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-10"
      decimals="2"
      id="f-631"
      unitRef="usdPerShare">19.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-632" unitRef="shares">3700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-633"
      unitRef="usdPerShare">16.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-4" decimals="INF" id="f-634" unitRef="shares">7850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-635"
      unitRef="usdPerShare">20.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-636" unitRef="shares">5500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-637"
      unitRef="usdPerShare">22.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-4" decimals="INF" id="f-638" unitRef="shares">5650</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-639"
      unitRef="usdPerShare">14.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-31"
      decimals="INF"
      id="f-640"
      unitRef="shares">24700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-31"
      decimals="2"
      id="f-641"
      unitRef="usdPerShare">20.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-20"
      decimals="INF"
      id="f-642"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-20"
      decimals="2"
      id="f-643"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-31"
      decimals="INF"
      id="f-644"
      unitRef="shares">24700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-31"
      decimals="2"
      id="f-645"
      unitRef="usdPerShare">20.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-20"
      decimals="INF"
      id="f-646"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-20"
      decimals="2"
      id="f-647"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c-1" id="f-648">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.717%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$15.85-$23.62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.68 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-1"
      decimals="INF"
      id="f-649"
      unitRef="usdPerShare">15.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-1"
      decimals="INF"
      id="f-650"
      unitRef="usdPerShare">23.62</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-31"
      decimals="INF"
      id="f-651"
      unitRef="shares">24700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-31"
      decimals="2"
      id="f-652"
      unitRef="usdPerShare">20.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-653">P1Y8M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-31" decimals="-3" id="f-654" unitRef="usd">386584000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-31"
      decimals="INF"
      id="f-655"
      unitRef="shares">24700</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="c-31"
      decimals="2"
      id="f-656"
      unitRef="usdPerShare">20.05</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-31" decimals="-3" id="f-657" unitRef="usd">386584000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-658">Stockholder's Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue 5,000,000 shares of Common Stock, par value of $2.50 per share. Holders of the Company's Common Stock are entitled to 1 vote per share. At April&#160;30, 2024, and April&#160;30, 2023, there were approximately 2,839,000 and 2,830,000 shares, respectively, of Common Stock issued and outstanding. The Company has not declared or paid any dividends with respect to its Common Stock during the fiscal year ended April 30, 2024. The declaration and payment of any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2023, the Board of Directors of the Company adopted a share repurchase program with authorization to repurchase up to 100,000 shares. There is no expiration date and currently, management has no plans to terminate this program. During the fiscal year ended April 30, 2024, the Company repurchased 66,191 shares of the Company's common stock for approximately $1,992,000, excluding other costs such as broker commissions and fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share repurchase activity for the three months ended April 30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price Paid Per Share &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased as Part of Publicly Announced Programs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares that May Yet Be Purchased Under the Plans or Programs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 1 - 29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 1 - 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$31.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1 - 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;        On August 31, 2023, the Board of Directors of Kewaunee Scientific Corporation (the "Company") adopted a share repurchase program with authorization to repurchase up to 100,000 shares of our Company's common stock, which commenced on September 1, 2023 and has no expiration date. The share repurchase program is designed to help offset the impact of future share dilution from employee stock issuances. The timing and amount of any repurchases under this program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions or any combination thereof. The program does not obligate the Company to acquire any particular amount of its common stock, and the share repurchase program may be suspended or discontinued at any time at the Company's discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;Excludes other costs such as broker commissions and fees.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transactions that occurred under the share repurchase program prior to the fourth quarter of fiscal year 2024 are presented in Item 2, Unregistered Sales of Equity Securities and Use of Proceeds, in the corresponding interim report on Form 10-Q for the periods ended &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;October&lt;/a&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552923000029/kequ-20231031.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt; 31, 2023&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/55529/000005552924000009/kequ-20240131.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;January 31, 2024&lt;/a&gt;&lt;/span&gt;, respectively.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c-31"
      decimals="INF"
      id="f-659"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-31"
      decimals="2"
      id="f-660"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-31" decimals="-3" id="f-661" unitRef="shares">2839000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="-3" id="f-662" unitRef="shares">2830000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-130" decimals="0" id="f-663" unitRef="shares">100000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="0" id="f-664" unitRef="shares">66191</us-gaap:TreasuryStockSharesAcquired>
    <kequ:TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod contextRef="c-1" decimals="0" id="f-665" unitRef="usd">1992000</kequ:TreasuryStockValueExcludingBrokerCommissionsAndFeesAcquiredCostMethod>
    <us-gaap:ScheduleOfStockByClassTextBlock contextRef="c-1" id="f-666">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share repurchase activity for the three months ended April 30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.553%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.378%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Price Paid Per Share &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Number of Shares Purchased as Part of Publicly Announced Programs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares that May Yet Be Purchased Under the Plans or Programs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 1 - 29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$29.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 1 - 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$31.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;April 1 - 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;        On August 31, 2023, the Board of Directors of Kewaunee Scientific Corporation (the "Company") adopted a share repurchase program with authorization to repurchase up to 100,000 shares of our Company's common stock, which commenced on September 1, 2023 and has no expiration date. The share repurchase program is designed to help offset the impact of future share dilution from employee stock issuances. The timing and amount of any repurchases under this program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions or any combination thereof. The program does not obligate the Company to acquire any particular amount of its common stock, and the share repurchase program may be suspended or discontinued at any time at the Company's discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;Excludes other costs such as broker commissions and fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-131" decimals="0" id="f-667" unitRef="shares">6932</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-131"
      decimals="2"
      id="f-668"
      unitRef="usdPerShare">29.18</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-132" decimals="0" id="f-669" unitRef="shares">6932</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c-133" decimals="2" id="f-670" unitRef="shares">63612</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-134" decimals="0" id="f-671" unitRef="shares">12758</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-134"
      decimals="2"
      id="f-672"
      unitRef="usdPerShare">31.63</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-135" decimals="0" id="f-673" unitRef="shares">12758</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c-136" decimals="2" id="f-674" unitRef="shares">50854</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-137" decimals="0" id="f-675" unitRef="shares">17045</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-137"
      decimals="2"
      id="f-676"
      unitRef="usdPerShare">35.11</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-138" decimals="0" id="f-677" unitRef="shares">17045</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c-31" decimals="2" id="f-678" unitRef="shares">33809</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-139" decimals="0" id="f-679" unitRef="shares">36735</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-140" decimals="0" id="f-680" unitRef="shares">36735</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-130" decimals="0" id="f-681" unitRef="shares">100000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="c-1" id="f-682">Accumulated Other Comprehensive Income (Loss)&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. The before tax income (loss), related income tax effect, and accumulated balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum&lt;br/&gt;Pension&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss included in net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes on postretirement benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-683">The before tax income (loss), related income tax effect, and accumulated balances are as follows:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum&lt;br/&gt;Pension&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement loss included in net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes on postretirement benefit plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-141" decimals="-3" id="f-684" unitRef="usd">-2543000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-142" decimals="-3" id="f-685" unitRef="usd">-1199000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-10" decimals="-3" id="f-686" unitRef="usd">-3742000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-143" decimals="-3" id="f-687" unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-4" decimals="-3" id="f-688" unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-144" decimals="-3" id="f-689" unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-4" decimals="-3" id="f-690" unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-145" decimals="-3" id="f-691" unitRef="usd">-2833000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-146" decimals="-3" id="f-692" unitRef="usd">-609000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-20" decimals="-3" id="f-693" unitRef="usd">-3442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-147" decimals="-3" id="f-694" unitRef="usd">-549000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-148" decimals="-3" id="f-695" unitRef="usd">-49000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="c-1" decimals="-3" id="f-696" unitRef="usd">-598000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-148" decimals="-3" id="f-697" unitRef="usd">509000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax contextRef="c-1" decimals="-3" id="f-698" unitRef="usd">509000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax contextRef="c-148" decimals="-3" id="f-699" unitRef="usd">4019000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax contextRef="c-1" decimals="-3" id="f-700" unitRef="usd">4019000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax contextRef="c-148" decimals="-3" id="f-701" unitRef="usd">-3870000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax contextRef="c-148" decimals="-3" id="f-702" unitRef="usd">-3870000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-149" decimals="-3" id="f-703" unitRef="usd">-3382000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-150" decimals="-3" id="f-704" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-31" decimals="-3" id="f-705" unitRef="usd">-3382000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-706">Leases, Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $7,454,000 and $9,170,000 at April&#160;30, 2024 and 2023, respectively. Operating cash paid to settle lease liabilities was $2,594,000 and $2,278,640 for the fiscal year ended April 30, 2024 and 2023, respectively. The Company's leases have remaining lease terms of up to 8 years. In addition, some of the leases may include options to extend the leases for up to 5 years or options to terminate the leases within 1 year. Operating lease expense was $3,458,000 for the twelve months ended April 30, 2024, inclusive of period cost for short-term leases, not included in lease liabilities, of $864,000. Operating lease expense was $3,344,000 for the fiscal year ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,065,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2024, the weighted average remaining lease term for the capitalized operating leases was 4.2 years and the weighted average discount rate was 5.1%. At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was 5.1 years and the weighted average discount rate was 5.0%. For the financing leases, the weighted average remaining lease term was 4.5 years and the weighted average discount rate was 8.3% at April&#160;30, 2024 as compared to 3.1 years and 6.8% at April&#160;30, 2023. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Company entered into a new lease that has not yet commenced as of April&#160;30, 2024 with future minimum lease payments in aggregate of $681,000 that are not yet reflected on the Condensed Consolidated Balance Sheet. This lease is expected to commence in the second quarter of fiscal year 2025 with a lease term of 3 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-31" decimals="-3" id="f-707" unitRef="usd">7454000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-20" decimals="-3" id="f-708" unitRef="usd">9170000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-1" id="f-709" unitRef="usd">2594000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-4" decimals="0" id="f-710" unitRef="usd">2278640</us-gaap:OperatingLeasePayments>
    <kequ:LesseeRemainingLeaseTerm contextRef="c-1" id="f-711">P8Y</kequ:LesseeRemainingLeaseTerm>
    <kequ:LesseeOptiontoExtendTerm contextRef="c-1" id="f-712">P5Y</kequ:LesseeOptiontoExtendTerm>
    <kequ:LesseeOptiontoTerminateTerm contextRef="c-1" id="f-713">P1Y</kequ:LesseeOptiontoTerminateTerm>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-3" id="f-714" unitRef="usd">3458000</us-gaap:OperatingLeaseExpense>
    <kequ:OperatingLeaseShortTermExpense contextRef="c-1" decimals="-3" id="f-715" unitRef="usd">864000</kequ:OperatingLeaseShortTermExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-4" decimals="-3" id="f-716" unitRef="usd">3344000</us-gaap:OperatingLeaseExpense>
    <kequ:OperatingLeaseShortTermExpense contextRef="c-4" decimals="-3" id="f-717" unitRef="usd">1065000</kequ:OperatingLeaseShortTermExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-31" id="f-718">P4Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-31" decimals="3" id="f-719" unitRef="number">0.051</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-20" id="f-720">P5Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-20" decimals="3" id="f-721" unitRef="number">0.050</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-31" id="f-722">P4Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-31" decimals="3" id="f-723" unitRef="number">0.083</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-20" id="f-724">P3Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-20" decimals="3" id="f-725" unitRef="number">0.068</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-727">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-726">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-31" decimals="-3" id="f-728" unitRef="usd">2437000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-31" decimals="-3" id="f-729" unitRef="usd">131000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-31" decimals="-3" id="f-730" unitRef="usd">1956000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-31" decimals="-3" id="f-731" unitRef="usd">112000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-31" decimals="-3" id="f-732" unitRef="usd">1656000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-31" decimals="-3" id="f-733" unitRef="usd">40000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-31" decimals="-3" id="f-734" unitRef="usd">1059000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-31" decimals="-3" id="f-735" unitRef="usd">40000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-31" decimals="-3" id="f-736" unitRef="usd">800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-31" decimals="-3" id="f-737" unitRef="usd">40000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-31" decimals="-3" id="f-738" unitRef="usd">1894000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-31" decimals="-3" id="f-739" unitRef="usd">56000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-31" decimals="-3" id="f-740" unitRef="usd">9802000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-31" decimals="-3" id="f-741" unitRef="usd">419000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-31" decimals="-3" id="f-742" unitRef="usd">2245000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-31" decimals="-3" id="f-743" unitRef="usd">73000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-31" decimals="-3" id="f-744" unitRef="usd">7557000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-31" decimals="-3" id="f-745" unitRef="usd">346000</us-gaap:FinanceLeaseLiability>
    <kequ:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount contextRef="c-1" decimals="-3" id="f-746" unitRef="usd">681000</kequ:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1 contextRef="c-31" id="f-747">P3Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-748">Retirement Benefits&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended April 30 ,2024, the Company settled its non-contributory defined benefit plans by transferring approximately $17.8 million of pension obligations through the purchase of group annuity contracts for all remaining liabilities under the pension plan. In connection with the transfer, the Company contributed $287,000 in cash to the pension plan, which was intended to fully fund the Company&#x2019;s remaining defined benefit pension liabilities.&#x202f;These non-contributory defined benefit pension plans, which covered some domestic employees, were amended as of April 30, 2005. Following this amendment, no further benefits have been earned under the plans, and no additional participants have been added. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation, April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to insurer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to insurer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&#x2014;under&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in the Consolidated Balance Sheets consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actual loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projection scale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MP-2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended April 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-796"&gt;Recognition of net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-801"&gt;Effect of settlement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-804"&gt;&lt;span style="-sec-ix-hidden:f-805"&gt;&lt;span style="-sec-ix-hidden:f-806"&gt;Total net periodic pension expense plus special events&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan assets by asset categories as of April&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.431%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.138%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Contribution Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age 21, completed three months of service, and who elect to participate. The plan provides that the Company make matching contributions equal to 100% of the employee's qualifying contribution up to 3% of the employee's compensation, and make matching contributions equal to 50% of the employee's contributions between 3% and 5% of the employee's compensation, resulting in a maximum employer contribution equal to 4% of the employee's compensation. The Company's matching contributions were $957,000 and $932,000 for years ending April&#160;30, 2024 and 2023. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2024 and 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <kequ:DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities contextRef="c-1" decimals="-5" id="f-749" unitRef="usd">17800000</kequ:DefinedBenefitPlanBenefitObligationRemainingPensionPlanLiabilities>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="0" id="f-750" unitRef="usd">287000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock contextRef="c-1" id="f-751">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation, April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to insurer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,558)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to insurer&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&#x2014;under&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in the Consolidated Balance Sheets consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actual loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projection scale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MP-2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended April 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-31" decimals="-3" id="f-752" unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation contextRef="c-20" decimals="-3" id="f-753" unitRef="usd">18368000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-20" decimals="-3" id="f-754" unitRef="usd">18368000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-10" decimals="-3" id="f-755" unitRef="usd">20022000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-3" id="f-756" unitRef="usd">890000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-4" decimals="-3" id="f-757" unitRef="usd">845000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-1" decimals="-3" id="f-758" unitRef="usd">53000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss contextRef="c-4" decimals="-3" id="f-759" unitRef="usd">-1113000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-1" decimals="-3" id="f-760" unitRef="usd">1558000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid contextRef="c-4" decimals="-3" id="f-761" unitRef="usd">1386000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-1" decimals="-3" id="f-762" unitRef="usd">17753000</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanSettlementsBenefitObligation contextRef="c-4" decimals="-3" id="f-763" unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-31" decimals="-3" id="f-764" unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation contextRef="c-20" decimals="-3" id="f-765" unitRef="usd">18368000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-20" decimals="-3" id="f-766" unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-10" decimals="-3" id="f-767" unitRef="usd">18867000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-1" decimals="-3" id="f-768" unitRef="usd">1292000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets contextRef="c-4" decimals="-3" id="f-769" unitRef="usd">251000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-1" decimals="-3" id="f-770" unitRef="usd">287000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="c-4" decimals="-3" id="f-771" unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-1" decimals="-3" id="f-772" unitRef="usd">1558000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid contextRef="c-4" decimals="-3" id="f-773" unitRef="usd">1386000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan contextRef="c-1" decimals="-3" id="f-774" unitRef="usd">17753000</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan contextRef="c-4" decimals="-3" id="f-775" unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsTransferredToFromPlan>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-31" decimals="-3" id="f-776" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-20" decimals="-3" id="f-777" unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-31" decimals="-3" id="f-778" unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan contextRef="c-20" decimals="-3" id="f-779" unitRef="usd">-636000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent contextRef="c-31" decimals="-3" id="f-780" unitRef="usd">0</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent contextRef="c-20" decimals="-3" id="f-781" unitRef="usd">636000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-31" decimals="-3" id="f-782" unitRef="usd">0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax contextRef="c-20" decimals="-3" id="f-783" unitRef="usd">4526000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-31" decimals="-3" id="f-784" unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits contextRef="c-20" decimals="-3" id="f-785" unitRef="usd">1064000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-31" decimals="-3" id="f-786" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-20" decimals="-3" id="f-787" unitRef="usd">3462000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate contextRef="c-20" decimals="4" id="f-788" unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate contextRef="c-4" decimals="4" id="f-789" unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets contextRef="c-4" decimals="4" id="f-790" unitRef="number">0.0775</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="c-1" id="f-791">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-796"&gt;Recognition of net loss&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic pension expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-801"&gt;Effect of settlement&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,019&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-804"&gt;&lt;span style="-sec-ix-hidden:f-805"&gt;&lt;span style="-sec-ix-hidden:f-806"&gt;Total net periodic pension expense plus special events&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-1" decimals="-3" id="f-792" unitRef="usd">890000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="c-4" decimals="-3" id="f-793" unitRef="usd">845000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-1" decimals="-3" id="f-794" unitRef="usd">1312000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="c-4" decimals="-3" id="f-795" unitRef="usd">1402000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-1" decimals="-3" id="f-797" unitRef="usd">-580000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="c-4" decimals="-3" id="f-798" unitRef="usd">-628000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent contextRef="c-1" decimals="-3" id="f-799" unitRef="usd">158000</kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent>
    <kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent contextRef="c-4" decimals="-3" id="f-800" unitRef="usd">71000</kequ:DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingSettlementCostComponent>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-1" decimals="-3" id="f-802" unitRef="usd">-4019000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 contextRef="c-4" decimals="-3" id="f-803" unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-1" decimals="-3" id="f-807" unitRef="usd">4177000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="c-4" decimals="-3" id="f-808" unitRef="usd">71000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock contextRef="c-1" id="f-809">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan assets by asset categories as of April&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.431%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.138%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.752%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.139%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-151" decimals="-3" id="f-810" unitRef="usd">12724000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-151" decimals="2" id="f-811" unitRef="number">0.72</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-152" decimals="-3" id="f-812" unitRef="usd">4845000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-152" decimals="2" id="f-813" unitRef="number">0.27</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-153" decimals="-3" id="f-814" unitRef="usd">163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations contextRef="c-153" decimals="2" id="f-815" unitRef="number">0.01</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-20" decimals="-3" id="f-816" unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="c-20"
      decimals="INF"
      id="f-817"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock contextRef="c-1" id="f-818">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-154" decimals="-3" id="f-819" unitRef="usd">7326000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-155" decimals="-3" id="f-820" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-156" decimals="-3" id="f-821" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-157" decimals="-3" id="f-822" unitRef="usd">2326000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-158" decimals="-3" id="f-823" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-159" decimals="-3" id="f-824" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-160" decimals="-3" id="f-825" unitRef="usd">1743000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-161" decimals="-3" id="f-826" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-162" decimals="-3" id="f-827" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-163" decimals="-3" id="f-828" unitRef="usd">702000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-164" decimals="-3" id="f-829" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-165" decimals="-3" id="f-830" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-166" decimals="-3" id="f-831" unitRef="usd">4845000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-167" decimals="-3" id="f-832" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-168" decimals="-3" id="f-833" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-169" decimals="-3" id="f-834" unitRef="usd">627000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-170" decimals="-3" id="f-835" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-171" decimals="-3" id="f-836" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-172" decimals="-3" id="f-837" unitRef="usd">163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-173" decimals="-3" id="f-838" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-174" decimals="-3" id="f-839" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-68" decimals="-3" id="f-840" unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-69" decimals="-3" id="f-841" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets contextRef="c-175" decimals="-3" id="f-842" unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions contextRef="c-1" id="f-843">P21Y</kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions>
    <kequ:DefinedContributionPlanEligibilityMinimumServicePeriod contextRef="c-1" id="f-844">P3M</kequ:DefinedContributionPlanEligibilityMinimumServicePeriod>
    <kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution
      contextRef="c-114"
      decimals="INF"
      id="f-845"
      unitRef="number">1</kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent contextRef="c-1" decimals="INF" id="f-846" unitRef="number">0.03</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution
      contextRef="c-113"
      decimals="INF"
      id="f-847"
      unitRef="number">0.50</kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-114"
      decimals="INF"
      id="f-848"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-113"
      decimals="INF"
      id="f-849"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-114"
      decimals="INF"
      id="f-850"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <kequ:DefinedContributionPlanEmployerMatchingContributionsAmount contextRef="c-1" decimals="-3" id="f-851" unitRef="usd">957000</kequ:DefinedContributionPlanEmployerMatchingContributionsAmount>
    <kequ:DefinedContributionPlanEmployerMatchingContributionsAmount contextRef="c-4" decimals="-3" id="f-852" unitRef="usd">932000</kequ:DefinedContributionPlanEmployerMatchingContributionsAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-853">Segment Information&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i7c2284e7bf3e47828f4617b389f29ad2_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note&#160;1&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;203,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,125&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;43,110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134,766&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-854"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-855">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;137,238&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;203,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,062&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,125&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,048&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,119&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,935&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;304&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,808&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,055&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,753&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;43,110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;134,766&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;614&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-176" decimals="-3" id="f-856" unitRef="usd">137238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-39" decimals="-3" id="f-857" unitRef="usd">66517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-858" unitRef="usd">203755000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-177" decimals="-3" id="f-859" unitRef="usd">636000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-178" decimals="-3" id="f-860" unitRef="usd">4062000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-179" decimals="-3" id="f-861" unitRef="usd">-4698000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-1" decimals="-3" id="f-862" unitRef="usd">0</kequ:RevenuesIncludingIntersegmentMarkup>
    <us-gaap:Depreciation contextRef="c-176" decimals="-3" id="f-863" unitRef="usd">2524000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-39" decimals="-3" id="f-864" unitRef="usd">408000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-179" decimals="-3" id="f-865" unitRef="usd">193000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-866" unitRef="usd">3125000</us-gaap:Depreciation>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-176" decimals="-3" id="f-867" unitRef="usd">15048000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-868" unitRef="usd">6295000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-180" decimals="-3" id="f-869" unitRef="usd">-8224000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-870" unitRef="usd">13119000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-176" decimals="-3" id="f-871" unitRef="usd">3240000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-39" decimals="-3" id="f-872" unitRef="usd">2935000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-180" decimals="-3" id="f-873" unitRef="usd">-12113000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-874" unitRef="usd">-5938000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-875" unitRef="usd">304000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-876" unitRef="usd">304000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-176" decimals="-3" id="f-877" unitRef="usd">11808000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-39" decimals="-3" id="f-878" unitRef="usd">3055000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-180" decimals="-3" id="f-879" unitRef="usd">3890000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-880" unitRef="usd">18753000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-181" decimals="-3" id="f-881" unitRef="usd">91656000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-182" decimals="-3" id="f-882" unitRef="usd">43110000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-31" decimals="-3" id="f-883" unitRef="usd">134766000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-176" decimals="-3" id="f-884" unitRef="usd">3759000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-39" decimals="-3" id="f-885" unitRef="usd">614000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-1" decimals="-3" id="f-886" unitRef="usd">4373000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-183" decimals="-3" id="f-887" unitRef="usd">1175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-184" decimals="-3" id="f-888" unitRef="usd">66517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-185" decimals="-3" id="f-889" unitRef="usd">67692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-186" decimals="-3" id="f-890" unitRef="usd">146716000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-40" decimals="-3" id="f-891" unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-3" id="f-892" unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-187" decimals="-3" id="f-893" unitRef="usd">1604000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-188" decimals="-3" id="f-894" unitRef="usd">9822000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-189" decimals="-3" id="f-895" unitRef="usd">-11426000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup contextRef="c-4" decimals="-3" id="f-896" unitRef="usd">0</kequ:RevenuesIncludingIntersegmentMarkup>
    <us-gaap:Depreciation contextRef="c-186" decimals="-3" id="f-897" unitRef="usd">2394000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-40" decimals="-3" id="f-898" unitRef="usd">282000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-189" decimals="-3" id="f-899" unitRef="usd">191000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-4" decimals="-3" id="f-900" unitRef="usd">2867000</us-gaap:Depreciation>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-186" decimals="-3" id="f-901" unitRef="usd">3408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-902" unitRef="usd">7382000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-190" decimals="-3" id="f-903" unitRef="usd">-6292000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-904" unitRef="usd">4498000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-186" decimals="-3" id="f-905" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-40" decimals="-3" id="f-906" unitRef="usd">2250000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-190" decimals="-3" id="f-907" unitRef="usd">889000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-4" decimals="-3" id="f-908" unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-909" unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-910" unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-186" decimals="-3" id="f-911" unitRef="usd">3408000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-40" decimals="-3" id="f-912" unitRef="usd">4511000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-190" decimals="-3" id="f-913" unitRef="usd">-7181000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-3" id="f-914" unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-191" decimals="-3" id="f-915" unitRef="usd">80000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-192" decimals="-3" id="f-916" unitRef="usd">38898000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-20" decimals="-3" id="f-917" unitRef="usd">118898000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-186" decimals="-3" id="f-918" unitRef="usd">2856000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-40" decimals="-3" id="f-919" unitRef="usd">1292000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-4" decimals="-3" id="f-920" unitRef="usd">4148000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-193" decimals="-3" id="f-921" unitRef="usd">2559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-194" decimals="-3" id="f-922" unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-195" decimals="-3" id="f-923" unitRef="usd">75337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-924">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-139" id="f-925">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-139" id="f-926">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-139" id="f-927">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-139" id="f-928">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
